assays_cell_id,assays_doc_id,assays_assay_organism,assays_src_id,assays_assay_cell_type,assays_relationship_type,assays_tid,assays_src_assay_id,assays_description,assays_assay_category,assays_assay_strain,assays_bao_format,assays_variant_id,assays_assay_id,assays_assay_tissue,assays_confidence_score,assays_assay_tax_id,assays_chembl_id,assays_assay_test_type,assays_tissue_id,assays_curated_by,assays_assay_type,assays_assay_subcellular_fraction
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,,BAO_0000218,,7524,Kidney,1,10116.0,CHEMBL618647,In vivo,2113.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,,,BAO_0000218,,7525,Kidney,1,10116.0,CHEMBL618648,In vivo,2113.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,,,BAO_0000218,,7526,Kidney,1,10116.0,CHEMBL618649,In vivo,2113.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,,BAO_0000218,,7527,Liver,1,10116.0,CHEMBL618650,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,,,BAO_0000218,,7528,Liver,1,10116.0,CHEMBL618651,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,,,BAO_0000218,,7529,Liver,1,10116.0,CHEMBL876497,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,,BAO_0000218,,7530,Lung,1,10116.0,CHEMBL618652,In vivo,2048.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,,,BAO_0000218,,7531,Lung,1,10116.0,CHEMBL618653,In vivo,2048.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,,,BAO_0000218,,7532,Lung,1,10116.0,CHEMBL618654,In vivo,2048.0,Intermediate,A,
,6351,Rattus norvegicus,1,,N,50597,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,,,BAO_0000218,,7533,,1,10116.0,CHEMBL618655,,,Intermediate,A,
,1465,Rattus norvegicus,1,,N,50597,,Compound was tested for solubility in water,,,BAO_0000218,,7534,,1,10116.0,CHEMBL618656,,,Intermediate,A,
,5182,,1,,U,22229,,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),,,BAO_0000100,,7535,,0,,CHEMBL618657,,,Intermediate,P,
,17847,Rattus norvegicus,1,,N,50597,,Solubility was determined,,,BAO_0000218,,7536,,1,10116.0,CHEMBL618658,,,Intermediate,A,
,15339,Rattus norvegicus,1,,N,50597,,solubility in water (ug/mL) at 37 degree C.,,,BAO_0000218,,7537,,1,10116.0,CHEMBL618659,,,Intermediate,A,
,5202,Rattus norvegicus,1,,N,50597,,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,,,BAO_0000218,,7538,,1,10116.0,CHEMBL618660,,,Intermediate,A,
,1088,Rattus norvegicus,1,,N,50597,,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,,,BAO_0000218,,7539,,1,10116.0,CHEMBL618661,,,Intermediate,A,
,3169,Rattus norvegicus,1,,N,50597,,Half life in rats,,,BAO_0000218,,7540,,1,10116.0,CHEMBL873807,,,Intermediate,A,
,5353,Rattus norvegicus,1,,N,50597,,Half life in Dawley rat,,,BAO_0000218,,7541,,1,10116.0,CHEMBL618662,,,Intermediate,A,
,2864,Rattus norvegicus,1,,N,50597,,Half life period after 3 mg/kg iv administration,,,BAO_0000218,,7542,,1,10116.0,CHEMBL618663,In vivo,,Intermediate,A,
,2864,Rattus norvegicus,1,,N,50597,,Half life period after 3 mg/kg iv administration in rat,,,BAO_0000218,,7543,,1,10116.0,CHEMBL618664,In vivo,,Intermediate,A,
,2864,Rattus norvegicus,1,,N,50597,,Half life period after 3 mg/kg iv administration in the rat,,,BAO_0000218,,7544,,1,10116.0,CHEMBL618665,In vivo,,Intermediate,A,
,6362,Rattus norvegicus,1,,N,50597,,Half life period in female Sprague-Dawley rats,,,BAO_0000218,,7545,,1,10116.0,CHEMBL876498,,,Intermediate,A,
,6249,Rattus norvegicus,1,,N,50597,,Half life period in rat,,,BAO_0000218,,7546,,1,10116.0,CHEMBL618666,,,Intermediate,A,
,3169,Rattus norvegicus,1,,N,50597,,Half-life in rats was determined,,,BAO_0000218,,7547,,1,10116.0,CHEMBL620440,,,Intermediate,A,
,3169,Rattus norvegicus,1,,N,50597,,Half-life in rats with metabolic oxidation,,,BAO_0000218,,7548,,1,10116.0,CHEMBL620441,,,Intermediate,A,
,3169,Rattus norvegicus,1,,N,50597,,Half-life in rats,,,BAO_0000218,,7549,,1,10116.0,CHEMBL620442,,,Intermediate,A,
,17260,Rattus norvegicus,1,,N,50597,,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,,BAO_0000218,,7550,,1,10116.0,CHEMBL620443,In vivo,,Intermediate,A,
,17260,Rattus norvegicus,1,,N,50597,,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,,BAO_0000218,,7551,,1,10116.0,CHEMBL620444,In vivo,,Intermediate,A,
,17260,Rattus norvegicus,1,,N,50597,,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,,BAO_0000218,,7552,,1,10116.0,CHEMBL620445,In vivo,,Intermediate,A,
,17260,Rattus norvegicus,1,,N,50597,,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,,BAO_0000218,,7553,,1,10116.0,CHEMBL620446,In vivo,,Intermediate,A,
,2879,Rattus norvegicus,1,,N,50597,,Biological half-life measured in plasma of rat,,,BAO_0000218,,7554,Plasma,1,10116.0,CHEMBL620447,,1969.0,Intermediate,A,
,2879,Rattus norvegicus,1,,N,50597,,Biological half-life measured in plasma of rat; 22-25,,,BAO_0000218,,7555,Plasma,1,10116.0,CHEMBL621129,,1969.0,Intermediate,A,
,2879,Rattus norvegicus,1,,N,50597,,Biological half-life measured in plasma of rat; 9-16,,,BAO_0000218,,7556,Plasma,1,10116.0,CHEMBL621130,,1969.0,Intermediate,A,
,3184,Rattus norvegicus,1,,N,50597,,Compound was evaluated for its half life when administered intravenously in rat,,,BAO_0000218,,7557,,1,10116.0,CHEMBL873808,In vivo,,Intermediate,A,
,4891,Rattus norvegicus,1,,N,50597,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,,,BAO_0000218,,7558,,1,10116.0,CHEMBL876598,In vivo,,Intermediate,A,
,429,Rattus norvegicus,1,,N,50597,,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,,,BAO_0000218,,7559,,1,10116.0,CHEMBL621131,In vivo,,Intermediate,A,
,5656,Rattus norvegicus,1,,N,50597,,Half life (T1/2) after oral administration in rat,,,BAO_0000218,,7560,,1,10116.0,CHEMBL621132,In vivo,,Intermediate,A,
,4413,Rattus norvegicus,1,,N,50597,,Half life of compound after iv administration of 20 mg/kg dose in rat,,,BAO_0000218,,7561,,1,10116.0,CHEMBL621133,In vivo,,Intermediate,A,
,3598,Rattus norvegicus,1,,N,50597,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,,BAO_0000218,,7562,,1,10116.0,CHEMBL621312,In vivo,,Expert,A,
,17267,Rattus norvegicus,1,,N,50597,,Half life of compound was determined in rat,,,BAO_0000218,,7563,,1,10116.0,CHEMBL621313,,,Intermediate,A,
,4727,Rattus norvegicus,1,,N,50597,,Half life of compound was determined in rat blood,,,BAO_0000218,,7564,Blood,1,10116.0,CHEMBL621314,,178.0,Intermediate,A,
,17651,Rattus norvegicus,1,,N,50597,,Half life at 1 mg/kg was determined in rat,,,BAO_0000218,,7565,,1,10116.0,CHEMBL621315,In vivo,,Intermediate,A,
,17651,Rattus norvegicus,1,,N,50597,,Half life at 10 mg/kg was determined in rat,,,BAO_0000218,,7566,,1,10116.0,CHEMBL621316,In vivo,,Intermediate,A,
,401,Rattus norvegicus,1,,N,50597,,Half life in rats,,,BAO_0000218,,7567,,1,10116.0,CHEMBL621317,,,Intermediate,A,
,4942,Rattus norvegicus,1,,N,50597,,Half life in rats in hours,,,BAO_0000218,,7568,,1,10116.0,CHEMBL621318,,,Intermediate,A,
,17735,Rattus norvegicus,1,,N,50597,,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,,BAO_0000218,,7569,,1,10116.0,CHEMBL621319,In vivo,,Intermediate,A,
,6056,Rattus norvegicus,1,,N,50597,,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,,,BAO_0000218,,7570,,1,10116.0,CHEMBL621377,In vivo,,Intermediate,A,
,5213,Rattus norvegicus,1,,N,50597,,Half life was determined,,,BAO_0000218,,7571,,1,10116.0,CHEMBL621378,,,Intermediate,A,
,6616,Rattus norvegicus,1,,N,50597,,Half life after i.v. administration,,,BAO_0000218,,7572,,1,10116.0,CHEMBL876599,In vivo,,Intermediate,A,
,5937,Rattus norvegicus,1,,N,50597,,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,,,BAO_0000218,,7573,,1,10116.0,CHEMBL621379,In vivo,,Intermediate,A,
,5819,Rattus norvegicus,1,,N,50597,,Half life in rat plasma,,,BAO_0000218,,7574,Plasma,1,10116.0,CHEMBL621380,,1969.0,Intermediate,A,
,5819,Rattus norvegicus,1,,N,50597,,Half life in rat plasma; Not detected,,,BAO_0000218,,7575,Plasma,1,10116.0,CHEMBL621381,,1969.0,Intermediate,A,
,6803,Rattus norvegicus,1,,N,50597,,Half life in rats,,,BAO_0000218,,7576,,1,10116.0,CHEMBL618515,,,Intermediate,A,
,17804,Rattus norvegicus,1,,N,50597,,Half life period of compound was determined after peroral administration,,,BAO_0000218,,7577,,1,10116.0,CHEMBL618516,In vivo,,Intermediate,A,
,17804,Rattus norvegicus,1,,N,50597,,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,,,BAO_0000218,,7578,,1,10116.0,CHEMBL618517,In vivo,,Intermediate,A,
,5948,Rattus norvegicus,1,,N,50597,,Half life period in rat,,,BAO_0000218,,7579,,1,10116.0,CHEMBL618518,,,Intermediate,A,
,1916,Rattus norvegicus,1,,N,50597,,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,,BAO_0000218,,7580,,1,10116.0,CHEMBL618519,In vivo,,Intermediate,A,
,1916,Rattus norvegicus,1,,N,50597,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,,BAO_0000218,,7581,,1,10116.0,CHEMBL618698,In vivo,,Intermediate,A,
,1916,Rattus norvegicus,1,,N,50597,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,,,BAO_0000218,,7582,,1,10116.0,CHEMBL618862,In vivo,,Intermediate,A,
,4890,Rattus norvegicus,1,,N,50597,,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,,BAO_0000218,,7583,,1,10116.0,CHEMBL618863,In vivo,,Intermediate,A,
,17764,Rattus norvegicus,1,,N,50597,,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,,,BAO_0000218,,7584,,1,10116.0,CHEMBL618864,In vivo,,Intermediate,A,
,4727,Rattus norvegicus,1,,N,50597,,Half life time in rat the dose of 2 mg/kg,,,BAO_0000218,,7585,,1,10116.0,CHEMBL618865,In vivo,,Intermediate,A,
,17509,Rattus norvegicus,1,,N,50597,,Half-life 24 hr after 10 mg/kg iv administration in rats,,,BAO_0000218,,7586,,1,10116.0,CHEMBL618866,In vivo,,Intermediate,A,
,17509,Rattus norvegicus,1,,N,50597,,Half-life 24 hr after 2 mg/kg iv administration in rats,,,BAO_0000218,,7587,,1,10116.0,CHEMBL618867,In vivo,,Intermediate,A,
,6597,Rattus norvegicus,1,,N,50597,,Half-life consistent with the observed metabolic steady state in rats,,,BAO_0000218,,7588,,1,10116.0,CHEMBL875828,,,Intermediate,A,
,17735,Rattus norvegicus,1,,N,50597,,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,,BAO_0000218,,7589,,1,10116.0,CHEMBL618868,In vivo,,Intermediate,A,
,6597,Rattus norvegicus,1,,N,50597,,Half-life for oxidative metabolic stability was determined using male human,,,BAO_0000218,,7590,,1,10116.0,CHEMBL618869,,,Intermediate,A,
,17670,Rattus norvegicus,1,,N,50597,,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",,,BAO_0000218,,7591,,1,10116.0,CHEMBL618870,In vivo,,Intermediate,A,
,1696,Rattus norvegicus,1,,N,50597,,Half-life in rat plasma,,,BAO_0000218,,7592,Plasma,1,10116.0,CHEMBL618871,,1969.0,Intermediate,A,
,1742,Rattus norvegicus,1,,N,50597,,Half-life in rat plasma was determined,,,BAO_0000218,,7593,Plasma,1,10116.0,CHEMBL618872,,1969.0,Intermediate,A,
,17800,Rattus norvegicus,1,,N,50597,,Half-life in rats was determined,,,BAO_0000218,,7594,,1,10116.0,CHEMBL873816,,,Intermediate,A,
,12923,,1,,U,22224,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,,,BAO_0000218,,7595,,0,,CHEMBL618873,,,Autocuration,A,
,11954,,1,,U,22224,,Area under curve after oral dose of 0.1 mg//kg,,,BAO_0000019,,7596,,0,,CHEMBL621602,,,Autocuration,A,
,11954,,1,,U,22224,,Area under curve after oral dose of 0.3 mg/kg,,,BAO_0000218,,7597,,0,,CHEMBL621603,,,Autocuration,A,
,11954,,1,,U,22224,,Area under curve after oral dose of 1 mg/kg,,,BAO_0000218,,7598,,0,,CHEMBL621604,,,Autocuration,A,
,11954,,1,,U,22224,,Area under curve after oral dose of 10 mg/kg,,,BAO_0000218,,7599,,0,,CHEMBL621605,,,Autocuration,A,
,11954,,1,,U,22224,,Area under curve after oral dose of 23.4 mg/kg,,,BAO_0000218,,7600,,0,,CHEMBL621606,,,Autocuration,A,
,11954,,1,,U,22224,,Area under curve after oral dose of 3 mg/kg,,,BAO_0000218,,7601,,0,,CHEMBL621607,,,Autocuration,A,
,11954,,1,,U,22224,,Area under curve after oral dose of 3.87 mg/kg,,,BAO_0000218,,7602,,0,,CHEMBL621608,,,Autocuration,A,
,5237,,1,,U,22224,,Area under curve was determined,,,BAO_0000019,,7603,,0,,CHEMBL621609,,,Autocuration,A,
,4026,,1,,U,22224,,Area under curve at a dose of 10 mg/kg,,,BAO_0000218,,7604,,0,,CHEMBL621610,,,Autocuration,A,
,5237,Rattus norvegicus,1,,N,50597,,Area under curve was determined; ND=No data,,,BAO_0000218,,7605,,1,10116.0,CHEMBL621611,,,Intermediate,A,
,14793,Rattus norvegicus,1,,N,50597,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,,BAO_0000218,,7606,,1,10116.0,CHEMBL621612,,,Intermediate,A,
,14793,Rattus norvegicus,1,,N,50597,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,,BAO_0000218,,7607,,1,10116.0,CHEMBL622308,,,Intermediate,A,
,14793,Rattus norvegicus,1,,N,50597,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,,BAO_0000218,,7608,,1,10116.0,CHEMBL622309,,,Intermediate,A,
,14793,Rattus norvegicus,1,,N,50597,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,,,BAO_0000218,,7609,,1,10116.0,CHEMBL622310,,,Intermediate,A,
,14793,Rattus norvegicus,1,,N,50597,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,,BAO_0000218,,7610,,1,10116.0,CHEMBL622311,,,Intermediate,A,
,14793,Rattus norvegicus,1,,N,50597,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,,,BAO_0000218,,7611,,1,10116.0,CHEMBL622312,,,Intermediate,A,
,14793,Rattus norvegicus,1,,N,50597,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,,BAO_0000218,,7612,,1,10116.0,CHEMBL622931,,,Intermediate,A,
,14793,Rattus norvegicus,1,,N,50597,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,,,BAO_0000218,,7613,,1,10116.0,CHEMBL622932,,,Intermediate,A,
,14793,Rattus norvegicus,1,,N,50597,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,,BAO_0000218,,7614,Plasma,1,10116.0,CHEMBL622736,,1969.0,Intermediate,A,
,14793,Rattus norvegicus,1,,N,50597,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,,BAO_0000218,,7615,Plasma,1,10116.0,CHEMBL622737,,1969.0,Intermediate,A,
,14793,Rattus norvegicus,1,,N,50597,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,,BAO_0000218,,7616,Plasma,1,10116.0,CHEMBL622738,,1969.0,Intermediate,A,
,14793,Rattus norvegicus,1,,N,50597,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,,,BAO_0000218,,7617,Plasma,1,10116.0,CHEMBL622739,,1969.0,Intermediate,A,
,14793,Rattus norvegicus,1,,N,50597,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,,BAO_0000218,,7618,Plasma,1,10116.0,CHEMBL622740,,1969.0,Intermediate,A,
,14793,Rattus norvegicus,1,,N,50597,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,,,BAO_0000218,,7619,Plasma,1,10116.0,CHEMBL622741,,1969.0,Intermediate,A,
,14793,Rattus norvegicus,1,,N,50597,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,,BAO_0000218,,7620,Plasma,1,10116.0,CHEMBL622742,,1969.0,Intermediate,A,
,14793,Rattus norvegicus,1,,N,50597,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,,,BAO_0000218,,7621,Plasma,1,10116.0,CHEMBL622743,,1969.0,Intermediate,A,
,11637,Mus musculus,1,,N,50594,,AUC in mice,,,BAO_0000218,,7622,Plasma,1,10090.0,CHEMBL622744,,1969.0,Intermediate,A,
,11149,,1,,U,22224,,Area under curve was measured from the graph obtained from concentration Vs time,,,BAO_0000019,,7623,,0,,CHEMBL624134,,,Autocuration,A,
,10016,,1,,U,22224,,Area under curve value of compound per hour after oral administration,,,BAO_0000019,,7624,,0,,CHEMBL624135,,,Autocuration,A,
,17796,Rattus norvegicus,1,,N,50597,,Area under curve was determined after oral administration in rats,,,BAO_0000218,,7625,,1,10116.0,CHEMBL624136,,,Intermediate,A,
,17796,Rattus norvegicus,1,,N,50597,,Area under curve was determined after oral administration in rats; No data,,,BAO_0000218,,7626,,1,10116.0,CHEMBL624137,,,Intermediate,A,
,17796,Rattus norvegicus,1,,N,50597,,Area under curve was determined after oral administration in rats;No data,,,BAO_0000218,,7627,,1,10116.0,CHEMBL624320,,,Intermediate,A,
,12923,Canis lupus familiaris,1,,N,50588,,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,,BAO_0000218,,7628,,1,9615.0,CHEMBL624321,,,Intermediate,A,
,15372,Rattus norvegicus,1,,N,50597,,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,,,BAO_0000218,,7629,,1,10116.0,CHEMBL624322,,,Intermediate,A,
,15372,Rattus norvegicus,1,,N,50597,,Area under curve was determined for the compound after iv dose of 5.06 in rats,,,BAO_0000218,,7630,,1,10116.0,CHEMBL624323,,,Intermediate,A,
,15372,Rattus norvegicus,1,,N,50597,,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,,,BAO_0000218,,7631,,1,10116.0,CHEMBL624324,,,Intermediate,A,
,15372,Rattus norvegicus,1,,N,50597,,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,,,BAO_0000218,,7632,,1,10116.0,CHEMBL624325,,,Intermediate,A,
,15372,Rattus norvegicus,1,,N,50597,,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,,,BAO_0000218,,7633,,1,10116.0,CHEMBL624326,,,Intermediate,A,
,15372,Rattus norvegicus,1,,N,50597,,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,,,BAO_0000218,,7634,,1,10116.0,CHEMBL624327,,,Intermediate,A,
,15372,Rattus norvegicus,1,,N,50597,,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,,,BAO_0000218,,7635,,1,10116.0,CHEMBL624328,,,Intermediate,A,
,14169,Canis lupus familiaris,1,,N,50588,,Area under curve was determined in Dogs after peroral administration,,,BAO_0000218,,7636,,1,9615.0,CHEMBL627848,,,Intermediate,A,
,14169,Rattus norvegicus,1,,N,50597,,Area under curve was determined in Rats after peroral administration,,,BAO_0000218,,7637,,1,10116.0,CHEMBL627849,,,Intermediate,A,
,14258,Rattus norvegicus,1,,N,50597,,Area under curve was determined in carotid blood of rat when administered intradermally,,,BAO_0000218,,7638,,1,10116.0,CHEMBL627850,,,Intermediate,A,
,14258,Rattus norvegicus,1,,N,50597,,Area under curve was determined in portal blood of rat when administered intradermally,,,BAO_0000218,,7639,,1,10116.0,CHEMBL627851,,,Intermediate,A,
,15011,Mus musculus,1,,N,50594,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,,BAO_0000218,,7640,,1,10090.0,CHEMBL627852,,,Intermediate,A,
,15011,Mus musculus,1,,N,50594,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,,BAO_0000218,,7641,,1,10090.0,CHEMBL627853,,,Intermediate,A,
,15011,Mus musculus,1,,N,50594,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,,BAO_0000218,,7642,,1,10090.0,CHEMBL627854,,,Intermediate,A,
,15011,Mus musculus,1,,N,50594,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,,BAO_0000218,,7643,,1,10090.0,CHEMBL627855,,,Intermediate,A,
,15011,Mus musculus,1,,N,50594,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),,,BAO_0000218,,7644,,1,10090.0,CHEMBL627856,,,Intermediate,A,
,15011,Mus musculus,1,,N,50594,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,,BAO_0000218,,7645,,1,10090.0,CHEMBL875339,,,Intermediate,A,
,15011,Mus musculus,1,,N,50594,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),,,BAO_0000218,,7646,,1,10090.0,CHEMBL627857,,,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,,,BAO_0000218,,7647,Spleen,1,10116.0,CHEMBL627858,In vivo,2106.0,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,,,BAO_0000218,,7648,Blood,1,10116.0,CHEMBL627859,,178.0,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,,,BAO_0000218,,7649,Brain,1,10116.0,CHEMBL627860,,955.0,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,,,BAO_0000218,,7650,Heart,1,10116.0,CHEMBL627019,,948.0,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,,,BAO_0000218,,7651,Liver,1,10116.0,CHEMBL627020,,2107.0,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,,,BAO_0000218,,7652,Lung,1,10116.0,CHEMBL627021,,2048.0,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,,,BAO_0000218,,7653,Muscle tissue,1,10116.0,CHEMBL627022,,2385.0,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,,,BAO_0000218,,7654,,1,10116.0,CHEMBL627023,,,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,,,BAO_0000218,,7655,Spleen,1,10116.0,CHEMBL627024,,2106.0,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,,,BAO_0000218,,7656,Thyroid gland,1,10116.0,CHEMBL627025,,2046.0,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,,,BAO_0000218,,7657,Kidney,1,10116.0,CHEMBL627026,,2113.0,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,,,BAO_0000218,,7658,Blood,1,10116.0,CHEMBL627027,,178.0,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,,,BAO_0000218,,7659,Brain,1,10116.0,CHEMBL627028,,955.0,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,,,BAO_0000218,,7660,Heart,1,10116.0,CHEMBL627029,,948.0,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,,,BAO_0000218,,7661,Kidney,1,10116.0,CHEMBL627030,,2113.0,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,,,BAO_0000218,,7662,Liver,1,10116.0,CHEMBL627031,,2107.0,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,,,BAO_0000218,,7663,Lung,1,10116.0,CHEMBL627032,,2048.0,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,,,BAO_0000218,,7664,Muscle tissue,1,10116.0,CHEMBL627033,,2385.0,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,,,BAO_0000218,,7665,,1,10116.0,CHEMBL627034,,,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,,,BAO_0000218,,7666,Spleen,1,10116.0,CHEMBL627035,,2106.0,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,,,BAO_0000218,,7667,Thyroid gland,1,10116.0,CHEMBL627036,,2046.0,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,,,BAO_0000218,,7668,Blood,1,10116.0,CHEMBL875340,,178.0,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,,,BAO_0000218,,7669,Heart,1,10116.0,CHEMBL627037,,948.0,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,,,BAO_0000218,,7670,Kidney,1,10116.0,CHEMBL627038,,2113.0,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,,,BAO_0000218,,7671,Liver,1,10116.0,CHEMBL627039,,2107.0,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,,,BAO_0000218,,7672,Muscle tissue,1,10116.0,CHEMBL627040,,2385.0,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,,,BAO_0000218,,7673,Spleen,1,10116.0,CHEMBL624663,,2106.0,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,,,BAO_0000218,,7674,Thyroid gland,1,10116.0,CHEMBL625963,,2046.0,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,,,BAO_0000218,,7675,Brain,1,10116.0,CHEMBL876799,,955.0,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,,,BAO_0000218,,7676,Lung,1,10116.0,CHEMBL626133,,2048.0,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,,,BAO_0000218,,7677,,1,10116.0,CHEMBL626134,,,Intermediate,A,
,6295,Rattus norvegicus,1,,N,50597,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,,BAO_0000218,,7678,,1,10116.0,CHEMBL626135,,,Intermediate,A,
,6296,Rattus norvegicus,1,,N,50597,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,,BAO_0000218,,7679,,1,10116.0,CHEMBL626136,,,Intermediate,A,
,6296,Rattus norvegicus,1,,N,50597,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,,,BAO_0000218,,7680,,1,10116.0,CHEMBL626137,,,Intermediate,A,
,6295,Rattus norvegicus,1,,N,50597,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,,BAO_0000218,,7681,,1,10116.0,CHEMBL626138,,,Intermediate,A,
,6296,Rattus norvegicus,1,,N,50597,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,,BAO_0000218,,7682,,1,10116.0,CHEMBL626139,,,Intermediate,A,
,17260,Rattus norvegicus,1,,N,50597,,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,,BAO_0000218,,7683,,1,10116.0,CHEMBL626140,In vivo,,Intermediate,A,
,17260,Rattus norvegicus,1,,N,50597,,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,,BAO_0000218,,7684,,1,10116.0,CHEMBL626141,In vivo,,Intermediate,A,
,17686,Rattus norvegicus,1,,N,50597,,C24h in rat p.o. at 20 mg/kg concentration,,,BAO_0000218,,7685,,1,10116.0,CHEMBL626142,,,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,,BAO_0000218,,7686,Muscle tissue,1,10116.0,CHEMBL627930,In vivo,2385.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,,,BAO_0000218,,7687,Muscle tissue,1,10116.0,CHEMBL627931,In vivo,2385.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,,,BAO_0000218,,7688,Muscle tissue,1,10116.0,CHEMBL627932,In vivo,2385.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,,BAO_0000218,,7689,Spleen,1,10116.0,CHEMBL627933,In vivo,2106.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,,,BAO_0000218,,7690,Spleen,1,10116.0,CHEMBL627934,In vivo,2106.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,,,BAO_0000218,,7691,Spleen,1,10116.0,CHEMBL627935,In vivo,2106.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,,,BAO_0000218,,7692,Blood,1,10116.0,CHEMBL627936,In vivo,178.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,,,BAO_0000218,,7693,Blood,1,10116.0,CHEMBL627937,In vivo,178.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,,,BAO_0000218,,7694,Blood,1,10116.0,CHEMBL627938,In vivo,178.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,,,BAO_0000218,,7695,Blood,1,10116.0,CHEMBL627939,In vivo,178.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,,,BAO_0000218,,7696,Blood,1,10116.0,CHEMBL627940,In vivo,178.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,,,BAO_0000218,,7697,Blood,1,10116.0,CHEMBL627941,In vivo,178.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,,BAO_0000218,,7698,Blood,1,10116.0,CHEMBL876800,In vivo,178.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,,,BAO_0000218,,7699,Blood,1,10116.0,CHEMBL627942,In vivo,178.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,,,BAO_0000218,,7700,Blood,1,10116.0,CHEMBL627943,In vivo,178.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,,,BAO_0000218,,7701,Blood,1,10116.0,CHEMBL627944,In vivo,178.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,,,BAO_0000218,,7702,Blood,1,10116.0,CHEMBL627945,In vivo,178.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,,,BAO_0000218,,7703,Blood,1,10116.0,CHEMBL628584,In vivo,178.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood in the presence of GdDTPA at 15 min,,,BAO_0000218,,7704,Blood,1,10116.0,CHEMBL628585,In vivo,178.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,,,BAO_0000218,,7705,Blood,1,10116.0,CHEMBL628586,In vivo,178.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood in the presence of GdDTPA at 30 min,,,BAO_0000218,,7706,Blood,1,10116.0,CHEMBL628587,In vivo,178.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,,,BAO_0000218,,7707,Blood,1,10116.0,CHEMBL628588,In vivo,178.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,,,BAO_0000218,,7708,Blood,1,10116.0,CHEMBL628589,In vivo,178.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,,,BAO_0000218,,7709,Blood,1,10116.0,CHEMBL625304,In vivo,178.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,,,BAO_0000218,,7710,Blood,1,10116.0,CHEMBL625305,In vivo,178.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,,,BAO_0000218,,7711,Blood,1,10116.0,CHEMBL625306,In vivo,178.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,,,BAO_0000218,,7712,Blood,1,10116.0,CHEMBL625307,In vivo,178.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,,,BAO_0000218,,7713,Blood,1,10116.0,CHEMBL625308,In vivo,178.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,,,BAO_0000218,,7714,Blood,1,10116.0,CHEMBL627740,In vivo,178.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,,,BAO_0000218,,7715,Blood,1,10116.0,CHEMBL627741,In vivo,178.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,,BAO_0000218,,7716,Blood,1,10116.0,CHEMBL627742,In vivo,178.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,,,BAO_0000218,,7717,Blood,1,10116.0,CHEMBL627743,In vivo,178.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,,,BAO_0000218,,7718,Blood,1,10116.0,CHEMBL627744,In vivo,178.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,,,BAO_0000218,,7719,Bone,1,10116.0,CHEMBL627745,In vivo,10000001.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,,,BAO_0000218,,7720,Bone,1,10116.0,CHEMBL627746,In vivo,10000001.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,,,BAO_0000218,,7721,Bone,1,10116.0,CHEMBL627747,In vivo,10000001.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,,,BAO_0000218,,7722,Bone,1,10116.0,CHEMBL876810,In vivo,10000001.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,,,BAO_0000218,,7723,Bone,1,10116.0,CHEMBL627748,In vivo,10000001.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,,,BAO_0000218,,7724,Bone,1,10116.0,CHEMBL627749,In vivo,10000001.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,,BAO_0000218,,7725,Bone,1,10116.0,CHEMBL627750,In vivo,10000001.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,,,BAO_0000218,,7726,Bone,1,10116.0,CHEMBL618728,In vivo,10000001.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,,,BAO_0000218,,7727,Bone,1,10116.0,CHEMBL618729,In vivo,10000001.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat bone in the presence of GdDTPA at 15 min,,,BAO_0000218,,7728,Bone,1,10116.0,CHEMBL618730,In vivo,10000001.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,,,BAO_0000218,,7729,Bone,1,10116.0,CHEMBL618731,In vivo,10000001.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat bone in the presence of GdDTPA at 30 min,,,BAO_0000218,,7730,Bone,1,10116.0,CHEMBL618732,In vivo,10000001.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,,,BAO_0000218,,7731,Bone,1,10116.0,CHEMBL618733,In vivo,10000001.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,,,BAO_0000218,,7732,Bone,1,10116.0,CHEMBL618734,In vivo,10000001.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,,,BAO_0000218,,7733,Bone,1,10116.0,CHEMBL618735,In vivo,10000001.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,,,BAO_0000218,,7734,Bone,1,10116.0,CHEMBL876602,In vivo,10000001.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,,,BAO_0000218,,7735,Bone,1,10116.0,CHEMBL618736,In vivo,10000001.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,,,BAO_0000218,,7736,Bone,1,10116.0,CHEMBL618737,In vivo,10000001.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,,,BAO_0000218,,7737,Bone,1,10116.0,CHEMBL618738,In vivo,10000001.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,,,BAO_0000218,,7738,Bone,1,10116.0,CHEMBL618739,In vivo,10000001.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,,,BAO_0000218,,7739,Bone,1,10116.0,CHEMBL618740,In vivo,10000001.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,,BAO_0000218,,7740,Bone,1,10116.0,CHEMBL618741,In vivo,10000001.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,,,BAO_0000218,,7741,Bone,1,10116.0,CHEMBL618742,In vivo,10000001.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,,,BAO_0000218,,7742,Bone,1,10116.0,CHEMBL618743,In vivo,10000001.0,Intermediate,A,
,17752,Rattus norvegicus,1,,N,50597,,Half-life from rat plasma at a single oral dose of 25 mg/kg,,,BAO_0000218,,7743,Plasma,1,10116.0,CHEMBL618744,In vivo,1969.0,Intermediate,A,
,5610,Rattus norvegicus,1,,N,50597,,Half-life in male rat,,,BAO_0000218,,7744,,1,10116.0,CHEMBL618745,,,Intermediate,A,
,5939,Rattus norvegicus,1,,N,50597,,Half-life in rat after peroral administration at 10 mg/kg concentration,,,BAO_0000218,,7745,,1,10116.0,CHEMBL620479,In vivo,,Intermediate,A,
,5939,Rattus norvegicus,1,,N,50597,,Half-life in rat after peroral administration at 5 mg/kg concentration,,,BAO_0000218,,7746,,1,10116.0,CHEMBL620480,In vivo,,Intermediate,A,
,17771,Rattus norvegicus,1,,N,50597,,Half-life in rat at a dose of 3 mg/kg,,,BAO_0000218,,7747,,1,10116.0,CHEMBL620481,In vivo,,Intermediate,A,
,1974,Rattus norvegicus,1,,N,50597,,Half-life was evaluated in rats,,,BAO_0000218,,7748,,1,10116.0,CHEMBL620482,,,Intermediate,A,
,4239,Rattus norvegicus,1,,N,50597,,Half-life was measured in rat,,,BAO_0000218,,7749,,1,10116.0,CHEMBL876603,,,Intermediate,A,
,6681,Rattus norvegicus,1,,N,50597,,Half-life period for the compound was determined in rats at 50 mg/kg dose,,,BAO_0000218,,7750,,1,10116.0,CHEMBL620483,In vivo,,Intermediate,A,
,17752,Rattus norvegicus,1,,N,50597,,Half-life period in rats after intravenous administration at 5 mg/kg,,,BAO_0000218,,7751,,1,10116.0,CHEMBL620484,In vivo,,Intermediate,A,
,6046,Rattus norvegicus,1,,N,50597,,Half-life period in rat at 10 mg/kg,,,BAO_0000218,,7752,,1,10116.0,CHEMBL620485,In vivo,,Intermediate,A,
,6685,Rattus norvegicus,1,,N,50597,,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",,,BAO_0000218,,7753,,1,10116.0,CHEMBL620486,In vivo,,Intermediate,A,
,6685,Rattus norvegicus,1,,N,50597,,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",,,BAO_0000218,,7754,,1,10116.0,CHEMBL620487,In vivo,,Intermediate,A,
,6685,Rattus norvegicus,1,,N,50597,,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",,,BAO_0000218,,7755,,1,10116.0,CHEMBL620488,In vivo,,Intermediate,A,
,4727,Rattus norvegicus,1,,N,50597,,Half-life time in rat the dose of 2 mg/kg,,,BAO_0000218,,7756,,1,10116.0,CHEMBL620489,In vivo,,Intermediate,A,
,1088,Rattus norvegicus,1,,N,50597,,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,,,BAO_0000218,,7757,,1,10116.0,CHEMBL620490,In vivo,,Intermediate,A,
,5610,Rattus norvegicus,1,,N,50597,,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,,,BAO_0000218,,7758,,1,10116.0,CHEMBL620491,In vivo,,Intermediate,A,
,3032,Rattus norvegicus,1,,N,50597,,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,,BAO_0000218,,7759,Plasma,1,10116.0,CHEMBL876604,In vivo,1969.0,Intermediate,A,
,5199,Rattus norvegicus,1,,N,50597,,Oral half life was determined,,,BAO_0000218,,7760,,1,10116.0,CHEMBL620492,In vivo,,Intermediate,A,
,14941,Rattus norvegicus,1,,N,50597,,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",,,BAO_0000218,,7761,,1,10116.0,CHEMBL620493,In vivo,,Intermediate,A,
,4408,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (t1/2) in rat,,,BAO_0000218,,7762,,1,10116.0,CHEMBL620494,In vivo,,Intermediate,A,
,2552,Rattus norvegicus,1,,N,50597,,Plasma elimination half-life was determined,,,BAO_0000218,,7763,Plasma,1,10116.0,CHEMBL620495,,1969.0,Intermediate,A,
,5199,Rattus norvegicus,1,,N,50597,,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,,BAO_0000218,,7764,Plasma,1,10116.0,CHEMBL620496,In vivo,1969.0,Intermediate,A,
,15662,Rattus norvegicus,1,,N,50597,,Plasma half life was observed after intravenous administration in rat,,,BAO_0000218,,7765,Plasma,1,10116.0,CHEMBL620497,In vivo,1969.0,Intermediate,A,
,1465,Rattus norvegicus,1,,N,50597,,Plasma half-life was determined,,,BAO_0000218,,7766,Plasma,1,10116.0,CHEMBL620498,,1969.0,Intermediate,A,
,1446,Rattus norvegicus,1,,N,50597,,Plasma half-life following oral administration in Fisher rats,,,BAO_0000218,,7767,Plasma,1,10116.0,CHEMBL620499,In vivo,1969.0,Intermediate,A,
,6824,Rattus norvegicus,1,,N,50597,,Plasma half-life in rat,,,BAO_0000218,,7768,Plasma,1,10116.0,CHEMBL620500,,1969.0,Intermediate,A,
,17533,Rattus norvegicus,1,,N,50597,,Plasmatic Half-life after intravenous administration to rat,,,BAO_0000218,,7769,Plasma,1,10116.0,CHEMBL873809,In vivo,1969.0,Intermediate,A,
,5979,Rattus norvegicus,1,,N,50597,,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,,BAO_0000218,,7770,,1,10116.0,CHEMBL620501,In vivo,,Intermediate,A,
,4689,Rattus norvegicus,1,,N,50597,,Terminal half life after intravenous administration (1 mg/kg) in rat,,,BAO_0000218,,7771,,1,10116.0,CHEMBL620502,In vivo,,Intermediate,A,
,4689,Rattus norvegicus,1,,N,50597,,Terminal half life in Rat at a oral dose of 5 mg/kg,,,BAO_0000218,,7772,,1,10116.0,CHEMBL620503,In vivo,,Intermediate,A,
,2463,Rattus norvegicus,1,,N,50597,,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,,BAO_0000218,,7773,,1,10116.0,CHEMBL620504,In vivo,,Intermediate,A,
,4883,Rattus norvegicus,1,,N,50597,,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,,,BAO_0000218,,7774,,1,10116.0,CHEMBL876605,In vivo,,Intermediate,A,
,4883,Rattus norvegicus,1,,N,50597,,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,,,BAO_0000218,,7775,,1,10116.0,CHEMBL620505,In vivo,,Intermediate,A,
,15662,Rattus norvegicus,1,,N,50597,,plasma half life was observed after intravenous administration in rat,,,BAO_0000218,,7776,Plasma,1,10116.0,CHEMBL873811,In vivo,1969.0,Intermediate,A,
,3598,Rattus norvegicus,1,,N,50597,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,,BAO_0000218,,7777,,1,10116.0,CHEMBL624016,In vivo,,Expert,A,
,4576,Rattus norvegicus,1,,N,50597,,Half life of compound determined in rat,,,BAO_0000218,,7778,,1,10116.0,CHEMBL624017,,,Intermediate,A,
,4576,Rattus norvegicus,1,,N,50597,,Mean residence time determined in rat,,,BAO_0000218,,7779,,1,10116.0,CHEMBL624018,,,Intermediate,A,
,4576,Rattus norvegicus,1,,N,50597,,Plasma half life determined in rat,,,BAO_0000218,,7780,,1,10116.0,CHEMBL624019,,,Intermediate,A,
,4910,Rattus norvegicus,1,,N,50597,,Compound was evaluated for Tmax in brain after intravenous administration in male rats,,,BAO_0000218,,7781,Brain,1,10116.0,CHEMBL624020,In vivo,955.0,Intermediate,A,
,4891,Rattus norvegicus,1,,N,50597,,Compound was evaluated for pharmacokinetic parameter maximum time period,,,BAO_0000218,,7782,,1,10116.0,CHEMBL624201,In vivo,,Intermediate,A,
,429,Rattus norvegicus,1,,N,50597,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,,BAO_0000218,,7783,,1,10116.0,CHEMBL872528,In vivo,,Intermediate,A,
,5974,Rattus norvegicus,1,,N,50597,,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,,7784,,1,10116.0,CHEMBL624202,In vivo,,Intermediate,A,
,5974,Rattus norvegicus,1,,N,50597,,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,,7785,,1,10116.0,CHEMBL624203,In vivo,,Intermediate,A,
,5974,Rattus norvegicus,1,,N,50597,,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,,7786,,1,10116.0,CHEMBL624350,In vivo,,Intermediate,A,
,5974,Rattus norvegicus,1,,N,50597,,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,,7787,,1,10116.0,CHEMBL621320,In vivo,,Intermediate,A,
,17582,Rattus norvegicus,1,,N,50597,,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,,BAO_0000218,,7788,,1,10116.0,CHEMBL621321,In vivo,,Intermediate,A,
,4026,Rattus norvegicus,1,,N,50597,,Maximum time (Tmax) required to reach Cmax in rats,,,BAO_0000218,,7789,,1,10116.0,CHEMBL621322,,,Intermediate,A,
,4890,Rattus norvegicus,1,,N,50597,,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,,BAO_0000218,,7790,,1,10116.0,CHEMBL621323,In vivo,,Intermediate,A,
,6571,Rattus norvegicus,1,,N,50597,,Maximum time of clearance of compound in rats after peroral administration,,,BAO_0000218,,7791,,1,10116.0,CHEMBL621324,In vivo,,Intermediate,A,
,4727,Rattus norvegicus,1,,N,50597,,Maximum time at the dose of 2 mg/kg in rat,,,BAO_0000218,,7792,,1,10116.0,CHEMBL621325,,,Intermediate,A,
,17651,Rattus norvegicus,1,,N,50597,,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,,,BAO_0000218,,7793,Plasma,1,10116.0,CHEMBL875837,In vivo,1969.0,Intermediate,A,
,17651,Rattus norvegicus,1,,N,50597,,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,,,BAO_0000218,,7794,Plasma,1,10116.0,CHEMBL621326,In vivo,1969.0,Intermediate,A,
,14465,Rattus norvegicus,1,,N,50597,,Tmax in Guinea pig (PO dose),,,BAO_0000218,,7795,,1,10116.0,CHEMBL621327,In vivo,,Intermediate,A,
,14941,Rattus norvegicus,1,,N,50597,,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",,,BAO_0000218,,7796,,1,10116.0,CHEMBL621328,In vivo,,Intermediate,A,
,5960,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter (Tmax) in rat,,,BAO_0000218,,7797,,1,10116.0,CHEMBL621329,In vivo,,Intermediate,A,
,5022,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter (Tmax) was estimated,,,BAO_0000218,,7798,,1,10116.0,CHEMBL621330,In vivo,,Intermediate,A,
,4408,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (Tmax) in rat,,,BAO_0000218,,7799,,1,10116.0,CHEMBL621331,In vivo,,Intermediate,A,
,5983,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,,BAO_0000218,,7800,,1,10116.0,CHEMBL621332,In vivo,,Intermediate,A,
,4689,Rattus norvegicus,1,,N,50597,,T max in Rat at a oral dose of 5 mg/kg,,,BAO_0000218,,7801,,1,10116.0,CHEMBL621333,In vivo,,Intermediate,A,
,2792,Rattus norvegicus,1,,N,50597,,T max was determined at 10 mg/kg po dose in rats,,,BAO_0000218,,7802,,1,10116.0,CHEMBL621334,In vivo,,Intermediate,A,
,15011,Mus musculus,1,,N,50594,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),,,BAO_0000218,,7803,,1,10090.0,CHEMBL621335,,,Intermediate,A,
,14180,Canis lupus familiaris,1,,N,50588,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,,,BAO_0000218,,7804,,1,9615.0,CHEMBL621336,,,Intermediate,A,
,14180,Rattus norvegicus,1,,N,50597,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,,,BAO_0000218,,7805,,1,10116.0,CHEMBL621337,,,Intermediate,A,
,14599,Canis lupus familiaris,1,,N,50588,,Area under curve was measured after i.v. administration into Beagle dog.,,,BAO_0000218,,7806,,1,9615.0,CHEMBL621338,,,Intermediate,A,
,14599,Canis lupus familiaris,1,,N,50588,,Area under curve was measured after iv administration into Beagle dog,,,BAO_0000218,,7807,,1,9615.0,CHEMBL875838,,,Intermediate,A,
,14599,Canis lupus familiaris,1,,N,50588,,Area under curve was measured after po administration into Beagle dog,,,BAO_0000218,,7808,,1,9615.0,CHEMBL621339,,,Intermediate,A,
,14599,Canis lupus familiaris,1,,N,50588,,Area under curve was measured after po administration into Beagle dog.,,,BAO_0000218,,7809,,1,9615.0,CHEMBL621340,,,Intermediate,A,
,15675,,1,,U,22224,,Area under curve was measured at peroral dose of 3 mg/kg,,,BAO_0000218,,7810,,0,,CHEMBL621341,,,Autocuration,A,
,12706,,1,,U,22224,,Area under curve was measured by using concentration Vs time,,,BAO_0000019,,7811,,0,,CHEMBL621342,,,Autocuration,A,
,12706,,1,,U,22224,,Area under curve was measured by using concentration Vs time; not tested,,,BAO_0000019,,7812,,0,,CHEMBL621343,,,Autocuration,A,
,9750,Mus musculus,1,,N,50594,,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),,,BAO_0000218,,7813,,1,10090.0,CHEMBL621344,,,Intermediate,A,
,9750,Mus musculus,1,,N,50594,,Area under curve(AUC) was measured in mice after oral administration.,,,BAO_0000218,,7814,,1,10090.0,CHEMBL621345,,,Intermediate,A,
,14691,,1,,U,22224,,Area under curve(AUC) value of the compound,,,BAO_0000019,,7815,,0,,CHEMBL621346,,,Autocuration,A,
,14691,,1,,U,22224,,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,,,BAO_0000218,,7816,,0,,CHEMBL621347,,,Autocuration,A,
,14691,Canis lupus familiaris,1,,N,50588,,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,,,BAO_0000218,,7817,,1,9615.0,CHEMBL621348,,,Intermediate,A,
,2939,,1,,U,22224,,Area under curve(carotid artery) was determined by the availability in blood,,,BAO_0000019,,7818,Blood,0,,CHEMBL621349,,178.0,Autocuration,A,
,2939,,1,,U,22224,,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,,,BAO_0000019,,7819,Blood,0,,CHEMBL621350,,178.0,Autocuration,A,
,2939,,1,,U,22224,,Area under curve(carotid artery) was determined by the availability in blood; No data,,,BAO_0000019,,7820,Blood,0,,CHEMBL875839,,178.0,Autocuration,A,
,2939,,1,,U,22224,,Area under curve(portal vein) was determined by the availability in blood,,,BAO_0000019,,7821,Blood,0,,CHEMBL620211,,178.0,Autocuration,A,
,2939,,1,,U,22224,,Area under curve(portal vein) was determined by the availability in blood; ND means no data,,,BAO_0000019,,7822,Blood,0,,CHEMBL620212,,178.0,Autocuration,A,
,2939,,1,,U,22224,,Area under curve(portal vein) was determined by the availability in blood; No data,,,BAO_0000019,,7823,Blood,0,,CHEMBL620213,,178.0,Autocuration,A,
,9552,Macaca mulatta,1,,N,50797,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,,BAO_0000218,,7824,Plasma,1,9544.0,CHEMBL620214,,1969.0,Intermediate,A,
,9552,Macaca mulatta,1,,N,50797,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,,BAO_0000218,,7825,Plasma,1,9544.0,CHEMBL620215,,1969.0,Intermediate,A,
,9552,Macaca mulatta,1,,N,50797,,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,,,BAO_0000218,,7826,Plasma,1,9544.0,CHEMBL620216,,1969.0,Intermediate,A,
,9552,Canis lupus familiaris,1,,N,50588,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",,,BAO_0000218,,7827,Plasma,1,9615.0,CHEMBL620888,,1969.0,Intermediate,A,
,9552,Canis lupus familiaris,1,,N,50588,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",,,BAO_0000218,,7828,Plasma,1,9615.0,CHEMBL620889,,1969.0,Intermediate,A,
,9552,,1,,U,22224,,Area under plasma concentration vs time curve observed in rats for 0-3 h,,,BAO_0000019,,7829,Plasma,0,,CHEMBL620890,,1969.0,Autocuration,A,
,11911,Rattus norvegicus,1,,N,50597,,Area under plasma time curve determined in male rat,,,BAO_0000218,,7830,Plasma,1,10116.0,CHEMBL620891,,1969.0,Intermediate,A,
,16618,,1,,U,22224,,Area under the MAP curve measured over 5 min.,,,BAO_0000019,,7831,,0,,CHEMBL620892,,,Autocuration,A,
,14387,Mus musculus,1,,N,50594,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,,,BAO_0000218,,7832,,1,10090.0,CHEMBL621079,,,Intermediate,A,
,14387,Mus musculus,1,,N,50594,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,,,BAO_0000218,,7833,,1,10090.0,CHEMBL621080,,,Intermediate,A,
,12836,Canis lupus familiaris,1,,N,50588,,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,,,BAO_0000218,,7834,,1,9615.0,CHEMBL621081,,,Intermediate,A,
,12836,Cricetinae,1,,N,100712,,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,,,BAO_0000218,,7835,,1,10026.0,CHEMBL621082,,,Intermediate,A,
,12836,Rattus norvegicus,1,,N,50597,,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,,,BAO_0000218,,7836,,1,10116.0,CHEMBL621083,,,Intermediate,A,
,14339,Canis lupus familiaris,1,,N,50588,,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,,,BAO_0000218,,7837,,1,9615.0,CHEMBL621084,,,Intermediate,A,
,14339,Canis lupus familiaris,1,,N,50588,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,,,BAO_0000218,,7838,,1,9615.0,CHEMBL621085,,,Intermediate,A,
,14339,Canis lupus familiaris,1,,N,50588,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,,,BAO_0000218,,7839,,1,9615.0,CHEMBL621086,,,Intermediate,A,
,10524,Canis lupus familiaris,1,,N,50588,,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,,BAO_0000218,,7840,,1,9615.0,CHEMBL621087,,,Intermediate,A,
,9994,Canis lupus familiaris,1,,N,50588,,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),,,BAO_0000218,,7841,,1,9615.0,CHEMBL622607,,,Intermediate,A,
,11325,Canis lupus familiaris,1,,N,50588,,Serum AUC in marmosets (IV dose),,,BAO_0000218,,7842,,1,9615.0,CHEMBL622608,,,Intermediate,A,
,12536,,1,,U,22224,,Area under the curve after intravenous administration at a dose of 10 umol/kg,,,BAO_0000019,,7843,,0,,CHEMBL624481,,,Autocuration,A,
,12536,,1,,U,22224,,Area under the curve after intravenous administration at a dose of 2 umol/kg,,,BAO_0000019,,7844,,0,,CHEMBL624482,,,Autocuration,A,
,12536,,1,,U,22224,,Area under the curve after intravenous administration at a dose of 4 umol/kg,,,BAO_0000019,,7845,,0,,CHEMBL624483,,,Autocuration,A,
,12536,,1,,U,22224,,Area under the curve after intravenous administration at a dose of 40 umol/kg,,,BAO_0000019,,7846,,0,,CHEMBL624484,,,Autocuration,A,
,12536,,1,,U,22224,,Area under the curve after intravenous administration at a dose of 5 umol/kg,,,BAO_0000019,,7847,,0,,CHEMBL624485,,,Autocuration,A,
,15556,Rattus norvegicus,1,,N,50597,,Area under the curve for fumarate salt was evaluated in F344 Rats.,,,BAO_0000218,,7848,,1,10116.0,CHEMBL624486,,,Intermediate,A,
,2809,,1,,U,22224,,Area under the curve for the compound was calculated.,,,BAO_0000019,,7849,,0,,CHEMBL624487,,,Autocuration,A,
,9511,,1,,U,22224,,Area under the curve in concentration/ time,,,BAO_0000019,,7850,,0,,CHEMBL624488,,,Autocuration,A,
,12818,Rattus norvegicus,1,,N,50597,,Area under the curve administered intraintestinal in rats.,,,BAO_0000218,,7851,,1,10116.0,CHEMBL624489,,,Intermediate,A,
,12818,Rattus norvegicus,1,,N,50597,,Area under the curve administered intravenously in rats.,,,BAO_0000218,,7852,,1,10116.0,CHEMBL625184,,,Intermediate,A,
,15118,,1,,U,22224,,Area under the curve during intravenous administration,,,BAO_0000019,,7853,,0,,CHEMBL625185,,,Autocuration,A,
,15118,,1,,U,22224,,Area under the curve during intravenous administration; Not determined,,,BAO_0000019,,7854,,0,,CHEMBL875954,,,Autocuration,A,
,15118,,1,,U,22224,,Area under the curve during systemic administration,,,BAO_0000019,,7855,,0,,CHEMBL625186,,,Autocuration,A,
,15118,,1,,U,22224,,Area under the curve during systemic administration; Not determined,,,BAO_0000019,,7856,,0,,CHEMBL625187,,,Autocuration,A,
,2632,,1,,U,22224,,Area under the curve was calculated for the compound.,,,BAO_0000019,,7857,,0,,CHEMBL625188,,,Autocuration,A,
,14346,Canis lupus familiaris,1,,N,50588,,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,,,BAO_0000218,,7858,,1,9615.0,CHEMBL625189,,,Intermediate,A,
,14346,Canis lupus familiaris,1,,N,50588,,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,,,BAO_0000218,,7859,,1,9615.0,CHEMBL625190,,,Intermediate,A,
,14346,Rattus norvegicus,1,,N,50597,,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,,,BAO_0000218,,7860,,1,10116.0,CHEMBL621733,,,Intermediate,A,
,14346,Rattus norvegicus,1,,N,50597,,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,,,BAO_0000218,,7861,,1,10116.0,CHEMBL621734,,,Intermediate,A,
,11149,Rattus norvegicus,1,,N,50597,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,,,BAO_0000218,,7862,,1,10116.0,CHEMBL621735,,,Intermediate,A,
,17796,Rattus norvegicus,1,,N,50597,,Clearance of the drug was measured in the plasma of rat; No data,,,BAO_0000218,,7863,Plasma,1,10116.0,CHEMBL621736,,1969.0,Intermediate,A,
,5247,Rattus norvegicus,1,,N,50597,,The pharmacokinetic parameter plasma clearance in vivo in rats,,,BAO_0000218,,7864,Plasma,1,10116.0,CHEMBL621737,,1969.0,Intermediate,A,
,4727,Rattus norvegicus,1,,N,50597,,Plasma clearance at the dose of 2 mg/kg in rat,,,BAO_0000218,,7865,,1,10116.0,CHEMBL621738,,,Intermediate,A,
,5654,Rattus norvegicus,1,,N,50597,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,,BAO_0000218,,7866,,1,10116.0,CHEMBL622806,In vivo,,Intermediate,A,
,5654,Rattus norvegicus,1,,N,50597,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,,BAO_0000218,,7867,,1,10116.0,CHEMBL623519,In vivo,,Intermediate,A,
,17260,Rattus norvegicus,1,,N,50597,,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,,BAO_0000218,,7868,,1,10116.0,CHEMBL623520,In vivo,,Intermediate,A,
,17065,Rattus norvegicus,1,,N,50597,,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,,,BAO_0000218,,7869,,1,10116.0,CHEMBL623521,In vivo,,Intermediate,A,
,17671,Rattus norvegicus,1,,N,50597,,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,,BAO_0000218,,7870,,1,10116.0,CHEMBL623522,In vivo,,Intermediate,A,
,6672,Rattus norvegicus,1,,N,50597,,Clearance rate in rat,,,BAO_0000218,,7871,,1,10116.0,CHEMBL623523,In vivo,,Intermediate,A,
,6673,Rattus norvegicus,1,,N,50597,,Clearance rate in rat,,,BAO_0000218,,7872,,1,10116.0,CHEMBL623690,In vivo,,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,BAO_0000218,,7873,,1,10116.0,CHEMBL623691,In vivo,,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,BAO_0000218,,7874,,1,10116.0,CHEMBL623692,In vivo,,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,BAO_0000218,,7875,,1,10116.0,CHEMBL623693,In vivo,,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,BAO_0000218,,7876,,1,10116.0,CHEMBL623694,In vivo,,Intermediate,A,
,4413,Rattus norvegicus,1,,N,50597,,Clearance of compound after iv administration of 20 mg/kg dose in rat,,,BAO_0000218,,7877,,1,10116.0,CHEMBL623695,In vivo,,Intermediate,A,
,2661,Rattus norvegicus,1,,N,50597,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,,,BAO_0000218,,7878,,1,10116.0,CHEMBL623696,In vivo,,Intermediate,A,
,2661,Rattus norvegicus,1,,N,50597,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,,,BAO_0000218,,7879,,1,10116.0,CHEMBL623697,In vivo,,Intermediate,A,
,5005,Macaca mulatta,1,,U,22224,,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,,BAO_0000218,,7880,Plasma,0,9544.0,CHEMBL623698,In vivo,1969.0,Intermediate,A,
,5005,Rattus norvegicus,1,,U,22224,,Compound was tested for its plasma clearance rate in Sprague Dawley rats,,,BAO_0000218,,7881,Plasma,0,10116.0,CHEMBL623699,In vivo,1969.0,Intermediate,A,
,15765,Rattus norvegicus,1,,N,50597,,Mean (%CV) PK parameters for CL(mL/min/kg).,,,BAO_0000218,,7882,,1,10116.0,CHEMBL623700,In vivo,,Intermediate,A,
,3747,Rattus norvegicus,1,,N,50597,,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,,,BAO_0000218,,7883,,1,10116.0,CHEMBL623701,In vivo,,Intermediate,A,
,16366,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,,,BAO_0000218,,7884,Plasma,1,10116.0,CHEMBL623702,In vivo,1969.0,Intermediate,A,
,4199,Rattus norvegicus,1,,N,50597,,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,,,BAO_0000218,,7885,,1,10116.0,CHEMBL623703,In vivo,,Intermediate,A,
,17267,Rattus norvegicus,1,,N,50597,,Plasma clearance in rat was determined,,,BAO_0000218,,7886,,1,10116.0,CHEMBL623704,In vivo,,Intermediate,A,
,6535,Rattus norvegicus,1,,N,50597,,Plasma clearance in rat after administration of 2 mg/kg iv,,,BAO_0000218,,7887,,1,10116.0,CHEMBL623705,In vivo,,Intermediate,A,
,6535,Rattus norvegicus,1,,N,50597,,Plasma clearance in rat after administration of 2 mg/kg iv,,,BAO_0000218,,7888,,1,10116.0,CHEMBL623706,In vivo,,Intermediate,A,
,5041,Rattus norvegicus,1,,N,50597,,Plasma clearance was determined,,,BAO_0000218,,7889,,1,10116.0,CHEMBL623707,In vivo,,Intermediate,A,
,5960,Rattus norvegicus,1,,N,50597,,Plasma clearance in rat,,,BAO_0000218,,7890,,1,10116.0,CHEMBL623708,In vivo,,Intermediate,A,
,5937,Rattus norvegicus,1,,N,50597,,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,,,BAO_0000218,,7891,,1,10116.0,CHEMBL623709,In vivo,,Intermediate,A,
,5871,Rattus norvegicus,1,,N,50597,,Plasma clearance in rat by iv administration,,,BAO_0000218,,7892,,1,10116.0,CHEMBL623710,In vivo,,Intermediate,A,
,5874,Rattus norvegicus,1,,N,50597,,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,,,BAO_0000218,,7893,,1,10116.0,CHEMBL623711,In vivo,,Intermediate,A,
,6504,Rattus norvegicus,1,,N,50597,,Plasma clearance in rat p.o.,,,BAO_0000218,,7894,,1,10116.0,CHEMBL623712,In vivo,,Intermediate,A,
,6803,Rattus norvegicus,1,,N,50597,,Plasma clearance in rats,,,BAO_0000218,,7895,,1,10116.0,CHEMBL623713,In vivo,,Intermediate,A,
,5041,Rattus norvegicus,1,,N,50597,,Plasma clearance was determined; ND denotes no data,,,BAO_0000218,,7896,,1,10116.0,CHEMBL623714,In vivo,,Intermediate,A,
,5041,Rattus norvegicus,1,,N,50597,,Plasma clearance was determined; ND denotes not determined,,,BAO_0000218,,7897,,1,10116.0,CHEMBL623715,In vivo,,Intermediate,A,
,1916,Rattus norvegicus,1,,N,50597,,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,,BAO_0000218,,7898,,1,10116.0,CHEMBL623716,In vivo,,Intermediate,A,
,5199,Rattus norvegicus,1,,N,50597,,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,,BAO_0000218,,7899,,1,10116.0,CHEMBL622980,In vivo,,Intermediate,A,
,16367,Rattus norvegicus,1,,N,50597,,Plasma administration to rats,,,BAO_0000218,,7900,,1,10116.0,CHEMBL622981,In vivo,,Intermediate,A,
,6362,Rattus norvegicus,1,,N,50597,,Plasma clearance of the compound in female Sprague-Dawley rats,,,BAO_0000218,,7901,,1,10116.0,CHEMBL622982,In vivo,,Intermediate,A,
,15662,Rattus norvegicus,1,,N,50597,,Plasma clearance was observed after intravenous administration in rat,,,BAO_0000218,,7902,,1,10116.0,CHEMBL622983,In vivo,,Intermediate,A,
,6215,Rattus norvegicus,1,,N,50597,,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,,,BAO_0000218,,7903,,1,10116.0,CHEMBL622984,In vivo,,Intermediate,A,
,1466,Rattus norvegicus,1,,N,50597,,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,,,BAO_0000218,,7904,,1,10116.0,CHEMBL622985,In vivo,,Intermediate,A,
,15662,Rattus norvegicus,1,,N,50597,,plasma clearance was observed after intravenous administration in rat,,,BAO_0000218,,7905,Plasma,1,10116.0,CHEMBL623631,In vivo,1969.0,Intermediate,A,
,4723,Rattus norvegicus,1,,N,50597,,In vivo CL/F determined,,,BAO_0000218,,7906,,1,10116.0,CHEMBL623632,In vivo,,Intermediate,A,
,2792,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,,,BAO_0000218,,7907,Plasma,1,10116.0,CHEMBL623633,In vivo,1969.0,Intermediate,A,
,2792,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,,,BAO_0000218,,7908,Plasma,1,10116.0,CHEMBL623634,In vivo,1969.0,Intermediate,A,
,5213,Rattus norvegicus,1,,N,50597,,Compound was tested for the lower blood clearance in rat,,,BAO_0000218,,7909,,1,10116.0,CHEMBL623635,In vivo,,Intermediate,A,
,4687,Rattus norvegicus,1,,N,50597,,Evaluated for the low clearance in rat (in vivo),,,BAO_0000218,,7910,,1,10116.0,CHEMBL621195,In vivo,,Intermediate,A,
,3371,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (CLb)of the compound was determined in rat,,,BAO_0000218,,7911,,1,10116.0,CHEMBL621196,In vivo,,Intermediate,A,
,4690,Rattus norvegicus,1,,N,50597,,Rapid clearance after intravenous administration in rat was determined,,,BAO_0000218,,7912,,1,10116.0,CHEMBL875287,In vivo,,Intermediate,A,
,5702,Rattus norvegicus,1,,N,50597,,Clearance measured in rat,,,BAO_0000218,,7913,,1,10116.0,CHEMBL621197,In vivo,,Intermediate,A,
,740,Rattus norvegicus,1,,N,50597,,Compound was evaluated for plasma clearance in rat,,,BAO_0000218,,7914,Plasma,1,10116.0,CHEMBL621198,In vivo,1969.0,Intermediate,A,
,4853,Rattus norvegicus,1,,N,50597,,Low plasma clearance was calculated in rat,,,BAO_0000218,,7915,Plasma,1,10116.0,CHEMBL621199,In vivo,1969.0,Intermediate,A,
,5789,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (Clp) in rat,,,BAO_0000218,,7916,,1,10116.0,CHEMBL621200,In vivo,,Intermediate,A,
,4527,Rattus norvegicus,1,,N,50597,,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,,,BAO_0000218,,7917,,1,10116.0,CHEMBL621201,In vivo,,Intermediate,A,
,4527,Rattus norvegicus,1,,N,50597,,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,,,BAO_0000218,,7918,,1,10116.0,CHEMBL621202,In vivo,,Intermediate,A,
,6518,Rattus norvegicus,1,,N,50597,,Plasma clearance after IV dosing at 0.5 mg/kg in rat,,,BAO_0000218,,7919,,1,10116.0,CHEMBL621203,In vivo,,Intermediate,A,
,6518,Rattus norvegicus,1,,N,50597,,Plasma clearance after IV dosing at 1 mg/kg in rat,,,BAO_0000218,,7920,,1,10116.0,CHEMBL621204,In vivo,,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,,,BAO_0000218,,7921,Heart,1,10116.0,CHEMBL621205,In vivo,948.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,,,BAO_0000218,,7922,Heart,1,10116.0,CHEMBL621206,In vivo,948.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,,,BAO_0000218,,7923,Heart,1,10116.0,CHEMBL621207,In vivo,948.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,,,BAO_0000218,,7924,Heart,1,10116.0,CHEMBL621208,In vivo,948.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,,,BAO_0000218,,7925,Heart,1,10116.0,CHEMBL621209,In vivo,948.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,,,BAO_0000218,,7926,Heart,1,10116.0,CHEMBL876484,In vivo,948.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,,BAO_0000218,,7927,Heart,1,10116.0,CHEMBL621210,In vivo,948.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,,,BAO_0000218,,7928,Heart,1,10116.0,CHEMBL621211,In vivo,948.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,,,BAO_0000218,,7929,Heart,1,10116.0,CHEMBL621212,In vivo,948.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart in the presence of GdDTPA at 15 min,,,BAO_0000218,,7930,Heart,1,10116.0,CHEMBL621213,In vivo,948.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,,,BAO_0000218,,7931,Heart,1,10116.0,CHEMBL621214,In vivo,948.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart in the presence of GdDTPA at 30 min,,,BAO_0000218,,7932,Heart,1,10116.0,CHEMBL621215,In vivo,948.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,,,BAO_0000218,,7933,Heart,1,10116.0,CHEMBL621216,In vivo,948.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,,,BAO_0000218,,7934,Heart,1,10116.0,CHEMBL621217,In vivo,948.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,,,BAO_0000218,,7935,Heart,1,10116.0,CHEMBL621218,In vivo,948.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,,,BAO_0000218,,7936,Heart,1,10116.0,CHEMBL621219,In vivo,948.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,,,BAO_0000218,,7937,Heart,1,10116.0,CHEMBL621220,In vivo,948.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,,,BAO_0000218,,7938,Heart,1,10116.0,CHEMBL621221,In vivo,948.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,,,BAO_0000218,,7939,Heart,1,10116.0,CHEMBL621222,In vivo,948.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,,,BAO_0000218,,7940,Heart,1,10116.0,CHEMBL621223,In vivo,948.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,,,BAO_0000218,,7941,Heart,1,10116.0,CHEMBL876485,In vivo,948.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,,BAO_0000218,,7942,Heart,1,10116.0,CHEMBL621224,In vivo,948.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,,,BAO_0000218,,7943,Heart,1,10116.0,CHEMBL621225,In vivo,948.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,,,BAO_0000218,,7944,Heart,1,10116.0,CHEMBL621226,In vivo,948.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,,,BAO_0000218,,7945,Kidney,1,10116.0,CHEMBL621227,In vivo,2113.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,,,BAO_0000218,,7946,Kidney,1,10116.0,CHEMBL621228,In vivo,2113.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,,,BAO_0000218,,7947,Kidney,1,10116.0,CHEMBL621229,In vivo,2113.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,,,BAO_0000218,,7948,Kidney,1,10116.0,CHEMBL621230,In vivo,2113.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,,,BAO_0000218,,7949,Kidney,1,10116.0,CHEMBL621231,In vivo,2113.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,,,BAO_0000218,,7950,Kidney,1,10116.0,CHEMBL621232,In vivo,2113.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,,BAO_0000218,,7951,Kidney,1,10116.0,CHEMBL621233,In vivo,2113.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,,,BAO_0000218,,7952,Kidney,1,10116.0,CHEMBL621234,In vivo,2113.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,,BAO_0000218,,7953,Kidney,1,10116.0,CHEMBL621235,In vivo,2113.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,,BAO_0000218,,7954,Kidney,1,10116.0,CHEMBL621236,In vivo,2113.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,,,BAO_0000218,,7955,Kidney,1,10116.0,CHEMBL621237,In vivo,2113.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,,,BAO_0000218,,7956,Kidney,1,10116.0,CHEMBL876486,In vivo,2113.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,,,BAO_0000218,,7957,Intestine,1,10116.0,CHEMBL622436,In vivo,160.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,,,BAO_0000218,,7958,Intestine,1,10116.0,CHEMBL622437,In vivo,160.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,,,BAO_0000218,,7959,Intestine,1,10116.0,CHEMBL622438,In vivo,160.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,,,BAO_0000218,,7960,Liver,1,10116.0,CHEMBL622439,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,,,BAO_0000218,,7961,Liver,1,10116.0,CHEMBL622440,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,,,BAO_0000218,,7962,Liver,1,10116.0,CHEMBL622441,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,,,BAO_0000218,,7963,Liver,1,10116.0,CHEMBL622442,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,,,BAO_0000218,,7964,Liver,1,10116.0,CHEMBL622443,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,,,BAO_0000218,,7965,Liver,1,10116.0,CHEMBL622444,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,,,BAO_0000218,,7966,Liver,1,10116.0,CHEMBL622445,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,,,BAO_0000218,,7967,Liver,1,10116.0,CHEMBL622446,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,,BAO_0000218,,7968,Liver,1,10116.0,CHEMBL622447,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,,,BAO_0000218,,7969,Liver,1,10116.0,CHEMBL622448,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,,BAO_0000218,,7970,Liver,1,10116.0,CHEMBL622449,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,,,BAO_0000218,,7971,Liver,1,10116.0,CHEMBL622450,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,,,BAO_0000218,,7972,Liver,1,10116.0,CHEMBL622451,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver in the presence of GdDTPA at 15 min,,,BAO_0000218,,7973,Liver,1,10116.0,CHEMBL622452,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,,,BAO_0000218,,7974,Liver,1,10116.0,CHEMBL622453,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver in the presence of GdDTPA at 30 min,,,BAO_0000218,,7975,Liver,1,10116.0,CHEMBL622454,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,,,BAO_0000218,,7976,Liver,1,10116.0,CHEMBL622455,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,,,BAO_0000218,,7977,Liver,1,10116.0,CHEMBL876024,In vivo,2107.0,Intermediate,A,
,2792,Rattus norvegicus,1,,N,50597,,T max was determined at 3 mg/kg po dose in rats,,,BAO_0000218,,7978,,1,10116.0,CHEMBL622456,In vivo,,Intermediate,A,
,15078,Rattus norvegicus,1,,N,50597,,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,,7979,,1,10116.0,CHEMBL622457,In vivo,,Intermediate,A,
,15078,Rattus norvegicus,1,,N,50597,,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,,7980,,1,10116.0,CHEMBL622458,In vivo,,Intermediate,A,
,15022,Rattus norvegicus,1,,N,50597,,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,,,BAO_0000218,,7981,,1,10116.0,CHEMBL622459,,,Intermediate,A,
,15022,Rattus norvegicus,1,,N,50597,,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,,,BAO_0000218,,7982,,1,10116.0,CHEMBL873343,,,Intermediate,A,
,15022,Rattus norvegicus,1,,N,50597,,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,,,BAO_0000218,,7983,,1,10116.0,CHEMBL622460,,,Intermediate,A,
,4576,Rattus norvegicus,1,,N,50597,,Time for maximum plasma concentration determined in rat,,,BAO_0000218,,7984,Plasma,1,10116.0,CHEMBL622461,,1969.0,Intermediate,A,
,6681,Rattus norvegicus,1,,N,50597,,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,,BAO_0000218,,7985,Plasma,1,10116.0,CHEMBL622462,In vivo,1969.0,Intermediate,A,
,16365,Rattus norvegicus,1,,N,50597,,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,,,BAO_0000218,,7986,,1,10116.0,CHEMBL622463,In vivo,,Intermediate,A,
,16365,Rattus norvegicus,1,,N,50597,,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,,,BAO_0000218,,7987,,1,10116.0,CHEMBL622464,In vivo,,Intermediate,A,
,16365,Rattus norvegicus,1,,N,50597,,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,,,BAO_0000218,,7988,,1,10116.0,CHEMBL622465,In vivo,,Intermediate,A,
,16365,Rattus norvegicus,1,,N,50597,,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,,,BAO_0000218,,7989,,1,10116.0,CHEMBL622466,In vivo,,Intermediate,A,
,16365,Rattus norvegicus,1,,N,50597,,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,,,BAO_0000218,,7990,,1,10116.0,CHEMBL622467,In vivo,,Intermediate,A,
,6824,Rattus norvegicus,1,,N,50597,,Time of maximum plasma concentration in rat,,,BAO_0000218,,7991,Plasma,1,10116.0,CHEMBL622468,,1969.0,Intermediate,A,
,6685,Rattus norvegicus,1,,N,50597,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,,BAO_0000218,,7992,Plasma,1,10116.0,CHEMBL876025,,1969.0,Intermediate,A,
,6685,Rattus norvegicus,1,,N,50597,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,,BAO_0000218,,7993,Plasma,1,10116.0,CHEMBL622469,,1969.0,Intermediate,A,
,6685,Rattus norvegicus,1,,N,50597,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,,BAO_0000218,,7994,Plasma,1,10116.0,CHEMBL622470,,1969.0,Intermediate,A,
,15662,Rattus norvegicus,1,,N,50597,,Time required to reach maximum concentration (Cmax) after oral administration in rat,,,BAO_0000218,,7995,,1,10116.0,CHEMBL622471,In vivo,,Intermediate,A,
,1742,Rattus norvegicus,1,,N,50597,,Time required to reach maximum concentration in rat plasma,,,BAO_0000218,,7996,Plasma,1,10116.0,CHEMBL622472,,1969.0,Intermediate,A,
,2774,Rattus norvegicus,1,,N,50597,,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,,BAO_0000218,,7997,Plasma,1,10116.0,CHEMBL622473,In vivo,1969.0,Intermediate,A,
,5199,Rattus norvegicus,1,,N,50597,,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,,BAO_0000218,,7998,Plasma,1,10116.0,CHEMBL624282,In vivo,1969.0,Intermediate,A,
,12873,Rattus norvegicus,1,,N,50597,,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,,BAO_0000218,,7999,Plasma,1,10116.0,CHEMBL624283,In vivo,1969.0,Intermediate,A,
,12873,Rattus norvegicus,1,,N,50597,,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,,BAO_0000218,,8000,Plasma,1,10116.0,CHEMBL624284,In vivo,1969.0,Intermediate,A,
,1916,Rattus norvegicus,1,,N,50597,,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,,BAO_0000218,,8001,Plasma,1,10116.0,CHEMBL624285,In vivo,1969.0,Intermediate,A,
,16367,Rattus norvegicus,1,,N,50597,,Time to reach Cmax after oral administration to rats,,,BAO_0000218,,8002,,1,10116.0,CHEMBL624286,In vivo,,Intermediate,A,
,16366,Rattus norvegicus,1,,N,50597,,Time to reach Cmax when a dose of 1 mg/kg is administered orally,,,BAO_0000218,,8003,,1,10116.0,CHEMBL624287,In vivo,,Intermediate,A,
,216,Rattus norvegicus,1,,N,50597,,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,,,BAO_0000218,,8004,,1,10116.0,CHEMBL624288,,,Intermediate,A,
,6410,Rattus norvegicus,1,,N,50597,,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,,,BAO_0000218,,8005,Plasma,1,10116.0,CHEMBL624289,In vivo,1969.0,Intermediate,A,
,6410,Rattus norvegicus,1,,N,50597,,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,,,BAO_0000218,,8006,Plasma,1,10116.0,CHEMBL873344,In vivo,1969.0,Intermediate,A,
,6215,Rattus norvegicus,1,,N,50597,,Tmax after peroral administration (10 mg/kg) was determined in rat,,,BAO_0000218,,8007,,1,10116.0,CHEMBL619623,In vivo,,Intermediate,A,
,3598,Rattus norvegicus,1,,N,50597,,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,,,BAO_0000218,,8008,,1,10116.0,CHEMBL621399,In vivo,,Expert,A,
,4527,Rattus norvegicus,1,,N,50597,,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,,,BAO_0000218,,8009,,1,10116.0,CHEMBL621400,In vivo,,Intermediate,A,
,17670,Rattus norvegicus,1,,N,50597,,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",,,BAO_0000218,,8010,,1,10116.0,CHEMBL621401,In vivo,,Intermediate,A,
,1465,Rattus norvegicus,1,,N,50597,,Tmax was determined,,,BAO_0000218,,8011,,1,10116.0,CHEMBL621402,,,Intermediate,A,
,2552,Rattus norvegicus,1,,N,50597,,Tmax was determined,,,BAO_0000218,,8012,,1,10116.0,CHEMBL621403,,,Intermediate,A,
,5656,Rattus norvegicus,1,,N,50597,,Tmax after oral administration in rat,,,BAO_0000218,,8013,,1,10116.0,CHEMBL621121,In vivo,,Intermediate,A,
,17764,Rattus norvegicus,1,,N,50597,,Tmax after peroral administration in rats at 2.4 uM/kg,,,BAO_0000218,,8014,,1,10116.0,CHEMBL872525,In vivo,,Intermediate,A,
,5610,Rattus norvegicus,1,,N,50597,,Tmax in male rat,,,BAO_0000218,,8015,,1,10116.0,CHEMBL621122,,,Intermediate,A,
,6046,Rattus norvegicus,1,,N,50597,,Tmax in rat at 10 mg/kg,,,BAO_0000218,,8016,,1,10116.0,CHEMBL621123,In vivo,,Intermediate,A,
,5874,Rattus norvegicus,1,,N,50597,,Tmax in rat by po administration at a dose of 40 mg/kg,,,BAO_0000218,,8017,,1,10116.0,CHEMBL621124,In vivo,,Intermediate,A,
,17596,Rattus norvegicus,1,,N,50597,,Tmax in rats,,,BAO_0000218,,8018,,1,10116.0,CHEMBL621125,,,Intermediate,A,
,17804,Rattus norvegicus,1,,N,50597,,Tmax was measured in rats after peroral administration at 5 mg/kg,,,BAO_0000218,,8019,,1,10116.0,CHEMBL621126,In vivo,,Intermediate,A,
,1908,Rattus norvegicus,1,,N,50597,,Tmax value after oral dose at a dose of 10 mg/kg in rats.,,,BAO_0000218,,8020,,1,10116.0,CHEMBL621127,In vivo,,Intermediate,A,
,2959,Rattus norvegicus,1,,N,50597,,Tmax value after administration of 20 mg/Kg oral dose in rat,,,BAO_0000218,,8021,,1,10116.0,CHEMBL621128,In vivo,,Intermediate,A,
,6757,Rattus norvegicus,1,,N,50597,,Tmax value at a dose of 10 mg/kg in male SD rats,,,BAO_0000218,,8022,,1,10116.0,CHEMBL618263,In vivo,,Intermediate,A,
,6757,Rattus norvegicus,1,,N,50597,,Tmax value at a dose of 100 mg/kg in male SD rats,,,BAO_0000218,,8023,,1,10116.0,CHEMBL618264,In vivo,,Intermediate,A,
,6757,Rattus norvegicus,1,,N,50597,,Tmax value at a dose of 50 mg/kg in male SD rats,,,BAO_0000218,,8024,,1,10116.0,CHEMBL618265,In vivo,,Intermediate,A,
,4186,Rattus norvegicus,1,,N,50597,,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,,BAO_0000218,,8025,Plasma,1,10116.0,CHEMBL618266,In vivo,1969.0,Intermediate,A,
,15662,Rattus norvegicus,1,,N,50597,,time required to reach maximum concentration (Cmax) after oral administration in rat,,,BAO_0000218,,8026,,1,10116.0,CHEMBL618267,In vivo,,Intermediate,A,
,429,Rattus norvegicus,1,,N,50597,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),,,BAO_0000218,,8027,Urine,1,10116.0,CHEMBL618450,,1088.0,Intermediate,A,
,429,Rattus norvegicus,1,,N,50597,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),,,BAO_0000218,,8028,Urine,1,10116.0,CHEMBL618451,,1088.0,Intermediate,A,
,5546,Rattus norvegicus,1,,N,50597,,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,,BAO_0000218,,8029,,1,10116.0,CHEMBL618452,,,Intermediate,A,
,3173,Rattus norvegicus,1,,N,50597,,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,,,BAO_0000218,,8030,Urine,1,10116.0,CHEMBL618453,,1088.0,Intermediate,A,
,3173,Rattus norvegicus,1,,N,50597,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,,,BAO_0000218,,8031,Urine,1,10116.0,CHEMBL618454,,1088.0,Intermediate,A,
,3173,Rattus norvegicus,1,,N,50597,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,,,BAO_0000218,,8032,Urine,1,10116.0,CHEMBL618455,,1088.0,Intermediate,A,
,4257,Rattus norvegicus,1,,N,50597,,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,,,BAO_0000218,,8033,,1,10116.0,CHEMBL618456,In vivo,,Intermediate,A,
,6011,Rattus norvegicus,1,,N,50597,,Compound distribution in rat tissues was determined,,,BAO_0000218,,8034,,1,10116.0,CHEMBL618457,In vivo,,Intermediate,A,
,5472,Rattus norvegicus,1,,N,50597,,Volume of distribution was evaluated in rat,,,BAO_0000218,,8035,,1,10116.0,CHEMBL618458,In vivo,,Intermediate,A,
,14346,Rattus norvegicus,1,,N,50597,,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,,,BAO_0000218,,8036,,1,10116.0,CHEMBL618459,,,Intermediate,A,
,14346,Rattus norvegicus,1,,N,50597,,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,,,BAO_0000218,,8037,,1,10116.0,CHEMBL876733,,,Intermediate,A,
,14346,Canis lupus familiaris,1,,N,50588,,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,,,BAO_0000218,,8038,,1,9615.0,CHEMBL618460,,,Intermediate,A,
,14346,Rattus norvegicus,1,,N,50597,,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,,,BAO_0000218,,8039,,1,10116.0,CHEMBL618461,,,Intermediate,A,
,15469,,1,,U,22224,,Area under the curve was determined after oral administration (300 uM/Kg),,,BAO_0000019,,8040,,0,,CHEMBL618462,,,Autocuration,A,
,14346,Rattus norvegicus,1,,N,50597,,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,,,BAO_0000218,,8041,,1,10116.0,CHEMBL618463,,,Intermediate,A,
,14346,Rattus norvegicus,1,,N,50597,,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,,,BAO_0000218,,8042,,1,10116.0,CHEMBL618464,,,Intermediate,A,
,14346,Rattus norvegicus,1,,N,50597,,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,,,BAO_0000218,,8043,,1,10116.0,CHEMBL618465,,,Intermediate,A,
,14346,Rattus norvegicus,1,,N,50597,,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,,,BAO_0000218,,8044,,1,10116.0,CHEMBL618466,,,Intermediate,A,
,14346,Rattus norvegicus,1,,N,50597,,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,,,BAO_0000218,,8045,,1,10116.0,CHEMBL618467,,,Intermediate,A,
,15372,Rattus norvegicus,1,,N,50597,,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,,,BAO_0000218,,8046,,1,10116.0,CHEMBL618468,,,Intermediate,A,
,12935,Canis lupus familiaris,1,,N,50588,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,,,BAO_0000218,,8047,Plasma,1,9615.0,CHEMBL618469,,1969.0,Intermediate,A,
,12935,Canis lupus familiaris,1,,N,50588,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,,,BAO_0000218,,8048,Plasma,1,9615.0,CHEMBL618470,,1969.0,Intermediate,A,
,14813,,1,,U,22224,,Plasma drug AUC in rat (PO dose),,,BAO_0000218,,8049,,0,,CHEMBL618471,,,Autocuration,A,
,15792,Mus musculus,1,,N,50594,,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,,,BAO_0000218,,8050,,1,10090.0,CHEMBL618472,,,Intermediate,A,
,3579,,1,,U,22224,,Area under was determined at a dose of 30 mg/kg,,,BAO_0000218,,8051,,0,,CHEMBL618473,,,Autocuration,A,
,12487,Mustela putorius furo,1,,N,50506,,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,,,BAO_0000218,,8052,,1,9669.0,CHEMBL621699,,,Intermediate,A,
,12487,Rattus norvegicus,1,,N,50597,,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,,,BAO_0000218,,8053,,1,10116.0,CHEMBL621700,,,Intermediate,A,
,12487,Rattus norvegicus,1,,N,50597,,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,,,BAO_0000218,,8054,,1,10116.0,CHEMBL621701,,,Intermediate,A,
,12487,Mustela putorius furo,1,,N,50506,,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,,,BAO_0000218,,8055,,1,9669.0,CHEMBL621702,,,Intermediate,A,
,12487,Canis lupus familiaris,1,,N,50588,,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,,,BAO_0000218,,8056,,1,9615.0,CHEMBL621703,,,Intermediate,A,
,12487,Canis lupus familiaris,1,,N,50588,,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,,,BAO_0000218,,8057,,1,9615.0,CHEMBL621704,,,Intermediate,A,
,12902,Rattus norvegicus,1,,N,50597,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",,,BAO_0000218,,8058,,1,10116.0,CHEMBL624259,,,Intermediate,A,
,12902,Rattus norvegicus,1,,N,50597,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",,,BAO_0000218,,8059,,1,10116.0,CHEMBL624260,,,Intermediate,A,
,12902,Rattus norvegicus,1,,N,50597,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",,,BAO_0000218,,8060,,1,10116.0,CHEMBL624430,,,Intermediate,A,
,12902,Rattus norvegicus,1,,N,50597,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",,,BAO_0000218,,8061,,1,10116.0,CHEMBL624431,,,Intermediate,A,
,12902,Rattus norvegicus,1,,N,50597,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",,,BAO_0000218,,8062,,1,10116.0,CHEMBL624432,,,Intermediate,A,
,12902,Rattus norvegicus,1,,N,50597,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",,,BAO_0000218,,8063,,1,10116.0,CHEMBL624433,,,Intermediate,A,
,12902,Rattus norvegicus,1,,N,50597,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",,,BAO_0000218,,8064,,1,10116.0,CHEMBL624434,,,Intermediate,A,
,12902,Rattus norvegicus,1,,N,50597,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",,,BAO_0000218,,8065,,1,10116.0,CHEMBL624435,,,Intermediate,A,
,12745,Mus musculus,1,,N,50594,,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,,,BAO_0000218,,8066,,1,10090.0,CHEMBL618570,,,Intermediate,A,
,12745,Mus musculus,1,,N,50594,,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,,BAO_0000218,,8067,,1,10090.0,CHEMBL618571,,,Intermediate,A,
,12745,Mus musculus,1,,N,50594,,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,,,BAO_0000218,,8068,,1,10090.0,CHEMBL618572,,,Intermediate,A,
,12745,Mus musculus,1,,N,50594,,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,,BAO_0000218,,8069,,1,10090.0,CHEMBL618573,,,Intermediate,A,
,12745,Mus musculus,1,,N,50594,,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,,,BAO_0000218,,8070,,1,10090.0,CHEMBL619267,,,Intermediate,A,
,12745,Mus musculus,1,,N,50594,,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,,BAO_0000218,,8071,,1,10090.0,CHEMBL619431,,,Intermediate,A,
,12745,Mus musculus,1,,N,50594,,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,,,BAO_0000218,,8072,,1,10090.0,CHEMBL619432,,,Intermediate,A,
,12745,Mus musculus,1,,N,50594,,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,,BAO_0000218,,8073,,1,10090.0,CHEMBL619433,,,Intermediate,A,
,13298,,1,,U,22224,,AUC in mice after oral dose (50 mg/kg),,,BAO_0000218,,8074,Plasma,0,,CHEMBL619434,,1969.0,Autocuration,A,
,12226,Mus musculus,1,,N,50594,,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,,,BAO_0000218,,8075,Serum,1,10090.0,CHEMBL619435,,1977.0,Intermediate,A,
,12634,,1,,U,22224,,AUC (0-4 hr) ug/ml/h,,,BAO_0000019,,8076,Plasma,0,,CHEMBL619436,,1969.0,Autocuration,A,
,14810,Rattus norvegicus,1,,N,50597,,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,,,BAO_0000218,,8077,,1,10116.0,CHEMBL619437,,,Intermediate,A,
,13889,,1,,U,22224,,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,,,BAO_0000218,,8078,,0,,CHEMBL619438,,,Autocuration,A,
,10018,Mus musculus,1,,N,50594,,Compound was evaluated for Area under curve in mice,,,BAO_0000218,,8079,,1,10090.0,CHEMBL619439,,,Intermediate,A,
,8758,Rattus norvegicus,1,,N,50597,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,,BAO_0000218,,8080,,1,10116.0,CHEMBL619440,,,Intermediate,A,
,8758,,1,,U,22224,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,,BAO_0000218,,8081,,0,,CHEMBL619441,,,Autocuration,F,
,8758,Rattus norvegicus,1,,N,50597,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,,BAO_0000218,,8082,,1,10116.0,CHEMBL619442,,,Intermediate,A,
,2249,,1,,U,22224,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,,,BAO_0000019,,8083,,0,,CHEMBL875156,,,Autocuration,A,
,2249,,1,,U,22224,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,,,BAO_0000019,,8084,,0,,CHEMBL619443,,,Autocuration,A,
,2249,,1,,U,22224,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,,,BAO_0000019,,8085,,0,,CHEMBL619444,,,Autocuration,A,
,2249,,1,,U,22224,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,,,BAO_0000019,,8086,,0,,CHEMBL623464,,,Autocuration,A,
,15115,Mus musculus,1,,N,50594,,Compound was evaluated for area under curve when administered through oral route in mouse,,,BAO_0000218,,8087,,1,10090.0,CHEMBL623465,,,Intermediate,A,
,6518,Rattus norvegicus,1,,N,50597,,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,,,BAO_0000218,,8088,,1,10116.0,CHEMBL623466,In vivo,,Intermediate,A,
,6518,Rattus norvegicus,1,,N,50597,,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,,,BAO_0000218,,8089,,1,10116.0,CHEMBL623467,In vivo,,Intermediate,A,
,6249,Rattus norvegicus,1,,N,50597,,Plasma clearance in rat,,,BAO_0000218,,8090,,1,10116.0,CHEMBL623468,In vivo,,Intermediate,A,
,2463,Rattus norvegicus,1,,N,50597,,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,,BAO_0000218,,8091,,1,10116.0,CHEMBL622660,In vivo,,Intermediate,A,
,4969,Rattus norvegicus,1,,N,50597,,Plasma clearance rate in Sprague-Dawley rats,,,BAO_0000218,,8092,,1,10116.0,CHEMBL622661,In vivo,,Intermediate,A,
,17720,Rattus norvegicus,1,,N,50597,,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,,,BAO_0000218,,8093,,1,10116.0,CHEMBL622662,In vivo,,Intermediate,F,
,3457,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (total body clearance) in rat,,,BAO_0000218,,8094,,1,10116.0,CHEMBL622663,In vivo,,Intermediate,A,
,5983,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,,,BAO_0000218,,8095,,1,10116.0,CHEMBL622664,In vivo,,Intermediate,A,
,6295,Rattus norvegicus,1,,N,50597,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,,BAO_0000218,,8096,,1,10116.0,CHEMBL622665,,,Intermediate,A,
,6296,Rattus norvegicus,1,,N,50597,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,,BAO_0000218,,8097,,1,10116.0,CHEMBL622666,,,Intermediate,A,
,17686,Rattus norvegicus,1,,N,50597,,Cl in rat i.v. at 2 mg/kg concentration,,,BAO_0000218,,8098,,1,10116.0,CHEMBL621615,In vivo,,Intermediate,A,
,17764,Rattus norvegicus,1,,N,50597,,Clearance of compound after intravenous administration in rats at 24 uM/kg,,,BAO_0000218,,8099,,1,10116.0,CHEMBL621616,In vivo,,Intermediate,A,
,5503,Rattus norvegicus,1,,N,50597,,Clearance was determined,,,BAO_0000218,,8100,,1,10116.0,CHEMBL621617,In vivo,,Intermediate,A,
,4368,Rattus norvegicus,1,,N,50597,,Clearance by intravenous administration of 3.4 mg/kg in rat,,,BAO_0000218,,8101,,1,10116.0,CHEMBL621618,In vivo,,Intermediate,A,
,6005,Rattus norvegicus,1,,N,50597,,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,,BAO_0000218,,8102,,1,10116.0,CHEMBL621619,In vivo,,Intermediate,A,
,5031,Rattus norvegicus,1,,N,50597,,Clearance rate after i.v. administration in rats,,,BAO_0000218,,8103,,1,10116.0,CHEMBL621620,In vivo,,Intermediate,A,
,4890,Rattus norvegicus,1,,N,50597,,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,,BAO_0000218,,8104,,1,10116.0,CHEMBL621786,In vivo,,Intermediate,A,
,5182,Rattus norvegicus,1,,N,50597,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,,BAO_0000218,,8105,,1,10116.0,CHEMBL621787,In vivo,,Intermediate,A,
,5979,Rattus norvegicus,1,,N,50597,,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,,,BAO_0000218,,8106,,1,10116.0,CHEMBL621788,In vivo,,Intermediate,A,
,5656,Rattus norvegicus,1,,N,50597,,Clearance (Cl) after oral administration in rat,,,BAO_0000218,,8107,,1,10116.0,CHEMBL621789,In vivo,,Intermediate,A,
,17804,Rattus norvegicus,1,,N,50597,,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,,,BAO_0000218,,8108,,1,10116.0,CHEMBL621790,In vivo,,Intermediate,A,
,4839,Rattus norvegicus,1,,N,50597,,Compound was tested for plasma clearance in rat,,,BAO_0000218,,8109,Plasma,1,10116.0,CHEMBL621791,In vivo,1969.0,Intermediate,A,
,5041,Rattus norvegicus,1,,N,50597,,In vitro microsome metabolism clearance in rat was determined,,,BAO_0000218,,8110,,1,10116.0,CHEMBL621792,In vitro,,Intermediate,A,Microsomes
,5041,Rattus norvegicus,1,,N,50597,,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,,,BAO_0000218,,8111,,1,10116.0,CHEMBL621793,In vitro,,Intermediate,A,Microsomes
,5974,Rattus norvegicus,1,,N,50597,,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,,8112,,1,10116.0,CHEMBL621794,In vivo,,Intermediate,A,
,5496,Rattus norvegicus,1,,N,50597,,In vivo plasma clearance was determined,,,BAO_0000218,,8113,Plasma,1,10116.0,CHEMBL621795,In vivo,1969.0,Intermediate,A,
,5739,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,,,BAO_0000218,,8114,,1,10116.0,CHEMBL621796,In vivo,,Intermediate,A,
401.0,5676,Rattus norvegicus,1,Hepatocyte,N,50597,,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,,,BAO_0000218,,8115,Liver,1,10116.0,CHEMBL621797,In vivo,2107.0,Intermediate,A,
,4239,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (Plasma clearance) was measured in rat,,,BAO_0000218,,8116,,1,10116.0,CHEMBL621798,In vivo,,Intermediate,A,
,5676,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (clearance) in rat i.v.,,,BAO_0000218,,8117,,1,10116.0,CHEMBL621799,In vivo,,Intermediate,A,
,1918,Rattus norvegicus,1,,N,50597,,"Plasma Clearance was evaluated in rats, iv",,,BAO_0000218,,8118,,1,10116.0,CHEMBL621800,In vivo,,Intermediate,A,
,17800,Rattus norvegicus,1,,N,50597,,Plasma clearance (in vivo) in rats was determined,,,BAO_0000218,,8119,,1,10116.0,CHEMBL621801,In vivo,,Intermediate,A,
,6056,Rattus norvegicus,1,,N,50597,,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,,,BAO_0000218,,8120,,1,10116.0,CHEMBL621802,In vivo,,Intermediate,A,
,5496,Rattus norvegicus,1,,N,50597,,Plasma clearance was determined,,,BAO_0000218,,8121,,1,10116.0,CHEMBL618596,In vivo,,Intermediate,A,
,5939,Rattus norvegicus,1,,N,50597,,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,,,BAO_0000218,,8122,,1,10116.0,CHEMBL618597,In vivo,,Intermediate,A,
,5939,Rattus norvegicus,1,,N,50597,,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,,,BAO_0000218,,8123,,1,10116.0,CHEMBL618598,In vivo,,Intermediate,A,
,17752,Rattus norvegicus,1,,N,50597,,Plasma clearance in rats,,,BAO_0000218,,8124,,1,10116.0,CHEMBL618599,In vivo,,Intermediate,A,
,4576,Rattus norvegicus,1,,N,50597,,Plasma clearance rate determined in rat,,,BAO_0000218,,8125,,1,10116.0,CHEMBL618600,In vivo,,Intermediate,A,
,6011,Rattus norvegicus,1,,N,50597,,Plasma clearance was determined in rat,,,BAO_0000218,,8126,,1,10116.0,CHEMBL618601,In vivo,,Intermediate,A,
,5510,Rattus norvegicus,1,,N,50597,,Plasma clearance was determined,,,BAO_0000218,,8127,,1,10116.0,CHEMBL618602,In vivo,,Intermediate,A,
,5948,Rattus norvegicus,1,,N,50597,,Plasma clearance value in rat,,,BAO_0000218,,8128,,1,10116.0,CHEMBL618603,In vivo,,Intermediate,A,
,6125,Rattus norvegicus,1,,N,50597,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,,BAO_0000218,,8129,Liver,1,10116.0,CHEMBL618604,Ex vivo,2107.0,Intermediate,A,
,4839,Rattus norvegicus,1,,N,50597,,Clearance in rat,,,BAO_0000218,,8130,,1,10116.0,CHEMBL618605,In vivo,,Intermediate,A,
,17686,Rattus norvegicus,1,,N,50597,,Total body clearance in rat i.v. at 2 mg/kg concentration,,,BAO_0000218,,8131,,1,10116.0,CHEMBL618606,In vivo,,Intermediate,A,
,6571,Rattus norvegicus,1,,N,50597,,Clearance of compound in rats after intravenous administration,,,BAO_0000218,,8132,,1,10116.0,CHEMBL618607,In vivo,,Intermediate,A,
,3364,Rattus norvegicus,1,,N,50597,,Clearance after iv administration to rats,,,BAO_0000218,,8133,,1,10116.0,CHEMBL618608,In vivo,,Intermediate,A,
,13569,Rattus norvegicus,1,,N,50597,,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,,BAO_0000218,,8134,,1,10116.0,CHEMBL618609,In vivo,,Intermediate,A,
,13569,Rattus norvegicus,1,,N,50597,,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,,BAO_0000218,,8135,,1,10116.0,CHEMBL618610,In vivo,,Intermediate,A,
,13569,Rattus norvegicus,1,,N,50597,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,,BAO_0000218,,8136,,1,10116.0,CHEMBL618611,In vivo,,Intermediate,A,
,13569,Rattus norvegicus,1,,N,50597,,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,,BAO_0000218,,8137,,1,10116.0,CHEMBL618612,In vivo,,Intermediate,A,
,13569,Rattus norvegicus,1,,N,50597,,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,,BAO_0000218,,8138,,1,10116.0,CHEMBL618613,In vivo,,Intermediate,A,
,13569,Rattus norvegicus,1,,N,50597,,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,,BAO_0000218,,8139,,1,10116.0,CHEMBL621076,In vivo,,Intermediate,A,
,13569,Rattus norvegicus,1,,N,50597,,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,,BAO_0000218,,8140,,1,10116.0,CHEMBL621077,In vivo,,Intermediate,A,
,17670,Rattus norvegicus,1,,N,50597,,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",,,BAO_0000218,,8141,,1,10116.0,CHEMBL621078,In vivo,,Intermediate,A,
,5970,Rattus norvegicus,1,,N,50597,,Clearance in rat,,,BAO_0000218,,8142,,1,10116.0,CHEMBL621251,In vivo,,Intermediate,A,
,6495,Rattus norvegicus,1,,N,50597,,Clearance in rat after oral administration at 10 mg/kg,,,BAO_0000218,,8143,,1,10116.0,CHEMBL621252,In vivo,,Intermediate,A,
,4590,Rattus norvegicus,1,,N,50597,,Clearance in rat.,,,BAO_0000218,,8144,,1,10116.0,CHEMBL621253,In vivo,,Intermediate,A,
,6193,Rattus norvegicus,1,,N,50597,,Clearance rate following an oral dose of 20 mg/kg in rats,,,BAO_0000218,,8145,,1,10116.0,CHEMBL621254,In vivo,,Intermediate,A,
,2832,Rattus norvegicus,1,,N,50597,,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,,,BAO_0000218,,8146,,1,10116.0,CHEMBL621255,In vivo,,Intermediate,A,
,1052,Rattus norvegicus,1,,N,50597,,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,,,BAO_0000218,,8147,Plasma,1,10116.0,CHEMBL621256,In vivo,1969.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,,,BAO_0000218,,8148,Liver,1,10116.0,CHEMBL621257,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,,,BAO_0000218,,8149,Liver,1,10116.0,CHEMBL621258,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,,,BAO_0000218,,8150,Liver,1,10116.0,CHEMBL621259,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,,,BAO_0000218,,8151,Liver,1,10116.0,CHEMBL621260,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,,,BAO_0000218,,8152,Liver,1,10116.0,CHEMBL876494,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,,,BAO_0000218,,8153,Liver,1,10116.0,CHEMBL621261,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,,,BAO_0000218,,8154,Liver,1,10116.0,CHEMBL621262,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,,BAO_0000218,,8155,Liver,1,10116.0,CHEMBL621263,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,,,BAO_0000218,,8156,Liver,1,10116.0,CHEMBL621264,In vivo,2107.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,,,BAO_0000218,,8157,Muscle tissue,1,10116.0,CHEMBL621265,In vivo,2385.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,,,BAO_0000218,,8158,Muscle tissue,1,10116.0,CHEMBL621266,In vivo,2385.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,,,BAO_0000218,,8159,Muscle tissue,1,10116.0,CHEMBL621267,In vivo,2385.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,,,BAO_0000218,,8160,Muscle tissue,1,10116.0,CHEMBL621268,In vivo,2385.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,,,BAO_0000218,,8161,Muscle tissue,1,10116.0,CHEMBL621269,In vivo,2385.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,,,BAO_0000218,,8162,Muscle tissue,1,10116.0,CHEMBL621270,In vivo,2385.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,,,BAO_0000218,,8163,Muscle tissue,1,10116.0,CHEMBL621271,In vivo,2385.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,,,BAO_0000218,,8164,Muscle tissue,1,10116.0,CHEMBL621272,In vivo,2385.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,,,BAO_0000218,,8165,Muscle tissue,1,10116.0,CHEMBL621273,In vivo,2385.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,,,BAO_0000218,,8166,Muscle tissue,1,10116.0,CHEMBL621274,In vivo,2385.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,,,BAO_0000218,,8167,Muscle tissue,1,10116.0,CHEMBL876495,In vivo,2385.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,,,BAO_0000218,,8168,Muscle tissue,1,10116.0,CHEMBL621275,In vivo,2385.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,,,BAO_0000218,,8169,Muscle tissue,1,10116.0,CHEMBL621276,In vivo,2385.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,,,BAO_0000218,,8170,Muscle tissue,1,10116.0,CHEMBL621277,In vivo,2385.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,,,BAO_0000218,,8171,Intestine,1,10116.0,CHEMBL621278,In vivo,160.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,,,BAO_0000218,,8172,Intestine,1,10116.0,CHEMBL621279,In vivo,160.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),,,BAO_0000218,,8173,Intestine,1,10116.0,CHEMBL621280,In vivo,160.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,,,BAO_0000218,,8174,Spleen,1,10116.0,CHEMBL621281,In vivo,2106.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,,,BAO_0000218,,8175,Spleen,1,10116.0,CHEMBL621282,In vivo,2106.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,,,BAO_0000218,,8176,Spleen,1,10116.0,CHEMBL621283,In vivo,2106.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,,,BAO_0000218,,8177,Spleen,1,10116.0,CHEMBL621284,In vivo,2106.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,,,BAO_0000218,,8178,Spleen,1,10116.0,CHEMBL621285,In vivo,2106.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,,,BAO_0000218,,8179,Spleen,1,10116.0,CHEMBL621286,In vivo,2106.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,,,BAO_0000218,,8180,Spleen,1,10116.0,CHEMBL623220,In vivo,2106.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,,,BAO_0000218,,8181,Spleen,1,10116.0,CHEMBL623221,In vivo,2106.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,,,BAO_0000218,,8182,Spleen,1,10116.0,CHEMBL876029,In vivo,2106.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,,,BAO_0000218,,8183,Stomach,1,10116.0,CHEMBL623222,In vivo,945.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,,,BAO_0000218,,8184,Stomach,1,10116.0,CHEMBL623223,In vivo,945.0,Intermediate,A,
,9866,Rattus norvegicus,1,,N,50597,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,,,BAO_0000218,,8185,Stomach,1,10116.0,CHEMBL621445,In vivo,945.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8186,Blood,1,10116.0,CHEMBL621446,In vivo,178.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8187,Blood,1,10116.0,CHEMBL621447,In vivo,178.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8188,Blood,1,10116.0,CHEMBL619681,In vivo,178.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8189,Blood,1,10116.0,CHEMBL619682,In vivo,178.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8190,Blood,1,10116.0,CHEMBL619683,In vivo,178.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8191,Brain,1,10116.0,CHEMBL619684,In vivo,955.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8192,Brain,1,10116.0,CHEMBL619685,In vivo,955.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8193,Brain,1,10116.0,CHEMBL619686,In vivo,955.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8194,Brain,1,10116.0,CHEMBL619687,In vivo,955.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8195,Brain,1,10116.0,CHEMBL619688,In vivo,955.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8196,Heart,1,10116.0,CHEMBL619689,In vivo,948.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8197,Heart,1,10116.0,CHEMBL619690,In vivo,948.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8198,Heart,1,10116.0,CHEMBL619691,In vivo,948.0,Intermediate,A,
,6062,Rattus norvegicus,1,,N,50597,,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,,,BAO_0000218,,8199,,1,10116.0,CHEMBL619692,In vivo,,Intermediate,A,
,3598,Rattus norvegicus,1,,N,50597,,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,,,BAO_0000218,,8200,,1,10116.0,CHEMBL619693,,,Expert,A,
,1908,Rattus norvegicus,1,,N,50597,,Vc value after IV dose at a dose of 5 mg/kg in rats.,,,BAO_0000218,,8201,,1,10116.0,CHEMBL619694,In vivo,,Intermediate,A,
,17596,Rattus norvegicus,1,,N,50597,,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,,,BAO_0000218,,8202,,1,10116.0,CHEMBL619695,In vivo,,Intermediate,A,
,4891,Rattus norvegicus,1,,N,50597,,Compound was evaluated for pharmacokinetic parameter volume of distribution,,,BAO_0000218,,8203,,1,10116.0,CHEMBL619696,In vivo,,Intermediate,A,
,740,Rattus norvegicus,1,,N,50597,,Compound was evaluated for volume of distribution in rat,,,BAO_0000218,,8204,,1,10116.0,CHEMBL619697,In vivo,,Intermediate,A,
,16366,Rattus norvegicus,1,,N,50597,,Steady state volume distribution was determined; steady state(ss),,,BAO_0000218,,8205,,1,10116.0,CHEMBL619698,In vivo,,Intermediate,A,
,3364,Rattus norvegicus,1,,N,50597,,Steady state volume of distribution after iv administration to rats,,,BAO_0000218,,8206,,1,10116.0,CHEMBL619699,In vivo,,Intermediate,A,
,2552,Rattus norvegicus,1,,N,50597,,Steady state volume of distribution dosing at 3 mg/kg iv,,,BAO_0000218,,8207,,1,10116.0,CHEMBL619700,In vivo,,Intermediate,A,
,406,Rattus norvegicus,1,,N,50597,,The compound was evaluated for volume of distribution in rat,,,BAO_0000218,,8208,,1,10116.0,CHEMBL619701,In vivo,,Intermediate,A,
,12500,Rattus norvegicus,1,,N,50597,,The compound was tested for volume of distribution in rat,,,BAO_0000218,,8209,,1,10116.0,CHEMBL619702,In vivo,,Intermediate,A,
,12500,Rattus norvegicus,1,,N,50597,,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,,,BAO_0000218,,8210,,1,10116.0,CHEMBL620335,In vivo,,Intermediate,A,
,5656,Rattus norvegicus,1,,N,50597,,Volume distribution (VD) after oral administration in rat,,,BAO_0000218,,8211,,1,10116.0,CHEMBL620336,In vivo,,Intermediate,A,
,17671,Rattus norvegicus,1,,N,50597,,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,,BAO_0000218,,8212,,1,10116.0,CHEMBL620337,In vivo,,Intermediate,A,
,1094,Rattus norvegicus,1,,N,50597,,Volume distribution in rat,,,BAO_0000218,,8213,,1,10116.0,CHEMBL620520,In vivo,,Intermediate,A,
,5833,Rattus norvegicus,1,,N,50597,,Volume distribution in rat,,,BAO_0000218,,8214,,1,10116.0,CHEMBL620521,In vivo,,Intermediate,A,
,5939,Rattus norvegicus,1,,N,50597,,Volume distribution in rat after peroral administration at 10 mg/kg,,,BAO_0000218,,8215,,1,10116.0,CHEMBL875825,In vivo,,Intermediate,A,
,5939,Rattus norvegicus,1,,N,50597,,Volume distribution in rat after peroral administration at 5 mg/kg,,,BAO_0000218,,8216,,1,10116.0,CHEMBL620522,In vivo,,Intermediate,A,
,6005,Rattus norvegicus,1,,N,50597,,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,,BAO_0000218,,8217,,1,10116.0,CHEMBL620523,In vivo,,Intermediate,A,
,1696,Rattus norvegicus,1,,N,50597,,Volume of distribution in rat.,,,BAO_0000218,,8218,,1,10116.0,CHEMBL620524,In vivo,,Intermediate,A,
,6672,Rattus norvegicus,1,,N,50597,,Volume of distribution in rat,,,BAO_0000218,,8219,,1,10116.0,CHEMBL620525,In vivo,,Intermediate,A,
,6673,Rattus norvegicus,1,,N,50597,,Volume of distribution in rat,,,BAO_0000218,,8220,,1,10116.0,CHEMBL620526,In vivo,,Intermediate,A,
,5871,Rattus norvegicus,1,,N,50597,,Volume of distribution in rat by iv administration,,,BAO_0000218,,8221,,1,10116.0,CHEMBL620527,In vivo,,Intermediate,A,
,6803,Rattus norvegicus,1,,N,50597,,Volume of distribution in rats,,,BAO_0000218,,8222,,1,10116.0,CHEMBL620528,In vivo,,Intermediate,A,
,5199,Rattus norvegicus,1,,N,50597,,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,,BAO_0000218,,8223,,1,10116.0,CHEMBL620529,In vivo,,Intermediate,A,
,4727,Rattus norvegicus,1,,N,50597,,Volume distribution at the dose of 2 mg/kg in rat,,,BAO_0000218,,8224,,1,10116.0,CHEMBL620530,,,Intermediate,A,
,16367,Rattus norvegicus,1,,N,50597,,Steady state volume of distribution was determined,,,BAO_0000218,,8225,,1,10116.0,CHEMBL620531,In vivo,,Intermediate,A,
,5005,Macaca mulatta,1,,U,22224,,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,,BAO_0000218,,8226,,0,9544.0,CHEMBL620532,In vivo,,Intermediate,A,
,5005,Rattus norvegicus,1,,U,22224,,Compound was tested for its plasma volume distribution in Sprague Dawley rats,,,BAO_0000218,,8227,,0,10116.0,CHEMBL620533,In vivo,,Intermediate,A,
,5005,Rattus norvegicus,1,,U,22224,,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,,,BAO_0000218,,8228,,0,10116.0,CHEMBL620534,In vivo,,Intermediate,A,
,15765,Rattus norvegicus,1,,N,50597,,Mean (%CV) PK parameters for Vdss(mL/kg).,,,BAO_0000218,,8229,,1,10116.0,CHEMBL620535,In vivo,,Intermediate,A,
,2792,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,,,BAO_0000218,,8230,,1,10116.0,CHEMBL875826,In vivo,,Intermediate,A,
,2792,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,,,BAO_0000218,,8231,,1,10116.0,CHEMBL620536,In vivo,,Intermediate,A,
,5334,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,,BAO_0000218,,8232,,1,10116.0,CHEMBL620537,In vivo,,Intermediate,A,
,5334,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,,,BAO_0000218,,8233,,1,10116.0,CHEMBL618526,In vivo,,Intermediate,A,
,5739,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,,,BAO_0000218,,8234,,1,10116.0,CHEMBL618527,In vivo,,Intermediate,A,
,5789,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (Vdss) in rat,,,BAO_0000218,,8235,,1,10116.0,CHEMBL618528,In vivo,,Intermediate,A,
,4239,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (vdss) was measured in rat,,,BAO_0000218,,8236,,1,10116.0,CHEMBL618529,In vivo,,Intermediate,A,
,4709,Rattus norvegicus,1,,N,50597,,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,,,BAO_0000218,,8237,,1,10116.0,CHEMBL618530,In vivo,,Intermediate,A,
,6642,Rattus norvegicus,1,,N,50597,,Volume of distribution in rat,,,BAO_0000218,,8238,,1,10116.0,CHEMBL618531,In vivo,,Intermediate,A,
,5247,Rattus norvegicus,1,,N,50597,,The pharmacokinetic parameter volume of distribution in vivo in rats,,,BAO_0000218,,8239,,1,10116.0,CHEMBL618532,In vivo,,Intermediate,A,
,17720,Rattus norvegicus,1,,N,50597,,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,,,BAO_0000218,,8240,,1,10116.0,CHEMBL618533,In vivo,,Intermediate,F,
,17686,Rattus norvegicus,1,,N,50597,,Vdss in rat i.v. at 2 mg/kg concentration,,,BAO_0000218,,8241,,1,10116.0,CHEMBL618534,In vivo,,Intermediate,A,
,4689,Rattus norvegicus,1,,N,50597,,Volume distribution after intravenous administration (1 mg/kg) in rat,,,BAO_0000218,,8242,,1,10116.0,CHEMBL618535,In vivo,,Intermediate,A,
,5654,Rattus norvegicus,1,,N,50597,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,,BAO_0000218,,8243,,1,10116.0,CHEMBL618536,In vivo,,Intermediate,A,
,5654,Rattus norvegicus,1,,N,50597,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,,BAO_0000218,,8244,,1,10116.0,CHEMBL618537,In vivo,,Intermediate,A,
,4527,Rattus norvegicus,1,,N,50597,,Volume distribution at a dose of 10 uM/kg in rat was determined,,,BAO_0000218,,8245,,1,10116.0,CHEMBL618538,In vivo,,Intermediate,A,
,4521,Rattus norvegicus,1,,N,50597,,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,,BAO_0000218,,8246,,1,10116.0,CHEMBL618539,In vivo,,Intermediate,A,
,6057,Rattus norvegicus,1,,N,50597,,Volume distribution was calculated in rat,,,BAO_0000218,,8247,,1,10116.0,CHEMBL618540,In vivo,,Intermediate,A,
,5510,Rattus norvegicus,1,,N,50597,,Volume distribution was determined,,,BAO_0000218,,8248,,1,10116.0,CHEMBL618541,In vivo,,Intermediate,A,
,2938,Rattus norvegicus,1,,N,50597,,Volume of distribution after intravenous administration was evaluated in rat,,,BAO_0000218,,8249,,1,10116.0,CHEMBL618542,In vivo,,Intermediate,A,
,6679,Rattus norvegicus,1,,N,50597,,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,,BAO_0000218,,8250,,1,10116.0,CHEMBL622544,In vivo,,Intermediate,A,
,6685,Rattus norvegicus,1,,N,50597,,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",,,BAO_0000218,,8251,,1,10116.0,CHEMBL622545,In vivo,,Intermediate,A,
,6685,Rattus norvegicus,1,,N,50597,,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,,BAO_0000218,,8252,,1,10116.0,CHEMBL622546,In vivo,,Intermediate,A,
,6685,Rattus norvegicus,1,,N,50597,,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",,,BAO_0000218,,8253,,1,10116.0,CHEMBL622547,In vivo,,Intermediate,A,
,5145,Rattus norvegicus,1,,N,50597,,Volume of distribution in steady state was determined in rat,,,BAO_0000218,,8254,,1,10116.0,CHEMBL622548,In vivo,,Intermediate,A,
,6467,Rattus norvegicus,1,,N,50597,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,,,BAO_0000218,,8255,,1,10116.0,CHEMBL622549,In vivo,,Intermediate,A,
,6467,Rattus norvegicus,1,,N,50597,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,,BAO_0000218,,8256,,1,10116.0,CHEMBL622550,In vivo,,Intermediate,A,
,15115,Mus musculus,1,,N,50594,,Compound was evaluated for area under curve when administered through oral route to mouse,,,BAO_0000218,,8257,,1,10090.0,CHEMBL622551,,,Intermediate,A,
,8758,Rattus norvegicus,1,,N,50597,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,,BAO_0000218,,8258,,1,10116.0,CHEMBL622552,,,Intermediate,A,
,8758,Rattus norvegicus,1,,N,50597,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,,BAO_0000218,,8259,,1,10116.0,CHEMBL622553,,,Intermediate,A,
,8267,,1,,U,22224,,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,,,BAO_0000218,,8260,,0,,CHEMBL622554,In vivo,,Autocuration,F,
,8267,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,,,BAO_0000218,,8261,,1,9615.0,CHEMBL622555,,,Intermediate,A,
,14239,Mus musculus,1,,N,50594,,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,,,BAO_0000218,,8262,,1,10090.0,CHEMBL622556,,,Intermediate,A,
,14239,Mus musculus,1,,N,50594,,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,,,BAO_0000218,,8263,,1,10090.0,CHEMBL622557,,,Intermediate,A,
,10754,Mus musculus,1,,N,50594,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,,,BAO_0000218,,8264,Blood,1,10090.0,CHEMBL622558,,178.0,Intermediate,A,
,10754,Mus musculus,1,,N,50594,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,,,BAO_0000218,,8265,Blood,1,10090.0,CHEMBL622559,,178.0,Intermediate,A,
,10754,Canis lupus familiaris,1,,N,50588,,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,,,BAO_0000218,,8266,,1,9615.0,CHEMBL622560,,,Intermediate,A,
,14681,Rattus norvegicus,1,,N,50597,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,,,BAO_0000218,,8267,,1,10116.0,CHEMBL622561,,,Intermediate,A,
,14681,Rattus norvegicus,1,,N,50597,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,,,BAO_0000218,,8268,,1,10116.0,CHEMBL622562,,,Intermediate,A,
,14681,Rattus norvegicus,1,,N,50597,,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,,BAO_0000218,,8269,,1,10116.0,CHEMBL622563,,,Intermediate,A,
,13118,,1,,U,22224,,Concentration of compound in Central nervous system,,,BAO_0000019,,8270,,0,,CHEMBL622564,,,Autocuration,A,
,13118,,1,,U,22224,,Concentration of compound in Central nervous system; Not detectable,,,BAO_0000019,,8271,,0,,CHEMBL622565,,,Autocuration,A,
,13318,Mus musculus,1,,N,50594,,"Concentration of diester in the blood, following oral administration in mice",,,BAO_0000218,,8272,,1,10090.0,CHEMBL622566,,,Intermediate,A,
,13318,Mus musculus,1,,N,50594,,"Concentration of monoester in the blood, following oral administration in mice",,,BAO_0000218,,8273,,1,10090.0,CHEMBL624515,,,Intermediate,A,
,13318,Mus musculus,1,,N,50594,,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,,,BAO_0000218,,8274,,1,10090.0,CHEMBL624516,,,Intermediate,A,
,15692,,1,,U,22224,,Evaluated for Pharmacokinetic property: Area under the curve,,,BAO_0000019,,8275,,0,,CHEMBL624517,,,Autocuration,A,
,14839,Mus musculus,1,,N,50594,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,,,BAO_0000218,,8276,,1,10090.0,CHEMBL624518,,,Intermediate,A,
,14839,Macaca fascicularis,1,,N,100710,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,,,BAO_0000218,,8277,,1,9541.0,CHEMBL624519,,,Intermediate,A,
,14839,Macaca fascicularis,1,,N,100710,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,,,BAO_0000218,,8278,,1,9541.0,CHEMBL624520,,,Intermediate,A,
,14839,Macaca fascicularis,1,,N,100710,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,,,BAO_0000218,,8279,,1,9541.0,CHEMBL624521,,,Intermediate,A,
,14839,Macaca fascicularis,1,,N,100710,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,,,BAO_0000218,,8280,,1,9541.0,CHEMBL624522,,,Intermediate,A,
,14839,Macaca fascicularis,1,,N,100710,,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,,,BAO_0000218,,8281,,1,9541.0,CHEMBL624523,,,Intermediate,A,
,14839,Macaca fascicularis,1,,N,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,,BAO_0000218,,8282,,1,9541.0,CHEMBL624409,,,Intermediate,A,
,14839,Macaca fascicularis,1,,N,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",,,BAO_0000218,,8283,,1,9541.0,CHEMBL624410,,,Intermediate,A,
,14839,Macaca fascicularis,1,,N,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,,BAO_0000218,,8284,,1,9541.0,CHEMBL624411,,,Intermediate,A,
,14839,Macaca fascicularis,1,,N,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",,,BAO_0000218,,8285,,1,9541.0,CHEMBL623531,,,Intermediate,A,
,14839,Macaca fascicularis,1,,N,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",,,BAO_0000218,,8286,,1,9541.0,CHEMBL623532,,,Intermediate,A,
,14839,Macaca fascicularis,1,,N,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",,,BAO_0000218,,8287,,1,9541.0,CHEMBL623533,,,Intermediate,A,
,14839,Macaca fascicularis,1,,N,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,,BAO_0000218,,8288,,1,9541.0,CHEMBL623534,,,Intermediate,A,
,14839,Mus musculus,1,,N,50594,,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,,,BAO_0000218,,8289,,1,10090.0,CHEMBL623535,,,Intermediate,A,
,14839,Mus musculus,1,,N,50594,,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,,,BAO_0000218,,8290,,1,10090.0,CHEMBL623536,,,Intermediate,A,
,14839,Mus musculus,1,,N,50594,,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,,,BAO_0000218,,8291,,1,10090.0,CHEMBL623537,,,Intermediate,A,
,14839,Mus musculus,1,,N,50594,,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,,,BAO_0000218,,8292,,1,10090.0,CHEMBL623538,,,Intermediate,A,
,14839,Mus musculus,1,,N,50594,,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,,,BAO_0000218,,8293,,1,10090.0,CHEMBL623539,,,Intermediate,A,
,14839,Mus musculus,1,,N,50594,,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,,,BAO_0000218,,8294,,1,10090.0,CHEMBL623540,,,Intermediate,A,
,14839,Mus musculus,1,,N,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",,,BAO_0000218,,8295,,1,10090.0,CHEMBL623541,,,Intermediate,A,
,14839,Mus musculus,1,,N,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",,,BAO_0000218,,8296,,1,10090.0,CHEMBL623542,,,Intermediate,A,
,14839,Mus musculus,1,,N,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",,,BAO_0000218,,8297,,1,10090.0,CHEMBL623543,,,Intermediate,A,
,14839,Mus musculus,1,,N,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",,,BAO_0000218,,8298,,1,10090.0,CHEMBL623544,,,Intermediate,A,
,14839,Mus musculus,1,,N,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",,,BAO_0000218,,8299,,1,10090.0,CHEMBL623545,,,Intermediate,A,
,14839,Mus musculus,1,,N,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",,,BAO_0000218,,8300,,1,10090.0,CHEMBL623546,,,Intermediate,A,
,5408,Rattus norvegicus,1,,N,50597,,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,,,BAO_0000218,,8301,Plasma,1,10116.0,CHEMBL623547,In vivo,1969.0,Intermediate,A,
,6827,Rattus norvegicus,1,,N,50597,,High i.v. clearance in Dawley rats,,,BAO_0000218,,8302,,1,10116.0,CHEMBL623548,In vivo,,Intermediate,A,
,17538,Rattus norvegicus,1,,N,50597,,In vitro clearance in rat liver microsomes,,,BAO_0000218,,8303,Liver,1,10116.0,CHEMBL623549,In vitro,2107.0,Intermediate,A,Microsomes
,6331,Rattus norvegicus,1,,N,50597,,Intrinsic clearance in rat liver microsomes was determined,,,BAO_0000218,,8304,Liver,1,10116.0,CHEMBL623550,In vitro,2107.0,Intermediate,A,Microsomes
401.0,5948,Rattus norvegicus,1,Hepatocyte,N,50597,,Intrinsic clearance in rat hepatocytes was determined,,,BAO_0000218,,8305,Liver,1,10116.0,CHEMBL875276,In vitro,2107.0,Intermediate,A,
,4026,Rattus norvegicus,1,,N,50597,,Plasma Clearance was determined,,,BAO_0000218,,8306,,1,10116.0,CHEMBL621872,In vivo,,Intermediate,A,
,6647,Rattus norvegicus,1,,N,50597,,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,,,BAO_0000218,,8307,,1,10116.0,CHEMBL621873,In vivo,,Intermediate,A,
,1696,Rattus norvegicus,1,,N,50597,,Plasma clearance in rat.,,,BAO_0000218,,8308,,1,10116.0,CHEMBL621874,In vivo,,Intermediate,A,
,6597,Rattus norvegicus,1,,N,50597,,Plasma clearance in rats,,,BAO_0000218,,8309,,1,10116.0,CHEMBL621875,In vivo,,Intermediate,A,
,347,Rattus norvegicus,1,,N,50597,,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,,,BAO_0000218,,8310,,1,10116.0,CHEMBL621876,In vivo,,Intermediate,A,
,16423,Rattus norvegicus,1,,N,50597,,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,,,BAO_0000218,,8311,,1,10116.0,CHEMBL621877,In vivo,,Intermediate,A,
,2879,Rattus norvegicus,1,,N,50597,,Plasma clearance was measured in rat,,,BAO_0000218,,8312,,1,10116.0,CHEMBL621878,In vivo,,Intermediate,A,
,4883,Rattus norvegicus,1,,N,50597,,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,,BAO_0000218,,8313,,1,10116.0,CHEMBL621879,In vivo,,Intermediate,A,
,5328,Rattus norvegicus,1,,N,50597,,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",,,BAO_0000218,,8314,Plasma,1,10116.0,CHEMBL621880,In vivo,1969.0,Intermediate,A,
,5160,Rattus norvegicus,1,,N,50597,,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,,,BAO_0000218,,8315,,1,10116.0,CHEMBL621881,In vivo,,Intermediate,A,
,17582,Rattus norvegicus,1,,N,50597,,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,,BAO_0000218,,8316,,1,10116.0,CHEMBL621882,In vivo,,Intermediate,A,
,17651,Rattus norvegicus,1,,N,50597,,Total clearance at 1 mg/kg was determined in rat,,,BAO_0000218,,8317,,1,10116.0,CHEMBL875283,In vivo,,Intermediate,A,
,17651,Rattus norvegicus,1,,N,50597,,Total clearance at 10 mg/kg was determined in rat,,,BAO_0000218,,8318,,1,10116.0,CHEMBL621883,In vivo,,Intermediate,A,
,6596,Rattus norvegicus,1,,N,50597,,Clearance in rat,,,BAO_0000218,,8319,,1,10116.0,CHEMBL621884,In vivo,,Intermediate,A,
,4796,Rattus norvegicus,1,,N,50597,,Plasma clearance rate determined in rats,,,BAO_0000218,,8320,,1,10116.0,CHEMBL621885,In vivo,,Intermediate,A,
,6850,Rattus norvegicus,1,,N,50597,,Clearance of compound in rat was evaluated,,,BAO_0000218,,8321,,1,10116.0,CHEMBL621886,In vivo,,Intermediate,A,
,5932,Rattus norvegicus,1,,N,50597,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,,BAO_0000218,,8322,Plasma,1,10116.0,CHEMBL621887,In vivo,1969.0,Intermediate,A,
,3371,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (blood clearance) in rat,,,BAO_0000218,,8323,,1,10116.0,CHEMBL621888,In vivo,,Intermediate,A,
,2083,Rattus norvegicus,1,,N,50597,,Plasma clearance in rat,,,BAO_0000218,,8324,,1,10116.0,CHEMBL621889,In vivo,,Intermediate,A,
,4942,Rattus norvegicus,1,,N,50597,,Plasma clearance in rats,,,BAO_0000218,,8325,,1,10116.0,CHEMBL621890,In vivo,,Intermediate,A,
,6838,Rattus norvegicus,1,,N,50597,,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,,,BAO_0000218,,8326,Liver,1,10116.0,CHEMBL621891,In vitro,2107.0,Intermediate,A,Microsomes
,5353,Rattus norvegicus,1,,N,50597,,Clearance in Dawley rat,,,BAO_0000218,,8327,,1,10116.0,CHEMBL621892,In vivo,,Intermediate,A,
,6641,Rattus norvegicus,1,,N,50597,,Clearance rat,,,BAO_0000218,,8328,,1,10116.0,CHEMBL621893,In vivo,,Intermediate,A,
,6641,Rattus norvegicus,1,,N,50597,,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),,,BAO_0000218,,8329,,1,10116.0,CHEMBL621894,In vivo,,Intermediate,A,
,6641,Rattus norvegicus,1,,N,50597,,Clearance rat; Not determined,,,BAO_0000218,,8330,,1,10116.0,CHEMBL621895,In vivo,,Intermediate,A,
,6444,Rattus norvegicus,1,,N,50597,,Clearance rate was determined in rat at a dose of 1 mpk i.v.,,,BAO_0000218,,8331,,1,10116.0,CHEMBL875284,In vivo,,Intermediate,A,
,6444,Rattus norvegicus,1,,N,50597,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,,BAO_0000218,,8332,,1,10116.0,CHEMBL618699,In vivo,,Intermediate,A,
,6444,Rattus norvegicus,1,,N,50597,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,,BAO_0000218,,8333,,1,10116.0,CHEMBL618700,In vivo,,Intermediate,A,
,6211,Rattus norvegicus,1,,N,50597,,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,,BAO_0000218,,8334,,1,10116.0,CHEMBL618701,In vivo,,Intermediate,A,
,12873,Rattus norvegicus,1,,N,50597,,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,,BAO_0000218,,8335,Plasma,1,10116.0,CHEMBL876600,In vivo,1969.0,Intermediate,A,
,6570,Rattus norvegicus,1,,N,50597,,Clearance of compound in rat after 1 mg/kg i.v. administration,,,BAO_0000218,,8336,,1,10116.0,CHEMBL618702,In vivo,,Intermediate,A,
,3341,Rattus norvegicus,1,,N,50597,,Compound was evaluated for Hepatic clearance in rat,,,BAO_0000218,,8337,,1,10116.0,CHEMBL618703,In vivo,,Intermediate,A,
,4891,Rattus norvegicus,1,,N,50597,,In vivo clearance after 5 mg/kg dose,,,BAO_0000218,,8338,,1,10116.0,CHEMBL618704,In vivo,,Intermediate,A,
,1094,Rattus norvegicus,1,,N,50597,,Compound was tested for plasma clearance in rats,,,BAO_0000218,,8339,Plasma,1,10116.0,CHEMBL618705,In vivo,1969.0,Intermediate,A,
,2938,Rattus norvegicus,1,,N,50597,,Hepatic clearance after intravenous administration was evaluated in rat,,,BAO_0000218,,8340,,1,10116.0,CHEMBL618706,In vivo,,Intermediate,A,
,17853,Rattus norvegicus,1,,N,50597,,Lower clearance in rat (i.v.) at 0.5 mpk,,,BAO_0000218,,8341,,1,10116.0,CHEMBL618707,In vivo,,Intermediate,A,
,6049,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter expressed as plasma clearance in rat,,,BAO_0000218,,8342,Plasma,1,10116.0,CHEMBL618708,In vivo,1969.0,Intermediate,A,
,5789,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (Clp) in rat,,,BAO_0000218,,8343,,1,10116.0,CHEMBL618709,In vivo,,Intermediate,A,
,4514,Rattus norvegicus,1,,N,50597,,Plasma clearance in Sprague-Dawley rats,,,BAO_0000218,,8344,,1,10116.0,CHEMBL618710,In vivo,,Intermediate,A,
,6448,Rattus norvegicus,1,,N,50597,,Plasma clearance (Clp) in rat,,,BAO_0000218,,8345,,1,10116.0,CHEMBL618711,In vivo,,Intermediate,A,
,6062,Rattus norvegicus,1,,N,50597,,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,,,BAO_0000218,,8346,,1,10116.0,CHEMBL618712,In vivo,,Intermediate,A,
,5710,Rattus norvegicus,1,,N,50597,,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,,,BAO_0000218,,8347,,1,10116.0,CHEMBL618713,In vivo,,Intermediate,A,
,4709,Rattus norvegicus,1,,N,50597,,Plasma clearance after intravenous administration of 1 mg/kg in rat,,,BAO_0000218,,8348,,1,10116.0,CHEMBL618714,In vivo,,Intermediate,A,
,4521,Rattus norvegicus,1,,N,50597,,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,,BAO_0000218,,8349,,1,10116.0,CHEMBL618715,In vivo,,Intermediate,A,
,1742,Rattus norvegicus,1,,N,50597,,Plasma clearance in rat was determined,,,BAO_0000218,,8350,,1,10116.0,CHEMBL618716,In vivo,,Intermediate,A,
,6057,Rattus norvegicus,1,,N,50597,,Plasma clearance measured in rat,,,BAO_0000218,,8351,,1,10116.0,CHEMBL876601,In vivo,,Intermediate,A,
,6057,Rattus norvegicus,1,,N,50597,,Plasma clearance was calculated in rat,,,BAO_0000218,,8352,,1,10116.0,CHEMBL618717,In vivo,,Intermediate,A,
,5145,Rattus norvegicus,1,,N,50597,,Plasma clearance in rat,,,BAO_0000218,,8353,,1,10116.0,CHEMBL618718,In vivo,,Intermediate,A,
,5833,Rattus norvegicus,1,,N,50597,,Plasma clearance in rat,,,BAO_0000218,,8354,,1,10116.0,CHEMBL618719,In vivo,,Intermediate,A,
,6453,Rattus norvegicus,1,,N,50597,,Plasma clearance in rat,,,BAO_0000218,,8355,,1,10116.0,CHEMBL618720,In vivo,,Intermediate,A,
,6640,Rattus norvegicus,1,,N,50597,,Plasma clearance in rat,,,BAO_0000218,,8356,,1,10116.0,CHEMBL618721,In vivo,,Intermediate,A,
,6305,Rattus norvegicus,1,,N,50597,,Plasma clearance in rats,,,BAO_0000218,,8357,,1,10116.0,CHEMBL621477,In vivo,,Intermediate,A,
,6642,Rattus norvegicus,1,,N,50597,,Plasma clearance in rat,,,BAO_0000218,,8358,,1,10116.0,CHEMBL621478,In vivo,,Intermediate,A,
,5472,Rattus norvegicus,1,,N,50597,,Plasma clearance was evaluated in rat,,,BAO_0000218,,8359,,1,10116.0,CHEMBL621479,In vivo,,Intermediate,A,
,5472,Rattus norvegicus,1,,N,50597,,Plasma clearance was evaluated in rat; Not tested,,,BAO_0000218,,8360,,1,10116.0,CHEMBL621480,In vivo,,Intermediate,A,
,5144,Rattus norvegicus,1,,N,50597,,Plasma clearance rate was determined for the compound in rat,,,BAO_0000218,,8361,,1,10116.0,CHEMBL621481,In vivo,,Intermediate,A,
,6685,Rattus norvegicus,1,,N,50597,,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",,,BAO_0000218,,8362,,1,10116.0,CHEMBL621482,In vivo,,Intermediate,A,
,6685,Rattus norvegicus,1,,N,50597,,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,,BAO_0000218,,8363,,1,10116.0,CHEMBL621483,In vivo,,Intermediate,A,
,6685,Rattus norvegicus,1,,N,50597,,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",,,BAO_0000218,,8364,,1,10116.0,CHEMBL621484,In vivo,,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8365,Heart,1,10116.0,CHEMBL621485,In vivo,948.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8366,Heart,1,10116.0,CHEMBL621486,In vivo,948.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8367,Intestine,1,10116.0,CHEMBL621487,In vivo,160.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8368,Intestine,1,10116.0,CHEMBL621488,In vivo,160.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8369,Intestine,1,10116.0,CHEMBL621489,In vivo,160.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8370,Intestine,1,10116.0,CHEMBL621490,In vivo,160.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8371,Intestine,1,10116.0,CHEMBL621491,In vivo,160.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8372,Kidney,1,10116.0,CHEMBL621492,In vivo,2113.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8373,Kidney,1,10116.0,CHEMBL621493,In vivo,2113.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8374,Kidney,1,10116.0,CHEMBL621494,In vivo,2113.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8375,Kidney,1,10116.0,CHEMBL621495,In vivo,2113.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8376,Kidney,1,10116.0,CHEMBL621496,In vivo,2113.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8377,Liver,1,10116.0,CHEMBL621497,In vivo,2107.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8378,Liver,1,10116.0,CHEMBL621498,In vivo,2107.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8379,Liver,1,10116.0,CHEMBL621499,In vivo,2107.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8380,Liver,1,10116.0,CHEMBL618634,In vivo,2107.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8381,Liver,1,10116.0,CHEMBL618635,In vivo,2107.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8382,Lung,1,10116.0,CHEMBL618636,In vivo,2048.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8383,Lung,1,10116.0,CHEMBL619737,In vivo,2048.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8384,Lung,1,10116.0,CHEMBL619738,In vivo,2048.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8385,Lung,1,10116.0,CHEMBL624329,In vivo,2048.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8386,Lung,1,10116.0,CHEMBL624330,In vivo,2048.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8387,Muscle tissue,1,10116.0,CHEMBL624331,In vivo,2385.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8388,Muscle tissue,1,10116.0,CHEMBL624332,In vivo,2385.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8389,Muscle tissue,1,10116.0,CHEMBL624333,In vivo,2385.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8390,Muscle tissue,1,10116.0,CHEMBL624334,In vivo,2385.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8391,Muscle tissue,1,10116.0,CHEMBL624335,In vivo,2385.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8392,Spleen,1,10116.0,CHEMBL620016,In vivo,2106.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8393,Spleen,1,10116.0,CHEMBL620169,In vivo,2106.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8394,Spleen,1,10116.0,CHEMBL620170,In vivo,2106.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8395,Spleen,1,10116.0,CHEMBL620171,In vivo,2106.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8396,Spleen,1,10116.0,CHEMBL620172,In vivo,2106.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8397,Stomach,1,10116.0,CHEMBL620173,In vivo,945.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8398,Stomach,1,10116.0,CHEMBL620174,In vivo,945.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8399,Stomach,1,10116.0,CHEMBL620175,In vivo,945.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8400,Stomach,1,10116.0,CHEMBL620176,In vivo,945.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8401,Stomach,1,10116.0,CHEMBL620177,In vivo,945.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8402,Cerebellum,1,10116.0,CHEMBL620178,,2037.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8403,Cerebellum,1,10116.0,CHEMBL620179,,2037.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8404,,1,10116.0,CHEMBL620180,,,Intermediate,A,
,6570,Rattus norvegicus,1,,N,50597,,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,,,BAO_0000218,,8405,,1,10116.0,CHEMBL620181,In vivo,,Intermediate,A,
,6571,Rattus norvegicus,1,,N,50597,,Volume of distribution of compound in rats after intravenous administration,,,BAO_0000218,,8406,,1,10116.0,CHEMBL620182,In vivo,,Intermediate,A,
,6453,Rattus norvegicus,1,,N,50597,,Volume of distribution in rat,,,BAO_0000218,,8407,,1,10116.0,CHEMBL620183,In vivo,,Intermediate,A,
,6444,Rattus norvegicus,1,,N,50597,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,,,BAO_0000218,,8408,,1,10116.0,CHEMBL620184,In vivo,,Intermediate,A,
,6444,Rattus norvegicus,1,,N,50597,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,,BAO_0000218,,8409,,1,10116.0,CHEMBL620185,In vivo,,Intermediate,A,
,6444,Rattus norvegicus,1,,N,50597,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,,BAO_0000218,,8410,,1,10116.0,CHEMBL620186,In vivo,,Intermediate,A,
,5353,Rattus norvegicus,1,,N,50597,,Volume of distribution was determined in Dawley rat,,,BAO_0000218,,8411,,1,10116.0,CHEMBL620187,In vivo,,Intermediate,A,
,5334,Rattus norvegicus,1,,N,50597,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,,BAO_0000218,,8412,,1,10116.0,CHEMBL620188,In vivo,,Intermediate,A,
,5334,Rattus norvegicus,1,,N,50597,,Volume of distribution was reported in Sprague-Dawley rat,,,BAO_0000218,,8413,,1,10116.0,CHEMBL620189,In vivo,,Intermediate,A,
,6641,Rattus norvegicus,1,,N,50597,,Volumes of distribution in rat after peroral administration,,,BAO_0000218,,8414,,1,10116.0,CHEMBL620190,In vivo,,Intermediate,A,
,6641,Rattus norvegicus,1,,N,50597,,Volumes of distribution in rat after po administration,,,BAO_0000218,,8415,,1,10116.0,CHEMBL620191,In vivo,,Intermediate,A,
,6641,Rattus norvegicus,1,,N,50597,,Volumes of distribution in rat after po administration; Not determined,,,BAO_0000218,,8416,,1,10116.0,CHEMBL620192,In vivo,,Intermediate,A,
,5676,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (Volume) in rat i.v.,,,BAO_0000218,,8417,,1,10116.0,CHEMBL620193,In vivo,,Intermediate,A,
,6410,Rattus norvegicus,1,,N,50597,,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,,,BAO_0000218,,8418,,1,10116.0,CHEMBL620194,In vivo,,Intermediate,A,
,17670,Rattus norvegicus,1,,N,50597,,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",,,BAO_0000218,,8419,,1,10116.0,CHEMBL876730,In vivo,,Intermediate,A,
,6495,Rattus norvegicus,1,,N,50597,,Volume distribution in rat after oral administration at 10 mg/kg,,,BAO_0000218,,8420,,1,10116.0,CHEMBL620195,In vivo,,Intermediate,A,
,5408,Rattus norvegicus,1,,N,50597,,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,,,BAO_0000218,,8421,,1,10116.0,CHEMBL620196,In vivo,,Intermediate,A,
,4883,Rattus norvegicus,1,,N,50597,,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,,BAO_0000218,,8422,,1,10116.0,CHEMBL620197,In vivo,,Intermediate,A,
,6647,Rattus norvegicus,1,,N,50597,,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,,,BAO_0000218,,8423,,1,10116.0,CHEMBL620198,In vivo,,Intermediate,A,
,6495,Rattus norvegicus,1,,N,50597,,Volume of distribution in rats,,,BAO_0000218,,8424,,1,10116.0,CHEMBL620199,In vivo,,Intermediate,A,
,2661,Rattus norvegicus,1,,N,50597,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,,,BAO_0000218,,8425,,1,10116.0,CHEMBL620200,In vivo,,Intermediate,A,
,2661,Rattus norvegicus,1,,N,50597,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,,,BAO_0000218,,8426,,1,10116.0,CHEMBL620201,In vivo,,Intermediate,A,
,5974,Rattus norvegicus,1,,N,50597,,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,,8427,,1,10116.0,CHEMBL620202,In vivo,,Intermediate,A,
,5974,Rattus norvegicus,1,,N,50597,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,,8428,,1,10116.0,CHEMBL620203,In vivo,,Intermediate,A,
,5974,Rattus norvegicus,1,,N,50597,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,,,BAO_0000218,,8429,,1,10116.0,CHEMBL620204,In vivo,,Intermediate,A,
,5974,Rattus norvegicus,1,,N,50597,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,,8430,,1,10116.0,CHEMBL620205,In vivo,,Intermediate,A,
,5960,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter (Vss) in rat,,,BAO_0000218,,8431,,1,10116.0,CHEMBL624664,In vivo,,Intermediate,A,
,5676,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (Volume) in rat i.v.,,,BAO_0000218,,8432,,1,10116.0,CHEMBL624665,In vivo,,Intermediate,A,
,5948,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (Vss) in rat,,,BAO_0000218,,8433,,1,10116.0,CHEMBL624666,,,Intermediate,A,
,5979,Rattus norvegicus,1,,N,50597,,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,,BAO_0000218,,8434,,1,10116.0,CHEMBL624667,In vivo,,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,,,BAO_0000218,,8435,,1,10116.0,CHEMBL624668,In vivo,,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,BAO_0000218,,8436,,1,10116.0,CHEMBL624669,In vivo,,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,BAO_0000218,,8437,,1,10116.0,CHEMBL624670,In vivo,,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,BAO_0000218,,8438,,1,10116.0,CHEMBL624671,In vivo,,Intermediate,A,
,6448,Rattus norvegicus,1,,N,50597,,Steady state volume distribution in rat,,,BAO_0000218,,8439,,1,10116.0,CHEMBL624672,In vivo,,Intermediate,A,
,12873,Rattus norvegicus,1,,N,50597,,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",,,BAO_0000218,,8440,Plasma,1,10116.0,CHEMBL624673,In vivo,1969.0,Intermediate,A,
,4576,Rattus norvegicus,1,,N,50597,,Steady state volume of distribution determined in rat,,,BAO_0000218,,8441,,1,10116.0,CHEMBL624674,In vivo,,Intermediate,A,
,17582,Rattus norvegicus,1,,N,50597,,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,,BAO_0000218,,8442,,1,10116.0,CHEMBL624675,In vivo,,Intermediate,A,
,1466,Rattus norvegicus,1,,N,50597,,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,,,BAO_0000218,,8443,,1,10116.0,CHEMBL621728,In vivo,,Intermediate,A,
,5182,Rattus norvegicus,1,,N,50597,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,,,BAO_0000218,,8444,,1,10116.0,CHEMBL621729,,,Intermediate,A,
,5182,Rattus norvegicus,1,,N,50597,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,,,BAO_0000218,,8445,,1,10116.0,CHEMBL621730,,,Intermediate,A,
,6535,Rattus norvegicus,1,,N,50597,,Volume distribution in rat after administration of 2 mg/kg iv,,,BAO_0000218,,8446,,1,10116.0,CHEMBL621731,In vivo,,Intermediate,A,
,6535,Rattus norvegicus,1,,N,50597,,Volume distribution in rat after administration of 2 mg/kg iv,,,BAO_0000218,,8447,,1,10116.0,CHEMBL621732,In vivo,,Intermediate,A,
,5041,Rattus norvegicus,1,,N,50597,,Volume in steady state distribution value was determined,,,BAO_0000218,,8448,,1,10116.0,CHEMBL621908,In vivo,,Intermediate,A,
,5041,Rattus norvegicus,1,,N,50597,,Volume in steady state distribution value was determined; ND denotes no data,,,BAO_0000218,,8449,,1,10116.0,CHEMBL875347,In vivo,,Intermediate,A,
,5041,Rattus norvegicus,1,,N,50597,,Volume in steady state distribution value was determined; ND denotes not determined,,,BAO_0000218,,8450,,1,10116.0,CHEMBL621909,In vivo,,Intermediate,A,
,17065,Rattus norvegicus,1,,N,50597,,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,,,BAO_0000218,,8451,,1,10116.0,CHEMBL621910,In vivo,,Intermediate,A,
,6597,Rattus norvegicus,1,,N,50597,,Volume of distribution at steady state was evaluated in rats,,,BAO_0000218,,8452,,1,10116.0,CHEMBL621911,In vivo,,Intermediate,A,
,15662,Rattus norvegicus,1,,N,50597,,Volume of distribution at steady state was observed after intravenous administration in rat,,,BAO_0000218,,8453,,1,10116.0,CHEMBL621912,In vivo,,Intermediate,A,
,6485,Rattus norvegicus,1,,N,50597,,Volume of distribution in steady state was determined in rat,,,BAO_0000218,,8454,,1,10116.0,CHEMBL621913,In vivo,,Intermediate,A,
,17655,Rattus norvegicus,1,,N,50597,,Volume of distribution in steady state was determined in rat,,,BAO_0000218,,8455,,1,10116.0,CHEMBL621914,In vivo,,Intermediate,A,
,6616,Rattus norvegicus,1,,N,50597,,Volume of distribution after i.v. administration,,,BAO_0000218,,8456,,1,10116.0,CHEMBL621915,In vivo,,Intermediate,A,
,1916,Rattus norvegicus,1,,N,50597,,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,,BAO_0000218,,8457,,1,10116.0,CHEMBL621916,In vivo,,Intermediate,A,
,16438,Mus musculus,1,,N,50594,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,,BAO_0000218,,8458,Liver,1,10090.0,CHEMBL621917,In vivo,2107.0,Intermediate,A,
,16438,Mus musculus,1,,N,50594,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,,BAO_0000218,,8459,Liver,1,10090.0,CHEMBL621918,In vivo,2107.0,Intermediate,A,
,16438,Mus musculus,1,,N,50594,,Biodistribution of compound (oxidized form) in spleen tissue,,,BAO_0000218,,8460,Spleen,1,10090.0,CHEMBL621919,In vivo,2106.0,Intermediate,A,
,16438,Mus musculus,1,,N,50594,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",,,BAO_0000218,,8461,Spleen,1,10090.0,CHEMBL621920,In vivo,2106.0,Intermediate,A,
,16438,Mus musculus,1,,N,50594,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",,,BAO_0000218,,8462,Spleen,1,10090.0,CHEMBL621921,In vivo,2106.0,Intermediate,A,
,16438,Mus musculus,1,,N,50594,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,,BAO_0000218,,8463,Spleen,1,10090.0,CHEMBL622401,In vivo,2106.0,Intermediate,A,
,16438,Mus musculus,1,,N,50594,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,,BAO_0000218,,8464,Spleen,1,10090.0,CHEMBL875348,In vivo,2106.0,Intermediate,A,
,16438,Mus musculus,1,,N,50594,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,,BAO_0000218,,8465,Spleen,1,10090.0,CHEMBL622402,In vivo,2106.0,Intermediate,A,
,16438,Mus musculus,1,,N,50594,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,,,BAO_0000218,,8466,Blood,1,10090.0,CHEMBL622403,In vivo,178.0,Intermediate,A,
,16438,Mus musculus,1,,N,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,,BAO_0000218,,8467,Blood,1,10090.0,CHEMBL622404,In vivo,178.0,Intermediate,A,
,16438,Mus musculus,1,,N,50594,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,,,BAO_0000218,,8468,Brain,1,10090.0,CHEMBL622405,In vivo,955.0,Intermediate,A,
,16438,Mus musculus,1,,N,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,,BAO_0000218,,8469,Brain,1,10090.0,CHEMBL622406,In vivo,955.0,Intermediate,A,
,16438,Mus musculus,1,,N,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,,BAO_0000218,,8470,Brain,1,10090.0,CHEMBL622407,In vivo,955.0,Intermediate,A,
,16438,Mus musculus,1,,N,50594,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,,,BAO_0000218,,8471,Heart,1,10090.0,CHEMBL622408,In vivo,948.0,Intermediate,A,
,16438,Mus musculus,1,,N,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,,BAO_0000218,,8472,Heart,1,10090.0,CHEMBL622409,In vivo,948.0,Intermediate,A,
,16438,Mus musculus,1,,N,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,,BAO_0000218,,8473,Heart,1,10090.0,CHEMBL622410,In vivo,948.0,Intermediate,A,
,16438,Mus musculus,1,,N,50594,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,,,BAO_0000218,,8474,Kidney,1,10090.0,CHEMBL622411,In vivo,2113.0,Intermediate,A,
,16438,Mus musculus,1,,N,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",,,BAO_0000218,,8475,Kidney,1,10090.0,CHEMBL627864,In vivo,2113.0,Intermediate,A,
,16438,Mus musculus,1,,N,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,,BAO_0000218,,8476,Kidney,1,10090.0,CHEMBL627865,In vivo,2113.0,Intermediate,A,
,16438,Mus musculus,1,,N,50594,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,,,BAO_0000218,,8477,Liver,1,10090.0,CHEMBL627866,In vivo,2107.0,Intermediate,A,
,16438,Mus musculus,1,,N,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,,BAO_0000218,,8478,Liver,1,10090.0,CHEMBL627751,In vivo,2107.0,Intermediate,A,
,16438,Mus musculus,1,,N,50594,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,,,BAO_0000218,,8479,Spleen,1,10090.0,CHEMBL627752,In vivo,2106.0,Intermediate,A,
,16438,Mus musculus,1,,N,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",,,BAO_0000218,,8480,Spleen,1,10090.0,CHEMBL627753,In vivo,2106.0,Intermediate,A,
,16438,Mus musculus,1,,N,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,,BAO_0000218,,8481,Spleen,1,10090.0,CHEMBL627754,In vivo,2106.0,Intermediate,A,
,12467,Mus musculus,1,,N,50594,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,,,BAO_0000218,,8482,,1,10090.0,CHEMBL627755,,,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8483,Brain,1,10090.0,CHEMBL627756,In vivo,955.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8484,Brain,1,10090.0,CHEMBL627757,In vivo,955.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8485,Brain,1,10090.0,CHEMBL627758,In vivo,955.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8486,Brain,1,10090.0,CHEMBL627759,In vivo,955.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8487,Brain,1,10090.0,CHEMBL627760,In vivo,955.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8488,Brain,1,10090.0,CHEMBL627761,In vivo,955.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8489,Heart,1,10090.0,CHEMBL876811,In vivo,948.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8490,Heart,1,10090.0,CHEMBL627762,In vivo,948.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8491,Heart,1,10090.0,CHEMBL627763,In vivo,948.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8492,Heart,1,10090.0,CHEMBL627764,In vivo,948.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8493,Heart,1,10090.0,CHEMBL627765,In vivo,948.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8494,Heart,1,10090.0,CHEMBL627766,In vivo,948.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8495,Kidney,1,10090.0,CHEMBL627767,In vivo,2113.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8496,Kidney,1,10090.0,CHEMBL627768,In vivo,2113.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8497,Kidney,1,10090.0,CHEMBL628422,In vivo,2113.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8498,Kidney,1,10090.0,CHEMBL628423,In vivo,2113.0,Intermediate,A,
,5089,Rattus norvegicus,1,,N,50597,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,,,BAO_0000218,,8499,,1,10116.0,CHEMBL628424,In vivo,,Intermediate,A,
,5089,Rattus norvegicus,1,,N,50597,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,,,BAO_0000218,,8500,,1,10116.0,CHEMBL628425,In vivo,,Intermediate,A,
,4257,Rattus norvegicus,1,,N,50597,,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,,,BAO_0000218,,8501,,1,10116.0,CHEMBL628426,In vivo,,Intermediate,A,
,6679,Rattus norvegicus,1,,N,50597,,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,,BAO_0000218,,8502,,1,10116.0,CHEMBL628427,In vivo,,Intermediate,A,
,5546,Rattus norvegicus,1,,N,50597,,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,,BAO_0000218,,8503,,1,10116.0,CHEMBL626938,In vivo,,Intermediate,A,
,6141,Rattus norvegicus,1,,N,50597,,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,,BAO_0000218,,8504,,1,10116.0,CHEMBL626939,In vivo,,Intermediate,A,
,5334,Rattus norvegicus,1,,N,50597,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,,BAO_0000218,,8505,,1,10116.0,CHEMBL626940,In vivo,,Intermediate,A,
,5334,Rattus norvegicus,1,,N,50597,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,,BAO_0000218,,8506,,1,10116.0,CHEMBL626941,In vivo,,Intermediate,A,
,5334,Rattus norvegicus,1,,N,50597,,Plasma clearance was reported in Sprague-Dawley rat,,,BAO_0000218,,8507,,1,10116.0,CHEMBL626942,In vivo,,Intermediate,A,
,4689,Rattus norvegicus,1,,N,50597,,Plasma clearance after intravenous administration (1 mg/kg) in rat,,,BAO_0000218,,8508,,1,10116.0,CHEMBL876812,In vivo,,Intermediate,A,
,6848,Rattus norvegicus,1,,N,50597,,Plasma clearance of compound in rats was evaluated,,,BAO_0000218,,8509,,1,10116.0,CHEMBL626943,In vivo,,Intermediate,A,
,6848,Rattus norvegicus,1,,N,50597,,Plasma clearance of compound in rats was evaluated; ND indicates not determined,,,BAO_0000218,,8510,,1,10116.0,CHEMBL626944,In vivo,,Intermediate,A,
,6467,Rattus norvegicus,1,,N,50597,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,,,BAO_0000218,,8511,,1,10116.0,CHEMBL626945,In vivo,,Intermediate,A,
,6467,Rattus norvegicus,1,,N,50597,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,,BAO_0000218,,8512,,1,10116.0,CHEMBL626946,In vivo,,Intermediate,A,
,4956,Rattus norvegicus,1,,N,50597,,Plasma clearance rate in Sprague-Dawley rats,,,BAO_0000218,,8513,,1,10116.0,CHEMBL626856,In vivo,,Intermediate,A,
,5529,Rattus norvegicus,1,,N,50597,,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),,,BAO_0000218,,8514,,1,10116.0,CHEMBL626857,In vivo,,Intermediate,A,
,406,Rattus norvegicus,1,,N,50597,,The compound was evaluated for plasma clearance in rat,,,BAO_0000218,,8515,Plasma,1,10116.0,CHEMBL626858,In vivo,1969.0,Intermediate,A,
,17655,Rattus norvegicus,1,,N,50597,,Total plasma clearance in rat,,,BAO_0000218,,8516,Plasma,1,10116.0,CHEMBL627018,In vivo,1969.0,Intermediate,A,
,3293,Rattus norvegicus,1,,N,50597,,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,,,BAO_0000218,,8517,Blood,1,10116.0,CHEMBL625331,In vivo,178.0,Intermediate,A,
,4075,Rattus norvegicus,1,,N,50597,,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,,,BAO_0000218,,8518,Blood,1,10116.0,CHEMBL625332,In vivo,178.0,Intermediate,A,
,2792,Rattus norvegicus,1,,N,50597,,C max was determined at 10 mg/kg po dose in rats,,,BAO_0000218,,8519,,1,10116.0,CHEMBL877590,In vivo,,Intermediate,A,
,2792,Rattus norvegicus,1,,N,50597,,C max was determined at 3 mg/kg po dose in rats,,,BAO_0000218,,8520,,1,10116.0,CHEMBL625333,In vivo,,Intermediate,A,
,17594,Rattus norvegicus,1,,N,50597,,Cmax after repeated oral dose of compound at 1 mg/kg in rats,,,BAO_0000218,,8521,,1,10116.0,CHEMBL625334,In vivo,,Intermediate,A,
,17594,Rattus norvegicus,1,,N,50597,,Cmax after single intravenous bolus of 1 mg/kg in rats,,,BAO_0000218,,8522,,1,10116.0,CHEMBL625335,In vivo,,Intermediate,A,
,4762,Rattus norvegicus,1,,N,50597,,Cmax of compound at 5 mg/kg after po administration was determined in rat,,,BAO_0000218,,8523,,1,10116.0,CHEMBL625336,In vivo,,Intermediate,A,
,17509,Rattus norvegicus,1,,N,50597,,Cmax 24 hr after 10 mg/kg oral administration in rats,,,BAO_0000218,,8524,,1,10116.0,CHEMBL625337,In vivo,,Intermediate,A,
,17509,Rattus norvegicus,1,,N,50597,,Cmax 24 hr after 2 mg/kg oral administration in rats,,,BAO_0000218,,8525,,1,10116.0,CHEMBL625338,In vivo,,Intermediate,A,
,1466,Rattus norvegicus,1,,N,50597,,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,,,BAO_0000218,,8526,Plasma,1,10116.0,CHEMBL625339,In vivo,1969.0,Intermediate,A,
,6535,Rattus norvegicus,1,,N,50597,,Cmax in rat after administration of 2 mg/kg iv,,,BAO_0000218,,8527,,1,10116.0,CHEMBL625340,In vivo,,Intermediate,A,
,6535,Rattus norvegicus,1,,N,50597,,Cmax in rat after administration of 2 mg/kg iv,,,BAO_0000218,,8528,,1,10116.0,CHEMBL625341,In vivo,,Intermediate,A,
,3169,Rattus norvegicus,1,,N,50597,,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,,,BAO_0000218,,8529,,1,10116.0,CHEMBL622687,In vivo,,Intermediate,A,
,6515,Rattus norvegicus,1,,N,50597,,Cmax wa determined in rat plasma at 30 mg/kg after po administration,,,BAO_0000218,,8530,Plasma,1,10116.0,CHEMBL622688,In vivo,1969.0,Intermediate,A,
,11149,Rattus norvegicus,1,,N,50597,,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,,,BAO_0000218,,8531,Blood,1,10116.0,CHEMBL622689,In vivo,178.0,Intermediate,A,
,11149,Rattus norvegicus,1,,N,50597,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,,,BAO_0000218,,8532,Blood,1,10116.0,CHEMBL620295,In vivo,178.0,Intermediate,A,
,17858,Rattus norvegicus,1,,N,50597,,Cmax after 10 mg/kg oral administration in rat,,,BAO_0000218,,8533,,1,10116.0,CHEMBL620296,In vivo,,Intermediate,A,
,6518,Rattus norvegicus,1,,N,50597,,Cmax after IV dosing at 0.5 mg/kg in rat; no data,,,BAO_0000218,,8534,,1,10116.0,CHEMBL620297,In vivo,,Intermediate,A,
,6518,Rattus norvegicus,1,,N,50597,,Cmax after IV dosing at 1 mg/kg in rat; no data,,,BAO_0000218,,8535,,1,10116.0,CHEMBL620298,In vivo,,Intermediate,A,
,4426,Rattus norvegicus,1,,N,50597,,Cmax after oral administration at 20 mpk in rats,,,BAO_0000218,,8536,,1,10116.0,CHEMBL620299,In vivo,,Intermediate,A,
,4426,Rattus norvegicus,1,,N,50597,,Cmax after oral administration at 20 mpk in rats; Not performed.,,,BAO_0000218,,8537,,1,10116.0,CHEMBL620300,In vivo,,Intermediate,A,
,4426,Rattus norvegicus,1,,N,50597,,Cmax after oral administration at 20 mpk in rats d; Not performed.,,,BAO_0000218,,8538,,1,10116.0,CHEMBL620301,In vivo,,Intermediate,A,
,5656,Rattus norvegicus,1,,N,50597,,Cmax after oral administration in rat,,,BAO_0000218,,8539,,1,10116.0,CHEMBL620302,In vivo,,Intermediate,A,
,6518,Rattus norvegicus,1,,N,50597,,Cmax after oral administration at a dose of 2 mg/kg in rat,,,BAO_0000218,,8540,,1,10116.0,CHEMBL620303,In vivo,,Intermediate,A,
,6518,Rattus norvegicus,1,,N,50597,,Cmax after oral administration at a dose of 4 mg/kg in rat,,,BAO_0000218,,8541,,1,10116.0,CHEMBL620304,In vivo,,Intermediate,A,
,6113,Rattus norvegicus,1,,N,50597,,Cmax in rats after 20 mg/kg oral dose,,,BAO_0000218,,8542,,1,10116.0,CHEMBL620305,In vivo,,Intermediate,A,
,17764,Rattus norvegicus,1,,N,50597,,Cmax after peroral administration in rats at 2.4 uM/kg,,,BAO_0000218,,8543,,1,10116.0,CHEMBL620306,In vivo,,Intermediate,A,
,4756,Rattus norvegicus,1,,N,50597,,Cmax at the dose of 2 mg/Kg administered perorally in rats,,,BAO_0000218,,8544,,1,10116.0,CHEMBL620307,In vivo,,Intermediate,A,
,4756,Rattus norvegicus,1,,N,50597,,Cmax at the dose of 5 mg/Kg administered perorally in rats,,,BAO_0000218,,8545,,1,10116.0,CHEMBL620308,In vivo,,Intermediate,A,
,6402,Rattus norvegicus,1,,N,50597,,Cmax by administering at 20 mg/kg p.o. in rats,,,BAO_0000218,,8546,,1,10116.0,CHEMBL620309,In vivo,,Intermediate,A,
,5610,Rattus norvegicus,1,,N,50597,,Cmax in male rat,,,BAO_0000218,,8547,,1,10116.0,CHEMBL620310,In vivo,,Intermediate,A,
,5207,Rattus norvegicus,1,,N,50597,,Cmax in rat,,,BAO_0000218,,8548,,1,10116.0,CHEMBL620311,In vivo,,Intermediate,A,
,6011,Rattus norvegicus,1,,N,50597,,Cmax in rat,,,BAO_0000218,,8549,,1,10116.0,CHEMBL620312,In vivo,,Intermediate,A,
,6504,Rattus norvegicus,1,,N,50597,,Cmax in rat,,,BAO_0000218,,8550,,1,10116.0,CHEMBL620313,In vivo,,Intermediate,A,
,6046,Rattus norvegicus,1,,N,50597,,Cmax in rat at 10 mg/kg,,,BAO_0000218,,8551,,1,10116.0,CHEMBL620314,In vivo,,Intermediate,A,
,6504,Rattus norvegicus,1,,N,50597,,Cmax in rat at the dose of 1 mg/kg i.v.,,,BAO_0000218,,8552,,1,10116.0,CHEMBL620315,In vivo,,Intermediate,A,
,5874,Rattus norvegicus,1,,N,50597,,Cmax in rat by po administration at a dose of 40 mg/kg,,,BAO_0000218,,8553,,1,10116.0,CHEMBL620316,In vivo,,Intermediate,A,
,17686,Rattus norvegicus,1,,N,50597,,Cmax in rat p.o. at 20 mg/kg concentration,,,BAO_0000218,,8554,,1,10116.0,CHEMBL620317,In vivo,,Intermediate,A,
,5836,Rattus norvegicus,1,,N,50597,,Cmax in rats,,,BAO_0000218,,8555,,1,10116.0,CHEMBL620318,In vivo,,Intermediate,A,
,17596,Rattus norvegicus,1,,N,50597,,Cmax in rats,,,BAO_0000218,,8556,,1,10116.0,CHEMBL620319,In vivo,,Intermediate,A,
,16423,Rattus norvegicus,1,,N,50597,,Cmax was evaluated after 20 uM/kg of peroral administration,,,BAO_0000218,,8557,,1,10116.0,CHEMBL620320,In vivo,,Intermediate,A,
,17804,Rattus norvegicus,1,,N,50597,,Cmax was measured in rats after peroral administration at 3 mg/kg,,,BAO_0000218,,8558,,1,10116.0,CHEMBL620321,In vivo,,Intermediate,A,
,1908,Rattus norvegicus,1,,N,50597,,Cmax value after oral dose at a dose of 10 mg/kg in rats.,,,BAO_0000218,,8559,,1,10116.0,CHEMBL620322,In vivo,,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8560,,1,10116.0,CHEMBL620323,,,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8561,Frontal cortex,1,10116.0,CHEMBL620324,,1870.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8562,Frontal cortex,1,10116.0,CHEMBL620325,,1870.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8563,Hippocampus,1,10116.0,CHEMBL620326,,10000000.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8564,Hippocampus,1,10116.0,CHEMBL620327,,10000000.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8565,,1,10116.0,CHEMBL620328,,,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8566,,1,10116.0,CHEMBL620329,,,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8567,Midbrain,1,10116.0,CHEMBL620330,,1891.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8568,Midbrain,1,10116.0,CHEMBL875286,,1891.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8569,,1,10116.0,CHEMBL620331,,,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8570,,1,10116.0,CHEMBL620332,,,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8571,Striatum,1,10116.0,CHEMBL620333,,2435.0,Intermediate,A,
,13950,Rattus norvegicus,1,,N,50597,,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,,8572,Striatum,1,10116.0,CHEMBL620334,,2435.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,BAO_0000218,,8573,Blood,1,10116.0,CHEMBL621015,,178.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,BAO_0000218,,8574,Blood,1,10116.0,CHEMBL621016,,178.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,BAO_0000218,,8575,Blood,1,10116.0,CHEMBL621191,,178.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,BAO_0000218,,8576,Blood,1,10116.0,CHEMBL621192,,178.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,BAO_0000218,,8577,Blood,1,10116.0,CHEMBL621193,,178.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,BAO_0000218,,8578,Blood,1,10116.0,CHEMBL621194,,178.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,BAO_0000218,,8579,Blood,1,10116.0,CHEMBL624204,,178.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,BAO_0000218,,8580,Blood,1,10116.0,CHEMBL624205,,178.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,BAO_0000218,,8581,Blood,1,10116.0,CHEMBL624206,,178.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,BAO_0000218,,8582,Blood,1,10116.0,CHEMBL624207,,178.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,BAO_0000218,,8583,Blood,1,10116.0,CHEMBL624208,,178.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,BAO_0000218,,8584,Blood,1,10116.0,CHEMBL624209,,178.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,BAO_0000218,,8585,Blood,1,10116.0,CHEMBL624210,,178.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,BAO_0000218,,8586,Blood,1,10116.0,CHEMBL624211,,178.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,BAO_0000218,,8587,Blood,1,10116.0,CHEMBL624212,,178.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,BAO_0000218,,8588,Blood,1,10116.0,CHEMBL624213,,178.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,BAO_0000218,,8589,Blood,1,10116.0,CHEMBL876611,,178.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,BAO_0000218,,8590,Blood,1,10116.0,CHEMBL624214,,178.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,BAO_0000218,,8591,Blood,1,10116.0,CHEMBL624215,,178.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,BAO_0000218,,8592,Blood,1,10116.0,CHEMBL624216,,178.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,BAO_0000218,,8593,Blood,1,10116.0,CHEMBL624217,,178.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,BAO_0000218,,8594,Blood,1,10116.0,CHEMBL624218,,178.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,BAO_0000218,,8595,Blood,1,10116.0,CHEMBL624219,,178.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,BAO_0000218,,8596,Blood,1,10116.0,CHEMBL624220,,178.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,BAO_0000218,,8597,Blood,1,10116.0,CHEMBL624221,,178.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,BAO_0000218,,8598,,1,10116.0,CHEMBL624222,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,BAO_0000218,,8599,,1,10116.0,CHEMBL624223,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,BAO_0000218,,8600,,1,10116.0,CHEMBL624224,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,BAO_0000218,,8601,,1,10116.0,CHEMBL624225,,,Intermediate,A,
,17764,Rattus norvegicus,1,,N,50597,,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,,,BAO_0000218,,8602,,1,10116.0,CHEMBL622420,In vivo,,Intermediate,A,
,5031,Rattus norvegicus,1,,N,50597,,Volume of steady state distribution after i.v. administration in rats,,,BAO_0000218,,8603,,1,10116.0,CHEMBL622421,In vivo,,Intermediate,A,
,6215,Rattus norvegicus,1,,N,50597,,Vss after intravenous administration (5.0 mg/kg) was determined in rat,,,BAO_0000218,,8604,,1,10116.0,CHEMBL622422,In vivo,,Intermediate,A,
,17671,Rattus norvegicus,1,,N,50597,,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,,BAO_0000218,,8605,,1,10116.0,CHEMBL622423,In vivo,,Intermediate,A,
,17752,Rattus norvegicus,1,,N,50597,,Vss was determined,,,BAO_0000218,,8606,,1,10116.0,CHEMBL622424,In vivo,,Intermediate,A,
,6596,Rattus norvegicus,1,,N,50597,,Vss in rat,,,BAO_0000218,,8607,,1,10116.0,CHEMBL622425,In vivo,,Intermediate,A,
,16423,Rattus norvegicus,1,,N,50597,,Vss was evaluated after 10 uM/kg of intra arterial administration,,,BAO_0000218,,8608,,1,10116.0,CHEMBL876612,In vivo,,Intermediate,A,
,15662,Rattus norvegicus,1,,N,50597,,volume of distribution at steady state was observed after intravenous administration in rat,,,BAO_0000218,,8609,,1,10116.0,CHEMBL622426,In vivo,,Intermediate,A,
,6062,Rattus norvegicus,1,,N,50597,,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,,,BAO_0000218,,8610,,1,10116.0,CHEMBL622427,In vivo,,Intermediate,A,
,5874,Rattus norvegicus,1,,N,50597,,Pharmacokinetic (PK) parameter Vz in rat,,,BAO_0000218,,8611,,1,10116.0,CHEMBL622428,In vivo,,Intermediate,A,
,4942,Rattus norvegicus,1,,N,50597,,Volume distribution in rats,,,BAO_0000218,,8612,,1,10116.0,CHEMBL622429,In vivo,,Intermediate,A,
,17796,Rattus norvegicus,1,,N,50597,,Volume of distribution in rat; No data,,,BAO_0000218,,8613,,1,10116.0,CHEMBL622430,In vivo,,Intermediate,A,
,4890,Rattus norvegicus,1,,N,50597,,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,,BAO_0000218,,8614,,1,10116.0,CHEMBL622431,In vivo,,Intermediate,A,
,15765,Rattus norvegicus,1,,N,50597,,% absorption predicted from in vitro rat ileum transport studies,,,BAO_0000218,,8615,Ileum,1,10116.0,CHEMBL622432,,2116.0,Intermediate,A,
,13569,Rattus norvegicus,1,,N,50597,,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,,BAO_0000218,,8616,,1,10116.0,CHEMBL622433,In vivo,,Intermediate,A,
,13569,Rattus norvegicus,1,,N,50597,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,,BAO_0000218,,8617,,1,10116.0,CHEMBL622434,In vivo,,Intermediate,A,
,13569,Rattus norvegicus,1,,N,50597,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,,,BAO_0000218,,8618,,1,10116.0,CHEMBL622435,In vivo,,Intermediate,A,
,13569,Rattus norvegicus,1,,N,50597,,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),,,BAO_0000218,,8619,,1,10116.0,CHEMBL618748,In vivo,,Intermediate,A,
,13569,Rattus norvegicus,1,,N,50597,,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,,BAO_0000218,,8620,,1,10116.0,CHEMBL618749,In vivo,,Intermediate,A,
,13569,Rattus norvegicus,1,,N,50597,,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,,BAO_0000218,,8621,,1,10116.0,CHEMBL618750,In vivo,,Intermediate,A,
,13569,Rattus norvegicus,1,,N,50597,,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,,BAO_0000218,,8622,,1,10116.0,CHEMBL618751,In vivo,,Intermediate,A,
,13569,Rattus norvegicus,1,,N,50597,,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,,BAO_0000218,,8623,,1,10116.0,CHEMBL618752,In vivo,,Intermediate,A,
,4576,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,8624,,1,10116.0,CHEMBL618753,In vivo,,Intermediate,A,
,750,Rattus norvegicus,1,,N,50597,,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,,,BAO_0000218,,8625,Plasma,1,10116.0,CHEMBL618754,In vivo,1969.0,Intermediate,A,
,750,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,8626,,1,10116.0,CHEMBL618755,In vivo,,Intermediate,A,
,4590,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,8627,,1,10116.0,CHEMBL618756,In vivo,,Intermediate,A,
,1716,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,8628,,1,10116.0,CHEMBL618757,In vivo,,Intermediate,A,
,1974,Rattus norvegicus,1,,N,50597,,Bioavailability in rat,,,BAO_0000218,,8629,,1,10116.0,CHEMBL618758,In vivo,,Intermediate,A,
,4502,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (dose 30 mg/kg),,,BAO_0000218,,8630,,1,10116.0,CHEMBL621088,In vivo,,Intermediate,A,
,3371,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (cLogP) in rat,,,BAO_0000218,,8631,,1,10116.0,CHEMBL621089,,,Intermediate,A,
,9099,Rattus norvegicus,1,,N,50597,,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,,,BAO_0000218,,8632,Blood,1,10116.0,CHEMBL621090,,178.0,Intermediate,F,
,9099,Rattus norvegicus,1,,N,50597,,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,,,BAO_0000218,,8633,Blood,1,10116.0,CHEMBL621091,,178.0,Intermediate,F,
,4590,Rattus norvegicus,1,,N,50597,,Clearance in rat.,,,BAO_0000218,,8634,,1,10116.0,CHEMBL876731,In vivo,,Intermediate,A,
,3184,Rattus norvegicus,1,,N,50597,,Compound was evaluated for its clearance when administered intravenously in rat,,,BAO_0000218,,8635,,1,10116.0,CHEMBL621092,In vivo,,Intermediate,A,
,16456,Rattus norvegicus,1,,N,50597,,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,,BAO_0000218,,8636,,1,10116.0,CHEMBL621093,In vivo,,Intermediate,A,
,4199,Rattus norvegicus,1,,N,50597,,Blood: Brain distribution ratio is determined in rat,,,BAO_0000218,,8637,,1,10116.0,CHEMBL621094,,,Intermediate,A,
,4199,Rattus norvegicus,1,,N,50597,,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,,,BAO_0000218,,8638,,1,10116.0,CHEMBL621095,,,Intermediate,A,
,4199,Rattus norvegicus,1,,N,50597,,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,,,BAO_0000218,,8639,,1,10116.0,CHEMBL621096,,,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,,8640,Kidney,1,10116.0,CHEMBL621097,In vivo,2113.0,Intermediate,A,
,7449,Rattus norvegicus,1,,N,50597,,Percent dose excreted in 0-48 hours administered ip to male rat,,,BAO_0000218,,8641,,1,10116.0,CHEMBL621098,,,Intermediate,F,
,11977,Rattus norvegicus,1,,N,50597,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8642,Cerebellum,1,10116.0,CHEMBL621099,,2037.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8643,Cerebellum,1,10116.0,CHEMBL621100,,2037.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,BAO_0000218,,8644,Cerebellum,1,10116.0,CHEMBL621101,,2037.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8645,Cerebellum,1,10116.0,CHEMBL621102,,2037.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8646,Cerebellum,1,10116.0,CHEMBL876732,,2037.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8647,,1,10116.0,CHEMBL621103,,,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8648,,1,10116.0,CHEMBL621104,,,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,BAO_0000218,,8649,,1,10116.0,CHEMBL621105,,,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8650,,1,10116.0,CHEMBL621106,,,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8651,,1,10116.0,CHEMBL621107,,,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8652,,1,10116.0,CHEMBL621108,,,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8653,,1,10116.0,CHEMBL621109,,,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8654,Kidney,1,10090.0,CHEMBL621110,In vivo,2113.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8655,Kidney,1,10090.0,CHEMBL621111,In vivo,2113.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8656,Liver,1,10090.0,CHEMBL622541,In vivo,2107.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8657,Liver,1,10090.0,CHEMBL622542,In vivo,2107.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8658,Liver,1,10090.0,CHEMBL622543,In vivo,2107.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8659,Liver,1,10090.0,CHEMBL624412,In vivo,2107.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8660,Liver,1,10090.0,CHEMBL624413,In vivo,2107.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8661,Liver,1,10090.0,CHEMBL624414,In vivo,2107.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8662,Lung,1,10090.0,CHEMBL624415,In vivo,2048.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8663,Lung,1,10090.0,CHEMBL624416,In vivo,2048.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8664,Lung,1,10090.0,CHEMBL624417,In vivo,2048.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8665,Lung,1,10090.0,CHEMBL624418,In vivo,2048.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8666,Lung,1,10090.0,CHEMBL624419,In vivo,2048.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8667,Lung,1,10090.0,CHEMBL624420,In vivo,2048.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8668,Muscle tissue,1,10090.0,CHEMBL624421,In vivo,2385.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8669,Muscle tissue,1,10090.0,CHEMBL624422,In vivo,2385.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8670,Muscle tissue,1,10090.0,CHEMBL624423,In vivo,2385.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8671,Muscle tissue,1,10090.0,CHEMBL625123,In vivo,2385.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8672,Muscle tissue,1,10090.0,CHEMBL625124,In vivo,2385.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8673,Muscle tissue,1,10090.0,CHEMBL625125,In vivo,2385.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8674,Zone of skin,1,10090.0,CHEMBL625126,In vivo,14.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8675,Zone of skin,1,10090.0,CHEMBL626947,In vivo,14.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8676,Zone of skin,1,10090.0,CHEMBL626948,In vivo,14.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8677,Zone of skin,1,10090.0,CHEMBL626949,In vivo,14.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8678,Zone of skin,1,10090.0,CHEMBL626950,In vivo,14.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8679,Zone of skin,1,10090.0,CHEMBL626951,In vivo,14.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8680,Spleen,1,10090.0,CHEMBL626952,In vivo,2106.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8681,Spleen,1,10090.0,CHEMBL626953,In vivo,2106.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8682,Spleen,1,10090.0,CHEMBL626954,In vivo,2106.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8683,Spleen,1,10090.0,CHEMBL626955,In vivo,2106.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8684,Spleen,1,10090.0,CHEMBL626956,In vivo,2106.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8685,Spleen,1,10090.0,CHEMBL626957,In vivo,2106.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8686,Blood,1,10090.0,CHEMBL626958,In vivo,178.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8687,Blood,1,10090.0,CHEMBL626959,In vivo,178.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8688,Blood,1,10090.0,CHEMBL626960,In vivo,178.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8689,Blood,1,10090.0,CHEMBL626961,In vivo,178.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8690,Blood,1,10090.0,CHEMBL627589,In vivo,178.0,Intermediate,A,
,17208,Mus musculus,1,,N,50594,,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,,8691,Blood,1,10090.0,CHEMBL627590,In vivo,178.0,Intermediate,A,
,3132,Mus musculus,1,,N,50594,,Time taken for EC90 was determined when tested in mouse,,,BAO_0000218,,8692,,1,10090.0,CHEMBL627591,,,Intermediate,A,
,3132,Mus musculus,1,,N,50594,,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,,,BAO_0000218,,8693,,1,10090.0,CHEMBL627592,,,Intermediate,A,
,16597,Mus musculus,1,,N,50594,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),,,BAO_0000218,,8694,,1,10090.0,CHEMBL627593,In vivo,,Intermediate,A,
,5727,Mus musculus,1,,N,50594,,Half life in mice,,,BAO_0000218,,8695,,1,10090.0,CHEMBL627594,,,Intermediate,A,
,5302,Mus musculus,1,,N,50594,,Half life period in mouse after 10 mg/Kg dose,,,BAO_0000218,,8696,,1,10090.0,CHEMBL876813,In vivo,,Intermediate,A,
,5302,Mus musculus,1,,N,50594,,Half life period in mouse after 10 mg/kg dose,,,BAO_0000218,,8697,,1,10090.0,CHEMBL627595,In vivo,,Intermediate,A,
,6348,Mus musculus,1,,N,50594,,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,,,BAO_0000218,,8698,,1,10090.0,CHEMBL627596,In vivo,,Intermediate,A,
,5964,Rattus norvegicus,1,,N,50597,,Cmax value at 5 mg/kg po was determined in rat,,,BAO_0000218,,8699,,1,10116.0,CHEMBL627597,In vivo,,Intermediate,A,
,6078,Rattus norvegicus,1,,N,50597,,Cmax value evaluated in rat,,,BAO_0000218,,8700,,1,10116.0,CHEMBL627598,In vivo,,Intermediate,A,
,5206,Rattus norvegicus,1,,N,50597,,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,,,BAO_0000218,,8701,Brain,1,10116.0,CHEMBL627599,In vivo,955.0,Intermediate,A,
,2959,Rattus norvegicus,1,,N,50597,,Cmax value after administration of 20 mg/Kg oral dose in rat,,,BAO_0000218,,8702,,1,10116.0,CHEMBL627600,In vivo,,Intermediate,A,
,5964,Rattus norvegicus,1,,N,50597,,Cmax value at 1 mg/kg po in rat,,,BAO_0000218,,8703,,1,10116.0,CHEMBL627601,In vivo,,Intermediate,A,
,5964,Rattus norvegicus,1,,N,50597,,Cmax value at 5 mg/kg po in rat,,,BAO_0000218,,8704,,1,10116.0,CHEMBL627776,In vivo,,Intermediate,A,
,6757,Rattus norvegicus,1,,N,50597,,Cmax value at a dose of 10 mg/kg in male SD rats,,,BAO_0000218,,8705,,1,10116.0,CHEMBL627777,In vivo,,Intermediate,A,
,6757,Rattus norvegicus,1,,N,50597,,Cmax value at a dose of 100 mg/kg in male SD rats,,,BAO_0000218,,8706,,1,10116.0,CHEMBL627778,In vivo,,Intermediate,A,
,6757,Rattus norvegicus,1,,N,50597,,Cmax value at a dose of 50 mg/kg in male SD rats,,,BAO_0000218,,8707,,1,10116.0,CHEMBL627779,In vivo,,Intermediate,A,
,17617,Rattus norvegicus,1,,N,50597,,Cmax value in rats at 10 mg/kg,,,BAO_0000218,,8708,,1,10116.0,CHEMBL876814,In vivo,,Intermediate,A,
,1445,Rattus norvegicus,1,,N,50597,,Cmax value was evaluated in rats at a dose of 20 mg/kg,,,BAO_0000218,,8709,,1,10116.0,CHEMBL627780,In vivo,,Intermediate,A,
,6082,Rattus norvegicus,1,,N,50597,,Cmax value was determined after peroral administration of 20 mg/kg in rat,,,BAO_0000218,,8710,,1,10116.0,CHEMBL627781,In vivo,,Intermediate,A,
,1446,Rattus norvegicus,1,,N,50597,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,,BAO_0000218,,8711,,1,10116.0,CHEMBL627782,In vivo,,Intermediate,A,
,5407,Rattus norvegicus,1,,N,50597,,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,,,BAO_0000218,,8712,Plasma,1,10116.0,CHEMBL627783,In vivo,1969.0,Intermediate,A,
,2690,Rattus norvegicus,1,,N,50597,,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,,,BAO_0000218,,8713,Plasma,1,10116.0,CHEMBL627784,In vivo,1969.0,Intermediate,A,
,2661,Rattus norvegicus,1,,N,50597,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,,,BAO_0000218,,8714,,1,10116.0,CHEMBL627785,In vivo,,Intermediate,A,
,2661,Rattus norvegicus,1,,N,50597,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,,,BAO_0000218,,8715,,1,10116.0,CHEMBL627786,In vivo,,Intermediate,A,
,4891,Rattus norvegicus,1,,N,50597,,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,,,BAO_0000218,,8716,Plasma,1,10116.0,CHEMBL627787,In vivo,1969.0,Intermediate,A,
,2807,Rattus norvegicus,1,,N,50597,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,,,BAO_0000218,,8717,Plasma,1,10116.0,CHEMBL627788,In vivo,1969.0,Intermediate,A,
,2807,Rattus norvegicus,1,,N,50597,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,,,BAO_0000218,,8718,Plasma,1,10116.0,CHEMBL626579,In vivo,1969.0,Intermediate,A,
,2807,Rattus norvegicus,1,,N,50597,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,,,BAO_0000218,,8719,Plasma,1,10116.0,CHEMBL626580,In vivo,1969.0,Intermediate,A,
,3634,Rattus norvegicus,1,,N,50597,,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,,,BAO_0000218,,8720,,1,10116.0,CHEMBL876815,In vivo,,Intermediate,A,
,1881,Rattus norvegicus,1,,N,50597,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,,,BAO_0000218,,8721,Plasma,1,10116.0,CHEMBL626581,In vivo,1969.0,Intermediate,A,
,1881,Rattus norvegicus,1,,N,50597,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,,,BAO_0000218,,8722,Plasma,1,10116.0,CHEMBL626582,In vivo,1969.0,Intermediate,A,
,429,Rattus norvegicus,1,,N,50597,,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,,,BAO_0000218,,8723,,1,10116.0,CHEMBL626583,In vivo,,Intermediate,A,
,5974,Rattus norvegicus,1,,N,50597,,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,,8724,,1,10116.0,CHEMBL626205,In vivo,,Intermediate,A,
,5974,Rattus norvegicus,1,,N,50597,,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,,8725,,1,10116.0,CHEMBL626206,In vivo,,Intermediate,A,
,5974,Rattus norvegicus,1,,N,50597,,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,,8726,,1,10116.0,CHEMBL626207,In vivo,,Intermediate,A,
,5974,Rattus norvegicus,1,,N,50597,,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,,8727,,1,10116.0,CHEMBL623882,In vivo,,Intermediate,A,
,17582,Rattus norvegicus,1,,N,50597,,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,,,BAO_0000218,,8728,,1,10116.0,CHEMBL623883,In vivo,,Intermediate,A,
,17582,Rattus norvegicus,1,,N,50597,,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,,,BAO_0000218,,8729,,1,10116.0,CHEMBL623884,In vivo,,Intermediate,A,
,3032,Rattus norvegicus,1,,N,50597,,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,,BAO_0000218,,8730,Plasma,1,10116.0,CHEMBL623885,In vivo,1969.0,Intermediate,A,
,6295,Rattus norvegicus,1,,N,50597,,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,,,BAO_0000218,,8731,Plasma,1,10116.0,CHEMBL623886,In vivo,1969.0,Intermediate,A,
,6619,Rattus norvegicus,1,,N,50597,,Maximal concentration in rat was determined,,,BAO_0000218,,8732,,1,10116.0,CHEMBL623887,In vivo,,Intermediate,A,
,6616,Rattus norvegicus,1,,N,50597,,Maximal concentration after i.v. administration,,,BAO_0000218,,8733,,1,10116.0,CHEMBL623888,In vivo,,Intermediate,A,
,3249,Rattus norvegicus,1,,N,50597,,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,,,BAO_0000218,,8734,Plasma,1,10116.0,CHEMBL623889,In vivo,1969.0,Intermediate,A,
,17791,Rattus norvegicus,1,,N,50597,,Maximal plasma concentration in rat after oral administration at 50 mg/kg,,,BAO_0000218,,8735,Plasma,1,10116.0,CHEMBL623890,In vivo,1969.0,Intermediate,A,
,17791,Rattus norvegicus,1,,N,50597,,Cmax in rat plasma after oral dose (50 mg/Kg),,,BAO_0000218,,8736,Plasma,1,10116.0,CHEMBL623891,In vivo,1969.0,Intermediate,A,
,1360,Rattus norvegicus,1,,N,50597,,Maximal plasma concentration was determined.,,,BAO_0000218,,8737,Plasma,1,10116.0,CHEMBL623892,In vivo,1969.0,Intermediate,A,
,2552,Rattus norvegicus,1,,N,50597,,Maximal plasma drug concentration was determined,,,BAO_0000218,,8738,Plasma,1,10116.0,CHEMBL623893,In vivo,1969.0,Intermediate,A,
,6571,Rattus norvegicus,1,,N,50597,,Maximal concentration in rats after peroral administration,,,BAO_0000218,,8739,,1,10116.0,CHEMBL877616,In vivo,,Intermediate,A,
,6570,Rattus norvegicus,1,,N,50597,,Maximum concentration in rat after 2 mg/kg peroral administration,,,BAO_0000218,,8740,,1,10116.0,CHEMBL623894,In vivo,,Intermediate,A,
,6567,Rattus norvegicus,1,,N,50597,,Maximum concentration in rat plasma after 5 mg/kg oral gavage,,,BAO_0000218,,8741,Plasma,1,10116.0,CHEMBL623895,In vivo,1969.0,Intermediate,A,
,3031,Rattus norvegicus,1,,N,50597,,Maximum concentration of compound in rat was evaluated.,,,BAO_0000218,,8742,,1,10116.0,CHEMBL623896,In vivo,,Intermediate,A,
,3436,Rattus norvegicus,1,,N,50597,,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,,,BAO_0000218,,8743,,1,10116.0,CHEMBL623897,In vivo,,Intermediate,A,
,3436,Rattus norvegicus,1,,N,50597,,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,,,BAO_0000218,,8744,,1,10116.0,CHEMBL623898,In vivo,,Intermediate,A,
,2083,Rattus norvegicus,1,,N,50597,,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,,,BAO_0000218,,8745,,1,10116.0,CHEMBL623899,In vivo,,Intermediate,A,
,3436,Rattus norvegicus,1,,N,50597,,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,,,BAO_0000218,,8746,,1,10116.0,CHEMBL623900,In vivo,,Intermediate,A,
,4527,Rattus norvegicus,1,,N,50597,,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,,,BAO_0000218,,8747,,1,10116.0,CHEMBL623901,In vivo,,Intermediate,A,
,1974,Rattus norvegicus,1,,N,50597,,Maximum concentration was evaluated in rats,,,BAO_0000218,,8748,,1,10116.0,CHEMBL623902,In vivo,,Intermediate,A,
,3307,Rattus norvegicus,1,,N,50597,,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,,,BAO_0000218,,8749,Cerebrospinal fluid,1,10116.0,CHEMBL623903,In vivo,1359.0,Intermediate,A,
,3307,Rattus norvegicus,1,,N,50597,,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,,,BAO_0000218,,8750,Plasma,1,10116.0,CHEMBL623904,In vivo,1969.0,Intermediate,A,
,1916,Rattus norvegicus,1,,N,50597,,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,,BAO_0000218,,8751,Plasma,1,10116.0,CHEMBL877617,In vivo,1969.0,Intermediate,A,
,1500,Rattus norvegicus,1,,N,50597,,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,,,BAO_0000218,,8752,,1,10116.0,CHEMBL623905,In vivo,,Intermediate,A,
,1500,Rattus norvegicus,1,,N,50597,,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,,,BAO_0000218,,8753,,1,10116.0,CHEMBL623906,In vivo,,Intermediate,A,
,4186,Rattus norvegicus,1,,N,50597,,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,,BAO_0000218,,8754,Plasma,1,10116.0,CHEMBL623907,In vivo,1969.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,BAO_0000218,,8755,,1,10116.0,CHEMBL623908,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,,,BAO_0000218,,8756,,1,10116.0,CHEMBL623909,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,BAO_0000218,,8757,,1,10116.0,CHEMBL623910,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,BAO_0000218,,8758,,1,10116.0,CHEMBL623911,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,BAO_0000218,,8759,,1,10116.0,CHEMBL623912,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,BAO_0000218,,8760,,1,10116.0,CHEMBL624616,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,BAO_0000218,,8761,,1,10116.0,CHEMBL624617,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,BAO_0000218,,8762,,1,10116.0,CHEMBL624618,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,BAO_0000218,,8763,,1,10116.0,CHEMBL624619,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,BAO_0000218,,8764,,1,10116.0,CHEMBL624794,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,BAO_0000218,,8765,,1,10116.0,CHEMBL624795,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,BAO_0000218,,8766,,1,10116.0,CHEMBL623921,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,BAO_0000218,,8767,,1,10116.0,CHEMBL623922,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,BAO_0000218,,8768,,1,10116.0,CHEMBL623923,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,BAO_0000218,,8769,,1,10116.0,CHEMBL623924,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,BAO_0000218,,8770,,1,10116.0,CHEMBL623925,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,BAO_0000218,,8771,,1,10116.0,CHEMBL623926,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,BAO_0000218,,8772,,1,10116.0,CHEMBL623927,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,BAO_0000218,,8773,,1,10116.0,CHEMBL623928,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,BAO_0000218,,8774,,1,10116.0,CHEMBL623929,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,BAO_0000218,,8775,,1,10116.0,CHEMBL623930,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,BAO_0000218,,8776,Brain,1,10116.0,CHEMBL623931,,955.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,BAO_0000218,,8777,Brain,1,10116.0,CHEMBL622165,,955.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,BAO_0000218,,8778,Brain,1,10116.0,CHEMBL621249,,955.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,BAO_0000218,,8779,Brain,1,10116.0,CHEMBL621250,,955.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,BAO_0000218,,8780,Brain,1,10116.0,CHEMBL621448,,955.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,BAO_0000218,,8781,Brain,1,10116.0,CHEMBL621449,,955.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,BAO_0000218,,8782,Brain,1,10116.0,CHEMBL621450,,955.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,BAO_0000218,,8783,Brain,1,10116.0,CHEMBL621451,,955.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,BAO_0000218,,8784,Brain,1,10116.0,CHEMBL621452,,955.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,BAO_0000218,,8785,Brain,1,10116.0,CHEMBL621453,,955.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,BAO_0000218,,8786,Brain,1,10116.0,CHEMBL621454,,955.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,BAO_0000218,,8787,Brain,1,10116.0,CHEMBL621455,,955.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,BAO_0000218,,8788,Brain,1,10116.0,CHEMBL621456,,955.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,BAO_0000218,,8789,Brain,1,10116.0,CHEMBL625145,,955.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,BAO_0000218,,8790,Brain,1,10116.0,CHEMBL875847,,955.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,BAO_0000218,,8791,Brain,1,10116.0,CHEMBL625146,,955.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,BAO_0000218,,8792,Brain,1,10116.0,CHEMBL625147,,955.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,BAO_0000218,,8793,Brain,1,10116.0,CHEMBL625148,,955.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,BAO_0000218,,8794,Brain,1,10116.0,CHEMBL625149,,955.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,BAO_0000218,,8795,Brain,1,10116.0,CHEMBL625150,,955.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,BAO_0000218,,8796,Brain,1,10116.0,CHEMBL625151,,955.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,BAO_0000218,,8797,Brain,1,10116.0,CHEMBL625152,,955.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,BAO_0000218,,8798,Brain,1,10116.0,CHEMBL625153,,955.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,BAO_0000218,,8799,Brain,1,10116.0,CHEMBL625154,,955.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,BAO_0000218,,8800,Brain,1,10116.0,CHEMBL625155,,955.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,BAO_0000218,,8801,,1,10116.0,CHEMBL625156,,,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8802,,1,10116.0,CHEMBL624354,,,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8803,Hippocampus,1,10116.0,CHEMBL624355,,10000000.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8804,Hippocampus,1,10116.0,CHEMBL624356,,10000000.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8805,Hippocampus,1,10116.0,CHEMBL624357,,10000000.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8806,Hippocampus,1,10116.0,CHEMBL624358,,10000000.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8807,Striatum,1,10116.0,CHEMBL624359,,2435.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8808,Striatum,1,10116.0,CHEMBL624360,,2435.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,BAO_0000218,,8809,Striatum,1,10116.0,CHEMBL624361,,2435.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8810,Striatum,1,10116.0,CHEMBL624362,,2435.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8811,Striatum,1,10116.0,CHEMBL624363,,2435.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8812,Blood,1,10116.0,CHEMBL624364,In vivo,178.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8813,Blood,1,10116.0,CHEMBL624365,In vivo,178.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8814,Blood,1,10116.0,CHEMBL624366,In vivo,178.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8815,Blood,1,10116.0,CHEMBL624367,In vivo,178.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8816,Brain,1,10116.0,CHEMBL624368,In vivo,955.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8817,Brain,1,10116.0,CHEMBL624369,In vivo,955.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,BAO_0000218,,8818,Brain,1,10116.0,CHEMBL624370,In vivo,955.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8819,Brain,1,10116.0,CHEMBL625069,In vivo,955.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8820,Brain,1,10116.0,CHEMBL625070,In vivo,955.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8821,Heart,1,10116.0,CHEMBL626051,In vivo,948.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8822,Heart,1,10116.0,CHEMBL626052,In vivo,948.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,BAO_0000218,,8823,Heart,1,10116.0,CHEMBL626053,In vivo,948.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8824,Heart,1,10116.0,CHEMBL626054,In vivo,948.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8825,Heart,1,10116.0,CHEMBL626055,In vivo,948.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8826,Kidney,1,10116.0,CHEMBL626056,In vivo,2113.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8827,Kidney,1,10116.0,CHEMBL626057,In vivo,2113.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8828,Kidney,1,10116.0,CHEMBL625193,In vivo,2113.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8829,Kidney,1,10116.0,CHEMBL625194,In vivo,2113.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8830,Liver,1,10116.0,CHEMBL625195,In vivo,2107.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8831,Liver,1,10116.0,CHEMBL625196,In vivo,2107.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,BAO_0000218,,8832,Liver,1,10116.0,CHEMBL625197,In vivo,2107.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8833,Liver,1,10116.0,CHEMBL625198,In vivo,2107.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8834,Liver,1,10116.0,CHEMBL627929,In vivo,2107.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8835,Lung,1,10116.0,CHEMBL627074,In vivo,2048.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8836,Lung,1,10116.0,CHEMBL627075,In vivo,2048.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,BAO_0000218,,8837,Lung,1,10116.0,CHEMBL627076,In vivo,2048.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8838,Lung,1,10116.0,CHEMBL627077,In vivo,2048.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8839,Lung,1,10116.0,CHEMBL627078,In vivo,2048.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),,,BAO_0000218,,8840,Muscle tissue,1,10116.0,CHEMBL627079,In vivo,2385.0,Intermediate,A,
,4573,Mus musculus,1,,N,50594,,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,,,BAO_0000218,,8841,,1,10090.0,CHEMBL873824,In vivo,,Intermediate,A,
,3132,Mus musculus,1,,N,50594,,Half life in mouse plasma was determined at dose 25 mg/kg,,,BAO_0000218,,8842,Plasma,1,10090.0,CHEMBL627080,In vivo,1969.0,Intermediate,A,
,17718,Mus musculus,1,,N,50594,,Half life was determined,,,BAO_0000218,,8843,,1,10090.0,CHEMBL627081,,,Intermediate,A,
,17728,Mus musculus,1,,N,50594,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,,BAO_0000218,,8844,,1,10090.0,CHEMBL627082,In vivo,,Intermediate,A,
,5961,Mus musculus,1,,N,50594,,Half-life in male mice after 1 mg/kg intravenous dose,,,BAO_0000218,,8845,,1,10090.0,CHEMBL627083,In vivo,,Intermediate,A,
,17731,Mus musculus,1,,N,50594,,Half life in mice plasma,,,BAO_0000218,,8847,Plasma,1,10090.0,CHEMBL627085,,1969.0,Intermediate,A,
,17592,Mus musculus,1,,N,50594,,Half life in mouse,,,BAO_0000218,,8848,,1,10090.0,CHEMBL627086,,,Intermediate,A,
,3132,Mus musculus,1,,N,50594,,Half life in mouse plasma at dose 25 mg/kg,,,BAO_0000218,,8849,Plasma,1,10090.0,CHEMBL627087,In vivo,1969.0,Intermediate,A,
,17729,Mus musculus,1,,N,50594,,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,,,BAO_0000218,,8850,,1,10090.0,CHEMBL627088,In vivo,,Intermediate,A,
,17729,Mus musculus,1,,N,50594,,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,,,BAO_0000218,,8851,,1,10090.0,CHEMBL627089,In vivo,,Intermediate,A,
,17729,Mus musculus,1,,N,50594,,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,,,BAO_0000218,,8852,,1,10090.0,CHEMBL627090,In vivo,,Intermediate,A,
,3277,Mus musculus,1,,N,50594,,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),,,BAO_0000218,,8853,,1,10090.0,CHEMBL627091,In vivo,,Intermediate,A,
,3760,Mus musculus,1,,N,50594,,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",,,BAO_0000218,,8854,,1,10090.0,CHEMBL627092,In vivo,,Intermediate,A,
,3760,Mus musculus,1,,N,50594,,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",,,BAO_0000218,,8855,,1,10090.0,CHEMBL876785,In vivo,,Intermediate,A,
,2862,Mus musculus,1,,N,50594,,Half-life by iv administration in mouse,,,BAO_0000218,,8856,,1,10090.0,CHEMBL627093,In vivo,,Intermediate,A,
,2862,Mus musculus,1,,N,50594,,Half-life by oral administration in mouse,,,BAO_0000218,,8857,,1,10090.0,CHEMBL627094,In vivo,,Intermediate,A,
,5980,Mus musculus,1,,N,50594,,Half-life in mice,,,BAO_0000218,,8858,,1,10090.0,CHEMBL627095,,,Intermediate,A,
,6159,Mus musculus,1,,N,50594,,Half-life using mouse brain homogenate,,,BAO_0000218,,8859,Brain,1,10090.0,CHEMBL627096,,955.0,Intermediate,A,
,6254,Mus musculus,1,,N,50594,,Half-life was measured in mice,,,BAO_0000218,,8860,,1,10090.0,CHEMBL627097,,,Intermediate,A,
,6062,Mus musculus,1,,N,50594,,Half-life was measured in mouse after an iv dose of 1 mg/kg,,,BAO_0000218,,8861,,1,10090.0,CHEMBL627098,In vivo,,Intermediate,A,
,1574,Mus musculus,1,,N,50594,,Half-life period was determined in mouse blood,,,BAO_0000218,,8862,Blood,1,10090.0,CHEMBL627099,,178.0,Intermediate,A,
,56,Mus musculus,1,,N,50594,,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",,,BAO_0000218,,8863,Brain,1,10090.0,CHEMBL627100,,955.0,Intermediate,A,
,993,Mus musculus,1,,N,50594,,Plasma half life in mouse,,,BAO_0000218,,8864,Plasma,1,10090.0,CHEMBL627101,,1969.0,Intermediate,A,
,6652,Mus musculus,1,,N,50594,,Stability of the peptide in the presence of mouse serum,,,BAO_0000218,,8865,,1,10090.0,CHEMBL627102,,,Intermediate,A,
,17852,Mus musculus,1,,N,50594,,Terminal half life of compound was determined in mouse,,,BAO_0000218,,8866,,1,10090.0,CHEMBL627103,,,Intermediate,A,
,2675,Mus musculus,1,,N,50594,,Terminal half life was evaluated in mice after intravenous administration,,,BAO_0000218,,8867,,1,10090.0,CHEMBL627104,In vivo,,Intermediate,A,
,2675,Mus musculus,1,,N,50594,,Terminal half life was evaluated in mice after oral administration,,,BAO_0000218,,8868,,1,10090.0,CHEMBL627105,In vivo,,Intermediate,A,
,499,Mus musculus,1,,N,50594,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,,,BAO_0000218,,8869,,1,10090.0,CHEMBL876786,,,Intermediate,A,
,499,Mus musculus,1,,N,50594,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,,,BAO_0000218,,8870,,1,10090.0,CHEMBL873825,,,Intermediate,A,
,499,Mus musculus,1,,N,50594,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,,,BAO_0000218,,8871,,1,10090.0,CHEMBL627106,,,Intermediate,A,
,14239,Mus musculus,1,,N,50594,,half life period is evaluated by administering intravenously at 25 mg/kg in mice,,,BAO_0000218,,8872,,1,10090.0,CHEMBL626336,In vivo,,Intermediate,A,
,5506,Mus musculus,1,,N,50594,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",,,BAO_0000218,,8873,,1,10090.0,CHEMBL877462,In vivo,,Intermediate,A,
,5506,Mus musculus,1,,N,50594,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",,,BAO_0000218,,8874,,1,10090.0,CHEMBL626337,In vivo,,Intermediate,A,
,17734,Mus musculus,1,,N,50594,,Half life after intraperitoneal administration of 100 mg/kg in mice,,,BAO_0000218,,8875,,1,10090.0,CHEMBL626338,,,Intermediate,A,
,17728,Mus musculus,1,,N,50594,,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,,,BAO_0000218,,8876,,1,10090.0,CHEMBL626339,In vivo,,Intermediate,A,
,17728,Mus musculus,1,,N,50594,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,,BAO_0000218,,8877,,1,10090.0,CHEMBL626340,In vivo,,Intermediate,A,
,17728,Mus musculus,1,,N,50594,,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,,,BAO_0000218,,8878,,1,10090.0,CHEMBL625377,In vivo,,Intermediate,A,
,17728,Mus musculus,1,,N,50594,,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,,,BAO_0000218,,8879,,1,10090.0,CHEMBL625378,In vivo,,Intermediate,A,
,17728,Mus musculus,1,,N,50594,,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,,,BAO_0000218,,8880,,1,10090.0,CHEMBL625379,In vivo,,Intermediate,A,
,14294,Sus scrofa,1,,U,22224,,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),,,BAO_0000251,,8881,,0,9823.0,CHEMBL625380,,,Autocuration,A,Microsomes
,14294,Sus scrofa,1,,U,22224,,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),,,BAO_0000251,,8882,,0,9823.0,CHEMBL625381,,,Autocuration,A,Microsomes
,6056,Sus scrofa,1,,U,22224,,Stability to porcine renal DHP-I,,,BAO_0000019,,8883,,0,9823.0,CHEMBL625382,,,Autocuration,A,
,1317,Sus scrofa,1,,U,22224,,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,,,BAO_0000218,,8884,,0,9823.0,CHEMBL873828,In vivo,,Autocuration,A,
,1317,Sus scrofa,1,,U,22224,,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,,,BAO_0000218,,8885,,0,9823.0,CHEMBL625383,In vivo,,Autocuration,A,
,5229,Sus scrofa,1,,U,22224,,Half-life of the parent prodrug in porcine esterase solution,,,BAO_0000019,,8886,,0,9823.0,CHEMBL625384,,,Autocuration,A,
,4231,Sus scrofa,1,,U,22224,,"First order rate constant, k was determined in in pig liver Esterase",,,BAO_0000019,,8887,,0,9823.0,CHEMBL625385,,,Autocuration,A,
,4231,Sus scrofa,1,,U,22224,,Half life of the in pig liver Esterase,,,BAO_0000221,,8888,Liver,0,9823.0,CHEMBL625386,,2107.0,Autocuration,A,
,5318,Sus scrofa,1,,U,22224,,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,,,BAO_0000221,,8889,Liver,0,9823.0,CHEMBL623571,,2107.0,Autocuration,A,
,5318,Sus scrofa,1,,U,22224,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,,,BAO_0000221,,8890,Liver,0,9823.0,CHEMBL623572,,2107.0,Autocuration,A,
,5318,Sus scrofa,1,,U,22224,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,,,BAO_0000221,,8891,Liver,0,9823.0,CHEMBL623573,,2107.0,Autocuration,A,
,3305,Sus scrofa,1,,U,22224,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,,,BAO_0000221,,8892,Liver,0,9823.0,CHEMBL623574,,2107.0,Autocuration,A,
,3305,Sus scrofa,1,,U,22224,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,,,BAO_0000221,,8893,Liver,0,9823.0,CHEMBL623575,,2107.0,Autocuration,A,
,2842,Sus scrofa,1,,U,22224,,Half-life in the presence of pig liver esterase(PLE) was evaluated.,,,BAO_0000221,,8894,Liver,0,9823.0,CHEMBL623749,,2107.0,Autocuration,A,
,2842,Sus scrofa,1,,U,22224,,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,,,BAO_0000221,,8895,Liver,0,9823.0,CHEMBL623750,,2107.0,Autocuration,A,
,889,Sus scrofa,1,,U,22224,,Half-life in vitro in pig liver,,,BAO_0000221,,8896,Liver,0,9823.0,CHEMBL623751,In vitro,2107.0,Autocuration,A,
,1904,Sus scrofa,1,,U,22224,,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,,,BAO_0000221,,8897,Liver,0,9823.0,CHEMBL623752,,2107.0,Autocuration,A,
,4186,Rattus norvegicus,1,,N,50597,,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,,,BAO_0000218,,8898,Plasma,1,10116.0,CHEMBL623753,In vivo,1969.0,Intermediate,A,
,2774,Rattus norvegicus,1,,N,50597,,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,,BAO_0000218,,8899,Plasma,1,10116.0,CHEMBL623754,In vivo,1969.0,Intermediate,A,
,1742,Rattus norvegicus,1,,N,50597,,Maximum concentration in rat plasma was determined,,,BAO_0000218,,8900,Plasma,1,10116.0,CHEMBL623755,In vivo,1969.0,Intermediate,A,
,3169,Rattus norvegicus,1,,N,50597,,Maximum concentration in rats,,,BAO_0000218,,8901,,1,10116.0,CHEMBL623756,In vivo,,Intermediate,A,
,3169,Rattus norvegicus,1,,N,50597,,Maximum concentration in rats at 1-2 hours,,,BAO_0000218,,8902,,1,10116.0,CHEMBL623757,In vivo,,Intermediate,A,
,2081,Rattus norvegicus,1,,N,50597,,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,,,BAO_0000218,,8903,,1,10116.0,CHEMBL623758,In vivo,,Intermediate,A,
,3307,Rattus norvegicus,1,,N,50597,,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,,,BAO_0000218,,8904,Brain,1,10116.0,CHEMBL623759,In vivo,955.0,Intermediate,A,
,4727,Rattus norvegicus,1,,N,50597,,Maximum concentration at the dose of 2 mg/kg in rat,,,BAO_0000218,,8905,,1,10116.0,CHEMBL623760,In vivo,,Intermediate,A,
,6597,Rattus norvegicus,1,,N,50597,,Maximum concentration was evaluated in rats,,,BAO_0000218,,8906,,1,10116.0,CHEMBL623761,In vivo,,Intermediate,A,
,16365,Rattus norvegicus,1,,N,50597,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,,,BAO_0000218,,8907,Plasma,1,10116.0,CHEMBL623762,In vivo,1969.0,Intermediate,A,
,16365,Rattus norvegicus,1,,N,50597,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,,,BAO_0000218,,8908,Plasma,1,10116.0,CHEMBL877594,In vivo,1969.0,Intermediate,A,
,16365,Rattus norvegicus,1,,N,50597,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,,,BAO_0000218,,8909,Plasma,1,10116.0,CHEMBL623763,In vivo,1969.0,Intermediate,A,
,16365,Rattus norvegicus,1,,N,50597,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,,,BAO_0000218,,8910,Plasma,1,10116.0,CHEMBL623764,In vivo,1969.0,Intermediate,A,
,16365,Rattus norvegicus,1,,N,50597,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,,,BAO_0000218,,8911,Plasma,1,10116.0,CHEMBL623765,In vivo,1969.0,Intermediate,A,
,2591,Rattus norvegicus,1,,N,50597,,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,,,BAO_0000218,,8912,Blood,1,10116.0,CHEMBL623766,In vivo,178.0,Intermediate,A,
,2591,Rattus norvegicus,1,,N,50597,,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,,,BAO_0000218,,8913,Blood,1,10116.0,CHEMBL623767,In vivo,178.0,Intermediate,A,
,2591,Rattus norvegicus,1,,N,50597,,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,,,BAO_0000218,,8914,Blood,1,10116.0,CHEMBL623768,In vivo,178.0,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,,,BAO_0000218,,8915,Plasma,1,10116.0,CHEMBL623769,In vivo,1969.0,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,,,BAO_0000218,,8916,Plasma,1,10116.0,CHEMBL623770,In vivo,1969.0,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,,,BAO_0000218,,8917,Plasma,1,10116.0,CHEMBL623771,In vivo,1969.0,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,,,BAO_0000218,,8918,Plasma,1,10116.0,CHEMBL623772,In vivo,1969.0,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,,,BAO_0000218,,8919,Plasma,1,10116.0,CHEMBL623773,In vivo,1969.0,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,,,BAO_0000218,,8920,Plasma,1,10116.0,CHEMBL623774,In vivo,1969.0,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,,,BAO_0000218,,8921,Plasma,1,10116.0,CHEMBL623775,In vivo,1969.0,Intermediate,A,
,14465,Rattus norvegicus,1,,N,50597,,Cmax in rat (PO dose),,,BAO_0000218,,8922,,1,10116.0,CHEMBL623776,In vivo,,Intermediate,A,
,4723,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,BAO_0000218,,8923,Plasma,1,10116.0,CHEMBL622191,In vivo,1969.0,Intermediate,A,
,4723,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,BAO_0000218,,8924,Plasma,1,10116.0,CHEMBL622192,In vivo,1969.0,Intermediate,A,
,4576,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration determined in rat,,,BAO_0000218,,8925,Plasma,1,10116.0,CHEMBL622193,In vivo,1969.0,Intermediate,A,
,12873,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,,BAO_0000218,,8926,Plasma,1,10116.0,CHEMBL622194,In vivo,1969.0,Intermediate,A,
,12873,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,,BAO_0000218,,8927,Plasma,1,10116.0,CHEMBL622195,In vivo,1969.0,Intermediate,A,
,6824,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration in rat,,,BAO_0000218,,8928,Plasma,1,10116.0,CHEMBL622196,In vivo,1969.0,Intermediate,A,
,17065,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,,,BAO_0000218,,8929,Plasma,1,10116.0,CHEMBL622197,In vivo,1969.0,Intermediate,A,
,2932,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,,,BAO_0000218,,8930,Plasma,1,10116.0,CHEMBL622198,In vivo,1969.0,Intermediate,A,
,2932,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,,,BAO_0000218,,8931,Plasma,1,10116.0,CHEMBL622199,In vivo,1969.0,Intermediate,A,
,2879,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration of compound was measured in rat,,,BAO_0000218,,8932,Plasma,1,10116.0,CHEMBL622200,In vivo,1969.0,Intermediate,A,
,2864,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration after 20 mg/kg oral administration in rat,,,BAO_0000218,,8933,Plasma,1,10116.0,CHEMBL622201,In vivo,1969.0,Intermediate,A,
,16367,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration after oral administration to rats,,,BAO_0000218,,8934,Plasma,1,10116.0,CHEMBL623990,In vivo,1969.0,Intermediate,A,
,17717,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,BAO_0000218,,8935,Plasma,1,10116.0,CHEMBL623991,In vivo,1969.0,Intermediate,A,
,17717,Rattus norvegicus,1,,N,50597,,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",,,BAO_0000218,,8936,Plasma,1,10116.0,CHEMBL623992,In vivo,1969.0,Intermediate,A,
,17717,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,BAO_0000218,,8937,Plasma,1,10116.0,CHEMBL623993,In vivo,1969.0,Intermediate,A,
,17717,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,,,BAO_0000218,,8938,Plasma,1,10116.0,CHEMBL623994,In vivo,1969.0,Intermediate,A,
,17720,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,,,BAO_0000218,,8939,Plasma,1,10116.0,CHEMBL623995,In vivo,1969.0,Intermediate,F,
,17720,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,,,BAO_0000218,,8940,Plasma,1,10116.0,CHEMBL623996,In vivo,1969.0,Intermediate,F,
,17720,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,,,BAO_0000218,,8941,Plasma,1,10116.0,CHEMBL623997,In vivo,1969.0,Intermediate,F,
,4516,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration dosed orally in rats,,,BAO_0000218,,8942,Plasma,1,10116.0,CHEMBL623998,In vivo,1969.0,Intermediate,A,
,4516,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration dosed orally in rats after 6 hours,,,BAO_0000218,,8943,Plasma,1,10116.0,CHEMBL623999,In vivo,1969.0,Intermediate,A,
,4516,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,,,BAO_0000218,,8944,Plasma,1,10116.0,CHEMBL624000,In vivo,1969.0,Intermediate,A,
,5199,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,,BAO_0000218,,8945,Plasma,1,10116.0,CHEMBL624001,In vivo,1969.0,Intermediate,A,
,17538,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration in rat after po administration,,,BAO_0000218,,8946,Plasma,1,10116.0,CHEMBL624002,In vivo,1969.0,Intermediate,A,
,6685,Rattus norvegicus,1,,N,50597,,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",,,BAO_0000218,,8947,Plasma,1,10116.0,CHEMBL624003,In vivo,1969.0,Intermediate,A,
,6685,Rattus norvegicus,1,,N,50597,,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",,,BAO_0000218,,8948,Plasma,1,10116.0,CHEMBL624004,In vivo,1969.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,BAO_0000218,,8949,Heart,1,10116.0,CHEMBL624005,,948.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,BAO_0000218,,8950,Heart,1,10116.0,CHEMBL624006,,948.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,BAO_0000218,,8951,Heart,1,10116.0,CHEMBL624007,,948.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,BAO_0000218,,8952,Heart,1,10116.0,CHEMBL624008,,948.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,BAO_0000218,,8953,Heart,1,10116.0,CHEMBL624009,,948.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,BAO_0000218,,8954,Heart,1,10116.0,CHEMBL874387,,948.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,BAO_0000218,,8955,Heart,1,10116.0,CHEMBL624010,,948.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,,BAO_0000218,,8956,Heart,1,10116.0,CHEMBL624011,,948.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,BAO_0000218,,8957,Heart,1,10116.0,CHEMBL624012,,948.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,BAO_0000218,,8958,Heart,1,10116.0,CHEMBL624013,,948.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,BAO_0000218,,8959,Heart,1,10116.0,CHEMBL624736,,948.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,BAO_0000218,,8960,Heart,1,10116.0,CHEMBL624737,,948.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,BAO_0000218,,8961,Heart,1,10116.0,CHEMBL624738,,948.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,BAO_0000218,,8962,Heart,1,10116.0,CHEMBL624739,,948.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,BAO_0000218,,8963,Heart,1,10116.0,CHEMBL624740,,948.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,BAO_0000218,,8964,Heart,1,10116.0,CHEMBL624896,,948.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,BAO_0000218,,8965,Heart,1,10116.0,CHEMBL624897,,948.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,BAO_0000218,,8966,Heart,1,10116.0,CHEMBL624108,,948.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,BAO_0000218,,8967,Heart,1,10116.0,CHEMBL624109,,948.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,BAO_0000218,,8968,Heart,1,10116.0,CHEMBL624110,,948.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,BAO_0000218,,8969,Heart,1,10116.0,CHEMBL624111,,948.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,BAO_0000218,,8970,Heart,1,10116.0,CHEMBL624112,,948.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,BAO_0000218,,8971,Heart,1,10116.0,CHEMBL624113,,948.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,BAO_0000218,,8972,Heart,1,10116.0,CHEMBL619709,,948.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,BAO_0000218,,8973,Heart,1,10116.0,CHEMBL619710,,948.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,BAO_0000218,,8974,Kidney,1,10116.0,CHEMBL619711,,2113.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,BAO_0000218,,8975,Kidney,1,10116.0,CHEMBL619712,,2113.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,BAO_0000218,,8976,Kidney,1,10116.0,CHEMBL619713,,2113.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,BAO_0000218,,8977,Kidney,1,10116.0,CHEMBL619714,,2113.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,BAO_0000218,,8978,Kidney,1,10116.0,CHEMBL619715,,2113.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,BAO_0000218,,8979,Kidney,1,10116.0,CHEMBL619716,,2113.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,BAO_0000218,,8980,Kidney,1,10116.0,CHEMBL619717,,2113.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,BAO_0000218,,8981,Kidney,1,10116.0,CHEMBL619718,,2113.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,BAO_0000218,,8982,Kidney,1,10116.0,CHEMBL619719,,2113.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,BAO_0000218,,8983,Kidney,1,10116.0,CHEMBL875329,,2113.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,BAO_0000218,,8984,Kidney,1,10116.0,CHEMBL619720,,2113.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,BAO_0000218,,8985,Kidney,1,10116.0,CHEMBL619721,,2113.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,BAO_0000218,,8986,Kidney,1,10116.0,CHEMBL619722,,2113.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,BAO_0000218,,8987,Kidney,1,10116.0,CHEMBL619723,,2113.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,BAO_0000218,,8988,Kidney,1,10116.0,CHEMBL619724,,2113.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,BAO_0000218,,8989,Kidney,1,10116.0,CHEMBL619725,,2113.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,BAO_0000218,,8990,Kidney,1,10116.0,CHEMBL619726,,2113.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,BAO_0000218,,8991,Kidney,1,10116.0,CHEMBL619727,,2113.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,BAO_0000218,,8992,Kidney,1,10116.0,CHEMBL619728,,2113.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,BAO_0000218,,8993,Kidney,1,10116.0,CHEMBL619729,,2113.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8994,Muscle tissue,1,10116.0,CHEMBL619730,In vivo,2385.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8995,Muscle tissue,1,10116.0,CHEMBL619731,In vivo,2385.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,BAO_0000218,,8996,Muscle tissue,1,10116.0,CHEMBL619732,In vivo,2385.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8997,Muscle tissue,1,10116.0,CHEMBL619733,In vivo,2385.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8998,Muscle tissue,1,10116.0,CHEMBL619734,In vivo,2385.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,8999,Zone of skin,1,10116.0,CHEMBL619735,In vivo,14.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,9000,Zone of skin,1,10116.0,CHEMBL875330,In vivo,14.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,BAO_0000218,,9001,Zone of skin,1,10116.0,CHEMBL628465,In vivo,14.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,9002,Zone of skin,1,10116.0,CHEMBL628466,In vivo,14.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,9003,Zone of skin,1,10116.0,CHEMBL628467,In vivo,14.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,9004,Spleen,1,10116.0,CHEMBL628468,In vivo,2106.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,9005,Spleen,1,10116.0,CHEMBL628469,In vivo,2106.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,BAO_0000218,,9006,Spleen,1,10116.0,CHEMBL628470,In vivo,2106.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,9007,Spleen,1,10116.0,CHEMBL628471,In vivo,2106.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,9008,Spleen,1,10116.0,CHEMBL628472,In vivo,2106.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,9009,Thyroid gland,1,10116.0,CHEMBL625191,In vivo,2046.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,9010,Thyroid gland,1,10116.0,CHEMBL625192,In vivo,2046.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,BAO_0000218,,9011,Thyroid gland,1,10116.0,CHEMBL875337,In vivo,2046.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,9012,Thyroid gland,1,10116.0,CHEMBL626341,In vivo,2046.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,9013,Thyroid gland,1,10116.0,CHEMBL626342,In vivo,2046.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,,9014,Liver,1,10116.0,CHEMBL621943,In vivo,2107.0,Intermediate,A,
,3748,Rattus norvegicus,1,,N,50597,,Half life in rats,,,BAO_0000218,,9015,,1,10116.0,CHEMBL621944,,,Intermediate,A,
,15765,Rattus norvegicus,1,,N,50597,,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,,,BAO_0000218,,9016,,1,10116.0,CHEMBL621945,,,Intermediate,A,
,4871,Rattus norvegicus,1,,N,50597,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),,,BAO_0000218,,9017,,1,10116.0,CHEMBL621946,,,Intermediate,A,
,4871,Rattus norvegicus,1,,N,50597,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,,,BAO_0000218,,9018,,1,10116.0,CHEMBL621947,,,Intermediate,A,
,4872,Rattus norvegicus,1,,N,50597,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),,,BAO_0000218,,9019,,1,10116.0,CHEMBL621948,,,Intermediate,A,
,4872,Rattus norvegicus,1,,N,50597,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,,,BAO_0000218,,9020,,1,10116.0,CHEMBL621949,,,Intermediate,A,
,5413,Rattus norvegicus,1,,N,50597,,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),,,BAO_0000218,,9021,,1,10116.0,CHEMBL621950,,,Intermediate,A,
,5413,Rattus norvegicus,1,,N,50597,,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,,,BAO_0000218,,9022,,1,10116.0,CHEMBL621951,,,Intermediate,A,
,15272,Rattus norvegicus,1,,N,50597,,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,,,BAO_0000218,,9023,Blood,1,10116.0,CHEMBL621952,In vivo,178.0,Intermediate,A,
,4689,Rattus norvegicus,1,,N,50597,,Stability (%) in rat liver microsomes,,,BAO_0000218,,9024,Liver,1,10116.0,CHEMBL621953,,2107.0,Intermediate,A,
,6057,Rattus norvegicus,1,,N,50597,,Area under curve was calculated after intravenous administration,,,BAO_0000218,,9025,,1,10116.0,CHEMBL621954,,,Intermediate,A,
,6057,Rattus norvegicus,1,,N,50597,,Area under the curve was calculated after iv administration in rat,,,BAO_0000218,,9026,,1,10116.0,CHEMBL621955,,,Intermediate,A,
,6057,Rattus norvegicus,1,,N,50597,,Area under the curve was calculated in rat after peroral administration,,,BAO_0000218,,9027,,1,10116.0,CHEMBL621956,,,Intermediate,A,
,6211,Rattus norvegicus,1,,N,50597,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,,BAO_0000218,,9028,,1,10116.0,CHEMBL621957,,,Intermediate,A,
,5710,Rattus norvegicus,1,,N,50597,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,,,BAO_0000218,,9029,,1,10116.0,CHEMBL621958,,,Intermediate,A,
,5710,Rattus norvegicus,1,,N,50597,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,,,BAO_0000218,,9030,,1,10116.0,CHEMBL621959,,,Intermediate,A,
,17853,Rattus norvegicus,1,,N,50597,,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,,,BAO_0000218,,9031,,1,10116.0,CHEMBL621960,,,Intermediate,A,
,17853,Rattus norvegicus,1,,N,50597,,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,,,BAO_0000218,,9032,,1,10116.0,CHEMBL621961,,,Intermediate,A,
,15765,Rattus norvegicus,1,,N,50597,,p value of the compound,,,BAO_0000218,,9033,,1,10116.0,CHEMBL621962,,,Intermediate,A,
,15765,Rattus norvegicus,1,,N,50597,,p value of the compound,,,BAO_0000218,,9034,,1,10116.0,CHEMBL876787,,,Intermediate,F,
,15765,Rattus norvegicus,1,,N,50597,,p value of the compound,,,BAO_0000218,,9035,,1,10116.0,CHEMBL621963,,,Intermediate,A,
,6175,Rattus norvegicus,1,,N,50597,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,BAO_0000218,,9036,Stomach,1,10116.0,CHEMBL622637,,945.0,Intermediate,A,
,6175,Rattus norvegicus,1,,N,50597,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,BAO_0000218,,9037,Stomach,1,10116.0,CHEMBL622638,,945.0,Intermediate,A,
,6175,Rattus norvegicus,1,,N,50597,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,BAO_0000218,,9038,Stomach,1,10116.0,CHEMBL626561,,945.0,Intermediate,A,
,7991,Oryctolagus cuniculus,1,,U,22224,,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),,,BAO_0000019,,9039,,0,9986.0,CHEMBL626562,,,Autocuration,F,
,429,Oryctolagus cuniculus,1,,U,22224,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),,,BAO_0000218,,9040,,0,9986.0,CHEMBL626563,,,Autocuration,A,
,429,Oryctolagus cuniculus,1,,U,22224,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),,,BAO_0000218,,9041,,0,9986.0,CHEMBL626564,,,Autocuration,A,
,6253,Oryctolagus cuniculus,1,,U,22224,,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,,BAO_0000218,,9042,,0,9986.0,CHEMBL626565,In vivo,,Autocuration,A,
,6253,Oryctolagus cuniculus,1,,U,22224,,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,,BAO_0000218,,9043,,0,9986.0,CHEMBL626566,In vivo,,Autocuration,A,
,3615,Oryctolagus cuniculus,1,,U,22224,,Clearance rate in rabbits,,,BAO_0000218,,9044,,0,9986.0,CHEMBL626567,In vivo,,Autocuration,A,
,4059,Oryctolagus cuniculus,1,,U,22224,,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,,BAO_0000218,,9045,,0,9986.0,CHEMBL626568,In vivo,,Autocuration,A,
,5124,Oryctolagus cuniculus,1,,U,22224,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,,BAO_0000218,,9046,,0,9986.0,CHEMBL626569,In vivo,,Autocuration,A,
,5124,Oryctolagus cuniculus,1,,U,22224,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,,BAO_0000218,,9047,,0,9986.0,CHEMBL626570,In vivo,,Autocuration,A,
,5124,Oryctolagus cuniculus,1,,U,22224,,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,,BAO_0000218,,9048,,0,9986.0,CHEMBL626571,In vivo,,Autocuration,A,
,429,Oryctolagus cuniculus,1,,U,22224,,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,,,BAO_0000218,,9049,,0,9986.0,CHEMBL626572,In vivo,,Autocuration,A,
,4059,Oryctolagus cuniculus,1,,U,22224,,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,,BAO_0000218,,9050,Plasma,0,9986.0,CHEMBL626573,In vivo,1969.0,Autocuration,A,
,9659,Oryctolagus cuniculus,1,,U,22224,,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,,,BAO_0000251,,9051,Liver,0,9986.0,CHEMBL626574,,2107.0,Autocuration,A,Microsomes
,9659,Oryctolagus cuniculus,1,,U,22224,,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,,,BAO_0000251,,9052,Liver,0,9986.0,CHEMBL626575,,2107.0,Autocuration,A,Microsomes
,3639,Oryctolagus cuniculus,1,,U,22224,,Dose at which bioavailability of intravenously administered compound was tested in rabbit,,,BAO_0000218,,9053,,0,9986.0,CHEMBL626576,,,Autocuration,A,
,3639,Oryctolagus cuniculus,1,,U,22224,,Dose at which bioavailability of perorally administered compound was tested in rabbit,,,BAO_0000218,,9054,,0,9986.0,CHEMBL626577,,,Autocuration,A,
,3639,Oryctolagus cuniculus,1,,U,22224,,The compound was tested for its bioavailability in rabbit (by oral dosage).,,,BAO_0000218,,9055,,0,9986.0,CHEMBL626578,In vivo,,Autocuration,A,
,5124,Oryctolagus cuniculus,1,,U,22224,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,,BAO_0000218,,9056,,0,9986.0,CHEMBL625263,In vivo,,Autocuration,A,
,5124,Oryctolagus cuniculus,1,,U,22224,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,,BAO_0000218,,9057,,0,9986.0,CHEMBL625264,In vivo,,Autocuration,A,
,5124,Oryctolagus cuniculus,1,,U,22224,,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,,BAO_0000218,,9058,,0,9986.0,CHEMBL625265,In vivo,,Autocuration,A,
,14294,Oryctolagus cuniculus,1,,U,22224,,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),,,BAO_0000251,,9059,,0,9986.0,CHEMBL625266,,,Autocuration,A,Microsomes
,14294,Oryctolagus cuniculus,1,,U,22224,,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),,,BAO_0000251,,9060,,0,9986.0,CHEMBL876796,,,Autocuration,A,Microsomes
,429,Oryctolagus cuniculus,1,,U,22224,,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,,,BAO_0000218,,9061,,0,9986.0,CHEMBL625267,In vivo,,Autocuration,A,
,5124,Oryctolagus cuniculus,1,,U,22224,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,,BAO_0000218,,9062,Plasma,0,9986.0,CHEMBL625268,In vivo,1969.0,Autocuration,A,
,5124,Oryctolagus cuniculus,1,,U,22224,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,,BAO_0000218,,9063,Plasma,0,9986.0,CHEMBL625269,In vivo,1969.0,Autocuration,A,
,5124,Oryctolagus cuniculus,1,,U,22224,,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,,BAO_0000218,,9064,Plasma,0,9986.0,CHEMBL624689,In vivo,1969.0,Autocuration,A,
,429,Oryctolagus cuniculus,1,,U,22224,,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,,,BAO_0000218,,9065,,0,9986.0,CHEMBL624690,In vivo,,Autocuration,A,
,429,Oryctolagus cuniculus,1,,U,22224,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),,,BAO_0000218,,9066,Urine,0,9986.0,CHEMBL624691,,1088.0,Autocuration,A,
,429,Oryctolagus cuniculus,1,,U,22224,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),,,BAO_0000218,,9067,Urine,0,9986.0,CHEMBL624692,,1088.0,Autocuration,A,
,4059,Oryctolagus cuniculus,1,,U,22224,,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,,,BAO_0000218,,9068,,0,9986.0,CHEMBL624693,In vivo,,Autocuration,A,
,4137,Oryctolagus cuniculus,1,,U,22224,,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,,,BAO_0000218,,9069,,0,9986.0,CHEMBL624694,In vivo,,Autocuration,A,
,11672,Oryctolagus cuniculus,1,,U,22224,,In vitro Biological half-life in crude homogenate of rabbit renal cortex,,,BAO_0000221,,9070,,0,9986.0,CHEMBL877596,In vitro,,Autocuration,A,
,12886,Oryctolagus cuniculus,1,,U,22224,,Time within which only 10% of the drug was degraded,,,BAO_0000019,,9071,,0,9986.0,CHEMBL624695,,,Autocuration,A,
,3853,Oryctolagus cuniculus,1,,U,22224,,Half life period in rabbit liver homogenate,,,BAO_0000221,,9072,Liver,0,9986.0,CHEMBL624696,,2107.0,Autocuration,A,
,3615,Oryctolagus cuniculus,1,,U,22224,,Half life value in rabbits,,,BAO_0000019,,9073,,0,9986.0,CHEMBL624697,,,Autocuration,A,
,6253,Oryctolagus cuniculus,1,,U,22224,,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,,BAO_0000218,,9074,Blood,0,9986.0,CHEMBL624698,In vivo,178.0,Autocuration,A,
,6253,Oryctolagus cuniculus,1,,U,22224,,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,,BAO_0000218,,9075,Blood,0,9986.0,CHEMBL624699,In vivo,178.0,Autocuration,A,
,6077,Oryctolagus cuniculus,1,,U,22224,,Half-life period in rabbits following intravenous administration at 2 mg/kg,,,BAO_0000218,,9076,,0,9986.0,CHEMBL624700,In vivo,,Autocuration,A,
,17617,Rattus norvegicus,1,,N,50597,,AUC 0-8 hr value in rats at 10 mg/kg,,,BAO_0000218,,9077,Plasma,1,10116.0,CHEMBL622903,,1969.0,Intermediate,A,
,17594,Rattus norvegicus,1,,N,50597,,AUC after administration at 2000 mg/kg/day in rats,,,BAO_0000218,,9078,Plasma,1,10116.0,CHEMBL622904,,1969.0,Intermediate,A,
,6149,Rattus norvegicus,1,,N,50597,,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,,,BAO_0000218,,9079,Plasma,1,10116.0,CHEMBL622905,,1969.0,Intermediate,A,
,17260,Rattus norvegicus,1,,N,50597,,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,,BAO_0000218,,9080,Plasma,1,10116.0,CHEMBL622906,,1969.0,Intermediate,A,
,17260,Rattus norvegicus,1,,N,50597,,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,,BAO_0000218,,9081,Plasma,1,10116.0,CHEMBL622907,,1969.0,Intermediate,A,
,6644,Rattus norvegicus,1,,N,50597,,AUC in rat after oral administration at 10.5 mg/kg dose,,,BAO_0000218,,9082,Plasma,1,10116.0,CHEMBL622908,,1969.0,Intermediate,A,
,6644,Rattus norvegicus,1,,N,50597,,AUC in rat after oral administration at 11.2 mg/kg dose,,,BAO_0000218,,9083,Plasma,1,10116.0,CHEMBL622909,,1969.0,Intermediate,A,
,6644,Rattus norvegicus,1,,N,50597,,AUC in rat after oral administration at 9.7 mg/kg dose,,,BAO_0000218,,9084,Plasma,1,10116.0,CHEMBL622910,,1969.0,Intermediate,A,
,6495,Rattus norvegicus,1,,N,50597,,AUC in rat brain after oral administration at 10 mg/kg,,,BAO_0000218,,9085,Brain,1,10116.0,CHEMBL622911,,955.0,Intermediate,A,
,6504,Rattus norvegicus,1,,N,50597,,AUC in rat p.o.,,,BAO_0000218,,9086,Plasma,1,10116.0,CHEMBL622912,,1969.0,Intermediate,A,
,17686,Rattus norvegicus,1,,N,50597,,AUC in rat p.o. at 20 mg/kg concentration,,,BAO_0000218,,9087,Plasma,1,10116.0,CHEMBL622913,,1969.0,Intermediate,A,
,6495,Rattus norvegicus,1,,N,50597,,AUC in rat plasma after oral administration at 10 mg/kg,,,BAO_0000218,,9088,Plasma,1,10116.0,CHEMBL622914,,1969.0,Intermediate,A,
,216,Rattus norvegicus,1,,N,50597,,AUC in rats,,,BAO_0000218,,9089,Plasma,1,10116.0,CHEMBL622915,,1969.0,Intermediate,A,
,1908,Rattus norvegicus,1,,N,50597,,AUC value after IV dose at a dose of 5 mg/kg in rats.,,,BAO_0000218,,9090,Plasma,1,10116.0,CHEMBL622916,,1969.0,Intermediate,A,
,1908,Rattus norvegicus,1,,N,50597,,AUC value after oral dose at a dose of 10 mg/kg in rats.,,,BAO_0000218,,9091,Plasma,1,10116.0,CHEMBL622917,,1969.0,Intermediate,A,
,6685,Rattus norvegicus,1,,N,50597,,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,,BAO_0000218,,9092,Plasma,1,10116.0,CHEMBL622918,In vivo,1969.0,Intermediate,A,
,216,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,,,BAO_0000218,,9093,Plasma,1,10116.0,CHEMBL622919,In vivo,1969.0,Intermediate,A,
,6049,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration was evaluated in rat,,,BAO_0000218,,9094,Plasma,1,10116.0,CHEMBL622920,In vivo,1969.0,Intermediate,A,
,2463,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,,BAO_0000218,,9095,Plasma,1,10116.0,CHEMBL622921,In vivo,1969.0,Intermediate,A,
,6679,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,,,BAO_0000218,,9096,Plasma,1,10116.0,CHEMBL622922,In vivo,1969.0,Intermediate,A,
,6681,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,,BAO_0000218,,9097,Plasma,1,10116.0,CHEMBL622923,In vivo,1969.0,Intermediate,A,
,4890,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,,BAO_0000218,,9098,Plasma,1,10116.0,CHEMBL877604,In vivo,1969.0,Intermediate,A,
,6410,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,,,BAO_0000218,,9099,Plasma,1,10116.0,CHEMBL622924,In vivo,1969.0,Intermediate,A,
,6410,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,,,BAO_0000218,,9100,Plasma,1,10116.0,CHEMBL622925,In vivo,1969.0,Intermediate,A,
,16366,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,,,BAO_0000218,,9101,Plasma,1,10116.0,CHEMBL622926,In vivo,1969.0,Intermediate,A,
,6227,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,,,BAO_0000218,,9102,Plasma,1,10116.0,CHEMBL623625,In vivo,1969.0,Intermediate,A,
,3598,Rattus norvegicus,1,,N,50597,,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,,,BAO_0000218,,9103,Plasma,1,10116.0,CHEMBL623626,In vivo,1969.0,Expert,A,
,1465,Rattus norvegicus,1,,N,50597,,Maximum plasma drug concentration was determined,,,BAO_0000218,,9104,Plasma,1,10116.0,CHEMBL623627,In vivo,1969.0,Intermediate,A,
,4368,Rattus norvegicus,1,,N,50597,,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,,,BAO_0000218,,9105,,1,10116.0,CHEMBL623628,In vivo,,Intermediate,A,
,15662,Rattus norvegicus,1,,N,50597,,Mean peak plasma concentration was observed after intravenous administration in rat,,,BAO_0000218,,9106,Plasma,1,10116.0,CHEMBL623629,In vivo,1969.0,Intermediate,A,
,15662,Rattus norvegicus,1,,N,50597,,Mean peak plasma concentration was observed after oral administration in rat,,,BAO_0000218,,9107,Plasma,1,10116.0,CHEMBL623630,In vivo,1969.0,Intermediate,A,
,5355,Rattus norvegicus,1,,N,50597,,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,,,BAO_0000218,,9108,,1,10116.0,CHEMBL623804,In vivo,,Intermediate,A,
,5355,Rattus norvegicus,1,,N,50597,,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,,,BAO_0000218,,9109,,1,10116.0,CHEMBL623805,In vivo,,Intermediate,A,
,1567,Rattus norvegicus,1,,N,50597,,Peak oral plasma concentration was determined in rats by oral administration,,,BAO_0000218,,9110,Plasma,1,10116.0,CHEMBL623806,In vivo,1969.0,Intermediate,A,
,4026,Rattus norvegicus,1,,N,50597,,Peak plasma concentration (Cmax) was determined,,,BAO_0000218,,9111,Plasma,1,10116.0,CHEMBL623807,In vivo,1969.0,Intermediate,A,
,6193,Rattus norvegicus,1,,N,50597,,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,,,BAO_0000218,,9112,Plasma,1,10116.0,CHEMBL623808,In vivo,1969.0,Intermediate,A,
,4026,Rattus norvegicus,1,,N,50597,,Peak plasma concentration (Cmax) in rats,,,BAO_0000218,,9113,Plasma,1,10116.0,CHEMBL623809,In vivo,1969.0,Intermediate,A,
,6485,Rattus norvegicus,1,,N,50597,,Peak plasma concentration at 1 mg/kg peroral administration,,,BAO_0000218,,9114,Plasma,1,10116.0,CHEMBL623810,In vivo,1969.0,Intermediate,A,
,17655,Rattus norvegicus,1,,N,50597,,Peak plasma concentration in rat,,,BAO_0000218,,9115,Plasma,1,10116.0,CHEMBL623811,In vivo,1969.0,Intermediate,A,
,14941,Rattus norvegicus,1,,N,50597,,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",,,BAO_0000218,,9116,Plasma,1,10116.0,CHEMBL623812,In vivo,1969.0,Intermediate,A,
,5394,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,,,BAO_0000218,,9117,,1,10116.0,CHEMBL877605,In vivo,,Intermediate,A,
,4408,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (Cmax) in rat,,,BAO_0000218,,9118,,1,10116.0,CHEMBL623813,In vivo,,Intermediate,A,
,5983,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,,BAO_0000218,,9119,,1,10116.0,CHEMBL623814,In vivo,,Intermediate,A,
,4878,Rattus norvegicus,1,,N,50597,,Cmax in rat after 3mg/kg oral dose,,,BAO_0000218,,9120,,1,10116.0,CHEMBL623815,In vivo,,Intermediate,A,
,5862,Rattus norvegicus,1,,N,50597,,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,,Sprague-Dawley,BAO_0000218,,9121,,1,10116.0,CHEMBL623816,In vivo,,Intermediate,A,
,4517,Rattus norvegicus,1,,N,50597,,Cmax in rats after 20 mg/kg oral dose,,,BAO_0000218,,9122,,1,10116.0,CHEMBL623145,In vivo,,Intermediate,A,
,5932,Rattus norvegicus,1,,N,50597,,Cmax in rat plasma after 30mg/kg oral dose,,,BAO_0000218,,9123,Plasma,1,10116.0,CHEMBL623146,In vivo,1969.0,Intermediate,A,
,5436,Rattus norvegicus,1,,N,50597,,Plasma concentration after oral administration of 100 mg/kg to rats,,,BAO_0000218,,9124,Plasma,1,10116.0,CHEMBL623147,In vivo,1969.0,Intermediate,A,
,4910,Rattus norvegicus,1,,N,50597,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,,BAO_0000218,,9125,Brain,1,10116.0,CHEMBL623042,In vivo,955.0,Intermediate,A,
,4950,Rattus norvegicus,1,,N,50597,,Tested for the Cmax in rat at 10 mg/kg per orally,,,BAO_0000218,,9126,,1,10116.0,CHEMBL623043,In vivo,,Intermediate,A,
,15078,Rattus norvegicus,1,,N,50597,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,,9127,,1,10116.0,CHEMBL623044,In vivo,,Intermediate,A,
,15078,Rattus norvegicus,1,,N,50597,,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,,9128,,1,10116.0,CHEMBL623045,In vivo,,Intermediate,A,
,3360,Rattus norvegicus,1,,N,50597,,Bioavailability as oral Cmax in rats at 30 mins,,,BAO_0000218,,9129,,1,10116.0,CHEMBL623046,In vivo,,Intermediate,A,
,3360,Rattus norvegicus,1,,N,50597,,Bioavailability as oral Cmax in rats at 6hr,,,BAO_0000218,,9130,,1,10116.0,CHEMBL623226,In vivo,,Intermediate,A,
,15022,Rattus norvegicus,1,,N,50597,,The maximum concentration of compound was measured at the dose of 100 umol/kg,,,BAO_0000218,,9131,,1,10116.0,CHEMBL623227,In vivo,,Intermediate,A,
,15022,Rattus norvegicus,1,,N,50597,,The maximum concentration of compound was measured at the dose of 300 umol/kg,,,BAO_0000218,,9132,,1,10116.0,CHEMBL623228,In vivo,,Intermediate,A,
,15022,Rattus norvegicus,1,,N,50597,,The maximum concentration of compound was measured at the dose of 30 umol/kg,,,BAO_0000218,,9133,,1,10116.0,CHEMBL623229,In vivo,,Intermediate,A,
,5160,Rattus norvegicus,1,,N,50597,,The maximum plasma levels for the compounds were determined by LC-MS.,,,BAO_0000218,,9134,Plasma,1,10116.0,CHEMBL623230,In vivo,1969.0,Intermediate,A,
,15662,Rattus norvegicus,1,,N,50597,,mean peak plasma concentration was observed after intravenous administration in rat,,,BAO_0000218,,9135,Plasma,1,10116.0,CHEMBL623231,In vivo,1969.0,Intermediate,A,
,15662,Rattus norvegicus,1,,N,50597,,mean peak plasma concentration was observed after oral administration in rat,,,BAO_0000218,,9136,Plasma,1,10116.0,CHEMBL623232,In vivo,1969.0,Intermediate,A,
,4709,Rattus norvegicus,1,,N,50597,,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,,,BAO_0000218,,9137,,1,10116.0,CHEMBL623233,,,Intermediate,A,
,3535,Rattus norvegicus,1,,N,50597,,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,,,BAO_0000218,,9138,,1,10116.0,CHEMBL623234,,,Intermediate,A,
,3535,Rattus norvegicus,1,,N,50597,,Concentration in plasma (portal) following oral dose in rats at 1 hr,,,BAO_0000218,,9139,,1,10116.0,CHEMBL623235,,,Intermediate,A,
,3535,Rattus norvegicus,1,,N,50597,,Concentration in plasma (portal) following oral dose in rats at 2 hr,,,BAO_0000218,,9140,,1,10116.0,CHEMBL623236,,,Intermediate,A,
,3535,Rattus norvegicus,1,,N,50597,,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,,,BAO_0000218,,9141,,1,10116.0,CHEMBL623237,,,Intermediate,A,
,3535,Rattus norvegicus,1,,N,50597,,Concentration in plasma (systemic) following oral dose in rats at 1 hr,,,BAO_0000218,,9142,,1,10116.0,CHEMBL623238,,,Intermediate,A,
,3535,Rattus norvegicus,1,,N,50597,,Concentration in plasma (systemic) following oral dose in rats at 2 hr,,,BAO_0000218,,9143,,1,10116.0,CHEMBL623239,,,Intermediate,A,
,5005,Rattus norvegicus,1,,U,22224,,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,,,BAO_0000218,,9144,Plasma,0,10116.0,CHEMBL623240,In vivo,1969.0,Intermediate,A,
,6326,Rattus norvegicus,1,,N,50597,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",,,BAO_0000218,,9145,Hypothalamus,1,10116.0,CHEMBL623241,,1898.0,Intermediate,A,
,6326,Rattus norvegicus,1,,N,50597,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",,,BAO_0000218,,9146,Hypothalamus,1,10116.0,CHEMBL623242,,1898.0,Intermediate,A,
,6326,Rattus norvegicus,1,,N,50597,,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",,,BAO_0000218,,9147,,1,10116.0,CHEMBL874394,,,Intermediate,A,
,6326,Rattus norvegicus,1,,N,50597,,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",,,BAO_0000218,,9148,,1,10116.0,CHEMBL623243,,,Intermediate,A,
,17411,Rattus norvegicus,1,,N,50597,,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,BAO_0000218,,9149,,1,10116.0,CHEMBL623244,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,BAO_0000218,,9150,Kidney,1,10116.0,CHEMBL623245,,2113.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,BAO_0000218,,9151,Kidney,1,10116.0,CHEMBL623246,,2113.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,BAO_0000218,,9152,Kidney,1,10116.0,CHEMBL623247,,2113.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,BAO_0000218,,9153,Kidney,1,10116.0,CHEMBL623248,,2113.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,BAO_0000218,,9154,Kidney,1,10116.0,CHEMBL623249,,2113.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,BAO_0000218,,9155,Liver,1,10116.0,CHEMBL625072,,2107.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,BAO_0000218,,9156,Liver,1,10116.0,CHEMBL625073,,2107.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,BAO_0000218,,9157,Liver,1,10116.0,CHEMBL625074,,2107.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,BAO_0000218,,9158,Liver,1,10116.0,CHEMBL625075,,2107.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,,,BAO_0000218,,9159,Liver,1,10116.0,CHEMBL625076,,2107.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,BAO_0000218,,9160,Liver,1,10116.0,CHEMBL625077,,2107.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,BAO_0000218,,9161,Liver,1,10116.0,CHEMBL625078,,2107.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,BAO_0000218,,9162,Liver,1,10116.0,CHEMBL874395,,2107.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,BAO_0000218,,9163,Liver,1,10116.0,CHEMBL625079,,2107.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,BAO_0000218,,9164,Liver,1,10116.0,CHEMBL625080,,2107.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,BAO_0000218,,9165,Liver,1,10116.0,CHEMBL625081,,2107.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,BAO_0000218,,9166,Liver,1,10116.0,CHEMBL625082,,2107.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,BAO_0000218,,9167,Liver,1,10116.0,CHEMBL625083,,2107.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,BAO_0000218,,9168,Liver,1,10116.0,CHEMBL625084,,2107.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,BAO_0000218,,9169,Liver,1,10116.0,CHEMBL625085,,2107.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,BAO_0000218,,9170,Liver,1,10116.0,CHEMBL625086,,2107.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,BAO_0000218,,9171,Liver,1,10116.0,CHEMBL625087,,2107.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,BAO_0000218,,9172,Liver,1,10116.0,CHEMBL625088,,2107.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,BAO_0000218,,9173,Liver,1,10116.0,CHEMBL622205,,2107.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,BAO_0000218,,9174,Liver,1,10116.0,CHEMBL622206,,2107.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,BAO_0000218,,9175,Liver,1,10116.0,CHEMBL622207,,2107.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,BAO_0000218,,9176,Liver,1,10116.0,CHEMBL622366,,2107.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,BAO_0000218,,9177,Liver,1,10116.0,CHEMBL622367,,2107.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,BAO_0000218,,9178,Liver,1,10116.0,CHEMBL875331,,2107.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,BAO_0000218,,9179,Liver,1,10116.0,CHEMBL622368,,2107.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,BAO_0000218,,9180,Lung,1,10116.0,CHEMBL622369,,2048.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,BAO_0000218,,9181,Lung,1,10116.0,CHEMBL622370,,2048.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,BAO_0000218,,9182,Lung,1,10116.0,CHEMBL622371,,2048.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,BAO_0000218,,9183,Lung,1,10116.0,CHEMBL622372,,2048.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,BAO_0000218,,9184,Lung,1,10116.0,CHEMBL622373,,2048.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,BAO_0000218,,9185,Lung,1,10116.0,CHEMBL622374,,2048.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,BAO_0000218,,9186,Lung,1,10116.0,CHEMBL622375,,2048.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,,BAO_0000218,,9187,Lung,1,10116.0,CHEMBL622376,,2048.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,BAO_0000218,,9188,Lung,1,10116.0,CHEMBL622377,,2048.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,BAO_0000218,,9189,Lung,1,10116.0,CHEMBL622378,,2048.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,BAO_0000218,,9190,Lung,1,10116.0,CHEMBL622379,,2048.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,BAO_0000218,,9191,Lung,1,10116.0,CHEMBL622380,,2048.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,BAO_0000218,,9192,Lung,1,10116.0,CHEMBL622381,,2048.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,BAO_0000218,,9193,Lung,1,10116.0,CHEMBL622382,,2048.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,,,BAO_0000218,,9194,Lung,1,10116.0,CHEMBL622383,,2048.0,Intermediate,A,
,6175,Rattus norvegicus,1,,N,50597,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,BAO_0000218,,9195,Stomach,1,10116.0,CHEMBL875332,,945.0,Intermediate,A,
,6175,Rattus norvegicus,1,,N,50597,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,BAO_0000218,,9196,Stomach,1,10116.0,CHEMBL622384,,945.0,Intermediate,A,
,6175,Rattus norvegicus,1,,N,50597,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,BAO_0000218,,9197,Stomach,1,10116.0,CHEMBL622385,,945.0,Intermediate,A,
,6175,Rattus norvegicus,1,,N,50597,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,BAO_0000218,,9198,Stomach,1,10116.0,CHEMBL622386,,945.0,Intermediate,A,
,10839,Rattus norvegicus,1,,N,50597,,The compound was tested for the plasma binding in rat,,,BAO_0000218,,9199,,1,10116.0,CHEMBL622387,,,Intermediate,A,
,16459,Rattus norvegicus,1,,N,50597,,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",,,BAO_0000218,,9200,,1,10116.0,CHEMBL622388,,,Intermediate,A,
,16459,Rattus norvegicus,1,,N,50597,,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",,,BAO_0000218,,9201,,1,10116.0,CHEMBL622389,,,Intermediate,A,
,16459,Rattus norvegicus,1,,N,50597,,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",,,BAO_0000218,,9202,,1,10116.0,CHEMBL622390,,,Intermediate,A,
,16459,Rattus norvegicus,1,,N,50597,,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),,,BAO_0000218,,9203,,1,10116.0,CHEMBL622391,,,Intermediate,A,
,16459,Rattus norvegicus,1,,N,50597,,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),,,BAO_0000218,,9204,,1,10116.0,CHEMBL622392,,,Intermediate,A,
,16459,Rattus norvegicus,1,,N,50597,,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),,,BAO_0000218,,9205,,1,10116.0,CHEMBL622393,,,Intermediate,A,
,3278,Rattus norvegicus,1,,N,50597,,Plasma level at 2 hr after administration of the compound,,,BAO_0000218,,9206,,1,10116.0,CHEMBL622394,,,Intermediate,A,
,3278,Rattus norvegicus,1,,N,50597,,plasma level at 2 hr after administration of the compound,,,BAO_0000218,,9207,,1,10116.0,CHEMBL622395,,,Intermediate,A,
,4684,Rattus norvegicus,1,,N,50597,,Stability in rat serum measured as % recovery at 1 min,,,BAO_0000218,,9208,Serum,1,10116.0,CHEMBL622396,,1977.0,Intermediate,A,
,4684,Rattus norvegicus,1,,N,50597,,Stability in rat serum measured as % recovery at 10 min,,,BAO_0000218,,9209,Serum,1,10116.0,CHEMBL624894,,1977.0,Intermediate,A,
,4684,Rattus norvegicus,1,,N,50597,,Stability in rat serum measured as % recovery at 10 mins,,,BAO_0000218,,9210,Serum,1,10116.0,CHEMBL624895,,1977.0,Intermediate,A,
,4684,Rattus norvegicus,1,,N,50597,,Stability in rat serum measured as % recovery at 2 hr,,,BAO_0000218,,9211,Serum,1,10116.0,CHEMBL624058,,1977.0,Intermediate,A,
,4684,Rattus norvegicus,1,,N,50597,,Stability in rat serum measured as % recovery at 3 min,,,BAO_0000218,,9212,Serum,1,10116.0,CHEMBL624059,,1977.0,Intermediate,A,
,4684,Rattus norvegicus,1,,N,50597,,Stability in rat serum measured as % recovery at 3 mins,,,BAO_0000218,,9213,Serum,1,10116.0,CHEMBL624060,,1977.0,Intermediate,A,
,4684,Rattus norvegicus,1,,N,50597,,Stability in rat serum measured as % recovery at 5 min,,,BAO_0000218,,9214,Serum,1,10116.0,CHEMBL624061,,1977.0,Intermediate,A,
,4684,Rattus norvegicus,1,,N,50597,,Stability in rat serum measured as % recovery at 5 mins,,,BAO_0000218,,9215,Serum,1,10116.0,CHEMBL624062,,1977.0,Intermediate,A,
,16456,Rattus norvegicus,1,,N,50597,,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,,BAO_0000218,,9216,,1,10116.0,CHEMBL624063,In vivo,,Intermediate,A,
,16456,Rattus norvegicus,1,,N,50597,,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,,BAO_0000218,,9217,,1,10116.0,CHEMBL624064,In vivo,,Intermediate,A,
,723,Rattus norvegicus,1,,N,50597,,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,,,BAO_0000218,,9218,Plasma,1,10116.0,CHEMBL624065,,1969.0,Intermediate,A,
,723,Rattus norvegicus,1,,N,50597,,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,,,BAO_0000218,,9219,Plasma,1,10116.0,CHEMBL624066,,1969.0,Intermediate,A,
,5160,Rattus norvegicus,1,,N,50597,,Half life tested in mature male rat at a dose of 30 mg/kg,,,BAO_0000218,,9220,,1,10116.0,CHEMBL877490,In vivo,,Intermediate,A,
,4709,Rattus norvegicus,1,,N,50597,,Half life after intravenous administration of 1 mg/kg in rat,,,BAO_0000218,,9221,,1,10116.0,CHEMBL874442,In vivo,,Intermediate,A,
,5633,Rattus norvegicus,1,,N,50597,,Half life period after administration (30 mg/kg) in rat,,,BAO_0000218,,9222,,1,10116.0,CHEMBL626890,In vivo,,Intermediate,A,
,5302,Rattus norvegicus,1,,N,50597,,Half life period in rat after 5 mg/Kg dose,,,BAO_0000218,,9223,,1,10116.0,CHEMBL626891,In vivo,,Intermediate,A,
,5302,Rattus norvegicus,1,,N,50597,,Half life period in rat after 5 mg/kg dose,,,BAO_0000218,,9224,,1,10116.0,CHEMBL626892,In vivo,,Intermediate,A,
,17791,Rattus norvegicus,1,,N,50597,,Half life period was determined,,,BAO_0000218,,9225,,1,10116.0,CHEMBL626893,,,Intermediate,A,
,17791,Rattus norvegicus,1,,N,50597,,Half life period was evaluated in rat,,,BAO_0000218,,9226,,1,10116.0,CHEMBL626894,,,Intermediate,A,
,17791,Rattus norvegicus,1,,N,50597,,Half life period was evaluated in rat; 0.5-1.0,,,BAO_0000218,,9227,,1,10116.0,CHEMBL626895,,,Intermediate,A,
,17791,Rattus norvegicus,1,,N,50597,,Half life period was evaluated in rat; 5.9-7.5,,,BAO_0000218,,9228,,1,10116.0,CHEMBL626896,,,Intermediate,A,
,14512,Rattus norvegicus,1,,N,50597,,Half-life in rat plasma,,,BAO_0000218,,9229,Plasma,1,10116.0,CHEMBL626897,,1969.0,Intermediate,A,
,6230,Rattus norvegicus,1,,N,50597,,Half-life time in rat was determined,,,BAO_0000218,,9230,,1,10116.0,CHEMBL626898,,,Intermediate,A,
,3364,Rattus norvegicus,1,,N,50597,,Terminal half-life after iv administration to rats,,,BAO_0000218,,9231,,1,10116.0,CHEMBL626899,In vivo,,Intermediate,A,
,6874,Rattus norvegicus,1,,N,50597,,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,,,BAO_0000218,,9232,,1,10116.0,CHEMBL626900,In vivo,,Intermediate,A,
,857,Rattus norvegicus,1,,N,50597,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,,,BAO_0000218,,9233,,1,10116.0,CHEMBL626901,,,Intermediate,A,
,858,Rattus norvegicus,1,,N,50597,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),,,BAO_0000218,,9234,,1,10116.0,CHEMBL626902,In vivo,,Intermediate,A,
,858,Rattus norvegicus,1,,N,50597,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),,,BAO_0000218,,9235,,1,10116.0,CHEMBL626903,In vivo,,Intermediate,A,
,5355,Rattus norvegicus,1,,N,50597,,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,,,BAO_0000218,,9236,,1,10116.0,CHEMBL874443,In vivo,,Intermediate,A,
,5355,Rattus norvegicus,1,,N,50597,,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,,,BAO_0000218,,9237,,1,10116.0,CHEMBL626904,In vivo,,Intermediate,A,
,6305,Rattus norvegicus,1,,N,50597,,Half life in rats,,,BAO_0000218,,9238,,1,10116.0,CHEMBL626905,,,Intermediate,A,
,13501,Rattus norvegicus,1,,N,50597,,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,,,BAO_0000218,,9239,Plasma,1,10116.0,CHEMBL873830,In vivo,1969.0,Intermediate,A,
,17594,Rattus norvegicus,1,,N,50597,,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,,,BAO_0000218,,9240,,1,10116.0,CHEMBL626906,In vivo,,Intermediate,A,
,4186,Rattus norvegicus,1,,N,50597,,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,,BAO_0000218,,9241,Plasma,1,10116.0,CHEMBL631076,In vivo,1969.0,Intermediate,A,
,2932,Rattus norvegicus,1,,N,50597,,Biological half-life was measured in plasma of rats,,,BAO_0000218,,9242,Plasma,1,10116.0,CHEMBL631077,,1969.0,Intermediate,A,
,17065,Rattus norvegicus,1,,N,50597,,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,,,BAO_0000218,,9243,,1,10116.0,CHEMBL631078,In vivo,,Intermediate,A,
,15765,Rattus norvegicus,1,,N,50597,,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,,,BAO_0000218,,9244,,1,10116.0,CHEMBL631079,In vivo,,Intermediate,A,
,2713,Rattus norvegicus,1,,N,50597,,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,,,BAO_0000218,,9245,,1,10116.0,CHEMBL631080,In vivo,,Intermediate,A,
,2661,Rattus norvegicus,1,,N,50597,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,,,BAO_0000218,,9246,,1,10116.0,CHEMBL631081,In vivo,,Intermediate,A,
,2661,Rattus norvegicus,1,,N,50597,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,,,BAO_0000218,,9247,,1,10116.0,CHEMBL631239,In vivo,,Intermediate,A,
,740,Rattus norvegicus,1,,N,50597,,Compound was evaluated for plasma half life in rat,,,BAO_0000218,,9248,Plasma,1,10116.0,CHEMBL631240,,1969.0,Intermediate,A,
,6597,Rattus norvegicus,1,,N,50597,,AUC value at a dose of 5 mg/kg (p.o.) in rats,,,BAO_0000218,,9249,Plasma,1,10116.0,CHEMBL631241,,1969.0,Intermediate,A,
,2959,Rattus norvegicus,1,,N,50597,,AUC value after administration of 20 mg/Kg oral dose in rat,,,BAO_0000218,,9250,Plasma,1,10116.0,CHEMBL631242,,1969.0,Intermediate,A,
,17594,Rattus norvegicus,1,,N,50597,,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,,,BAO_0000218,,9251,Plasma,1,10116.0,CHEMBL631243,,1969.0,Intermediate,A,
,17596,Rattus norvegicus,1,,N,50597,,AUC0-96 after administration at 50 mg/kg,,,BAO_0000218,,9252,Plasma,1,10116.0,CHEMBL874444,,1969.0,Intermediate,A,
,17594,Rattus norvegicus,1,,N,50597,,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,,,BAO_0000218,,9253,Plasma,1,10116.0,CHEMBL631244,,1969.0,Intermediate,A,
,3293,Rattus norvegicus,1,,N,50597,,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",,,BAO_0000218,,9254,,1,10116.0,CHEMBL631245,,,Intermediate,A,
,6757,Rattus norvegicus,1,,N,50597,,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,,,BAO_0000218,,9255,,1,10116.0,CHEMBL627162,,,Intermediate,A,
,6757,Rattus norvegicus,1,,N,50597,,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,,,BAO_0000218,,9256,,1,10116.0,CHEMBL627163,,,Intermediate,A,
,6757,Rattus norvegicus,1,,N,50597,,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,,,BAO_0000218,,9257,,1,10116.0,CHEMBL627164,,,Intermediate,A,
,5979,Rattus norvegicus,1,,N,50597,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,,,BAO_0000218,,9258,Kidney,1,10116.0,CHEMBL627165,,2113.0,Intermediate,A,
,5979,Rattus norvegicus,1,,N,50597,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,,,BAO_0000218,,9259,,1,10116.0,CHEMBL627166,,,Intermediate,A,
,5979,Rattus norvegicus,1,,N,50597,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,,,BAO_0000218,,9260,,1,10116.0,CHEMBL627167,,,Intermediate,A,
,4026,Rattus norvegicus,1,,N,50597,,Area under curve (AUC) at a dose of 30 mg/kg in rats,,,BAO_0000218,,9261,,1,10116.0,CHEMBL627822,,,Intermediate,A,
,5355,Rattus norvegicus,1,,N,50597,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,,BAO_0000218,,9262,,1,10116.0,CHEMBL627823,,,Intermediate,A,
,5355,Rattus norvegicus,1,,N,50597,,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,,,BAO_0000218,,9263,,1,10116.0,CHEMBL627824,,,Intermediate,A,
,5355,Rattus norvegicus,1,,N,50597,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,,BAO_0000218,,9264,,1,10116.0,CHEMBL627825,,,Intermediate,A,
,5633,Rattus norvegicus,1,,N,50597,,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,,,BAO_0000218,,9265,,1,10116.0,CHEMBL627826,,,Intermediate,A,
,1716,Rattus norvegicus,1,,N,50597,,Area under curve (Pharmacokinetic property) was determined,,,BAO_0000218,,9266,,1,10116.0,CHEMBL627827,,,Intermediate,A,
,1716,Rattus norvegicus,1,,N,50597,,Area under curve (Pharmacokinetic property) of the compound; Not determined,,,BAO_0000218,,9267,,1,10116.0,CHEMBL627828,,,Intermediate,A,
,4689,Rattus norvegicus,1,,N,50597,,Area under curve after intravenous administration (1 mg/kg) in rat,,,BAO_0000218,,9268,,1,10116.0,CHEMBL627829,,,Intermediate,A,
,4527,Rattus norvegicus,1,,N,50597,,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,,,BAO_0000218,,9269,,1,10116.0,CHEMBL627830,,,Intermediate,A,
,4527,Rattus norvegicus,1,,N,50597,,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,,,BAO_0000218,,9270,,1,10116.0,CHEMBL627831,,,Intermediate,A,
,15662,Rattus norvegicus,1,,N,50597,,Area under curve in male SD rats was observed after oral administration in rat,,,BAO_0000218,,9271,,1,10116.0,CHEMBL627832,,,Intermediate,A,
,4413,Rattus norvegicus,1,,N,50597,,Area under curve of compound after iv administration of 20 mg/kg dose in rat,,,BAO_0000218,,9272,,1,10116.0,CHEMBL627833,,,Intermediate,A,
,3598,Rattus norvegicus,1,,N,50597,,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,,,BAO_0000218,,9273,,1,10116.0,CHEMBL627834,,,Expert,A,
,3598,Rattus norvegicus,1,,N,50597,,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,,,BAO_0000218,,9274,,1,10116.0,CHEMBL628004,,,Expert,A,
,5964,Rattus norvegicus,1,,N,50597,,Area under curve at 5 mg/kg po was determined in rat,,,BAO_0000218,,9275,,1,10116.0,CHEMBL628005,,,Intermediate,A,
,4689,Rattus norvegicus,1,,N,50597,,Area under curve in Rat at a oral dose of 5 mg/kg,,,BAO_0000218,,9276,,1,10116.0,CHEMBL628006,,,Intermediate,A,
,4186,Rattus norvegicus,1,,N,50597,,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,,BAO_0000218,,9277,,1,10116.0,CHEMBL628007,,,Intermediate,A,
,5510,Rattus norvegicus,1,,N,50597,,Area under curve was determined,,,BAO_0000218,,9278,,1,10116.0,CHEMBL625676,,,Intermediate,A,
,17858,Rattus norvegicus,1,,N,50597,,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,,,BAO_0000218,,9279,,1,10116.0,CHEMBL631309,,,Intermediate,A,
,17804,Rattus norvegicus,1,,N,50597,,Area under curve after intravenous administration at 3 mg/kg,,,BAO_0000218,,9280,,1,10116.0,CHEMBL631310,,,Intermediate,A,
,6106,Rattus norvegicus,1,,N,50597,,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,,,BAO_0000218,,9281,,1,10116.0,CHEMBL631311,,,Intermediate,A,
,5964,Rattus norvegicus,1,,N,50597,,Area under curve at 4 hr in rat,,,BAO_0000218,,9282,,1,10116.0,CHEMBL631312,,,Intermediate,A,
,4026,Rattus norvegicus,1,,N,50597,,Area under curve at a dose of 30 mg/kg,,,BAO_0000218,,9283,,1,10116.0,CHEMBL631313,,,Intermediate,A,
,4756,Rattus norvegicus,1,,N,50597,,Area under curve at the dose of 2 mg/Kg administered perorally in rats,,,BAO_0000218,,9284,,1,10116.0,CHEMBL631314,,,Intermediate,A,
,4756,Rattus norvegicus,1,,N,50597,,Area under curve at the dose of 5 mg/Kg administered perorally in rats,,,BAO_0000218,,9285,,1,10116.0,CHEMBL631315,,,Intermediate,A,
,5862,Rattus norvegicus,1,,N,50597,,Area under curve for a 2-mpk po dose in SD rats,,,BAO_0000218,,9286,,1,10116.0,CHEMBL631316,,,Intermediate,A,
,5862,Rattus norvegicus,1,,N,50597,,Area under curve in SD rats,,,BAO_0000218,,9287,,1,10116.0,CHEMBL631317,,,Intermediate,A,
,6644,Rattus norvegicus,1,,N,50597,,Area under curve in rat after oral administration at 13 mg/kg dose,,,BAO_0000218,,9288,,1,10116.0,CHEMBL874471,,,Intermediate,A,
,5871,Rattus norvegicus,1,,N,50597,,Area under curve in rat by po administration at 0-24 hr,,,BAO_0000218,,9289,,1,10116.0,CHEMBL631318,,,Intermediate,A,
,5919,Rattus norvegicus,1,,N,50597,,Area under curve in rat plasma,,,BAO_0000218,,9290,Plasma,1,10116.0,CHEMBL631319,,1969.0,Intermediate,A,
,5939,Rattus norvegicus,1,,N,50597,,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,,,BAO_0000218,,9291,,1,10116.0,CHEMBL631320,,,Intermediate,A,
,5939,Rattus norvegicus,1,,N,50597,,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,,,BAO_0000218,,9292,,1,10116.0,CHEMBL631321,,,Intermediate,A,
,10,Rattus norvegicus,1,,N,50597,,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,,,BAO_0000218,,9293,,1,10116.0,CHEMBL631322,,,Intermediate,A,
,11149,Rattus norvegicus,1,,N,50597,,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,,,BAO_0000218,,9294,,1,10116.0,CHEMBL631323,,,Intermediate,A,
,5302,Rattus norvegicus,1,,N,50597,,Area under curve value in rat at a dose of 5 mg/kg,,,BAO_0000218,,9295,,1,10116.0,CHEMBL631324,,,Intermediate,A,
,17796,Rattus norvegicus,1,,N,50597,,Area under curve was determined after oral administration in rats,,,BAO_0000218,,9296,,1,10116.0,CHEMBL631325,,,Intermediate,A,
,4890,Rattus norvegicus,1,,N,50597,,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,,BAO_0000218,,9297,,1,10116.0,CHEMBL631326,,,Intermediate,A,
,6011,Rattus norvegicus,1,,N,50597,,Area under curve was determined after peroral administration in rat,,,BAO_0000218,,9298,,1,10116.0,CHEMBL631327,,,Intermediate,A,
,5375,Rattus norvegicus,1,,N,50597,,Area under curve was determined at a dose 30 mpk administered orally.,,,BAO_0000218,,9299,,1,10116.0,CHEMBL631328,,,Intermediate,A,
,17764,Rattus norvegicus,1,,N,50597,,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,,,BAO_0000218,,9300,,1,10116.0,CHEMBL631329,,,Intermediate,A,
,4368,Rattus norvegicus,1,,N,50597,,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,,,BAO_0000218,,9301,,1,10116.0,CHEMBL627217,,,Intermediate,A,
,5610,Rattus norvegicus,1,,N,50597,,Area under curve was determined in male rat,,,BAO_0000218,,9302,,1,10116.0,CHEMBL626352,,,Intermediate,A,
,5833,Rattus norvegicus,1,,N,50597,,Area under curve was determined in rat after PO administration,,,BAO_0000218,,9303,,1,10116.0,CHEMBL626353,,,Intermediate,A,
,4257,Rattus norvegicus,1,,N,50597,,Area under curve was determined in rat after a 3 mg/kg of oral dose,,,BAO_0000218,,9304,,1,10116.0,CHEMBL626354,,,Intermediate,A,
,5937,Rattus norvegicus,1,,N,50597,,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,,,BAO_0000218,,9305,,1,10116.0,CHEMBL626355,,,Intermediate,A,
,5932,Rattus norvegicus,1,,N,50597,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,,,BAO_0000218,,9306,,1,10116.0,CHEMBL626356,,,Intermediate,A,
,5932,Rattus norvegicus,1,,N,50597,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,,,BAO_0000218,,9307,,1,10116.0,CHEMBL626357,,,Intermediate,A,
,17411,Rattus norvegicus,1,,N,50597,,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,BAO_0000218,,9308,,1,10116.0,CHEMBL626358,,,Intermediate,A,
,17411,Rattus norvegicus,1,,N,50597,,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,BAO_0000218,,9309,,1,10116.0,CHEMBL626359,,,Intermediate,A,
,17771,Rattus norvegicus,1,,N,50597,,Peak plasma concentration in rat at a dose of 3 mg/kg,,,BAO_0000218,,9310,Plasma,1,10116.0,CHEMBL626360,,1969.0,Intermediate,A,
,1628,Rattus norvegicus,1,,N,50597,,Plasma concentration at 2 hr in rats was evaluated.,,,BAO_0000218,,9311,,1,10116.0,CHEMBL626361,,,Intermediate,A,
,1628,Rattus norvegicus,1,,N,50597,,Plasma concentration at 2 hr in rats was evaluated; Not available,,,BAO_0000218,,9312,,1,10116.0,CHEMBL626362,,,Intermediate,A,
,17411,Rattus norvegicus,1,,N,50597,,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,BAO_0000218,,9313,,1,10116.0,CHEMBL626363,,,Intermediate,A,
,4910,Rattus norvegicus,1,,N,50597,,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,,BAO_0000218,,9314,,1,10116.0,CHEMBL626970,,,Intermediate,A,
,4910,Rattus norvegicus,1,,N,50597,,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,,,BAO_0000218,,9315,,1,10116.0,CHEMBL626971,,,Intermediate,A,
,4910,Rattus norvegicus,1,,N,50597,,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,,BAO_0000218,,9316,Plasma,1,10116.0,CHEMBL626972,,1969.0,Intermediate,A,
,4910,Rattus norvegicus,1,,N,50597,,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,,,BAO_0000218,,9317,Plasma,1,10116.0,CHEMBL626973,,1969.0,Intermediate,A,
,4910,Rattus norvegicus,1,,N,50597,,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,,BAO_0000218,,9318,Plasma,1,10116.0,CHEMBL626974,,1969.0,Intermediate,A,
,4910,Rattus norvegicus,1,,N,50597,,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,,,BAO_0000218,,9319,Plasma,1,10116.0,CHEMBL874592,,1969.0,Intermediate,A,
,5510,Rattus norvegicus,1,,N,50597,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,,,BAO_0000218,,9320,,1,10116.0,CHEMBL626975,,,Intermediate,A,
,5510,Rattus norvegicus,1,,N,50597,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,,,BAO_0000218,,9321,,1,10116.0,CHEMBL626976,,,Intermediate,A,
,5510,Rattus norvegicus,1,,N,50597,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,,,BAO_0000218,,9322,,1,10116.0,CHEMBL626977,,,Intermediate,A,
,5510,Rattus norvegicus,1,,N,50597,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,,,BAO_0000218,,9323,,1,10116.0,CHEMBL626978,,,Intermediate,A,
,16427,Rattus norvegicus,1,,N,50597,,PK study was carried to determine the relative absorption ranking in rat.,,,BAO_0000218,,9324,,1,10116.0,CHEMBL626979,,,Intermediate,A,
,4689,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,,,BAO_0000218,,9325,Plasma,1,10116.0,CHEMBL626980,In vivo,1969.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",,,BAO_0000218,,9326,Blood,1,10116.0,CHEMBL626981,,178.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",,,BAO_0000218,,9327,Blood,1,10116.0,CHEMBL626982,,178.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",,,BAO_0000218,,9328,Blood,1,10116.0,CHEMBL626983,,178.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",,,BAO_0000218,,9329,Blood,1,10116.0,CHEMBL622522,,178.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",,,BAO_0000218,,9330,Blood,1,10116.0,CHEMBL622523,,178.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",,,BAO_0000218,,9331,Blood,1,10116.0,CHEMBL622524,,178.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",,,BAO_0000218,,9332,Brain,1,10116.0,CHEMBL622525,,955.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",,,BAO_0000218,,9333,Brain,1,10116.0,CHEMBL622526,,955.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",,,BAO_0000218,,9334,Brain,1,10116.0,CHEMBL619849,,955.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",,,BAO_0000218,,9335,Brain,1,10116.0,CHEMBL619850,,955.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",,,BAO_0000218,,9336,Brain,1,10116.0,CHEMBL623864,,955.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",,,BAO_0000218,,9337,Brain,1,10116.0,CHEMBL623865,,955.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",,,BAO_0000218,,9338,Heart,1,10116.0,CHEMBL623866,,948.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",,,BAO_0000218,,9339,Heart,1,10116.0,CHEMBL623867,,948.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",,,BAO_0000218,,9340,Heart,1,10116.0,CHEMBL877615,,948.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",,,BAO_0000218,,9341,Heart,1,10116.0,CHEMBL623868,,948.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",,,BAO_0000218,,9342,Heart,1,10116.0,CHEMBL623869,,948.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",,,BAO_0000218,,9343,Heart,1,10116.0,CHEMBL623870,,948.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,,BAO_0000218,,9344,Lung,1,10116.0,CHEMBL623871,,2048.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,BAO_0000218,,9345,Lung,1,10116.0,CHEMBL623872,,2048.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,BAO_0000218,,9346,Lung,1,10116.0,CHEMBL622129,,2048.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,BAO_0000218,,9347,Lung,1,10116.0,CHEMBL622130,,2048.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,BAO_0000218,,9348,Lung,1,10116.0,CHEMBL622131,,2048.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,BAO_0000218,,9349,Lung,1,10116.0,CHEMBL622132,,2048.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,BAO_0000218,,9350,Lung,1,10116.0,CHEMBL622133,,2048.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,BAO_0000218,,9351,Lung,1,10116.0,CHEMBL622134,,2048.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,BAO_0000218,,9352,Lung,1,10116.0,CHEMBL622135,,2048.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,BAO_0000218,,9353,Lung,1,10116.0,CHEMBL622136,,2048.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,BAO_0000218,,9354,Muscle tissue,1,10116.0,CHEMBL622137,,2385.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,BAO_0000218,,9355,Muscle tissue,1,10116.0,CHEMBL622138,,2385.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,BAO_0000218,,9356,Muscle tissue,1,10116.0,CHEMBL623017,,2385.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,BAO_0000218,,9357,Muscle tissue,1,10116.0,CHEMBL623018,,2385.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,BAO_0000218,,9358,Muscle tissue,1,10116.0,CHEMBL623019,,2385.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,BAO_0000218,,9359,Muscle tissue,1,10116.0,CHEMBL623020,,2385.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,,,BAO_0000218,,9360,Muscle tissue,1,10116.0,CHEMBL623021,,2385.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,,BAO_0000218,,9361,Muscle tissue,1,10116.0,CHEMBL623022,,2385.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,BAO_0000218,,9362,Muscle tissue,1,10116.0,CHEMBL623023,,2385.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,BAO_0000218,,9363,Muscle tissue,1,10116.0,CHEMBL623024,,2385.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,BAO_0000218,,9364,Muscle tissue,1,10116.0,CHEMBL623025,,2385.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,BAO_0000218,,9365,Muscle tissue,1,10116.0,CHEMBL620545,,2385.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,BAO_0000218,,9366,Muscle tissue,1,10116.0,CHEMBL620546,,2385.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,BAO_0000218,,9367,Muscle tissue,1,10116.0,CHEMBL620547,,2385.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,BAO_0000218,,9368,Muscle tissue,1,10116.0,CHEMBL620548,,2385.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,BAO_0000218,,9369,Muscle tissue,1,10116.0,CHEMBL620549,,2385.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,BAO_0000218,,9370,Muscle tissue,1,10116.0,CHEMBL620550,,2385.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,,BAO_0000218,,9371,Muscle tissue,1,10116.0,CHEMBL620551,,2385.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,BAO_0000218,,9372,Muscle tissue,1,10116.0,CHEMBL620552,,2385.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,BAO_0000218,,9373,Muscle tissue,1,10116.0,CHEMBL620553,,2385.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,BAO_0000218,,9374,Muscle tissue,1,10116.0,CHEMBL620554,,2385.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,BAO_0000218,,9375,Muscle tissue,1,10116.0,CHEMBL875845,,2385.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,BAO_0000218,,9376,Muscle tissue,1,10116.0,CHEMBL620555,,2385.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,BAO_0000218,,9377,Muscle tissue,1,10116.0,CHEMBL620556,,2385.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,BAO_0000218,,9378,Muscle tissue,1,10116.0,CHEMBL620557,,2385.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,BAO_0000218,,9379,,1,10116.0,CHEMBL620558,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,BAO_0000218,,9380,,1,10116.0,CHEMBL620559,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,BAO_0000218,,9381,,1,10116.0,CHEMBL622939,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,BAO_0000218,,9382,,1,10116.0,CHEMBL622940,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,BAO_0000218,,9383,,1,10116.0,CHEMBL622941,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,BAO_0000218,,9384,,1,10116.0,CHEMBL622942,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,BAO_0000218,,9385,,1,10116.0,CHEMBL622943,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,BAO_0000218,,9386,,1,10116.0,CHEMBL622944,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,BAO_0000218,,9387,,1,10116.0,CHEMBL622945,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,BAO_0000218,,9388,,1,10116.0,CHEMBL622946,,,Intermediate,A,
,3341,Rattus norvegicus,1,,N,50597,,Compound was evaluated for terminal half life in rat,,,BAO_0000218,,9389,,1,10116.0,CHEMBL622947,,,Intermediate,A,
,3634,Rattus norvegicus,1,,N,50597,,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,,,BAO_0000218,,9390,Plasma,1,10116.0,CHEMBL622948,In vivo,1969.0,Intermediate,A,
,3634,Rattus norvegicus,1,,N,50597,,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,,,BAO_0000218,,9391,Plasma,1,10116.0,CHEMBL622949,In vivo,1969.0,Intermediate,A,
,4839,Rattus norvegicus,1,,N,50597,,Compound was tested for its half life in rat,,,BAO_0000218,,9392,,1,10116.0,CHEMBL622950,,,Intermediate,A,
,5005,Macaca mulatta,1,,U,22224,,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,,,BAO_0000218,,9393,Plasma,0,9544.0,CHEMBL622951,In vivo,1969.0,Intermediate,A,
,5005,Rattus norvegicus,1,,U,22224,,Compound was tested for its plasma half life in Sprague Dawley rats,,,BAO_0000366,,9394,Plasma,0,10116.0,CHEMBL622952,,1969.0,Intermediate,A,
,5005,Rattus norvegicus,1,,U,22224,,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,,,BAO_0000366,,9395,Plasma,0,10116.0,CHEMBL622953,,1969.0,Intermediate,A,
,1094,Rattus norvegicus,1,,N,50597,,Compound was tested for plasma half-life period in rat,,,BAO_0000218,,9396,Plasma,1,10116.0,CHEMBL873818,,1969.0,Intermediate,A,
,5031,Rattus norvegicus,1,,N,50597,,Elimination half life after i.v. administration of compound in rats,,,BAO_0000218,,9397,,1,10116.0,CHEMBL622954,In vivo,,Intermediate,A,
,6518,Rattus norvegicus,1,,N,50597,,Elimination half-life after IV dosing at 0.5 mg/kg in rat,,,BAO_0000218,,9398,,1,10116.0,CHEMBL622955,In vivo,,Intermediate,A,
,6518,Rattus norvegicus,1,,N,50597,,Elimination half-life after IV dosing at 1 mg/kg in rat,,,BAO_0000218,,9399,,1,10116.0,CHEMBL875229,In vivo,,Intermediate,A,
,6518,Rattus norvegicus,1,,N,50597,,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,,,BAO_0000218,,9400,,1,10116.0,CHEMBL622956,In vivo,,Intermediate,A,
,6518,Rattus norvegicus,1,,N,50597,,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,,,BAO_0000218,,9401,,1,10116.0,CHEMBL622957,In vivo,,Intermediate,A,
,5408,Rattus norvegicus,1,,N,50597,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,,BAO_0000218,,9402,Brain,1,10116.0,CHEMBL622958,In vivo,955.0,Intermediate,A,
,5408,Rattus norvegicus,1,,N,50597,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,,BAO_0000218,,9403,Plasma,1,10116.0,CHEMBL622959,In vivo,1969.0,Intermediate,A,
,5408,Rattus norvegicus,1,,N,50597,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,,BAO_0000218,,9404,Brain,1,10116.0,CHEMBL622960,In vivo,955.0,Intermediate,A,
,5408,Rattus norvegicus,1,,N,50597,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,,BAO_0000218,,9405,Plasma,1,10116.0,CHEMBL622961,In vivo,1969.0,Intermediate,A,
,4687,Rattus norvegicus,1,,N,50597,,Evaluated for the half life in rat (in vivo),,,BAO_0000218,,9406,,1,10116.0,CHEMBL622962,In vivo,,Intermediate,A,
,6640,Rattus norvegicus,1,,N,50597,,Hafl life in rat,,,BAO_0000218,,9407,,1,10116.0,CHEMBL622963,,,Intermediate,A,
,6640,Rattus norvegicus,1,,N,50597,,Hafl life rat,,,BAO_0000218,,9408,,1,10116.0,CHEMBL622964,,,Intermediate,A,
,6641,Rattus norvegicus,1,,N,50597,,Hafl life rat,,,BAO_0000218,,9409,,1,10116.0,CHEMBL622965,,,Intermediate,A,
,6640,Rattus norvegicus,1,,N,50597,,Hafl life rat; Not determined,,,BAO_0000218,,9410,,1,10116.0,CHEMBL622966,,,Intermediate,A,
,6641,Rattus norvegicus,1,,N,50597,,Hafl life rat; Not determined,,,BAO_0000218,,9411,,1,10116.0,CHEMBL622967,,,Intermediate,A,
,17411,Rattus norvegicus,1,,N,50597,,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,,BAO_0000218,,9412,Kidney,1,10116.0,CHEMBL622968,In vivo,2113.0,Intermediate,A,
,17411,Rattus norvegicus,1,,N,50597,,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,,BAO_0000218,,9413,Liver,1,10116.0,CHEMBL622969,In vivo,2107.0,Intermediate,A,
,17411,Rattus norvegicus,1,,N,50597,,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,,BAO_0000218,,9414,Lung,1,10116.0,CHEMBL875327,In vivo,2048.0,Intermediate,A,
,6570,Rattus norvegicus,1,,N,50597,,Half life in rat after 1 mg/kg i.v. administration,,,BAO_0000218,,9415,,1,10116.0,CHEMBL628638,In vivo,,Intermediate,A,
,6570,Rattus norvegicus,1,,N,50597,,Half life in rat after 2 mg/kg peroral administration,,,BAO_0000218,,9416,,1,10116.0,CHEMBL628639,In vivo,,Intermediate,A,
,17411,Rattus norvegicus,1,,N,50597,,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,,BAO_0000218,,9417,,1,10116.0,CHEMBL625840,In vivo,,Intermediate,A,
,4722,Rattus norvegicus,1,,N,50597,,Half life of 10 mg/kg oral dose determined in rats,,,BAO_0000218,,9418,,1,10116.0,CHEMBL625841,In vivo,,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,BAO_0000218,,9419,,1,10116.0,CHEMBL625842,In vivo,,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,,BAO_0000218,,9420,,1,10116.0,CHEMBL625843,In vivo,,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,,BAO_0000218,,9421,,1,10116.0,CHEMBL625844,In vivo,,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,,BAO_0000218,,9422,,1,10116.0,CHEMBL873822,In vivo,,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,BAO_0000218,,9423,,1,10116.0,CHEMBL625845,In vivo,,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,BAO_0000218,,9424,,1,10116.0,CHEMBL627059,In vivo,,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,,,BAO_0000218,,9425,,1,10116.0,CHEMBL627060,In vivo,,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,BAO_0000218,,9426,,1,10116.0,CHEMBL627061,In vivo,,Intermediate,A,
,4762,Rattus norvegicus,1,,N,50597,,Half life of compound at 5 mg/kg after po administration was determined in rat,,,BAO_0000218,,9427,,1,10116.0,CHEMBL627709,In vivo,,Intermediate,A,
,5327,Rattus norvegicus,1,,N,50597,,Half life of compound determined after intravenous administration to rat,,,BAO_0000218,,9428,,1,10116.0,CHEMBL627710,In vivo,,Intermediate,A,
,4847,Rattus norvegicus,1,,N,50597,,Half life of compound was determined in rat,,,BAO_0000218,,9429,,1,10116.0,CHEMBL627711,,,Intermediate,A,
,17720,Rattus norvegicus,1,,N,50597,,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,,,BAO_0000218,,9430,Plasma,1,10116.0,CHEMBL627712,In vivo,1969.0,Intermediate,A,
,4723,Rattus norvegicus,1,,N,50597,,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,BAO_0000218,,9431,,1,10116.0,CHEMBL627713,In vivo,,Intermediate,A,
,4723,Rattus norvegicus,1,,N,50597,,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,BAO_0000218,,9432,,1,10116.0,CHEMBL627714,In vivo,,Intermediate,A,
,4256,Macaca fascicularis,1,,U,22224,,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,,,BAO_0000218,,9433,,0,9541.0,CHEMBL627889,In vivo,,Intermediate,A,
,4256,Rattus norvegicus,1,,U,22224,,Half life determined in rat by intravenous administration,,,BAO_0000218,,9434,,0,10116.0,CHEMBL627890,In vivo,,Intermediate,A,
,4722,Rattus norvegicus,1,,N,50597,,Half life determined in rats after iv administration,,,BAO_0000218,,9435,,1,10116.0,CHEMBL627891,In vivo,,Intermediate,A,
,6535,Rattus norvegicus,1,,N,50597,,Half life in rat plasma after administration of 2 mg/kg iv,,,BAO_0000218,,9436,Plasma,1,10116.0,CHEMBL627892,In vivo,1969.0,Intermediate,A,
,6535,Rattus norvegicus,1,,N,50597,,Half life in rat plasma after administration of 2 mg/kg iv,,,BAO_0000218,,9437,Plasma,1,10116.0,CHEMBL627893,In vivo,1969.0,Intermediate,A,
,1435,Rattus norvegicus,1,,N,50597,,Half life in rat plasma was determined,,,BAO_0000218,,9438,Plasma,1,10116.0,CHEMBL627894,,1969.0,Intermediate,A,
,1435,Rattus norvegicus,1,,N,50597,,Half life in rat plasma was determined; NA means not applicable,,,BAO_0000218,,9439,Plasma,1,10116.0,CHEMBL627895,,1969.0,Intermediate,A,
,5206,Rattus norvegicus,1,,N,50597,,Half life in rat was tested,,,BAO_0000218,,9440,,1,10116.0,CHEMBL627896,,,Intermediate,A,
,6080,Rattus norvegicus,1,,N,50597,,Half life measured in rat plasma,,,BAO_0000218,,9441,Plasma,1,10116.0,CHEMBL627897,,1969.0,Intermediate,A,
,4449,Rattus norvegicus,1,,N,50597,,Half life recorded in rats,,,BAO_0000218,,9442,,1,10116.0,CHEMBL627898,,,Intermediate,A,
,6057,Rattus norvegicus,1,,N,50597,,Half life was calculated,,,BAO_0000218,,9443,,1,10116.0,CHEMBL627899,,,Intermediate,A,
,6057,Rattus norvegicus,1,,N,50597,,Half life was calculated in rat,,,BAO_0000218,,9444,,1,10116.0,CHEMBL873823,,,Intermediate,A,
,3747,Rattus norvegicus,1,,N,50597,,Half life was determined,,,BAO_0000218,,9445,,1,10116.0,CHEMBL627900,,,Intermediate,A,
,17858,Rattus norvegicus,1,,N,50597,,Half life after 10 mg/kg oral administration in rat,,,BAO_0000218,,9446,,1,10116.0,CHEMBL627901,In vivo,,Intermediate,A,
,16365,Rattus norvegicus,1,,N,50597,,Half life after administering orally a dose of 10 mg/kg to a fasting rat,,,BAO_0000218,,9447,,1,10116.0,CHEMBL627902,In vivo,,Intermediate,A,
,16365,Rattus norvegicus,1,,N,50597,,Half life after administering orally a dose of 30 mg/kg,,,BAO_0000218,,9448,,1,10116.0,CHEMBL627903,In vivo,,Intermediate,A,
,5031,Rattus norvegicus,1,,N,50597,,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,,,BAO_0000218,,9449,,1,10116.0,CHEMBL627904,,,Intermediate,A,
,4722,Rattus norvegicus,1,,N,50597,,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,,,BAO_0000218,,9450,,1,10116.0,CHEMBL627905,,,Intermediate,A,
,6078,Rattus norvegicus,1,,N,50597,,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,,,BAO_0000218,,9451,,1,10116.0,CHEMBL627906,,,Intermediate,A,
,6078,Rattus norvegicus,1,,N,50597,,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,,,BAO_0000218,,9452,,1,10116.0,CHEMBL627907,,,Intermediate,A,
,6078,Rattus norvegicus,1,,N,50597,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,,,BAO_0000218,,9453,,1,10116.0,CHEMBL876783,,,Intermediate,A,
,6078,Rattus norvegicus,1,,N,50597,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,,,BAO_0000218,,9454,,1,10116.0,CHEMBL627908,,,Intermediate,A,
,17065,Rattus norvegicus,1,,N,50597,,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,,,BAO_0000218,,9455,,1,10116.0,CHEMBL627909,,,Intermediate,A,
,1353,Rattus norvegicus,1,,N,50597,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,,,BAO_0000218,,9456,,1,10116.0,CHEMBL627910,,,Intermediate,A,
,1353,Rattus norvegicus,1,,N,50597,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),,,BAO_0000218,,9457,,1,10116.0,CHEMBL627911,,,Intermediate,A,
,1353,Rattus norvegicus,1,,N,50597,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),,,BAO_0000218,,9458,,1,10116.0,CHEMBL627912,,,Intermediate,A,
,1353,Rattus norvegicus,1,,N,50597,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),,,BAO_0000218,,9459,,1,10116.0,CHEMBL627913,,,Intermediate,A,
,1353,Rattus norvegicus,1,,N,50597,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),,,BAO_0000218,,9460,,1,10116.0,CHEMBL627914,,,Intermediate,A,
,16423,Rattus norvegicus,1,,N,50597,,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,,,BAO_0000218,,9461,,1,10116.0,CHEMBL627915,,,Intermediate,A,
,16423,Rattus norvegicus,1,,N,50597,,Area under the curve was evaluated after 20 uM/kg of peroral administration,,,BAO_0000218,,9462,,1,10116.0,CHEMBL627916,,,Intermediate,A,
,6062,Rattus norvegicus,1,,N,50597,,Area under the curve was measured in rat after an iv dose of 1 mg/kg,,,BAO_0000218,,9463,,1,10116.0,CHEMBL627917,,,Intermediate,A,
,6056,Rattus norvegicus,1,,N,50597,,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,,,BAO_0000218,,9464,,1,10116.0,CHEMBL627918,,,Intermediate,A,
,5182,Rattus norvegicus,1,,N,50597,,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,,,BAO_0000218,,9465,,1,10116.0,CHEMBL627919,,,Intermediate,A,
,6410,Rattus norvegicus,1,,N,50597,,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,,,BAO_0000218,,9466,,1,10116.0,CHEMBL627920,,,Intermediate,A,
,6410,Rattus norvegicus,1,,N,50597,,Area under the curve was evaluated at an oral dose of 30 mg/kg,,,BAO_0000218,,9467,,1,10116.0,CHEMBL627921,,,Intermediate,A,
,4723,Rattus norvegicus,1,,N,50597,,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,BAO_0000218,,9468,,1,10116.0,CHEMBL627922,,,Intermediate,A,
,4723,Rattus norvegicus,1,,N,50597,,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,BAO_0000218,,9469,,1,10116.0,CHEMBL876784,,,Intermediate,A,
,4723,Rattus norvegicus,1,,N,50597,,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,BAO_0000218,,9470,,1,10116.0,CHEMBL627923,,,Intermediate,A,
,4723,Rattus norvegicus,1,,N,50597,,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,BAO_0000218,,9471,,1,10116.0,CHEMBL626208,,,Intermediate,A,
,4723,Rattus norvegicus,1,,N,50597,,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,BAO_0000218,,9472,,1,10116.0,CHEMBL626209,,,Intermediate,A,
,4723,Rattus norvegicus,1,,N,50597,,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,BAO_0000218,,9473,,1,10116.0,CHEMBL626210,,,Intermediate,A,
,2463,Rattus norvegicus,1,,N,50597,,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,,BAO_0000218,,9474,Plasma,1,10116.0,CHEMBL627994,,1969.0,Intermediate,A,
,4709,Rattus norvegicus,1,,N,50597,,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,,,BAO_0000218,,9475,,1,10116.0,CHEMBL627995,,,Intermediate,A,
,4075,Rattus norvegicus,1,,N,50597,,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,,,BAO_0000218,,9476,,1,10116.0,CHEMBL627996,,,Intermediate,A,
,5394,Rattus norvegicus,1,,N,50597,,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,,,BAO_0000218,,9477,,1,10116.0,CHEMBL627997,,,Intermediate,A,
,2661,Rattus norvegicus,1,,N,50597,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,,,BAO_0000218,,9478,,1,10116.0,CHEMBL627998,,,Intermediate,A,
,2661,Rattus norvegicus,1,,N,50597,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,,,BAO_0000218,,9479,,1,10116.0,CHEMBL628640,,,Intermediate,A,
,2661,Rattus norvegicus,1,,N,50597,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,,,BAO_0000218,,9480,,1,10116.0,CHEMBL628641,,,Intermediate,A,
,2661,Rattus norvegicus,1,,N,50597,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,,,BAO_0000218,,9481,,1,10116.0,CHEMBL628642,,,Intermediate,A,
,17791,Rattus norvegicus,1,,N,50597,,Compound was evaluated for area under the curve expressed as (h*ug/ml),,,BAO_0000218,,9482,,1,10116.0,CHEMBL628643,,,Intermediate,A,
,2591,Rattus norvegicus,1,,N,50597,,Compound was tested for area under curve in rat,,,BAO_0000218,,9483,,1,10116.0,CHEMBL628644,,,Intermediate,A,
,6567,Rattus norvegicus,1,,N,50597,,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,,,BAO_0000218,,9484,,1,10116.0,CHEMBL628645,,,Intermediate,A,
,6211,Rattus norvegicus,1,,N,50597,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,,BAO_0000218,,9485,,1,10116.0,CHEMBL628646,,,Intermediate,A,
,5529,Rattus norvegicus,1,,N,50597,,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),,,BAO_0000218,,9486,,1,10116.0,CHEMBL628647,,,Intermediate,A,
,5408,Rattus norvegicus,1,,N,50597,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,,BAO_0000218,,9487,,1,10116.0,CHEMBL628648,,,Intermediate,A,
,5408,Rattus norvegicus,1,,N,50597,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,,BAO_0000218,,9488,,1,10116.0,CHEMBL625358,,,Intermediate,A,
,5408,Rattus norvegicus,1,,N,50597,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,,BAO_0000218,,9489,,1,10116.0,CHEMBL625359,,,Intermediate,A,
,5408,Rattus norvegicus,1,,N,50597,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,,BAO_0000218,,9490,,1,10116.0,CHEMBL625360,,,Intermediate,A,
,429,Rattus norvegicus,1,,N,50597,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),,,BAO_0000218,,9491,,1,10116.0,CHEMBL625361,,,Intermediate,A,
,429,Rattus norvegicus,1,,N,50597,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),,,BAO_0000218,,9492,,1,10116.0,CHEMBL625362,,,Intermediate,A,
,429,Rattus norvegicus,1,,N,50597,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),,,BAO_0000218,,9493,,1,10116.0,CHEMBL625363,,,Intermediate,A,
,4796,Rattus norvegicus,1,,N,50597,,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,,BAO_0000218,,9494,,1,10116.0,CHEMBL625364,,,Intermediate,A,
,5974,Rattus norvegicus,1,,N,50597,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,,9495,,1,10116.0,CHEMBL625365,,,Intermediate,A,
,5974,Rattus norvegicus,1,,N,50597,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,,9496,,1,10116.0,CHEMBL625366,,,Intermediate,A,
,5974,Rattus norvegicus,1,,N,50597,,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,,9497,,1,10116.0,CHEMBL625367,,,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",,,BAO_0000218,,9498,Kidney,1,10116.0,CHEMBL625368,,2113.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",,,BAO_0000218,,9499,Kidney,1,10116.0,CHEMBL625369,,2113.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",,,BAO_0000218,,9500,Kidney,1,10116.0,CHEMBL625370,,2113.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",,,BAO_0000218,,9501,Kidney,1,10116.0,CHEMBL625371,,2113.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",,,BAO_0000218,,9502,Kidney,1,10116.0,CHEMBL625372,,2113.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",,,BAO_0000218,,9503,Kidney,1,10116.0,CHEMBL625373,,2113.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",,,BAO_0000218,,9504,Liver,1,10116.0,CHEMBL625374,,2107.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",,,BAO_0000218,,9505,Liver,1,10116.0,CHEMBL877593,,2107.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",,,BAO_0000218,,9506,Liver,1,10116.0,CHEMBL625375,,2107.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",,,BAO_0000218,,9507,Liver,1,10116.0,CHEMBL625376,,2107.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",,,BAO_0000218,,9508,Liver,1,10116.0,CHEMBL621973,,2107.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",,,BAO_0000218,,9509,Liver,1,10116.0,CHEMBL621974,,2107.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",,,BAO_0000218,,9510,Lung,1,10116.0,CHEMBL621975,,2048.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",,,BAO_0000218,,9511,Lung,1,10116.0,CHEMBL622166,,2048.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",,,BAO_0000218,,9512,Lung,1,10116.0,CHEMBL622167,,2048.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",,,BAO_0000218,,9513,Lung,1,10116.0,CHEMBL622168,,2048.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",,,BAO_0000218,,9514,Lung,1,10116.0,CHEMBL622169,,2048.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",,,BAO_0000218,,9515,Lung,1,10116.0,CHEMBL622170,,2048.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",,,BAO_0000218,,9516,Thyroid gland,1,10116.0,CHEMBL622171,,2046.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",,,BAO_0000218,,9517,Thyroid gland,1,10116.0,CHEMBL622172,,2046.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",,,BAO_0000218,,9518,Thyroid gland,1,10116.0,CHEMBL622173,,2046.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",,,BAO_0000218,,9519,Thyroid gland,1,10116.0,CHEMBL622174,,2046.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",,,BAO_0000218,,9520,Thyroid gland,1,10116.0,CHEMBL622175,,2046.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",,,BAO_0000218,,9521,Thyroid gland,1,10116.0,CHEMBL622176,,2046.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",,,BAO_0000218,,9522,Thyroid gland,1,10116.0,CHEMBL622177,,2046.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",,,BAO_0000218,,9523,Thyroid gland,1,10116.0,CHEMBL622178,,2046.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",,,BAO_0000218,,9524,Thyroid gland,1,10116.0,CHEMBL622179,,2046.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",,,BAO_0000218,,9525,Thyroid gland,1,10116.0,CHEMBL622180,,2046.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,BAO_0000218,,9526,,1,10116.0,CHEMBL622181,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,BAO_0000218,,9527,,1,10116.0,CHEMBL622182,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,BAO_0000218,,9528,,1,10116.0,CHEMBL622183,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,BAO_0000218,,9529,,1,10116.0,CHEMBL622184,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,BAO_0000218,,9530,,1,10116.0,CHEMBL622185,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,BAO_0000218,,9531,,1,10116.0,CHEMBL622186,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,BAO_0000218,,9532,,1,10116.0,CHEMBL622187,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,,BAO_0000218,,9533,,1,10116.0,CHEMBL625002,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,,,BAO_0000218,,9534,,1,10116.0,CHEMBL622090,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,BAO_0000218,,9535,,1,10116.0,CHEMBL622091,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,BAO_0000218,,9536,,1,10116.0,CHEMBL622092,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,BAO_0000218,,9537,,1,10116.0,CHEMBL622093,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,BAO_0000218,,9538,,1,10116.0,CHEMBL622094,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,BAO_0000218,,9539,,1,10116.0,CHEMBL622095,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,BAO_0000218,,9540,,1,10116.0,CHEMBL622264,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,BAO_0000218,,9541,Spleen,1,10116.0,CHEMBL622265,,2106.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,BAO_0000218,,9542,Spleen,1,10116.0,CHEMBL622266,,2106.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,BAO_0000218,,9543,Spleen,1,10116.0,CHEMBL622267,,2106.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,BAO_0000218,,9544,Spleen,1,10116.0,CHEMBL622268,,2106.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,BAO_0000218,,9545,Spleen,1,10116.0,CHEMBL622269,,2106.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,BAO_0000218,,9546,Spleen,1,10116.0,CHEMBL625071,,2106.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,BAO_0000218,,9547,Spleen,1,10116.0,CHEMBL621621,,2106.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,BAO_0000218,,9548,Spleen,1,10116.0,CHEMBL621622,,2106.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,BAO_0000218,,9549,Spleen,1,10116.0,CHEMBL621623,,2106.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,BAO_0000218,,9550,Spleen,1,10116.0,CHEMBL621624,,2106.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,BAO_0000218,,9551,Spleen,1,10116.0,CHEMBL621625,,2106.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,BAO_0000218,,9552,Spleen,1,10116.0,CHEMBL621626,,2106.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,BAO_0000218,,9553,Spleen,1,10116.0,CHEMBL621627,,2106.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,BAO_0000218,,9554,Spleen,1,10116.0,CHEMBL621628,,2106.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,BAO_0000218,,9555,Spleen,1,10116.0,CHEMBL875328,,2106.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,BAO_0000218,,9556,Spleen,1,10116.0,CHEMBL621629,,2106.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,BAO_0000218,,9557,Spleen,1,10116.0,CHEMBL621630,,2106.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,BAO_0000218,,9558,Spleen,1,10116.0,CHEMBL621631,,2106.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,BAO_0000218,,9559,Spleen,1,10116.0,CHEMBL621632,,2106.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,BAO_0000218,,9560,Spleen,1,10116.0,CHEMBL621633,,2106.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,BAO_0000218,,9561,Spleen,1,10116.0,CHEMBL621634,,2106.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,BAO_0000218,,9562,Spleen,1,10116.0,CHEMBL621635,,2106.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,BAO_0000218,,9563,Spleen,1,10116.0,CHEMBL621636,,2106.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,BAO_0000218,,9564,Spleen,1,10116.0,CHEMBL621637,,2106.0,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,BAO_0000218,,9565,Spleen,1,10116.0,CHEMBL621638,,2106.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,BAO_0000218,,9566,,1,10116.0,CHEMBL618883,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,BAO_0000218,,9567,,1,10116.0,CHEMBL618884,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,BAO_0000218,,9568,,1,10116.0,CHEMBL628627,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,BAO_0000218,,9569,,1,10116.0,CHEMBL628628,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,BAO_0000218,,9570,,1,10116.0,CHEMBL628629,,,Intermediate,A,
,16365,Rattus norvegicus,1,,N,50597,,Half life after administering orally a dose of 3 mg/kg,,,BAO_0000218,,9571,,1,10116.0,CHEMBL628630,In vivo,,Intermediate,A,
,16365,Rattus norvegicus,1,,N,50597,,Half life after administering orally a dose of 3 mg/kg to a fasting rat,,,BAO_0000218,,9572,,1,10116.0,CHEMBL628631,In vivo,,Intermediate,A,
,16365,Rattus norvegicus,1,,N,50597,,Half life after administering intravenously a dose of 1 mg/kg,,,BAO_0000218,,9573,,1,10116.0,CHEMBL628632,In vivo,,Intermediate,A,
,526,Rattus norvegicus,1,,N,50597,,Half life after oral dosing in rats,,,BAO_0000218,,9574,,1,10116.0,CHEMBL628633,In vivo,,Intermediate,A,
,16365,Rattus norvegicus,1,,N,50597,,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,,,BAO_0000218,,9575,,1,10116.0,CHEMBL628634,In vivo,,Intermediate,A,
,4368,Rattus norvegicus,1,,N,50597,,Half life by intravenous administration of 3.4 mg/kg in rat,,,BAO_0000218,,9576,,1,10116.0,CHEMBL627789,In vivo,,Intermediate,A,
,3371,Rattus norvegicus,1,,N,50597,,Half life in rat,,,BAO_0000218,,9577,,1,10116.0,CHEMBL627790,,,Intermediate,A,
,6448,Rattus norvegicus,1,,N,50597,,Half life in rat,,,BAO_0000218,,9578,,1,10116.0,CHEMBL627791,,,Intermediate,A,
,6453,Rattus norvegicus,1,,N,50597,,Half life in rat,,,BAO_0000218,,9579,,1,10116.0,CHEMBL627792,,,Intermediate,A,
,4353,Rattus norvegicus,1,,N,50597,,Half life in rat after intravenous administration of the compound,,,BAO_0000218,,9580,,1,10116.0,CHEMBL627793,In vivo,,Intermediate,A,
,4353,Rattus norvegicus,1,,N,50597,,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,,,BAO_0000218,,9581,Plasma,1,10116.0,CHEMBL627794,In vivo,1969.0,Intermediate,A,
,4353,Rattus norvegicus,1,,N,50597,,Half life in rat after po administration of the compound,,,BAO_0000218,,9582,,1,10116.0,CHEMBL627795,In vivo,,Intermediate,A,
,4353,Rattus norvegicus,1,,N,50597,,Half life in rat after po administration of the compound; ND means Not determined,,,BAO_0000218,,9583,,1,10116.0,CHEMBL627796,In vivo,,Intermediate,A,
,4353,Rattus norvegicus,1,,N,50597,,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,,,BAO_0000218,,9584,Plasma,1,10116.0,CHEMBL875335,In vivo,1969.0,Intermediate,A,
,4353,Rattus norvegicus,1,,N,50597,,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,,,BAO_0000218,,9585,Plasma,1,10116.0,CHEMBL627797,In vivo,1969.0,Intermediate,A,
,5789,Rattus norvegicus,1,,N,50597,,Half life in rat i.v.,,,BAO_0000218,,9586,,1,10116.0,CHEMBL627798,In vivo,,Intermediate,A,
,17686,Rattus norvegicus,1,,N,50597,,Half life in rat i.v. at 2 mg/kg concentration,,,BAO_0000218,,9587,,1,10116.0,CHEMBL627799,In vivo,,Intermediate,A,
,6495,Rattus norvegicus,1,,N,50597,,Half life in rats,,,BAO_0000218,,9588,,1,10116.0,CHEMBL627800,,,Intermediate,A,
,484,Rattus norvegicus,1,,N,50597,,Half life in rats after intravenous administration,,,BAO_0000218,,9589,,1,10116.0,CHEMBL627801,In vivo,,Intermediate,A,
,6467,Rattus norvegicus,1,,N,50597,,Half life in rats at the dose of 1.0 mpk by i.v. administration,,,BAO_0000218,,9590,,1,10116.0,CHEMBL627802,In vivo,,Intermediate,A,
,6642,Rattus norvegicus,1,,N,50597,,Half life in rat,,,BAO_0000218,,9591,,1,10116.0,CHEMBL627803,,,Expert,A,
,16367,Rattus norvegicus,1,,N,50597,,Half life was evaluated after intravenous administration to rats,,,BAO_0000218,,9592,,1,10116.0,CHEMBL873820,In vivo,,Intermediate,A,
,1369,Rattus norvegicus,1,,N,50597,,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),,,BAO_0000218,,9593,,1,10116.0,CHEMBL627804,,,Intermediate,A,
,5472,Rattus norvegicus,1,,N,50597,,Half life was evaluated in rat,,,BAO_0000218,,9594,,1,10116.0,CHEMBL627805,,,Intermediate,A,
,6049,Rattus norvegicus,1,,N,50597,,Half life was evaluated in rat,,,BAO_0000218,,9595,,1,10116.0,CHEMBL627806,,,Intermediate,A,
,5472,Rattus norvegicus,1,,N,50597,,Half life was evaluated in rat; Not tested,,,BAO_0000218,,9596,,1,10116.0,CHEMBL627107,,,Intermediate,A,
,16366,Rattus norvegicus,1,,N,50597,,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,,,BAO_0000218,,9597,,1,10116.0,CHEMBL627108,In vivo,,Intermediate,A,
,11149,Rattus norvegicus,1,,N,50597,,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,,,BAO_0000218,,9598,,1,10116.0,CHEMBL627109,In vivo,,Intermediate,A,
,11149,Rattus norvegicus,1,,N,50597,,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,,,BAO_0000218,,9599,Blood,1,10116.0,CHEMBL627110,In vivo,178.0,Intermediate,A,
,2891,Primates,1,,U,22224,,Half life was measured in monkey at dose of 10 mg/kg by po administration,,,BAO_0000218,,9600,,0,9443.0,CHEMBL627111,In vivo,,Intermediate,A,
,2891,Primates,1,,U,22224,,Half life was measured in monkey at dose of 10 mg/kg by po administration,,,BAO_0000218,,9601,,0,9443.0,CHEMBL627112,In vivo,,Intermediate,A,
,2891,Rattus norvegicus,1,,U,22224,,Half life was measured in rat at dose of 30 mg/kg by iv administration,,,BAO_0000218,,9602,,0,10116.0,CHEMBL627113,In vivo,,Intermediate,A,
,2891,Rattus norvegicus,1,,U,22224,,Half life was measured in rat at dose of 30 mg/kg by po administration,,,BAO_0000218,,9603,,0,10116.0,CHEMBL627114,In vivo,,Intermediate,A,
,4026,Rattus norvegicus,1,,N,50597,,Half life (t1/2) was determined,,,BAO_0000218,,9604,,1,10116.0,CHEMBL627115,,,Intermediate,A,
,4527,Rattus norvegicus,1,,N,50597,,Half life period at a dose of 10 uM/kg in rat was determined,,,BAO_0000218,,9605,,1,10116.0,CHEMBL627116,,,Intermediate,A,
,4527,Rattus norvegicus,1,,N,50597,,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,,,BAO_0000218,,9606,,1,10116.0,CHEMBL627117,In vivo,,Intermediate,A,
,5503,Rattus norvegicus,1,,N,50597,,Half life period was determined,,,BAO_0000218,,9607,,1,10116.0,CHEMBL627118,,,Intermediate,A,
,4426,Rattus norvegicus,1,,N,50597,,Half life period after intravenous administration at 20 mpk in rats,,,BAO_0000218,,9608,,1,10116.0,CHEMBL627119,In vivo,,Intermediate,A,
,4426,Rattus norvegicus,1,,N,50597,,Half life period after intravenous administration at 20 mpk in rats; Not performed.,,,BAO_0000218,,9609,,1,10116.0,CHEMBL627120,In vivo,,Intermediate,A,
,6109,Rattus norvegicus,1,,N,50597,,Half life period after intravenous administration in rat,,,BAO_0000218,,9610,,1,10116.0,CHEMBL626922,In vivo,,Intermediate,A,
,5654,Rattus norvegicus,1,,N,50597,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,,BAO_0000218,,9611,,1,10116.0,CHEMBL626923,In vivo,,Intermediate,A,
,5654,Rattus norvegicus,1,,N,50597,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,,BAO_0000218,,9612,,1,10116.0,CHEMBL626924,In vivo,,Intermediate,A,
,4755,Rattus norvegicus,1,,N,50597,,Half life period in 80% rat plasma at 37 degree Centigrade,,,BAO_0000218,,9613,Plasma,1,10116.0,CHEMBL626925,,1969.0,Intermediate,A,
,5862,Rattus norvegicus,1,,N,50597,,Half life period in SD rats,,,BAO_0000218,,9614,,1,10116.0,CHEMBL626926,,,Intermediate,A,
,1515,Rattus norvegicus,1,,N,50597,,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),,,BAO_0000218,,9615,Plasma,1,10116.0,CHEMBL626927,,1969.0,Intermediate,A,
,1515,Rattus norvegicus,1,,N,50597,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),,,BAO_0000218,,9616,Plasma,1,10116.0,CHEMBL626928,,1969.0,Intermediate,A,
,1515,Rattus norvegicus,1,,N,50597,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,,BAO_0000218,,9617,Plasma,1,10116.0,CHEMBL626929,,1969.0,Intermediate,A,
,1515,Rattus norvegicus,1,,N,50597,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,,BAO_0000218,,9618,Plasma,1,10116.0,CHEMBL626930,,1969.0,Intermediate,A,
,5960,Rattus norvegicus,1,,N,50597,,Half life period in rat,,,BAO_0000218,,9619,,1,10116.0,CHEMBL626931,,,Intermediate,A,
,6103,Rattus norvegicus,1,,N,50597,,Half life period in rat,,,BAO_0000218,,9620,,1,10116.0,CHEMBL626932,,,Intermediate,A,
,6317,Rattus norvegicus,1,,N,50597,,Half life period in rat,,,BAO_0000218,,9621,,1,10116.0,CHEMBL626933,,,Intermediate,A,
,6644,Rattus norvegicus,1,,N,50597,,Half life period in rat after oral administration at 10.5 mg/kg dose,,,BAO_0000218,,9622,,1,10116.0,CHEMBL873826,In vivo,,Intermediate,A,
,6644,Rattus norvegicus,1,,N,50597,,Half life period in rat after oral administration at 11.2 mg/kg dose,,,BAO_0000218,,9623,,1,10116.0,CHEMBL626934,In vivo,,Intermediate,A,
,6644,Rattus norvegicus,1,,N,50597,,Half life period in rat after oral administration at 13 mg/kg dose,,,BAO_0000218,,9624,,1,10116.0,CHEMBL626935,In vivo,,Intermediate,A,
,6644,Rattus norvegicus,1,,N,50597,,Half life period in rat after oral administration at 9.7 mg/kg dose,,,BAO_0000218,,9625,,1,10116.0,CHEMBL626936,In vivo,,Intermediate,A,
,5974,Rattus norvegicus,1,,N,50597,,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,,9626,,1,10116.0,CHEMBL626937,,,Intermediate,A,
,6295,Rattus norvegicus,1,,N,50597,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,,BAO_0000218,,9627,,1,10116.0,CHEMBL625906,,,Intermediate,A,
,6296,Rattus norvegicus,1,,N,50597,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,,BAO_0000218,,9628,,1,10116.0,CHEMBL625907,,,Intermediate,A,
,16427,Rattus norvegicus,1,,N,50597,,PK study was carried to determine AUC (area under curve) value in rat,,,BAO_0000218,,9629,,1,10116.0,CHEMBL625908,,,Intermediate,A,
,16367,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter AUC after intravenous administration to rats,,,BAO_0000218,,9630,,1,10116.0,CHEMBL625909,,,Intermediate,A,
,16367,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter AUC after oral administration to rats,,,BAO_0000218,,9631,,1,10116.0,CHEMBL625910,,,Intermediate,A,
,16365,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,,,BAO_0000218,,9632,,1,10116.0,CHEMBL625911,,,Intermediate,A,
,16365,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,,,BAO_0000218,,9633,,1,10116.0,CHEMBL625912,,,Intermediate,A,
,16365,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,,,BAO_0000218,,9634,,1,10116.0,CHEMBL626538,,,Intermediate,A,
,16365,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,,,BAO_0000218,,9635,,1,10116.0,CHEMBL876794,,,Intermediate,A,
,16365,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,,,BAO_0000218,,9636,,1,10116.0,CHEMBL626539,,,Intermediate,A,
,16365,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,,,BAO_0000218,,9637,,1,10116.0,CHEMBL626540,,,Intermediate,A,
,5394,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,,,BAO_0000218,,9638,,1,10116.0,CHEMBL626541,,,Intermediate,A,
,5394,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,,,BAO_0000218,,9639,,1,10116.0,CHEMBL626542,,,Intermediate,A,
,2792,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,,,BAO_0000218,,9640,,1,10116.0,CHEMBL626543,,,Intermediate,A,
,2792,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,,,BAO_0000218,,9641,,1,10116.0,CHEMBL626544,,,Intermediate,A,
,2792,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,,,BAO_0000218,,9642,,1,10116.0,CHEMBL626545,,,Intermediate,A,
,2792,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,,,BAO_0000218,,9643,,1,10116.0,CHEMBL626546,,,Intermediate,A,
,5334,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter area under curve was reported,,,BAO_0000218,,9644,,1,10116.0,CHEMBL626547,,,Intermediate,A,
,4408,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (AUC) in rat,,,BAO_0000218,,9645,,1,10116.0,CHEMBL626548,,,Intermediate,A,
,5983,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,,,BAO_0000218,,9646,,1,10116.0,CHEMBL626549,,,Intermediate,A,
,4397,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,,,BAO_0000218,,9647,,1,10116.0,CHEMBL626550,,,Intermediate,A,
,4397,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,,,BAO_0000218,,9648,,1,10116.0,CHEMBL626551,,,Intermediate,A,
,5491,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property was determined,,,BAO_0000218,,9649,,1,10116.0,CHEMBL623777,,,Intermediate,A,
,5491,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,,,BAO_0000218,,9650,,1,10116.0,CHEMBL623778,,,Intermediate,A,
,5491,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,,,BAO_0000218,,9651,,1,10116.0,CHEMBL623779,,,Intermediate,A,
,4199,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,,BAO_0000218,,9652,Plasma,1,10116.0,CHEMBL623780,,1969.0,Intermediate,A,
,4199,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,,,BAO_0000218,,9653,Plasma,1,10116.0,CHEMBL622015,,1969.0,Intermediate,A,
,4199,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,,,BAO_0000218,,9654,Plasma,1,10116.0,CHEMBL622016,,1969.0,Intermediate,A,
,5173,Rattus norvegicus,1,,N,50597,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",,,BAO_0000218,,9655,,1,10116.0,CHEMBL622017,,,Intermediate,A,
,5173,Rattus norvegicus,1,,N,50597,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",,,BAO_0000218,,9656,,1,10116.0,CHEMBL622018,,,Intermediate,A,
,5173,Rattus norvegicus,1,,N,50597,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",,,BAO_0000218,,9657,,1,10116.0,CHEMBL622019,,,Intermediate,A,
,5173,Rattus norvegicus,1,,N,50597,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",,,BAO_0000218,,9658,,1,10116.0,CHEMBL622020,,,Intermediate,A,
,16366,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,,,BAO_0000218,,9659,,1,10116.0,CHEMBL622021,,,Intermediate,A,
,16366,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,,,BAO_0000218,,9660,,1,10116.0,CHEMBL622022,,,Intermediate,A,
,5327,Rattus norvegicus,1,,N,50597,,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,,,BAO_0000218,,9661,,1,10116.0,CHEMBL622023,,,Intermediate,A,
,6681,Rattus norvegicus,1,,N,50597,,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,,,BAO_0000218,,9662,,1,10116.0,CHEMBL622024,,,Intermediate,A,
,12873,Rattus norvegicus,1,,N,50597,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),,,BAO_0000218,,9663,,1,10116.0,CHEMBL622693,,,Intermediate,A,
,12873,Rattus norvegicus,1,,N,50597,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),,,BAO_0000218,,9664,,1,10116.0,CHEMBL622694,,,Intermediate,A,
,6685,Rattus norvegicus,1,,N,50597,,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,,BAO_0000218,,9665,,1,10116.0,CHEMBL622695,,,Intermediate,A,
,6685,Rattus norvegicus,1,,N,50597,,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,,BAO_0000218,,9666,,1,10116.0,CHEMBL622696,,,Intermediate,A,
,6685,Rattus norvegicus,1,,N,50597,,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",,,BAO_0000218,,9667,,1,10116.0,CHEMBL622697,,,Intermediate,A,
,6619,Rattus norvegicus,1,,N,50597,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",,,BAO_0000218,,9668,,1,10116.0,CHEMBL622874,,,Intermediate,A,
,6619,Rattus norvegicus,1,,N,50597,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",,,BAO_0000218,,9669,,1,10116.0,CHEMBL622875,,,Intermediate,A,
,10363,Rattus norvegicus,1,,N,50597,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,,BAO_0000218,,9670,,1,10116.0,CHEMBL622876,,,Intermediate,A,
,4796,Rattus norvegicus,1,,N,50597,,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,,BAO_0000218,,9671,,1,10116.0,CHEMBL622877,,,Intermediate,A,
,4910,Rattus norvegicus,1,,N,50597,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,,BAO_0000218,,9672,,1,10116.0,CHEMBL622878,,,Intermediate,A,
,4910,Rattus norvegicus,1,,N,50597,,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,,,BAO_0000218,,9673,Plasma,1,10116.0,CHEMBL622879,,1969.0,Intermediate,A,
,4839,Rattus norvegicus,1,,N,50597,,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,,,BAO_0000218,,9674,,1,10116.0,CHEMBL877602,,,Intermediate,A,
,15078,Rattus norvegicus,1,,N,50597,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,,9675,,1,10116.0,CHEMBL622880,,,Intermediate,A,
,15078,Rattus norvegicus,1,,N,50597,,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,,9676,,1,10116.0,CHEMBL622881,,,Intermediate,A,
,15078,Rattus norvegicus,1,,N,50597,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,,9677,,1,10116.0,CHEMBL622882,,,Intermediate,A,
,15078,Rattus norvegicus,1,,N,50597,,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,,9678,,1,10116.0,CHEMBL622883,,,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",,,BAO_0000218,,9679,Thyroid gland,1,10116.0,CHEMBL622884,,2046.0,Intermediate,A,
,11450,Rattus norvegicus,1,,N,50597,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",,,BAO_0000218,,9680,Thyroid gland,1,10116.0,CHEMBL622885,,2046.0,Intermediate,A,
,8151,Rattus norvegicus,1,,N,50597,,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,,BAO_0000218,,9681,,1,10116.0,CHEMBL622886,,,Intermediate,A,
,8151,Rattus norvegicus,1,,N,50597,,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,,BAO_0000218,,9682,,1,10116.0,CHEMBL622887,,,Intermediate,A,
,8151,Rattus norvegicus,1,,N,50597,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,,BAO_0000218,,9683,Urine,1,10116.0,CHEMBL622888,,1088.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,,9684,Blood,1,10116.0,CHEMBL622889,In vivo,178.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,,9685,Blood,1,10116.0,CHEMBL622890,In vivo,178.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,,9686,Blood,1,10116.0,CHEMBL622891,In vivo,178.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,,9687,Blood,1,10116.0,CHEMBL877603,In vivo,178.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,,9688,Brain,1,10116.0,CHEMBL622892,In vivo,955.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,,9689,Brain,1,10116.0,CHEMBL622893,In vivo,955.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,,9690,Brain,1,10116.0,CHEMBL622894,In vivo,955.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,,9691,Brain,1,10116.0,CHEMBL622895,In vivo,955.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,,,BAO_0000218,,9692,Brain,1,10116.0,CHEMBL622896,In vivo,955.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,,9693,Heart,1,10116.0,CHEMBL622897,In vivo,948.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,,9694,Heart,1,10116.0,CHEMBL622898,In vivo,948.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,,9695,Heart,1,10116.0,CHEMBL622899,In vivo,948.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,,9696,Kidney,1,10116.0,CHEMBL622900,In vivo,2113.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,,9697,Kidney,1,10116.0,CHEMBL624114,In vivo,2113.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,,9698,Kidney,1,10116.0,CHEMBL624115,In vivo,2113.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,,9699,Kidney,1,10116.0,CHEMBL624116,In vivo,2113.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,,9700,Liver,1,10116.0,CHEMBL624117,In vivo,2107.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,,9701,Liver,1,10116.0,CHEMBL624118,In vivo,2107.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,,9702,Liver,1,10116.0,CHEMBL624119,In vivo,2107.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,,9703,Liver,1,10116.0,CHEMBL624120,In vivo,2107.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,,9704,Lung,1,10116.0,CHEMBL624121,In vivo,2048.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,,9705,Lung,1,10116.0,CHEMBL624122,In vivo,2048.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,,9706,Lung,1,10116.0,CHEMBL624123,In vivo,2048.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,,9707,Lung,1,10116.0,CHEMBL624124,In vivo,2048.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,,9708,Muscle tissue,1,10116.0,CHEMBL624125,In vivo,2385.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,,9709,Muscle tissue,1,10116.0,CHEMBL624126,In vivo,2385.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,,9710,Muscle tissue,1,10116.0,CHEMBL624127,In vivo,2385.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,,9711,Muscle tissue,1,10116.0,CHEMBL624128,In vivo,2385.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,,9712,Zone of skin,1,10116.0,CHEMBL624129,In vivo,14.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,,9713,Zone of skin,1,10116.0,CHEMBL624130,In vivo,14.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,,9714,Zone of skin,1,10116.0,CHEMBL622340,In vivo,14.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,,9715,Zone of skin,1,10116.0,CHEMBL622341,In vivo,14.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,,9716,Intestine,1,10116.0,CHEMBL622342,In vivo,160.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,,9717,Intestine,1,10116.0,CHEMBL622343,In vivo,160.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,,9718,Intestine,1,10116.0,CHEMBL622344,In vivo,160.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,,9719,Intestine,1,10116.0,CHEMBL622345,In vivo,160.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,,9720,Spleen,1,10116.0,CHEMBL622346,In vivo,2106.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,,9721,Spleen,1,10116.0,CHEMBL622347,In vivo,2106.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,,9722,Spleen,1,10116.0,CHEMBL622348,In vivo,2106.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,,9723,Spleen,1,10116.0,CHEMBL622349,In vivo,2106.0,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,BAO_0000218,,9724,,1,10116.0,CHEMBL622350,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,BAO_0000218,,9725,,1,10116.0,CHEMBL622351,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,BAO_0000218,,9726,,1,10116.0,CHEMBL622352,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,BAO_0000218,,9727,,1,10116.0,CHEMBL622353,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,BAO_0000218,,9728,,1,10116.0,CHEMBL622354,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,BAO_0000218,,9729,,1,10116.0,CHEMBL622355,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,BAO_0000218,,9730,,1,10116.0,CHEMBL622356,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,BAO_0000218,,9731,,1,10116.0,CHEMBL622357,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,BAO_0000218,,9732,,1,10116.0,CHEMBL622358,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,BAO_0000218,,9733,,1,10116.0,CHEMBL622359,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,BAO_0000218,,9734,,1,10116.0,CHEMBL874393,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,BAO_0000218,,9735,,1,10116.0,CHEMBL622872,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,BAO_0000218,,9736,,1,10116.0,CHEMBL622873,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,BAO_0000218,,9737,,1,10116.0,CHEMBL623047,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,BAO_0000218,,9738,,1,10116.0,CHEMBL623048,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,BAO_0000218,,9739,,1,10116.0,CHEMBL623049,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,BAO_0000218,,9740,,1,10116.0,CHEMBL623050,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,BAO_0000218,,9741,,1,10116.0,CHEMBL623051,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,BAO_0000218,,9742,,1,10116.0,CHEMBL623052,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,BAO_0000218,,9743,,1,10116.0,CHEMBL626343,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,BAO_0000218,,9744,,1,10116.0,CHEMBL626344,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,BAO_0000218,,9745,,1,10116.0,CHEMBL626345,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,BAO_0000218,,9746,,1,10116.0,CHEMBL626346,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,BAO_0000218,,9747,,1,10116.0,CHEMBL626347,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,BAO_0000218,,9748,,1,10116.0,CHEMBL626348,,,Intermediate,A,
,16434,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,BAO_0000218,,9749,,1,10116.0,CHEMBL626349,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,BAO_0000218,,9750,,1,10116.0,CHEMBL626350,,,Intermediate,F,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,BAO_0000218,,9751,,1,10116.0,CHEMBL626351,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,BAO_0000218,,9752,,1,10116.0,CHEMBL627650,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,BAO_0000218,,9753,,1,10116.0,CHEMBL627651,,,Intermediate,F,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,BAO_0000218,,9754,,1,10116.0,CHEMBL627652,,,Intermediate,A,
,16435,Rattus norvegicus,1,,N,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,BAO_0000218,,9755,,1,10116.0,CHEMBL627653,,,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,,,BAO_0000218,,9756,,1,10116.0,CHEMBL627654,,,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,,,BAO_0000218,,9757,,1,10116.0,CHEMBL627835,,,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,,,BAO_0000218,,9758,,1,10116.0,CHEMBL627836,,,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,,,BAO_0000218,,9759,,1,10116.0,CHEMBL627837,,,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,,,BAO_0000218,,9760,,1,10116.0,CHEMBL627838,,,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,,,BAO_0000218,,9761,,1,10116.0,CHEMBL875338,,,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,,,BAO_0000218,,9762,,1,10116.0,CHEMBL627839,,,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,,,BAO_0000218,,9763,,1,10116.0,CHEMBL627840,,,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,,,BAO_0000218,,9764,,1,10116.0,CHEMBL627841,,,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,,,BAO_0000218,,9765,,1,10116.0,CHEMBL627842,,,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,,,BAO_0000218,,9766,,1,10116.0,CHEMBL627843,,,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,,,BAO_0000218,,9767,,1,10116.0,CHEMBL627844,,,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,,,BAO_0000218,,9768,,1,10116.0,CHEMBL627845,,,Intermediate,A,
,5874,Rattus norvegicus,1,,N,50597,,Half life period in rat by iv administration at a dose of 3 mg/kg,,,BAO_0000218,,9769,,1,10116.0,CHEMBL627846,In vivo,,Intermediate,A,
,1515,Rattus norvegicus,1,,N,50597,,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),,,BAO_0000218,,9770,Plasma,1,10116.0,CHEMBL627847,,1969.0,Intermediate,A,
,1515,Rattus norvegicus,1,,N,50597,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),,,BAO_0000218,,9771,Plasma,1,10116.0,CHEMBL873821,,1969.0,Intermediate,A,
,1515,Rattus norvegicus,1,,N,50597,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,,BAO_0000218,,9772,Plasma,1,10116.0,CHEMBL626079,,1969.0,Intermediate,A,
,1515,Rattus norvegicus,1,,N,50597,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,,BAO_0000218,,9773,Plasma,1,10116.0,CHEMBL626080,,1969.0,Intermediate,A,
,5491,Rattus norvegicus,1,,N,50597,,Half life period was evaluated in rat plasma,,,BAO_0000218,,9774,Plasma,1,10116.0,CHEMBL626081,,1969.0,Intermediate,A,
,5491,Rattus norvegicus,1,,N,50597,,Half life period was evaluated in rat plasma; Not tested,,,BAO_0000218,,9775,Plasma,1,10116.0,CHEMBL875344,,1969.0,Intermediate,A,
,1918,Rattus norvegicus,1,,N,50597,,Half life period was evaluated in rats,,,BAO_0000218,,9776,,1,10116.0,CHEMBL626082,,,Intermediate,A,
,1918,Rattus norvegicus,1,,N,50597,,"Half life period was evaluated in rats, iv",,,BAO_0000218,,9777,,1,10116.0,CHEMBL626250,In vivo,,Intermediate,A,
,6113,Rattus norvegicus,1,,N,50597,,Half life period after intravenous administration at 5 mg/kg in rat,,,BAO_0000218,,9778,,1,10116.0,CHEMBL626251,In vivo,,Intermediate,A,
,5546,Rattus norvegicus,1,,N,50597,,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,,BAO_0000218,,9779,,1,10116.0,CHEMBL626252,In vivo,,Intermediate,A,
,5553,Rattus norvegicus,1,,N,50597,,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,,,BAO_0000218,,9780,,1,10116.0,CHEMBL626253,In vivo,,Intermediate,A,
,4188,Rattus norvegicus,1,,N,50597,,Half life stability of compound was evaluated in rat plasma,,,BAO_0000218,,9781,Plasma,1,10116.0,CHEMBL626254,,1969.0,Intermediate,A,
,6215,Rattus norvegicus,1,,N,50597,,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,,,BAO_0000218,,9782,,1,10116.0,CHEMBL626255,In vivo,,Intermediate,A,
,6141,Rattus norvegicus,1,,N,50597,,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,,BAO_0000218,,9783,,1,10116.0,CHEMBL626256,In vivo,,Intermediate,A,
,5182,Rattus norvegicus,1,,N,50597,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,,BAO_0000218,,9784,,1,10116.0,CHEMBL626257,In vivo,,Intermediate,A,
,5182,Rattus norvegicus,1,,N,50597,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,,,BAO_0000218,,9785,,1,10116.0,CHEMBL626258,In vivo,,Intermediate,A,
,5710,Rattus norvegicus,1,,N,50597,,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,,,BAO_0000218,,9786,,1,10116.0,CHEMBL626259,In vivo,,Intermediate,A,
,5789,Rattus norvegicus,1,,N,50597,,Half in rat i.v.,,,BAO_0000218,,9787,,1,10116.0,CHEMBL626260,In vivo,,Intermediate,A,
,6011,Rattus norvegicus,1,,N,50597,,Half period in rat after intravenous administration,,,BAO_0000218,,9788,,1,10116.0,CHEMBL875345,In vivo,,Intermediate,A,
,17594,Rattus norvegicus,1,,N,50597,,Half-life after repeated oral dose of compound at 1 mg/kg in rats,,,BAO_0000218,,9789,,1,10116.0,CHEMBL626261,In vivo,,Intermediate,A,
,12357,Rattus norvegicus,1,,N,50597,,Half-life measured in in vitro Cathepsin B assay in rat liver,,,BAO_0000218,,9790,Liver,1,10116.0,CHEMBL626262,In vitro,2107.0,Intermediate,A,
,5210,Rattus norvegicus,1,,N,50597,,Half-life of compound was determined in rats,,,BAO_0000218,,9791,,1,10116.0,CHEMBL626263,,,Intermediate,A,
,17596,Rattus norvegicus,1,,N,50597,,Half-life at 10 mg/kg in rat upon intravenous administration,,,BAO_0000218,,9792,,1,10116.0,CHEMBL625270,In vivo,,Intermediate,A,
,6672,Rattus norvegicus,1,,N,50597,,Half-life determined in rat,,,BAO_0000218,,9793,,1,10116.0,CHEMBL625271,,,Intermediate,A,
,6673,Rattus norvegicus,1,,N,50597,,Half-life determined in rat,,,BAO_0000218,,9794,,1,10116.0,CHEMBL625272,,,Intermediate,A,
,4910,Rattus norvegicus,1,,N,50597,,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,,,BAO_0000218,,9795,Brain,1,10116.0,CHEMBL625273,In vivo,955.0,Intermediate,A,
,3741,Rattus norvegicus,1,,N,50597,,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",,,BAO_0000218,,9796,Plasma,1,10116.0,CHEMBL625274,,1969.0,Intermediate,A,
,17671,Rattus norvegicus,1,,N,50597,,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,,BAO_0000218,,9797,,1,10116.0,CHEMBL625275,In vivo,,Intermediate,A,
,4910,Rattus norvegicus,1,,N,50597,,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,,,BAO_0000218,,9798,Plasma,1,10116.0,CHEMBL625276,In vivo,1969.0,Intermediate,A,
,17537,Rattus norvegicus,1,,N,50597,,Half-life in rat plasma,,,BAO_0000218,,9799,Plasma,1,10116.0,CHEMBL625277,,1969.0,Intermediate,A,
,4965,Rattus norvegicus,1,,N,50597,,Half-life in rat plasma was determined,,,BAO_0000218,,9800,Plasma,1,10116.0,CHEMBL625278,,1969.0,Intermediate,A,
,17537,Rattus norvegicus,1,,N,50597,,Half-life in rat plasma; Not tested,,,BAO_0000218,,9801,Plasma,1,10116.0,CHEMBL625279,,1969.0,Intermediate,A,
,6124,Rattus norvegicus,1,,N,50597,,Half-life in rat serum,,,BAO_0000218,,9802,Serum,1,10116.0,CHEMBL625280,,1977.0,Intermediate,A,
,6124,Rattus norvegicus,1,,N,50597,,Half-life in rat serum; na is not available,,,BAO_0000218,,9803,Serum,1,10116.0,CHEMBL876797,,1977.0,Intermediate,A,
,6078,Rattus norvegicus,1,,N,50597,,Half-life was calculated in rat,,,BAO_0000218,,9804,,1,10116.0,CHEMBL625281,,,Intermediate,A,
,17668,Rattus norvegicus,1,,N,50597,,Half-life was calculated in rat plasma,,,BAO_0000218,,9805,Plasma,1,10116.0,CHEMBL873827,,1969.0,Intermediate,A,
,3185,Rattus norvegicus,1,,N,50597,,Half-life was determined,,,BAO_0000218,,9806,,1,10116.0,CHEMBL625282,,,Intermediate,A,
,4883,Rattus norvegicus,1,,N,50597,,Half-life was determined,,,BAO_0000218,,9807,,1,10116.0,CHEMBL625283,,,Intermediate,A,
,2959,Rattus norvegicus,1,,N,50597,,Half-life after administration of 20 mg/Kg oral dose in rat,,,BAO_0000218,,9808,,1,10116.0,CHEMBL625284,In vivo,,Intermediate,A,
,4029,Rattus norvegicus,1,,N,50597,,Half-life after administration of 3.2 mg/kg intravenously in male rat,,,BAO_0000218,,9809,,1,10116.0,CHEMBL625285,In vivo,,Intermediate,A,
,4029,Rattus norvegicus,1,,N,50597,,Half-life after intravenous administration in female rat,,,BAO_0000218,,9810,,1,10116.0,CHEMBL625286,In vivo,,Intermediate,A,
,4029,Rattus norvegicus,1,,N,50597,,Half-life after intravenous administration in male rat,,,BAO_0000218,,9811,,1,10116.0,CHEMBL625287,In vivo,,Intermediate,A,
,6180,Rattus norvegicus,1,,N,50597,,Half-life after intravenous dose in rat,,,BAO_0000218,,9812,,1,10116.0,CHEMBL625288,In vivo,,Intermediate,A,
,1557,Rattus norvegicus,1,,N,50597,,Half-life in a rat liver homogenate preparation,,,BAO_0000218,,9813,Liver,1,10116.0,CHEMBL625289,,2107.0,Intermediate,A,
,12500,Rattus norvegicus,1,,N,50597,,Half-life in plasma of rat,,,BAO_0000218,,9814,Plasma,1,10116.0,CHEMBL625290,,1969.0,Intermediate,A,
,12500,Rattus norvegicus,1,,N,50597,,Half-life in plasma of rat at dose of 3-10 mgkg,,,BAO_0000218,,9815,Plasma,1,10116.0,CHEMBL876798,,1969.0,Intermediate,A,
,5064,Rattus norvegicus,1,,N,50597,,Half-life in rat,,,BAO_0000218,,9816,,1,10116.0,CHEMBL625291,,,Intermediate,A,
,5145,Rattus norvegicus,1,,N,50597,,Half-life in rat,,,BAO_0000218,,9817,,1,10116.0,CHEMBL625292,,,Intermediate,A,
,5147,Rattus norvegicus,1,,N,50597,,Half-life in rat,,,BAO_0000218,,9818,,1,10116.0,CHEMBL625293,,,Intermediate,A,
,5833,Rattus norvegicus,1,,N,50597,,Half-life in rat,,,BAO_0000218,,9819,,1,10116.0,CHEMBL622832,,,Intermediate,A,
,6596,Rattus norvegicus,1,,N,50597,,Half-life in rat,,,BAO_0000218,,9820,,1,10116.0,CHEMBL622833,,,Intermediate,A,
,17655,Rattus norvegicus,1,,N,50597,,Half-life in rat,,,BAO_0000218,,9821,,1,10116.0,CHEMBL622834,,,Intermediate,A,
,6495,Rattus norvegicus,1,,N,50597,,Half-life in rat after oral administration at 10 mg/kg,,,BAO_0000218,,9822,,1,10116.0,CHEMBL622835,In vivo,,Intermediate,A,
,17538,Rattus norvegicus,1,,N,50597,,Half-life in rat after po administration at a dose of 10 mg/kg,,,BAO_0000218,,9823,,1,10116.0,CHEMBL622836,In vivo,,Intermediate,A,
,17538,Rattus norvegicus,1,,N,50597,,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,,,BAO_0000218,,9824,,1,10116.0,CHEMBL622837,In vivo,,Intermediate,A,
,10,Rattus norvegicus,1,,N,50597,,Half-life in rat at 3 mg/kg dose administered intravenously,,,BAO_0000218,,9825,,1,10116.0,CHEMBL622838,In vivo,,Intermediate,A,
,17669,Rattus norvegicus,1,,N,50597,,Half-life in rat brain homogenate,,,BAO_0000218,,9826,Brain,1,10116.0,CHEMBL622839,,955.0,Intermediate,A,
,17065,Rattus norvegicus,1,,N,50597,,Half-life in rat plasma,,,BAO_0000218,,9827,Plasma,1,10116.0,CHEMBL622840,,1969.0,Intermediate,A,
,4333,Rattus norvegicus,1,,N,50597,,Half-life in rats,,,BAO_0000218,,9828,,1,10116.0,CHEMBL622841,,,Intermediate,A,
,6827,Rattus norvegicus,1,,N,50597,,Half-life in Dawley rats,,,BAO_0000218,,9829,,1,10116.0,CHEMBL622842,,,Intermediate,A,
,889,Rattus norvegicus,1,,N,50597,,Half-life in vitro in rat plasma,,,BAO_0000218,,9830,Plasma,1,10116.0,CHEMBL622843,In vitro,1969.0,Intermediate,A,
,889,Rattus norvegicus,1,,N,50597,,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,,,BAO_0000218,,9831,Plasma,1,10116.0,CHEMBL622844,In vitro,1969.0,Intermediate,A,
,3747,Rattus norvegicus,1,,N,50597,,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",,,BAO_0000218,,9832,,1,10116.0,CHEMBL622845,,,Intermediate,A,
,15022,Rattus norvegicus,1,,N,50597,,The area under the curve of compound was measured at the dose of 100 umol/kg,,,BAO_0000218,,9833,,1,10116.0,CHEMBL622846,,,Intermediate,A,
,15022,Rattus norvegicus,1,,N,50597,,The area under the curve of compound was measured at the dose of 300 umol/kg,,,BAO_0000218,,9834,,1,10116.0,CHEMBL622847,,,Intermediate,A,
,15022,Rattus norvegicus,1,,N,50597,,The area under the curve of compound was measured at the dose of 30 umol/kg,,,BAO_0000218,,9835,,1,10116.0,CHEMBL622848,,,Intermediate,A,
,3360,Rattus norvegicus,1,,N,50597,,Bioavailability as oral AUC in rats,,,BAO_0000218,,9836,,1,10116.0,CHEMBL622849,In vivo,,Intermediate,A,
,5334,Rattus norvegicus,1,,N,50597,,The plasma concentration versus time curve (AUC) was determined,,,BAO_0000218,,9837,Plasma,1,10116.0,CHEMBL622850,,1969.0,Intermediate,A,
,17411,Rattus norvegicus,1,,N,50597,,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,BAO_0000218,,9838,,1,10116.0,CHEMBL876807,,,Intermediate,A,
,17411,Rattus norvegicus,1,,N,50597,,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,BAO_0000218,,9839,,1,10116.0,CHEMBL622851,,,Intermediate,A,
,17411,Rattus norvegicus,1,,N,50597,,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,BAO_0000218,,9840,,1,10116.0,CHEMBL622852,,,Intermediate,A,
,6570,Rattus norvegicus,1,,N,50597,,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,,,BAO_0000218,,9841,,1,10116.0,CHEMBL622853,,,Intermediate,A,
,6570,Rattus norvegicus,1,,N,50597,,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,,,BAO_0000218,,9842,,1,10116.0,CHEMBL622854,,,Intermediate,A,
,17411,Rattus norvegicus,1,,N,50597,,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,BAO_0000218,,9843,,1,10116.0,CHEMBL622855,,,Intermediate,A,
,14941,Rattus norvegicus,1,,N,50597,,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",,,BAO_0000218,,9844,Plasma,1,10116.0,CHEMBL622856,,1969.0,Intermediate,A,
,14941,Rattus norvegicus,1,,N,50597,,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",,,BAO_0000218,,9845,Plasma,1,10116.0,CHEMBL622857,,1969.0,Intermediate,A,
,17538,Rattus norvegicus,1,,N,50597,,AUC in rat after po administration at a dose of 10 mg/kg,,,BAO_0000218,,9846,Plasma,1,10116.0,CHEMBL622858,,1969.0,Intermediate,A,
,17752,Rattus norvegicus,1,,N,50597,,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,,,BAO_0000218,,9847,Plasma,1,10116.0,CHEMBL622859,,1969.0,Intermediate,A,
,17509,Rattus norvegicus,1,,N,50597,,Area under curve value 24 hr after 10 mg/kg iv administration in rats,,,BAO_0000218,,9848,,1,10116.0,CHEMBL622860,,,Intermediate,A,
,17509,Rattus norvegicus,1,,N,50597,,Area under curve value 24 hr after 10 mg/kg oral administration in rats,,,BAO_0000218,,9849,,1,10116.0,CHEMBL622861,,,Intermediate,A,
,17509,Rattus norvegicus,1,,N,50597,,Area under curve value 24 hr after 2 mg/kg iv administration in rats,,,BAO_0000218,,9850,,1,10116.0,CHEMBL622862,,,Intermediate,A,
,17509,Rattus norvegicus,1,,N,50597,,Area under curve value 24 hr after 2 mg/kg oral administration in rats,,,BAO_0000218,,9851,,1,10116.0,CHEMBL622863,,,Intermediate,A,
,17509,Rattus norvegicus,1,,N,50597,,Area under curve value 6 hr after po administration in rat,,,BAO_0000218,,9852,,1,10116.0,CHEMBL623817,,,Intermediate,A,
,17717,Rattus norvegicus,1,,N,50597,,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,BAO_0000218,,9853,,1,10116.0,CHEMBL623818,,,Intermediate,A,
,17717,Rattus norvegicus,1,,N,50597,,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",,,BAO_0000218,,9854,,1,10116.0,CHEMBL623819,,,Intermediate,A,
,17717,Rattus norvegicus,1,,N,50597,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,BAO_0000218,,9855,,1,10116.0,CHEMBL623820,,,Intermediate,A,
,17717,Rattus norvegicus,1,,N,50597,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,,,BAO_0000218,,9856,,1,10116.0,CHEMBL623821,,,Intermediate,A,
,6642,Rattus norvegicus,1,,N,50597,,AUC normalized for dose (AUCN) in rat,,,BAO_0000218,,9857,Plasma,1,10116.0,CHEMBL623822,,1969.0,Intermediate,A,
,6640,Rattus norvegicus,1,,N,50597,,Area under curve in rat after p.o. administration,,,BAO_0000218,,9858,,1,10116.0,CHEMBL623823,,,Intermediate,A,
,6641,Rattus norvegicus,1,,N,50597,,Area under curve in rat after p.o. administration,,,BAO_0000218,,9859,,1,10116.0,CHEMBL623824,,,Intermediate,A,
,6641,Rattus norvegicus,1,,N,50597,,Area under curve in rat after p.o. administration; Not determined,,,BAO_0000218,,9860,,1,10116.0,CHEMBL623825,,,Intermediate,A,
,6641,Rattus norvegicus,1,,N,50597,,Area under curve in rat after peroral administration,,,BAO_0000218,,9861,,1,10116.0,CHEMBL622070,,,Intermediate,A,
,3603,Rattus norvegicus,1,,N,50597,,Area under curve (carotid artery) value of the compound,,,BAO_0000218,,9862,,1,10116.0,CHEMBL622071,,,Intermediate,A,
,3550,Rattus norvegicus,1,,N,50597,,Bioavailability expressed as the area under curve of rat carotid artery,,,BAO_0000218,,9863,,1,10116.0,CHEMBL622072,,,Intermediate,A,
,15662,Rattus norvegicus,1,,N,50597,,Area under curve in male SD rats was observed after intravenous administration in rat,,,BAO_0000218,,9864,,1,10116.0,CHEMBL622073,,,Intermediate,A,
,17720,Rattus norvegicus,1,,N,50597,,Area under curve of the compound was determined,,,BAO_0000218,,9865,,1,10116.0,CHEMBL622074,,,Intermediate,A,
,5407,Rattus norvegicus,1,,N,50597,,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,,,BAO_0000218,,9866,,1,10116.0,CHEMBL622075,,,Intermediate,A,
,17752,Rattus norvegicus,1,,N,50597,,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,,,BAO_0000218,,9867,Plasma,1,10116.0,CHEMBL622076,,1969.0,Intermediate,A,
,17752,Rattus norvegicus,1,,N,50597,,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,,,BAO_0000218,,9868,Plasma,1,10116.0,CHEMBL622077,,1969.0,Intermediate,A,
,3603,Rattus norvegicus,1,,N,50597,,Area under curve (portal vein) value of the compound,,,BAO_0000218,,9869,,1,10116.0,CHEMBL622078,,,Intermediate,A,
,3550,Rattus norvegicus,1,,N,50597,,Bioavailability expressed as the area under curve of rat portal vein,,,BAO_0000218,,9870,,1,10116.0,CHEMBL622079,,,Intermediate,A,
,17655,Rattus norvegicus,1,,N,50597,,Area Under plasma concentration time curve in rat upon peroral administration,,,BAO_0000218,,9871,Plasma,1,10116.0,CHEMBL622080,,1969.0,Intermediate,A,
,17582,Rattus norvegicus,1,,N,50597,,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,,,BAO_0000218,,9872,,1,10116.0,CHEMBL877612,,,Intermediate,A,
,17582,Rattus norvegicus,1,,N,50597,,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,,,BAO_0000218,,9873,,1,10116.0,CHEMBL622081,,,Intermediate,A,
,17791,Rattus norvegicus,1,,N,50597,,Compound was evaluated for oral bioavailability in rats,,,BAO_0000218,,9874,,1,10116.0,CHEMBL622082,,,Intermediate,A,
,17791,Rattus norvegicus,1,,N,50597,,Compound was evaluated for oral bioavailability in rats after iv administration,,,BAO_0000218,,9875,,1,10116.0,CHEMBL622083,,,Intermediate,A,
,17791,Rattus norvegicus,1,,N,50597,,Compound was evaluated for oral bioavailability in rats; 30-80,,,BAO_0000218,,9876,,1,10116.0,CHEMBL622084,,,Intermediate,A,
,17791,Rattus norvegicus,1,,N,50597,,Compound was evaluated for oral bioavailability in rats; 50-60,,,BAO_0000218,,9877,,1,10116.0,CHEMBL622085,,,Intermediate,A,
,17791,Rattus norvegicus,1,,N,50597,,Compound was evaluated for oral bioavailability in rats; no data,,,BAO_0000218,,9878,,1,10116.0,CHEMBL622086,,,Intermediate,A,
,17791,Rattus norvegicus,1,,N,50597,,Compound was evaluated for oral bioavailability in rats; peptide,,,BAO_0000218,,9879,,1,10116.0,CHEMBL622087,,,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",,,BAO_0000218,,9880,Blood,1,10116.0,CHEMBL622088,,178.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",,,BAO_0000218,,9881,Blood,1,10116.0,CHEMBL622089,,178.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",,,BAO_0000218,,9882,Blood,1,10116.0,CHEMBL623685,,178.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",,,BAO_0000218,,9883,Blood,1,10116.0,CHEMBL623686,,178.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,,9884,Stomach,1,10116.0,CHEMBL623687,In vivo,945.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,,9885,Stomach,1,10116.0,CHEMBL623688,In vivo,945.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,,9886,Stomach,1,10116.0,CHEMBL623689,In vivo,945.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,,9887,Stomach,1,10116.0,CHEMBL622485,In vivo,945.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,,9888,Thyroid gland,1,10116.0,CHEMBL622486,In vivo,2046.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,,9889,Thyroid gland,1,10116.0,CHEMBL877613,In vivo,2046.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,,9890,Thyroid gland,1,10116.0,CHEMBL622487,In vivo,2046.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,,9891,Thyroid gland,1,10116.0,CHEMBL622488,In vivo,2046.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,,9892,Heart,1,10116.0,CHEMBL622489,In vivo,948.0,Intermediate,A,
,6899,Rattus norvegicus,1,,N,50597,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,,BAO_0000218,,9893,Urine,1,10116.0,CHEMBL622490,,1088.0,Intermediate,A,
,6899,Rattus norvegicus,1,,N,50597,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,,BAO_0000218,,9894,Urine,1,10116.0,CHEMBL622491,,1088.0,Intermediate,A,
,6899,Rattus norvegicus,1,,N,50597,,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,,,BAO_0000218,,9895,Liver,1,10116.0,CHEMBL622492,,2107.0,Intermediate,A,
,6899,Rattus norvegicus,1,,N,50597,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,,BAO_0000218,,9896,Urine,1,10116.0,CHEMBL622493,,1088.0,Intermediate,A,
,6899,Rattus norvegicus,1,,N,50597,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,,BAO_0000218,,9897,Urine,1,10116.0,CHEMBL622494,,1088.0,Intermediate,A,
,8677,Rattus norvegicus,1,,N,50597,,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,,9898,Muscle tissue,1,10116.0,CHEMBL622495,,2385.0,Intermediate,A,
,6899,Rattus norvegicus,1,,N,50597,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,,,BAO_0000218,,9899,,1,10116.0,CHEMBL622496,,,Intermediate,A,
,6899,Rattus norvegicus,1,,N,50597,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,,BAO_0000218,,9900,Urine,1,10116.0,CHEMBL622497,,1088.0,Intermediate,A,
,2189,Rattus norvegicus,1,,N,50597,,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,,,BAO_0000218,,9901,,1,10116.0,CHEMBL622498,,,Intermediate,A,
,2189,Rattus norvegicus,1,,N,50597,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,,,BAO_0000218,,9902,Urine,1,10116.0,CHEMBL624918,,1088.0,Intermediate,A,
,2189,Rattus norvegicus,1,,N,50597,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,,,BAO_0000218,,9903,Urine,1,10116.0,CHEMBL624919,,1088.0,Intermediate,A,
,10839,Rattus norvegicus,1,,N,50597,,Biodistribution of compound in rat blood after 5 min of administration,,,BAO_0000218,,9904,Blood,1,10116.0,CHEMBL624920,In vivo,178.0,Intermediate,A,
,10839,Rattus norvegicus,1,,N,50597,,Biodistribution of compound in rat blood after 5 min of administration.,,,BAO_0000218,,9905,Blood,1,10116.0,CHEMBL624921,In vivo,178.0,Intermediate,A,
,10839,Rattus norvegicus,1,,N,50597,,Biodistribution of compound in rat brain after 5 min of administration,,,BAO_0000218,,9906,Brain,1,10116.0,CHEMBL624922,In vivo,955.0,Intermediate,A,
,10839,Rattus norvegicus,1,,N,50597,,Biodistribution of compound in rat heart after 5 min of administration,,,BAO_0000218,,9907,Heart,1,10116.0,CHEMBL624923,In vivo,948.0,Intermediate,A,
,10839,Rattus norvegicus,1,,N,50597,,Biodistribution of compound in rat heart after 5 min of administration.,,,BAO_0000218,,9908,Heart,1,10116.0,CHEMBL624924,In vivo,948.0,Intermediate,A,
,10839,Rattus norvegicus,1,,N,50597,,Biodistribution of compound in rat kidney after 5 min of administration,,,BAO_0000218,,9909,Kidney,1,10116.0,CHEMBL624925,In vivo,2113.0,Intermediate,A,
,10839,Rattus norvegicus,1,,N,50597,,Biodistribution of compound in rat kidney after 5 min of administration.,,,BAO_0000218,,9910,Kidney,1,10116.0,CHEMBL624926,In vivo,2113.0,Intermediate,A,
,10839,Rattus norvegicus,1,,N,50597,,Biodistribution of compound in rat liver after 5 min of administration,,,BAO_0000218,,9911,Liver,1,10116.0,CHEMBL624927,In vivo,2107.0,Intermediate,A,
,10839,Rattus norvegicus,1,,N,50597,,Biodistribution of compound in rat liver after 5 min of administration.,,,BAO_0000218,,9912,Liver,1,10116.0,CHEMBL874402,In vivo,2107.0,Intermediate,A,
,10839,Rattus norvegicus,1,,N,50597,,Biodistribution of compound in rat lung after 5 min of administration,,,BAO_0000218,,9913,Lung,1,10116.0,CHEMBL624928,In vivo,2048.0,Intermediate,A,
,10839,Rattus norvegicus,1,,N,50597,,Biodistribution of compound in rat lung after 5 min of administration.,,,BAO_0000218,,9914,Lung,1,10116.0,CHEMBL624929,In vivo,2048.0,Intermediate,A,
,10839,Rattus norvegicus,1,,N,50597,,Biodistribution of compound in rat muscle after 5 min of administration,,,BAO_0000218,,9915,Muscle tissue,1,10116.0,CHEMBL624930,In vivo,2385.0,Intermediate,A,
,10839,Rattus norvegicus,1,,N,50597,,Biodistribution of compound in rat muscle after 5 min of administration.,,,BAO_0000218,,9916,Muscle tissue,1,10116.0,CHEMBL624931,In vivo,2385.0,Intermediate,A,
,4043,Rattus norvegicus,1,,N,50597,,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,BAO_0000218,,9917,Heart,1,10116.0,CHEMBL624932,,948.0,Intermediate,A,
,4043,Rattus norvegicus,1,,N,50597,,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,BAO_0000218,,9918,Heart,1,10116.0,CHEMBL624933,,948.0,Intermediate,A,
,4043,Rattus norvegicus,1,,N,50597,,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,BAO_0000218,,9919,Liver,1,10116.0,CHEMBL624934,,2107.0,Intermediate,A,
,4043,Rattus norvegicus,1,,N,50597,,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,BAO_0000218,,9920,Liver,1,10116.0,CHEMBL624935,,2107.0,Intermediate,A,
,4043,Rattus norvegicus,1,,N,50597,,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,BAO_0000218,,9921,,1,10116.0,CHEMBL624936,,,Intermediate,A,
,4043,Rattus norvegicus,1,,N,50597,,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,BAO_0000218,,9922,,1,10116.0,CHEMBL624937,,,Intermediate,A,
,4043,Rattus norvegicus,1,,N,50597,,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,BAO_0000218,,9923,Spleen,1,10116.0,CHEMBL624938,,2106.0,Intermediate,A,
,4043,Rattus norvegicus,1,,N,50597,,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,BAO_0000218,,9924,Spleen,1,10116.0,CHEMBL624939,,2106.0,Intermediate,A,
,4043,Rattus norvegicus,1,,N,50597,,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,BAO_0000218,,9925,,1,10116.0,CHEMBL624940,,,Intermediate,A,
,4043,Rattus norvegicus,1,,N,50597,,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,BAO_0000218,,9926,,1,10116.0,CHEMBL874403,,,Intermediate,A,
,1446,Rattus norvegicus,1,,N,50597,,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,,,BAO_0000218,,9927,,1,10116.0,CHEMBL624941,,,Intermediate,A,
,9971,Rattus norvegicus,1,,N,50597,,Dose required to lower urine osmolality to 300 mOsm/kg in rat,,,BAO_0000218,,9928,Urine,1,10116.0,CHEMBL624942,,1088.0,Intermediate,A,
,9971,Rattus norvegicus,1,,N,50597,,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,,,BAO_0000218,,9929,Urine,1,10116.0,CHEMBL624943,,1088.0,Intermediate,A,
,5765,Rattus norvegicus,1,,N,50597,,% Bioavailability after 1 day of the drug administration in rats,,,BAO_0000218,,9930,,1,10116.0,CHEMBL624944,In vivo,,Intermediate,A,
,5765,Rattus norvegicus,1,,N,50597,,% Bioavailability after 4 day of the drug administration in rats,,,BAO_0000218,,9931,,1,10116.0,CHEMBL624945,In vivo,,Intermediate,A,
,4257,Rattus norvegicus,1,,N,50597,,Absolute bioavailability was evaluated in rat,,,BAO_0000218,,9932,,1,10116.0,CHEMBL624946,In vivo,,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,,,BAO_0000218,,9933,,1,10116.0,CHEMBL624947,,,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,,,BAO_0000218,,9934,,1,10116.0,CHEMBL624948,,,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,,,BAO_0000218,,9935,,1,10116.0,CHEMBL624949,,,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,,,BAO_0000218,,9936,Kidney,1,10116.0,CHEMBL622025,,2113.0,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,,,BAO_0000218,,9937,Kidney,1,10116.0,CHEMBL622026,,2113.0,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,,,BAO_0000218,,9938,Kidney,1,10116.0,CHEMBL622027,,2113.0,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,,,BAO_0000218,,9939,Kidney,1,10116.0,CHEMBL622028,,2113.0,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,,,BAO_0000218,,9940,Liver,1,10116.0,CHEMBL622029,,2107.0,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,,,BAO_0000218,,9941,Liver,1,10116.0,CHEMBL622208,,2107.0,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,,,BAO_0000218,,9942,Liver,1,10116.0,CHEMBL622209,,2107.0,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,,,BAO_0000218,,9943,Liver,1,10116.0,CHEMBL622210,,2107.0,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,,,BAO_0000218,,9944,,1,10116.0,CHEMBL622211,,,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,,,BAO_0000218,,9945,,1,10116.0,CHEMBL622212,,,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,,,BAO_0000218,,9946,,1,10116.0,CHEMBL622213,,,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,,,BAO_0000218,,9947,,1,10116.0,CHEMBL874404,,,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,,,BAO_0000218,,9948,Muscle tissue,1,10116.0,CHEMBL620452,,2385.0,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,,,BAO_0000218,,9949,Muscle tissue,1,10116.0,CHEMBL620453,,2385.0,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,,,BAO_0000218,,9950,Muscle tissue,1,10116.0,CHEMBL620454,,2385.0,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,,,BAO_0000218,,9951,Muscle tissue,1,10116.0,CHEMBL624067,,2385.0,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,,,BAO_0000218,,9952,,1,10116.0,CHEMBL624068,,,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,,,BAO_0000218,,9953,Female gonad,1,10116.0,CHEMBL624069,,992.0,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,,,BAO_0000218,,9954,Female gonad,1,10116.0,CHEMBL624070,,992.0,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,,,BAO_0000218,,9955,Female gonad,1,10116.0,CHEMBL624071,,992.0,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,,,BAO_0000218,,9956,Uterus,1,10116.0,CHEMBL624072,,995.0,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,,,BAO_0000218,,9957,Uterus,1,10116.0,CHEMBL624073,,995.0,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,,,BAO_0000218,,9958,Uterus,1,10116.0,CHEMBL624788,,995.0,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,,,BAO_0000218,,9959,Uterus,1,10116.0,CHEMBL624789,,995.0,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,,,BAO_0000218,,9960,,1,10116.0,CHEMBL624790,,,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,,,BAO_0000218,,9961,,1,10116.0,CHEMBL624791,,,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,,,BAO_0000218,,9962,,1,10116.0,CHEMBL624792,,,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,,,BAO_0000218,,9963,,1,10116.0,CHEMBL624793,,,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,,,BAO_0000218,,9964,Muscle tissue,1,10116.0,CHEMBL877491,,2385.0,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,,,BAO_0000218,,9965,Muscle tissue,1,10116.0,CHEMBL624957,,2385.0,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,,,BAO_0000218,,9966,Muscle tissue,1,10116.0,CHEMBL624958,,2385.0,Intermediate,A,
,13091,Rattus norvegicus,1,,N,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,,,BAO_0000218,,9967,Muscle tissue,1,10116.0,CHEMBL624959,,2385.0,Intermediate,A,
,11977,Rattus norvegicus,1,,N,50597,,Dissociation constant was determined,,,BAO_0000218,,9968,,1,10116.0,CHEMBL624960,,,Intermediate,A,
,14941,Rattus norvegicus,1,,N,50597,,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",,,BAO_0000218,,9969,,1,10116.0,CHEMBL624961,,,Intermediate,A,
,15078,Rattus norvegicus,1,,N,50597,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,,9970,,1,10116.0,CHEMBL624962,,,Intermediate,A,
,15078,Rattus norvegicus,1,,N,50597,,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,,9971,,1,10116.0,CHEMBL624963,,,Intermediate,A,
,4755,Rattus norvegicus,1,,N,50597,,Observed rate constant in 80% rat plasma at 37 degree Centigrade,,,BAO_0000218,,9972,,1,10116.0,CHEMBL624964,,,Intermediate,A,
,589,Rattus norvegicus,1,,N,50597,,LogP value was evaluated in the in situ rat gut perfusion assay,,,BAO_0000218,,9973,,1,10116.0,CHEMBL624965,,,Intermediate,A,
,17582,Rattus norvegicus,1,,N,50597,,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,,BAO_0000218,,9974,,1,10116.0,CHEMBL624966,In vivo,,Intermediate,A,
,5031,Rattus norvegicus,1,,N,50597,,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,,,BAO_0000218,,9975,,1,10116.0,CHEMBL624967,In vivo,,Intermediate,A,
,17764,Rattus norvegicus,1,,N,50597,,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,,,BAO_0000218,,9976,,1,10116.0,CHEMBL624968,In vivo,,Intermediate,A,
,17720,Rattus norvegicus,1,,N,50597,,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,,,BAO_0000218,,9977,,1,10116.0,CHEMBL624969,,,Intermediate,A,
,2862,Rattus norvegicus,1,,N,50597,,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,,,BAO_0000218,,9978,,1,10116.0,CHEMBL624970,,,Expert,F,
,16423,Rattus norvegicus,1,,N,50597,,Half-life was evaluated after 10 uM/kg of intra arterial administration,,,BAO_0000218,,9979,,1,10116.0,CHEMBL624971,,,Intermediate,A,
,16423,Rattus norvegicus,1,,N,50597,,Half-life was evaluated after 20 uM/kg of peroral administration,,,BAO_0000218,,9980,,1,10116.0,CHEMBL624972,In vivo,,Intermediate,A,
,6005,Rattus norvegicus,1,,N,50597,,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,,BAO_0000218,,9981,,1,10116.0,CHEMBL624973,In vivo,,Intermediate,A,
,2938,Rattus norvegicus,1,,N,50597,,Half-life was evaluated in plasma of rat,,,BAO_0000218,,9982,Plasma,1,10116.0,CHEMBL624974,,1969.0,Intermediate,A,
,6410,Rattus norvegicus,1,,N,50597,,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,,,BAO_0000218,,9983,,1,10116.0,CHEMBL624975,In vivo,,Intermediate,A,
,6410,Rattus norvegicus,1,,N,50597,,Half-life was evaluated in rats at an oral dose of 30 mg/kg,,,BAO_0000218,,9984,,1,10116.0,CHEMBL877492,In vivo,,Intermediate,A,
,6062,Rattus norvegicus,1,,N,50597,,Half-life was measured in rat after an iv dose of 1 mg/kg,,,BAO_0000218,,9985,,1,10116.0,CHEMBL624976,In vivo,,Intermediate,A,
,6571,Rattus norvegicus,1,,N,50597,,Half-life period of compound in rats after peroral administration,,,BAO_0000218,,9986,,1,10116.0,CHEMBL624977,In vivo,,Intermediate,A,
,3136,Rattus norvegicus,1,,N,50597,,Half-life period of compound was measured in rat plasma.,,,BAO_0000218,,9987,Plasma,1,10116.0,CHEMBL626848,,1969.0,Intermediate,A,
,3136,Rattus norvegicus,1,,N,50597,,Half-life period of compound was measured in rat plasma; ND is not determined,,,BAO_0000218,,9988,Plasma,1,10116.0,CHEMBL626849,,1969.0,Intermediate,A,
,3136,Rattus norvegicus,1,,N,50597,,Half-life period of compound was measured in rat plasma; not determined,,,BAO_0000218,,9989,Plasma,1,10116.0,CHEMBL626850,,1969.0,Intermediate,A,
,4521,Rattus norvegicus,1,,N,50597,,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,,BAO_0000218,,9990,,1,10116.0,CHEMBL626851,In vivo,,Intermediate,A,
,5871,Rattus norvegicus,1,,N,50597,,Half-life period in rat by iv administration,,,BAO_0000218,,9991,,1,10116.0,CHEMBL626852,In vivo,,Intermediate,A,
,6077,Rattus norvegicus,1,,N,50597,,Half-life period in rats following intravenous administration at 2 mg/kg,,,BAO_0000218,,9992,,1,10116.0,CHEMBL626853,In vivo,,Intermediate,A,
,6679,Rattus norvegicus,1,,N,50597,,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,,BAO_0000218,,9993,,1,10116.0,CHEMBL626854,In vivo,,Intermediate,A,
,5144,Rattus norvegicus,1,,N,50597,,Half-life period was determined for the compound in rat,,,BAO_0000218,,9994,,1,10116.0,CHEMBL627486,,,Intermediate,A,
,4498,Rattus norvegicus,1,,N,50597,,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",,,BAO_0000218,,9995,,1,10116.0,CHEMBL627487,In vivo,,Intermediate,A,
,4498,Rattus norvegicus,1,,N,50597,,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",,,BAO_0000218,,9996,,1,10116.0,CHEMBL627488,In vivo,,Intermediate,A,
,1908,Rattus norvegicus,1,,N,50597,,Half-life value after IV dose at a dose of 5 mg/kg in rats.,,,BAO_0000218,,9997,,1,10116.0,CHEMBL627489,In vivo,,Intermediate,A,
,6211,Rattus norvegicus,1,,N,50597,,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,,BAO_0000218,,9998,,1,10116.0,CHEMBL627490,In vivo,,Intermediate,A,
,5529,Rattus norvegicus,1,,N,50597,,Half-life was determined in rat after intravenous administration (0.5 mg/kg),,,BAO_0000218,,9999,,1,10116.0,CHEMBL873829,In vivo,,Intermediate,A,
,6444,Rattus norvegicus,1,,N,50597,,Half-life was determined in rat at a dose of 1 mpk i.v.,,,BAO_0000218,,10000,,1,10116.0,CHEMBL627655,In vivo,,Intermediate,A,
,6444,Rattus norvegicus,1,,N,50597,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,,BAO_0000218,,10001,,1,10116.0,CHEMBL625994,In vivo,,Intermediate,A,
,6444,Rattus norvegicus,1,,N,50597,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,,BAO_0000218,,10002,,1,10116.0,CHEMBL625995,In vivo,,Intermediate,A,
,5207,Rattus norvegicus,1,,N,50597,,Half-life in rat,,,BAO_0000218,,10003,,1,10116.0,CHEMBL625996,,,Intermediate,A,
,530,Rattus norvegicus,1,,N,50597,,In vitro half life in rat plasma,,,BAO_0000218,,10004,Plasma,1,10116.0,CHEMBL625850,In vitro,1969.0,Intermediate,A,
,1116,Rattus norvegicus,1,,N,50597,,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",,,BAO_0000218,,10005,Plasma,1,10116.0,CHEMBL625851,In vitro,1969.0,Intermediate,A,
,3219,Rattus norvegicus,1,,N,50597,,In vitro half life in rat,,,BAO_0000218,,10006,,1,10116.0,CHEMBL625852,In vitro,,Intermediate,A,
,6109,Rattus norvegicus,1,,N,50597,,In vivo half life period after intravenous administration in rat,,,BAO_0000218,,10007,,1,10116.0,CHEMBL625853,In vivo,,Intermediate,A,
,17582,Rattus norvegicus,1,,N,50597,,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,,BAO_0000218,,10008,,1,10116.0,CHEMBL625854,In vivo,,Intermediate,A,
,17582,Rattus norvegicus,1,,N,50597,,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,,BAO_0000218,,10009,,1,10116.0,CHEMBL874450,In vivo,,Intermediate,A,
,5974,Rattus norvegicus,1,,N,50597,,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,,10010,,1,10116.0,CHEMBL625855,In vivo,,Intermediate,A,
,5974,Rattus norvegicus,1,,N,50597,,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,,10011,,1,10116.0,CHEMBL625856,In vivo,,Intermediate,A,
,5974,Rattus norvegicus,1,,N,50597,,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,,10012,,1,10116.0,CHEMBL625857,In vivo,,Intermediate,A,
,5974,Rattus norvegicus,1,,N,50597,,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,,10013,,1,10116.0,CHEMBL873831,In vivo,,Intermediate,A,
,17853,Rattus norvegicus,1,,N,50597,,Longer half-life in rat (i.v.) at 0.5 mpk,,,BAO_0000218,,10014,,1,10116.0,CHEMBL625858,In vivo,,Intermediate,A,
,17853,Rattus norvegicus,1,,N,50597,,Longer half-life in rat (p.o.) at 2.0 mpk,,,BAO_0000218,,10015,,1,10116.0,CHEMBL625859,In vivo,,Intermediate,A,
,3457,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (half life) in rat,,,BAO_0000218,,10016,,1,10116.0,CHEMBL625860,,,Intermediate,A,
,2792,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,,,BAO_0000218,,10017,,1,10116.0,CHEMBL625861,In vivo,,Intermediate,A,
,2792,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,,,BAO_0000218,,10018,,1,10116.0,CHEMBL625862,In vivo,,Intermediate,A,
,2792,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,,,BAO_0000218,,10019,,1,10116.0,CHEMBL625863,In vivo,,Intermediate,A,
,2792,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,,,BAO_0000218,,10020,,1,10116.0,CHEMBL625864,In vivo,,Intermediate,A,
,5739,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,,,BAO_0000218,,10021,,1,10116.0,CHEMBL625865,In vivo,,Intermediate,A,
,15765,Rattus norvegicus,1,,N,50597,,Pharmacokinetic half time was determined intravenously in rats.,,,BAO_0000218,,10022,,1,10116.0,CHEMBL625866,In vivo,,Intermediate,A,
,6567,Rattus norvegicus,1,,N,50597,,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,,,BAO_0000218,,10023,Plasma,1,10116.0,CHEMBL625867,In vivo,1969.0,Intermediate,A,
,2448,Rattus norvegicus,1,,N,50597,,Plasma half life of hydrolysis of the compound,,,BAO_0000218,,10024,Plasma,1,10116.0,CHEMBL625868,,1969.0,Intermediate,A,
,5423,Rattus norvegicus,1,,N,50597,,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,,,BAO_0000218,,10025,Plasma,1,10116.0,CHEMBL625869,In vivo,1969.0,Intermediate,A,
,4853,Rattus norvegicus,1,,N,50597,,Plasma half life period was calculated in rat,,,BAO_0000218,,10026,Plasma,1,10116.0,CHEMBL874451,,1969.0,Intermediate,A,
,4514,Rattus norvegicus,1,,N,50597,,Plasma half-life in Sprague-Dawley rats,,,BAO_0000218,,10027,Plasma,1,10116.0,CHEMBL625870,,1969.0,Intermediate,A,
,4514,Rattus norvegicus,1,,N,50597,,Plasma half-life in Sprague-Dawley rats; Not determined,,,BAO_0000218,,10028,Plasma,1,10116.0,CHEMBL625871,,1969.0,Intermediate,A,
,1500,Rattus norvegicus,1,,N,50597,,Plasma half-life in rats,,,BAO_0000218,,10029,Plasma,1,10116.0,CHEMBL625872,,1969.0,Intermediate,A,
,1500,Rattus norvegicus,1,,N,50597,,Plasma half-life in rats; <MQL,,,BAO_0000218,,10030,Plasma,1,10116.0,CHEMBL625873,,1969.0,Intermediate,A,
,5334,Rattus norvegicus,1,,N,50597,,Plasma half-life period (0-8 h) was determined,,,BAO_0000218,,10031,Plasma,1,10116.0,CHEMBL625874,,1969.0,Intermediate,A,
,5334,Rattus norvegicus,1,,N,50597,,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,,,BAO_0000218,,10032,Plasma,1,10116.0,CHEMBL625875,,1969.0,Intermediate,A,
,5334,Rattus norvegicus,1,,N,50597,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,,BAO_0000218,,10033,Plasma,1,10116.0,CHEMBL625876,In vivo,1969.0,Intermediate,A,
,5334,Rattus norvegicus,1,,N,50597,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,,BAO_0000218,,10034,Plasma,1,10116.0,CHEMBL631258,In vivo,1969.0,Intermediate,A,
,4956,Rattus norvegicus,1,,N,50597,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,,,BAO_0000218,,10035,Plasma,1,10116.0,CHEMBL631259,,1969.0,Intermediate,A,
,4956,Rattus norvegicus,1,,N,50597,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,,,BAO_0000218,,10036,Plasma,1,10116.0,CHEMBL631260,,1969.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",,,BAO_0000218,,10037,Blood,1,10116.0,CHEMBL631261,,178.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",,,BAO_0000218,,10038,Blood,1,10116.0,CHEMBL631262,,178.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",,,BAO_0000218,,10039,Blood,1,10116.0,CHEMBL631263,,178.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",,,BAO_0000218,,10040,,1,10116.0,CHEMBL631264,,,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",,,BAO_0000218,,10041,,1,10116.0,CHEMBL631265,,,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",,,BAO_0000218,,10042,,1,10116.0,CHEMBL631266,,,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",,,BAO_0000218,,10043,,1,10116.0,CHEMBL631267,,,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",,,BAO_0000218,,10044,,1,10116.0,CHEMBL631268,,,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",,,BAO_0000218,,10045,,1,10116.0,CHEMBL631269,,,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",,,BAO_0000218,,10046,,1,10116.0,CHEMBL631270,,,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,,BAO_0000218,,10047,Heart,1,10116.0,CHEMBL631271,,948.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",,,BAO_0000218,,10048,Heart,1,10116.0,CHEMBL631272,,948.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",,,BAO_0000218,,10049,Heart,1,10116.0,CHEMBL631273,,948.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",,,BAO_0000218,,10050,Heart,1,10116.0,CHEMBL631274,,948.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",,,BAO_0000218,,10051,Heart,1,10116.0,CHEMBL631275,,948.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",,,BAO_0000218,,10052,Heart,1,10116.0,CHEMBL626984,,948.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",,,BAO_0000218,,10053,Heart,1,10116.0,CHEMBL626985,,948.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,,BAO_0000218,,10054,Liver,1,10116.0,CHEMBL626986,,2107.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",,,BAO_0000218,,10055,Liver,1,10116.0,CHEMBL626987,,2107.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",,,BAO_0000218,,10056,Liver,1,10116.0,CHEMBL626988,,2107.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",,,BAO_0000218,,10057,Liver,1,10116.0,CHEMBL626989,,2107.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",,,BAO_0000218,,10058,Liver,1,10116.0,CHEMBL626990,,2107.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",,,BAO_0000218,,10059,Liver,1,10116.0,CHEMBL626991,,2107.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",,,BAO_0000218,,10060,Liver,1,10116.0,CHEMBL626992,,2107.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",,,BAO_0000218,,10061,Lung,1,10116.0,CHEMBL626993,,2048.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",,,BAO_0000218,,10062,Lung,1,10116.0,CHEMBL874593,,2048.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",,,BAO_0000218,,10063,Lung,1,10116.0,CHEMBL626994,,2048.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",,,BAO_0000218,,10064,Lung,1,10116.0,CHEMBL626995,,2048.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",,,BAO_0000218,,10065,Lung,1,10116.0,CHEMBL626190,,2048.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",,,BAO_0000218,,10066,Lung,1,10116.0,CHEMBL626191,,2048.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",,,BAO_0000218,,10067,Lung,1,10116.0,CHEMBL626364,,2048.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",,,BAO_0000218,,10068,Thyroid gland,1,10116.0,CHEMBL626365,,2046.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",,,BAO_0000218,,10069,Thyroid gland,1,10116.0,CHEMBL626366,,2046.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",,,BAO_0000218,,10070,Thyroid gland,1,10116.0,CHEMBL626367,,2046.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",,,BAO_0000218,,10071,Thyroid gland,1,10116.0,CHEMBL626368,,2046.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",,,BAO_0000218,,10072,Thyroid gland,1,10116.0,CHEMBL626369,,2046.0,Intermediate,A,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",,,BAO_0000218,,10073,Thyroid gland,1,10116.0,CHEMBL626370,,2046.0,Intermediate,A,
,4498,Rattus norvegicus,1,,N,50597,,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",,,BAO_0000218,,10074,,1,10116.0,CHEMBL626371,In vivo,,Intermediate,A,
,4498,Rattus norvegicus,1,,N,50597,,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",,,BAO_0000218,,10075,,1,10116.0,CHEMBL626372,In vivo,,Intermediate,A,
,3603,Rattus norvegicus,1,,N,50597,,Bioavailability after a dose of 10 mg/kg p.o.,,,BAO_0000218,,10076,,1,10116.0,CHEMBL626373,In vivo,,Intermediate,A,
,6215,Rattus norvegicus,1,,N,50597,,Bioavailability after peroral administration (10 mg/kg) was determined in rat,,,BAO_0000218,,10077,,1,10116.0,CHEMBL626374,In vivo,,Intermediate,A,
,5710,Rattus norvegicus,1,,N,50597,,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,,,BAO_0000218,,10078,,1,10116.0,CHEMBL626375,In vivo,,Intermediate,A,
,5710,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),,,BAO_0000218,,10079,,1,10116.0,CHEMBL626376,In vivo,,Intermediate,A,
,5676,Rattus norvegicus,1,,N,50597,,Bioavailability in rat po was determined,,,BAO_0000218,,10080,,1,10116.0,CHEMBL626377,In vivo,,Intermediate,A,
,17667,Rattus norvegicus,1,,N,50597,,Bioavailability of compound at 10 mg/kg in rat after oral administration,,,BAO_0000218,,10081,,1,10116.0,CHEMBL626378,In vivo,,Intermediate,A,
,17667,Rattus norvegicus,1,,N,50597,,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,,,BAO_0000218,,10082,,1,10116.0,CHEMBL626379,In vivo,,Intermediate,A,
,6848,Rattus norvegicus,1,,N,50597,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,,BAO_0000218,,10083,,1,10116.0,CHEMBL626380,In vivo,,Intermediate,A,
,6848,Rattus norvegicus,1,,N,50597,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,,BAO_0000218,,10084,,1,10116.0,CHEMBL626381,In vivo,,Intermediate,A,
,17267,Rattus norvegicus,1,,N,50597,,Bioavailability in rat,,,BAO_0000218,,10085,,1,10116.0,CHEMBL626382,In vivo,,Intermediate,A,
,6362,Rattus norvegicus,1,,N,50597,,Bioavailability in rat (Sprague-Dawley) (female),,,BAO_0000218,,10086,,1,10116.0,CHEMBL626383,In vivo,,Intermediate,A,
,17671,Rattus norvegicus,1,,N,50597,,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,,BAO_0000218,,10087,,1,10116.0,CHEMBL874652,In vivo,,Intermediate,A,
,17671,Rattus norvegicus,1,,N,50597,,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),,,BAO_0000218,,10088,,1,10116.0,CHEMBL626384,In vivo,,Intermediate,A,
,4333,Rattus norvegicus,1,,N,50597,,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,,,BAO_0000218,,10089,,1,10116.0,CHEMBL626385,In vivo,,Intermediate,A,
,6077,Rattus norvegicus,1,,N,50597,,Bioavailability in rat at an oral dose of 2 mg/kg,,,BAO_0000218,,10090,,1,10116.0,CHEMBL626386,In vivo,,Intermediate,A,
,3278,Rattus norvegicus,1,,N,50597,,Bioavailability in rat,,,BAO_0000218,,10091,,1,10116.0,CHEMBL626387,In vivo,,Intermediate,A,
,5964,Rattus norvegicus,1,,N,50597,,Bioavailability in rat,,,BAO_0000218,,10092,,1,10116.0,CHEMBL626388,In vivo,,Intermediate,A,
,4884,Rattus norvegicus,1,,N,50597,,Bioavailability in rat,,,BAO_0000218,,10093,,1,10116.0,CHEMBL626389,In vivo,,Intermediate,A,
,4905,Rattus norvegicus,1,,N,50597,,Bioavailability in rat,,,BAO_0000218,,10094,,1,10116.0,CHEMBL626390,In vivo,,Intermediate,A,
,4884,Rattus norvegicus,1,,N,50597,,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,,,BAO_0000218,,10095,,1,10116.0,CHEMBL626391,In vivo,,Intermediate,A,
,6850,Rattus norvegicus,1,,N,50597,,Bioavailability in rat,,,BAO_0000218,,10096,,1,10116.0,CHEMBL626392,In vivo,,Intermediate,A,
,2864,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10097,,1,10116.0,CHEMBL626393,In vivo,,Intermediate,A,
,5780,Rattus norvegicus,1,,N,50597,,Bioavailability was determined in rat,,,BAO_0000218,,10098,,1,10116.0,CHEMBL623026,In vivo,,Intermediate,A,
,1465,Rattus norvegicus,1,,N,50597,,Bioavailability,,,BAO_0000218,,10099,,1,10116.0,CHEMBL623027,In vivo,,Intermediate,A,
,5199,Rattus norvegicus,1,,N,50597,,Bioavailability,,,BAO_0000218,,10100,,1,10116.0,CHEMBL623028,In vivo,,Intermediate,A,
,5765,Rattus norvegicus,1,,N,50597,,Bioavailability in rat after 1 day dosing,,,BAO_0000218,,10101,,1,10116.0,CHEMBL623029,In vivo,,Intermediate,A,
,5765,Rattus norvegicus,1,,N,50597,,Bioavailability in rat after 4 day dosing,,,BAO_0000218,,10102,,1,10116.0,CHEMBL623030,In vivo,,Intermediate,A,
,6518,Rattus norvegicus,1,,N,50597,,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,,,BAO_0000218,,10103,,1,10116.0,CHEMBL623031,In vivo,,Intermediate,A,
,6518,Rattus norvegicus,1,,N,50597,,Bioavailability after IV dosing at 1 mg/kg in rat; no data,,,BAO_0000218,,10104,,1,10116.0,CHEMBL623032,In vivo,,Intermediate,A,
,6518,Rattus norvegicus,1,,N,50597,,Bioavailability after oral administration at a dose of 2 mg/kg in rat,,,BAO_0000218,,10105,,1,10116.0,CHEMBL623033,In vivo,,Intermediate,A,
,6518,Rattus norvegicus,1,,N,50597,,Bioavailability after oral administration at a dose of 4 mg/kg in rat,,,BAO_0000218,,10106,,1,10116.0,CHEMBL623034,In vivo,,Intermediate,A,
,2083,Rattus norvegicus,1,,N,50597,,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,,,BAO_0000218,,10107,,1,10116.0,CHEMBL623035,In vivo,,Intermediate,A,
,17260,Rattus norvegicus,1,,N,50597,,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,,BAO_0000218,,10108,,1,10116.0,CHEMBL623036,In vivo,,Intermediate,A,
,4956,Rattus norvegicus,1,,N,50597,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,,BAO_0000218,,10109,,1,10116.0,CHEMBL623037,In vivo,,Intermediate,A,
,4368,Rattus norvegicus,1,,N,50597,,Bioavailability by intravenous administration of 3.4 mg/kg in rat,,,BAO_0000218,,10110,,1,10116.0,CHEMBL623038,In vivo,,Intermediate,A,
,17752,Rattus norvegicus,1,,N,50597,,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,,,BAO_0000218,,10111,Plasma,1,10116.0,CHEMBL874385,In vivo,1969.0,Intermediate,A,
,1446,Rattus norvegicus,1,,N,50597,,Bioavailability in rat (Fisher) (fasted),,,BAO_0000218,,10112,,1,10116.0,CHEMBL623039,In vivo,,Intermediate,A,
,2891,Primates,1,,U,22224,,Bioavailability in monkey after po administration of 10 mg/kg dose,,,BAO_0000218,,10113,,0,9443.0,CHEMBL623040,In vivo,,Intermediate,A,
,2891,Primates,1,,U,22224,,Oral bioavailability in monkey (dose 10 mg/kg),,,BAO_0000218,,10114,,0,9443.0,CHEMBL623041,In vivo,,Intermediate,A,
,6672,Rattus norvegicus,1,,N,50597,,Bioavailability in rat,,,BAO_0000218,,10115,,1,10116.0,CHEMBL623741,In vivo,,Intermediate,A,
,6673,Rattus norvegicus,1,,N,50597,,Bioavailability in rat,,,BAO_0000218,,10116,,1,10116.0,CHEMBL623742,In vivo,,Intermediate,A,
,17655,Rattus norvegicus,1,,N,50597,,Bioavailability in rat,,,BAO_0000218,,10117,,1,10116.0,CHEMBL623743,In vivo,,Intermediate,A,
,17796,Rattus norvegicus,1,,N,50597,,Bioavailability in rat,,,BAO_0000218,,10118,,1,10116.0,CHEMBL623744,In vivo,,Intermediate,A,
,17853,Rattus norvegicus,1,,N,50597,,Bioavailability in rat (dose 2.0 mg/kg p.o.),,,BAO_0000218,,10119,,1,10116.0,CHEMBL623745,In vivo,,Intermediate,A,
,4521,Rattus norvegicus,1,,N,50597,,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),,,BAO_0000218,,10120,,1,10116.0,CHEMBL623746,In vivo,,Intermediate,A,
,4940,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (dose 5 mg/kg p.o.),,,BAO_0000218,,10121,,1,10116.0,CHEMBL623747,In vivo,,Intermediate,A,
,2891,Rattus norvegicus,1,,U,22224,,Bioavailability in rat after po administration of 30 mg/kg dose,,,BAO_0000218,,10122,,0,10116.0,CHEMBL623748,In vivo,,Intermediate,A,
,2891,Rattus norvegicus,1,,U,22224,,Bioavailability in rat after po administration of 30 mg/kg dose,,,BAO_0000218,,10123,,0,10116.0,CHEMBL623916,In vivo,,Intermediate,A,
,4521,Rattus norvegicus,1,,N,50597,,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,,BAO_0000218,,10124,,1,10116.0,CHEMBL623917,In vivo,,Intermediate,A,
,17686,Rattus norvegicus,1,,N,50597,,Bioavailability in rat (dose 2 mg/kg i.v.),,,BAO_0000218,,10125,,1,10116.0,CHEMBL623918,In vivo,,Intermediate,A,
,17796,Rattus norvegicus,1,,N,50597,,Bioavailability in rat,,,BAO_0000218,,10126,,1,10116.0,CHEMBL874386,In vivo,,Intermediate,A,
,17796,Rattus norvegicus,1,,N,50597,,Bioavailability in rat; Only traces detected in rat plasma,,,BAO_0000218,,10127,Plasma,1,10116.0,CHEMBL623919,In vivo,1969.0,Intermediate,A,
,5064,Rattus norvegicus,1,,N,50597,,Bioavailability in rat,,,BAO_0000218,,10128,,1,10116.0,CHEMBL623920,In vivo,,Intermediate,A,
,5147,Rattus norvegicus,1,,N,50597,,Bioavailability upon oral administration of compound,,,BAO_0000218,,10129,,1,10116.0,CHEMBL623148,In vivo,,Intermediate,A,
,1916,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),,,BAO_0000218,,10130,,1,10116.0,CHEMBL623149,In vivo,,Intermediate,A,
,6049,Rattus norvegicus,1,,N,50597,,Bioavailability in rat,,,BAO_0000218,,10131,,1,10116.0,CHEMBL623150,In vivo,,Intermediate,A,
,1445,Rattus norvegicus,1,,N,50597,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",,,BAO_0000218,,10132,,1,10116.0,CHEMBL623151,In vivo,,Intermediate,A,
,1445,Rattus norvegicus,1,,N,50597,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",,,BAO_0000218,,10133,,1,10116.0,CHEMBL623152,In vivo,,Intermediate,A,
,2862,Rattus norvegicus,1,,N,50597,,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,,,BAO_0000218,,10134,,1,10116.0,CHEMBL623153,,,Expert,F,
,2862,Rattus norvegicus,1,,N,50597,,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,,,BAO_0000218,,10135,,1,10116.0,CHEMBL623154,,,Expert,F,
,4194,Rattus norvegicus,1,,N,50597,,In vitro and metabolic stability was determined,,,BAO_0000218,,10136,,1,10116.0,CHEMBL623155,,,Intermediate,A,
,4194,Rattus norvegicus,1,,N,50597,,In vitro metabolic stability in rat hepatocytes,,,BAO_0000218,,10137,,1,10116.0,CHEMBL623156,,,Intermediate,A,
,5486,Rattus norvegicus,1,,N,50597,,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,,,BAO_0000218,,10138,,1,10116.0,CHEMBL623157,,,Intermediate,A,
401.0,17582,Rattus norvegicus,1,Hepatocyte,N,50597,,Metabolic rate for compound was observed in rat hepatocytes,,,BAO_0000218,,10139,Liver,1,10116.0,CHEMBL623158,In vitro,2107.0,Intermediate,A,
,5600,Rattus norvegicus,1,,N,50597,,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,,,BAO_0000218,,10140,,1,10116.0,CHEMBL623159,,,Intermediate,A,
,14294,Rattus norvegicus,1,,N,50597,,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),,,BAO_0000218,,10141,,1,10116.0,CHEMBL874390,,,Intermediate,A,
,14294,Rattus norvegicus,1,,N,50597,,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),,,BAO_0000218,,10142,,1,10116.0,CHEMBL623160,,,Intermediate,A,
,14294,Rattus norvegicus,1,,N,50597,,Metabolism of compound in rat S9 microsomes; Trace,,,BAO_0000218,,10143,,1,10116.0,CHEMBL623161,,,Intermediate,A,
,17847,Rattus norvegicus,1,,N,50597,,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,,,BAO_0000218,,10144,,1,10116.0,CHEMBL623162,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,,,BAO_0000218,,10145,,1,10116.0,CHEMBL623163,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,,,BAO_0000218,,10146,,1,10116.0,CHEMBL623164,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,,,BAO_0000218,,10147,,1,10116.0,CHEMBL623165,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,,,BAO_0000218,,10148,,1,10116.0,CHEMBL623166,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,,,BAO_0000218,,10149,,1,10116.0,CHEMBL624983,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,,,BAO_0000218,,10150,,1,10116.0,CHEMBL624984,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,,,BAO_0000218,,10151,,1,10116.0,CHEMBL624985,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,,,BAO_0000218,,10152,,1,10116.0,CHEMBL622970,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,,,BAO_0000218,,10153,,1,10116.0,CHEMBL622971,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,,,BAO_0000218,,10154,,1,10116.0,CHEMBL622972,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,,,BAO_0000218,,10155,,1,10116.0,CHEMBL622973,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,,,BAO_0000218,,10156,,1,10116.0,CHEMBL622974,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,,,BAO_0000218,,10157,,1,10116.0,CHEMBL622975,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,,,BAO_0000218,,10158,,1,10116.0,CHEMBL622976,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,,,BAO_0000218,,10159,,1,10116.0,CHEMBL622977,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,,BAO_0000218,,10160,,1,10116.0,CHEMBL624351,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,,,BAO_0000218,,10161,,1,10116.0,CHEMBL624352,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,,BAO_0000218,,10162,,1,10116.0,CHEMBL624353,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,,,BAO_0000218,,10163,,1,10116.0,CHEMBL622397,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,,,BAO_0000218,,10164,,1,10116.0,CHEMBL622398,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,,,BAO_0000218,,10165,,1,10116.0,CHEMBL622399,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,,BAO_0000218,,10166,,1,10116.0,CHEMBL622400,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,,,BAO_0000218,,10167,,1,10116.0,CHEMBL628428,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,,,BAO_0000218,,10168,,1,10116.0,CHEMBL628590,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,,BAO_0000218,,10169,,1,10116.0,CHEMBL628591,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,,,BAO_0000218,,10170,,1,10116.0,CHEMBL628592,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,,BAO_0000218,,10171,,1,10116.0,CHEMBL628593,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,,,BAO_0000218,,10172,,1,10116.0,CHEMBL875333,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,,BAO_0000218,,10173,,1,10116.0,CHEMBL628594,,,Intermediate,A,
,4969,Rattus norvegicus,1,,N,50597,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,,,BAO_0000218,,10174,Plasma,1,10116.0,CHEMBL628595,,1969.0,Intermediate,A,
,6737,Rattus norvegicus,1,,N,50597,,Stability in rat plasma was determined,,,BAO_0000218,,10175,Plasma,1,10116.0,CHEMBL628596,,1969.0,Intermediate,A,
,6737,Rattus norvegicus,1,,N,50597,,Stability in rat plasma was determined; ND= no data,,,BAO_0000218,,10176,Plasma,1,10116.0,CHEMBL628597,,1969.0,Intermediate,A,
,5089,Rattus norvegicus,1,,N,50597,,Tested for plasma half life period in rat (0-8 hr),,,BAO_0000218,,10177,Plasma,1,10116.0,CHEMBL628598,,1969.0,Intermediate,A,
,5089,Rattus norvegicus,1,,N,50597,,Tested for plasma half life period in rat (0-8 hr); Not determined,,,BAO_0000218,,10178,Plasma,1,10116.0,CHEMBL628599,,1969.0,Intermediate,A,
,1466,Rattus norvegicus,1,,N,50597,,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,,,BAO_0000218,,10179,,1,10116.0,CHEMBL628600,In vivo,,Intermediate,A,
,1466,Rattus norvegicus,1,,N,50597,,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,,,BAO_0000218,,10180,,1,10116.0,CHEMBL628601,In vivo,,Intermediate,A,
,4950,Rattus norvegicus,1,,N,50597,,Tested for the half life in rat,,,BAO_0000218,,10181,,1,10116.0,CHEMBL628602,,,Intermediate,A,
,2412,Rattus norvegicus,1,,N,50597,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,,,BAO_0000218,,10182,,1,10116.0,CHEMBL628603,In vitro,,Intermediate,A,
,2412,Rattus norvegicus,1,,N,50597,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,,,BAO_0000218,,10183,,1,10116.0,CHEMBL628604,In vitro,,Intermediate,A,
,2412,Rattus norvegicus,1,,N,50597,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,,,BAO_0000218,,10184,,1,10116.0,CHEMBL628605,In vitro,,Intermediate,A,
,2412,Rattus norvegicus,1,,N,50597,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,,,BAO_0000218,,10185,,1,10116.0,CHEMBL628606,In vitro,,Intermediate,A,
,2412,Rattus norvegicus,1,,N,50597,,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,,,BAO_0000218,,10186,,1,10116.0,CHEMBL628607,In vitro,,Intermediate,A,
,15022,Rattus norvegicus,1,,N,50597,,The biological half life the compound was measured at the dose of 100 umol/kg,,,BAO_0000218,,10187,,1,10116.0,CHEMBL628608,,,Intermediate,A,
,15022,Rattus norvegicus,1,,N,50597,,The biological half life the compound was measured at the dose of 30 umol/kg,,,BAO_0000218,,10188,,1,10116.0,CHEMBL628609,,,Intermediate,A,
,406,Rattus norvegicus,1,,N,50597,,The compound was evaluated for plasma half life period in rat,,,BAO_0000218,,10189,Plasma,1,10116.0,CHEMBL628610,,1969.0,Intermediate,A,
,15078,Rattus norvegicus,1,,N,50597,,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,,10190,,1,10116.0,CHEMBL873819,In vivo,,Intermediate,A,
,15078,Rattus norvegicus,1,,N,50597,,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,,10191,,1,10116.0,CHEMBL628611,In vivo,,Intermediate,A,
,5247,Rattus norvegicus,1,,N,50597,,The pharmacokinetic parameter half-life period in vivo in rats,,,BAO_0000218,,10192,,1,10116.0,CHEMBL628612,In vivo,,Intermediate,A,
,5041,Rattus norvegicus,1,,N,50597,,"The pharmacokinetic property, Half-life was determined",,,BAO_0000218,,10193,,1,10116.0,CHEMBL628613,In vivo,,Intermediate,A,
,5041,Rattus norvegicus,1,,N,50597,,"The pharmacokinetic property, Half-life in rat in vivo",,,BAO_0000218,,10194,,1,10116.0,CHEMBL628614,In vivo,,Intermediate,A,
,5041,Rattus norvegicus,1,,N,50597,,"The pharmacokinetic property, Half-life was determined; ND denotes no data",,,BAO_0000218,,10195,,1,10116.0,CHEMBL628615,In vivo,,Intermediate,A,
,5041,Rattus norvegicus,1,,N,50597,,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",,,BAO_0000218,,10196,,1,10116.0,CHEMBL628616,In vivo,,Intermediate,A,
,3918,Rattus norvegicus,1,,N,50597,,The plasma half life period in rats,,,BAO_0000218,,10197,Plasma,1,10116.0,CHEMBL627924,,1969.0,Intermediate,A,
,2906,Rattus norvegicus,1,,N,50597,,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,,,BAO_0000218,,10198,Liver,1,10116.0,CHEMBL627925,,2107.0,Intermediate,A,
,6467,Rattus norvegicus,1,,N,50597,,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,,BAO_0000218,,10199,,1,10116.0,CHEMBL627926,In vivo,,Intermediate,A,
,5510,Rattus norvegicus,1,,N,50597,,t1/2 (apparent elimination)of the compound was determined,,,BAO_0000218,,10200,,1,10116.0,CHEMBL627927,,,Intermediate,A,
,3788,Rattus norvegicus,1,,N,50597,,t1/2 value in rat,,,BAO_0000218,,10201,,1,10116.0,CHEMBL627928,,,Intermediate,A,
,17796,Rattus norvegicus,1,,N,50597,,Half life in rat,,,BAO_0000218,,10202,,1,10116.0,CHEMBL627539,,,Intermediate,A,
,12873,Rattus norvegicus,1,,N,50597,,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,,BAO_0000218,,10203,Plasma,1,10116.0,CHEMBL876790,In vivo,1969.0,Intermediate,A,
,5983,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,,,BAO_0000218,,10204,,1,10116.0,CHEMBL858186,In vivo,,Intermediate,A,
,15765,Rattus norvegicus,1,,N,50597,,Half-life period in fasted rats,,,BAO_0000218,,10205,,1,10116.0,CHEMBL627540,,,Intermediate,A,
,2661,Rattus norvegicus,1,,N,50597,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,,,BAO_0000218,,10206,,1,10116.0,CHEMBL627541,In vivo,,Intermediate,A,
,2661,Rattus norvegicus,1,,N,50597,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,,,BAO_0000218,,10207,,1,10116.0,CHEMBL627715,In vivo,,Intermediate,A,
,429,Rattus norvegicus,1,,N,50597,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,,BAO_0000218,,10208,,1,10116.0,CHEMBL627716,In vivo,,Intermediate,A,
,17655,Rattus norvegicus,1,,N,50597,,Maximum time required to achieve Cmax was determined in rat,,,BAO_0000218,,10209,,1,10116.0,CHEMBL627717,,,Intermediate,A,
,17717,Rattus norvegicus,1,,N,50597,,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,BAO_0000218,,10210,,1,10116.0,CHEMBL627718,In vivo,,Intermediate,A,
,17717,Rattus norvegicus,1,,N,50597,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,BAO_0000218,,10211,,1,10116.0,CHEMBL627719,In vivo,,Intermediate,A,
,17717,Rattus norvegicus,1,,N,50597,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,,,BAO_0000218,,10212,,1,10116.0,CHEMBL627720,In vivo,,Intermediate,A,
,6570,Rattus norvegicus,1,,N,50597,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,,,BAO_0000218,,10213,,1,10116.0,CHEMBL627721,In vivo,,Intermediate,A,
,6570,Rattus norvegicus,1,,N,50597,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,,,BAO_0000218,,10214,,1,10116.0,CHEMBL627722,In vivo,,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,,BAO_0000218,,10215,,1,10116.0,CHEMBL627723,In vivo,,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,,BAO_0000218,,10216,,1,10116.0,CHEMBL626058,In vivo,,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,,BAO_0000218,,10217,,1,10116.0,CHEMBL626059,In vivo,,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,,BAO_0000218,,10218,,1,10116.0,CHEMBL626060,In vivo,,Intermediate,A,
,17720,Rattus norvegicus,1,,N,50597,,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,,,BAO_0000218,,10219,Plasma,1,10116.0,CHEMBL626061,In vivo,1969.0,Intermediate,A,
,4723,Rattus norvegicus,1,,N,50597,,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,BAO_0000218,,10220,,1,10116.0,CHEMBL876791,In vivo,,Intermediate,A,
,4723,Rattus norvegicus,1,,N,50597,,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,BAO_0000218,,10221,,1,10116.0,CHEMBL626062,In vivo,,Intermediate,A,
,4756,Rattus norvegicus,1,,N,50597,,Tmax at the dose of 2 mg/Kg administered perorally in rats,,,BAO_0000218,,10222,,1,10116.0,CHEMBL626063,In vivo,,Intermediate,A,
,4756,Rattus norvegicus,1,,N,50597,,Tmax at the dose of 5 mg/Kg administered perorally in rats,,,BAO_0000218,,10223,,1,10116.0,CHEMBL626064,In vivo,,Intermediate,A,
,17720,Rattus norvegicus,1,,N,50597,,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,,,BAO_0000218,,10224,Plasma,1,10116.0,CHEMBL626065,In vivo,1969.0,Intermediate,A,
,17720,Rattus norvegicus,1,,N,50597,,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,,,BAO_0000218,,10225,Plasma,1,10116.0,CHEMBL626066,In vivo,1969.0,Intermediate,A,
,1466,Rattus norvegicus,1,,N,50597,,tmax upon peroral administration of 10.0 mg/Kg dose in rat,,,BAO_0000218,,10226,,1,10116.0,CHEMBL626067,In vivo,,Intermediate,A,
,7449,Rattus norvegicus,1,,N,50597,,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,,,BAO_0000218,,10227,,1,10116.0,CHEMBL626068,,,Intermediate,F,
,7449,Rattus norvegicus,1,,N,50597,,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,,,BAO_0000218,,10228,,1,10116.0,CHEMBL626069,,,Intermediate,F,
,7449,Rattus norvegicus,1,,N,50597,,Percent total excretion of 3-methoxyacetaminophen glucuronide,,,BAO_0000218,,10229,,1,10116.0,CHEMBL626070,,,Intermediate,F,
,7449,Rattus norvegicus,1,,N,50597,,Percent total excretion of N-methoxyacetaminophen glucuronide,,,BAO_0000218,,10230,,1,10116.0,CHEMBL626071,,,Intermediate,F,
,7449,Rattus norvegicus,1,,N,50597,,Percent total excretion of N-methoxyacetaminophen sulfate,,,BAO_0000218,,10231,,1,10116.0,CHEMBL626072,,,Intermediate,F,
,7449,Rattus norvegicus,1,,N,50597,,Percent total excretion of acetaminophen,,,BAO_0000218,,10232,,1,10116.0,CHEMBL626073,,,Intermediate,F,
,7768,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",,,BAO_0000218,,10233,Thyroid gland,1,10116.0,CHEMBL626741,,2046.0,Intermediate,A,
,17655,Rattus norvegicus,1,,N,50597,,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",,,BAO_0000218,,10234,,1,10116.0,CHEMBL626742,,,Intermediate,A,
,17735,Rattus norvegicus,1,,N,50597,,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,,,BAO_0000218,,10235,,1,10116.0,CHEMBL626743,,,Intermediate,A,
,5960,Rattus norvegicus,1,,N,50597,,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,,,BAO_0000218,,10236,,1,10116.0,CHEMBL876792,,,Intermediate,A,
,17735,Rattus norvegicus,1,,N,50597,,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,,BAO_0000218,,10237,,1,10116.0,CHEMBL626744,,,Intermediate,A,
,7116,Rattus norvegicus,1,,N,50597,,Compound was tested for antidiuretic activity in rats,,,BAO_0000218,,10238,,1,10116.0,CHEMBL626745,,,Intermediate,A,
,4878,Rattus norvegicus,1,,N,50597,,AUC in rat after 3mg/kg oral dose,,,BAO_0000218,,10239,Plasma,1,10116.0,CHEMBL626746,In vivo,1969.0,Intermediate,A,
,5939,Rattus norvegicus,1,,N,50597,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,,,BAO_0000218,,10240,,1,10116.0,CHEMBL626747,,,Intermediate,A,
,5939,Rattus norvegicus,1,,N,50597,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,,,BAO_0000218,,10241,,1,10116.0,CHEMBL626748,,,Intermediate,A,
,16367,Rattus norvegicus,1,,N,50597,,Bioavailability administered orally at a dose of 10 mg/kg to rats,,,BAO_0000218,,10242,,1,10116.0,CHEMBL626749,,,Intermediate,A,
,16366,Rattus norvegicus,1,,N,50597,,Oral Bioavailability was determined,,,BAO_0000218,,10243,,1,10116.0,CHEMBL626750,,,Intermediate,A,
,4426,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10244,,1,10116.0,CHEMBL626751,,,Intermediate,A,
,4426,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat; Not performed.,,,BAO_0000218,,10245,,1,10116.0,CHEMBL626913,,,Intermediate,A,
,5041,Rattus norvegicus,1,,N,50597,,Bioavailability,,,BAO_0000218,,10246,,1,10116.0,CHEMBL626914,,,Intermediate,A,
,5041,Rattus norvegicus,1,,N,50597,,Bioavailability was determined; ND denotes no data,,,BAO_0000218,,10247,,1,10116.0,CHEMBL626915,,,Intermediate,A,
,1500,Rattus norvegicus,1,,N,50597,,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,,,BAO_0000218,,10248,,1,10116.0,CHEMBL626916,,,Intermediate,A,
,1500,Rattus norvegicus,1,,N,50597,,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,,,BAO_0000218,,10249,,1,10116.0,CHEMBL626917,,,Intermediate,A,
,17409,Rattus norvegicus,1,,N,50597,,Binding towards rat plasma protein at 10 uM,,,BAO_0000218,,10250,,1,10116.0,CHEMBL626918,,,Intermediate,A,
,17409,Rattus norvegicus,1,,N,50597,,Binding towards rat plasma protein at 100 uM,,,BAO_0000218,,10251,,1,10116.0,CHEMBL626919,,,Intermediate,A,
,2959,Rattus norvegicus,1,,N,50597,,Bioavailability in rat (dose 20 mg/kg p.o.),,,BAO_0000218,,10252,,1,10116.0,CHEMBL626920,In vivo,,Intermediate,A,
,13501,Rattus norvegicus,1,,N,50597,,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,,,BAO_0000218,,10253,,1,10116.0,CHEMBL621976,In vivo,,Intermediate,A,
,6567,Rattus norvegicus,1,,N,50597,,Bioavailability in rat after 5 mg/kg oral gavage,,,BAO_0000218,,10254,,1,10116.0,CHEMBL877599,In vivo,,Intermediate,A,
,6571,Rattus norvegicus,1,,N,50597,,Bioavailability in rat,,,BAO_0000218,,10255,,1,10116.0,CHEMBL621977,In vivo,,Intermediate,A,
,6715,Rattus norvegicus,1,,N,50597,,Bioavailability in rat (dose 1 mg/kg i.v.),,,BAO_0000218,,10256,,1,10116.0,CHEMBL621978,In vivo,,Intermediate,A,
,6715,Rattus norvegicus,1,,N,50597,,Bioavailability in rat (dose 3 mg/kg p.o.),,,BAO_0000218,,10257,,1,10116.0,CHEMBL621979,In vivo,,Intermediate,A,
,2932,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10258,,1,10116.0,CHEMBL621980,In vivo,,Intermediate,A,
,4171,Rattus norvegicus,1,,N,50597,,Bioavailability of the compound in rats after administration of 30 mg/kg,,,BAO_0000218,,10259,,1,10116.0,CHEMBL621981,In vivo,,Intermediate,A,
,17509,Rattus norvegicus,1,,N,50597,,Bioavailability after administration of 10 mg/kg in rats,,,BAO_0000218,,10260,,1,10116.0,CHEMBL621982,In vivo,,Intermediate,A,
,17509,Rattus norvegicus,1,,N,50597,,Bioavailability after administration of 2 mg/kg in rats,,,BAO_0000218,,10261,,1,10116.0,CHEMBL882953,In vivo,,Intermediate,A,
,4527,Rattus norvegicus,1,,N,50597,,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,,,BAO_0000218,,10262,,1,10116.0,CHEMBL621983,In vivo,,Intermediate,A,
,4026,Rattus norvegicus,1,,N,50597,,Bioavailability in dogs was determined; high,,,BAO_0000218,,10263,,1,10116.0,CHEMBL621984,In vivo,,Intermediate,A,
,6659,Rattus norvegicus,1,,N,50597,,Bioavailability in monkey after intravenous administration at 1 mpk,,,BAO_0000218,,10264,,1,10116.0,CHEMBL621985,In vivo,,Intermediate,A,
,6659,Rattus norvegicus,1,,N,50597,,Bioavailability in monkey after peroral administration at 10 mpk,,,BAO_0000218,,10265,,1,10116.0,CHEMBL621986,In vivo,,Intermediate,A,
,6659,Rattus norvegicus,1,,N,50597,,Bioavailability in rat after intravenous administration at 1 mpk,,,BAO_0000218,,10266,,1,10116.0,CHEMBL621987,In vivo,,Intermediate,A,
,6659,Rattus norvegicus,1,,N,50597,,Bioavailability in rat after intravenous administration at 2 mpk,,,BAO_0000218,,10267,,1,10116.0,CHEMBL877600,In vivo,,Intermediate,F,
,6659,Rattus norvegicus,1,,N,50597,,Bioavailability in rat after peroral administration at 30 mpk,,,BAO_0000218,,10268,,1,10116.0,CHEMBL621988,In vivo,,Intermediate,A,
,6659,Rattus norvegicus,1,,N,50597,,Bioavailability in rat after peroral administration at at 100 mpk,,,BAO_0000218,,10269,,1,10116.0,CHEMBL621989,In vivo,,Intermediate,F,
,6597,Rattus norvegicus,1,,N,50597,,Bioavailability in rats was evaluated,,,BAO_0000218,,10270,,1,10116.0,CHEMBL621990,In vivo,,Intermediate,A,
,1202,Rattus norvegicus,1,,N,50597,,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,,,BAO_0000218,,10271,,1,10116.0,CHEMBL621991,In vivo,,Intermediate,A,
,1202,Rattus norvegicus,1,,N,50597,,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,,,BAO_0000218,,10272,,1,10116.0,CHEMBL621992,In vivo,,Intermediate,A,
,1202,Rattus norvegicus,1,,N,50597,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,,,BAO_0000218,,10273,,1,10116.0,CHEMBL621993,In vivo,,Intermediate,A,
,1202,Rattus norvegicus,1,,N,50597,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,,,BAO_0000218,,10274,,1,10116.0,CHEMBL621994,In vivo,,Intermediate,A,
,5207,Rattus norvegicus,1,,N,50597,,Bioavailability in rat,,,BAO_0000218,,10275,,1,10116.0,CHEMBL621995,In vivo,,Intermediate,A,
,5970,Rattus norvegicus,1,,N,50597,,Bioavailability in rat,,,BAO_0000218,,10276,,1,10116.0,CHEMBL621996,In vivo,,Intermediate,A,
,17538,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (dose 10 mg/kg),,,BAO_0000218,,10277,,1,10116.0,CHEMBL621997,In vivo,,Intermediate,A,
,17538,Rattus norvegicus,1,,N,50597,,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,,,BAO_0000218,,10278,,1,10116.0,CHEMBL621998,In vivo,,Intermediate,A,
,1466,Rattus norvegicus,1,,N,50597,,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,,,BAO_0000218,,10279,,1,10116.0,CHEMBL621999,In vivo,,Intermediate,A,
,2879,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10280,,1,10116.0,CHEMBL622000,In vivo,,Intermediate,A,
,2879,Rattus norvegicus,1,,N,50597,,Bioavailability was measured in rat after oral administration; 2-4,,,BAO_0000218,,10281,,1,10116.0,CHEMBL622001,In vivo,,Intermediate,A,
,2879,Rattus norvegicus,1,,N,50597,,Bioavailability was measured in rat after oral administration; 3-7,,,BAO_0000218,,10282,,1,10116.0,CHEMBL622002,In vivo,,Intermediate,A,
,3777,Rattus norvegicus,1,,N,50597,,Bioavailability in rat (intraduodenal administration),,,BAO_0000218,,10283,,1,10116.0,CHEMBL622003,In vivo,,Intermediate,A,
,3777,Rattus norvegicus,1,,N,50597,,Bioavailability in rat (intraduodenal administration),,,BAO_0000218,,10284,,1,10116.0,CHEMBL877601,In vivo,,Intermediate,A,
,3777,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10285,,1,10116.0,CHEMBL624871,In vivo,,Intermediate,A,
,3777,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10286,,1,10116.0,CHEMBL622004,In vivo,,Intermediate,A,
,5423,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),,,BAO_0000218,,10287,,1,10116.0,CHEMBL882954,In vivo,,Intermediate,A,
,16365,Rattus norvegicus,1,,N,50597,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,,,BAO_0000218,,10288,,1,10116.0,CHEMBL622005,In vivo,,Intermediate,A,
,16365,Rattus norvegicus,1,,N,50597,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,,,BAO_0000218,,10289,,1,10116.0,CHEMBL622006,In vivo,,Intermediate,A,
,4239,Rattus norvegicus,1,,N,50597,,Bioavailability was measured in rat,,,BAO_0000218,,10290,,1,10116.0,CHEMBL622007,In vivo,,Intermediate,A,
,5438,Rattus norvegicus,1,,N,50597,,Bioavailability was reported,,,BAO_0000218,,10291,,1,10116.0,CHEMBL622008,In vivo,,Intermediate,A,
,5334,Rattus norvegicus,1,,N,50597,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,,BAO_0000218,,10292,,1,10116.0,CHEMBL622009,In vivo,,Intermediate,A,
,5334,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,,BAO_0000218,,10293,,1,10116.0,CHEMBL622010,In vivo,,Intermediate,A,
,4199,Rattus norvegicus,1,,N,50597,,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,,BAO_0000218,,10294,,1,10116.0,CHEMBL622011,In vivo,,Intermediate,A,
,4199,Rattus norvegicus,1,,N,50597,,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),,,BAO_0000218,,10295,,1,10116.0,CHEMBL622012,In vivo,,Intermediate,A,
,4199,Rattus norvegicus,1,,N,50597,,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),,,BAO_0000218,,10296,,1,10116.0,CHEMBL622013,In vivo,,Intermediate,A,
,4890,Rattus norvegicus,1,,N,50597,,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,,BAO_0000218,,10297,,1,10116.0,CHEMBL622014,In vivo,,Intermediate,A,
,2792,Rattus norvegicus,1,,N,50597,,Bioavailability was determined at 3 mg/kg po dose in rats,,,BAO_0000218,,10298,,1,10116.0,CHEMBL624749,In vivo,,Intermediate,A,
,5529,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (dose 2 mg/kg),,,BAO_0000218,,10299,,1,10116.0,CHEMBL624750,In vivo,,Intermediate,A,
,6685,Rattus norvegicus,1,,N,50597,,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",,,BAO_0000218,,10300,,1,10116.0,CHEMBL624751,In vivo,,Intermediate,A,
,6685,Rattus norvegicus,1,,N,50597,,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,,BAO_0000218,,10301,,1,10116.0,CHEMBL624752,In vivo,,Intermediate,A,
,6685,Rattus norvegicus,1,,N,50597,,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,,BAO_0000218,,10302,,1,10116.0,CHEMBL624753,In vivo,,Intermediate,A,
,6005,Rattus norvegicus,1,,N,50597,,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,,,BAO_0000218,,10303,,1,10116.0,CHEMBL624754,In vivo,,Intermediate,A,
,6410,Rattus norvegicus,1,,N,50597,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,,BAO_0000218,,10304,,1,10116.0,CHEMBL624755,In vivo,,Intermediate,A,
,6410,Rattus norvegicus,1,,N,50597,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,,BAO_0000218,,10305,,1,10116.0,CHEMBL624756,In vivo,,Intermediate,A,
,6103,Rattus norvegicus,1,,N,50597,,Bioavailability in rat,,,BAO_0000218,,10306,,1,10116.0,CHEMBL624757,In vivo,,Intermediate,A,
,6410,Rattus norvegicus,1,,N,50597,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,,BAO_0000218,,10307,,1,10116.0,CHEMBL624758,In vivo,,Intermediate,A,
,6410,Rattus norvegicus,1,,N,50597,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,,BAO_0000218,,10308,,1,10116.0,CHEMBL622270,In vivo,,Intermediate,A,
,5353,Rattus norvegicus,1,,N,50597,,Bioavailability in rat (Sprague-Dawley),,,BAO_0000218,,10309,,1,10116.0,CHEMBL622271,In vivo,,Intermediate,A,
,4727,Rattus norvegicus,1,,N,50597,,Bioavailability in rat at the dose of 2 mg/kg,,,BAO_0000218,,10310,,1,10116.0,CHEMBL622272,In vivo,,Intermediate,A,
,17804,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10311,,1,10116.0,CHEMBL622273,In vivo,,Intermediate,A,
,5809,Rattus norvegicus,1,,N,50597,,Bioavailability in rat (cannulated) (dose 2 mg/kg),,,BAO_0000218,,10312,,1,10116.0,CHEMBL622274,In vivo,,Intermediate,A,
,17804,Rattus norvegicus,1,,N,50597,,Bioavailability value of compound in rats was determined after peroral administration,,,BAO_0000218,,10313,,1,10116.0,CHEMBL622275,In vivo,,Intermediate,A,
,3634,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (dose 20 mg/kg),,,BAO_0000218,,10314,,1,10116.0,CHEMBL622276,In vivo,,Intermediate,A,
,3341,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10315,,1,10116.0,CHEMBL622277,In vivo,,Intermediate,A,
,2690,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (dose 5 mg/kg),,,BAO_0000218,,10316,,1,10116.0,CHEMBL622278,In vivo,,Intermediate,A,
,3184,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10317,,1,10116.0,CHEMBL622279,In vivo,,Intermediate,A,
,740,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10318,,1,10116.0,CHEMBL622280,In vivo,,Intermediate,A,
,1806,Rattus norvegicus,1,,N,50597,,Compound was evaluated for oral bioavailability in rats; 15-27 %,,,BAO_0000218,,10319,,1,10116.0,CHEMBL624083,In vivo,,Intermediate,A,
,4891,Rattus norvegicus,1,,N,50597,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,,,BAO_0000218,,10320,,1,10116.0,CHEMBL624084,In vivo,,Intermediate,A,
,3634,Rattus norvegicus,1,,N,50597,,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),,,BAO_0000218,,10321,,1,10116.0,CHEMBL624085,In vivo,,Intermediate,A,
,64,Rattus norvegicus,1,,N,50597,,Compound was tested for bioavailability in rats,,,BAO_0000218,,10322,,1,10116.0,CHEMBL624086,In vivo,,Intermediate,A,
,4839,Rattus norvegicus,1,,N,50597,,Bioavailability in rat,,,BAO_0000218,,10323,,1,10116.0,CHEMBL624087,In vivo,,Intermediate,A,
,1094,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10324,,1,10116.0,CHEMBL624088,In vivo,,Intermediate,A,
,5005,Macaca mulatta,1,,U,22224,,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,,,BAO_0000218,,10325,,0,9544.0,CHEMBL624089,In vivo,,Intermediate,A,
,5005,Rattus norvegicus,1,,U,22224,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,,BAO_0000218,,10326,,0,10116.0,CHEMBL624090,In vivo,,Intermediate,A,
,4687,Rattus norvegicus,1,,N,50597,,Evaluated for the bioavailability in rat (in vivo),,,BAO_0000218,,10327,,1,10116.0,CHEMBL624091,In vivo,,Intermediate,A,
,17804,Rattus norvegicus,1,,N,50597,,F value of compound in rats was determined after peroral administration,,,BAO_0000218,,10328,,1,10116.0,CHEMBL624092,In vivo,,Intermediate,A,
,5974,Rattus norvegicus,1,,N,50597,,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,,10329,,1,10116.0,CHEMBL624093,In vivo,,Intermediate,A,
,5974,Rattus norvegicus,1,,N,50597,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,,10330,,1,10116.0,CHEMBL624094,In vivo,,Intermediate,A,
,5974,Rattus norvegicus,1,,N,50597,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,,10331,,1,10116.0,CHEMBL624095,In vivo,,Intermediate,A,
,5974,Rattus norvegicus,1,,N,50597,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,,10332,,1,10116.0,CHEMBL624096,In vivo,,Intermediate,A,
,1088,Rattus norvegicus,1,,N,50597,,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",,,BAO_0000218,,10333,,1,10116.0,CHEMBL624097,In vivo,,Intermediate,A,
,1742,Rattus norvegicus,1,,N,50597,,Maximum fall in carotid flow in rat,,,BAO_0000218,,10334,,1,10116.0,CHEMBL624098,In vivo,,Intermediate,A,
,4689,Rattus norvegicus,1,,N,50597,,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,,,BAO_0000218,,10335,,1,10116.0,CHEMBL874392,In vivo,,Intermediate,A,
,2463,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (dose 5 mg/kg),,,BAO_0000218,,10336,,1,10116.0,CHEMBL624099,In vivo,,Intermediate,A,
,5654,Rattus norvegicus,1,,N,50597,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,,BAO_0000218,,10337,,1,10116.0,CHEMBL624100,In vivo,,Intermediate,A,
,5654,Rattus norvegicus,1,,N,50597,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,,BAO_0000218,,10338,,1,10116.0,CHEMBL624101,In vivo,,Intermediate,A,
,6874,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (male Wistar),,,BAO_0000218,,10339,,1,10116.0,CHEMBL624102,In vivo,,Intermediate,A,
,5633,Rattus norvegicus,1,,N,50597,,Oral bioavailability after administration (30 mg/kg) in rat; good,,,BAO_0000218,,10340,,1,10116.0,CHEMBL624103,In vivo,,Intermediate,A,
,5496,Rattus norvegicus,1,,N,50597,,Oral bioavailability at the dose of 2 mg/kg in rat,,,BAO_0000218,,10341,,1,10116.0,CHEMBL624104,In vivo,,Intermediate,A,
,2358,Rattus norvegicus,1,,N,50597,,Oral bioavailability determined in rats,,,BAO_0000218,,10342,,1,10116.0,CHEMBL624105,In vivo,,Intermediate,A,
,16456,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),,,BAO_0000218,,10343,,1,10116.0,CHEMBL624106,In vivo,,Intermediate,A,
,5302,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (dose single 10 mg/kg),,,BAO_0000218,,10344,,1,10116.0,CHEMBL624107,In vivo,,Intermediate,A,
,5302,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (dose single 10 mg/kg),,,BAO_0000218,,10345,,1,10116.0,CHEMBL623943,In vivo,,Intermediate,A,
,5302,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (dose 5 mg/kg,,,BAO_0000218,,10346,,1,10116.0,CHEMBL623944,In vivo,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,,,BAO_0000218,,10347,,1,10116.0,CHEMBL623945,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,,,BAO_0000218,,10348,,1,10116.0,CHEMBL623946,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,,,BAO_0000218,,10349,,1,10116.0,CHEMBL623947,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,,,BAO_0000218,,10350,,1,10116.0,CHEMBL623948,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,,,BAO_0000218,,10351,,1,10116.0,CHEMBL623949,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,,,BAO_0000218,,10352,,1,10116.0,CHEMBL623950,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,,,BAO_0000218,,10353,,1,10116.0,CHEMBL874398,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,,,BAO_0000218,,10354,,1,10116.0,CHEMBL623951,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,,,BAO_0000218,,10355,,1,10116.0,CHEMBL623952,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,,,BAO_0000218,,10356,,1,10116.0,CHEMBL623953,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,,,BAO_0000218,,10357,,1,10116.0,CHEMBL623954,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,,,BAO_0000218,,10358,,1,10116.0,CHEMBL623955,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,,,BAO_0000218,,10359,,1,10116.0,CHEMBL623956,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,,,BAO_0000218,,10360,,1,10116.0,CHEMBL627807,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,,,BAO_0000218,,10361,,1,10116.0,CHEMBL627808,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,,,BAO_0000218,,10362,,1,10116.0,CHEMBL627809,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,,,BAO_0000218,,10363,,1,10116.0,CHEMBL627810,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",,,BAO_0000218,,10364,,1,10116.0,CHEMBL627811,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",,,BAO_0000218,,10365,,1,10116.0,CHEMBL627812,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",,,BAO_0000218,,10366,,1,10116.0,CHEMBL627813,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",,,BAO_0000218,,10367,,1,10116.0,CHEMBL627814,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",,,BAO_0000218,,10368,,1,10116.0,CHEMBL875336,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",,,BAO_0000218,,10369,,1,10116.0,CHEMBL627815,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",,,BAO_0000218,,10370,,1,10116.0,CHEMBL627816,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",,,BAO_0000218,,10371,,1,10116.0,CHEMBL627817,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",,,BAO_0000218,,10372,,1,10116.0,CHEMBL627818,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",,,BAO_0000218,,10373,,1,10116.0,CHEMBL627819,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",,,BAO_0000218,,10374,,1,10116.0,CHEMBL627820,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",,,BAO_0000218,,10375,,1,10116.0,CHEMBL627821,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,,BAO_0000218,,10376,,1,10116.0,CHEMBL628464,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,,,BAO_0000218,,10377,,1,10116.0,CHEMBL626239,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,,,BAO_0000218,,10378,,1,10116.0,CHEMBL626240,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,,,BAO_0000218,,10379,,1,10116.0,CHEMBL626241,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,,,BAO_0000218,,10380,,1,10116.0,CHEMBL626242,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,,,BAO_0000218,,10381,,1,10116.0,CHEMBL626243,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,,,BAO_0000218,,10382,,1,10116.0,CHEMBL626244,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,,,BAO_0000218,,10383,,1,10116.0,CHEMBL626907,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,,BAO_0000218,,10384,,1,10116.0,CHEMBL626908,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,,BAO_0000218,,10385,,1,10116.0,CHEMBL626909,,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,,BAO_0000218,,10386,,1,10116.0,CHEMBL626910,,,Intermediate,A,
,7449,Rattus norvegicus,1,,N,50597,,Percent total excretion of acetaminophen cysteine conjugate,,,BAO_0000218,,10387,,1,10116.0,CHEMBL875342,,,Intermediate,F,
,7449,Rattus norvegicus,1,,N,50597,,Percent total excretion of acetaminophen glucuronide,,,BAO_0000218,,10388,,1,10116.0,CHEMBL626911,,,Intermediate,F,
,7449,Rattus norvegicus,1,,N,50597,,Percent total excretion of acetaminophen sulfate,,,BAO_0000218,,10389,,1,10116.0,CHEMBL626912,,,Intermediate,F,
,7449,Rattus norvegicus,1,,N,50597,,Percent total excretion of acetaminophen-mercapturic acid,,,BAO_0000218,,10390,,1,10116.0,CHEMBL627065,,,Intermediate,F,
,3172,Rattus norvegicus,1,,N,50597,,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,,,BAO_0000218,,10391,Urine,1,10116.0,CHEMBL627066,,1088.0,Intermediate,A,
,16456,Rattus norvegicus,1,,N,50597,,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,,BAO_0000218,,10392,,1,10116.0,CHEMBL627067,In vivo,,Intermediate,A,
,10839,ratrat,1,,U,22224,,Biodistribution of compound in rat muscle after 5 min of administration,,,BAO_0000218,,10393,Muscle tissue,0,8656.0,CHEMBL627068,In vivo,2385.0,Autocuration,A,
,10839,ratrat,1,,U,22224,,Biodistribution of compound in rat muscle after 5 min of administration.,,,BAO_0000218,,10394,Muscle tissue,0,8656.0,CHEMBL627069,In vivo,2385.0,Autocuration,A,
,5334,Ovis aries,1,,U,22224,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,,BAO_0000218,,10395,,0,9940.0,CHEMBL627070,In vivo,,Autocuration,A,
,5334,Ovis aries,1,,U,22224,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,,BAO_0000218,,10396,,0,9940.0,CHEMBL627071,In vivo,,Autocuration,A,
,5334,Ovis aries,1,,U,22224,,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,,BAO_0000218,,10397,,0,9940.0,CHEMBL627072,In vivo,,Autocuration,A,
,5334,Ovis aries,1,,U,22224,,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,,BAO_0000218,,10398,,0,9940.0,CHEMBL627073,In vivo,,Autocuration,A,
,5334,Ovis aries,1,,U,22224,,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,,BAO_0000218,,10399,,0,9940.0,CHEMBL625387,In vivo,,Autocuration,A,
,5334,Ovis aries,1,,U,22224,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,,BAO_0000218,,10400,,0,9940.0,CHEMBL625388,In vivo,,Autocuration,A,
,5334,Ovis aries,1,,U,22224,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,,BAO_0000218,,10401,Plasma,0,9940.0,CHEMBL625389,In vivo,1969.0,Autocuration,A,
,5334,Ovis aries,1,,U,22224,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,,BAO_0000218,,10402,Plasma,0,9940.0,CHEMBL875343,In vivo,1969.0,Autocuration,A,
,1735,Serpentes,1,,N,50497,,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),,,BAO_0000218,,10403,,1,8570.0,CHEMBL876795,,,Intermediate,A,
,1469,Serpentes,1,,N,50497,,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,,,BAO_0000218,,10404,,1,8570.0,CHEMBL626552,,,Intermediate,A,
,1336,Serpentes,1,,N,50497,,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,,,BAO_0000218,,10405,,1,8570.0,CHEMBL626553,,,Intermediate,A,
,12403,Homo sapiens,1,,U,22224,,The human biological plasma half life of the compound,,,BAO_0000366,,10406,Plasma,0,9606.0,CHEMBL626554,,1969.0,Autocuration,A,
,8151,Rattus norvegicus,1,,N,50597,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,,BAO_0000218,,10407,Urine,1,10116.0,CHEMBL626555,,1088.0,Intermediate,A,
,8004,Rattus norvegicus,1,,N,50597,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,,,BAO_0000218,,10408,,1,10116.0,CHEMBL626556,,,Intermediate,A,
,8004,Rattus norvegicus,1,,N,50597,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,,,BAO_0000218,,10409,,1,10116.0,CHEMBL626557,,,Intermediate,A,
,8004,Rattus norvegicus,1,,N,50597,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,,,BAO_0000218,,10410,,1,10116.0,CHEMBL626558,,,Intermediate,A,
,8004,Rattus norvegicus,1,,N,50597,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,,,BAO_0000218,,10411,,1,10116.0,CHEMBL626559,,,Intermediate,A,
,8004,Rattus norvegicus,1,,N,50597,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,,,BAO_0000218,,10412,,1,10116.0,CHEMBL626560,,,Intermediate,A,
,8004,Rattus norvegicus,1,,N,50597,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,,,BAO_0000218,,10413,,1,10116.0,CHEMBL876803,,,Intermediate,A,
,8004,Rattus norvegicus,1,,N,50597,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,,,BAO_0000218,,10414,,1,10116.0,CHEMBL627964,,,Intermediate,A,
,8004,Rattus norvegicus,1,,N,50597,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,,,BAO_0000218,,10415,,1,10116.0,CHEMBL627965,,,Intermediate,A,
,8004,Rattus norvegicus,1,,N,50597,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,,,BAO_0000218,,10416,,1,10116.0,CHEMBL627966,,,Intermediate,A,
,8004,Rattus norvegicus,1,,N,50597,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,,,BAO_0000218,,10417,,1,10116.0,CHEMBL627967,,,Intermediate,A,
,8004,Rattus norvegicus,1,,N,50597,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,,,BAO_0000218,,10418,,1,10116.0,CHEMBL627968,,,Intermediate,A,
,8004,Rattus norvegicus,1,,N,50597,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,,,BAO_0000218,,10419,,1,10116.0,CHEMBL627969,,,Intermediate,A,
,8004,Rattus norvegicus,1,,N,50597,,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,,,BAO_0000218,,10420,,1,10116.0,CHEMBL627970,,,Intermediate,A,
,8004,Rattus norvegicus,1,,N,50597,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,,,BAO_0000218,,10421,Blood,1,10116.0,CHEMBL627971,,178.0,Intermediate,A,
,8004,Rattus norvegicus,1,,N,50597,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,,,BAO_0000218,,10422,Blood,1,10116.0,CHEMBL627972,,178.0,Intermediate,A,
,15917,Homo sapiens,1,,D,180,,Dissociation constant against binding to human cyclophilin A,,,BAO_0000357,,10423,,9,9606.0,CHEMBL856029,,,Expert,B,
,12396,Bos taurus,1,,H,11591,,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,,,BAO_0000019,,10424,,8,9913.0,CHEMBL627973,,,Expert,B,
,7065,,1,,U,22224,,-Log C was determined by performing the electroshock minimum test,,,BAO_0000019,,10425,,0,,CHEMBL627974,,,Autocuration,A,
,7065,,1,,U,22224,,-Log C was determined by performing the foot shock test,,,BAO_0000019,,10426,,0,,CHEMBL627975,,,Autocuration,A,
,7065,,1,,U,22224,,-Log C was determined by performing the incl screen test,,,BAO_0000019,,10427,,0,,CHEMBL627976,,,Autocuration,A,
,7065,,1,,U,22224,,-Log C was determined by performing the maximum electroshock test,,,BAO_0000019,,10428,,0,,CHEMBL627977,,,Autocuration,A,
,7065,,1,,U,22224,,-Log C was determined by performing the pentylenetetrazole test,,,BAO_0000019,,10429,,0,,CHEMBL627978,,,Autocuration,A,
,12415,,1,,U,22224,,Tested for experimental arotinoid inhibitory dose,,,BAO_0000019,,10430,,0,,CHEMBL627979,,,Autocuration,A,
,10256,,1,,U,22224,,Negative log transformed activity,,,BAO_0000019,,10431,,0,,CHEMBL876804,,,Autocuration,A,
,7991,,1,,U,22224,,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",,,BAO_0000019,,10432,,0,,CHEMBL627980,,,Autocuration,A,
,14342,Cavia porcellus,1,,N,50512,,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,,,BAO_0000218,,10433,,1,10141.0,CHEMBL627981,,,Intermediate,A,
,14342,Cavia porcellus,1,,N,50512,,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,,,BAO_0000218,,10434,,1,10141.0,CHEMBL627982,,,Intermediate,A,
,14342,Cavia porcellus,1,,N,50512,,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,,,BAO_0000218,,10435,,1,10141.0,CHEMBL627983,,,Intermediate,A,
,14342,Cavia porcellus,1,,N,50512,,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,,,BAO_0000218,,10436,Ileum,1,10141.0,CHEMBL627984,,2116.0,Intermediate,A,
,6047,,1,,U,22229,,Solubility in water was determined; values expressed as -log,,,BAO_0000100,,10437,,0,,CHEMBL627985,,,Autocuration,P,
,17269,,1,,U,22224,,Ratio of Kcat to that of Km was determined,,,BAO_0000019,,10438,,0,,CHEMBL627986,,,Autocuration,A,
,10026,,1,,U,22224,,Observed first order rate constant,,,BAO_0000019,,10439,,0,,CHEMBL627987,,,Autocuration,A,
,14583,,1,,U,22224,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,,,BAO_0000019,,10440,,0,,CHEMBL627988,,,Autocuration,A,
,2661,Rattus norvegicus,1,,N,50597,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,,,BAO_0000218,,10441,,1,10116.0,CHEMBL627989,In vivo,,Intermediate,A,
,2661,Rattus norvegicus,1,,N,50597,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,,,BAO_0000218,,10442,,1,10116.0,CHEMBL627990,In vivo,,Intermediate,A,
,4029,Rattus norvegicus,1,,N,50597,,Oral Bioavailability after administration of 10 mg/kg in male rat,,,BAO_0000218,,10443,,1,10116.0,CHEMBL876805,In vivo,,Intermediate,A,
,17735,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),,,BAO_0000218,,10444,,1,10116.0,CHEMBL627991,In vivo,,Intermediate,A,
,4576,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10445,,1,10116.0,CHEMBL627992,In vivo,,Intermediate,A,
,17582,Rattus norvegicus,1,,N,50597,,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,,,BAO_0000218,,10446,,1,10116.0,CHEMBL627993,In vivo,,Intermediate,A,
,17651,Rattus norvegicus,1,,N,50597,,Oral bioavailability at 1 mg/kg was determined in rat,,,BAO_0000218,,10447,,1,10116.0,CHEMBL622817,In vivo,,Intermediate,A,
,17651,Rattus norvegicus,1,,N,50597,,Oral bioavailability at 10 mg/kg was determined in rat,,,BAO_0000218,,10448,,1,10116.0,CHEMBL622818,In vivo,,Intermediate,A,
,17670,Rattus norvegicus,1,,N,50597,,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",,,BAO_0000218,,10449,,1,10116.0,CHEMBL622819,In vivo,,Intermediate,A,
,5045,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10450,,1,10116.0,CHEMBL872267,In vivo,,Intermediate,A,
,1696,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10451,,1,10116.0,CHEMBL622820,In vivo,,Intermediate,A,
,17764,Rattus norvegicus,1,,N,50597,,Oral bioavailability after intravenous administration in rats at 24 uM/kg,,,BAO_0000218,,10452,,1,10116.0,CHEMBL622821,In vivo,,Intermediate,A,
,6448,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10453,,1,10116.0,CHEMBL622822,In vivo,,Intermediate,A,
,6596,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10454,,1,10116.0,CHEMBL622823,In vivo,,Intermediate,A,
,17547,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10455,,1,10116.0,CHEMBL622824,In vivo,,Intermediate,A,
,17771,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat at a dose of 3 mg/kg,,,BAO_0000218,,10456,,1,10116.0,CHEMBL622825,In vivo,,Intermediate,A,
,6495,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat after oral administration at 10 mg/kg,,,BAO_0000218,,10457,,1,10116.0,CHEMBL622901,In vivo,,Intermediate,A,
,4558,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10458,,1,10116.0,CHEMBL622902,In vivo,,Intermediate,A,
,17596,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10459,,1,10116.0,CHEMBL621844,In vivo,,Intermediate,A,
,6827,Rattus norvegicus,1,,N,50597,,Oral bioavailability in Dawley rats,,,BAO_0000218,,10460,,1,10116.0,CHEMBL621845,In vivo,,Intermediate,A,
,4026,Rattus norvegicus,1,,N,50597,,Oral bioavailability,,,BAO_0000218,,10461,,1,10116.0,CHEMBL621846,In vivo,,Intermediate,A,
,10,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (dose 30 mg/kg),,,BAO_0000218,,10462,,1,10116.0,CHEMBL621847,In vivo,,Intermediate,A,
,17717,Rattus norvegicus,1,,N,50597,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,,BAO_0000218,,10463,,1,10116.0,CHEMBL877609,In vivo,,Intermediate,A,
,17717,Rattus norvegicus,1,,N,50597,,Bioavailability in rat (dose 3 mg/kg i.v.),,,BAO_0000218,,10464,,1,10116.0,CHEMBL621848,In vivo,,Intermediate,A,
,17717,Rattus norvegicus,1,,N,50597,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,,BAO_0000218,,10465,,1,10116.0,CHEMBL621849,In vivo,,Intermediate,A,
,17717,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (dose 60 mg/kg p.o.),,,BAO_0000218,,10466,,1,10116.0,CHEMBL622030,In vivo,,Intermediate,A,
,4796,Rattus norvegicus,1,,N,50597,,Percent oral bioavailability determined in rats,,,BAO_0000218,,10467,,1,10116.0,CHEMBL622031,In vivo,,Intermediate,A,
,4883,Rattus norvegicus,1,,N,50597,,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,,BAO_0000218,,10468,,1,10116.0,CHEMBL622032,In vivo,,Intermediate,A,
,2137,Rattus norvegicus,1,,N,50597,,The compound was evaluated for bioavailability in rats; 32-51,,,BAO_0000218,,10469,,1,10116.0,CHEMBL622033,In vivo,,Intermediate,A,
,2959,Rattus norvegicus,1,,N,50597,,Bioavailability in rat (dose 20 mg/kg p.o.),,,BAO_0000218,,10470,,1,10116.0,CHEMBL622034,In vivo,,Intermediate,A,
,1361,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10471,,1,10116.0,CHEMBL622035,In vivo,,Intermediate,A,
,4727,Rattus norvegicus,1,,N,50597,,Bioavailability percent in rat at the dose of 2 mg/kg,,,BAO_0000218,,10472,,1,10116.0,CHEMBL882966,In vivo,,Intermediate,A,
,16423,Rattus norvegicus,1,,N,50597,,Bioavailability was evaluated after 20 uM/kg of peroral administration,,,BAO_0000218,,10473,,1,10116.0,CHEMBL622036,In vivo,,Intermediate,A,
,5206,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10474,,1,10116.0,CHEMBL622037,In vivo,,Intermediate,A,
,6448,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10475,,1,10116.0,CHEMBL622038,In vivo,,Intermediate,A,
,17723,Rattus norvegicus,1,,N,50597,,Bioavailability in rats,,,BAO_0000218,,10476,,1,10116.0,CHEMBL622039,In vivo,,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,,,BAO_0000218,,10477,Blood,1,10116.0,CHEMBL622040,In vivo,178.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,,,BAO_0000218,,10478,Blood,1,10116.0,CHEMBL622041,In vivo,178.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,,,BAO_0000218,,10479,Blood,1,10116.0,CHEMBL622042,In vivo,178.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,,,BAO_0000218,,10480,Blood,1,10116.0,CHEMBL622043,In vivo,178.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,,,BAO_0000218,,10481,Blood,1,10116.0,CHEMBL622044,In vivo,178.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,,,BAO_0000218,,10482,Bone,1,10116.0,CHEMBL622045,In vivo,10000001.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,,,BAO_0000218,,10483,Bone,1,10116.0,CHEMBL622046,In vivo,10000001.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,,,BAO_0000218,,10484,Bone,1,10116.0,CHEMBL622047,In vivo,10000001.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,,,BAO_0000218,,10485,Bone,1,10116.0,CHEMBL877610,In vivo,10000001.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,,,BAO_0000218,,10486,Brain,1,10116.0,CHEMBL622048,In vivo,955.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,,,BAO_0000218,,10487,Brain,1,10116.0,CHEMBL622049,In vivo,955.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,,,BAO_0000218,,10488,Brain,1,10116.0,CHEMBL622050,In vivo,955.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,,,BAO_0000218,,10489,Brain,1,10116.0,CHEMBL622051,In vivo,955.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,,,BAO_0000218,,10490,,1,10116.0,CHEMBL622052,In vivo,,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,,,BAO_0000218,,10491,,1,10116.0,CHEMBL622053,In vivo,,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,,,BAO_0000218,,10492,,1,10116.0,CHEMBL622054,In vivo,,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,,,BAO_0000218,,10493,,1,10116.0,CHEMBL622055,In vivo,,Intermediate,A,
,5237,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rats was determined; High,,,BAO_0000218,,10494,,1,10116.0,CHEMBL622056,In vivo,,Intermediate,A,
,5503,Rattus norvegicus,1,,N,50597,,Oral bioavailability in the rat was determined,,,BAO_0000218,,10495,,1,10116.0,CHEMBL622057,In vivo,,Intermediate,A,
,15765,Rattus norvegicus,1,,N,50597,,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,,,BAO_0000218,,10496,,1,10116.0,CHEMBL628008,In vivo,,Intermediate,A,
,15660,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),,,BAO_0000218,,10497,,1,10116.0,CHEMBL622058,In vivo,,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,,BAO_0000218,,10498,,1,10116.0,CHEMBL622059,In vivo,,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,,BAO_0000218,,10499,,1,10116.0,CHEMBL622060,In vivo,,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,,BAO_0000218,,10500,,1,10116.0,CHEMBL622061,In vivo,,Intermediate,A,
,5978,Rattus norvegicus,1,,N,50597,,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,,BAO_0000218,,10501,,1,10116.0,CHEMBL622062,In vivo,,Intermediate,A,
,5656,Rattus norvegicus,1,,N,50597,,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,,,BAO_0000218,,10502,,1,10116.0,CHEMBL622063,In vivo,,Intermediate,A,
,3598,Rattus norvegicus,1,,N,50597,,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,,,BAO_0000218,,10503,,1,10116.0,CHEMBL877611,In vivo,,Expert,A,
,4216,Rattus norvegicus,1,,N,50597,,Oral bioavailability of compound in Sprague Dawley rats,,,BAO_0000218,,10504,,1,10116.0,CHEMBL622064,In vivo,,Intermediate,A,
,17839,Rattus norvegicus,1,,N,50597,,Oral bioavailability of compound in rat,,,BAO_0000218,,10505,,1,10116.0,CHEMBL622065,In vivo,,Intermediate,A,
,6570,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (dose 2 mg/kg),,,BAO_0000218,,10506,,1,10116.0,CHEMBL622066,In vivo,,Intermediate,A,
,5334,Rattus norvegicus,1,,N,50597,,Oral bioavailability of compound in rat was determined,,,BAO_0000218,,10507,,1,10116.0,CHEMBL622067,In vivo,,Intermediate,A,
,6886,Rattus norvegicus,1,,N,50597,,Oral bioavailability of compound in rats,,,BAO_0000218,,10508,,1,10116.0,CHEMBL622068,In vivo,,Intermediate,A,
,5210,Rattus norvegicus,1,,N,50597,,Oral bioavailability of compound was determined in rats,,,BAO_0000218,,10509,,1,10116.0,CHEMBL622069,In vivo,,Intermediate,A,
,4170,Rattus norvegicus,1,,N,50597,,Oral bioavailability at a dose of 30 mg/kg in rats,,,BAO_0000218,,10510,,1,10116.0,CHEMBL624796,In vivo,,Intermediate,A,
,6028,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (dose 10 mg/kg),,,BAO_0000218,,10511,,1,10116.0,CHEMBL624797,In vivo,,Intermediate,A,
,6028,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (dose 10 mg/kg),,,BAO_0000218,,10512,,1,10116.0,CHEMBL623053,In vivo,,Intermediate,A,
,6078,Rattus norvegicus,1,,N,50597,,Oral bioavailability evaluated in rat,,,BAO_0000218,,10513,,1,10116.0,CHEMBL623054,In vivo,,Intermediate,A,
,6168,Rattus norvegicus,1,,N,50597,,Oral bioavailability in fasted rat,,,BAO_0000218,,10514,,1,10116.0,CHEMBL623055,In vivo,,Intermediate,A,
,6168,Rattus norvegicus,1,,N,50597,,Oral bioavailability in fed rat,,,BAO_0000218,,10515,,1,10116.0,CHEMBL623056,In vivo,,Intermediate,A,
,5160,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (mature male) (dose 30 mg/kg),,,BAO_0000218,,10516,,1,10116.0,CHEMBL623057,In vivo,,Intermediate,A,
,6057,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10517,,1,10116.0,CHEMBL623058,In vivo,,Intermediate,A,
,6535,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (dose 10 mg/kg p.o.),,,BAO_0000218,,10518,,1,10116.0,CHEMBL623059,In vivo,,Intermediate,A,
,6535,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat after administration of 10 mg/kg po,,,BAO_0000218,,10519,,1,10116.0,CHEMBL623060,In vivo,,Intermediate,A,
,4194,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10520,,1,10116.0,CHEMBL623061,In vivo,,Intermediate,A,
,6230,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10521,,1,10116.0,CHEMBL623062,In vivo,,Intermediate,A,
,6619,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10522,,1,10116.0,CHEMBL623063,In vivo,,Intermediate,A,
,17607,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10523,,1,10116.0,CHEMBL623064,In vivo,,Intermediate,A,
,4942,Rattus norvegicus,1,,N,50597,,Oral bioavailability in ratrs,,,BAO_0000218,,10524,,1,10116.0,CHEMBL623065,In vivo,,Intermediate,A,
,4942,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10525,,1,10116.0,CHEMBL623066,In vivo,,Intermediate,A,
,6646,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10526,,1,10116.0,CHEMBL623067,In vivo,,Intermediate,A,
,5237,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rats was determined; High,,,BAO_0000218,,10527,,1,10116.0,CHEMBL623068,In vivo,,Intermediate,A,
,6646,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10528,,1,10116.0,CHEMBL623069,In vivo,,Intermediate,A,
,4449,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10529,,1,10116.0,CHEMBL623070,In vivo,,Intermediate,A,
,6057,Rattus norvegicus,1,,N,50597,,Oral bioavailability was calculated in rat,,,BAO_0000218,,10530,,1,10116.0,CHEMBL623071,In vivo,,Intermediate,A,
,2552,Rattus norvegicus,1,,N,50597,,Oral bioavailability,,,BAO_0000218,,10531,,1,10116.0,CHEMBL623072,In vivo,,Intermediate,A,
,5496,Rattus norvegicus,1,,N,50597,,Oral bioavailability,,,BAO_0000218,,10532,,1,10116.0,CHEMBL623073,In vivo,,Intermediate,A,
,6484,Rattus norvegicus,1,,N,50597,,Oral bioavailability,,,BAO_0000218,,10533,,1,10116.0,CHEMBL623074,In vivo,,Intermediate,A,
,6485,Rattus norvegicus,1,,N,50597,,Oral bioavailability,,,BAO_0000218,,10534,,1,10116.0,CHEMBL623075,In vivo,,Intermediate,A,
,6616,Rattus norvegicus,1,,N,50597,,Oral bioavailability after i.v. administration,,,BAO_0000218,,10535,,1,10116.0,CHEMBL623076,In vivo,,Intermediate,A,
,4969,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,,BAO_0000218,,10536,,1,10116.0,CHEMBL623077,In vivo,,Intermediate,A,
,5862,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (Sprague-Dawley),,,BAO_0000218,,10537,,1,10116.0,CHEMBL623078,In vivo,,Intermediate,A,
,4514,Rattus norvegicus,1,,N,50597,,Oral bioavailability in Sprague-Dawley rats,,,BAO_0000218,,10538,,1,10116.0,CHEMBL623079,In vivo,,Intermediate,A,
,4514,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,,BAO_0000218,,10539,,1,10116.0,CHEMBL623080,In vivo,,Intermediate,A,
,4514,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,,BAO_0000218,,10540,,1,10116.0,CHEMBL623081,In vivo,,Intermediate,A,
,5546,Rattus norvegicus,1,,N,50597,,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,,,BAO_0000218,,10541,,1,10116.0,CHEMBL623082,In vivo,,Intermediate,A,
,6168,Rattus norvegicus,1,,N,50597,,Oral bioavailability in fasted rat,,,BAO_0000218,,10542,,1,10116.0,CHEMBL874400,In vivo,,Intermediate,A,
,6168,Rattus norvegicus,1,,N,50597,,Oral bioavailability in fed rat,,,BAO_0000218,,10543,,1,10116.0,CHEMBL623083,In vivo,,Intermediate,A,
,3624,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10544,,1,10116.0,CHEMBL623084,In vivo,,Intermediate,A,
,5213,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10545,,1,10116.0,CHEMBL623085,In vivo,,Intermediate,A,
,5496,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10546,,1,10116.0,CHEMBL623086,In vivo,,Intermediate,A,
,5553,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10547,,1,10116.0,CHEMBL623087,In vivo,,Intermediate,A,
,5833,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10548,,1,10116.0,CHEMBL623088,In vivo,,Intermediate,A,
,5836,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10549,,1,10116.0,CHEMBL623089,In vivo,,Intermediate,A,
,5865,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10550,,1,10116.0,CHEMBL623090,In vivo,,Intermediate,A,
,5960,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10551,,1,10116.0,CHEMBL623091,In vivo,,Intermediate,A,
,6249,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10552,,1,10116.0,CHEMBL623092,In vivo,,Intermediate,A,
,6448,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10553,,1,10116.0,CHEMBL623093,In vivo,,Intermediate,A,
,6453,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10554,,1,10116.0,CHEMBL874401,In vivo,,Intermediate,A,
,6640,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10555,,1,10116.0,CHEMBL623094,In vivo,,Intermediate,A,
,17607,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10556,,1,10116.0,CHEMBL623095,In vivo,,Intermediate,A,
,5939,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat after peroral administration at 10 mg/kg,,,BAO_0000218,,10557,,1,10116.0,CHEMBL623096,In vivo,,Intermediate,A,
,5939,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat after peroral administration at 5 mg/kg,,,BAO_0000218,,10558,,1,10116.0,CHEMBL624913,In vivo,,Intermediate,A,
,6281,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),,,BAO_0000218,,10559,,1,10116.0,CHEMBL624914,In vivo,,Intermediate,A,
,5874,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,,,BAO_0000218,,10560,,1,10116.0,CHEMBL624915,In vivo,,Intermediate,A,
,5213,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat; Not measured,,,BAO_0000218,,10561,,1,10116.0,CHEMBL624916,In vivo,,Intermediate,A,
,4964,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10562,,1,10116.0,CHEMBL624917,In vivo,,Intermediate,A,
,11020,Rattus norvegicus,1,,N,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,,,BAO_0000218,,10563,,1,10116.0,CHEMBL625157,,,Intermediate,A,
,6251,Rattus norvegicus,1,,N,50597,,In vitro metabolic potential in rat liver microsomes,,,BAO_0000218,,10564,Liver,1,10116.0,CHEMBL625158,,2107.0,Intermediate,A,
,1568,Rattus norvegicus,1,,N,50597,,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",,,BAO_0000218,,10565,,1,10116.0,CHEMBL625159,In vivo,,Intermediate,A,
,3032,Rattus norvegicus,1,,N,50597,,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",,,BAO_0000218,,10566,,1,10116.0,CHEMBL625160,In vivo,,Intermediate,A,
,3748,Rattus norvegicus,1,,N,50597,,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,,,BAO_0000218,,10567,,1,10116.0,CHEMBL625161,In vivo,,Intermediate,A,
,401,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10568,,1,10116.0,CHEMBL625162,In vivo,,Intermediate,A,
,6512,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10569,,1,10116.0,CHEMBL625163,In vivo,,Intermediate,A,
,17617,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rats at 10 mg/kg,,,BAO_0000218,,10570,,1,10116.0,CHEMBL625164,In vivo,,Intermediate,A,
,6679,Rattus norvegicus,1,,N,50597,,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,,BAO_0000218,,10571,,1,10116.0,CHEMBL625165,In vivo,,Intermediate,A,
,6742,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10572,,1,10116.0,CHEMBL625166,In vivo,,Intermediate,A,
,589,Rattus norvegicus,1,,N,50597,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,,,BAO_0000218,,10573,,1,10116.0,CHEMBL625167,,,Intermediate,A,
,589,Rattus norvegicus,1,,N,50597,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,,,BAO_0000218,,10574,,1,10116.0,CHEMBL625168,,,Intermediate,A,
,3185,Rattus norvegicus,1,,N,50597,,Plasma clearance of the compound,,,BAO_0000218,,10575,,1,10116.0,CHEMBL625169,In vivo,,Intermediate,A,
,17596,Rattus norvegicus,1,,N,50597,,Plasma clearance at 10 mg/kg in rat upon intravenous administration,,,BAO_0000218,,10576,,1,10116.0,CHEMBL626264,In vivo,,Intermediate,A,
,2713,Rattus norvegicus,1,,N,50597,,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,,,BAO_0000218,,10577,,1,10116.0,CHEMBL626265,In vivo,,Intermediate,A,
,12500,Rattus norvegicus,1,,N,50597,,The compound was tested for plasma clearance in rat,,,BAO_0000218,,10578,Plasma,1,10116.0,CHEMBL626266,In vivo,1969.0,Intermediate,A,
,12500,Rattus norvegicus,1,,N,50597,,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,,,BAO_0000218,,10579,Plasma,1,10116.0,CHEMBL626267,In vivo,1969.0,Intermediate,A,
,2713,Rattus norvegicus,1,,N,50597,,Plasma concentration upon oral administration of 1 mg/Kg in rats,,,BAO_0000218,,10580,,1,10116.0,CHEMBL626268,,,Intermediate,A,
,1446,Rattus norvegicus,1,,N,50597,,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,,,BAO_0000218,,10581,,1,10116.0,CHEMBL626269,,,Intermediate,A,
,6227,Rattus norvegicus,1,,N,50597,,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,,,BAO_0000218,,10582,,1,10116.0,CHEMBL626270,,,Intermediate,A,
,4709,Rattus norvegicus,1,,N,50597,,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,,,BAO_0000218,,10583,,1,10116.0,CHEMBL626271,,,Intermediate,A,
,5510,Rattus norvegicus,1,,N,50597,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",,,BAO_0000218,,10584,,1,10116.0,CHEMBL626272,,,Intermediate,A,
,5510,Rattus norvegicus,1,,N,50597,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,,BAO_0000218,,10585,,1,10116.0,CHEMBL626273,,,Intermediate,A,
,5510,Rattus norvegicus,1,,N,50597,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,,BAO_0000218,,10586,,1,10116.0,CHEMBL875346,,,Intermediate,A,
,5510,Rattus norvegicus,1,,N,50597,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",,,BAO_0000218,,10587,,1,10116.0,CHEMBL626274,,,Intermediate,A,
,4514,Rattus norvegicus,1,,N,50597,,Compound was tested for protein binding in rat plasma,,,BAO_0000218,,10588,,1,10116.0,CHEMBL626275,,,Intermediate,A,
,2713,Rattus norvegicus,1,,N,50597,,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,,,BAO_0000218,,10589,,1,10116.0,CHEMBL624646,,,Intermediate,A,
,2713,Rattus norvegicus,1,,N,50597,,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,,,BAO_0000218,,10590,,1,10116.0,CHEMBL624647,,,Intermediate,A,
,5340,Rattus norvegicus,1,,N,50597,,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,,,BAO_0000218,,10591,Liver,1,10116.0,CHEMBL624648,,2107.0,Intermediate,A,
,12058,Rattus norvegicus,1,,N,50597,,Area under curve ratio was determined (po/iv) in rat,,,BAO_0000218,,10592,,1,10116.0,CHEMBL624649,,,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,,,BAO_0000218,,10593,,1,10116.0,CHEMBL624650,,,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,,,BAO_0000218,,10594,,1,10116.0,CHEMBL624651,,,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,,,BAO_0000218,,10595,,1,10116.0,CHEMBL624652,,,Intermediate,A,
,6495,Rattus norvegicus,1,,N,50597,,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,,,BAO_0000218,,10596,,1,10116.0,CHEMBL624653,,,Intermediate,A,
,6078,Rattus norvegicus,1,,N,50597,,Ratio of AUCbrain to AUCplasma,,,BAO_0000218,,10597,,1,10116.0,CHEMBL624654,,,Intermediate,A,
,5656,Rattus norvegicus,1,,N,50597,,Ratio of brain to plasma,,,BAO_0000218,,10598,,1,10116.0,CHEMBL624655,,,Intermediate,A,
,4910,Rattus norvegicus,1,,N,50597,,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,,,BAO_0000218,,10599,,1,10116.0,CHEMBL624656,,,Intermediate,A,
,4910,Rattus norvegicus,1,,N,50597,,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,,BAO_0000218,,10600,,1,10116.0,CHEMBL624657,,,Intermediate,A,
,4910,Rattus norvegicus,1,,N,50597,,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,,BAO_0000218,,10601,,1,10116.0,CHEMBL624658,,,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,,,BAO_0000218,,10602,,1,10116.0,CHEMBL624659,,,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,,,BAO_0000218,,10603,,1,10116.0,CHEMBL624660,,,Intermediate,A,
,10130,Rattus norvegicus,1,,N,50597,,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,,,BAO_0000218,,10604,,1,10116.0,CHEMBL624661,,,Intermediate,A,
,5213,Rattus norvegicus,1,,N,50597,,Steady state brain :blood ratio was determined,,,BAO_0000218,,10605,,1,10116.0,CHEMBL624662,,,Intermediate,A,
,4910,Rattus norvegicus,1,,N,50597,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,,BAO_0000218,,10606,,1,10116.0,CHEMBL625199,,,Intermediate,A,
,4910,Rattus norvegicus,1,,N,50597,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,,BAO_0000218,,10607,,1,10116.0,CHEMBL625200,,,Intermediate,A,
,4910,Rattus norvegicus,1,,N,50597,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,,,BAO_0000218,,10608,,1,10116.0,CHEMBL625201,,,Intermediate,A,
,4910,Rattus norvegicus,1,,N,50597,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,,BAO_0000218,,10609,,1,10116.0,CHEMBL625202,,,Intermediate,A,
,2083,Rattus norvegicus,1,,N,50597,,Percentage recovery after 3h incubation with rat hapatocytes was determined,,,BAO_0000218,,10610,,1,10116.0,CHEMBL625203,,,Intermediate,A,
,2082,Rattus norvegicus,1,,N,50597,,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,,,BAO_0000218,,10611,,1,10116.0,CHEMBL625204,,,Intermediate,A,
,2082,Rattus norvegicus,1,,N,50597,,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,,,BAO_0000218,,10612,,1,10116.0,CHEMBL625205,,,Intermediate,A,
,6351,Rattus norvegicus,1,,N,50597,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,,,BAO_0000218,,10613,,1,10116.0,CHEMBL625206,,,Intermediate,A,
,14583,,1,,U,22224,,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",,,BAO_0000019,,10614,,0,,CHEMBL625207,,,Autocuration,A,
,14583,,1,,U,22224,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,,,BAO_0000019,,10615,,0,,CHEMBL625208,,,Autocuration,A,
495.0,4608,Homo sapiens,1,Caco-2,N,50587,,In vivo absorption in Caco-2 cell line monolayers was determined,,,BAO_0000218,,10616,,1,9606.0,CHEMBL625209,,,Intermediate,A,
,13668,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,10617,,0,,CHEMBL625210,,,Autocuration,P,
,5669,Rattus norvegicus,1,,N,50597,,Area under curve was determine after peroral administration at 10 mpk in Rat,,,BAO_0000218,,10618,,1,10116.0,CHEMBL625211,,,Intermediate,A,
,5669,Macaca mulatta,1,,N,50797,,Area under curve was determine after peroral administration at 10 mpk in Rhesus,,,BAO_0000218,,10619,,1,9544.0,CHEMBL625212,,,Intermediate,A,
,5669,Rattus norvegicus,1,,N,50597,,Area under curve was determine after peroral administration at 160 mpk in Rat,,,BAO_0000218,,10620,,1,10116.0,CHEMBL625213,,,Intermediate,A,
,5669,Rattus norvegicus,1,,N,50597,,Area under curve was determine after peroral administration at 20 mpk in Rat,,,BAO_0000218,,10621,,1,10116.0,CHEMBL625214,,,Intermediate,A,
,5669,Rattus norvegicus,1,,N,50597,,Area under curve was determine after peroral administration at 50 mpk in Rat,,,BAO_0000218,,10622,,1,10116.0,CHEMBL874542,,,Intermediate,A,
,6472,,1,,U,22229,,Calculated partition coefficient (clogP) (AlogP),,,BAO_0000100,,10623,,0,,CHEMBL625215,,,Autocuration,P,
,15106,,1,,U,22224,,Activated partial thromboplastin time measured,,,BAO_0000019,,10624,,0,,CHEMBL625216,,,Autocuration,A,
,15207,,1,,U,22224,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),,,BAO_0000100,,10625,,0,,CHEMBL625217,,,Autocuration,P,
,15207,,1,,U,22224,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),,,BAO_0000100,,10626,,0,,CHEMBL625218,,,Autocuration,P,
,13941,Canis lupus familiaris,1,,N,50588,,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,,,BAO_0000218,,10627,Plasma,1,9615.0,CHEMBL622864,,1969.0,Intermediate,A,
,13941,Rattus norvegicus,1,,N,50597,,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,,,BAO_0000218,,10628,Plasma,1,10116.0,CHEMBL622865,,1969.0,Intermediate,A,
,13941,Rattus norvegicus,1,,N,50597,,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,,,BAO_0000218,,10629,Plasma,1,10116.0,CHEMBL622866,,1969.0,Intermediate,A,
,13941,Canis lupus familiaris,1,,N,50588,,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,,,BAO_0000218,,10630,Plasma,1,9615.0,CHEMBL622867,,1969.0,Intermediate,A,
,15240,Cavia porcellus,1,,N,50512,,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,,,BAO_0000218,,10631,Plasma,1,10141.0,CHEMBL876808,,1969.0,Intermediate,A,
,10655,,1,,U,22224,,AUC in brain,,,BAO_0000019,,10632,Brain,0,,CHEMBL627725,,955.0,Autocuration,A,
,10655,,1,,U,22224,,AUC in serum,,,BAO_0000019,,10633,Serum,0,,CHEMBL627726,,1977.0,Autocuration,A,
,6504,,1,,U,22224,,AUC was determined,,,BAO_0000019,,10634,Plasma,0,,CHEMBL627727,,1969.0,Autocuration,A,
,10615,,1,,U,22224,,AUC of the compound.,,,BAO_0000019,,10635,Plasma,0,,CHEMBL627728,,1969.0,Autocuration,A,
,10353,,1,,U,22224,,AUC value (0-4 hr),,,BAO_0000019,,10636,Plasma,0,,CHEMBL627729,,1969.0,Autocuration,A,
,14907,,1,,U,22224,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",,,BAO_0000019,,10637,Plasma,0,,CHEMBL627730,,1969.0,Autocuration,A,
,14907,,1,,U,22224,,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,,,BAO_0000019,,10638,Plasma,0,,CHEMBL627731,,1969.0,Autocuration,A,
,14907,,1,,U,22224,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",,,BAO_0000019,,10639,Plasma,0,,CHEMBL627732,,1969.0,Autocuration,A,
,14907,,1,,U,22224,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",,,BAO_0000019,,10640,Plasma,0,,CHEMBL627733,,1969.0,Autocuration,A,
,16359,Rattus norvegicus,1,,N,50597,,AUC(area under curve) was determined after intravenous administration in rats,,,BAO_0000218,,10641,Plasma,1,10116.0,CHEMBL627734,,1969.0,Intermediate,A,
,16359,Rattus norvegicus,1,,N,50597,,AUC(area under curve) was determined after oral administration in rats,,,BAO_0000218,,10642,Plasma,1,10116.0,CHEMBL627735,,1969.0,Intermediate,A,
,15240,Cavia porcellus,1,,N,50512,,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,,,BAO_0000218,,10643,Plasma,1,10141.0,CHEMBL627736,,1969.0,Intermediate,A,
,15240,Rattus norvegicus,1,,N,50597,,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,,,BAO_0000218,,10644,Plasma,1,10116.0,CHEMBL876809,,1969.0,Intermediate,A,
,15469,,1,,U,22224,,Area Under Curve after oral dosing of 100 uM/Kg,,,BAO_0000019,,10645,,0,,CHEMBL627737,,,Autocuration,A,
,15469,,1,,U,22224,,Area Under Curve after oral dosing of 30 uM/Kg,,,BAO_0000019,,10646,,0,,CHEMBL627738,,,Autocuration,A,
,13520,,1,,U,22224,,Area Under Curve was measured by ploting the graph between concentration verses time,,,BAO_0000019,,10647,,0,,CHEMBL627739,,,Autocuration,A,
,17025,Canis lupus familiaris,1,,N,50588,,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,,,BAO_0000218,,10648,,1,9615.0,CHEMBL626143,,,Intermediate,A,
,17025,Simiiformes,1,,U,22224,,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,,,BAO_0000218,,10649,,0,314293.0,CHEMBL626144,,,Autocuration,A,
,17025,Oryctolagus cuniculus,1,,N,50592,,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,,,BAO_0000218,,10650,,1,9986.0,CHEMBL626145,,,Intermediate,A,
,17025,Rattus norvegicus,1,,N,50597,,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,,,BAO_0000218,,10651,,1,10116.0,CHEMBL626146,,,Intermediate,A,
,12032,Rattus norvegicus,1,,N,50597,,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,,,BAO_0000218,,10652,Blood,1,10116.0,CHEMBL626147,,178.0,Intermediate,A,
,10291,,1,,U,22224,,Area under curve (AUC) was determined,,,BAO_0000019,,10653,,0,,CHEMBL626148,,,Autocuration,A,
,5767,,1,,U,22224,,Area under curve (AUC) following ip administration at 1 mg/kg,,,BAO_0000218,,10654,,0,,CHEMBL626149,,,Autocuration,A,
,1434,,1,,U,22224,,Area under curve (AUC) was determined; ND is Not determined,,,BAO_0000019,,10655,,0,,CHEMBL626150,,,Autocuration,A,
,14925,Canis lupus familiaris,1,,N,50588,,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,,,BAO_0000218,,10656,,1,9615.0,CHEMBL626151,,,Intermediate,A,
,14925,Canis lupus familiaris,1,,N,50588,,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,,,BAO_0000218,,10657,,1,9615.0,CHEMBL626152,,,Intermediate,A,
,14925,Canis lupus familiaris,1,,N,50588,,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,,,BAO_0000218,,10658,,1,9615.0,CHEMBL626153,,,Intermediate,A,
,1434,,1,,U,22224,,Area under curve (AUR) was determined,,,BAO_0000019,,10659,,0,,CHEMBL626154,,,Autocuration,A,
,11883,,1,,U,22224,,Area under curve at 1 uM/dg administered intravenously,,,BAO_0000019,,10660,,0,,CHEMBL626155,,,Autocuration,A,
,11883,,1,,U,22224,,Area under curve at 10 uM/dg administered perorally,,,BAO_0000019,,10661,,0,,CHEMBL626156,,,Autocuration,A,
,11883,,1,,U,22224,,Area under curve at 2 uM/dg administered intravenously,,,BAO_0000019,,10662,,0,,CHEMBL626157,,,Autocuration,A,
,11883,,1,,U,22224,,Area under curve at 20 uM/dg administered perorally,,,BAO_0000019,,10663,,0,,CHEMBL626158,,,Autocuration,A,
,15233,Canis lupus familiaris,1,,N,50588,,Area under curve at a peroral dose of 3 mg/kg in dog,,,BAO_0000218,,10664,,1,9615.0,CHEMBL626159,,,Intermediate,A,
,15233,Rattus norvegicus,1,,N,50597,,Area under curve at a peroral dose of 3 mg/kg in rat,,,BAO_0000218,,10665,,1,10116.0,CHEMBL626160,,,Intermediate,A,
,15233,Canis lupus familiaris,1,,N,50588,,Area under curve at an iv dose of 1 mg/kg in dog,,,BAO_0000218,,10666,,1,9615.0,CHEMBL626161,,,Intermediate,A,
,15233,Rattus norvegicus,1,,N,50597,,Area under curve at an iv dose of 1 mg/kg in rat,,,BAO_0000218,,10667,,1,10116.0,CHEMBL626162,,,Intermediate,A,
,12978,,1,,U,22224,,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,,,BAO_0000019,,10668,,0,,CHEMBL626163,,,Autocuration,A,
,12978,,1,,U,22224,,Area under curve gives the effective duration for the angiotensin II antagonist effect.,,,BAO_0000019,,10669,,0,,CHEMBL626164,,,Autocuration,A,
,11355,Mus musculus,1,,N,50594,,Area under curve measured as conc vs time after intravenous administration to mice.,,,BAO_0000218,,10670,,1,10090.0,CHEMBL626165,,,Intermediate,A,
,11355,Mus musculus,1,,N,50594,,Area under curve measured as conc vs time after peroral administration to mice.,,,BAO_0000218,,10671,,1,10090.0,CHEMBL626166,,,Intermediate,A,
,12923,Canis lupus familiaris,1,,N,50588,,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,,BAO_0000218,,10672,,1,9615.0,CHEMBL626167,,,Intermediate,A,
,12923,Canis lupus familiaris,1,,N,50588,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,,,BAO_0000218,,10673,,1,9615.0,CHEMBL626168,,,Intermediate,A,
,12923,Canis lupus familiaris,1,,N,50588,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,,,BAO_0000218,,10674,,1,9615.0,CHEMBL877463,,,Intermediate,A,
,12923,Canis lupus familiaris,1,,N,50588,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,,,BAO_0000218,,10675,,1,9615.0,CHEMBL626169,,,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,,,BAO_0000218,,10676,Heart,1,10116.0,CHEMBL626170,In vivo,948.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,,,BAO_0000218,,10677,Heart,1,10116.0,CHEMBL626171,In vivo,948.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,,,BAO_0000218,,10678,Heart,1,10116.0,CHEMBL626172,In vivo,948.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,,,BAO_0000218,,10679,Heart,1,10116.0,CHEMBL626173,In vivo,948.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,,,BAO_0000218,,10680,Kidney,1,10116.0,CHEMBL626174,In vivo,2113.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,,,BAO_0000218,,10681,Kidney,1,10116.0,CHEMBL626175,In vivo,2113.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,,,BAO_0000218,,10682,Kidney,1,10116.0,CHEMBL626176,In vivo,2113.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,,,BAO_0000218,,10683,Kidney,1,10116.0,CHEMBL626177,In vivo,2113.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,,,BAO_0000218,,10684,Kidney,1,10116.0,CHEMBL622499,In vivo,2113.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,,,BAO_0000218,,10685,Liver,1,10116.0,CHEMBL622500,In vivo,2107.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,,,BAO_0000218,,10686,Liver,1,10116.0,CHEMBL622501,In vivo,2107.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,,,BAO_0000218,,10687,Liver,1,10116.0,CHEMBL622502,In vivo,2107.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,,,BAO_0000218,,10688,Liver,1,10116.0,CHEMBL622503,In vivo,2107.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,,,BAO_0000218,,10689,Liver,1,10116.0,CHEMBL877614,In vivo,2107.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,,,BAO_0000218,,10690,Lung,1,10116.0,CHEMBL624839,In vivo,2048.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,,,BAO_0000218,,10691,Lung,1,10116.0,CHEMBL624840,In vivo,2048.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,,,BAO_0000218,,10692,Lung,1,10116.0,CHEMBL624841,In vivo,2048.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,,,BAO_0000218,,10693,Lung,1,10116.0,CHEMBL624842,In vivo,2048.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,,,BAO_0000218,,10694,Muscle tissue,1,10116.0,CHEMBL624843,In vivo,2385.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,,,BAO_0000218,,10695,Muscle tissue,1,10116.0,CHEMBL624844,In vivo,2385.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,,,BAO_0000218,,10696,Muscle tissue,1,10116.0,CHEMBL624845,In vivo,2385.0,Intermediate,A,
,17738,Rattus norvegicus,1,,N,50597,,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,,,BAO_0000218,,10697,Muscle tissue,1,10116.0,CHEMBL621904,In vivo,2385.0,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,,,BAO_0000218,,10698,Blood,1,10116.0,CHEMBL621905,In vivo,178.0,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,,,BAO_0000218,,10699,Blood,1,10116.0,CHEMBL874382,In vivo,178.0,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,,,BAO_0000218,,10700,Blood,1,10116.0,CHEMBL621906,In vivo,178.0,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,,,BAO_0000218,,10701,Brain,1,10116.0,CHEMBL621907,In vivo,955.0,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,,,BAO_0000218,,10702,Brain,1,10116.0,CHEMBL622096,In vivo,955.0,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,,,BAO_0000218,,10703,Brain,1,10116.0,CHEMBL622097,In vivo,955.0,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,,,BAO_0000218,,10704,Heart,1,10116.0,CHEMBL622098,In vivo,948.0,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,,,BAO_0000218,,10705,Heart,1,10116.0,CHEMBL622099,In vivo,948.0,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,,,BAO_0000218,,10706,Heart,1,10116.0,CHEMBL622100,In vivo,948.0,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,,,BAO_0000218,,10707,Kidney,1,10116.0,CHEMBL622101,In vivo,2113.0,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,,,BAO_0000218,,10708,Kidney,1,10116.0,CHEMBL622102,In vivo,2113.0,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,,,BAO_0000218,,10709,Kidney,1,10116.0,CHEMBL622103,In vivo,2113.0,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,,,BAO_0000218,,10710,Liver,1,10116.0,CHEMBL622104,In vivo,2107.0,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,,,BAO_0000218,,10711,Liver,1,10116.0,CHEMBL622105,In vivo,2107.0,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,,,BAO_0000218,,10712,Liver,1,10116.0,CHEMBL622106,In vivo,2107.0,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,,,BAO_0000218,,10713,Lung,1,10116.0,CHEMBL622107,In vivo,2048.0,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,,,BAO_0000218,,10714,Lung,1,10116.0,CHEMBL622108,In vivo,2048.0,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,,,BAO_0000218,,10715,Lung,1,10116.0,CHEMBL622109,In vivo,2048.0,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,,,BAO_0000218,,10716,Muscle tissue,1,10116.0,CHEMBL622110,In vivo,2385.0,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,,,BAO_0000218,,10717,Muscle tissue,1,10116.0,CHEMBL622111,In vivo,2385.0,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,,,BAO_0000218,,10718,Muscle tissue,1,10116.0,CHEMBL874383,In vivo,2385.0,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,,,BAO_0000218,,10719,Zone of skin,1,10116.0,CHEMBL622112,In vivo,14.0,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,,,BAO_0000218,,10720,Zone of skin,1,10116.0,CHEMBL622113,In vivo,14.0,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,,,BAO_0000218,,10721,Zone of skin,1,10116.0,CHEMBL622114,In vivo,14.0,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,,,BAO_0000218,,10722,Spleen,1,10116.0,CHEMBL622115,In vivo,2106.0,Intermediate,A,
,11195,Rattus norvegicus,1,,N,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,,,BAO_0000218,,10723,Spleen,1,10116.0,CHEMBL622116,In vivo,2106.0,Intermediate,A,
,6193,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10724,,1,10116.0,CHEMBL622117,In vivo,,Intermediate,A,
,6803,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10725,,1,10116.0,CHEMBL622118,In vivo,,Intermediate,A,
,6647,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rats at 6 mg/kg,,,BAO_0000218,,10726,,1,10116.0,CHEMBL622119,In vivo,,Intermediate,A,
,6647,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (dose 6 mg/kg),,,BAO_0000218,,10727,,1,10116.0,CHEMBL622120,In vivo,,Intermediate,A,
,6647,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rats at 6 mg/kg dose; Not tested,,,BAO_0000218,,10728,,1,10116.0,CHEMBL622121,In vivo,,Intermediate,A,
,6640,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10729,,1,10116.0,CHEMBL622122,In vivo,,Intermediate,A,
,6641,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10730,,1,10116.0,CHEMBL622123,In vivo,,Intermediate,A,
,6641,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10731,,1,10116.0,CHEMBL622124,In vivo,,Intermediate,A,
,6642,Rattus norvegicus,1,,N,50597,,Bioavailability in rat,,,BAO_0000218,,10732,,1,10116.0,CHEMBL622125,In vivo,,Intermediate,A,
,5472,Rattus norvegicus,1,,N,50597,,Oral bioavailability,,,BAO_0000218,,10733,,1,10116.0,CHEMBL622126,In vivo,,Intermediate,A,
,6141,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,,BAO_0000218,,10734,,1,10116.0,CHEMBL620455,In vivo,,Intermediate,A,
,4390,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10735,,1,10116.0,CHEMBL620456,In vivo,,Intermediate,A,
,5472,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10736,,1,10116.0,CHEMBL620457,In vivo,,Intermediate,A,
,5472,Rattus norvegicus,1,,N,50597,,Oral bioavailability was evaluated; Not tested,,,BAO_0000218,,10737,,1,10116.0,CHEMBL620458,In vivo,,Intermediate,A,
,5438,Rattus norvegicus,1,,N,50597,,Oral bioavailability,,,BAO_0000218,,10738,,1,10116.0,CHEMBL620459,In vivo,,Intermediate,A,
,4883,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat by oral dosing,,,BAO_0000218,,10739,,1,10116.0,CHEMBL620460,In vivo,,Intermediate,A,
,1908,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (dose 10 mg/kg p.o.),,,BAO_0000218,,10740,,1,10116.0,CHEMBL620461,In vivo,,Intermediate,A,
,4853,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (Sprague-Dawley),,,BAO_0000218,,10741,,1,10116.0,CHEMBL620462,In vivo,,Intermediate,A,
,4853,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,,BAO_0000218,,10742,,1,10116.0,CHEMBL620463,In vivo,,Intermediate,A,
,4853,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,,BAO_0000218,,10743,,1,10116.0,CHEMBL620464,In vivo,,Intermediate,A,
,4853,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,,BAO_0000218,,10744,,1,10116.0,CHEMBL620465,In vivo,,Intermediate,A,
,4853,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),,,BAO_0000218,,10745,,1,10116.0,CHEMBL620466,In vivo,,Intermediate,A,
,4853,Rattus norvegicus,1,,N,50597,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,,,BAO_0000218,,10746,,1,10116.0,CHEMBL620467,In vivo,,Intermediate,A,
,4853,Rattus norvegicus,1,,N,50597,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,,,BAO_0000218,,10747,,1,10116.0,CHEMBL620468,In vivo,,Intermediate,A,
,12873,Rattus norvegicus,1,,N,50597,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,,,BAO_0000218,,10748,,1,10116.0,CHEMBL620469,In vivo,,Intermediate,A,
,12873,Rattus norvegicus,1,,N,50597,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,,,BAO_0000218,,10749,,1,10116.0,CHEMBL620470,In vivo,,Intermediate,A,
,3169,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10750,,1,10116.0,CHEMBL620471,In vivo,,Intermediate,A,
,6305,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10751,,1,10116.0,CHEMBL620472,In vivo,,Intermediate,A,
,4762,Rattus norvegicus,1,,N,50597,,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,,,BAO_0000218,,10752,,1,10116.0,CHEMBL620473,In vivo,,Intermediate,A,
,17847,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10753,,1,10116.0,CHEMBL620474,In vivo,,Intermediate,A,
,6211,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),,,BAO_0000218,,10754,,1,10116.0,CHEMBL620475,In vivo,,Intermediate,A,
,6011,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10755,,1,10116.0,CHEMBL620476,In vivo,,Intermediate,A,
,6317,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10756,,1,10116.0,CHEMBL620477,In vivo,,Intermediate,A,
,6644,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,,,BAO_0000218,,10757,,1,10116.0,CHEMBL620478,In vivo,,Intermediate,A,
,6644,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,,,BAO_0000218,,10758,,1,10116.0,CHEMBL618768,In vivo,,Intermediate,A,
,6644,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat after oral administration at 13 mg/kg dose,,,BAO_0000218,,10759,,1,10116.0,CHEMBL618769,In vivo,,Intermediate,A,
,6644,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,,,BAO_0000218,,10760,,1,10116.0,CHEMBL618770,In vivo,,Intermediate,A,
,6113,Rattus norvegicus,1,,N,50597,,Oral bioavailability (dose 20 mg/kg p.o.),,,BAO_0000218,,10761,,1,10116.0,CHEMBL618771,In vivo,,Intermediate,A,
,5937,Rattus norvegicus,1,,N,50597,,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,,,BAO_0000218,,10762,,1,10116.0,CHEMBL618772,In vivo,,Intermediate,A,
,5711,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat at 10 mg/kg of the compound,,,BAO_0000218,,10763,,1,10116.0,CHEMBL618773,In vivo,,Intermediate,A,
,17717,Rattus norvegicus,1,,N,50597,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,,BAO_0000218,,10764,,1,10116.0,CHEMBL875842,In vivo,,Intermediate,A,
,17717,Rattus norvegicus,1,,N,50597,,Bioavailability in rat (dose 3 mg/kg i.v.),,,BAO_0000218,,10765,,1,10116.0,CHEMBL618774,In vivo,,Intermediate,A,
,17717,Rattus norvegicus,1,,N,50597,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,,BAO_0000218,,10766,,1,10116.0,CHEMBL618775,In vivo,,Intermediate,A,
,17717,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (dose 60 mg/kg p.o.),,,BAO_0000218,,10767,,1,10116.0,CHEMBL618776,In vivo,,Intermediate,A,
,4722,Rattus norvegicus,1,,N,50597,,Percent bioavailability (F) in rats after iv administration,,,BAO_0000218,,10768,,1,10116.0,CHEMBL618777,In vivo,,Intermediate,A,
,4722,Rattus norvegicus,1,,N,50597,,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,,,BAO_0000218,,10769,,1,10116.0,CHEMBL618778,In vivo,,Intermediate,A,
,4353,Rattus norvegicus,1,,N,50597,,Bioavailability in rat (dose 5 uM/kg p.o.),,,BAO_0000218,,10770,,1,10116.0,CHEMBL618779,In vivo,,Intermediate,A,
,15662,Rattus norvegicus,1,,N,50597,,Oral bioavailability,,,BAO_0000218,,10771,,1,10116.0,CHEMBL618780,In vivo,,Intermediate,A,
,4756,Rattus norvegicus,1,,N,50597,,Bioavailability in rat (dose 2 mg/kg p.o.),,,BAO_0000218,,10772,,1,10116.0,CHEMBL618781,In vivo,,Intermediate,A,
,4756,Rattus norvegicus,1,,N,50597,,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,,,BAO_0000218,,10773,,1,10116.0,CHEMBL618782,In vivo,,Intermediate,A,
,3436,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (dose 20 mg/kg),,,BAO_0000218,,10774,,1,10116.0,CHEMBL618783,In vivo,,Intermediate,A,
,17800,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10775,,1,10116.0,CHEMBL618784,In vivo,,Intermediate,A,
,15762,Rattus norvegicus,1,,N,50597,,Percent oral bioavailability evaluated in rat,,,BAO_0000218,,10776,,1,10116.0,CHEMBL618785,In vivo,,Intermediate,A,
,5089,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10777,,1,10116.0,CHEMBL618786,In vivo,,Intermediate,A,
,5089,Rattus norvegicus,1,,N,50597,,Percent oral bioavailability in rat; Not determined,,,BAO_0000218,,10778,,1,10116.0,CHEMBL618787,In vivo,,Intermediate,A,
,3185,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat,,,BAO_0000218,,10779,,1,10116.0,CHEMBL618788,In vivo,,Intermediate,A,
,5145,Rattus norvegicus,1,,N,50597,,Bioavailability in rat,,,BAO_0000218,,10780,,1,10116.0,CHEMBL618789,In vivo,,Intermediate,A,
,3457,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),,,BAO_0000218,,10781,,1,10116.0,CHEMBL618790,In vivo,,Intermediate,A,
,3457,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),,,BAO_0000218,,10782,,1,10116.0,CHEMBL618791,In vivo,,Intermediate,A,
,5983,Rattus norvegicus,1,,N,50597,,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,,,BAO_0000218,,10783,,1,10116.0,CHEMBL875843,In vivo,,Intermediate,A,
,5739,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat (dose 20 mg/kg p.o.),,,BAO_0000218,,10784,,1,10116.0,CHEMBL618792,In vivo,,Intermediate,A,
,3579,Rattus norvegicus,1,,N,50597,,Cmax at a dose of 30 mg/kg in rat,,,BAO_0000218,,10785,,1,10116.0,CHEMBL623395,In vivo,,Intermediate,A,
,17788,Simiiformes,1,,U,22224,,Cmax in monkeys at a dose of 1 mg/kg,,,BAO_0000218,,10786,,0,314293.0,CHEMBL623396,In vivo,,Autocuration,A,
,14956,Rattus norvegicus,1,,N,50597,,Cmax in rat,,,BAO_0000218,,10787,,1,10116.0,CHEMBL623397,In vivo,,Intermediate,A,
,17788,Rattus norvegicus,1,,N,50597,,Cmax in rats at a dose of 1 mg/kg,,,BAO_0000218,,10788,,1,10116.0,CHEMBL623398,In vivo,,Intermediate,A,
,9750,Mus musculus,1,,N,50594,,Cmax was measured in mice after an oral dose of 50 mg/kg.,,,BAO_0000218,,10789,,1,10090.0,CHEMBL623399,In vivo,,Intermediate,A,
,12767,,1,,U,22224,,"Cmax value at a dose of 12.7 uM/kg, po",,,BAO_0000218,,10790,,0,,CHEMBL623400,In vivo,,Autocuration,A,
,12767,,1,,U,22224,,"Cmax value at a dose of 6.3 uM/kg, iv",,,BAO_0000218,,10791,,0,,CHEMBL623401,In vivo,,Autocuration,A,
,12767,,1,,U,22224,,"Cmax value at a dose of 7.1 uM/kg, iv",,,BAO_0000218,,10792,,0,,CHEMBL623402,In vivo,,Autocuration,A,
,12703,,1,,U,22224,,Cmax value of compound was determined after 1 hr,,,BAO_0000218,,10793,,0,,CHEMBL623403,In vivo,,Autocuration,A,
,15778,,1,,U,22224,,Cmax value of the compound,,,BAO_0000218,,10794,,0,,CHEMBL623404,In vivo,,Autocuration,A,
,12818,Rattus norvegicus,1,,N,50597,,Cmax value administered intraintestinal in rats.,,,BAO_0000218,,10795,,1,10116.0,CHEMBL625997,In vivo,,Intermediate,A,
,14964,Rattus norvegicus,1,,N,50597,,Cmax value administered perorally was determined in rat; Not determined,,,BAO_0000218,,10796,,1,10116.0,CHEMBL625998,In vivo,,Intermediate,A,
,15808,,1,,U,22224,,Cmax value at the dose of 2.3 mg/kg,,,BAO_0000218,,10797,,0,,CHEMBL625999,In vivo,,Autocuration,A,
,15808,,1,,U,22224,,Cmax value at the dose of 5 mg/kg,,,BAO_0000218,,10798,,0,,CHEMBL626000,In vivo,,Autocuration,A,
,15778,,1,,U,22224,,Cmax value in the period of 8 hr after dosing. ,,,BAO_0000218,,10799,,0,,CHEMBL626001,In vivo,,Autocuration,A,
,3715,,1,,U,22224,,Cmax value at a oral dose of 20 mg/kg; Not tested,,,BAO_0000218,,10800,,0,,CHEMBL626002,In vivo,,Autocuration,A,
,3715,,1,,U,22224,,Cmax value at a oral dose of 20 mg/kg,,,BAO_0000218,,10801,,0,,CHEMBL626003,In vivo,,Autocuration,A,
,1446,Rattus norvegicus,1,,N,50597,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,,BAO_0000218,,10802,,1,10116.0,CHEMBL626004,In vivo,,Intermediate,A,
,15240,Cavia porcellus,1,,N,50512,,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,,,BAO_0000218,,10803,,1,10141.0,CHEMBL626005,In vivo,,Intermediate,A,
,15240,Rattus norvegicus,1,,N,50597,,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,,,BAO_0000218,,10804,,1,10116.0,CHEMBL626006,In vivo,,Intermediate,A,
,14810,Rattus norvegicus,1,,N,50597,,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,,,BAO_0000218,,10805,Plasma,1,10116.0,CHEMBL626007,In vivo,1969.0,Intermediate,A,
,14239,Mus musculus,1,,N,50594,,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,,,BAO_0000218,,10806,Plasma,1,10090.0,CHEMBL626008,In vivo,1969.0,Intermediate,A,
,12555,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,,,BAO_0000218,,10807,Liver,1,9615.0,CHEMBL626009,In vivo,2107.0,Intermediate,A,
,10754,Canis lupus familiaris,1,,N,50588,,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,,,BAO_0000218,,10808,,1,9615.0,CHEMBL626010,In vivo,,Intermediate,A,
,10754,Mus musculus,1,,N,50594,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,,,BAO_0000218,,10809,Blood,1,10090.0,CHEMBL626011,In vivo,178.0,Intermediate,A,
,10754,Mus musculus,1,,N,50594,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,,,BAO_0000218,,10810,Blood,1,10090.0,CHEMBL626012,In vivo,178.0,Intermediate,A,
,10754,Mus musculus,1,,N,50594,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,,,BAO_0000218,,10811,Blood,1,10090.0,CHEMBL626013,In vivo,178.0,Intermediate,A,
,10754,Mus musculus,1,,N,50594,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,,,BAO_0000218,,10812,Blood,1,10090.0,CHEMBL626014,In vivo,178.0,Intermediate,A,
,10754,Mus musculus,1,,N,50594,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,,,BAO_0000218,,10813,Blood,1,10090.0,CHEMBL877496,In vivo,178.0,Intermediate,A,
,14600,Canis lupus familiaris,1,,N,50588,,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,,,BAO_0000218,,10814,,1,9615.0,CHEMBL626015,In vivo,,Intermediate,F,
,14600,Canis lupus familiaris,1,,N,50588,,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,,,BAO_0000218,,10815,,1,9615.0,CHEMBL626016,In vivo,,Intermediate,F,
,14600,Canis lupus familiaris,1,,N,50588,,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,,,BAO_0000218,,10816,,1,9615.0,CHEMBL626017,In vivo,,Intermediate,F,
,13543,Canis lupus familiaris,1,,N,50588,,Bioavailability as maximal plasma concentration in dogs,,,BAO_0000218,,10817,Plasma,1,9615.0,CHEMBL626018,In vivo,1969.0,Intermediate,A,
,13543,Canis lupus familiaris,1,,N,50588,,Bioavailability as maximal plasma concentration in dogs,,,BAO_0000218,,10818,Plasma,1,9615.0,CHEMBL626692,In vivo,1969.0,Intermediate,A,
,13543,Rattus norvegicus,1,,N,50597,,Bioavailability as maximal plasma concentration in rats,,,BAO_0000218,,10819,Plasma,1,10116.0,CHEMBL626693,In vivo,1969.0,Intermediate,A,
,13543,Rattus norvegicus,1,,U,22224,,Bioavailability as maximal plasma concentration in rats,,,BAO_0000218,,10820,Plasma,0,10116.0,CHEMBL626694,In vivo,1969.0,Autocuration,A,
,14600,Canis lupus familiaris,1,,N,50588,,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,,BAO_0000218,,10821,Blood,1,9615.0,CHEMBL626695,In vivo,178.0,Intermediate,A,
,14600,Canis lupus familiaris,1,,N,50588,,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,,BAO_0000218,,10822,Blood,1,9615.0,CHEMBL626696,In vivo,178.0,Intermediate,A,
,14600,Canis lupus familiaris,1,,N,50588,,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,,BAO_0000218,,10823,Blood,1,9615.0,CHEMBL626697,In vivo,178.0,Intermediate,A,
,14600,Canis lupus familiaris,1,,N,50588,,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,,,BAO_0000218,,10824,Blood,1,9615.0,CHEMBL626859,In vivo,178.0,Intermediate,A,
,14600,Canis lupus familiaris,1,,N,50588,,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,,BAO_0000218,,10825,Blood,1,9615.0,CHEMBL626860,In vivo,178.0,Intermediate,A,
,14600,Canis lupus familiaris,1,,N,50588,,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,,BAO_0000218,,10826,Blood,1,9615.0,CHEMBL626861,In vivo,178.0,Intermediate,A,
,14681,Rattus norvegicus,1,,N,50597,,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,,BAO_0000218,,10827,,1,10116.0,CHEMBL626296,In vivo,,Intermediate,A,
,15905,,1,,U,22224,,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,,,BAO_0000218,,10828,,0,,CHEMBL626297,In vivo,,Autocuration,A,
,15905,,1,,U,22224,,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,,,BAO_0000218,,10829,Plasma,0,,CHEMBL626298,In vivo,1969.0,Autocuration,A,
,13304,Rattus norvegicus,1,,N,50597,,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",,,BAO_0000218,,10830,Plasma,1,10116.0,CHEMBL626299,In vivo,1969.0,Intermediate,A,
,15137,Rattus norvegicus,1,,N,50597,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,,,BAO_0000218,,10831,Plasma,1,10116.0,CHEMBL626300,In vivo,1969.0,Intermediate,A,
,15137,Rattus norvegicus,1,,N,50597,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,,,BAO_0000218,,10832,Plasma,1,10116.0,CHEMBL626301,In vivo,1969.0,Intermediate,A,
,15137,Rattus norvegicus,1,,N,50597,,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,,,BAO_0000218,,10833,Plasma,1,10116.0,CHEMBL626962,In vivo,1969.0,Intermediate,A,
,15137,Rattus norvegicus,1,,N,50597,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,,,BAO_0000218,,10834,Plasma,1,10116.0,CHEMBL626963,In vivo,1969.0,Intermediate,A,
,15137,Rattus norvegicus,1,,N,50597,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,,,BAO_0000218,,10835,Plasma,1,10116.0,CHEMBL626964,In vivo,1969.0,Intermediate,A,
,14839,Macaca fascicularis,1,,N,100710,,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,,,BAO_0000218,,10836,Plasma,1,9541.0,CHEMBL626965,In vivo,1969.0,Intermediate,A,
,14839,Mus musculus,1,,N,50594,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,,BAO_0000218,,10837,Plasma,1,10090.0,CHEMBL626966,In vivo,1969.0,Intermediate,A,
,14839,Mus musculus,1,,N,50594,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,,BAO_0000218,,10838,Plasma,1,10090.0,CHEMBL626967,In vivo,1969.0,Intermediate,A,
,14839,Macaca fascicularis,1,,N,100710,,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,,,BAO_0000218,,10839,Plasma,1,9541.0,CHEMBL626968,In vivo,1969.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,,,BAO_0000218,,10840,Heart,1,10116.0,CHEMBL626969,,948.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,,,BAO_0000218,,10841,Heart,1,10116.0,CHEMBL627126,,948.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,,,BAO_0000218,,10842,Heart,1,10116.0,CHEMBL631276,,948.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,,,BAO_0000218,,10843,Heart,1,10116.0,CHEMBL631277,,948.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,,,BAO_0000218,,10844,Heart,1,10116.0,CHEMBL631278,,948.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,,,BAO_0000218,,10845,Heart,1,10116.0,CHEMBL874457,,948.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,,,BAO_0000218,,10846,Heart,1,10116.0,CHEMBL631279,,948.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,,,BAO_0000218,,10847,Heart,1,10116.0,CHEMBL631280,,948.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,,,BAO_0000218,,10848,Heart,1,10116.0,CHEMBL631281,,948.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,,,BAO_0000218,,10849,Heart,1,10116.0,CHEMBL631968,,948.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,,,BAO_0000218,,10850,Heart,1,10116.0,CHEMBL631969,,948.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,,,BAO_0000218,,10851,Heart,1,10116.0,CHEMBL631970,,948.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,,,BAO_0000218,,10852,Heart,1,10116.0,CHEMBL631971,,948.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,,,BAO_0000218,,10853,Heart,1,10116.0,CHEMBL631972,,948.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,,,BAO_0000218,,10854,Heart,1,10116.0,CHEMBL630435,,948.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,,,BAO_0000218,,10855,Heart,1,10116.0,CHEMBL630436,,948.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,,,BAO_0000218,,10856,Heart,1,10116.0,CHEMBL630437,,948.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,,,BAO_0000218,,10857,Heart,1,10116.0,CHEMBL630438,,948.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,,,BAO_0000218,,10858,Heart,1,10116.0,CHEMBL630439,,948.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,,,BAO_0000218,,10859,Kidney,1,10116.0,CHEMBL630440,,2113.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,,,BAO_0000218,,10860,Kidney,1,10116.0,CHEMBL630441,,2113.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,,,BAO_0000218,,10861,Kidney,1,10116.0,CHEMBL630442,,2113.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,,,BAO_0000218,,10862,Kidney,1,10116.0,CHEMBL625234,,2113.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,,,BAO_0000218,,10863,Kidney,1,10116.0,CHEMBL625235,,2113.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,,,BAO_0000218,,10864,Kidney,1,10116.0,CHEMBL625236,,2113.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,,,BAO_0000218,,10865,Kidney,1,10116.0,CHEMBL625237,,2113.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,,,BAO_0000218,,10866,Kidney,1,10116.0,CHEMBL626125,,2113.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,,,BAO_0000218,,10867,Kidney,1,10116.0,CHEMBL626126,,2113.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,,,BAO_0000218,,10868,Kidney,1,10116.0,CHEMBL626127,,2113.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,,,BAO_0000218,,10869,Kidney,1,10116.0,CHEMBL626128,,2113.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,,,BAO_0000218,,10870,Kidney,1,10116.0,CHEMBL626129,,2113.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,,,BAO_0000218,,10871,Kidney,1,10116.0,CHEMBL626130,,2113.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,,,BAO_0000218,,10872,Kidney,1,10116.0,CHEMBL626131,,2113.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,,,BAO_0000218,,10873,Kidney,1,10116.0,CHEMBL626132,,2113.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,,,BAO_0000218,,10874,Kidney,1,10116.0,CHEMBL626752,,2113.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,,,BAO_0000218,,10875,Kidney,1,10116.0,CHEMBL626753,,2113.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,,,BAO_0000218,,10876,Kidney,1,10116.0,CHEMBL626754,,2113.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,,,BAO_0000218,,10877,Kidney,1,10116.0,CHEMBL626755,,2113.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,,,BAO_0000218,,10878,Liver,1,10116.0,CHEMBL626756,,2107.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,,,BAO_0000218,,10879,Liver,1,10116.0,CHEMBL626757,,2107.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,,,BAO_0000218,,10880,Liver,1,10116.0,CHEMBL626758,,2107.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,,,BAO_0000218,,10881,Liver,1,10116.0,CHEMBL626759,,2107.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,,,BAO_0000218,,10882,Liver,1,10116.0,CHEMBL626760,,2107.0,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,,10883,,1,9615.0,CHEMBL626394,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,,,BAO_0000218,,10884,,1,9615.0,CHEMBL626395,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),,,BAO_0000218,,10885,,1,9615.0,CHEMBL626396,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,,BAO_0000218,,10886,,1,9615.0,CHEMBL626397,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,,BAO_0000218,,10887,,1,9615.0,CHEMBL626398,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,,10888,,1,9615.0,CHEMBL626399,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,,,BAO_0000218,,10889,,1,10116.0,CHEMBL874653,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,,10890,,1,10116.0,CHEMBL626400,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,,BAO_0000218,,10891,,1,10116.0,CHEMBL626401,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,,BAO_0000218,,10892,,1,10116.0,CHEMBL626402,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,,BAO_0000218,,10893,,1,10116.0,CHEMBL626403,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,,10894,,1,10116.0,CHEMBL626404,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,,,BAO_0000218,,10895,,1,10116.0,CHEMBL626405,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,,10896,,1,10116.0,CHEMBL625529,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,,BAO_0000218,,10897,,1,10116.0,CHEMBL625530,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,,BAO_0000218,,10898,,1,10116.0,CHEMBL625531,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,,BAO_0000218,,10899,,1,10116.0,CHEMBL625532,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,,10900,,1,10116.0,CHEMBL625533,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,,,BAO_0000218,,10901,,1,10116.0,CHEMBL875474,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,,10902,,1,10116.0,CHEMBL625534,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,,BAO_0000218,,10903,,1,10116.0,CHEMBL625535,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,,BAO_0000218,,10904,,1,10116.0,CHEMBL625536,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,,BAO_0000218,,10905,,1,10116.0,CHEMBL625537,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,,10906,,1,10116.0,CHEMBL625538,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,,,BAO_0000218,,10907,,1,10116.0,CHEMBL625539,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,,10908,,1,10116.0,CHEMBL625540,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,,BAO_0000218,,10909,,1,10116.0,CHEMBL625541,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,,BAO_0000218,,10910,,1,10116.0,CHEMBL625542,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,,BAO_0000218,,10911,,1,10116.0,CHEMBL625543,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,,10912,,1,10116.0,CHEMBL625544,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,,,BAO_0000218,,10913,,1,9615.0,CHEMBL625545,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,,BAO_0000218,,10914,,1,9615.0,CHEMBL625546,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,,,BAO_0000218,,10915,,1,9615.0,CHEMBL625547,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,,10916,,1,9615.0,CHEMBL625548,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,,10917,,1,9615.0,CHEMBL625549,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,,BAO_0000218,,10918,,1,9615.0,CHEMBL625550,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,,10919,,1,9615.0,CHEMBL625551,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,,10920,,1,9615.0,CHEMBL875475,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,,10921,,1,9615.0,CHEMBL625552,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,,BAO_0000218,,10922,,1,9615.0,CHEMBL625553,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,,BAO_0000218,,10923,,1,9615.0,CHEMBL625554,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,,BAO_0000218,,10924,,1,9615.0,CHEMBL625555,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,,10925,,1,9615.0,CHEMBL625556,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,,,BAO_0000218,,10926,,1,9615.0,CHEMBL624986,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,,BAO_0000218,,10927,,1,9615.0,CHEMBL624987,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,,BAO_0000218,,10928,,1,9615.0,CHEMBL624988,,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,,,BAO_0000218,,10929,Artery,1,9615.0,CHEMBL624989,In vivo,1637.0,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,,,BAO_0000218,,10930,Artery,1,9615.0,CHEMBL624990,In vivo,1637.0,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,,,BAO_0000218,,10931,Artery,1,9615.0,CHEMBL874391,In vivo,1637.0,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,,,BAO_0000218,,10932,Artery,1,9615.0,CHEMBL624991,In vivo,1637.0,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,,,BAO_0000218,,10933,Artery,1,9615.0,CHEMBL624992,In vivo,1637.0,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,,,BAO_0000218,,10934,Artery,1,9615.0,CHEMBL624993,In vivo,1637.0,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,,,BAO_0000218,,10935,Artery,1,9615.0,CHEMBL624994,In vivo,1637.0,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,,,BAO_0000218,,10936,Artery,1,9615.0,CHEMBL624995,In vivo,1637.0,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,,,BAO_0000218,,10937,Artery,1,9615.0,CHEMBL624996,In vivo,1637.0,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,,,BAO_0000218,,10938,Artery,1,9615.0,CHEMBL624997,In vivo,1637.0,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,,,BAO_0000218,,10939,Artery,1,9615.0,CHEMBL624998,In vivo,1637.0,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,,,BAO_0000218,,10940,Artery,1,9615.0,CHEMBL624999,In vivo,1637.0,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,,,BAO_0000218,,10941,Artery,1,9615.0,CHEMBL882955,In vivo,1637.0,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,,,BAO_0000218,,10942,Artery,1,9615.0,CHEMBL625000,In vivo,1637.0,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,,,BAO_0000218,,10943,Artery,1,9615.0,CHEMBL625001,In vivo,1637.0,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,,,BAO_0000218,,10944,Artery,1,9615.0,CHEMBL625089,In vivo,1637.0,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,,,BAO_0000218,,10945,Artery,1,9615.0,CHEMBL625090,In vivo,1637.0,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,,,BAO_0000218,,10946,Artery,1,9615.0,CHEMBL625091,In vivo,1637.0,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,,,BAO_0000218,,10947,Artery,1,9615.0,CHEMBL625092,In vivo,1637.0,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,,,BAO_0000218,,10948,Artery,1,9615.0,CHEMBL625093,In vivo,1637.0,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,,,BAO_0000218,,10949,Artery,1,9615.0,CHEMBL625094,In vivo,1637.0,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,,,BAO_0000218,,10950,Artery,1,9615.0,CHEMBL625095,In vivo,1637.0,Intermediate,A,
,2249,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for its bioavailability in the dogs,,,BAO_0000218,,10951,,1,9615.0,CHEMBL625096,In vivo,,Intermediate,A,
,2249,Rattus norvegicus,1,,N,50597,,Compound was evaluated for its bioavailability in the rats,,,BAO_0000218,,10952,,1,10116.0,CHEMBL625097,In vivo,,Intermediate,A,
,17515,,1,,U,22224,,Compound was evaluated for oral bioavailability,,,BAO_0000218,,10953,,0,,CHEMBL882956,In vivo,,Autocuration,A,
,14541,Rattus norvegicus,1,,N,50597,,Compound was evaluated for percentage of Oral bioavailability in rats,,,BAO_0000218,,10954,,1,10116.0,CHEMBL625098,In vivo,,Intermediate,A,
,12797,Cavia porcellus,1,,U,22224,,Bioavailability in guinea pig,,,BAO_0000218,,10955,,0,10141.0,CHEMBL625099,In vivo,,Autocuration,A,
,12797,Rattus norvegicus,1,,N,50597,,Compound was evaluated for the oral bioavailability in rat,,,BAO_0000218,,10956,,1,10116.0,CHEMBL625100,In vivo,,Intermediate,A,
,12797,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for the oral bioavailability in dog,,,BAO_0000218,,10957,,1,9615.0,CHEMBL625101,In vivo,,Intermediate,A,
,12797,Rattus norvegicus,1,,N,50597,,Compound was evaluated for the oral bioavailability in rat,,,BAO_0000218,,10958,,1,10116.0,CHEMBL874396,In vivo,,Intermediate,A,
,11727,Canis lupus familiaris,1,,U,22224,,Bioavailability in dog (dosed i.v.),,,BAO_0000218,,10959,,0,9615.0,CHEMBL625102,In vivo,,Autocuration,F,
,13249,Canis lupus familiaris,1,,N,50588,,Compound was tested for in vivo bioavailability in dog,,,BAO_0000218,,10960,,1,9615.0,CHEMBL625103,In vivo,,Intermediate,A,
,13249,Cricetinae,1,,N,100712,,Compound was tested for in vivo bioavailability in hamsters,,,BAO_0000218,,10961,,1,10026.0,CHEMBL625104,In vivo,,Intermediate,A,
,13249,Simiiformes,1,,U,22224,,Compound was tested for in vivo bioavailability in monkey,,,BAO_0000218,,10962,,0,314293.0,CHEMBL625105,In vivo,,Autocuration,A,
,13249,Rattus norvegicus,1,,N,50597,,Compound was tested for in vivo bioavailability in rat,,,BAO_0000218,,10963,,1,10116.0,CHEMBL625106,In vivo,,Intermediate,A,
,9552,Mus musculus,1,,U,22224,,Oral bioavailability in mouse,,,BAO_0000218,,10964,,0,10090.0,CHEMBL625107,In vivo,,Autocuration,A,
,9552,Mus musculus,1,,N,50594,,Compound was tested for percent of oral bioavailability in mice; 56-74,,,BAO_0000218,,10965,,1,10090.0,CHEMBL625108,In vivo,,Intermediate,A,
,14839,Mus musculus,1,,U,22224,,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),,,BAO_0000218,,10966,,0,10090.0,CHEMBL625109,In vivo,,Autocuration,A,
,14839,Macaca fascicularis,1,,U,22224,,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),,,BAO_0000218,,10967,,0,9541.0,CHEMBL625110,In vivo,,Autocuration,A,
,14839,Macaca fascicularis,1,,U,22224,,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),,,BAO_0000218,,10968,,0,9541.0,CHEMBL625111,In vivo,,Autocuration,A,
,14839,Mus musculus,1,,N,50594,,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),,,BAO_0000218,,10969,,1,10090.0,CHEMBL625112,In vivo,,Intermediate,A,
,14839,Mus musculus,1,,N,50594,,Oral bioavailability in nude mice,,,BAO_0000218,,10970,,1,10090.0,CHEMBL875334,In vivo,,Intermediate,A,
,11219,Primates,1,,U,22224,,Bioavailability in monkey (i.d. dosing),,,BAO_0000218,,10971,,0,9443.0,CHEMBL628617,In vivo,,Autocuration,A,
,9552,Rattus norvegicus,1,,U,22224,,Bioavailability in rat,,,BAO_0000218,,10972,,0,10116.0,CHEMBL628618,In vivo,,Autocuration,A,
,11732,,1,,U,22224,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,,,BAO_0000218,,10973,,0,,CHEMBL628619,In vivo,,Autocuration,A,
,11732,,1,,U,22224,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,,,BAO_0000218,,10974,,0,,CHEMBL628620,In vivo,,Autocuration,A,
,14839,Macaca fascicularis,1,,N,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,,BAO_0000218,,10975,,1,9541.0,CHEMBL628621,In vivo,,Intermediate,A,
,14839,Macaca fascicularis,1,,N,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,,BAO_0000218,,10976,,1,9541.0,CHEMBL628622,In vivo,,Intermediate,A,
,14839,Macaca fascicularis,1,,N,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,,BAO_0000218,,10977,,1,9541.0,CHEMBL628623,In vivo,,Intermediate,A,
,14839,Macaca fascicularis,1,,N,100710,,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,,,BAO_0000218,,10978,Plasma,1,9541.0,CHEMBL628624,In vivo,1969.0,Intermediate,A,
,14839,Mus musculus,1,,N,50594,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,,BAO_0000218,,10979,Plasma,1,10090.0,CHEMBL628625,In vivo,1969.0,Intermediate,A,
,14839,Macaca fascicularis,1,,N,100710,,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,,,BAO_0000218,,10980,Plasma,1,9541.0,CHEMBL628626,In vivo,1969.0,Intermediate,A,
,14839,Mus musculus,1,,N,50594,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,,BAO_0000218,,10981,Plasma,1,10090.0,CHEMBL627041,In vivo,1969.0,Intermediate,A,
,14839,Mus musculus,1,,N,50594,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,,BAO_0000218,,10982,Plasma,1,10090.0,CHEMBL627042,In vivo,1969.0,Intermediate,A,
,14839,Mus musculus,1,,N,50594,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,,BAO_0000218,,10983,Plasma,1,10090.0,CHEMBL627043,In vivo,1969.0,Intermediate,A,
,13932,,1,,U,22224,,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,,,BAO_0000218,,10984,Plasma,0,,CHEMBL627044,In vivo,1969.0,Autocuration,A,
,11637,Mus musculus,1,,N,50594,,Cmax in mouse plasma,,,BAO_0000218,,10985,Plasma,1,10090.0,CHEMBL627045,In vivo,1969.0,Intermediate,A,
,11637,,1,,U,22224,,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,,,BAO_0000218,,10986,Plasma,0,,CHEMBL627046,In vivo,1969.0,Autocuration,A,
,13960,Rattus norvegicus,1,,N,50597,,Maximal plasma concentration in rat,,,BAO_0000218,,10987,Plasma,1,10116.0,CHEMBL627047,In vivo,1969.0,Intermediate,A,
,15905,Rattus norvegicus,1,,N,50597,,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,,,BAO_0000218,,10988,Plasma,1,10116.0,CHEMBL627048,In vivo,1969.0,Intermediate,A,
,14062,Rattus norvegicus,1,,N,50597,,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,,,BAO_0000218,,10989,,1,10116.0,CHEMBL627049,In vivo,,Intermediate,A,
,14062,Rattus norvegicus,1,,N,50597,,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,,,BAO_0000218,,10990,,1,10116.0,CHEMBL627050,In vivo,,Intermediate,A,
,14062,Rattus norvegicus,1,,N,50597,,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,,,BAO_0000218,,10991,,1,10116.0,CHEMBL627051,In vivo,,Intermediate,A,
,14062,Rattus norvegicus,1,,N,50597,,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,,,BAO_0000218,,10992,,1,10116.0,CHEMBL627052,In vivo,,Intermediate,A,
,14062,Rattus norvegicus,1,,N,50597,,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,,,BAO_0000218,,10993,,1,10116.0,CHEMBL627053,In vivo,,Intermediate,A,
,14062,Rattus norvegicus,1,,N,50597,,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,,,BAO_0000218,,10994,,1,10116.0,CHEMBL627054,In vivo,,Intermediate,A,
,15011,Mus musculus,1,,N,50594,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,,BAO_0000218,,10995,,1,10090.0,CHEMBL627055,In vivo,,Intermediate,A,
,15011,Mus musculus,1,,N,50594,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,,BAO_0000218,,10996,,1,10090.0,CHEMBL627056,In vivo,,Intermediate,A,
,15011,Mus musculus,1,,N,50594,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,,BAO_0000218,,10997,,1,10090.0,CHEMBL627057,In vivo,,Intermediate,A,
,15011,Mus musculus,1,,N,50594,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,,BAO_0000218,,10998,,1,10090.0,CHEMBL627058,In vivo,,Intermediate,A,
,15011,Mus musculus,1,,N,50594,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,,BAO_0000218,,10999,,1,10090.0,CHEMBL626211,In vivo,,Intermediate,A,
,10291,,1,,U,22224,,Maximum Concentration of the compound.,,,BAO_0000218,,11000,,0,,CHEMBL626212,In vivo,,Autocuration,A,
,14599,Canis lupus familiaris,1,,N,50588,,Maximum Concentration was measured after iv administration into Beagle dog,,,BAO_0000218,,11001,,1,9615.0,CHEMBL626213,In vivo,,Intermediate,A,
,14599,Canis lupus familiaris,1,,N,50588,,Maximum Concentration was measured after iv administration into Beagle dog.,,,BAO_0000218,,11002,,1,9615.0,CHEMBL626214,In vivo,,Intermediate,A,
,14599,Canis lupus familiaris,1,,N,50588,,Maximum Concentration was measured after po administration into Beagle dog,,,BAO_0000218,,11003,,1,9615.0,CHEMBL626215,In vivo,,Intermediate,A,
,14599,Canis lupus familiaris,1,,N,50588,,Maximum Concentration was measured after po administration into Beagle dog.,,,BAO_0000218,,11004,,1,9615.0,CHEMBL626216,In vivo,,Intermediate,A,
,12767,,1,,U,22224,,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,,,BAO_0000218,,11005,Blood,0,,CHEMBL626217,In vivo,178.0,Autocuration,A,
,12767,,1,,U,22224,,Maximum blood level reached after an iv dose of 12.2 uM/kg,,,BAO_0000218,,11006,Blood,0,,CHEMBL626218,In vivo,178.0,Autocuration,A,
,12767,,1,,U,22224,,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,,,BAO_0000218,,11007,Blood,0,,CHEMBL626219,In vivo,178.0,Autocuration,A,
,12767,,1,,U,22224,,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,,,BAO_0000218,,11008,Blood,0,,CHEMBL626220,In vivo,178.0,Autocuration,A,
,12767,,1,,U,22224,,Maximum blood level reached after an oral dose of 5.0 mg/kg,,,BAO_0000218,,11009,Blood,0,,CHEMBL626221,In vivo,178.0,Autocuration,A,
,12767,,1,,U,22224,,Maximum blood level reached at dose of 10.6 uM/kg orally,,,BAO_0000218,,11010,Blood,0,,CHEMBL626222,In vivo,178.0,Autocuration,A,
,14706,Cavia porcellus,1,,N,50512,,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,,,BAO_0000218,,11011,,1,10141.0,CHEMBL626223,In vivo,,Intermediate,A,
,14706,Cavia porcellus,1,,N,50512,,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,,,BAO_0000218,,11012,,1,10141.0,CHEMBL626224,In vivo,,Intermediate,A,
,14793,Rattus norvegicus,1,,N,50597,,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,,,BAO_0000218,,11013,Brain,1,10116.0,CHEMBL626225,In vivo,955.0,Intermediate,A,
,14793,Rattus norvegicus,1,,N,50597,,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,,,BAO_0000218,,11014,Brain,1,10116.0,CHEMBL626226,In vivo,955.0,Intermediate,A,
,14793,Rattus norvegicus,1,,N,50597,,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,,,BAO_0000218,,11015,Brain,1,10116.0,CHEMBL626227,In vivo,955.0,Intermediate,A,
,14793,Rattus norvegicus,1,,N,50597,,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,,,BAO_0000218,,11016,Brain,1,10116.0,CHEMBL626228,In vivo,955.0,Intermediate,A,
,14793,Rattus norvegicus,1,,N,50597,,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,,BAO_0000218,,11017,,1,10116.0,CHEMBL626229,In vivo,,Intermediate,A,
,14793,Rattus norvegicus,1,,N,50597,,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,,,BAO_0000218,,11018,,1,10116.0,CHEMBL626921,In vivo,,Intermediate,A,
,14793,Rattus norvegicus,1,,N,50597,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,,,BAO_0000218,,11019,,1,10116.0,CHEMBL876793,In vivo,,Intermediate,A,
,14793,Rattus norvegicus,1,,N,50597,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,,,BAO_0000218,,11020,,1,10116.0,CHEMBL625309,In vivo,,Intermediate,A,
,10524,Bacillus subtilis,1,,N,50278,,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,,BAO_0000218,,11021,,1,1423.0,CHEMBL625310,In vivo,,Intermediate,A,
,11871,Simiiformes,1,,U,22224,,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,,,BAO_0000218,,11022,,0,314293.0,CHEMBL625311,In vivo,,Autocuration,A,
,11871,Rattus norvegicus,1,,N,50597,,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,,,BAO_0000218,,11023,,1,10116.0,CHEMBL625312,In vivo,,Intermediate,A,
,3437,,1,,U,22224,,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,,,BAO_0000218,,11024,,0,,CHEMBL625313,In vivo,,Autocuration,A,
,12038,Mus musculus,1,,N,50594,,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,,,BAO_0000218,,11025,,1,10090.0,CHEMBL625314,In vivo,,Intermediate,A,
,12038,Rattus norvegicus,1,,N,50597,,Maximum concentration in male rats after iv administration of 20 mg/kg,,,BAO_0000218,,11026,,1,10116.0,CHEMBL625315,In vivo,,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,,,BAO_0000218,,11027,Liver,1,10116.0,CHEMBL625316,,2107.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,,,BAO_0000218,,11028,Liver,1,10116.0,CHEMBL625317,,2107.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,,,BAO_0000218,,11029,Liver,1,10116.0,CHEMBL625318,,2107.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,,,BAO_0000218,,11030,Liver,1,10116.0,CHEMBL625319,,2107.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,,,BAO_0000218,,11031,Liver,1,10116.0,CHEMBL625320,,2107.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,,,BAO_0000218,,11032,Liver,1,10116.0,CHEMBL625321,,2107.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,,,BAO_0000218,,11033,Liver,1,10116.0,CHEMBL625322,,2107.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,,,BAO_0000218,,11034,Liver,1,10116.0,CHEMBL876801,,2107.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,,,BAO_0000218,,11035,Liver,1,10116.0,CHEMBL625323,,2107.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,,,BAO_0000218,,11036,Liver,1,10116.0,CHEMBL625324,,2107.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,,,BAO_0000218,,11037,Liver,1,10116.0,CHEMBL625325,,2107.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,,,BAO_0000218,,11038,Liver,1,10116.0,CHEMBL625326,,2107.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,,,BAO_0000218,,11039,Liver,1,10116.0,CHEMBL625327,,2107.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,,,BAO_0000218,,11040,Liver,1,10116.0,CHEMBL625328,,2107.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,,,BAO_0000218,,11041,Lung,1,10116.0,CHEMBL625329,,2048.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,,,BAO_0000218,,11042,Lung,1,10116.0,CHEMBL625330,,2048.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,,,BAO_0000218,,11043,Lung,1,10116.0,CHEMBL627774,,2048.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,,,BAO_0000218,,11044,Lung,1,10116.0,CHEMBL627775,,2048.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,,,BAO_0000218,,11045,Lung,1,10116.0,CHEMBL627949,,2048.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,,,BAO_0000218,,11046,Lung,1,10116.0,CHEMBL627950,,2048.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,,,BAO_0000218,,11047,Lung,1,10116.0,CHEMBL627951,,2048.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,,,BAO_0000218,,11048,Lung,1,10116.0,CHEMBL627952,,2048.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,,,BAO_0000218,,11049,Lung,1,10116.0,CHEMBL627953,,2048.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,,,BAO_0000218,,11050,Lung,1,10116.0,CHEMBL627954,,2048.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,,,BAO_0000218,,11051,Lung,1,10116.0,CHEMBL627955,,2048.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,,,BAO_0000218,,11052,Lung,1,10116.0,CHEMBL627956,,2048.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,,,BAO_0000218,,11053,Lung,1,10116.0,CHEMBL876802,,2048.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,,,BAO_0000218,,11054,Lung,1,10116.0,CHEMBL627957,,2048.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,,,BAO_0000218,,11055,Lung,1,10116.0,CHEMBL627958,,2048.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,,,BAO_0000218,,11056,Lung,1,10116.0,CHEMBL627959,,2048.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,,,BAO_0000218,,11057,Lung,1,10116.0,CHEMBL627960,,2048.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,,,BAO_0000218,,11058,Lung,1,10116.0,CHEMBL627961,,2048.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,,,BAO_0000218,,11059,Lung,1,10116.0,CHEMBL627962,,2048.0,Intermediate,A,
,9796,Rattus norvegicus,1,,N,50597,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,,BAO_0000218,,11060,,1,10116.0,CHEMBL627963,,,Intermediate,A,
,9796,Rattus norvegicus,1,,N,50597,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,,11061,,1,10116.0,CHEMBL624759,,,Intermediate,A,
,9796,Rattus norvegicus,1,,N,50597,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,,11062,,1,10116.0,CHEMBL624760,,,Intermediate,A,
,9796,Rattus norvegicus,1,,N,50597,,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,,11063,,1,10116.0,CHEMBL624761,,,Intermediate,A,
,9796,Rattus norvegicus,1,,N,50597,,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,,11064,,1,10116.0,CHEMBL877607,,,Intermediate,A,
,9796,Rattus norvegicus,1,,N,50597,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,,BAO_0000218,,11065,Liver,1,10116.0,CHEMBL624762,,2107.0,Intermediate,A,
,9796,Rattus norvegicus,1,,N,50597,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,,11066,Liver,1,10116.0,CHEMBL624763,,2107.0,Intermediate,A,
,9796,Rattus norvegicus,1,,N,50597,,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,,11067,Liver,1,10116.0,CHEMBL624764,,2107.0,Intermediate,A,
,9796,Rattus norvegicus,1,,N,50597,,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,,11068,Liver,1,10116.0,CHEMBL624765,,2107.0,Intermediate,A,
,9796,Rattus norvegicus,1,,N,50597,,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,,11069,Liver,1,10116.0,CHEMBL624766,,2107.0,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,,11070,,1,9615.0,CHEMBL624767,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,,,BAO_0000218,,11071,,1,9615.0,CHEMBL624768,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,,BAO_0000218,,11072,,1,9615.0,CHEMBL624769,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,,BAO_0000218,,11073,,1,9615.0,CHEMBL624770,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,,BAO_0000218,,11074,,1,9615.0,CHEMBL624771,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,,11075,,1,9615.0,CHEMBL624772,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,,,BAO_0000218,,11076,,1,10116.0,CHEMBL624773,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,,11077,,1,10116.0,CHEMBL624774,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,,BAO_0000218,,11078,,1,10116.0,CHEMBL624775,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,,BAO_0000218,,11079,,1,10116.0,CHEMBL624776,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,,BAO_0000218,,11080,,1,10116.0,CHEMBL624777,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,,11081,,1,10116.0,CHEMBL624778,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,,,BAO_0000218,,11082,,1,10116.0,CHEMBL624779,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,,BAO_0000218,,11083,,1,10116.0,CHEMBL624780,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,,BAO_0000218,,11084,,1,10116.0,CHEMBL624781,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,,11085,,1,10116.0,CHEMBL877608,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,,BAO_0000218,,11086,,1,10116.0,CHEMBL624782,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,,11087,,1,10116.0,CHEMBL624783,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,,,BAO_0000218,,11088,,1,10116.0,CHEMBL624784,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,,11089,,1,10116.0,CHEMBL624785,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,,BAO_0000218,,11090,,1,10116.0,CHEMBL624786,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,,BAO_0000218,,11091,,1,10116.0,CHEMBL624787,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,,11092,,1,10116.0,CHEMBL628676,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,,,BAO_0000218,,11093,,1,10116.0,CHEMBL621842,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,,11094,,1,10116.0,CHEMBL621843,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,,BAO_0000218,,11095,,1,10116.0,CHEMBL623873,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,,BAO_0000218,,11096,,1,10116.0,CHEMBL623874,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,,BAO_0000218,,11097,,1,10116.0,CHEMBL623875,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,,11098,,1,10116.0,CHEMBL623876,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,,,BAO_0000218,,11099,,1,9615.0,CHEMBL623877,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,,BAO_0000218,,11100,,1,9615.0,CHEMBL623878,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,,,BAO_0000218,,11101,,1,9615.0,CHEMBL623879,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,,11102,,1,9615.0,CHEMBL623880,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,,11103,,1,9615.0,CHEMBL623881,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,,BAO_0000218,,11104,,1,9615.0,CHEMBL623957,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,,11105,,1,9615.0,CHEMBL623958,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,,11106,,1,9615.0,CHEMBL623959,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,,11107,,1,9615.0,CHEMBL623960,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,,BAO_0000218,,11108,,1,9615.0,CHEMBL623961,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,,BAO_0000218,,11109,,1,9615.0,CHEMBL623962,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,,BAO_0000218,,11110,,1,9615.0,CHEMBL624676,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,,11111,,1,9615.0,CHEMBL624677,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,,,BAO_0000218,,11112,,1,9615.0,CHEMBL624678,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,,BAO_0000218,,11113,,1,9615.0,CHEMBL624679,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,,BAO_0000218,,11114,,1,9615.0,CHEMBL624680,,,Intermediate,A,
,11732,,1,,U,22224,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,,,BAO_0000218,,11115,,0,,CHEMBL624849,In vivo,,Autocuration,A,
,11732,,1,,U,22224,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,,,BAO_0000218,,11116,,0,,CHEMBL624850,In vivo,,Autocuration,A,
,11732,,1,,U,22224,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,,,BAO_0000218,,11117,,0,,CHEMBL874399,In vivo,,Autocuration,A,
,11732,,1,,U,22224,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,,,BAO_0000218,,11118,,0,,CHEMBL624851,In vivo,,Autocuration,A,
,11732,,1,,U,22224,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,,,BAO_0000218,,11119,,0,,CHEMBL624852,In vivo,,Autocuration,A,
,13359,Rattus norvegicus,1,,U,22224,,Oral bioavailability in rat (dose 10 mg/kg),,,BAO_0000218,,11120,,0,10116.0,CHEMBL624853,In vivo,,Autocuration,A,
,16618,Rattus norvegicus,1,,U,22224,,Oral bioavailability in rat (Sprague-Dawley),,,BAO_0000218,,11121,,0,10116.0,CHEMBL624854,In vivo,,Autocuration,A,
,13960,Rattus norvegicus,1,,U,22224,,Oral bioavailability in rat,,,BAO_0000218,,11122,,0,10116.0,CHEMBL624855,In vivo,,Autocuration,A,
,13917,Rattus norvegicus,1,,U,22224,,Oral bioavailability in rats was determined in vivo,,,BAO_0000218,,11123,,0,10116.0,CHEMBL624856,In vivo,,Autocuration,A,
,14266,Canis lupus familiaris,1,,U,22224,,Oral bioavailability in dog,,,BAO_0000218,,11124,,0,9615.0,CHEMBL882957,In vivo,,Autocuration,A,
,12359,Simiiformes,1,,U,22224,,Oral bioavailability of compound in monkey,,,BAO_0000218,,11125,,0,314293.0,CHEMBL624857,In vivo,,Autocuration,A,
,12359,Rattus norvegicus,1,,N,50597,,Oral bioavailability of compound in rat,,,BAO_0000218,,11126,,1,10116.0,CHEMBL622202,In vivo,,Intermediate,A,
,12359,Rattus norvegicus,1,,U,22224,,Bioavailability in rat of PMEA prodrug,,,BAO_0000218,,11127,,0,10116.0,CHEMBL622203,In vivo,,Autocuration,A,
,12359,Rattus norvegicus,1,,N,50597,,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,,,BAO_0000218,,11128,,1,10116.0,CHEMBL625522,In vivo,,Intermediate,A,
,10791,Macaca mulatta,1,,U,22224,,Serum conc at 3 hours following 25 mg/kg dose,,,BAO_0000218,,11129,,0,9544.0,CHEMBL622868,In vivo,,Autocuration,A,
,10791,Macaca mulatta,1,,U,22224,,Urine conc 0-5 hours following 25 mg/kg dose,,,BAO_0000218,,11130,Urine,0,9544.0,CHEMBL622869,In vivo,1088.0,Autocuration,A,
,10791,Macaca mulatta,1,,U,22224,,Urine conc 0-24 hours following 25 mg/kg dose,,,BAO_0000218,,11131,Urine,0,9544.0,CHEMBL622870,In vivo,1088.0,Autocuration,A,
,138,Chlorocebus aethiops,1,,U,22224,,Oral bioavailability in African green monkeys; 20-25,,,BAO_0000218,,11132,,0,9534.0,CHEMBL622871,In vivo,,Autocuration,A,
,14521,Macaca fascicularis,1,,N,100710,,Oral bioavailability in cynomolgus monkey.,,,BAO_0000218,,11133,,1,9541.0,CHEMBL620560,In vivo,,Intermediate,A,
,13953,Canis lupus familiaris,1,,U,22224,,Oral bioavailability in dog,,,BAO_0000218,,11134,,0,9615.0,CHEMBL620561,In vivo,,Autocuration,A,
,12836,Canis lupus familiaris,1,,N,50588,,Oral bioavailability in dog at 10 mg/kg oral dose,,,BAO_0000218,,11135,,1,9615.0,CHEMBL620562,In vivo,,Intermediate,A,
,12836,Cricetinae,1,,N,100712,,Oral bioavailability in hamster at 10 mg/kg oral dose,,,BAO_0000218,,11136,,1,10026.0,CHEMBL620563,In vivo,,Intermediate,A,
,12836,Rattus norvegicus,1,,N,50597,,Oral bioavailability in rat at 10 mg/kg oral dose,,,BAO_0000218,,11137,,1,10116.0,CHEMBL620564,In vivo,,Intermediate,A,
,14521,Rattus norvegicus,1,,U,22224,,Oral bioavailability in rat,,,BAO_0000218,,11138,,0,10116.0,CHEMBL872265,In vivo,,Autocuration,A,
,13953,Rattus norvegicus,1,,U,22224,,Oral bioavailability in rat,,,BAO_0000218,,11139,,0,10116.0,CHEMBL620565,In vivo,,Autocuration,A,
,6799,Eutheria,1,,U,22224,,Oral bioavailability,,,BAO_0000218,,11140,,0,9347.0,CHEMBL620566,In vivo,,Autocuration,A,
,11311,,1,,U,22224,,Oral bioavailability was determined; range 49-102%,,,BAO_0000218,,11141,,0,,CHEMBL620567,In vivo,,Autocuration,A,
,4013,Canis lupus familiaris,1,,N,50588,,Oral bioavailability was determined in dogs,,,BAO_0000218,,11142,,1,9615.0,CHEMBL620568,In vivo,,Intermediate,A,
,4013,Rattus norvegicus,1,,U,22224,,Oral bioavailability in rat,,,BAO_0000218,,11143,,0,10116.0,CHEMBL620569,In vivo,,Autocuration,A,
,17591,Eutheria,1,,U,22224,,Oral bioavailability,,,BAO_0000218,,11144,,0,9347.0,CHEMBL620570,In vivo,,Autocuration,A,
,17591,,1,,U,22224,,Oral bioavailability was determined; Not orally available,,,BAO_0000218,,11145,,0,,CHEMBL620571,In vivo,,Autocuration,A,
,15011,Mus musculus,1,,N,50594,,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),,,BAO_0000218,,11146,,1,10090.0,CHEMBL620572,In vivo,,Intermediate,A,
,15011,Mus musculus,1,,U,22224,,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),,,BAO_0000218,,11147,,0,10090.0,CHEMBL620573,In vivo,,Autocuration,A,
,15011,Mus musculus,1,,U,22224,,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,,,BAO_0000218,,11148,,0,10090.0,CHEMBL620574,In vivo,,Autocuration,A,
,9552,Macaca mulatta,1,,U,22224,,Oral bioavailability in Rhesus monkey,,,BAO_0000218,,11149,,0,9544.0,CHEMBL620575,In vivo,,Autocuration,A,
,9552,Canis lupus familiaris,1,,U,22224,,Oral bioavailability in dog (female mongrel),,,BAO_0000218,,11150,,0,9615.0,CHEMBL620576,In vivo,,Autocuration,A,
,3639,,1,,U,22224,,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,,,BAO_0000218,,11151,,0,,CHEMBL875846,In vivo,,Autocuration,A,
,13397,Canis lupus familiaris,1,,U,22224,,Oral bioavailability in dog,,,BAO_0000218,,11152,,0,9615.0,CHEMBL620577,In vivo,,Autocuration,A,
,3031,,1,,U,22224,,Percentage Bioavailability was evaluated.,,,BAO_0000218,,11153,,0,,CHEMBL620578,In vivo,,Autocuration,A,
,12818,Rattus norvegicus,1,,U,22224,,Bioavailability in rat administered i.d.,,,BAO_0000218,,11154,,0,10116.0,CHEMBL620579,In vivo,,Autocuration,A,
,4847,Eutheria,1,,U,22224,,Bioavailability,,,BAO_0000218,,11155,,0,9347.0,CHEMBL621248,In vivo,,Autocuration,A,
,12421,Canis lupus familiaris,1,,U,22224,,Bioavailability in dog (male Beagle) i.v. administration,,,BAO_0000218,,11156,,0,9615.0,CHEMBL625390,In vivo,,Autocuration,A,
,11966,Rattus norvegicus,1,,U,22224,,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",,,BAO_0000218,,11157,,0,10116.0,CHEMBL625391,In vivo,,Autocuration,A,
,11218,Primates,1,,U,22224,,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),,,BAO_0000218,,11158,,0,9443.0,CHEMBL872266,In vivo,,Autocuration,A,
,13129,Rattus norvegicus,1,,U,22224,,Oral bioavailability in rat (Sprague-Dawley) (male),,,BAO_0000218,,11159,,0,10116.0,CHEMBL625392,In vivo,,Autocuration,A,
,12350,Rattus norvegicus,1,,N,50597,,The oral bioavailability was measured on rats after oral administration,,,BAO_0000218,,11160,,1,10116.0,CHEMBL625393,In vivo,,Intermediate,A,
,2231,Rattus norvegicus,1,,N,50597,,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,,BAO_0000218,,11161,,1,10116.0,CHEMBL625394,In vivo,,Intermediate,A,
,2231,Macaca mulatta,1,,N,50797,,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,,BAO_0000218,,11162,,1,9544.0,CHEMBL625395,In vivo,,Intermediate,A,
,12187,Rattus norvegicus,1,,U,22224,,Bioavailability in rat (dose 10 mg/kg i.d.),,,BAO_0000218,,11163,,0,10116.0,CHEMBL625396,In vivo,,Autocuration,A,
,12421,Canis lupus familiaris,1,,U,22224,,Bioavailability in dog (male Beagle) i.v. administration,,,BAO_0000218,,11164,,0,9615.0,CHEMBL625397,In vivo,,Autocuration,A,
,13256,Mus musculus,1,,N,50594,,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,,11165,,1,10090.0,CHEMBL625398,In vivo,,Intermediate,A,
,13256,Mus musculus,1,,N,50594,,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,,11166,Blood,1,10090.0,CHEMBL625399,In vivo,178.0,Intermediate,A,
,13256,Mus musculus,1,,N,50594,,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,,11167,Cerebellum,1,10090.0,CHEMBL626074,In vivo,2037.0,Intermediate,A,
,13256,Mus musculus,1,,N,50594,,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,,11168,,1,10090.0,CHEMBL626075,In vivo,,Intermediate,A,
,2231,Rattus norvegicus,1,,N,50597,,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,,BAO_0000218,,11169,Plasma,1,10116.0,CHEMBL626076,In vivo,1969.0,Intermediate,A,
,2231,Macaca mulatta,1,,N,50797,,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,,BAO_0000218,,11170,Plasma,1,9544.0,CHEMBL626077,In vivo,1969.0,Intermediate,A,
,12178,Rattus norvegicus,1,,N,50597,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),,,BAO_0000218,,11171,Blood,1,10116.0,CHEMBL626078,In vivo,178.0,Intermediate,A,
,12178,,1,,U,22224,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),,,BAO_0000218,,11172,Blood,0,,CHEMBL625846,In vivo,178.0,Autocuration,A,
,12178,,1,,U,22224,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),,,BAO_0000218,,11173,Blood,0,,CHEMBL625847,In vivo,178.0,Autocuration,A,
,15633,Rattus norvegicus,1,,N,50597,,Maximum concentration observed in rats at an oral dose of 50 mg/kg,,,BAO_0000218,,11174,,1,10116.0,CHEMBL625848,In vivo,,Expert,A,
,14258,Rattus norvegicus,1,,N,50597,,Maximum concentration of compound in plasma administered orally to rats,,,BAO_0000218,,11175,Plasma,1,10116.0,CHEMBL625849,In vivo,1969.0,Intermediate,A,
,14224,Canis lupus familiaris,1,,N,50588,,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",,,BAO_0000218,,11176,Plasma,1,9615.0,CHEMBL626023,In vivo,1969.0,Intermediate,A,
,14224,Canis lupus familiaris,1,,N,50588,,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",,,BAO_0000218,,11177,Plasma,1,9615.0,CHEMBL626024,In vivo,1969.0,Intermediate,A,
,14224,Canis lupus familiaris,1,,N,50588,,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",,,BAO_0000218,,11178,Plasma,1,9615.0,CHEMBL626025,In vivo,1969.0,Intermediate,A,
,5566,,1,,U,22224,,Maximum concentration after 10 mg/kg by oral administration,,,BAO_0000218,,11179,,0,,CHEMBL626026,In vivo,,Autocuration,A,
,16935,,1,,U,22224,,Maximum concentration at a dose of 1.5 mg/kg,,,BAO_0000218,,11180,,0,,CHEMBL626027,In vivo,,Autocuration,A,
,16935,,1,,U,22224,,Maximum concentration at a dose of 2.0 mg/kg,,,BAO_0000218,,11181,,0,,CHEMBL626028,In vivo,,Autocuration,A,
,14224,Canis lupus familiaris,1,,N,50588,,Maximum concentration in dog plasma,,,BAO_0000218,,11182,Plasma,1,9615.0,CHEMBL626029,In vivo,1969.0,Intermediate,A,
,12536,,1,,U,22224,,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,,,BAO_0000218,,11183,Plasma,0,,CHEMBL626030,In vivo,1969.0,Autocuration,A,
,12536,,1,,U,22224,,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,,,BAO_0000218,,11184,Plasma,0,,CHEMBL626031,In vivo,1969.0,Autocuration,A,
,12536,,1,,U,22224,,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,,,BAO_0000218,,11185,Plasma,0,,CHEMBL626032,In vivo,1969.0,Autocuration,A,
,12536,,1,,U,22224,,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,,,BAO_0000218,,11186,Plasma,0,,CHEMBL626033,In vivo,1969.0,Autocuration,A,
,12536,,1,,U,22224,,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,,,BAO_0000218,,11187,Plasma,0,,CHEMBL626034,In vivo,1969.0,Autocuration,A,
,9994,Canis lupus familiaris,1,,N,50588,,Maximum concentration in plasma after oral administration in dog (25 mg/kg),,,BAO_0000218,,11188,Plasma,1,9615.0,CHEMBL626035,In vivo,1969.0,Intermediate,A,
,1434,,1,,U,22224,,Maximum concentration in plasma at Tmax,,,BAO_0000218,,11189,Plasma,0,,CHEMBL626036,In vivo,1969.0,Autocuration,A,
,12836,Canis lupus familiaris,1,,N,50588,,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,,,BAO_0000218,,11190,Plasma,1,9615.0,CHEMBL626037,In vivo,1969.0,Expert,A,
,12836,Cricetinae,1,,N,100712,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,,,BAO_0000218,,11191,Plasma,1,10026.0,CHEMBL626038,In vivo,1969.0,Intermediate,A,
,12836,Rattus norvegicus,1,,N,50597,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,,,BAO_0000218,,11192,Plasma,1,10116.0,CHEMBL626039,In vivo,1969.0,Intermediate,A,
,12545,Rattus norvegicus,1,,N,50597,,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,,,BAO_0000218,,11193,Plasma,1,10116.0,CHEMBL626040,In vivo,1969.0,Intermediate,A,
,13856,Oryctolagus cuniculus,1,,N,50592,,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,,,BAO_0000218,,11194,Plasma,1,9986.0,CHEMBL626041,In vivo,1969.0,Intermediate,A,
,3550,,1,,U,22224,,Maximum concentration was calculated,,,BAO_0000218,,11195,,0,,CHEMBL626042,In vivo,,Autocuration,A,
,2632,,1,,U,22224,,Maximum concentration was calculated.,,,BAO_0000218,,11196,,0,,CHEMBL626043,In vivo,,Autocuration,A,
,5566,,1,,U,22224,,Maximum concentration at a peroral dose of 10 mg/kg,,,BAO_0000218,,11197,,0,,CHEMBL626044,In vivo,,Autocuration,A,
,11883,,1,,U,22224,,Maximum concentration of the drug at 10 uM/dg administered perorally,,,BAO_0000218,,11198,,0,,CHEMBL626045,In vivo,,Autocuration,A,
,11883,,1,,U,22224,,Maximum concentration of the drug at 2 uM/dg administered intravenously,,,BAO_0000218,,11199,,0,,CHEMBL626046,In vivo,,Autocuration,A,
,14122,Canis lupus familiaris,1,,N,50588,,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",,,BAO_0000218,,11200,Plasma,1,9615.0,CHEMBL626047,In vivo,1969.0,Intermediate,A,
,14122,Cricetinae,1,,N,100712,,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",,,BAO_0000218,,11201,Plasma,1,10026.0,CHEMBL626048,In vivo,1969.0,Intermediate,A,
,14122,Rattus norvegicus,1,,N,50597,,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",,,BAO_0000218,,11202,Plasma,1,10116.0,CHEMBL626049,In vivo,1969.0,Intermediate,A,
,12542,Rattus norvegicus,1,,N,50597,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,,,BAO_0000218,,11203,Plasma,1,10116.0,CHEMBL626050,In vivo,1969.0,Intermediate,A,
,12542,Canis lupus familiaris,1,,N,50588,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,,,BAO_0000218,,11204,Plasma,1,9615.0,CHEMBL874541,In vivo,1969.0,Intermediate,A,
,12542,Cricetinae,1,,N,100712,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,,,BAO_0000218,,11205,Plasma,1,10026.0,CHEMBL622826,In vivo,1969.0,Intermediate,A,
,12542,Cricetinae,1,,N,100712,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,,,BAO_0000218,,11206,Plasma,1,10026.0,CHEMBL622827,In vivo,1969.0,Intermediate,A,
,12542,Rattus norvegicus,1,,N,50597,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,,,BAO_0000218,,11207,Plasma,1,10116.0,CHEMBL622828,In vivo,1969.0,Intermediate,A,
,14080,Rattus norvegicus,1,,N,50597,,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,,,BAO_0000218,,11208,Plasma,1,10116.0,CHEMBL622829,In vivo,1969.0,Intermediate,A,
,11911,Rattus norvegicus,1,,N,50597,,Maximum concentration reached following intravenous administration in male rat,,,BAO_0000218,,11209,,1,10116.0,CHEMBL876806,In vivo,,Intermediate,A,
,13204,Canis lupus familiaris,1,,N,50588,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,,,BAO_0000218,,11210,,1,9615.0,CHEMBL622830,In vivo,,Intermediate,A,
,13204,Rattus norvegicus,1,,N,50597,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,,,BAO_0000218,,11211,,1,10116.0,CHEMBL622831,In vivo,,Intermediate,A,
,14346,Canis lupus familiaris,1,,N,50588,,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,,,BAO_0000218,,11212,,1,9615.0,CHEMBL626794,In vivo,,Intermediate,A,
,14346,Rattus norvegicus,1,,N,50597,,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,,,BAO_0000218,,11213,,1,10116.0,CHEMBL626795,In vivo,,Intermediate,A,
,14346,Rattus norvegicus,1,,N,50597,,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,,,BAO_0000218,,11214,,1,10116.0,CHEMBL626796,In vivo,,Intermediate,A,
,14346,Rattus norvegicus,1,,N,50597,,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,,,BAO_0000218,,11215,,1,10116.0,CHEMBL626797,In vivo,,Intermediate,A,
,14127,Rattus norvegicus,1,,N,50597,,Maximum drug concentration is determined after oral dosing in rats.,,,BAO_0000218,,11216,,1,10116.0,CHEMBL626798,In vivo,,Intermediate,A,
,14339,Canis lupus familiaris,1,,N,50588,,Maximum observed concentration in oral (5 mg/kg) fasted dogs,,,BAO_0000218,,11217,,1,9615.0,CHEMBL626799,In vivo,,Intermediate,A,
,14339,Canis lupus familiaris,1,,N,50588,,Maximum observed concentration in oral (5 mg/kg) fed dogs,,,BAO_0000218,,11218,,1,9615.0,CHEMBL626800,In vivo,,Intermediate,A,
,13494,,1,,U,22224,,Maximum plasma concentration,,,BAO_0000218,,11219,Plasma,0,,CHEMBL626801,In vivo,1969.0,Autocuration,A,
,14925,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,,,BAO_0000218,,11220,Plasma,1,10116.0,CHEMBL876816,In vivo,1969.0,Intermediate,A,
,14474,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,,,BAO_0000218,,11221,Plasma,1,10116.0,CHEMBL626802,In vivo,1969.0,Intermediate,A,
,14474,Canis lupus familiaris,1,,N,50588,,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,,,BAO_0000218,,11222,Plasma,1,9615.0,CHEMBL626803,In vivo,1969.0,Intermediate,A,
,13917,,1,,U,22224,,Maximum plasma concentration following oral administration of 30 umol/kg,,,BAO_0000218,,11223,Plasma,0,,CHEMBL626804,In vivo,1969.0,Autocuration,A,
,9796,Rattus norvegicus,1,,N,50597,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,,,BAO_0000218,,11224,Plasma,1,10116.0,CHEMBL626805,,1969.0,Intermediate,A,
,9796,Rattus norvegicus,1,,N,50597,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,,BAO_0000218,,11225,Plasma,1,10116.0,CHEMBL626309,,1969.0,Intermediate,A,
,9796,Rattus norvegicus,1,,N,50597,,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,,11226,Plasma,1,10116.0,CHEMBL626310,,1969.0,Intermediate,A,
,9796,Rattus norvegicus,1,,N,50597,,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,,11227,Plasma,1,10116.0,CHEMBL626311,,1969.0,Intermediate,A,
,9796,Rattus norvegicus,1,,N,50597,,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,,11228,Plasma,1,10116.0,CHEMBL626312,,1969.0,Intermediate,A,
,9796,Rattus norvegicus,1,,N,50597,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,,11229,Uterus,1,10116.0,CHEMBL626313,,995.0,Intermediate,A,
,9796,Rattus norvegicus,1,,N,50597,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,,BAO_0000218,,11230,Uterus,1,10116.0,CHEMBL626314,,995.0,Intermediate,A,
,9796,Rattus norvegicus,1,,N,50597,,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,,11231,Uterus,1,10116.0,CHEMBL626315,,995.0,Intermediate,A,
,9796,Rattus norvegicus,1,,N,50597,,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,,11232,Uterus,1,10116.0,CHEMBL626316,,995.0,Intermediate,A,
,9796,Rattus norvegicus,1,,N,50597,,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,,11233,Uterus,1,10116.0,CHEMBL626317,,995.0,Intermediate,A,
,8363,Rattus norvegicus,1,,N,50597,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),,,BAO_0000218,,11234,,1,10116.0,CHEMBL626318,,,Intermediate,A,
,8363,Rattus norvegicus,1,,N,50597,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),,,BAO_0000218,,11235,,1,10116.0,CHEMBL626319,,,Intermediate,A,
,8363,Rattus norvegicus,1,,N,50597,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),,,BAO_0000218,,11236,,1,10116.0,CHEMBL626320,,,Intermediate,A,
,8363,Rattus norvegicus,1,,N,50597,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),,,BAO_0000218,,11237,,1,10116.0,CHEMBL875053,,,Intermediate,A,
,8363,Rattus norvegicus,1,,N,50597,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),,,BAO_0000218,,11238,,1,10116.0,CHEMBL626321,,,Intermediate,A,
,8363,Rattus norvegicus,1,,N,50597,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),,,BAO_0000218,,11239,,1,10116.0,CHEMBL626322,,,Intermediate,A,
,8363,Rattus norvegicus,1,,N,50597,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),,,BAO_0000218,,11240,,1,10116.0,CHEMBL626323,,,Intermediate,A,
,8363,Rattus norvegicus,1,,N,50597,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),,,BAO_0000218,,11241,,1,10116.0,CHEMBL626324,,,Intermediate,A,
,8363,Rattus norvegicus,1,,N,50597,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),,,BAO_0000218,,11242,,1,10116.0,CHEMBL626325,,,Intermediate,A,
,8363,Rattus norvegicus,1,,N,50597,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),,,BAO_0000218,,11243,,1,10116.0,CHEMBL626326,,,Intermediate,A,
,8363,Rattus norvegicus,1,,N,50597,,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),,,BAO_0000218,,11244,,1,10116.0,CHEMBL626327,,,Intermediate,A,
,8363,Rattus norvegicus,1,,N,50597,,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),,,BAO_0000218,,11245,,1,10116.0,CHEMBL626328,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11246,Blood,1,10116.0,CHEMBL626329,,178.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11247,Blood,1,10116.0,CHEMBL626330,,178.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11248,Blood,1,10116.0,CHEMBL626331,,178.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11249,Blood,1,10116.0,CHEMBL626332,,178.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11250,Blood,1,10116.0,CHEMBL626333,,178.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11251,Blood,1,10116.0,CHEMBL626334,,178.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11252,Blood,1,10116.0,CHEMBL626335,,178.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11253,Blood,1,10116.0,CHEMBL624798,,178.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",,,BAO_0000218,,11254,Brain,1,10116.0,CHEMBL624799,,955.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",,,BAO_0000218,,11255,Brain,1,10116.0,CHEMBL624800,,955.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",,,BAO_0000218,,11256,Brain,1,10116.0,CHEMBL624801,,955.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",,,BAO_0000218,,11257,Brain,1,10116.0,CHEMBL624802,,955.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",,,BAO_0000218,,11258,Brain,1,10116.0,CHEMBL624803,,955.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",,,BAO_0000218,,11259,Brain,1,10116.0,CHEMBL624804,,955.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",,,BAO_0000218,,11260,Brain,1,10116.0,CHEMBL624805,,955.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",,,BAO_0000218,,11261,Brain,1,10116.0,CHEMBL624806,,955.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11262,,1,10116.0,CHEMBL624807,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11263,,1,10116.0,CHEMBL624808,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11264,,1,10116.0,CHEMBL624809,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11265,,1,10116.0,CHEMBL624810,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11266,,1,10116.0,CHEMBL877618,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11267,,1,10116.0,CHEMBL624811,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11268,,1,10116.0,CHEMBL624812,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11269,,1,10116.0,CHEMBL624813,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11270,,1,10116.0,CHEMBL624814,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11271,,1,10116.0,CHEMBL624815,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11272,,1,10116.0,CHEMBL624816,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11273,,1,10116.0,CHEMBL624817,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,,11274,,1,9615.0,CHEMBL624818,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,,,BAO_0000218,,11275,,1,9615.0,CHEMBL624819,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,,BAO_0000218,,11276,,1,9615.0,CHEMBL624820,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,,BAO_0000218,,11277,,1,9615.0,CHEMBL624821,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,,BAO_0000218,,11278,,1,9615.0,CHEMBL624822,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,,11279,,1,9615.0,CHEMBL624823,,,Intermediate,A,
,15599,Escherichia coli,1,,N,50212,,Observed diffusion coefficient in organic solvent for Escherichia coli,,,BAO_0000218,,11280,,1,562.0,CHEMBL624824,,,Intermediate,A,
,9614,Rattus norvegicus,1,,N,50597,,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,BAO_0000218,,11281,Blood,1,10116.0,CHEMBL624825,,178.0,Intermediate,A,
,9614,Rattus norvegicus,1,,N,50597,,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,BAO_0000218,,11282,Blood,1,10116.0,CHEMBL624826,,178.0,Intermediate,A,
,9614,Rattus norvegicus,1,,N,50597,,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,BAO_0000218,,11283,Cardiac atrium,1,10116.0,CHEMBL876817,,2081.0,Intermediate,A,
,9614,Rattus norvegicus,1,,N,50597,,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,BAO_0000218,,11284,Cardiac atrium,1,10116.0,CHEMBL624827,,2081.0,Intermediate,A,
,9614,Rattus norvegicus,1,,N,50597,,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,BAO_0000218,,11285,,1,10116.0,CHEMBL624828,,,Intermediate,A,
,9614,Rattus norvegicus,1,,N,50597,,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,BAO_0000218,,11286,,1,10116.0,CHEMBL624829,,,Intermediate,A,
,9614,Rattus norvegicus,1,,N,50597,,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,BAO_0000218,,11287,Liver,1,10116.0,CHEMBL624830,,2107.0,Intermediate,A,
,9614,Rattus norvegicus,1,,N,50597,,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,BAO_0000218,,11288,Liver,1,10116.0,CHEMBL624831,,2107.0,Intermediate,A,
,9614,Rattus norvegicus,1,,N,50597,,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,BAO_0000218,,11289,Cardiac atrium,1,10116.0,CHEMBL624832,,2081.0,Intermediate,A,
,9614,Rattus norvegicus,1,,N,50597,,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,BAO_0000218,,11290,Cardiac atrium,1,10116.0,CHEMBL624833,,2081.0,Intermediate,A,
,9614,Rattus norvegicus,1,,N,50597,,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,BAO_0000218,,11291,,1,10116.0,CHEMBL624834,,,Intermediate,A,
,9614,Rattus norvegicus,1,,N,50597,,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,BAO_0000218,,11292,,1,10116.0,CHEMBL624835,,,Intermediate,A,
,9614,Rattus norvegicus,1,,N,50597,,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,BAO_0000218,,11293,Spleen,1,10116.0,CHEMBL624836,,2106.0,Intermediate,A,
,9614,Rattus norvegicus,1,,N,50597,,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,BAO_0000218,,11294,Spleen,1,10116.0,CHEMBL624837,,2106.0,Intermediate,A,
,9071,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,,,BAO_0000218,,11295,Blood,1,10116.0,CHEMBL624838,,178.0,Intermediate,A,
,9071,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,,,BAO_0000218,,11296,Blood,1,10116.0,CHEMBL622188,,178.0,Intermediate,A,
,9071,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,,,BAO_0000218,,11297,Heart,1,10116.0,CHEMBL622189,,948.0,Intermediate,A,
,9071,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,,,BAO_0000218,,11298,Heart,1,10116.0,CHEMBL622190,,948.0,Intermediate,A,
,9071,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,,,BAO_0000218,,11299,Heart,1,10116.0,CHEMBL625170,,948.0,Intermediate,A,
,9071,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,,BAO_0000218,,11300,Kidney,1,10116.0,CHEMBL625171,,2113.0,Intermediate,A,
,9071,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,,BAO_0000218,,11301,Kidney,1,10116.0,CHEMBL625172,,2113.0,Intermediate,A,
,9071,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,,,BAO_0000218,,11302,Kidney,1,10116.0,CHEMBL625173,,2113.0,Intermediate,A,
,9071,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,,,BAO_0000218,,11303,Liver,1,10116.0,CHEMBL625174,,2107.0,Intermediate,A,
,9071,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,,,BAO_0000218,,11304,Liver,1,10116.0,CHEMBL625175,,2107.0,Intermediate,A,
,9071,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,,,BAO_0000218,,11305,Liver,1,10116.0,CHEMBL625176,,2107.0,Intermediate,A,
,9071,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,,BAO_0000218,,11306,Lung,1,10116.0,CHEMBL625177,,2048.0,Intermediate,A,
,9071,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,,,BAO_0000218,,11307,Lung,1,10116.0,CHEMBL625178,,2048.0,Intermediate,A,
,9071,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,,,BAO_0000218,,11308,Lung,1,10116.0,CHEMBL625179,,2048.0,Intermediate,A,
,9071,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,,BAO_0000218,,11309,Lung,1,10116.0,CHEMBL625180,,2048.0,Intermediate,A,
,10677,,1,,U,22224,,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",,,BAO_0000218,,11310,,0,,CHEMBL625181,,,Autocuration,A,
,9750,Mus musculus,1,,N,50594,,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,,,BAO_0000218,,11311,Urine,1,10090.0,CHEMBL625182,,1088.0,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,,BAO_0000218,,11312,,1,10116.0,CHEMBL625183,,,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,,BAO_0000218,,11313,,1,10116.0,CHEMBL875848,,,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,,BAO_0000218,,11314,,1,10116.0,CHEMBL622260,,,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,,BAO_0000218,,11315,,1,10116.0,CHEMBL622261,,,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,,BAO_0000218,,11316,,1,10116.0,CHEMBL622262,,,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,,BAO_0000218,,11317,Kidney,1,10116.0,CHEMBL622263,,2113.0,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,,BAO_0000218,,11318,Kidney,1,10116.0,CHEMBL622418,,2113.0,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,,BAO_0000218,,11319,Liver,1,10116.0,CHEMBL622419,,2107.0,Intermediate,A,
,13256,Mus musculus,1,,N,50594,,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,,11320,,1,10090.0,CHEMBL623388,In vivo,,Intermediate,A,
,13256,Mus musculus,1,,N,50594,,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,,11321,Liver,1,10090.0,CHEMBL623389,In vivo,2107.0,Intermediate,A,
,13256,Mus musculus,1,,N,50594,,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,,11322,,1,10090.0,CHEMBL623390,In vivo,,Intermediate,A,
,13256,Mus musculus,1,,N,50594,,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,,11323,,1,10090.0,CHEMBL623391,In vivo,,Intermediate,A,
,13256,Mus musculus,1,,N,50594,,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,,11324,Blood,1,10090.0,CHEMBL623392,In vivo,178.0,Intermediate,A,
,13256,Mus musculus,1,,N,50594,,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,,11325,Cerebellum,1,10090.0,CHEMBL623393,In vivo,2037.0,Intermediate,A,
,13256,Mus musculus,1,,N,50594,,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,,11326,,1,10090.0,CHEMBL623394,In vivo,,Intermediate,A,
,13256,Mus musculus,1,,N,50594,,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,,11327,,1,10090.0,CHEMBL618885,In vivo,,Intermediate,A,
,13256,Mus musculus,1,,N,50594,,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,,11328,Liver,1,10090.0,CHEMBL618886,In vivo,2107.0,Intermediate,A,
,13256,Mus musculus,1,,N,50594,,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,,11329,,1,10090.0,CHEMBL618887,In vivo,,Intermediate,A,
,13256,Mus musculus,1,,N,50594,,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,,11330,,1,10090.0,CHEMBL619535,In vivo,,Intermediate,A,
,13256,Mus musculus,1,,N,50594,,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,,11331,Blood,1,10090.0,CHEMBL619536,In vivo,178.0,Intermediate,A,
,13256,Mus musculus,1,,N,50594,,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,,11332,Cerebellum,1,10090.0,CHEMBL619537,In vivo,2037.0,Intermediate,A,
,13256,Mus musculus,1,,N,50594,,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,,11333,,1,10090.0,CHEMBL619705,In vivo,,Intermediate,A,
,13256,Mus musculus,1,,N,50594,,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,,11334,,1,10090.0,CHEMBL619706,In vivo,,Intermediate,A,
,13256,Mus musculus,1,,N,50594,,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,,11335,Liver,1,10090.0,CHEMBL619707,In vivo,2107.0,Intermediate,A,
,13256,Mus musculus,1,,N,50594,,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,,11336,,1,10090.0,CHEMBL619708,In vivo,,Intermediate,A,
,13256,Mus musculus,1,,N,50594,,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,,11337,,1,10090.0,CHEMBL625219,In vivo,,Intermediate,A,
,13256,Mus musculus,1,,N,50594,,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,,11338,Blood,1,10090.0,CHEMBL625220,In vivo,178.0,Intermediate,A,
,13256,Mus musculus,1,,N,50594,,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,,11339,Cerebellum,1,10090.0,CHEMBL625221,In vivo,2037.0,Intermediate,A,
,13256,Mus musculus,1,,N,50594,,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,,11340,,1,10090.0,CHEMBL625222,In vivo,,Intermediate,A,
,13256,Mus musculus,1,,N,50594,,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,,11341,,1,10090.0,CHEMBL625223,In vivo,,Intermediate,A,
,13256,Mus musculus,1,,N,50594,,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,,11342,Liver,1,10090.0,CHEMBL625224,In vivo,2107.0,Intermediate,A,
,13256,Mus musculus,1,,N,50594,,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,,11343,,1,10090.0,CHEMBL625225,In vivo,,Intermediate,A,
,8829,Rattus norvegicus,1,,N,50597,,Biodistribution in Rat blood after 24 hours of iv administration,,,BAO_0000218,,11344,Blood,1,10116.0,CHEMBL625226,In vivo,178.0,Intermediate,A,
,8829,Rattus norvegicus,1,,N,50597,,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,,,BAO_0000218,,11345,Blood,1,10116.0,CHEMBL625227,In vivo,178.0,Intermediate,A,
,8829,Rattus norvegicus,1,,N,50597,,Biodistribution in Rat blood after 30 minutes of iv administration,,,BAO_0000218,,11346,Blood,1,10116.0,CHEMBL625228,In vivo,178.0,Intermediate,A,
,8829,Rattus norvegicus,1,,N,50597,,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,,,BAO_0000218,,11347,Blood,1,10116.0,CHEMBL875354,In vivo,178.0,Intermediate,A,
,8829,Rattus norvegicus,1,,N,50597,,Biodistribution in Rat blood after 5 minutes of iv administration,,,BAO_0000218,,11348,Blood,1,10116.0,CHEMBL625229,In vivo,178.0,Intermediate,A,
,8829,Rattus norvegicus,1,,N,50597,,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,,,BAO_0000218,,11349,Blood,1,10116.0,CHEMBL625230,In vivo,178.0,Intermediate,A,
,8829,Rattus norvegicus,1,,N,50597,,Biodistribution in Rat heart after 24 hours of iv administration,,,BAO_0000218,,11350,Heart,1,10116.0,CHEMBL625231,In vivo,948.0,Intermediate,A,
,8829,Rattus norvegicus,1,,N,50597,,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,,,BAO_0000218,,11351,Heart,1,10116.0,CHEMBL625900,In vivo,948.0,Intermediate,A,
,8829,Rattus norvegicus,1,,N,50597,,Biodistribution in Rat heart after 30 minutes of iv administration,,,BAO_0000218,,11352,Heart,1,10116.0,CHEMBL625901,In vivo,948.0,Intermediate,A,
,8829,Rattus norvegicus,1,,N,50597,,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,,,BAO_0000218,,11353,Heart,1,10116.0,CHEMBL625902,In vivo,948.0,Intermediate,A,
,8829,Rattus norvegicus,1,,N,50597,,Biodistribution in Rat heart after 5 minutes of iv administration,,,BAO_0000218,,11354,Heart,1,10116.0,CHEMBL625903,In vivo,948.0,Intermediate,A,
,8829,Rattus norvegicus,1,,N,50597,,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,,,BAO_0000218,,11355,Heart,1,10116.0,CHEMBL625904,In vivo,948.0,Intermediate,A,
,8829,Rattus norvegicus,1,,N,50597,,Biodistribution in Rat liver after 24 hours of iv administration,,,BAO_0000218,,11356,Liver,1,10116.0,CHEMBL625905,In vivo,2107.0,Intermediate,A,
,8829,Rattus norvegicus,1,,N,50597,,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,,,BAO_0000218,,11357,Liver,1,10116.0,CHEMBL627861,In vivo,2107.0,Intermediate,A,
,8829,Rattus norvegicus,1,,N,50597,,Biodistribution in Rat liver after 30 minutes of iv administration,,,BAO_0000218,,11358,Liver,1,10116.0,CHEMBL627862,In vivo,2107.0,Intermediate,A,
,8829,Rattus norvegicus,1,,N,50597,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,,BAO_0000218,,11359,Liver,1,10116.0,CHEMBL627863,In vivo,2107.0,Intermediate,A,
,8829,Rattus norvegicus,1,,N,50597,,Biodistribution in Rat liver after 30 minutes of iv administration,,,BAO_0000218,,11360,Liver,1,10116.0,CHEMBL627769,In vivo,2107.0,Intermediate,A,
,13249,Canis lupus familiaris,1,,N,50588,,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,,BAO_0000218,,11361,Plasma,1,9615.0,CHEMBL627770,In vivo,1969.0,Intermediate,A,
,13622,Macaca fascicularis,1,,N,100710,,Cmax in cynomolgus monkey (PO dose),,,BAO_0000218,,11362,,1,9541.0,CHEMBL627771,In vivo,,Intermediate,A,
,13622,Rattus norvegicus,1,,N,50597,,Cmax in rat (PO dose),,,BAO_0000218,,11363,,1,10116.0,CHEMBL627772,In vivo,,Intermediate,A,
,13622,Rattus norvegicus,1,,N,50597,,Cmax in rat (PO dose),,,BAO_0000218,,11364,,1,10116.0,CHEMBL627773,In vivo,,Intermediate,A,
,13494,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,,,BAO_0000218,,11365,Plasma,1,10116.0,CHEMBL621922,In vivo,1969.0,Intermediate,A,
,12170,Rattus norvegicus,1,,N,50597,,Cmax in rat plasma after oral dose (10 mg/kg),,,BAO_0000218,,11366,Plasma,1,10116.0,CHEMBL621923,In vivo,1969.0,Intermediate,A,
,12170,,1,,U,22224,,Cmax in plasma after oral dose (10 mg/kg),,,BAO_0000218,,11367,Plasma,0,,CHEMBL621924,In vivo,1969.0,Autocuration,A,
,17025,Canis lupus familiaris,1,,N,50588,,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,,,BAO_0000218,,11368,Plasma,1,9615.0,CHEMBL621925,In vivo,1969.0,Intermediate,A,
,17025,Simiiformes,1,,U,22224,,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,,,BAO_0000218,,11369,Plasma,0,314293.0,CHEMBL621926,In vivo,1969.0,Autocuration,A,
,17025,Oryctolagus cuniculus,1,,N,50592,,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,,,BAO_0000218,,11370,Plasma,1,9986.0,CHEMBL621927,In vivo,1969.0,Intermediate,A,
,17025,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,,,BAO_0000218,,11371,Plasma,1,10116.0,CHEMBL621928,In vivo,1969.0,Intermediate,A,
,14187,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,,,BAO_0000218,,11372,Plasma,1,10116.0,CHEMBL621929,In vivo,1969.0,Intermediate,A,
,14816,Mus musculus,1,,N,50594,,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,,,BAO_0000218,,11373,Plasma,1,10090.0,CHEMBL621930,In vivo,1969.0,Intermediate,A,
,17820,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration after oral dosing in rat,,,BAO_0000218,,11374,Plasma,1,10116.0,CHEMBL621931,In vivo,1969.0,Intermediate,A,
,14380,,1,,U,22224,,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,,BAO_0000218,,11375,Plasma,0,,CHEMBL621932,In vivo,1969.0,Autocuration,A,
,14380,,1,,U,22224,,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,,BAO_0000218,,11376,Plasma,0,,CHEMBL621933,In vivo,1969.0,Autocuration,A,
,14691,Canis lupus familiaris,1,,N,50588,,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,,,BAO_0000218,,11377,Plasma,1,9615.0,CHEMBL621934,In vivo,1969.0,Intermediate,A,
,14691,Canis lupus familiaris,1,,N,50588,,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,,,BAO_0000218,,11378,Plasma,1,9615.0,CHEMBL621935,In vivo,1969.0,Intermediate,A,
,13375,Rattus norvegicus,1,,N,50597,,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,,,BAO_0000218,,11379,Plasma,1,10116.0,CHEMBL621936,In vivo,1969.0,Intermediate,A,
,6236,,1,,U,22224,,Maximum plasma concentration was determined,,,BAO_0000218,,11380,Plasma,0,,CHEMBL621937,In vivo,1969.0,Autocuration,A,
,14380,,1,,U,22224,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,,BAO_0000218,,11381,Plasma,0,,CHEMBL621938,In vivo,1969.0,Autocuration,A,
,14380,,1,,U,22224,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,,BAO_0000218,,11382,Plasma,0,,CHEMBL621939,In vivo,1969.0,Autocuration,A,
,14380,,1,,U,22224,,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,,,BAO_0000218,,11383,Plasma,0,,CHEMBL621940,In vivo,1969.0,Autocuration,A,
,14380,,1,,U,22224,,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,,,BAO_0000218,,11384,Plasma,0,,CHEMBL621941,In vivo,1969.0,Autocuration,A,
,14380,,1,,U,22224,,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,,BAO_0000218,,11385,Plasma,0,,CHEMBL621942,In vivo,1969.0,Autocuration,A,
,14380,,1,,U,22224,,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,,BAO_0000218,,11386,Plasma,0,,CHEMBL626178,In vivo,1969.0,Autocuration,A,
,14380,,1,,U,22224,,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,,,BAO_0000218,,11387,Plasma,0,,CHEMBL626179,In vivo,1969.0,Autocuration,A,
,14380,,1,,U,22224,,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,,,BAO_0000218,,11388,Plasma,0,,CHEMBL626180,In vivo,1969.0,Autocuration,A,
,13622,Rattus norvegicus,1,,N,50597,,Plasma Cmax in rat (PO dose),,,BAO_0000218,,11389,Plasma,1,10116.0,CHEMBL626181,In vivo,1969.0,Intermediate,A,
,15372,Rattus norvegicus,1,,N,50597,,Maximum serum concentration after po dose of 5.22 mg/kg in rats,,,BAO_0000218,,11390,,1,10116.0,CHEMBL626182,In vivo,,Intermediate,A,
,15372,Rattus norvegicus,1,,N,50597,,Maximum serum concentration after po dose of 5.46 mg/kg in rats,,,BAO_0000218,,11391,,1,10116.0,CHEMBL626183,In vivo,,Intermediate,A,
,15372,Rattus norvegicus,1,,N,50597,,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,,,BAO_0000218,,11392,,1,10116.0,CHEMBL626184,In vivo,,Intermediate,A,
,15372,Rattus norvegicus,1,,N,50597,,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,,,BAO_0000218,,11393,,1,10116.0,CHEMBL626185,In vivo,,Intermediate,A,
,14925,Canis lupus familiaris,1,,N,50588,,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,,,BAO_0000218,,11394,Plasma,1,9615.0,CHEMBL626186,In vivo,1969.0,Intermediate,A,
,14925,Canis lupus familiaris,1,,N,50588,,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,,,BAO_0000218,,11395,Plasma,1,9615.0,CHEMBL877589,In vivo,1969.0,Intermediate,A,
,11883,,1,,U,22224,,Maximum concentration of the drug at 1 uM/dg administered intravenously,,,BAO_0000218,,11396,,0,,CHEMBL626187,In vivo,,Autocuration,A,
,11883,,1,,U,22224,,Maximum concentration of the drug at 20 uM/dg administered perorally,,,BAO_0000218,,11397,,0,,CHEMBL626188,In vivo,,Autocuration,A,
,13391,,1,,U,22224,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,,,BAO_0000218,,11398,,0,,CHEMBL626189,In vivo,,Autocuration,A,
,13391,,1,,U,22224,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,,BAO_0000218,,11399,Blood,0,,CHEMBL626855,In vivo,178.0,Autocuration,A,
,13391,,1,,U,22224,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,,BAO_0000218,,11400,Blood,0,,CHEMBL623781,In vivo,178.0,Autocuration,A,
,13391,,1,,U,22224,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,,BAO_0000218,,11401,Blood,0,,CHEMBL623782,In vivo,178.0,Autocuration,A,
,16360,Rattus norvegicus,1,,N,50597,,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,,,BAO_0000218,,11402,Plasma,1,10116.0,CHEMBL623783,In vivo,1969.0,Intermediate,A,
,3673,Canis lupus familiaris,1,,N,50588,,Cmax in dog plasma after 1mg/kg oral dose,,,BAO_0000218,,11403,Plasma,1,9615.0,CHEMBL623784,In vivo,1969.0,Intermediate,A,
,14431,Canis lupus familiaris,1,,N,50588,,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,,,BAO_0000218,,11404,Plasma,1,9615.0,CHEMBL623785,In vivo,1969.0,Intermediate,A,
,14431,Rattus norvegicus,1,,N,50597,,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,,,BAO_0000218,,11405,Plasma,1,10116.0,CHEMBL623786,In vivo,1969.0,Intermediate,A,
,14964,Rattus norvegicus,1,,N,50597,,Oral maximum concentration in rat,,,BAO_0000218,,11406,,1,10116.0,CHEMBL623787,In vivo,,Intermediate,A,
,14964,Rattus norvegicus,1,,N,50597,,Oral maximum concentration in rat,,,BAO_0000218,,11407,,1,10116.0,CHEMBL623788,In vivo,,Intermediate,A,
,14209,Mus musculus,1,,N,50594,,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,,,BAO_0000218,,11408,Plasma,1,10090.0,CHEMBL623789,In vivo,1969.0,Intermediate,A,
,11355,Mus musculus,1,,N,50594,,Peak concentration in blood after intravenous administration to mice,,,BAO_0000218,,11409,Blood,1,10090.0,CHEMBL623790,In vivo,178.0,Intermediate,A,
,11355,Mus musculus,1,,N,50594,,Peak concentration in blood after peroral administration to mice,,,BAO_0000218,,11410,Blood,1,10090.0,CHEMBL623791,In vivo,178.0,Intermediate,A,
,11966,Rattus norvegicus,1,,N,50597,,Peak concentration in rat plasma was determined,,,BAO_0000218,,11411,Plasma,1,10116.0,CHEMBL623792,In vivo,1969.0,Intermediate,A,
,8918,Simiiformes,1,,U,22224,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,,,BAO_0000218,,11412,Plasma,0,314293.0,CHEMBL623793,In vivo,1969.0,Autocuration,A,
,8918,Mus musculus,1,,N,50594,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,,,BAO_0000218,,11413,Plasma,1,10090.0,CHEMBL623794,In vivo,1969.0,Intermediate,A,
,8918,Rattus norvegicus,1,,N,50597,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,,,BAO_0000218,,11414,Plasma,1,10116.0,CHEMBL623795,In vivo,1969.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11415,,1,10116.0,CHEMBL623796,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11416,,1,10116.0,CHEMBL623797,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11417,,1,10116.0,CHEMBL623798,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11418,,1,10116.0,CHEMBL623799,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11419,Intestine,1,10116.0,CHEMBL624490,,160.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11420,Intestine,1,10116.0,CHEMBL624491,,160.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11421,Intestine,1,10116.0,CHEMBL624492,,160.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11422,Intestine,1,10116.0,CHEMBL624493,,160.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11423,Intestine,1,10116.0,CHEMBL877595,,160.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11424,Intestine,1,10116.0,CHEMBL624494,,160.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11425,Intestine,1,10116.0,CHEMBL624495,,160.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11426,Intestine,1,10116.0,CHEMBL624681,,160.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11427,,1,10116.0,CHEMBL624682,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11428,,1,10116.0,CHEMBL624683,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11429,,1,10116.0,CHEMBL624684,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11430,,1,10116.0,CHEMBL624685,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11431,,1,10116.0,CHEMBL624686,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11432,,1,10116.0,CHEMBL624687,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11433,,1,10116.0,CHEMBL624688,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11434,,1,10116.0,CHEMBL627161,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11435,,1,10116.0,CHEMBL622127,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11436,,1,10116.0,CHEMBL622128,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11437,,1,10116.0,CHEMBL874384,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11438,,1,10116.0,CHEMBL624898,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11439,,1,10116.0,CHEMBL624899,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11440,,1,10116.0,CHEMBL624900,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11441,,1,10116.0,CHEMBL624901,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11442,,1,10116.0,CHEMBL624902,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11443,,1,10116.0,CHEMBL624903,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11444,,1,10116.0,CHEMBL624904,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11445,,1,10116.0,CHEMBL624905,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11446,,1,10116.0,CHEMBL624906,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11447,,1,10116.0,CHEMBL624907,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11448,,1,10116.0,CHEMBL624908,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11449,,1,10116.0,CHEMBL624909,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11450,,1,10116.0,CHEMBL624910,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11451,Muscle tissue,1,10116.0,CHEMBL624911,,2385.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11452,Muscle tissue,1,10116.0,CHEMBL874388,,2385.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11453,Muscle tissue,1,10116.0,CHEMBL624912,,2385.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11454,Muscle tissue,1,10116.0,CHEMBL622930,,2385.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11455,Muscle tissue,1,10116.0,CHEMBL623121,,2385.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11456,Muscle tissue,1,10116.0,CHEMBL623122,,2385.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11457,Muscle tissue,1,10116.0,CHEMBL623123,,2385.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11458,Muscle tissue,1,10116.0,CHEMBL623124,,2385.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11459,,1,10116.0,CHEMBL623125,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11460,,1,10116.0,CHEMBL623126,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11461,,1,10116.0,CHEMBL623127,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11462,,1,10116.0,CHEMBL623128,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11463,,1,10116.0,CHEMBL623129,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11464,,1,10116.0,CHEMBL623130,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11465,,1,10116.0,CHEMBL623131,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11466,,1,10116.0,CHEMBL623132,,,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,,BAO_0000218,,11467,Liver,1,10116.0,CHEMBL623133,,2107.0,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,,BAO_0000218,,11468,,1,10116.0,CHEMBL623134,,,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,,BAO_0000218,,11469,,1,10116.0,CHEMBL874389,,,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,,BAO_0000218,,11470,,1,10116.0,CHEMBL623135,,,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,,BAO_0000218,,11471,,1,10116.0,CHEMBL623136,,,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,,BAO_0000218,,11472,,1,10116.0,CHEMBL623137,,,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,,BAO_0000218,,11473,,1,10116.0,CHEMBL623138,,,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,,BAO_0000218,,11474,Kidney,1,10116.0,CHEMBL623139,,2113.0,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,,BAO_0000218,,11475,Kidney,1,10116.0,CHEMBL623140,,2113.0,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,,BAO_0000218,,11476,Liver,1,10116.0,CHEMBL623141,,2107.0,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,,BAO_0000218,,11477,Liver,1,10116.0,CHEMBL623142,,2107.0,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,,BAO_0000218,,11478,,1,10116.0,CHEMBL623143,,,Intermediate,A,
,14571,Mus musculus,1,,N,50594,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,,,BAO_0000218,,11479,Urine,1,10090.0,CHEMBL623144,,1088.0,Intermediate,A,
,14571,Rattus norvegicus,1,,N,50597,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,,,BAO_0000218,,11480,Urine,1,10116.0,CHEMBL623405,,1088.0,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,,BAO_0000218,,11481,,1,10116.0,CHEMBL624074,,,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,,BAO_0000218,,11482,,1,10116.0,CHEMBL624075,,,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,,BAO_0000218,,11483,,1,10116.0,CHEMBL624076,,,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,,BAO_0000218,,11484,,1,10116.0,CHEMBL624077,,,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,,BAO_0000218,,11485,,1,10116.0,CHEMBL624078,,,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,,BAO_0000218,,11486,Kidney,1,10116.0,CHEMBL624079,,2113.0,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,,BAO_0000218,,11487,Kidney,1,10116.0,CHEMBL624261,,2113.0,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,,BAO_0000218,,11488,,1,10116.0,CHEMBL624262,,,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,,BAO_0000218,,11489,,1,10116.0,CHEMBL624263,,,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,,BAO_0000218,,11490,,1,10116.0,CHEMBL624264,,,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,,BAO_0000218,,11491,,1,10116.0,CHEMBL624265,,,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,,BAO_0000218,,11492,,1,10116.0,CHEMBL624266,,,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,,BAO_0000218,,11493,,1,10116.0,CHEMBL624267,,,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,,BAO_0000218,,11494,,1,10116.0,CHEMBL624268,,,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,,BAO_0000218,,11495,,1,10116.0,CHEMBL875227,,,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,,BAO_0000218,,11496,Kidney,1,10116.0,CHEMBL624269,,2113.0,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,,BAO_0000218,,11497,Kidney,1,10116.0,CHEMBL624270,,2113.0,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,,BAO_0000218,,11498,,1,10116.0,CHEMBL624271,,,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,,BAO_0000218,,11499,,1,10116.0,CHEMBL624272,,,Intermediate,A,
,8319,Rattus norvegicus,1,,N,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,,BAO_0000218,,11500,,1,10116.0,CHEMBL624273,,,Intermediate,A,
,12064,Rattus norvegicus,1,,N,50597,,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,,,BAO_0000218,,11501,Urine,1,10116.0,CHEMBL624274,,1088.0,Intermediate,A,
,12064,Rattus norvegicus,1,,N,50597,,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,,,BAO_0000218,,11502,Urine,1,10116.0,CHEMBL624275,,1088.0,Intermediate,A,
,12064,Rattus norvegicus,1,,N,50597,,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,,,BAO_0000218,,11503,Urine,1,10116.0,CHEMBL624276,,1088.0,Intermediate,A,
,12038,Rattus norvegicus,1,,N,50597,,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,,,BAO_0000218,,11504,Urine,1,10116.0,CHEMBL624277,,1088.0,Intermediate,A,
,14314,,1,,U,22224,,% dose converted to 2-amino-5-chlorophenyl sulfate,,,BAO_0000019,,11505,,0,,CHEMBL624278,,,Autocuration,A,
,14314,,1,,U,22224,,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),,,BAO_0000019,,11506,,0,,CHEMBL624279,,,Autocuration,A,
,11488,Rattus norvegicus,1,,N,50597,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,,BAO_0000218,,11507,Feces,1,10116.0,CHEMBL624280,,1988.0,Intermediate,A,
,11488,Rattus norvegicus,1,,N,50597,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,,BAO_0000218,,11508,Feces,1,10116.0,CHEMBL624281,,1988.0,Intermediate,A,
,11488,Rattus norvegicus,1,,N,50597,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,,BAO_0000218,,11509,Feces,1,10116.0,CHEMBL622933,,1988.0,Intermediate,A,
,11488,Rattus norvegicus,1,,N,50597,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,,BAO_0000218,,11510,Feces,1,10116.0,CHEMBL622934,,1988.0,Intermediate,A,
,8829,Rattus norvegicus,1,,N,50597,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,,BAO_0000218,,11511,Liver,1,10116.0,CHEMBL622935,In vivo,2107.0,Intermediate,A,
,8829,Rattus norvegicus,1,,N,50597,,Biodistribution in Rat liver after 5 minutes of iv administration,,,BAO_0000218,,11512,Liver,1,10116.0,CHEMBL622936,In vivo,2107.0,Intermediate,A,
,8829,Rattus norvegicus,1,,N,50597,,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,,,BAO_0000218,,11513,Liver,1,10116.0,CHEMBL875228,In vivo,2107.0,Intermediate,A,
,8829,Rattus norvegicus,1,,N,50597,,Biodistribution in Rat lung after 24 hours of iv administration,,,BAO_0000218,,11514,Lung,1,10116.0,CHEMBL622937,In vivo,2048.0,Intermediate,A,
,8829,Rattus norvegicus,1,,N,50597,,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,,,BAO_0000218,,11515,Lung,1,10116.0,CHEMBL622938,In vivo,2048.0,Intermediate,A,
,8829,Rattus norvegicus,1,,N,50597,,Biodistribution in Rat lung after 30 minutes of iv administration,,,BAO_0000218,,11516,Lung,1,10116.0,CHEMBL619736,In vivo,2048.0,Intermediate,A,
,8829,Rattus norvegicus,1,,N,50597,,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,,,BAO_0000218,,11517,Lung,1,10116.0,CHEMBL625117,In vivo,2048.0,Intermediate,A,
,8829,Rattus norvegicus,1,,N,50597,,Biodistribution in Rat lung after 5 minutes of iv administration,,,BAO_0000218,,11518,Lung,1,10116.0,CHEMBL625118,In vivo,2048.0,Intermediate,A,
,8829,Rattus norvegicus,1,,N,50597,,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,,,BAO_0000218,,11519,Lung,1,10116.0,CHEMBL625119,In vivo,2048.0,Intermediate,A,
,14972,Rattus norvegicus,1,,N,50597,,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",,,BAO_0000218,,11520,Cerebellum,1,10116.0,CHEMBL625120,In vivo,2037.0,Intermediate,A,
,14972,Rattus norvegicus,1,,N,50597,,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",,,BAO_0000218,,11521,,1,10116.0,CHEMBL625121,In vivo,,Intermediate,A,
,14972,Rattus norvegicus,1,,N,50597,,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",,,BAO_0000218,,11522,Thalamus,1,10116.0,CHEMBL625122,In vivo,10000006.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,,11523,Blood,1,10116.0,CHEMBL622204,In vivo,178.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,,11524,Blood,1,10116.0,CHEMBL877503,In vivo,178.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,,11525,Blood,1,10116.0,CHEMBL627127,In vivo,178.0,Intermediate,A,
,14608,,1,,U,22224,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,,11526,Hippocampus,0,,CHEMBL627128,In vivo,10000000.0,Autocuration,A,
,14608,,1,,U,22224,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,,11527,Hippocampus,0,,CHEMBL627129,In vivo,10000000.0,Autocuration,A,
,14608,,1,,U,22224,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,,11528,Hippocampus,0,,CHEMBL627130,In vivo,10000000.0,Autocuration,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,,11529,Brain,1,10116.0,CHEMBL627131,In vivo,955.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,,11530,Brain,1,10116.0,CHEMBL627132,In vivo,955.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,,11531,Brain,1,10116.0,CHEMBL627133,In vivo,955.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,,11532,Cerebellum,1,10116.0,CHEMBL627134,In vivo,2037.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,,11533,Cerebellum,1,10116.0,CHEMBL627135,In vivo,2037.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,,11534,Cerebellum,1,10116.0,CHEMBL627136,In vivo,2037.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,,11535,,1,10116.0,CHEMBL628435,In vivo,,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,,11536,,1,10116.0,CHEMBL628436,In vivo,,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,,11537,,1,10116.0,CHEMBL628437,In vivo,,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,,11538,Heart,1,10116.0,CHEMBL628438,In vivo,948.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,,11539,Heart,1,10116.0,CHEMBL628439,In vivo,948.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,,11540,Heart,1,10116.0,CHEMBL628440,In vivo,948.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,,11541,Hippocampus,1,10116.0,CHEMBL628441,In vivo,10000000.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,,11542,Hippocampus,1,10116.0,CHEMBL628442,In vivo,10000000.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,,11543,Hippocampus,1,10116.0,CHEMBL628443,In vivo,10000000.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,,11544,Kidney,1,10116.0,CHEMBL628444,In vivo,2113.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,,11545,Kidney,1,10116.0,CHEMBL628445,In vivo,2113.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,,11546,Kidney,1,10116.0,CHEMBL877504,In vivo,2113.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,,11547,Liver,1,10116.0,CHEMBL628446,In vivo,2107.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,,11548,Liver,1,10116.0,CHEMBL626874,In vivo,2107.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,,11549,Liver,1,10116.0,CHEMBL626875,In vivo,2107.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,,11550,Lung,1,10116.0,CHEMBL626876,In vivo,2048.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,,11551,Lung,1,10116.0,CHEMBL626877,In vivo,2048.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,,11552,Lung,1,10116.0,CHEMBL626878,In vivo,2048.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,,11553,Muscle tissue,1,10116.0,CHEMBL626879,In vivo,2385.0,Intermediate,A,
,8918,Simiiformes,1,,U,22224,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,,,BAO_0000218,,11554,Plasma,0,314293.0,CHEMBL626880,In vivo,1969.0,Autocuration,A,
,8918,Mus musculus,1,,N,50594,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,,,BAO_0000218,,11555,Plasma,1,10090.0,CHEMBL626881,In vivo,1969.0,Intermediate,A,
,8918,Rattus norvegicus,1,,N,50597,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,,,BAO_0000218,,11556,Plasma,1,10116.0,CHEMBL626882,In vivo,1969.0,Intermediate,A,
,14470,Canis lupus familiaris,1,,N,50588,,Peak plasma concentration was measured in dogs,,,BAO_0000218,,11557,Plasma,1,9615.0,CHEMBL626883,In vivo,1969.0,Intermediate,A,
,14393,Rattus norvegicus,1,,N,50597,,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,BAO_0000218,,11558,,1,10116.0,CHEMBL626884,In vivo,,Intermediate,A,
,14886,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,,BAO_0000218,,11559,,1,10116.0,CHEMBL626885,In vivo,,Intermediate,A,
,14886,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,,BAO_0000218,,11560,,1,10116.0,CHEMBL626886,In vivo,,Intermediate,A,
,14886,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,,BAO_0000218,,11561,,1,10116.0,CHEMBL626887,In vivo,,Intermediate,A,
,14393,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,BAO_0000218,,11562,,1,10116.0,CHEMBL626888,In vivo,,Intermediate,A,
,13465,Canis lupus familiaris,1,,N,50588,,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,,,BAO_0000218,,11563,,1,9615.0,CHEMBL626889,In vivo,,Intermediate,A,
,13465,Simiiformes,1,,U,22224,,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,,,BAO_0000218,,11564,,0,314293.0,CHEMBL626761,In vivo,,Autocuration,A,
,13465,Canis lupus familiaris,1,,N,50588,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,,,BAO_0000218,,11565,,1,9615.0,CHEMBL626762,In vivo,,Intermediate,A,
,13465,Canis lupus familiaris,1,,N,50588,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,,,BAO_0000218,,11566,,1,9615.0,CHEMBL626763,In vivo,,Intermediate,A,
,13465,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,,,BAO_0000218,,11567,,1,10116.0,CHEMBL626764,In vivo,,Intermediate,A,
,13465,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,,,BAO_0000218,,11568,,1,10116.0,CHEMBL626765,In vivo,,Intermediate,A,
,13465,Canis lupus familiaris,1,,N,50588,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,,,BAO_0000218,,11569,,1,9615.0,CHEMBL626766,In vivo,,Intermediate,A,
,13465,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,,,BAO_0000218,,11570,,1,10116.0,CHEMBL626767,In vivo,,Intermediate,A,
,13465,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,,,BAO_0000218,,11571,,1,10116.0,CHEMBL626768,In vivo,,Intermediate,A,
,13465,Canis lupus familiaris,1,,N,50588,,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,,,BAO_0000218,,11572,,1,9615.0,CHEMBL626769,In vivo,,Intermediate,A,
,13465,Canis lupus familiaris,1,,N,50588,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,,,BAO_0000218,,11573,,1,9615.0,CHEMBL874463,In vivo,,Intermediate,A,
,13465,Simiiformes,1,,U,22224,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,,,BAO_0000218,,11574,,0,314293.0,CHEMBL626770,In vivo,,Autocuration,A,
,13465,Simiiformes,1,,U,22224,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,,,BAO_0000218,,11575,,0,314293.0,CHEMBL626771,In vivo,,Autocuration,A,
,13465,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,,,BAO_0000218,,11576,,1,10116.0,CHEMBL626772,In vivo,,Intermediate,A,
,14731,Macaca fascicularis,1,,N,100710,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,,BAO_0000218,,11577,,1,9541.0,CHEMBL626773,In vivo,,Intermediate,A,
,14731,Mus musculus,1,,N,50594,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,,,BAO_0000218,,11578,,1,10090.0,CHEMBL626774,In vivo,,Intermediate,A,
,13376,Canis lupus familiaris,1,,N,50588,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,,,BAO_0000218,,11579,,1,9615.0,CHEMBL626775,In vivo,,Intermediate,A,
,13376,Canis lupus familiaris,1,,N,50588,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,,,BAO_0000218,,11580,,1,9615.0,CHEMBL626776,In vivo,,Intermediate,A,
,14443,Rattus norvegicus,1,,N,50597,,Maximum concentration (Cmax) in rat when administered orally,,,BAO_0000218,,11581,,1,10116.0,CHEMBL626777,In vivo,,Intermediate,A,
,13465,Simiiformes,1,,U,22224,,Maximal concentration in monkey plasma after 25 mg/kg oral dose,,,BAO_0000218,,11582,Plasma,0,314293.0,CHEMBL626778,In vivo,1969.0,Autocuration,A,
,16359,Rattus norvegicus,1,,U,22224,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",,,BAO_0000218,,11583,,0,10116.0,CHEMBL626779,In vivo,,Autocuration,A,
,16359,Rattus norvegicus,1,,U,22224,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",,,BAO_0000218,,11584,,0,10116.0,CHEMBL626780,In vivo,,Autocuration,A,
,15618,,1,,U,22224,,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,,,BAO_0000218,,11585,Plasma,0,,CHEMBL626781,In vivo,1969.0,Autocuration,A,
,14554,Rattus norvegicus,1,,N,50597,,Pharmacokinetic profile Cmax was evaluated in rats,,,BAO_0000218,,11586,,1,10116.0,CHEMBL632164,In vivo,,Intermediate,A,
,11537,Canis lupus familiaris,1,,N,50588,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),,,BAO_0000218,,11587,,1,9615.0,CHEMBL632165,In vivo,,Intermediate,A,
,11537,Mus musculus,1,,N,50594,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),,,BAO_0000218,,11588,,1,10090.0,CHEMBL632166,In vivo,,Intermediate,A,
,11537,Canis lupus familiaris,1,,N,50588,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),,,BAO_0000218,,11589,,1,9615.0,CHEMBL632167,In vivo,,Intermediate,A,
,11537,Mus musculus,1,,N,50594,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),,,BAO_0000218,,11590,,1,10090.0,CHEMBL632168,In vivo,,Intermediate,A,
,2021,Rattus norvegicus,1,,U,22224,,Cmax in rat plasma,,,BAO_0000218,,11591,Plasma,0,10116.0,CHEMBL632169,In vivo,1969.0,Autocuration,A,
,5932,Canis lupus familiaris,1,,N,50588,,Cmax in dog plasma after 30mg/kg oral dose,,,BAO_0000218,,11592,Plasma,1,9615.0,CHEMBL632170,In vivo,1969.0,Intermediate,A,
,5932,Rattus norvegicus,1,,N,50597,,Cmax in rat plasma after 30mg/kg oral dose,,,BAO_0000218,,11593,Plasma,1,10116.0,CHEMBL632171,In vivo,1969.0,Intermediate,A,
,17320,Rattus norvegicus,1,,N,50597,,Plasma level in rats at 30 mg/kg,,,BAO_0000218,,11594,Plasma,1,10116.0,CHEMBL632172,In vivo,1969.0,Intermediate,A,
,15831,Mus musculus,1,,N,50594,,Tested for maximum plasma concentration in mice,,,BAO_0000218,,11595,Plasma,1,10090.0,CHEMBL632173,In vivo,1969.0,Intermediate,A,
,15078,Rattus norvegicus,1,,N,50597,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,,11596,,1,10116.0,CHEMBL632174,In vivo,,Intermediate,A,
,14941,Rattus norvegicus,1,,N,50597,,The Cmax values in female wistar rats.,,,BAO_0000218,,11597,,1,10116.0,CHEMBL632175,In vivo,,Intermediate,A,
,15343,Canis lupus familiaris,1,,N,50588,,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,,,BAO_0000218,,11598,Plasma,1,9615.0,CHEMBL632176,In vivo,1969.0,Intermediate,A,
,15343,Rattus norvegicus,1,,N,50597,,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,,,BAO_0000218,,11599,Plasma,1,10116.0,CHEMBL632177,In vivo,1969.0,Intermediate,A,
,14856,Rattus norvegicus,1,,N,50597,,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,,,BAO_0000218,,11600,Plasma,1,10116.0,CHEMBL632178,In vivo,1969.0,Intermediate,A,
,13129,Rattus norvegicus,1,,N,50597,,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,,,BAO_0000218,,11601,,1,10116.0,CHEMBL632179,In vivo,,Intermediate,A,
,13098,Rattus norvegicus,1,,N,50597,,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,,,BAO_0000218,,11602,Blood,1,10116.0,CHEMBL632180,In vivo,178.0,Intermediate,A,
,13098,Rattus norvegicus,1,,N,50597,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,,,BAO_0000218,,11603,Blood,1,10116.0,CHEMBL632181,In vivo,178.0,Intermediate,A,
,13098,Rattus norvegicus,1,,N,50597,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,,,BAO_0000218,,11604,Blood,1,10116.0,CHEMBL632182,In vivo,178.0,Intermediate,A,
,15478,Mus musculus,1,,U,22224,,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,,,BAO_0000218,,11605,Blood,0,10090.0,CHEMBL632183,In vivo,178.0,Autocuration,A,
,15341,Canis lupus familiaris,1,,N,50588,,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,,,BAO_0000218,,11606,,1,9615.0,CHEMBL632184,In vivo,,Intermediate,A,
,15341,Rattus norvegicus,1,,N,50597,,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,,,BAO_0000218,,11607,,1,10116.0,CHEMBL874470,In vivo,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11608,,1,10116.0,CHEMBL631302,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11609,,1,10116.0,CHEMBL631303,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11610,,1,10116.0,CHEMBL631304,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11611,,1,10116.0,CHEMBL631305,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11612,,1,10116.0,CHEMBL631306,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11613,,1,10116.0,CHEMBL631307,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11614,,1,10116.0,CHEMBL631308,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11615,,1,10116.0,CHEMBL625557,,,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11616,Spleen,1,10116.0,CHEMBL625558,,2106.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11617,Spleen,1,10116.0,CHEMBL625559,,2106.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11618,Spleen,1,10116.0,CHEMBL625560,,2106.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11619,Spleen,1,10116.0,CHEMBL625561,,2106.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11620,Spleen,1,10116.0,CHEMBL625562,,2106.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11621,Spleen,1,10116.0,CHEMBL875320,,2106.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11622,Spleen,1,10116.0,CHEMBL625563,,2106.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11623,Spleen,1,10116.0,CHEMBL625564,,2106.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11624,Uterus,1,10116.0,CHEMBL625565,,995.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11625,Uterus,1,10116.0,CHEMBL625566,,995.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11626,Uterus,1,10116.0,CHEMBL625567,,995.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11627,Uterus,1,10116.0,CHEMBL625568,,995.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11628,Uterus,1,10116.0,CHEMBL628217,,995.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",,,BAO_0000218,,11629,Uterus,1,10116.0,CHEMBL628218,,995.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11630,Uterus,1,10116.0,CHEMBL628219,,995.0,Intermediate,A,
,8684,Rattus norvegicus,1,,N,50597,,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",,,BAO_0000218,,11631,Uterus,1,10116.0,CHEMBL628220,,995.0,Intermediate,A,
,8926,,1,,U,22224,,Distribution in the blood after 120 min of intravenous administration,,,BAO_0000019,,11632,,0,,CHEMBL628221,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the blood after 15 min of intravenous administration,,,BAO_0000019,,11633,,0,,CHEMBL628222,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the blood after 30 min of intravenous administration,,,BAO_0000019,,11634,,0,,CHEMBL628223,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the blood after 5 min of intravenous administration,,,BAO_0000019,,11635,,0,,CHEMBL628224,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the blood after 60 min of intravenous administration,,,BAO_0000019,,11636,,0,,CHEMBL628225,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the blood after 90 min of intravenous administration,,,BAO_0000019,,11637,,0,,CHEMBL628226,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the bone after 120 min of intravenous administration,,,BAO_0000019,,11638,,0,,CHEMBL628227,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the bone after 15 min of intravenous administration,,,BAO_0000019,,11639,,0,,CHEMBL875481,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the bone after 30 min of intravenous administration,,,BAO_0000019,,11640,,0,,CHEMBL628228,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the bone after 5 min of intravenous administration,,,BAO_0000019,,11641,,0,,CHEMBL628229,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the bone after 60 min of intravenous administration,,,BAO_0000019,,11642,,0,,CHEMBL628230,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the bone after 90 min of intravenous administration,,,BAO_0000019,,11643,,0,,CHEMBL628231,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the heart after 120 min of intravenous administration,,,BAO_0000019,,11644,,0,,CHEMBL628232,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the heart after 15 min of intravenous administration,,,BAO_0000019,,11645,,0,,CHEMBL628233,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the heart after 30 min of intravenous administration,,,BAO_0000019,,11646,,0,,CHEMBL628234,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the heart after 5 min of intravenous administration,,,BAO_0000019,,11647,,0,,CHEMBL628235,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the heart after 60 min of intravenous administration,,,BAO_0000019,,11648,,0,,CHEMBL628236,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the heart after 90 min of intravenous administration,,,BAO_0000019,,11649,,0,,CHEMBL628237,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the kidneys after 120 min of intravenous administration,,,BAO_0000019,,11650,,0,,CHEMBL628238,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the kidneys after 15 min of intravenous administration,,,BAO_0000019,,11651,,0,,CHEMBL628239,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the kidneys after 30 min of intravenous administration,,,BAO_0000019,,11652,,0,,CHEMBL628240,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the kidneys after 5 min of intravenous administration,,,BAO_0000019,,11653,,0,,CHEMBL628241,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the kidneys after 60 min of intravenous administration,,,BAO_0000019,,11654,,0,,CHEMBL628242,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the kidneys after 90 min of intravenous administration,,,BAO_0000019,,11655,,0,,CHEMBL875482,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the liver after 120 min of intravenous administration,,,BAO_0000019,,11656,,0,,CHEMBL628243,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the liver after 15 min of intravenous administration,,,BAO_0000019,,11657,,0,,CHEMBL628244,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the liver after 30 min of intravenous administration,,,BAO_0000019,,11658,,0,,CHEMBL628245,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the liver after 5 min of intravenous administration,,,BAO_0000019,,11659,,0,,CHEMBL628246,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the liver after 60 min of intravenous administration,,,BAO_0000019,,11660,,0,,CHEMBL628247,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the liver after 90 min of intravenous administration,,,BAO_0000019,,11661,,0,,CHEMBL628248,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the lung after 120 min of intravenous administration,,,BAO_0000019,,11662,,0,,CHEMBL628249,,,Autocuration,A,
,14839,Mus musculus,1,,N,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",,,BAO_0000218,,11663,,1,10090.0,CHEMBL625452,,,Intermediate,A,
,14839,Mus musculus,1,,N,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",,,BAO_0000218,,11664,,1,10090.0,CHEMBL625453,,,Intermediate,A,
,14839,Mus musculus,1,,N,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",,,BAO_0000218,,11665,,1,10090.0,CHEMBL625454,,,Intermediate,A,
,14839,Mus musculus,1,,N,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",,,BAO_0000218,,11666,,1,10090.0,CHEMBL623844,,,Intermediate,A,
,12178,Rattus norvegicus,1,,N,50597,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,,,BAO_0000218,,11667,,1,10116.0,CHEMBL623845,,,Intermediate,A,
,12178,Rattus norvegicus,1,,N,50597,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,,,BAO_0000218,,11668,,1,10116.0,CHEMBL623846,,,Intermediate,A,
,12178,,1,,U,22224,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,,,BAO_0000218,,11669,,0,,CHEMBL623847,,,Autocuration,A,
,12186,Macaca fascicularis,1,,N,100710,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,,BAO_0000218,,11670,,1,9541.0,CHEMBL623848,,,Intermediate,A,
,12186,Macaca fascicularis,1,,N,100710,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,,BAO_0000218,,11671,,1,9541.0,CHEMBL623849,,,Intermediate,A,
,12186,Macaca fascicularis,1,,N,100710,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,,BAO_0000218,,11672,,1,9541.0,CHEMBL623850,,,Intermediate,A,
,12186,Macaca fascicularis,1,,N,100710,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,,BAO_0000218,,11673,,1,9541.0,CHEMBL623851,,,Intermediate,A,
,12187,Simiiformes,1,,U,22224,,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,,BAO_0000218,,11674,,0,314293.0,CHEMBL623852,,,Autocuration,A,
,12187,Mustela putorius furo,1,,N,50506,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,,BAO_0000218,,11675,,1,9669.0,CHEMBL624551,,,Intermediate,A,
,12187,Mustela putorius furo,1,,N,50506,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,,BAO_0000218,,11676,,1,9669.0,CHEMBL624552,,,Intermediate,A,
,12187,Simiiformes,1,,U,22224,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,,BAO_0000218,,11677,,0,314293.0,CHEMBL624553,,,Autocuration,A,
,12187,Simiiformes,1,,U,22224,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,,,BAO_0000218,,11678,,0,314293.0,CHEMBL624554,,,Autocuration,A,
,12187,Rattus norvegicus,1,,N,50597,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,,BAO_0000218,,11679,,1,10116.0,CHEMBL624555,,,Intermediate,A,
,12187,Rattus norvegicus,1,,N,50597,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,,BAO_0000218,,11680,,1,10116.0,CHEMBL624741,,,Intermediate,A,
,14122,Canis lupus familiaris,1,,N,50588,,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",,,BAO_0000218,,11681,,1,9615.0,CHEMBL624742,,,Intermediate,A,
,14122,Cricetinae,1,,N,100712,,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",,,BAO_0000218,,11682,,1,10026.0,CHEMBL624743,,,Intermediate,A,
,14122,Rattus norvegicus,1,,N,50597,,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",,,BAO_0000218,,11683,,1,10116.0,CHEMBL877606,,,Intermediate,A,
,13391,,1,,U,22224,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,,,BAO_0000218,,11684,,0,,CHEMBL624744,,,Autocuration,A,
,13391,,1,,U,22224,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,,BAO_0000218,,11685,Blood,0,,CHEMBL624745,,178.0,Autocuration,A,
,13391,,1,,U,22224,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,,BAO_0000218,,11686,Blood,0,,CHEMBL624746,,178.0,Autocuration,A,
,13391,,1,,U,22224,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,,BAO_0000218,,11687,Blood,0,,CHEMBL624747,,178.0,Autocuration,A,
,16360,,1,,U,22224,,Oral absorption expressed as Area under curve was determined,,,BAO_0000019,,11688,,0,,CHEMBL624748,,,Autocuration,A,
,3673,Canis lupus familiaris,1,,N,50588,,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,,,BAO_0000218,,11689,,1,9615.0,CHEMBL622504,,,Intermediate,A,
,14122,Canis lupus familiaris,1,,N,50588,,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",,,BAO_0000218,,11690,,1,9615.0,CHEMBL622505,,,Intermediate,A,
,14122,Cricetinae,1,,N,100712,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,,BAO_0000218,,11691,,1,10026.0,CHEMBL622506,,,Intermediate,A,
,14122,Cricetinae,1,,N,100712,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,,BAO_0000218,,11692,,1,10026.0,CHEMBL622507,,,Intermediate,A,
,14122,Rattus norvegicus,1,,N,50597,,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",,,BAO_0000218,,11693,,1,10116.0,CHEMBL622508,,,Intermediate,A,
,13889,,1,,U,22224,,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,,,BAO_0000019,,11694,,0,,CHEMBL622509,,,Autocuration,A,
,14393,Rattus norvegicus,1,,N,50597,,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,BAO_0000218,,11695,,1,10116.0,CHEMBL622510,,,Intermediate,A,
,17279,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),,,BAO_0000218,,11696,,1,10116.0,CHEMBL622511,,,Intermediate,A,
,14548,Macaca fascicularis,1,,N,100710,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,,BAO_0000218,,11697,,1,9541.0,CHEMBL622512,,,Intermediate,A,
,14548,Macaca fascicularis,1,,N,100710,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,,BAO_0000218,,11698,,1,9541.0,CHEMBL622513,,,Intermediate,A,
,14548,Macaca fascicularis,1,,N,100710,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,,,BAO_0000218,,11699,,1,9541.0,CHEMBL622514,,,Intermediate,A,
,14548,Canis lupus familiaris,1,,N,50588,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,,BAO_0000218,,11700,,1,9615.0,CHEMBL622515,,,Intermediate,A,
,14548,Canis lupus familiaris,1,,N,50588,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,,,BAO_0000218,,11701,,1,9615.0,CHEMBL622516,,,Intermediate,A,
,14548,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,,BAO_0000218,,11702,,1,10116.0,CHEMBL622517,,,Intermediate,A,
,14548,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,,,BAO_0000218,,11703,,1,10116.0,CHEMBL622518,,,Intermediate,A,
,14548,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,,,BAO_0000218,,11704,,1,10116.0,CHEMBL622519,,,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,,11705,Muscle tissue,1,10116.0,CHEMBL622520,In vivo,2385.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,,11706,Muscle tissue,1,10116.0,CHEMBL622521,In vivo,2385.0,Intermediate,A,
,14608,Mus musculus,1,,N,50594,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,,11707,Zone of skin,1,10090.0,CHEMBL625113,In vivo,14.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,,11708,Zone of skin,1,10116.0,CHEMBL625114,In vivo,14.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,,11709,Zone of skin,1,10116.0,CHEMBL874397,In vivo,14.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,,11710,Spleen,1,10116.0,CHEMBL625115,In vivo,2106.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,,11711,Spleen,1,10116.0,CHEMBL625116,In vivo,2106.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,,11712,Spleen,1,10116.0,CHEMBL623932,In vivo,2106.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,,11713,Striatum,1,10116.0,CHEMBL623933,In vivo,2435.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,,11714,Striatum,1,10116.0,CHEMBL623934,In vivo,2435.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,,11715,Striatum,1,10116.0,CHEMBL623935,In vivo,2435.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,,11716,Thyroid gland,1,10116.0,CHEMBL623936,In vivo,2046.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,,11717,Thyroid gland,1,10116.0,CHEMBL623937,In vivo,2046.0,Intermediate,A,
,14608,Rattus norvegicus,1,,N,50597,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,,11718,Thyroid gland,1,10116.0,CHEMBL623938,In vivo,2046.0,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,BAO_0000218,,11719,,1,10090.0,CHEMBL623939,,,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,,BAO_0000218,,11720,,1,10090.0,CHEMBL623940,,,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,,BAO_0000218,,11721,,1,10090.0,CHEMBL623941,,,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,BAO_0000218,,11722,,1,10090.0,CHEMBL627216,,,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,BAO_0000218,,11723,,1,10090.0,CHEMBL623942,,,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,BAO_0000218,,11724,Brain,1,10090.0,CHEMBL618793,,955.0,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,BAO_0000218,,11725,Brain,1,10090.0,CHEMBL618794,,955.0,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,BAO_0000218,,11726,Brain,1,10090.0,CHEMBL618795,,955.0,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,BAO_0000218,,11727,,1,10090.0,CHEMBL618796,,,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,BAO_0000218,,11728,,1,10090.0,CHEMBL618797,,,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,,BAO_0000218,,11729,Kidney,1,10090.0,CHEMBL618798,,2113.0,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,BAO_0000218,,11730,Kidney,1,10090.0,CHEMBL618799,,2113.0,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,,BAO_0000218,,11731,Kidney,1,10090.0,CHEMBL618800,,2113.0,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,,BAO_0000218,,11732,Kidney,1,10090.0,CHEMBL618801,,2113.0,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,BAO_0000218,,11733,Kidney,1,10090.0,CHEMBL618802,,2113.0,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,BAO_0000218,,11734,Kidney,1,10090.0,CHEMBL618803,,2113.0,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,,BAO_0000218,,11735,Liver,1,10090.0,CHEMBL618804,,2107.0,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,BAO_0000218,,11736,Liver,1,10090.0,CHEMBL618805,,2107.0,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,,BAO_0000218,,11737,Liver,1,10090.0,CHEMBL618806,,2107.0,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,,BAO_0000218,,11738,Liver,1,10090.0,CHEMBL618807,,2107.0,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,BAO_0000218,,11739,Liver,1,10090.0,CHEMBL618808,,2107.0,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,BAO_0000218,,11740,Liver,1,10090.0,CHEMBL618809,,2107.0,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,BAO_0000218,,11741,Muscle tissue,1,10090.0,CHEMBL618810,,2385.0,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,,BAO_0000218,,11742,Muscle tissue,1,10090.0,CHEMBL618811,,2385.0,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,,BAO_0000218,,11743,Muscle tissue,1,10090.0,CHEMBL875844,,2385.0,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,BAO_0000218,,11744,Muscle tissue,1,10090.0,CHEMBL618812,,2385.0,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,BAO_0000218,,11745,Muscle tissue,1,10090.0,CHEMBL618813,,2385.0,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,BAO_0000218,,11746,,1,10090.0,CHEMBL618814,,,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,BAO_0000218,,11747,,1,10090.0,CHEMBL618815,,,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,BAO_0000218,,11748,,1,10090.0,CHEMBL618816,,,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,BAO_0000218,,11749,,1,10090.0,CHEMBL618817,,,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,BAO_0000218,,11750,,1,10090.0,CHEMBL620544,,,Intermediate,A,
,15341,Rattus norvegicus,1,,N,50597,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,,,BAO_0000218,,11751,,1,10116.0,CHEMBL626230,In vivo,,Intermediate,A,
,15341,Rattus norvegicus,1,,N,50597,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,,,BAO_0000218,,11752,,1,10116.0,CHEMBL626231,In vivo,,Intermediate,A,
,15341,Rattus norvegicus,1,,N,50597,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,,,BAO_0000218,,11753,,1,10116.0,CHEMBL626232,In vivo,,Intermediate,A,
,14906,Canis lupus familiaris,1,,N,50588,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,,,BAO_0000218,,11754,Plasma,1,9615.0,CHEMBL626233,In vivo,1969.0,Intermediate,A,
,14906,Rattus norvegicus,1,,N,50597,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,,,BAO_0000218,,11755,Plasma,1,10116.0,CHEMBL626234,In vivo,1969.0,Intermediate,A,
,14906,Rattus norvegicus,1,,N,50597,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,,,BAO_0000218,,11756,Plasma,1,10116.0,CHEMBL875341,In vivo,1969.0,Intermediate,A,
,14215,Homo sapiens,1,,N,50587,,The maximum plasma concentration (100 mg/kg) administered orally in human,,,BAO_0000218,,11757,Plasma,1,9606.0,CHEMBL626235,In vivo,1969.0,Intermediate,A,
,14215,Callithrix,1,,U,22224,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,,,BAO_0000218,,11758,Plasma,0,9481.0,CHEMBL626236,In vivo,1969.0,Autocuration,A,
,14215,Simiiformes,1,,U,22224,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,,,BAO_0000218,,11759,Plasma,0,314293.0,CHEMBL626237,In vivo,1969.0,Autocuration,A,
,14215,Canis lupus familiaris,1,,N,50588,,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,,,BAO_0000218,,11760,Plasma,1,9615.0,CHEMBL626238,In vivo,1969.0,Intermediate,A,
,14215,Homo sapiens,1,,N,50587,,The maximum plasma concentration (200 mg/kg) administered orally in human,,,BAO_0000218,,11761,Plasma,1,9606.0,CHEMBL622412,In vivo,1969.0,Intermediate,A,
,14215,Rattus norvegicus,1,,N,50597,,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,,,BAO_0000218,,11762,Plasma,1,10116.0,CHEMBL623114,In vivo,1969.0,Intermediate,A,
,14215,Callithrix,1,,U,22224,,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,,,BAO_0000218,,11763,Plasma,0,9481.0,CHEMBL623115,In vivo,1969.0,Autocuration,A,
,14215,Simiiformes,1,,U,22224,,The maximum plasma concentration (25 mg/kg) administered orally in monkey,,,BAO_0000218,,11764,Plasma,0,314293.0,CHEMBL623116,In vivo,1969.0,Autocuration,A,
,14215,Canis lupus familiaris,1,,U,22224,,The maximum plasma concentration (30 mg/kg) administered orally in dog,,,BAO_0000218,,11765,Plasma,0,9615.0,CHEMBL623117,In vivo,1969.0,Autocuration,A,
,14215,Homo sapiens,1,,N,50587,,The maximum plasma concentration (400 mg/kg) administered orally in human,,,BAO_0000218,,11766,Plasma,1,9606.0,CHEMBL623118,In vivo,1969.0,Intermediate,A,
,14215,Rattus norvegicus,1,,N,50597,,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,,,BAO_0000218,,11767,Plasma,1,10116.0,CHEMBL623119,In vivo,1969.0,Intermediate,A,
,14215,Rattus norvegicus,1,,N,50597,,The maximum plasma concentration (50 mg/kg) administered orally in rat,,,BAO_0000218,,11768,Plasma,1,10116.0,CHEMBL623120,In vivo,1969.0,Intermediate,A,
,14215,Homo sapiens,1,,N,50587,,The maximum plasma concentration (800 mg/kg) administered orally in human,,,BAO_0000218,,11769,Plasma,1,9606.0,CHEMBL623286,In vivo,1969.0,Intermediate,A,
,14067,Rattus norvegicus,1,,N,50597,,The maximum plasma concentration was measured on rats,,,BAO_0000218,,11770,Plasma,1,10116.0,CHEMBL623287,In vivo,1969.0,Intermediate,A,
,12350,Rattus norvegicus,1,,N,50597,,The maximum plasma concentration was measured on rats after oral administration,,,BAO_0000218,,11771,Plasma,1,10116.0,CHEMBL623288,In vivo,1969.0,Intermediate,A,
,14813,Rattus norvegicus,1,,N,50597,,Plasma drug Cmax in rat (PO dose),,,BAO_0000218,,11772,Plasma,1,10116.0,CHEMBL623289,In vivo,1969.0,Intermediate,A,
,12536,,1,,U,22224,,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,,,BAO_0000218,,11773,,0,,CHEMBL623290,In vivo,,Autocuration,A,
,14169,Canis lupus familiaris,1,,N,50588,,maximum Plasma concentration in Dog was determined after Peroral administration,,,BAO_0000218,,11774,Plasma,1,9615.0,CHEMBL623291,In vivo,1969.0,Intermediate,A,
,14169,Rattus norvegicus,1,,N,50597,,maximum Plasma concentration in Rats was determined after Peroral administration,,,BAO_0000218,,11775,Plasma,1,10116.0,CHEMBL623292,In vivo,1969.0,Intermediate,A,
,15604,Canis lupus familiaris,1,,N,50588,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,,BAO_0000218,,11776,Plasma,1,9615.0,CHEMBL623293,In vivo,1969.0,Intermediate,A,
,15604,Simiiformes,1,,U,22224,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,,BAO_0000218,,11777,Plasma,0,314293.0,CHEMBL623294,In vivo,1969.0,Autocuration,A,
,15604,Rattus norvegicus,1,,N,50597,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,,BAO_0000218,,11778,Plasma,1,10116.0,CHEMBL623295,In vivo,1969.0,Intermediate,A,
,14387,Mus musculus,1,,N,50594,,maximum concentration was measured when administered through oral route in mice,,,BAO_0000218,,11779,,1,10090.0,CHEMBL623296,In vivo,,Intermediate,A,
,15115,Mus musculus,1,,N,50594,,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,,,BAO_0000218,,11780,,1,10090.0,CHEMBL875349,,,Intermediate,A,
,15115,Simiiformes,1,,U,22224,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,,,BAO_0000019,,11781,,0,314293.0,CHEMBL623297,,,Autocuration,A,
,15115,Simiiformes,1,,U,22224,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,,,BAO_0000019,,11782,,0,314293.0,CHEMBL623298,,,Autocuration,A,
,15115,Simiiformes,1,,U,22224,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,,,BAO_0000019,,11783,,0,314293.0,CHEMBL623299,,,Autocuration,A,
,16359,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter was evaluated in rats,,,BAO_0000218,,11784,,1,10116.0,CHEMBL623300,,,Intermediate,A,
,12829,Mus musculus,1,,N,50594,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,,BAO_0000218,,11785,,1,10090.0,CHEMBL623301,,,Intermediate,A,
,12829,Mus musculus,1,,N,50594,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,,,BAO_0000218,,11786,,1,10090.0,CHEMBL623302,,,Intermediate,A,
,12829,Mus musculus,1,,N,50594,,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,,BAO_0000218,,11787,,1,10090.0,CHEMBL623303,,,Intermediate,A,
,12829,Mus musculus,1,,N,50594,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,,,BAO_0000218,,11788,,1,10090.0,CHEMBL623304,,,Intermediate,A,
,12829,Mus musculus,1,,N,50594,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,,,BAO_0000218,,11789,,1,10090.0,CHEMBL623305,,,Intermediate,A,
,15137,Rattus norvegicus,1,,N,50597,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,,,BAO_0000218,,11790,Plasma,1,10116.0,CHEMBL623306,,1969.0,Intermediate,A,
,15137,Rattus norvegicus,1,,N,50597,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,,,BAO_0000218,,11791,Plasma,1,10116.0,CHEMBL623307,,1969.0,Intermediate,A,
,15137,Rattus norvegicus,1,,N,50597,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,,,BAO_0000218,,11792,Plasma,1,10116.0,CHEMBL623308,,1969.0,Intermediate,A,
,15137,Mus musculus,1,,N,50594,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,,,BAO_0000218,,11793,Plasma,1,10090.0,CHEMBL623309,,1969.0,Intermediate,A,
,13509,Mus musculus,1,,N,50594,,Plasma Concentration after 120 min of oral administration to mice,,,BAO_0000218,,11794,,1,10090.0,CHEMBL623310,,,Intermediate,A,
,13509,Mus musculus,1,,N,50594,,Plasma Concentration after 30 min of oral administration to mice,,,BAO_0000218,,11795,,1,10090.0,CHEMBL623311,,,Intermediate,A,
,13509,Macaca fascicularis,1,,N,100710,,Plasma Concentration after 60 min of oral administration to mice,,,BAO_0000218,,11796,,1,9541.0,CHEMBL623312,,,Intermediate,A,
,13509,Mus musculus,1,,N,50594,,Plasma Concentration after 60 min of oral administration to mice; Not determined,,,BAO_0000218,,11797,,1,10090.0,CHEMBL875350,,,Intermediate,A,
,13509,Mus musculus,1,,N,50594,,Plasma Concentration after 90 min of oral administration to mice,,,BAO_0000218,,11798,,1,10090.0,CHEMBL628635,,,Intermediate,A,
,12064,Rattus norvegicus,1,,N,50597,,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,,,BAO_0000218,,11799,,1,10116.0,CHEMBL628636,,,Intermediate,A,
,12064,Rattus norvegicus,1,,N,50597,,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,,,BAO_0000218,,11800,,1,10116.0,CHEMBL628637,,,Intermediate,A,
,12064,Rattus norvegicus,1,,N,50597,,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,,,BAO_0000218,,11801,,1,10116.0,CHEMBL628058,,,Intermediate,A,
,10677,Rattus norvegicus,1,,N,50597,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,,,BAO_0000218,,11802,,1,10116.0,CHEMBL628059,,,Intermediate,A,
,10677,Rattus norvegicus,1,,N,50597,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,,,BAO_0000218,,11803,,1,10116.0,CHEMBL628060,,,Intermediate,A,
,8926,,1,,U,22224,,Distribution in the lung after 15 min of intravenous administration,,,BAO_0000019,,11804,,0,,CHEMBL628061,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the lung after 30 min of intravenous administration,,,BAO_0000019,,11805,,0,,CHEMBL628062,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the lung after 5 min of intravenous administration,,,BAO_0000019,,11806,,0,,CHEMBL628063,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the lung after 60 min of intravenous administration,,,BAO_0000019,,11807,,0,,CHEMBL628064,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the lung after 90 min of intravenous administration,,,BAO_0000019,,11808,,0,,CHEMBL628065,,,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the muscle after 120 min of intravenous administration,,,BAO_0000019,,11809,Muscle tissue,0,,CHEMBL628066,,2385.0,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the muscle after 15 min of intravenous administration,,,BAO_0000019,,11810,Muscle tissue,0,,CHEMBL628067,,2385.0,Autocuration,A,
,8926,Mus musculus,1,,N,50594,,Distribution in the muscle after 30 min of intravenous administration,,,BAO_0000218,,11811,Muscle tissue,1,10090.0,CHEMBL874646,,2385.0,Intermediate,A,
,8926,,1,,U,22224,,Distribution in the muscle after 5 min of intravenous administration,,,BAO_0000019,,11812,Muscle tissue,0,,CHEMBL628068,,2385.0,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the muscle after 60 min of intravenous administration,,,BAO_0000019,,11813,Muscle tissue,0,,CHEMBL628069,,2385.0,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the muscle after 90 min of intravenous administration,,,BAO_0000019,,11814,Muscle tissue,0,,CHEMBL628070,,2385.0,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the spleen after 120 min of intravenous administration,,,BAO_0000019,,11815,Spleen,0,,CHEMBL628071,,2106.0,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the spleen after 15 min of intravenous administration,,,BAO_0000019,,11816,Spleen,0,,CHEMBL628072,,2106.0,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the spleen after 30 min of intravenous administration,,,BAO_0000019,,11817,Spleen,0,,CHEMBL628073,,2106.0,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the spleen after 5 min of intravenous administration,,,BAO_0000019,,11818,Spleen,0,,CHEMBL628074,,2106.0,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the spleen after 60 min of intravenous administration,,,BAO_0000019,,11819,Spleen,0,,CHEMBL628075,,2106.0,Autocuration,A,
,8926,,1,,U,22224,,Distribution in the spleen after 90 min of intravenous administration,,,BAO_0000019,,11820,Spleen,0,,CHEMBL628076,,2106.0,Autocuration,A,
,7570,Rattus norvegicus,1,,N,50597,,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,,,BAO_0000218,,11821,Adrenal cortex,1,10116.0,CHEMBL628077,,1235.0,Intermediate,A,
,7570,Rattus norvegicus,1,,N,50597,,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,,,BAO_0000218,,11822,Blood,1,10116.0,CHEMBL628078,,178.0,Intermediate,A,
,7570,Rattus norvegicus,1,,N,50597,,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,,,BAO_0000218,,11823,Liver,1,10116.0,CHEMBL628079,,2107.0,Intermediate,A,
,7570,Rattus norvegicus,1,,N,50597,,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,,,BAO_0000218,,11824,Female gonad,1,10116.0,CHEMBL628080,,992.0,Intermediate,A,
,7570,Rattus norvegicus,1,,N,50597,,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,,,BAO_0000218,,11825,Thyroid gland,1,10116.0,CHEMBL628081,,2046.0,Intermediate,A,
,7570,Rattus norvegicus,1,,N,50597,,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,,,BAO_0000218,,11826,Adrenal cortex,1,10116.0,CHEMBL628082,,1235.0,Intermediate,A,
,7570,Rattus norvegicus,1,,N,50597,,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,,,BAO_0000218,,11827,Blood,1,10116.0,CHEMBL874647,,178.0,Intermediate,A,
,7570,Rattus norvegicus,1,,N,50597,,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,,,BAO_0000218,,11828,Liver,1,10116.0,CHEMBL626406,,2107.0,Intermediate,A,
,7570,Rattus norvegicus,1,,N,50597,,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,,,BAO_0000218,,11829,Female gonad,1,10116.0,CHEMBL626407,,992.0,Intermediate,A,
,7570,Rattus norvegicus,1,,N,50597,,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,,,BAO_0000218,,11830,Thyroid gland,1,10116.0,CHEMBL626408,,2046.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",,,BAO_0000218,,11831,Blood,1,10116.0,CHEMBL626409,,178.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",,,BAO_0000218,,11832,Blood,1,10116.0,CHEMBL626410,,178.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",,,BAO_0000218,,11833,Blood,1,10116.0,CHEMBL626411,,178.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",,,BAO_0000218,,11834,Blood,1,10116.0,CHEMBL626412,,178.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",,,BAO_0000218,,11835,Blood,1,10116.0,CHEMBL626413,,178.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",,,BAO_0000218,,11836,Blood,1,10116.0,CHEMBL626414,,178.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",,,BAO_0000218,,11837,Blood,1,10116.0,CHEMBL626415,,178.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",,,BAO_0000218,,11838,Blood,1,10116.0,CHEMBL626416,,178.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",,,BAO_0000218,,11839,Blood,1,10116.0,CHEMBL627062,,178.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",,,BAO_0000218,,11840,Blood,1,10116.0,CHEMBL627063,,178.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",,,BAO_0000218,,11841,Blood,1,10116.0,CHEMBL627064,,178.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",,,BAO_0000218,,11842,Blood,1,10116.0,CHEMBL627227,,178.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",,,BAO_0000218,,11843,Blood,1,10116.0,CHEMBL627228,,178.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",,,BAO_0000218,,11844,Blood,1,10116.0,CHEMBL627229,,178.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",,,BAO_0000218,,11845,Blood,1,10116.0,CHEMBL625792,,178.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",,,BAO_0000218,,11846,Blood,1,10116.0,CHEMBL625793,,178.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",,,BAO_0000218,,11847,Blood,1,10116.0,CHEMBL625794,,178.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",,,BAO_0000218,,11848,Blood,1,10116.0,CHEMBL625795,,178.0,Intermediate,A,
,13792,Mus musculus,1,,N,50594,,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,,,BAO_0000218,,11849,,1,10090.0,CHEMBL625796,,,Intermediate,A,
,13376,Canis lupus familiaris,1,,N,50588,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,,,BAO_0000218,,11850,,1,9615.0,CHEMBL625797,,,Intermediate,A,
,13376,Canis lupus familiaris,1,,N,50588,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,,,BAO_0000218,,11851,,1,9615.0,CHEMBL625798,,,Intermediate,A,
,14380,,1,,U,22224,,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,,BAO_0000218,,11852,,0,,CHEMBL875613,,,Autocuration,A,
,14380,,1,,U,22224,,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,,BAO_0000218,,11853,,0,,CHEMBL625799,,,Autocuration,A,
,14380,,1,,U,22224,,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,,,BAO_0000218,,11854,,0,,CHEMBL625800,,,Autocuration,A,
,14380,,1,,U,22224,,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,,BAO_0000218,,11855,,0,,CHEMBL625801,,,Autocuration,A,
,14380,,1,,U,22224,,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,,BAO_0000218,,11856,,0,,CHEMBL625802,,,Autocuration,A,
,14380,,1,,U,22224,,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,,BAO_0000218,,11857,,0,,CHEMBL625803,,,Autocuration,A,
,14380,,1,,U,22224,,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,,,BAO_0000019,,11858,,0,,CHEMBL625804,,,Autocuration,A,
,14380,,1,,U,22224,,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,,,BAO_0000218,,11859,,0,,CHEMBL622530,,,Autocuration,A,
,13701,Mus musculus,1,,N,50594,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,,,BAO_0000218,,11860,,1,10090.0,CHEMBL622531,,,Intermediate,A,
,13701,Mus musculus,1,,N,50594,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,,BAO_0000218,,11861,,1,10090.0,CHEMBL622532,,,Intermediate,A,
,13701,Mus musculus,1,,N,50594,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,,BAO_0000218,,11862,,1,10090.0,CHEMBL623176,,,Intermediate,A,
,13701,Mus musculus,1,,N,50594,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,,BAO_0000218,,11863,,1,10090.0,CHEMBL623177,,,Intermediate,A,
,13701,Mus musculus,1,,N,50594,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,,BAO_0000218,,11864,,1,10090.0,CHEMBL623178,,,Intermediate,A,
,13701,Mus musculus,1,,N,50594,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,,,BAO_0000218,,11865,,1,10090.0,CHEMBL623179,,,Intermediate,A,
,13701,Mus musculus,1,,N,50594,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,,BAO_0000218,,11866,,1,10090.0,CHEMBL623180,,,Intermediate,A,
,13701,Mus musculus,1,,N,50594,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,,BAO_0000218,,11867,,1,10090.0,CHEMBL623181,,,Intermediate,A,
,13701,Mus musculus,1,,N,50594,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,,BAO_0000218,,11868,,1,10090.0,CHEMBL624131,,,Intermediate,A,
,13701,Mus musculus,1,,N,50594,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),,,BAO_0000218,,11869,,1,10090.0,CHEMBL624132,,,Intermediate,A,
,13701,Mus musculus,1,,N,50594,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,,BAO_0000218,,11870,,1,10090.0,CHEMBL624133,,,Intermediate,A,
,13701,Mus musculus,1,,N,50594,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,,,BAO_0000218,,11871,,1,10090.0,CHEMBL624846,,,Intermediate,A,
,13701,Mus musculus,1,,N,50594,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,,BAO_0000218,,11872,,1,10090.0,CHEMBL624847,,,Intermediate,A,
,13701,Mus musculus,1,,N,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,,BAO_0000218,,11873,,1,10090.0,CHEMBL624848,,,Intermediate,A,
,13701,Mus musculus,1,,N,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,,BAO_0000218,,11874,,1,10090.0,CHEMBL625012,,,Intermediate,A,
,13701,Mus musculus,1,,N,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,,BAO_0000218,,11875,,1,10090.0,CHEMBL625013,,,Intermediate,A,
,13701,Mus musculus,1,,N,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,,,BAO_0000218,,11876,,1,10090.0,CHEMBL625014,,,Intermediate,A,
,13701,Mus musculus,1,,N,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),,,BAO_0000218,,11877,,1,10090.0,CHEMBL625015,,,Intermediate,A,
,13701,Mus musculus,1,,N,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,,BAO_0000218,,11878,,1,10090.0,CHEMBL625016,,,Intermediate,A,
,13701,Mus musculus,1,,N,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,,,BAO_0000218,,11879,,1,10090.0,CHEMBL625017,,,Intermediate,A,
,13701,Mus musculus,1,,N,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,,BAO_0000218,,11880,,1,10090.0,CHEMBL625018,,,Intermediate,A,
,13701,Mus musculus,1,,N,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),,,BAO_0000218,,11881,,1,10090.0,CHEMBL625019,,,Intermediate,A,
,13701,Mus musculus,1,,N,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),,,BAO_0000218,,11882,,1,10090.0,CHEMBL625020,,,Intermediate,A,
,13701,Mus musculus,1,,N,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,,,BAO_0000218,,11883,,1,10090.0,CHEMBL625021,,,Intermediate,A,
,14393,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,BAO_0000218,,11884,,1,10116.0,CHEMBL625022,,,Intermediate,A,
,14731,Mus musculus,1,,N,50594,,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,,,BAO_0000218,,11885,,1,10090.0,CHEMBL625023,,,Intermediate,A,
,14731,Macaca fascicularis,1,,N,100710,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,,,BAO_0000218,,11886,,1,9541.0,CHEMBL625024,,,Intermediate,A,
,14731,Macaca fascicularis,1,,N,100710,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,,BAO_0000218,,11887,,1,9541.0,CHEMBL627626,,,Intermediate,A,
,13758,,1,,U,22224,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,,BAO_0000218,,11888,Brain,0,,CHEMBL627627,,955.0,Autocuration,A,
,13758,,1,,U,22224,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,,,BAO_0000218,,11889,Serum,0,,CHEMBL627628,,1977.0,Autocuration,A,
,13758,,1,,U,22224,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,,BAO_0000218,,11890,Brain,0,,CHEMBL627629,,955.0,Autocuration,A,
,13758,,1,,U,22224,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,,,BAO_0000218,,11891,Serum,0,,CHEMBL627630,,1977.0,Autocuration,A,
,16359,,1,,U,22224,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),,,BAO_0000019,,11892,,0,,CHEMBL627631,,,Autocuration,A,
,16359,,1,,U,22224,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),,,BAO_0000218,,11893,,0,,CHEMBL629515,,,Autocuration,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,BAO_0000218,,11894,Spleen,1,10090.0,CHEMBL629516,,2106.0,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,BAO_0000218,,11895,Spleen,1,10090.0,CHEMBL629517,,2106.0,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,BAO_0000218,,11896,Spleen,1,10090.0,CHEMBL629518,,2106.0,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,BAO_0000218,,11897,,1,10090.0,CHEMBL877499,,,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,,BAO_0000218,,11898,,1,10090.0,CHEMBL629519,,,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,BAO_0000218,,11899,,1,10090.0,CHEMBL629520,,,Intermediate,A,
,15383,Mus musculus,1,,N,50594,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,BAO_0000218,,11900,,1,10090.0,CHEMBL629521,,,Intermediate,A,
,14439,Mus musculus,1,,N,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),,,BAO_0000218,,11901,,1,10090.0,CHEMBL629522,,,Intermediate,A,
,14439,Mus musculus,1,,N,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),,,BAO_0000218,,11902,,1,10090.0,CHEMBL629523,,,Intermediate,A,
,14439,Mus musculus,1,,N,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),,,BAO_0000218,,11903,,1,10090.0,CHEMBL629524,,,Intermediate,A,
,14439,Mus musculus,1,,N,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),,,BAO_0000218,,11904,,1,10090.0,CHEMBL629525,,,Intermediate,A,
,14439,Mus musculus,1,,N,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),,,BAO_0000218,,11905,,1,10090.0,CHEMBL629526,,,Intermediate,A,
,14439,Mus musculus,1,,N,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),,,BAO_0000218,,11906,,1,10090.0,CHEMBL629527,,,Intermediate,A,
,14439,Mus musculus,1,,N,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),,,BAO_0000218,,11907,,1,10090.0,CHEMBL629528,,,Intermediate,A,
,14439,Mus musculus,1,,N,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),,,BAO_0000218,,11908,,1,10090.0,CHEMBL629529,,,Intermediate,A,
,14439,Mus musculus,1,,N,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),,,BAO_0000218,,11909,,1,10090.0,CHEMBL629530,,,Intermediate,A,
,14439,Mus musculus,1,,N,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),,,BAO_0000218,,11910,,1,10090.0,CHEMBL629531,,,Intermediate,A,
,14439,Mus musculus,1,,N,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),,,BAO_0000218,,11911,,1,10090.0,CHEMBL628656,,,Intermediate,A,
,14439,Mus musculus,1,,N,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),,,BAO_0000218,,11912,,1,10090.0,CHEMBL628657,,,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",,,BAO_0000218,,11913,,1,10116.0,CHEMBL628658,In vivo,,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,BAO_0000218,,11914,,1,10116.0,CHEMBL628659,In vivo,,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,BAO_0000218,,11915,,1,10116.0,CHEMBL877500,In vivo,,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,BAO_0000218,,11916,,1,10116.0,CHEMBL628660,In vivo,,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,BAO_0000218,,11917,,1,10116.0,CHEMBL628661,In vivo,,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,BAO_0000218,,11918,,1,10116.0,CHEMBL628662,In vivo,,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,BAO_0000218,,11919,,1,10116.0,CHEMBL628663,In vivo,,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,BAO_0000218,,11920,,1,10116.0,CHEMBL628664,In vivo,,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,BAO_0000218,,11921,Blood,1,10116.0,CHEMBL628665,In vivo,178.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,BAO_0000218,,11922,Blood,1,10116.0,CHEMBL628666,In vivo,178.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,BAO_0000218,,11923,Blood,1,10116.0,CHEMBL628667,In vivo,178.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,BAO_0000218,,11924,Blood,1,10116.0,CHEMBL628668,In vivo,178.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,BAO_0000218,,11925,Blood,1,10116.0,CHEMBL628669,In vivo,178.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,BAO_0000218,,11926,Blood,1,10116.0,CHEMBL628670,In vivo,178.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,BAO_0000218,,11927,Blood,1,10116.0,CHEMBL628671,In vivo,178.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,BAO_0000218,,11928,Bone,1,10116.0,CHEMBL628672,In vivo,10000001.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,BAO_0000218,,11929,Bone,1,10116.0,CHEMBL630300,In vivo,10000001.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,BAO_0000218,,11930,Bone,1,10116.0,CHEMBL629787,In vivo,10000001.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,BAO_0000218,,11931,Bone,1,10116.0,CHEMBL629788,In vivo,10000001.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,BAO_0000218,,11932,Brain,1,10116.0,CHEMBL629789,In vivo,955.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,BAO_0000218,,11933,Brain,1,10116.0,CHEMBL629790,In vivo,955.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,BAO_0000218,,11934,Brain,1,10116.0,CHEMBL629791,In vivo,955.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,BAO_0000218,,11935,Brain,1,10116.0,CHEMBL629792,In vivo,955.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,BAO_0000218,,11936,Brain,1,10116.0,CHEMBL629793,In vivo,955.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,BAO_0000218,,11937,Brain,1,10116.0,CHEMBL629794,In vivo,955.0,Intermediate,A,
,10677,Rattus norvegicus,1,,N,50597,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,,,BAO_0000218,,11938,,1,10116.0,CHEMBL874459,,,Intermediate,A,
,10677,Rattus norvegicus,1,,N,50597,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,,,BAO_0000218,,11939,,1,10116.0,CHEMBL629795,,,Intermediate,A,
,10677,Rattus norvegicus,1,,N,50597,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,,,BAO_0000218,,11940,,1,10116.0,CHEMBL629796,,,Intermediate,A,
,10677,Rattus norvegicus,1,,N,50597,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,,,BAO_0000218,,11941,,1,10116.0,CHEMBL629797,,,Intermediate,A,
,10677,Rattus norvegicus,1,,N,50597,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,,,BAO_0000218,,11942,,1,10116.0,CHEMBL629798,,,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,BAO_0000218,,11943,Adrenal gland,1,10116.0,CHEMBL629799,In vivo,2369.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,11944,Adrenal gland,1,10116.0,CHEMBL629800,In vivo,2369.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,11945,Adrenal gland,1,10116.0,CHEMBL629801,In vivo,2369.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,,,BAO_0000218,,11946,Adrenal gland,1,10116.0,CHEMBL629802,In vivo,2369.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,11947,Adrenal gland,1,10116.0,CHEMBL629803,In vivo,2369.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,BAO_0000218,,11948,Blood,1,10116.0,CHEMBL629804,In vivo,178.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,11949,Blood,1,10116.0,CHEMBL629805,In vivo,178.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,,BAO_0000218,,11950,Blood,1,10116.0,CHEMBL629806,In vivo,178.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,11951,Blood,1,10116.0,CHEMBL629807,In vivo,178.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,11952,Blood,1,10116.0,CHEMBL629808,In vivo,178.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,BAO_0000218,,11953,Brain,1,10116.0,CHEMBL629809,In vivo,955.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,11954,Brain,1,10116.0,CHEMBL629810,In vivo,955.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,,BAO_0000218,,11955,Brain,1,10116.0,CHEMBL629811,In vivo,955.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,11956,Brain,1,10116.0,CHEMBL629812,In vivo,955.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,,,BAO_0000218,,11957,Brain,1,10116.0,CHEMBL629813,In vivo,955.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,11958,Brain,1,10116.0,CHEMBL874460,In vivo,955.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,BAO_0000218,,11959,,1,10116.0,CHEMBL629814,In vivo,,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,11960,,1,10116.0,CHEMBL629815,In vivo,,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,11961,,1,10116.0,CHEMBL629816,In vivo,,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,11962,,1,10116.0,CHEMBL629817,In vivo,,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,BAO_0000218,,11963,Kidney,1,10116.0,CHEMBL626643,In vivo,2113.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,11964,Kidney,1,10116.0,CHEMBL626644,In vivo,2113.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,11965,Kidney,1,10116.0,CHEMBL626806,In vivo,2113.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,11966,Kidney,1,10116.0,CHEMBL626807,In vivo,2113.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,BAO_0000218,,11967,Liver,1,10116.0,CHEMBL627261,In vivo,2107.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,11968,Liver,1,10116.0,CHEMBL627262,In vivo,2107.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,11969,Liver,1,10116.0,CHEMBL627263,In vivo,2107.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,11970,Liver,1,10116.0,CHEMBL627264,In vivo,2107.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,BAO_0000218,,11971,Lung,1,10116.0,CHEMBL627265,In vivo,2048.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,11972,Lung,1,10116.0,CHEMBL627266,In vivo,2048.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,11973,Lung,1,10116.0,CHEMBL627267,In vivo,2048.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,11974,Lung,1,10116.0,CHEMBL627268,In vivo,2048.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,BAO_0000218,,11975,Muscle tissue,1,10116.0,CHEMBL627269,In vivo,2385.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,11976,Muscle tissue,1,10116.0,CHEMBL627270,In vivo,2385.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",,,BAO_0000218,,11977,,1,10116.0,CHEMBL627271,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",,,BAO_0000218,,11978,,1,10116.0,CHEMBL627946,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",,,BAO_0000218,,11979,,1,10116.0,CHEMBL875472,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",,,BAO_0000218,,11980,,1,10116.0,CHEMBL627947,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",,,BAO_0000218,,11981,,1,10116.0,CHEMBL627948,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",,,BAO_0000218,,11982,,1,10116.0,CHEMBL628113,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",,,BAO_0000218,,11983,,1,10116.0,CHEMBL628114,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",,,BAO_0000218,,11984,,1,10116.0,CHEMBL628115,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",,,BAO_0000218,,11985,,1,10116.0,CHEMBL628116,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",,,BAO_0000218,,11986,,1,10116.0,CHEMBL628117,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",,,BAO_0000218,,11987,,1,10116.0,CHEMBL628118,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",,,BAO_0000218,,11988,,1,10116.0,CHEMBL628119,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",,,BAO_0000218,,11989,,1,10116.0,CHEMBL628120,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",,,BAO_0000218,,11990,,1,10116.0,CHEMBL628121,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",,,BAO_0000218,,11991,,1,10116.0,CHEMBL628122,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",,,BAO_0000218,,11992,,1,10116.0,CHEMBL627297,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",,,BAO_0000218,,11993,,1,10116.0,CHEMBL627298,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",,,BAO_0000218,,11994,,1,10116.0,CHEMBL627299,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",,,BAO_0000218,,11995,,1,10116.0,CHEMBL627300,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",,,BAO_0000218,,11996,,1,10116.0,CHEMBL627301,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",,,BAO_0000218,,11997,,1,10116.0,CHEMBL627302,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",,,BAO_0000218,,11998,,1,10116.0,CHEMBL627303,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",,,BAO_0000218,,11999,,1,10116.0,CHEMBL627304,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",,,BAO_0000218,,12000,,1,10116.0,CHEMBL627305,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,,BAO_0000218,,12001,,1,10116.0,CHEMBL627306,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",,,BAO_0000218,,12002,,1,10116.0,CHEMBL623982,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",,,BAO_0000218,,12003,,1,10116.0,CHEMBL623983,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",,,BAO_0000218,,12004,,1,10116.0,CHEMBL623984,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",,,BAO_0000218,,12005,,1,10116.0,CHEMBL623985,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",,,BAO_0000218,,12006,,1,10116.0,CHEMBL623986,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",,,BAO_0000218,,12007,,1,10116.0,CHEMBL623987,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",,,BAO_0000218,,12008,,1,10116.0,CHEMBL623988,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",,,BAO_0000218,,12009,,1,10116.0,CHEMBL623989,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",,,BAO_0000218,,12010,,1,10116.0,CHEMBL622215,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",,,BAO_0000218,,12011,,1,10116.0,CHEMBL622216,,,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",,,BAO_0000218,,12012,,1,10116.0,CHEMBL877481,,,Intermediate,A,
,16359,,1,,U,22224,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),,,BAO_0000218,,12013,,0,,CHEMBL622217,,,Autocuration,A,
,13701,Mus musculus,1,,N,50594,,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,,BAO_0000218,,12014,,1,10090.0,CHEMBL622218,,,Intermediate,A,
,14554,Rattus norvegicus,1,,N,50597,,Pharmacokinetic profile AUC was evaluated in rats,,,BAO_0000218,,12015,,1,10116.0,CHEMBL622219,,,Intermediate,A,
,6241,,1,,U,22224,,Pharmacokinetic property (Area under curve),,,BAO_0000019,,12016,,0,,CHEMBL622220,,,Autocuration,A,
,11537,Canis lupus familiaris,1,,N,50588,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",,,BAO_0000218,,12017,,1,9615.0,CHEMBL622221,,,Intermediate,A,
,11537,Mus musculus,1,,N,50594,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",,,BAO_0000218,,12018,,1,10090.0,CHEMBL622222,,,Intermediate,A,
,11537,Canis lupus familiaris,1,,N,50588,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",,,BAO_0000218,,12019,,1,9615.0,CHEMBL622223,,,Intermediate,A,
,11537,Mus musculus,1,,N,50594,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",,,BAO_0000218,,12020,,1,10090.0,CHEMBL622224,,,Intermediate,A,
,13118,,1,,U,22224,,Plasma concentration (AUC) was determined,,,BAO_0000019,,12021,,0,,CHEMBL622225,,,Autocuration,A,
,13118,,1,,U,22224,,Plasma concentration (AUC) was determined; Not detectable,,,BAO_0000019,,12022,,0,,CHEMBL622226,,,Autocuration,A,
,9562,Cavia porcellus,1,,N,50512,,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),,,BAO_0000218,,12023,,1,10141.0,CHEMBL624154,,,Intermediate,A,
,10363,Rattus norvegicus,1,,N,50597,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,,,BAO_0000218,,12024,,1,10116.0,CHEMBL624155,,,Intermediate,A,
,10363,Rattus norvegicus,1,,N,50597,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,,BAO_0000218,,12025,,1,10116.0,CHEMBL624156,,,Intermediate,A,
,10363,Rattus norvegicus,1,,N,50597,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,,,BAO_0000218,,12026,,1,10116.0,CHEMBL624157,,,Intermediate,A,
,10363,Rattus norvegicus,1,,N,50597,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,,,BAO_0000218,,12027,,1,10116.0,CHEMBL624158,,,Intermediate,A,
,12504,Rattus norvegicus,1,,N,50597,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,,,BAO_0000218,,12028,,1,10116.0,CHEMBL624159,,,Intermediate,A,
,12504,Rattus norvegicus,1,,N,50597,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,,,BAO_0000218,,12029,,1,10116.0,CHEMBL624160,,,Intermediate,A,
,12504,Rattus norvegicus,1,,N,50597,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,,,BAO_0000218,,12030,,1,10116.0,CHEMBL624161,,,Intermediate,A,
,12504,Rattus norvegicus,1,,N,50597,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,,,BAO_0000218,,12031,,1,10116.0,CHEMBL624162,,,Intermediate,A,
,13317,Canis lupus familiaris,1,,N,50588,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,,,BAO_0000218,,12032,,1,9615.0,CHEMBL624163,,,Intermediate,A,
,15078,Rattus norvegicus,1,,N,50597,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,,12033,,1,10116.0,CHEMBL624164,,,Intermediate,A,
,14941,Rattus norvegicus,1,,N,50597,,The AUC(0-infinity) values in female wistar rats.,,,BAO_0000218,,12034,,1,10116.0,CHEMBL624165,,,Intermediate,A,
,15078,Rattus norvegicus,1,,N,50597,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,,12035,,1,10116.0,CHEMBL624166,,,Intermediate,A,
,15078,Rattus norvegicus,1,,N,50597,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",,,BAO_0000218,,12036,,1,10116.0,CHEMBL624167,,,Intermediate,A,
,14941,Rattus norvegicus,1,,N,50597,,The AUC(0-t)values in female wistar rats.,,,BAO_0000218,,12037,,1,10116.0,CHEMBL624168,,,Intermediate,A,
,14067,Rattus norvegicus,1,,N,50597,,The Area under the concentration time curve of compound was measured on rats,,,BAO_0000218,,12038,,1,10116.0,CHEMBL624169,,,Intermediate,A,
,14215,Homo sapiens,1,,N,50587,,The area under curve (100 mg/kg) administered orally in humans,,,BAO_0000218,,12039,,1,9606.0,CHEMBL624170,,,Intermediate,A,
,14215,Callithrix,1,,U,22224,,The area under curve (12.5 mg/kg) administered intravenously in marmoset,,,BAO_0000218,,12040,,0,9481.0,CHEMBL624171,,,Autocuration,A,
,14215,Simiiformes,1,,U,22224,,The area under curve (12.5 mg/kg) administered intravenously in monkey,,,BAO_0000218,,12041,,0,314293.0,CHEMBL624172,,,Autocuration,A,
,14215,Canis lupus familiaris,1,,N,50588,,The area under curve (15 mg/kg) administered intravenously in dog,,,BAO_0000218,,12042,,1,9615.0,CHEMBL624173,,,Intermediate,A,
,14215,Homo sapiens,1,,N,50587,,The area under curve (200 mg/kg) administered orally in humans,,,BAO_0000218,,12043,,1,9606.0,CHEMBL877488,,,Intermediate,A,
,14215,Rattus norvegicus,1,,N,50597,,The area under curve (25 mg/kg) administered intravenously in rat,,,BAO_0000218,,12044,,1,10116.0,CHEMBL624174,,,Intermediate,A,
,14215,Callithrix,1,,U,22224,,The area under curve (25 mg/kg) administered orally in marmoset,,,BAO_0000218,,12045,,0,9481.0,CHEMBL624175,,,Autocuration,A,
,14215,Simiiformes,1,,U,22224,,The area under curve (25 mg/kg) administered orally in monkey,,,BAO_0000218,,12046,,0,314293.0,CHEMBL624176,,,Autocuration,A,
,14215,Canis lupus familiaris,1,,N,50588,,The area under curve (30 mg/kg) administered orally in dog,,,BAO_0000218,,12047,,1,9615.0,CHEMBL624177,,,Intermediate,A,
,14215,Homo sapiens,1,,N,50587,,The area under curve (400 mg/kg) administered orally in humans,,,BAO_0000218,,12048,,1,9606.0,CHEMBL624178,,,Intermediate,A,
,14215,Rattus norvegicus,1,,N,50597,,The area under curve (50 mg/kg) administered orally in fasted rat,,,BAO_0000218,,12049,,1,10116.0,CHEMBL624179,,,Intermediate,A,
,14215,Rattus norvegicus,1,,N,50597,,The area under curve (50 mg/kg) administered orally in rat,,,BAO_0000218,,12050,,1,10116.0,CHEMBL627689,,,Intermediate,A,
,14215,Homo sapiens,1,,N,50587,,The area under curve (800 mg/kg) administered orally in humans,,,BAO_0000218,,12051,,1,9606.0,CHEMBL627690,,,Intermediate,A,
,11324,,1,,U,22224,,The compound was evaluated for area under the curve,,,BAO_0000019,,12052,,0,,CHEMBL627691,,,Autocuration,A,
,11324,Callithrix,1,,U,22224,,The compound was evaluated for area under the curve in marmosets,,,BAO_0000019,,12053,,0,9481.0,CHEMBL627692,,,Autocuration,A,
,11324,Callithrix,1,,U,22224,,The compound was evaluated for area under the curve in marmosets,,,BAO_0000019,,12054,,0,9481.0,CHEMBL627693,,,Autocuration,A,
,13875,Rattus norvegicus,1,,N,50597,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,,BAO_0000218,,12055,,1,10116.0,CHEMBL627694,,,Intermediate,A,
,13875,Rattus norvegicus,1,,N,50597,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,,,BAO_0000218,,12056,,1,10116.0,CHEMBL627695,,,Intermediate,A,
,13875,,1,,U,22224,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),,,BAO_0000218,,12057,,0,,CHEMBL627696,,,Autocuration,A,
,13875,Rattus norvegicus,1,,N,50597,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,,BAO_0000218,,12058,,1,10116.0,CHEMBL627697,,,Intermediate,A,
,13875,Rattus norvegicus,1,,N,50597,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,,BAO_0000218,,12059,,1,10116.0,CHEMBL627698,,,Intermediate,A,
,13875,Rattus norvegicus,1,,N,50597,,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,,,BAO_0000218,,12060,,1,10116.0,CHEMBL627699,,,Intermediate,A,
,13807,Rattus norvegicus,1,,N,50597,,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,,,BAO_0000218,,12061,,1,10116.0,CHEMBL627700,,,Intermediate,A,
,14127,Rattus norvegicus,1,,N,50597,,Total drug exposure is determined after oral dosing in rats.,,,BAO_0000218,,12062,,1,10116.0,CHEMBL627701,,,Intermediate,A,
,15116,,1,,U,22224,,Total drug exposure (5 mg/kg) when administered intravenously,,,BAO_0000218,,12063,,0,,CHEMBL627702,,,Autocuration,A,
,15116,,1,,U,22224,,Total drug exposure (5 mg/kg) when administered orally,,,BAO_0000218,,12064,,0,,CHEMBL627703,,,Autocuration,A,
,15604,Simiiformes,1,,U,22224,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,,BAO_0000218,,12065,,0,314293.0,CHEMBL626873,,,Autocuration,A,
,15604,Rattus norvegicus,1,,N,50597,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,,BAO_0000218,,12066,,1,10116.0,CHEMBL629583,,,Intermediate,A,
,15604,Canis lupus familiaris,1,,N,50588,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,,BAO_0000218,,12067,,1,9615.0,CHEMBL629584,,,Intermediate,A,
,15604,Canis lupus familiaris,1,,N,50588,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,,BAO_0000218,,12068,,1,9615.0,CHEMBL629585,,,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,BAO_0000218,,12069,Brain,1,10116.0,CHEMBL629586,In vivo,955.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,BAO_0000218,,12070,Brain,1,10116.0,CHEMBL629587,In vivo,955.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,BAO_0000218,,12071,,1,10116.0,CHEMBL629588,In vivo,,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,BAO_0000218,,12072,,1,10116.0,CHEMBL629589,In vivo,,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,BAO_0000218,,12073,,1,10116.0,CHEMBL629590,In vivo,,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,BAO_0000218,,12074,,1,10116.0,CHEMBL629591,In vivo,,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,BAO_0000218,,12075,,1,10116.0,CHEMBL629592,In vivo,,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,BAO_0000218,,12076,,1,10116.0,CHEMBL629593,In vivo,,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,BAO_0000218,,12077,,1,10116.0,CHEMBL629594,In vivo,,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,BAO_0000218,,12078,Heart,1,10116.0,CHEMBL629595,In vivo,948.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,BAO_0000218,,12079,Heart,1,10116.0,CHEMBL630290,In vivo,948.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,BAO_0000218,,12080,Heart,1,10116.0,CHEMBL627137,In vivo,948.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,BAO_0000218,,12081,Heart,1,10116.0,CHEMBL627138,In vivo,948.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,BAO_0000218,,12082,Heart,1,10116.0,CHEMBL627139,In vivo,948.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,BAO_0000218,,12083,Heart,1,10116.0,CHEMBL627140,In vivo,948.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,BAO_0000218,,12084,Heart,1,10116.0,CHEMBL627141,In vivo,948.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,BAO_0000218,,12085,Kidney,1,10116.0,CHEMBL627142,In vivo,2113.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,BAO_0000218,,12086,Kidney,1,10116.0,CHEMBL627143,In vivo,2113.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,BAO_0000218,,12087,Kidney,1,10116.0,CHEMBL874449,In vivo,2113.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,BAO_0000218,,12088,Kidney,1,10116.0,CHEMBL627144,In vivo,2113.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,BAO_0000218,,12089,Kidney,1,10116.0,CHEMBL627145,In vivo,2113.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,BAO_0000218,,12090,Kidney,1,10116.0,CHEMBL627146,In vivo,2113.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,BAO_0000218,,12091,Kidney,1,10116.0,CHEMBL627147,In vivo,2113.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,BAO_0000218,,12092,Liver,1,10116.0,CHEMBL627148,In vivo,2107.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,BAO_0000218,,12093,Lung,1,10116.0,CHEMBL627149,In vivo,2048.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,BAO_0000218,,12094,Lung,1,10116.0,CHEMBL632160,In vivo,2048.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,BAO_0000218,,12095,Lung,1,10116.0,CHEMBL632161,In vivo,2048.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,BAO_0000218,,12096,Lung,1,10116.0,CHEMBL632162,In vivo,2048.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,BAO_0000218,,12097,Lung,1,10116.0,CHEMBL632163,In vivo,2048.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,BAO_0000218,,12098,Lung,1,10116.0,CHEMBL874469,In vivo,2048.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,BAO_0000218,,12099,Lung,1,10116.0,CHEMBL627182,In vivo,2048.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,BAO_0000218,,12100,Muscle tissue,1,10116.0,CHEMBL627183,In vivo,2385.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,BAO_0000218,,12101,Muscle tissue,1,10116.0,CHEMBL627184,In vivo,2385.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,BAO_0000218,,12102,Muscle tissue,1,10116.0,CHEMBL627185,In vivo,2385.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,BAO_0000218,,12103,Muscle tissue,1,10116.0,CHEMBL627186,In vivo,2385.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,BAO_0000218,,12104,Muscle tissue,1,10116.0,CHEMBL627187,In vivo,2385.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,BAO_0000218,,12105,Muscle tissue,1,10116.0,CHEMBL627188,In vivo,2385.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,BAO_0000218,,12106,Muscle tissue,1,10116.0,CHEMBL627189,In vivo,2385.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,BAO_0000218,,12107,,1,10116.0,CHEMBL627190,In vivo,,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,BAO_0000218,,12108,Liver,1,10116.0,CHEMBL627191,In vivo,2107.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,BAO_0000218,,12109,Liver,1,10116.0,CHEMBL627192,In vivo,2107.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,BAO_0000218,,12110,Liver,1,10116.0,CHEMBL627193,In vivo,2107.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,,BAO_0000218,,12111,Muscle tissue,1,10116.0,CHEMBL874590,In vivo,2385.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,12112,Muscle tissue,1,10116.0,CHEMBL627194,In vivo,2385.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,12113,Muscle tissue,1,10116.0,CHEMBL627195,In vivo,2385.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,BAO_0000218,,12114,Female gonad,1,10116.0,CHEMBL627196,In vivo,992.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,12115,Female gonad,1,10116.0,CHEMBL627197,In vivo,992.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,12116,Female gonad,1,10116.0,CHEMBL627198,In vivo,992.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,,,BAO_0000218,,12117,Female gonad,1,10116.0,CHEMBL627199,In vivo,992.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,12118,Female gonad,1,10116.0,CHEMBL627200,In vivo,992.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,BAO_0000218,,12119,Plasma,1,10116.0,CHEMBL627201,In vivo,1969.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,12120,Plasma,1,10116.0,CHEMBL627202,In vivo,1969.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,12121,Plasma,1,10116.0,CHEMBL627203,In vivo,1969.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,12122,Plasma,1,10116.0,CHEMBL627204,In vivo,1969.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,BAO_0000218,,12123,Spleen,1,10116.0,CHEMBL627205,In vivo,2106.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,12124,Spleen,1,10116.0,CHEMBL627206,In vivo,2106.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,12125,Spleen,1,10116.0,CHEMBL627207,In vivo,2106.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,12126,Spleen,1,10116.0,CHEMBL627208,In vivo,2106.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,BAO_0000218,,12127,Thyroid gland,1,10116.0,CHEMBL627209,In vivo,2046.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,12128,Thyroid gland,1,10116.0,CHEMBL627210,In vivo,2046.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,12129,Thyroid gland,1,10116.0,CHEMBL627211,In vivo,2046.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,12130,Thyroid gland,1,10116.0,CHEMBL627212,In vivo,2046.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,BAO_0000218,,12131,Uterus,1,10116.0,CHEMBL627213,In vivo,995.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,12132,Uterus,1,10116.0,CHEMBL626599,In vivo,995.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,12133,Uterus,1,10116.0,CHEMBL626600,In vivo,995.0,Intermediate,A,
,10911,Rattus norvegicus,1,,N,50597,,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,,12134,Uterus,1,10116.0,CHEMBL626601,In vivo,995.0,Intermediate,A,
,8081,,1,,U,22224,,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,,,BAO_0000019,,12135,,0,,CHEMBL627484,,,Autocuration,A,
,17248,Macaca fascicularis,1,,N,100710,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),,,BAO_0000218,,12136,Plasma,1,9541.0,CHEMBL627485,,1969.0,Intermediate,A,
,17248,Macaca fascicularis,1,,N,100710,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,,,BAO_0000218,,12137,Plasma,1,9541.0,CHEMBL628147,,1969.0,Intermediate,A,
,17248,Macaca fascicularis,1,,N,100710,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,,,BAO_0000218,,12138,Plasma,1,9541.0,CHEMBL628148,,1969.0,Intermediate,A,
,17248,Canis lupus familiaris,1,,N,50588,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),,,BAO_0000218,,12139,Plasma,1,9615.0,CHEMBL628149,,1969.0,Intermediate,A,
,17248,Canis lupus familiaris,1,,N,50588,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,,,BAO_0000218,,12140,Plasma,1,9615.0,CHEMBL628150,,1969.0,Intermediate,A,
,17248,Canis lupus familiaris,1,,N,50588,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,,,BAO_0000218,,12141,Plasma,1,9615.0,CHEMBL628318,,1969.0,Intermediate,A,
,17248,Canis lupus familiaris,1,,N,50588,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,,,BAO_0000218,,12142,Plasma,1,9615.0,CHEMBL628319,,1969.0,Intermediate,A,
,15592,Canis lupus familiaris,1,,N,50588,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,,BAO_0000218,,12143,,1,9615.0,CHEMBL875609,,,Intermediate,A,
,7040,,1,,U,22224,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,,,BAO_0000019,,12144,,0,,CHEMBL628320,,,Autocuration,A,
,7040,,1,,U,22224,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,,,BAO_0000019,,12145,,0,,CHEMBL628321,,,Autocuration,A,
,7040,,1,,U,22224,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,,,BAO_0000019,,12146,,0,,CHEMBL628322,,,Autocuration,A,
,7040,,1,,U,22224,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,,,BAO_0000019,,12147,,0,,CHEMBL628323,,,Autocuration,A,
,7040,,1,,U,22224,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,,,BAO_0000019,,12148,,0,,CHEMBL628324,,,Autocuration,A,
,7040,,1,,U,22224,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,,,BAO_0000019,,12149,,0,,CHEMBL628325,,,Autocuration,A,
,7040,,1,,U,22224,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,,,BAO_0000019,,12150,,0,,CHEMBL628326,,,Autocuration,A,
,9614,Canis lupus familiaris,1,,N,50588,,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",,,BAO_0000218,,12151,Adrenal medulla,1,9615.0,CHEMBL628327,,1236.0,Intermediate,A,
,9614,Canis lupus familiaris,1,,N,50588,,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",,,BAO_0000218,,12152,Adrenal medulla,1,9615.0,CHEMBL628328,,1236.0,Intermediate,A,
,9614,Canis lupus familiaris,1,,N,50588,,"Concentration of compound in blood of dog 1, after administering intravenously",,,BAO_0000218,,12153,Blood,1,9615.0,CHEMBL628329,,178.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",,,BAO_0000218,,12154,Liver,1,10116.0,CHEMBL628330,,2107.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",,,BAO_0000218,,12155,Liver,1,10116.0,CHEMBL628331,,2107.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",,,BAO_0000218,,12156,Liver,1,10116.0,CHEMBL628332,,2107.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",,,BAO_0000218,,12157,Liver,1,10116.0,CHEMBL628333,,2107.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",,,BAO_0000218,,12158,Liver,1,10116.0,CHEMBL628334,,2107.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",,,BAO_0000218,,12159,Liver,1,10116.0,CHEMBL628335,,2107.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",,,BAO_0000218,,12160,Liver,1,10116.0,CHEMBL628336,,2107.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,,BAO_0000218,,12161,Liver,1,10116.0,CHEMBL628337,,2107.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",,,BAO_0000218,,12162,Liver,1,10116.0,CHEMBL628338,,2107.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",,,BAO_0000218,,12163,Liver,1,10116.0,CHEMBL875610,,2107.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",,,BAO_0000218,,12164,Liver,1,10116.0,CHEMBL628339,,2107.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",,,BAO_0000218,,12165,Liver,1,10116.0,CHEMBL628340,,2107.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",,,BAO_0000218,,12166,Liver,1,10116.0,CHEMBL628341,,2107.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",,,BAO_0000218,,12167,Liver,1,10116.0,CHEMBL622214,,2107.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",,,BAO_0000218,,12168,Liver,1,10116.0,CHEMBL623167,,2107.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",,,BAO_0000218,,12169,Liver,1,10116.0,CHEMBL623168,,2107.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",,,BAO_0000218,,12170,Liver,1,10116.0,CHEMBL623169,,2107.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",,,BAO_0000218,,12171,Liver,1,10116.0,CHEMBL623170,,2107.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",,,BAO_0000218,,12172,Lung,1,10116.0,CHEMBL627224,,2048.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",,,BAO_0000218,,12173,Lung,1,10116.0,CHEMBL875634,,2048.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",,,BAO_0000218,,12174,Lung,1,10116.0,CHEMBL627225,,2048.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",,,BAO_0000218,,12175,Lung,1,10116.0,CHEMBL627226,,2048.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",,,BAO_0000218,,12176,Lung,1,10116.0,CHEMBL626083,,2048.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",,,BAO_0000218,,12177,Lung,1,10116.0,CHEMBL626084,,2048.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",,,BAO_0000218,,12178,Lung,1,10116.0,CHEMBL626085,,2048.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",,,BAO_0000218,,12179,Lung,1,10116.0,CHEMBL626086,,2048.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",,,BAO_0000218,,12180,Lung,1,10116.0,CHEMBL626087,,2048.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",,,BAO_0000218,,12181,Lung,1,10116.0,CHEMBL626088,,2048.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",,,BAO_0000218,,12182,Lung,1,10116.0,CHEMBL626089,,2048.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",,,BAO_0000218,,12183,Lung,1,10116.0,CHEMBL626090,,2048.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",,,BAO_0000218,,12184,Lung,1,10116.0,CHEMBL626091,,2048.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",,,BAO_0000218,,12185,Lung,1,10116.0,CHEMBL626092,,2048.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",,,BAO_0000218,,12186,Lung,1,10116.0,CHEMBL626093,,2048.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",,,BAO_0000218,,12187,Lung,1,10116.0,CHEMBL626094,,2048.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",,,BAO_0000218,,12188,Lung,1,10116.0,CHEMBL626095,,2048.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",,,BAO_0000218,,12189,Lung,1,10116.0,CHEMBL626096,,2048.0,Intermediate,A,
,15604,Simiiformes,1,,U,22224,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,,BAO_0000218,,12190,,0,314293.0,CHEMBL626097,,,Autocuration,A,
,15604,Rattus norvegicus,1,,N,50597,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,,BAO_0000218,,12191,,1,10116.0,CHEMBL626098,,,Intermediate,A,
,1806,,1,,U,22224,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,,,BAO_0000218,,12192,Plasma,0,,CHEMBL626099,,1969.0,Autocuration,A,
,1806,,1,,U,22224,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,,,BAO_0000218,,12193,Plasma,0,,CHEMBL626100,,1969.0,Autocuration,A,
,17237,Canis lupus familiaris,1,,N,50588,,AUC 0-inf in dog,,,BAO_0000218,,12194,Plasma,1,9615.0,CHEMBL626101,,1969.0,Intermediate,A,
,17237,Cavia porcellus,1,,N,50512,,AUC 0-inf in guinea pig,,,BAO_0000218,,12195,Plasma,1,10141.0,CHEMBL626102,,1969.0,Intermediate,A,
,17237,Canis lupus familiaris,1,,N,50588,,AUC 0-t in dog,,,BAO_0000218,,12196,Plasma,1,9615.0,CHEMBL626103,,1969.0,Intermediate,A,
,17237,Cavia porcellus,1,,N,50512,,AUC 0-t in guinea pig,,,BAO_0000218,,12197,Plasma,1,10141.0,CHEMBL628391,,1969.0,Intermediate,A,
,15194,Rattus norvegicus,1,,N,50597,,The compound was tested for brain to plasma partition in rat,,,BAO_0000218,,12198,,1,10116.0,CHEMBL628392,,,Intermediate,A,
,15194,Rattus norvegicus,1,,N,50597,,The compound was tested for brain to plasma partition in rat.,,,BAO_0000218,,12199,,1,10116.0,CHEMBL628393,,,Intermediate,A,
,8787,,1,,U,22224,,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,,,BAO_0000019,,12200,Blood,0,,CHEMBL628394,,178.0,Autocuration,A,
,17025,Canis lupus familiaris,1,,N,50588,,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,,,BAO_0000218,,12201,,1,9615.0,CHEMBL628395,,,Intermediate,A,
,17025,Simiiformes,1,,U,22224,,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,,,BAO_0000218,,12202,,0,314293.0,CHEMBL628396,,,Autocuration,A,
,17025,Oryctolagus cuniculus,1,,N,50592,,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,,,BAO_0000218,,12203,,1,9986.0,CHEMBL628397,,,Intermediate,A,
,17025,Rattus norvegicus,1,,N,50597,,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,,,BAO_0000218,,12204,,1,10116.0,CHEMBL628398,,,Intermediate,A,
,4236,Macaca mulatta,1,,N,50797,,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,,,BAO_0000218,,12205,,1,9544.0,CHEMBL628399,,,Intermediate,A,
,15343,Canis lupus familiaris,1,,N,50588,,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,,,BAO_0000218,,12206,,1,9615.0,CHEMBL628400,,,Intermediate,A,
,15343,Rattus norvegicus,1,,N,50597,,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,,,BAO_0000218,,12207,,1,10116.0,CHEMBL874907,,,Intermediate,A,
,17720,,1,,U,22224,,Area under curve of the compound was determined,,,BAO_0000019,,12208,,0,,CHEMBL628401,,,Autocuration,A,
,17788,Simiiformes,1,,U,22224,,AUC in monkeys at a dose of 1 mg/kg,,,BAO_0000218,,12209,Plasma,0,314293.0,CHEMBL628402,,1969.0,Autocuration,A,
,17788,Rattus norvegicus,1,,N,50597,,AUC in rats at a dose of 1 mg/kg,,,BAO_0000218,,12210,Plasma,1,10116.0,CHEMBL628403,,1969.0,Intermediate,A,
,8778,,1,,U,22224,,Compound was evaluated for the overall absorbance loss at pH of 2,,,BAO_0000019,,12211,,0,,CHEMBL628404,,,Autocuration,A,
,8778,,1,,U,22224,,Compound was evaluated for the overall absorbance loss at pH of 4,,,BAO_0000019,,12212,,0,,CHEMBL628405,,,Autocuration,A,
,8778,,1,,U,22224,,Compound was evaluated for the overall absorbance loss at pH of 7,,,BAO_0000019,,12213,,0,,CHEMBL628406,,,Autocuration,A,
,2249,Rattus norvegicus,1,,N,50597,,Compound was evaluated for its absorption in the rats,,,BAO_0000218,,12214,,1,10116.0,CHEMBL628407,,,Intermediate,A,
,8881,Rattus norvegicus,1,,N,50597,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,,BAO_0000218,,12215,Urine,1,10116.0,CHEMBL628408,,1088.0,Intermediate,A,
,8881,Rattus norvegicus,1,,N,50597,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,,,BAO_0000218,,12216,Urine,1,10116.0,CHEMBL629171,,1088.0,Intermediate,A,
,8881,Rattus norvegicus,1,,N,50597,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,,BAO_0000218,,12217,Urine,1,10116.0,CHEMBL629172,,1088.0,Intermediate,A,
,8881,Rattus norvegicus,1,,N,50597,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,,,BAO_0000218,,12218,Urine,1,10116.0,CHEMBL629173,,1088.0,Intermediate,A,
,15286,Rattus norvegicus,1,,N,50597,,In vitro percent permeability into rat ileum,,,BAO_0000218,,12219,,1,10116.0,CHEMBL629174,,,Intermediate,A,
,15286,Rattus norvegicus,1,,N,50597,,In vitro percent permeability into rat ileum; Range is 10-17,,,BAO_0000218,,12220,,1,10116.0,CHEMBL629175,,,Intermediate,A,
,15286,Rattus norvegicus,1,,N,50597,,In vitro percent permeability into rat ileum; Range is 10-18,,,BAO_0000218,,12221,,1,10116.0,CHEMBL629176,,,Intermediate,A,
,15286,Rattus norvegicus,1,,N,50597,,In vitro percent permeability into rat ileum; Range is 10-19,,,BAO_0000218,,12222,,1,10116.0,CHEMBL629177,,,Intermediate,A,
,15286,Rattus norvegicus,1,,N,50597,,In vitro percent permeability into rat ileum; Range is 12-15,,,BAO_0000218,,12223,,1,10116.0,CHEMBL629178,,,Intermediate,A,
,15286,Rattus norvegicus,1,,N,50597,,In vitro percent permeability into rat ileum; Range is 13-19,,,BAO_0000218,,12224,,1,10116.0,CHEMBL631869,,,Intermediate,A,
,15286,Rattus norvegicus,1,,N,50597,,In vitro percent permeability into rat ileum; Range is 14-17,,,BAO_0000218,,12225,,1,10116.0,CHEMBL631870,,,Intermediate,A,
,15286,Rattus norvegicus,1,,N,50597,,In vitro percent permeability into rat ileum; Range is 15-18,,,BAO_0000218,,12226,,1,10116.0,CHEMBL631871,,,Intermediate,A,
,15286,Rattus norvegicus,1,,N,50597,,In vitro percent permeability into rat ileum; Range is 2-5,,,BAO_0000218,,12227,,1,10116.0,CHEMBL631872,,,Intermediate,A,
,15286,,1,,U,22224,,In vitro percent permeability into rat ileum; Range is 23-42,,,BAO_0000221,,12228,Ileum,0,,CHEMBL875775,,2116.0,Autocuration,A,
,15286,Rattus norvegicus,1,,N,50597,,In vitro percent permeability into rat ileum; Range is 28-36,,,BAO_0000218,,12229,,1,10116.0,CHEMBL631873,,,Intermediate,A,
,15286,Rattus norvegicus,1,,N,50597,,In vitro percent permeability into rat ileum; Range is 29-35,,,BAO_0000218,,12230,,1,10116.0,CHEMBL631874,,,Intermediate,A,
,15286,Rattus norvegicus,1,,N,50597,,In vitro percent permeability into rat ileum; Range is 46-66,,,BAO_0000218,,12231,,1,10116.0,CHEMBL631875,,,Intermediate,A,
,15286,Rattus norvegicus,1,,N,50597,,In vitro percent permeability into rat ileum; Range is 50-68,,,BAO_0000218,,12232,,1,10116.0,CHEMBL631876,,,Intermediate,A,
,15286,Rattus norvegicus,1,,N,50597,,In vitro percent permeability into rat ileum; Range is 78-81,,,BAO_0000218,,12233,,1,10116.0,CHEMBL631877,,,Intermediate,A,
,15286,Rattus norvegicus,1,,N,50597,,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,,,BAO_0000218,,12234,,1,10116.0,CHEMBL631878,,,Intermediate,A,
,15286,Rattus norvegicus,1,,N,50597,,In vitro percent permeability into rat ileum; nd indicates not detected,,,BAO_0000218,,12235,,1,10116.0,CHEMBL631879,,,Intermediate,A,
,15286,Rattus norvegicus,1,,N,50597,,In vitro percent permeability into rat ileum; nt indicates not detected,,,BAO_0000218,,12236,,1,10116.0,CHEMBL631880,,,Intermediate,A,
,15286,Rattus norvegicus,1,,N,50597,,In vitro percent permeability into rat ileum; nt indicates not tested,,,BAO_0000218,,12237,,1,10116.0,CHEMBL631881,,,Intermediate,A,
,13770,Rattus norvegicus,1,,N,50597,,Compound was tested for oral absorption in bile-duct cannulated rats,,,BAO_0000218,,12238,,1,10116.0,CHEMBL631882,,,Intermediate,A,
,13770,Rattus norvegicus,1,,N,50597,,Compound was tested for oral absorption in bile-duct cannulated rats.,,,BAO_0000218,,12239,,1,10116.0,CHEMBL630749,,,Intermediate,A,
,5202,Homo sapiens,1,,N,50587,,Oral absorption using Caco-2 cell monolayers.,,,BAO_0000218,,12240,,1,9606.0,CHEMBL630750,,,Intermediate,A,
,14920,Homo sapiens,1,,N,50587,,Percent of the drug absorbed after administration to humans was determined,,,BAO_0000218,,12241,,1,9606.0,CHEMBL630253,,,Intermediate,A,
,14103,Rattus norvegicus,1,,N,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,,BAO_0000218,,12242,Plasma,1,10116.0,CHEMBL630254,,1969.0,Intermediate,A,
,14103,Rattus norvegicus,1,,N,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,,BAO_0000218,,12243,Plasma,1,10116.0,CHEMBL630255,,1969.0,Intermediate,A,
,14103,Rattus norvegicus,1,,N,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,,BAO_0000218,,12244,Plasma,1,10116.0,CHEMBL630256,,1969.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,BAO_0000218,,12245,Liver,1,10116.0,CHEMBL875781,In vivo,2107.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,BAO_0000218,,12246,Liver,1,10116.0,CHEMBL630257,In vivo,2107.0,Intermediate,A,
,13751,Rattus norvegicus,1,,N,50597,,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,BAO_0000218,,12247,Liver,1,10116.0,CHEMBL630258,In vivo,2107.0,Intermediate,A,
,15807,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",,,BAO_0000218,,12248,,1,10116.0,CHEMBL630259,,,Intermediate,A,
,15807,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",,,BAO_0000218,,12249,Striatum,1,10116.0,CHEMBL630260,,2435.0,Intermediate,A,
,15807,Rattus norvegicus,1,,N,50597,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",,,BAO_0000218,,12250,Striatum,1,10116.0,CHEMBL630261,,2435.0,Intermediate,A,
,14950,Rattus norvegicus,1,,N,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,,,BAO_0000218,,12251,,1,10116.0,CHEMBL630262,,,Intermediate,A,
,14950,Rattus norvegicus,1,,N,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,,,BAO_0000218,,12252,,1,10116.0,CHEMBL630263,,,Intermediate,A,
,14950,Rattus norvegicus,1,,N,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,,,BAO_0000218,,12253,,1,10116.0,CHEMBL630264,,,Intermediate,A,
,14950,Rattus norvegicus,1,,N,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,,,BAO_0000218,,12254,,1,10116.0,CHEMBL630265,,,Intermediate,A,
,14950,Rattus norvegicus,1,,N,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,,,BAO_0000218,,12255,,1,10116.0,CHEMBL630266,,,Intermediate,A,
,14950,Rattus norvegicus,1,,N,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,,,BAO_0000218,,12256,Kidney,1,10116.0,CHEMBL630267,,2113.0,Intermediate,A,
,14950,Rattus norvegicus,1,,N,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,,,BAO_0000218,,12257,Kidney,1,10116.0,CHEMBL630268,,2113.0,Intermediate,A,
,14950,Rattus norvegicus,1,,N,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,,,BAO_0000218,,12258,,1,10116.0,CHEMBL630269,,,Intermediate,A,
,14950,Rattus norvegicus,1,,N,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,,,BAO_0000218,,12259,,1,10116.0,CHEMBL630270,,,Intermediate,A,
,14950,Rattus norvegicus,1,,N,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,,,BAO_0000218,,12260,Lung,1,10116.0,CHEMBL630141,,2048.0,Intermediate,A,
,14950,Rattus norvegicus,1,,N,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,,,BAO_0000218,,12261,Lung,1,10116.0,CHEMBL630142,,2048.0,Intermediate,A,
,14950,Rattus norvegicus,1,,N,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,,,BAO_0000218,,12262,Muscle tissue,1,10116.0,CHEMBL630143,,2385.0,Intermediate,A,
,14950,Rattus norvegicus,1,,N,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,,,BAO_0000218,,12263,Muscle tissue,1,10116.0,CHEMBL630144,,2385.0,Intermediate,A,
,14950,Rattus norvegicus,1,,N,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,,,BAO_0000218,,12264,Prostate gland,1,10116.0,CHEMBL630145,,2367.0,Intermediate,A,
,14950,Rattus norvegicus,1,,N,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,,,BAO_0000218,,12265,Prostate gland,1,10116.0,CHEMBL630146,,2367.0,Intermediate,A,
,14950,Rattus norvegicus,1,,N,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,,,BAO_0000218,,12266,,1,10116.0,CHEMBL630147,,,Intermediate,A,
,14950,Rattus norvegicus,1,,N,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,,,BAO_0000218,,12267,,1,10116.0,CHEMBL630148,,,Intermediate,A,
,14950,Rattus norvegicus,1,,N,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,,,BAO_0000218,,12268,,1,10116.0,CHEMBL630149,,,Intermediate,A,
,14950,Rattus norvegicus,1,,N,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,,,BAO_0000218,,12269,Spleen,1,10116.0,CHEMBL630150,,2106.0,Intermediate,A,
,14950,Rattus norvegicus,1,,N,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,,,BAO_0000218,,12270,Spleen,1,10116.0,CHEMBL630151,,2106.0,Intermediate,A,
,14950,Rattus norvegicus,1,,N,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,,,BAO_0000218,,12271,Thyroid gland,1,10116.0,CHEMBL632031,,2046.0,Intermediate,A,
,14950,Rattus norvegicus,1,,N,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,,,BAO_0000218,,12272,Thyroid gland,1,10116.0,CHEMBL632032,,2046.0,Intermediate,A,
,14950,Rattus norvegicus,1,,N,50597,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,,,BAO_0000218,,12273,,1,10116.0,CHEMBL632033,,,Intermediate,A,
,14950,Rattus norvegicus,1,,N,50597,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,,,BAO_0000218,,12274,,1,10116.0,CHEMBL632034,,,Intermediate,A,
,14950,Rattus norvegicus,1,,N,50597,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,,,BAO_0000218,,12275,Muscle tissue,1,10116.0,CHEMBL632035,,2385.0,Intermediate,A,
,14950,Rattus norvegicus,1,,N,50597,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,,,BAO_0000218,,12276,,1,10116.0,CHEMBL632036,,,Intermediate,A,
,14950,Rattus norvegicus,1,,N,50597,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,,,BAO_0000218,,12277,Thyroid gland,1,10116.0,CHEMBL632037,,2046.0,Intermediate,A,
,8631,Rattus norvegicus,1,,N,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,,BAO_0000218,,12278,Blood,1,10116.0,CHEMBL632038,,178.0,Intermediate,A,
,8631,Rattus norvegicus,1,,N,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,,BAO_0000218,,12279,Blood,1,10116.0,CHEMBL632039,,178.0,Intermediate,A,
,8631,Rattus norvegicus,1,,N,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,,BAO_0000218,,12280,Blood,1,10116.0,CHEMBL632040,,178.0,Intermediate,A,
,8631,Rattus norvegicus,1,,N,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,,BAO_0000218,,12281,Blood,1,10116.0,CHEMBL632041,,178.0,Intermediate,A,
,9614,Canis lupus familiaris,1,,N,50588,,"Concentration of compound in blood of dog 2, after administering intravenously",,,BAO_0000218,,12282,Blood,1,9615.0,CHEMBL632042,,178.0,Intermediate,A,
,9614,Canis lupus familiaris,1,,N,50588,,"Concentration of compound in left ventricle of dog 1, after administering intravenously",,,BAO_0000218,,12283,,1,9615.0,CHEMBL632043,,,Intermediate,A,
,9614,Canis lupus familiaris,1,,N,50588,,"Concentration of compound in left ventricle of dog 2, after administering intravenously",,,BAO_0000218,,12284,,1,9615.0,CHEMBL632044,,,Intermediate,A,
,9614,Canis lupus familiaris,1,,N,50588,,"Concentration of compound in liver of dog 1, after administering intravenously",,,BAO_0000218,,12285,Liver,1,9615.0,CHEMBL632045,,2107.0,Intermediate,A,
,9614,Canis lupus familiaris,1,,N,50588,,"Concentration of compound in liver of dog 2, after administering intravenously",,,BAO_0000218,,12286,Liver,1,9615.0,CHEMBL632046,,2107.0,Intermediate,A,
,9614,Canis lupus familiaris,1,,N,50588,,"Concentration of compound in lung of dog 1, after administering intravenously",,,BAO_0000218,,12287,Lung,1,9615.0,CHEMBL632047,,2048.0,Intermediate,A,
,9614,Canis lupus familiaris,1,,N,50588,,"Concentration of compound in lung of dog 2, after administering intravenously",,,BAO_0000218,,12288,Lung,1,9615.0,CHEMBL632048,,2048.0,Intermediate,A,
,9614,Canis lupus familiaris,1,,N,50588,,"Concentration of compound in muscle of dog 1, after administering intravenously",,,BAO_0000218,,12289,Muscle tissue,1,9615.0,CHEMBL632049,,2385.0,Intermediate,A,
,9614,Canis lupus familiaris,1,,N,50588,,"Concentration of compound in muscle of dog 2, after administering intravenously",,,BAO_0000218,,12290,Muscle tissue,1,9615.0,CHEMBL876418,,2385.0,Intermediate,A,
,9614,Canis lupus familiaris,1,,N,50588,,"Concentration of compound in spleen of dog 1,after administering intravenously",,,BAO_0000218,,12291,Spleen,1,9615.0,CHEMBL632050,,2106.0,Intermediate,A,
,9614,Canis lupus familiaris,1,,N,50588,,"Concentration of compound in spleen of dog 2, after administering intravenously",,,BAO_0000218,,12292,Spleen,1,9615.0,CHEMBL632051,,2106.0,Intermediate,A,
,10353,,1,,U,22224,,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,,,BAO_0000218,,12293,,0,,CHEMBL632052,,,Autocuration,F,
,10353,,1,,U,22224,,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,,,BAO_0000218,,12294,,0,,CHEMBL632053,,,Autocuration,F,
,10353,,1,,U,22224,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,,BAO_0000218,,12295,,0,,CHEMBL632054,,,Autocuration,A,
,10353,,1,,U,22224,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,,BAO_0000218,,12296,,0,,CHEMBL632055,,,Autocuration,F,
,10353,,1,,U,22224,,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,,,BAO_0000218,,12297,,0,,CHEMBL631181,,,Autocuration,F,
,9196,,1,,U,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,,,BAO_0000218,,12298,,0,,CHEMBL631182,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,,BAO_0000218,,12299,,0,,CHEMBL631183,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,BAO_0000218,,12300,,0,,CHEMBL631184,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,BAO_0000218,,12301,,0,,CHEMBL629774,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,BAO_0000218,,12302,,0,,CHEMBL629775,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,BAO_0000218,,12303,,0,,CHEMBL876549,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,BAO_0000218,,12304,,0,,CHEMBL628172,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,,BAO_0000218,,12305,,0,,CHEMBL628173,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,,,BAO_0000218,,12306,,0,,CHEMBL628174,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,,,BAO_0000218,,12307,,0,,CHEMBL628175,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,,BAO_0000218,,12308,,0,,CHEMBL628176,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,,BAO_0000218,,12309,,0,,CHEMBL628177,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,BAO_0000218,,12310,,0,,CHEMBL628178,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,,BAO_0000218,,12311,,0,,CHEMBL628179,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,,,BAO_0000218,,12312,,0,,CHEMBL628180,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,,,BAO_0000218,,12313,,0,,CHEMBL628181,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,BAO_0000218,,12314,,0,,CHEMBL628182,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,BAO_0000218,,12315,,0,,CHEMBL628183,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,,,BAO_0000218,,12316,,0,,CHEMBL628184,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,BAO_0000218,,12317,,0,,CHEMBL628185,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,BAO_0000218,,12318,,0,,CHEMBL875617,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,,BAO_0000218,,12319,,0,,CHEMBL628186,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,BAO_0000218,,12320,,0,,CHEMBL628187,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,,BAO_0000218,,12321,,0,,CHEMBL628188,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,,BAO_0000218,,12322,,0,,CHEMBL628189,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,,,BAO_0000218,,12323,,0,,CHEMBL628190,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,,BAO_0000218,,12324,,0,,CHEMBL628191,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,,,BAO_0000218,,12325,,0,,CHEMBL626513,,,Autocuration,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",,,BAO_0000218,,12326,Thyroid gland,1,10116.0,CHEMBL626514,,2046.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",,,BAO_0000218,,12327,Thyroid gland,1,10116.0,CHEMBL626515,,2046.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",,,BAO_0000218,,12328,Thyroid gland,1,10116.0,CHEMBL626516,,2046.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",,,BAO_0000218,,12329,Thyroid gland,1,10116.0,CHEMBL626517,,2046.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",,,BAO_0000218,,12330,Thyroid gland,1,10116.0,CHEMBL626518,,2046.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",,,BAO_0000218,,12331,Thyroid gland,1,10116.0,CHEMBL626519,,2046.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",,,BAO_0000218,,12332,Thyroid gland,1,10116.0,CHEMBL626520,,2046.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",,,BAO_0000218,,12333,Thyroid gland,1,10116.0,CHEMBL626521,,2046.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",,,BAO_0000218,,12334,Thyroid gland,1,10116.0,CHEMBL626522,,2046.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",,,BAO_0000218,,12335,Thyroid gland,1,10116.0,CHEMBL626523,,2046.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",,,BAO_0000218,,12336,Thyroid gland,1,10116.0,CHEMBL626524,,2046.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",,,BAO_0000218,,12337,Thyroid gland,1,10116.0,CHEMBL626688,,2046.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",,,BAO_0000218,,12338,Thyroid gland,1,10116.0,CHEMBL626689,,2046.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",,,BAO_0000218,,12339,Thyroid gland,1,10116.0,CHEMBL626690,,2046.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",,,BAO_0000218,,12340,Thyroid gland,1,10116.0,CHEMBL626691,,2046.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",,,BAO_0000218,,12341,Thyroid gland,1,10116.0,CHEMBL627319,,2046.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",,,BAO_0000218,,12342,Thyroid gland,1,10116.0,CHEMBL624052,,2046.0,Intermediate,A,
,8608,Rattus norvegicus,1,,N,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",,,BAO_0000218,,12343,Thyroid gland,1,10116.0,CHEMBL624053,,2046.0,Intermediate,A,
,8085,Rattus norvegicus,1,,N,50597,,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,BAO_0000218,,12344,,1,10116.0,CHEMBL624054,,,Intermediate,A,
,8085,Rattus norvegicus,1,,N,50597,,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,BAO_0000218,,12345,,1,10116.0,CHEMBL624055,,,Intermediate,A,
,8085,Rattus norvegicus,1,,N,50597,,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,BAO_0000218,,12346,,1,10116.0,CHEMBL624056,,,Intermediate,A,
,8085,Rattus norvegicus,1,,N,50597,,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,BAO_0000218,,12347,Uterus,1,10116.0,CHEMBL624057,,995.0,Intermediate,A,
,8085,Rattus norvegicus,1,,N,50597,,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,BAO_0000218,,12348,Uterus,1,10116.0,CHEMBL622281,,995.0,Intermediate,A,
,8085,Rattus norvegicus,1,,N,50597,,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,BAO_0000218,,12349,Uterus,1,10116.0,CHEMBL622282,,995.0,Intermediate,A,
,8085,Rattus norvegicus,1,,N,50597,,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,BAO_0000218,,12350,Uterus,1,10116.0,CHEMBL622283,,995.0,Intermediate,A,
,8085,Rattus norvegicus,1,,N,50597,,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,BAO_0000218,,12351,Uterus,1,10116.0,CHEMBL622284,,995.0,Intermediate,A,
,8085,Rattus norvegicus,1,,N,50597,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,BAO_0000218,,12352,Uterus,1,10116.0,CHEMBL622285,,995.0,Intermediate,A,
,8085,Rattus norvegicus,1,,N,50597,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,BAO_0000218,,12353,Uterus,1,10116.0,CHEMBL622286,,995.0,Intermediate,A,
,7657,,1,,U,22224,,Distribution coefficient (D %) between octanol and buffer of pH 7.4,,,BAO_0000100,,12354,,0,,CHEMBL622287,,,Autocuration,P,
,8935,Mus musculus,1,,N,50594,,Partition coefficient (logD7.4),,,BAO_0000218,,12355,,1,10090.0,CHEMBL622288,,,Intermediate,A,
,13792,Mus musculus,1,,N,50594,,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,,BAO_0000218,,12356,,1,10090.0,CHEMBL622289,,,Intermediate,A,
,13792,Mus musculus,1,,N,50594,,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,,BAO_0000218,,12357,Brain,1,10090.0,CHEMBL622290,,955.0,Intermediate,A,
,13792,Mus musculus,1,,N,50594,,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,,BAO_0000218,,12358,,1,10090.0,CHEMBL622291,,,Intermediate,A,
,13792,Mus musculus,1,,N,50594,,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,,BAO_0000218,,12359,Brain,1,10090.0,CHEMBL622292,,955.0,Intermediate,A,
,13792,Mus musculus,1,,N,50594,,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,,BAO_0000218,,12360,,1,10090.0,CHEMBL622293,,,Intermediate,A,
,13792,Mus musculus,1,,N,50594,,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,,BAO_0000218,,12361,Brain,1,10090.0,CHEMBL622294,,955.0,Intermediate,A,
,13792,Mus musculus,1,,N,50594,,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,,BAO_0000218,,12362,,1,10090.0,CHEMBL622295,,,Intermediate,A,
,13792,Rattus norvegicus,1,,N,50597,,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,,BAO_0000218,,12363,Brain,1,10116.0,CHEMBL622296,,955.0,Intermediate,A,
,14103,Rattus norvegicus,1,,N,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,,,BAO_0000218,,12364,Plasma,1,10116.0,CHEMBL874409,,1969.0,Intermediate,A,
,14103,Rattus norvegicus,1,,N,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,,BAO_0000218,,12365,Plasma,1,10116.0,CHEMBL622297,,1969.0,Intermediate,A,
,14103,Rattus norvegicus,1,,N,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,,BAO_0000218,,12366,Plasma,1,10116.0,CHEMBL622298,,1969.0,Intermediate,A,
,14103,Rattus norvegicus,1,,N,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,,BAO_0000218,,12367,Plasma,1,10116.0,CHEMBL622299,,1969.0,Intermediate,A,
,14103,Rattus norvegicus,1,,N,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,,BAO_0000218,,12368,Plasma,1,10116.0,CHEMBL622300,,1969.0,Intermediate,A,
,14103,Rattus norvegicus,1,,N,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,,BAO_0000218,,12369,Plasma,1,10116.0,CHEMBL622301,,1969.0,Intermediate,A,
,14103,Rattus norvegicus,1,,N,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,,BAO_0000218,,12370,Plasma,1,10116.0,CHEMBL622302,,1969.0,Intermediate,A,
,14103,Rattus norvegicus,1,,N,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,,BAO_0000218,,12371,Plasma,1,10116.0,CHEMBL622303,,1969.0,Intermediate,A,
,14103,Rattus norvegicus,1,,N,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,,BAO_0000218,,12372,Plasma,1,10116.0,CHEMBL622304,,1969.0,Intermediate,A,
,14103,Rattus norvegicus,1,,N,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,,,BAO_0000218,,12373,Plasma,1,10116.0,CHEMBL622305,,1969.0,Intermediate,A,
,14103,Rattus norvegicus,1,,N,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,,BAO_0000218,,12374,Plasma,1,10116.0,CHEMBL622306,,1969.0,Intermediate,A,
,14103,Rattus norvegicus,1,,N,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,,,BAO_0000218,,12375,Plasma,1,10116.0,CHEMBL626864,,1969.0,Intermediate,A,
,14103,Rattus norvegicus,1,,N,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,,BAO_0000218,,12376,Plasma,1,10116.0,CHEMBL626865,,1969.0,Intermediate,A,
,14103,Rattus norvegicus,1,,N,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,,,BAO_0000218,,12377,Plasma,1,10116.0,CHEMBL626866,,1969.0,Intermediate,A,
,14103,Rattus norvegicus,1,,N,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,,BAO_0000218,,12378,Plasma,1,10116.0,CHEMBL626867,,1969.0,Intermediate,A,
,14103,Rattus norvegicus,1,,N,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,,BAO_0000218,,12379,Plasma,1,10116.0,CHEMBL626868,,1969.0,Intermediate,A,
,14103,Rattus norvegicus,1,,N,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,,,BAO_0000218,,12380,Plasma,1,10116.0,CHEMBL626869,,1969.0,Intermediate,A,
,14103,Rattus norvegicus,1,,N,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,,BAO_0000218,,12381,Plasma,1,10116.0,CHEMBL626870,,1969.0,Intermediate,A,
,14103,Rattus norvegicus,1,,N,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,,,BAO_0000218,,12382,Plasma,1,10116.0,CHEMBL626871,,1969.0,Intermediate,A,
,14103,Rattus norvegicus,1,,N,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,,BAO_0000218,,12383,Plasma,1,10116.0,CHEMBL626872,,1969.0,Intermediate,A,
,14103,Rattus norvegicus,1,,N,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,,BAO_0000218,,12384,Plasma,1,10116.0,CHEMBL632185,,1969.0,Intermediate,A,
,14103,Rattus norvegicus,1,,N,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,,,BAO_0000218,,12385,Plasma,1,10116.0,CHEMBL632186,,1969.0,Intermediate,A,
,12904,,1,,U,22224,,Amount of acetic acid produced by the compound,,,BAO_0000019,,12386,,0,,CHEMBL629310,,,Autocuration,A,
,12904,,1,,U,22224,,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,,,BAO_0000019,,12387,,0,,CHEMBL629311,,,Autocuration,A,
,9663,Rattus norvegicus,1,,N,50597,,Log of (Cbrain/Cblood) in rats,,,BAO_0000218,,12388,,1,10116.0,CHEMBL629312,,,Intermediate,A,
,7652,,1,,U,22224,,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),,,BAO_0000221,,12389,,0,,CHEMBL629313,,,Autocuration,A,
,7652,,1,,U,22224,,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,,BAO_0000221,,12390,,0,,CHEMBL629314,,,Autocuration,A,
,7652,,1,,U,22224,,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),,,BAO_0000221,,12391,,0,,CHEMBL629315,,,Autocuration,A,
,7652,,1,,U,22224,,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),,,BAO_0000219,,12392,,0,,CHEMBL629316,,,Autocuration,B,
,7652,,1,,U,22224,,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,,BAO_0000221,,12393,,0,,CHEMBL629317,,,Autocuration,A,
,7652,,1,,U,22224,,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),,,BAO_0000019,,12394,,0,,CHEMBL629318,,,Autocuration,A,
,7652,,1,,U,22224,,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),,,BAO_0000019,,12395,,0,,CHEMBL877497,,,Autocuration,A,
,7652,,1,,U,22224,,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),,,BAO_0000019,,12396,,0,,CHEMBL629319,,,Autocuration,A,
,7652,,1,,U,22224,,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,,BAO_0000019,,12397,,0,,CHEMBL629320,,,Autocuration,A,
,7652,,1,,U,22224,,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),,,BAO_0000019,,12398,,0,,CHEMBL629496,,,Autocuration,A,
,7652,,1,,U,22224,,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),,,BAO_0000019,,12399,,0,,CHEMBL629497,,,Autocuration,A,
,7652,,1,,U,22224,,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),,,BAO_0000019,,12400,,0,,CHEMBL629498,,,Autocuration,A,
,7652,,1,,U,22224,,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),,,BAO_0000019,,12401,,0,,CHEMBL629499,,,Autocuration,A,
,7652,,1,,U,22224,,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),,,BAO_0000019,,12402,,0,,CHEMBL629500,,,Autocuration,A,
,7652,,1,,U,22224,,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),,,BAO_0000019,,12403,,0,,CHEMBL629501,,,Autocuration,A,
,7652,,1,,U,22224,,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),,,BAO_0000019,,12404,,0,,CHEMBL629502,,,Autocuration,A,
,8267,,1,,U,22224,,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,,,BAO_0000218,,12405,,0,,CHEMBL629503,In vivo,,Autocuration,F,
,8267,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,,,BAO_0000218,,12406,,1,9615.0,CHEMBL629504,,,Intermediate,A,
,14479,,1,,U,22224,,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,,,BAO_0000019,,12407,,0,,CHEMBL629505,,,Autocuration,A,
,17515,,1,,U,22224,,Compound was evaluated for total body clearance,,,BAO_0000019,,12408,,0,,CHEMBL629506,,,Autocuration,A,
,17515,,1,,U,22224,,Compound was evaluated for volume of distribution at steady state,,,BAO_0000019,,12409,,0,,CHEMBL629507,,,Autocuration,A,
,8142,,1,,U,22224,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,,,BAO_0000019,,12410,,0,,CHEMBL877498,,,Autocuration,A,
,14849,,1,,U,22224,,Percentage of the diamine which is monoprotonated at pH 7.4,,,BAO_0000019,,12411,,0,,CHEMBL629508,,,Autocuration,A,
,7653,,1,,U,22224,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,,,BAO_0000019,,12412,,0,,CHEMBL629509,,,Autocuration,A,
,8631,Rattus norvegicus,1,,N,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,,BAO_0000218,,12413,Blood,1,10116.0,CHEMBL629510,,178.0,Intermediate,A,
,8631,Rattus norvegicus,1,,N,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,,BAO_0000218,,12414,Blood,1,10116.0,CHEMBL629511,,178.0,Intermediate,A,
,8631,Rattus norvegicus,1,,N,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,,BAO_0000218,,12415,Blood,1,10116.0,CHEMBL629512,,178.0,Intermediate,A,
,8631,Rattus norvegicus,1,,N,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,,BAO_0000218,,12416,Blood,1,10116.0,CHEMBL629513,,178.0,Intermediate,A,
,8631,Rattus norvegicus,1,,N,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,,BAO_0000218,,12417,Blood,1,10116.0,CHEMBL629514,,178.0,Intermediate,A,
,8631,Rattus norvegicus,1,,N,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,,BAO_0000218,,12418,Blood,1,10116.0,CHEMBL628447,,178.0,Intermediate,A,
,8631,Rattus norvegicus,1,,N,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,,BAO_0000218,,12419,Blood,1,10116.0,CHEMBL628448,,178.0,Intermediate,A,
,8631,Rattus norvegicus,1,,N,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,,BAO_0000218,,12420,Blood,1,10116.0,CHEMBL628449,,178.0,Intermediate,A,
,8631,Rattus norvegicus,1,,N,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,,BAO_0000218,,12421,Blood,1,10116.0,CHEMBL631119,,178.0,Intermediate,A,
,8631,Rattus norvegicus,1,,N,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,,BAO_0000218,,12422,Blood,1,10116.0,CHEMBL631120,,178.0,Intermediate,A,
,8631,Rattus norvegicus,1,,N,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,,BAO_0000218,,12423,Blood,1,10116.0,CHEMBL631121,,178.0,Intermediate,A,
,8631,Rattus norvegicus,1,,N,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,,,BAO_0000218,,12424,Blood,1,10116.0,CHEMBL874458,,178.0,Intermediate,A,
,8631,Rattus norvegicus,1,,N,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,,BAO_0000218,,12425,Blood,1,10116.0,CHEMBL631122,,178.0,Intermediate,A,
,8631,Rattus norvegicus,1,,N,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,,BAO_0000218,,12426,Blood,1,10116.0,CHEMBL631123,,178.0,Intermediate,A,
,8631,Rattus norvegicus,1,,N,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,,BAO_0000218,,12427,Blood,1,10116.0,CHEMBL631124,,178.0,Intermediate,A,
,8631,Rattus norvegicus,1,,N,50597,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,,BAO_0000218,,12428,Blood,1,10116.0,CHEMBL631125,,178.0,Intermediate,A,
,8631,Rattus norvegicus,1,,N,50597,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,,BAO_0000218,,12429,Blood,1,10116.0,CHEMBL631290,,178.0,Intermediate,A,
,8631,Rattus norvegicus,1,,N,50597,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,,BAO_0000218,,12430,Blood,1,10116.0,CHEMBL631291,,178.0,Intermediate,A,
,8631,Rattus norvegicus,1,,N,50597,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,,BAO_0000218,,12431,Blood,1,10116.0,CHEMBL631292,,178.0,Intermediate,A,
,8631,Rattus norvegicus,1,,N,50597,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,,BAO_0000218,,12432,Blood,1,10116.0,CHEMBL631293,,178.0,Intermediate,A,
,8631,Rattus norvegicus,1,,N,50597,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,,BAO_0000218,,12433,Blood,1,10116.0,CHEMBL631294,,178.0,Intermediate,A,
,8631,Rattus norvegicus,1,,N,50597,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,,BAO_0000218,,12434,Blood,1,10116.0,CHEMBL631295,,178.0,Intermediate,A,
,8631,Rattus norvegicus,1,,N,50597,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,,BAO_0000218,,12435,Blood,1,10116.0,CHEMBL631296,,178.0,Intermediate,A,
,8631,Rattus norvegicus,1,,N,50597,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,,BAO_0000218,,12436,Blood,1,10116.0,CHEMBL631297,,178.0,Intermediate,A,
,10263,,1,,U,22224,,Maximum biodistribution (Bmax) was determined.,,,BAO_0000218,,12437,,0,,CHEMBL631298,,,Autocuration,A,
,12364,Mus musculus,1,,N,50594,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,,,BAO_0000218,,12438,,1,10090.0,CHEMBL631299,,,Intermediate,A,
,12364,Mus musculus,1,,N,50594,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,,,BAO_0000218,,12439,,1,10090.0,CHEMBL631300,,,Intermediate,A,
,12364,Mus musculus,1,,N,50594,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,,,BAO_0000218,,12440,,1,10090.0,CHEMBL631301,,,Intermediate,A,
,12364,Mus musculus,1,,N,50594,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,,,BAO_0000218,,12441,,1,10090.0,CHEMBL630291,,,Intermediate,A,
,14793,,1,,U,22224,,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,,,BAO_0000218,,12442,,0,,CHEMBL630292,,,Autocuration,A,
,14793,,1,,U,22224,,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,,,BAO_0000218,,12443,,0,,CHEMBL630293,,,Autocuration,A,
,14793,,1,,U,22224,,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,,,BAO_0000218,,12444,,0,,CHEMBL630294,,,Autocuration,A,
,14793,,1,,U,22224,,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,,,BAO_0000218,,12445,,0,,CHEMBL630295,,,Autocuration,A,
,14793,,1,,U,22224,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,,,BAO_0000218,,12446,,0,,CHEMBL630296,,,Autocuration,A,
,14793,,1,,U,22224,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,,,BAO_0000218,,12447,,0,,CHEMBL626782,,,Autocuration,A,
,14793,,1,,U,22224,,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,,,BAO_0000218,,12448,,0,,CHEMBL626783,,,Autocuration,A,
,14793,,1,,U,22224,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,,,BAO_0000218,,12449,,0,,CHEMBL626784,,,Autocuration,A,
,14793,,1,,U,22224,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,,,BAO_0000218,,12450,,0,,CHEMBL626785,,,Autocuration,A,
,14793,,1,,U,22224,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,,,BAO_0000218,,12451,,0,,CHEMBL626786,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,BAO_0000218,,12452,,0,,CHEMBL626787,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,,BAO_0000218,,12453,,0,,CHEMBL626788,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,,BAO_0000218,,12454,,0,,CHEMBL625927,,,Autocuration,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,,12455,Blood,1,10116.0,CHEMBL625928,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,BAO_0000218,,12456,Blood,1,10116.0,CHEMBL625929,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,,BAO_0000218,,12457,Blood,1,10116.0,CHEMBL625930,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",,,BAO_0000218,,12458,Blood,1,10116.0,CHEMBL625931,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,,,BAO_0000218,,12459,Blood,1,10116.0,CHEMBL627230,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,,12460,Blood,1,10116.0,CHEMBL627231,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,BAO_0000218,,12461,Blood,1,10116.0,CHEMBL627232,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,,BAO_0000218,,12462,Blood,1,10116.0,CHEMBL627233,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,,12463,Blood,1,10116.0,CHEMBL875470,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,,12464,Blood,1,10116.0,CHEMBL627234,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,,12465,Blood,1,10116.0,CHEMBL627235,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,,12466,Blood,1,10116.0,CHEMBL627236,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,,12467,Blood,1,10116.0,CHEMBL627237,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,,12468,Blood,1,10116.0,CHEMBL627238,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,,12469,Blood,1,10116.0,CHEMBL627239,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,,12470,Blood,1,10116.0,CHEMBL627240,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,,12471,Blood,1,10116.0,CHEMBL627241,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,,12472,Blood,1,10116.0,CHEMBL627242,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,,,BAO_0000218,,12473,Blood,1,10116.0,CHEMBL627243,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,BAO_0000218,,12474,Blood,1,10116.0,CHEMBL627244,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,,12475,Blood,1,10116.0,CHEMBL627245,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,,12476,Blood,1,10116.0,CHEMBL627246,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,,12477,Blood,1,10116.0,CHEMBL627247,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,,12478,Blood,1,10116.0,CHEMBL627248,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,,12479,Blood,1,10116.0,CHEMBL627249,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,,12480,Blood,1,10116.0,CHEMBL625569,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,,12481,Blood,1,10116.0,CHEMBL625570,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,,12482,Blood,1,10116.0,CHEMBL625571,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,BAO_0000218,,12483,Blood,1,10116.0,CHEMBL625572,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,BAO_0000218,,12484,Blood,1,10116.0,CHEMBL625573,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,,,BAO_0000218,,12485,Blood,1,10116.0,CHEMBL625574,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,BAO_0000218,,12486,Blood,1,10116.0,CHEMBL626245,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,,12487,Blood,1,10116.0,CHEMBL626246,,178.0,Intermediate,A,
,9196,,1,,U,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,BAO_0000218,,12488,,0,,CHEMBL626247,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,BAO_0000218,,12489,,0,,CHEMBL626248,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,,BAO_0000218,,12490,,0,,CHEMBL626249,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,BAO_0000218,,12491,,0,,CHEMBL626420,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,,BAO_0000218,,12492,,0,,CHEMBL626421,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,,BAO_0000218,,12493,,0,,CHEMBL626422,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,BAO_0000218,,12494,,0,,CHEMBL626423,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,BAO_0000218,,12495,,0,,CHEMBL626424,,,Autocuration,A,
,12023,Canis lupus familiaris,1,,N,50588,,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,,,BAO_0000218,,12496,,1,9615.0,CHEMBL626425,,,Intermediate,A,
,12023,Rattus norvegicus,1,,N,50597,,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,,,BAO_0000218,,12497,,1,10116.0,CHEMBL875476,,,Intermediate,A,
,12023,Macaca fascicularis,1,,N,100710,,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,,,BAO_0000218,,12498,,1,9541.0,CHEMBL626426,,,Intermediate,A,
,10580,,1,,U,22224,,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,,,BAO_0000100,,12499,,0,,CHEMBL626427,,,Autocuration,P,
,10580,,1,,U,22224,,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,,,BAO_0000100,,12500,,0,,CHEMBL626428,,,Autocuration,P,
,16032,,1,,U,22224,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,,,BAO_0000019,,12501,,0,,CHEMBL626429,,,Autocuration,A,
,16032,,1,,U,22224,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,,,BAO_0000019,,12502,Urine,0,,CHEMBL625025,,1088.0,Autocuration,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,BAO_0000218,,12503,Blood,1,10116.0,CHEMBL625026,,178.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,BAO_0000218,,12504,Blood,1,10116.0,CHEMBL625027,,178.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,BAO_0000218,,12505,Blood,1,10116.0,CHEMBL874410,,178.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,BAO_0000218,,12506,Blood,1,10116.0,CHEMBL625028,,178.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,BAO_0000218,,12507,Blood,1,10116.0,CHEMBL625029,,178.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,BAO_0000218,,12508,Blood,1,10116.0,CHEMBL625030,,178.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,BAO_0000218,,12509,Blood,1,10116.0,CHEMBL625031,,178.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,BAO_0000218,,12510,Blood,1,10116.0,CHEMBL625032,,178.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,BAO_0000218,,12511,Blood,1,10116.0,CHEMBL625033,,178.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,BAO_0000218,,12512,Blood,1,10116.0,CHEMBL625034,,178.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,BAO_0000218,,12513,Heart,1,10116.0,CHEMBL624872,,948.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12514,Heart,1,10116.0,CHEMBL624873,,948.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,BAO_0000218,,12515,Heart,1,10116.0,CHEMBL624874,,948.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,BAO_0000218,,12516,Heart,1,10116.0,CHEMBL624875,,948.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,BAO_0000218,,12517,Heart,1,10116.0,CHEMBL624876,,948.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,BAO_0000218,,12518,Heart,1,10116.0,CHEMBL624877,,948.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,BAO_0000218,,12519,Heart,1,10116.0,CHEMBL624878,,948.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,BAO_0000218,,12520,Heart,1,10116.0,CHEMBL624879,,948.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,BAO_0000218,,12521,Heart,1,10116.0,CHEMBL624880,,948.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,,,BAO_0000218,,12522,Heart,1,10116.0,CHEMBL624881,,948.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",,,BAO_0000218,,12523,Heart,1,10116.0,CHEMBL624882,,948.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,BAO_0000218,,12524,Kidney,1,10116.0,CHEMBL624883,,2113.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,BAO_0000218,,12525,Kidney,1,10116.0,CHEMBL624884,,2113.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,BAO_0000218,,12526,Kidney,1,10116.0,CHEMBL624885,,2113.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,BAO_0000218,,12527,Kidney,1,10116.0,CHEMBL624886,,2113.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,BAO_0000218,,12528,Kidney,1,10116.0,CHEMBL624887,,2113.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,BAO_0000218,,12529,Kidney,1,10116.0,CHEMBL624888,,2113.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,BAO_0000218,,12530,Kidney,1,10116.0,CHEMBL624889,,2113.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,BAO_0000218,,12531,Kidney,1,10116.0,CHEMBL624890,,2113.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,BAO_0000218,,12532,Kidney,1,10116.0,CHEMBL621964,,2113.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,BAO_0000218,,12533,Kidney,1,10116.0,CHEMBL621965,,2113.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,BAO_0000218,,12534,Liver,1,10116.0,CHEMBL621966,,2107.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,BAO_0000218,,12535,Liver,1,10116.0,CHEMBL621967,,2107.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,BAO_0000218,,12536,Liver,1,10116.0,CHEMBL622164,,2107.0,Intermediate,A,
,7653,,1,,U,22224,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),,,BAO_0000019,,12537,,0,,CHEMBL623097,,,Autocuration,A,
,7653,,1,,U,22224,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),,,BAO_0000019,,12538,,0,,CHEMBL623098,,,Autocuration,A,
,7653,,1,,U,22224,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,,,BAO_0000019,,12539,,0,,CHEMBL623099,,,Autocuration,A,
,7653,,1,,U,22224,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,,,BAO_0000019,,12540,,0,,CHEMBL623100,,,Autocuration,A,
,9104,Rattus norvegicus,1,,N,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",,,BAO_0000218,,12541,,1,10116.0,CHEMBL628673,,,Intermediate,A,
,9104,Rattus norvegicus,1,,N,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",,,BAO_0000218,,12542,,1,10116.0,CHEMBL628674,,,Intermediate,A,
,9104,Rattus norvegicus,1,,N,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",,,BAO_0000218,,12543,,1,10116.0,CHEMBL628675,,,Intermediate,A,
,9104,Rattus norvegicus,1,,N,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",,,BAO_0000218,,12544,,1,10116.0,CHEMBL627644,,,Intermediate,A,
,9104,Rattus norvegicus,1,,N,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",,,BAO_0000218,,12545,,1,10116.0,CHEMBL627645,,,Intermediate,A,
,9104,Rattus norvegicus,1,,N,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",,,BAO_0000218,,12546,,1,10116.0,CHEMBL627646,,,Intermediate,A,
,9104,Rattus norvegicus,1,,N,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",,,BAO_0000218,,12547,,1,10116.0,CHEMBL627647,,,Intermediate,A,
,9104,Rattus norvegicus,1,,N,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",,,BAO_0000218,,12548,,1,10116.0,CHEMBL627648,,,Intermediate,A,
,12902,Rattus norvegicus,1,,N,50597,,Free level in rat plasma,,,BAO_0000218,,12549,,1,10116.0,CHEMBL627649,,,Intermediate,A,
,6614,,1,,U,22224,,Level reaching in blood plasma of rat or human was determined,,,BAO_0000019,,12550,,0,,CHEMBL628313,,,Autocuration,A,
,9663,Rattus norvegicus,1,,N,50597,,Log (Cbrain/Cblood) in rats,,,BAO_0000218,,12551,,1,10116.0,CHEMBL628314,,,Intermediate,A,
,17658,,1,,U,22224,,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,,,BAO_0000019,,12552,,0,,CHEMBL628315,,,Autocuration,A,
,17658,,1,,U,22224,,Mean percentage of compound transport through membrane; expressed as membrane transport,,,BAO_0000019,,12553,,0,,CHEMBL628316,,,Autocuration,A,
,14314,,1,,U,22224,,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,,,BAO_0000218,,12554,,0,,CHEMBL628317,,,Autocuration,A,
,7385,,1,,U,22224,,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,,,BAO_0000019,,12555,,0,,CHEMBL628473,,,Autocuration,A,
,7385,,1,,U,22224,,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",,,BAO_0000019,,12556,,0,,CHEMBL628474,,,Autocuration,A,
,7385,,1,,U,22224,,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,,,BAO_0000019,,12557,,0,,CHEMBL628475,,,Autocuration,A,
,1329,,1,,U,22224,,Net water uptake by a carrier mediated transport (%cm) mechanism,,,BAO_0000019,,12558,,0,,CHEMBL628476,,,Autocuration,A,
,12187,Simiiformes,1,,U,22224,,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,,BAO_0000218,,12559,,0,314293.0,CHEMBL628477,,,Autocuration,A,
,12187,Mustela putorius furo,1,,N,50506,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,,BAO_0000218,,12560,,1,9669.0,CHEMBL628478,,,Intermediate,A,
,12187,Mustela putorius furo,1,,N,50506,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,,BAO_0000218,,12561,,1,9669.0,CHEMBL628479,,,Intermediate,A,
,12187,Simiiformes,1,,U,22224,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,,BAO_0000218,,12562,,0,314293.0,CHEMBL628480,,,Autocuration,A,
,12187,Simiiformes,1,,U,22224,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",,,BAO_0000218,,12563,,0,314293.0,CHEMBL628481,,,Autocuration,A,
,12187,Rattus norvegicus,1,,N,50597,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,,BAO_0000218,,12564,,1,10116.0,CHEMBL628482,,,Intermediate,A,
,12187,Rattus norvegicus,1,,N,50597,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,,BAO_0000218,,12565,,1,10116.0,CHEMBL628483,,,Intermediate,A,
,9278,Rattus norvegicus,1,,N,50597,,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,,BAO_0000218,,12566,Plasma,1,10116.0,CHEMBL628484,,1969.0,Intermediate,A,
,9278,Rattus norvegicus,1,,N,50597,,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,,BAO_0000218,,12567,Plasma,1,10116.0,CHEMBL628485,,1969.0,Intermediate,A,
,9278,Macaca fascicularis,1,,N,100710,,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",,,BAO_0000218,,12568,Plasma,1,9541.0,CHEMBL628486,,1969.0,Intermediate,A,
,9278,Homo sapiens,1,,N,50587,,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",,,BAO_0000218,,12569,Plasma,1,9606.0,CHEMBL628487,,1969.0,Intermediate,A,
,9278,Rattus norvegicus,1,,N,50597,,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,,BAO_0000218,,12570,Plasma,1,10116.0,CHEMBL628488,,1969.0,Intermediate,A,
,9278,Rattus norvegicus,1,,N,50597,,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,,BAO_0000218,,12571,Plasma,1,10116.0,CHEMBL628489,,1969.0,Intermediate,A,
,9278,Rattus norvegicus,1,,N,50597,,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,,BAO_0000218,,12572,Plasma,1,10116.0,CHEMBL628490,,1969.0,Intermediate,A,
,12186,Macaca fascicularis,1,,N,100710,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,,BAO_0000218,,12573,,1,9541.0,CHEMBL628491,,,Intermediate,A,
,12186,Macaca fascicularis,1,,N,100710,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,,BAO_0000218,,12574,,1,9541.0,CHEMBL877507,,,Intermediate,A,
,12186,,1,,U,22224,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,,BAO_0000218,,12575,,0,,CHEMBL628492,,,Autocuration,A,
,12041,Simiiformes,1,,U,22224,,% metabolized in monkey S-9 after 2 hours (10 ug/mL),,,BAO_0000019,,12576,,0,314293.0,CHEMBL628493,,,Autocuration,A,
,12041,Simiiformes,1,,U,22224,,% metabolized in monkey S-9 after 2 hours (1 ug/ml),,,BAO_0000019,,12577,,0,314293.0,CHEMBL628494,,,Autocuration,A,
,12041,Simiiformes,1,,U,22224,,% metabolized in monkey S-9 after 2 hours (10 ug/ml),,,BAO_0000019,,12578,,0,314293.0,CHEMBL628495,,,Autocuration,A,
,6737,Homo sapiens,1,,N,50587,,Permeability in Caco-2 assay at 10E-6,,,BAO_0000218,,12579,,1,9606.0,CHEMBL628496,,,Intermediate,A,
,13758,,1,,U,22224,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,,BAO_0000218,,12580,Brain,0,,CHEMBL628497,,955.0,Autocuration,A,
,13758,,1,,U,22224,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,,BAO_0000218,,12581,Brain,0,,CHEMBL628498,,955.0,Autocuration,A,
,5676,,1,,U,22224,,Plasma protein binding was determined,,,BAO_0000019,,12582,,0,,CHEMBL628499,,,Autocuration,A,
,14793,,1,,U,22224,,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,,,BAO_0000218,,12583,,0,,CHEMBL627656,,,Autocuration,A,
,14793,,1,,U,22224,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,,,BAO_0000218,,12584,,0,,CHEMBL627657,,,Autocuration,A,
,14793,,1,,U,22224,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,,,BAO_0000218,,12585,,0,,CHEMBL626808,,,Autocuration,A,
,14793,,1,,U,22224,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,,,BAO_0000218,,12586,,0,,CHEMBL626809,,,Autocuration,A,
,14793,,1,,U,22224,,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,,,BAO_0000218,,12587,,0,,CHEMBL626810,,,Autocuration,A,
,14793,,1,,U,22224,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,,,BAO_0000218,,12588,,0,,CHEMBL626811,,,Autocuration,A,
,14793,,1,,U,22224,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,,,BAO_0000218,,12589,,0,,CHEMBL874465,,,Autocuration,A,
,14793,,1,,U,22224,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,,,BAO_0000218,,12590,,0,,CHEMBL626812,,,Autocuration,A,
,14793,,1,,U,22224,,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,,,BAO_0000218,,12591,,0,,CHEMBL626813,,,Autocuration,A,
,14793,,1,,U,22224,,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,,,BAO_0000218,,12592,,0,,CHEMBL626814,,,Autocuration,A,
,14000,,1,,U,22224,,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,,,BAO_0000019,,12593,,0,,CHEMBL626815,,,Autocuration,A,
,5948,,1,,U,22224,,Partition coefficient (logP),,,BAO_0000019,,12594,,0,,CHEMBL628566,,,Autocuration,A,
,13824,,1,,U,22229,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,,BAO_0000100,,12595,,0,,CHEMBL628567,,,Autocuration,P,
,10778,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,12596,,0,,CHEMBL628568,,,Autocuration,P,
,17237,Canis lupus familiaris,1,,N,50588,,C max in dog,,,BAO_0000218,,12597,,1,9615.0,CHEMBL628569,In vivo,,Intermediate,A,
,17237,Cavia porcellus,1,,N,50512,,C max in guinea pig,,,BAO_0000218,,12598,,1,10141.0,CHEMBL628570,In vivo,,Intermediate,A,
,2809,,1,,U,22224,,C max value was evaluated,,,BAO_0000218,,12599,,0,,CHEMBL628571,In vivo,,Autocuration,A,
,11954,,1,,U,22224,,Cmax value after oral dose of 0.1 mg//kg,,,BAO_0000218,,12600,,0,,CHEMBL628572,In vivo,,Autocuration,A,
,11954,,1,,U,22224,,Cmax value after oral dose of 0.3 mg/kg,,,BAO_0000218,,12601,,0,,CHEMBL628573,In vivo,,Autocuration,A,
,11954,,1,,U,22224,,Cmax value after oral dose of 1 mg/kg,,,BAO_0000218,,12602,,0,,CHEMBL628574,In vivo,,Autocuration,A,
,11954,,1,,U,22224,,Cmax value after oral dose of 10 mg/kg,,,BAO_0000218,,12603,,0,,CHEMBL628575,In vivo,,Autocuration,A,
,11954,,1,,U,22224,,Cmax value after oral dose of 23.4 mg/kg,,,BAO_0000218,,12604,,0,,CHEMBL628576,In vivo,,Autocuration,A,
,11954,,1,,U,22224,,Cmax value after oral dose of 3 mg/kg,,,BAO_0000218,,12605,,0,,CHEMBL628577,In vivo,,Autocuration,A,
,11954,,1,,U,22224,,Cmax value after oral dose of 3.87 mg/kg,,,BAO_0000218,,12606,,0,,CHEMBL628578,In vivo,,Autocuration,A,
,12768,Canis lupus familiaris,1,,N,50588,,Cmax value in female Beagle dogs,,,BAO_0000218,,12607,,1,9615.0,CHEMBL874466,In vivo,,Intermediate,A,
,12768,Rattus norvegicus,1,,N,50597,,Cmax value in male rats,,,BAO_0000218,,12608,,1,10116.0,CHEMBL628579,In vivo,,Intermediate,A,
,12780,Rattus norvegicus,1,,N,50597,,Cmax value in rat plasma when administered 20 mg/kg perorally,,,BAO_0000218,,12609,Plasma,1,10116.0,CHEMBL628580,In vivo,1969.0,Intermediate,A,
,15592,Canis lupus familiaris,1,,N,50588,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,,BAO_0000218,,12610,Plasma,1,9615.0,CHEMBL628581,In vivo,1969.0,Intermediate,A,
,15592,Canis lupus familiaris,1,,N,50588,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,,BAO_0000218,,12611,Plasma,1,9615.0,CHEMBL628582,In vivo,1969.0,Intermediate,A,
,17025,Canis lupus familiaris,1,,N,50588,,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,,,BAO_0000218,,12612,,1,9615.0,CHEMBL628583,,,Intermediate,A,
,17025,Simiiformes,1,,U,22224,,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,,,BAO_0000218,,12613,,0,314293.0,CHEMBL625782,,,Autocuration,A,
,17025,Oryctolagus cuniculus,1,,N,50592,,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,,,BAO_0000218,,12614,,1,9986.0,CHEMBL625783,,,Intermediate,A,
,17025,Rattus norvegicus,1,,N,50597,,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,,,BAO_0000218,,12615,,1,10116.0,CHEMBL625784,,,Intermediate,A,
,4236,Macaca mulatta,1,,N,50797,,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,,,BAO_0000218,,12616,Plasma,1,9544.0,CHEMBL625785,,1969.0,Intermediate,A,
,15791,Rattus norvegicus,1,,N,50597,,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,,,BAO_0000218,,12617,,1,10116.0,CHEMBL625786,,,Intermediate,A,
,11149,,1,,U,22224,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,,,BAO_0000019,,12618,,0,,CHEMBL874467,,,Autocuration,A,
,15592,Canis lupus familiaris,1,,N,50588,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,,BAO_0000218,,12619,,1,9615.0,CHEMBL625787,,,Intermediate,A,
,15778,Human immunodeficiency virus,1,,N,50677,,cytotoxicity against HIV protease enzyme.,,,BAO_0000218,,12620,,1,12721.0,CHEMBL625964,,,Intermediate,A,
,12745,Mus musculus,1,,N,50594,,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,,,BAO_0000218,,12621,,1,10090.0,CHEMBL625965,,,Intermediate,A,
,12745,Mus musculus,1,,N,50594,,Apparent clearance in mice after oral administration of 100 mg/kg of dose,,,BAO_0000218,,12622,,1,10090.0,CHEMBL625966,,,Intermediate,A,
,13941,Canis lupus familiaris,1,,N,50588,,The plasma clearance in dog.,,,BAO_0000218,,12623,Plasma,1,9615.0,CHEMBL625967,In vivo,1969.0,Intermediate,A,
,13941,Rattus norvegicus,1,,N,50597,,The plasma clearance in rat.,,,BAO_0000218,,12624,Plasma,1,10116.0,CHEMBL625968,In vivo,1969.0,Intermediate,A,
,16449,Rattus norvegicus,1,,N,50597,,Clearance from plasma in male Sprague-Dawley rats,,,BAO_0000218,,12625,Plasma,1,10116.0,CHEMBL625969,In vivo,1969.0,Intermediate,A,
,16449,Macaca fascicularis,1,,N,100710,,Clearance from plasma in male cynomolgus monkeys,,,BAO_0000218,,12626,Plasma,1,9541.0,CHEMBL625970,In vivo,1969.0,Intermediate,A,
,14224,Canis lupus familiaris,1,,N,50588,,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",,,BAO_0000218,,12627,Plasma,1,9615.0,CHEMBL625971,In vivo,1969.0,Intermediate,A,
,14224,Canis lupus familiaris,1,,N,50588,,Clearance of compound in dog plasma,,,BAO_0000218,,12628,Plasma,1,9615.0,CHEMBL625972,In vivo,1969.0,Intermediate,A,
,14224,Homo sapiens,1,,N,50587,,Clearance of compound in human plasma,,,BAO_0000218,,12629,Plasma,1,9606.0,CHEMBL625973,In vivo,1969.0,Intermediate,A,
,14317,Canis lupus familiaris,1,,N,50588,,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,,,BAO_0000218,,12630,,1,9615.0,CHEMBL625974,In vivo,,Intermediate,A,
,14317,Canis lupus familiaris,1,,N,50588,,Clearance of compound when administered intravenously as an individual dose to a single dog.,,,BAO_0000218,,12631,,1,9615.0,CHEMBL625975,In vivo,,Intermediate,A,
,14224,Canis lupus familiaris,1,,N,50588,,"Clearance (10 mg/kg, intravenously) in dog plasma",,,BAO_0000218,,12632,Plasma,1,9615.0,CHEMBL625976,In vivo,1969.0,Intermediate,A,
,17237,Canis lupus familiaris,1,,N,50588,,Clearance value in dog,,,BAO_0000218,,12633,,1,9615.0,CHEMBL625977,In vivo,,Intermediate,A,
,17237,Cavia porcellus,1,,N,50512,,Clearance value in guinea pig,,,BAO_0000218,,12634,,1,10141.0,CHEMBL625978,In vivo,,Intermediate,A,
,14187,Rattus norvegicus,1,,N,50597,,Clearance values in rats after iv administration.,,,BAO_0000218,,12635,,1,10116.0,CHEMBL874468,In vivo,,Intermediate,A,
,4806,,1,,U,22224,,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,,,BAO_0000218,,12636,Plasma,0,,CHEMBL625421,In vivo,1969.0,Autocuration,A,
,15025,Oryctolagus cuniculus,1,,N,50592,,In vivo clearance (5 mg/kg) was determined in rabbits,,,BAO_0000218,,12637,,1,9986.0,CHEMBL625422,In vivo,,Intermediate,A,
,13197,Rattus norvegicus,1,,N,50597,,Plasma Clearance rate was determined for the compound in rats,,,BAO_0000218,,12638,,1,10116.0,CHEMBL625423,In vivo,,Intermediate,A,
,13197,Saimiri,1,,U,22224,,Plasma Clearance rate was determined for the compound in squirrel monkeys,,,BAO_0000218,,12639,,0,9520.0,CHEMBL625424,In vivo,,Autocuration,A,
,13960,Rattus norvegicus,1,,N,50597,,Plasma clearance in rat,,,BAO_0000218,,12640,,1,10116.0,CHEMBL625425,In vivo,,Intermediate,A,
,17820,,1,,U,22224,,Plasma clearance of the compound,,,BAO_0000218,,12641,,0,,CHEMBL625426,In vivo,,Autocuration,A,
,14706,Cavia porcellus,1,,N,50512,,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,,,BAO_0000218,,12642,,1,10141.0,CHEMBL625427,In vivo,,Intermediate,A,
,14706,Cavia porcellus,1,,N,50512,,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,,,BAO_0000218,,12643,,1,10141.0,CHEMBL625428,In vivo,,Intermediate,A,
,6504,,1,,U,22224,,Plasma clearance was determined,,,BAO_0000218,,12644,,0,,CHEMBL625429,In vivo,,Autocuration,A,
,14925,Canis lupus familiaris,1,,N,50588,,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,,,BAO_0000218,,12645,,1,9615.0,CHEMBL625430,In vivo,,Intermediate,A,
,13197,Rattus norvegicus,1,,N,50597,,Plasma clearance rate was determined for the compound in rats,,,BAO_0000218,,12646,,1,10116.0,CHEMBL625431,In vivo,,Intermediate,A,
,13197,Saimiri,1,,U,22224,,Plasma clearance rate was determined for the compound in squirrel monkeys,,,BAO_0000218,,12647,,0,9520.0,CHEMBL627307,In vivo,,Autocuration,A,
,3437,,1,,U,22224,,Slow clearance (CL) was determined,,,BAO_0000218,,12648,,0,,CHEMBL627308,In vivo,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,,BAO_0000218,,12649,,0,,CHEMBL627309,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,,,BAO_0000218,,12650,,0,,CHEMBL627310,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,,BAO_0000218,,12651,,0,,CHEMBL627311,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,,BAO_0000218,,12652,,0,,CHEMBL627312,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,,BAO_0000218,,12653,,0,,CHEMBL627313,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,,BAO_0000218,,12654,,0,,CHEMBL627314,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,,BAO_0000218,,12655,,0,,CHEMBL627315,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,BAO_0000218,,12656,,0,,CHEMBL627316,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,BAO_0000218,,12657,,0,,CHEMBL627317,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,BAO_0000218,,12658,,0,,CHEMBL627318,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,,BAO_0000218,,12659,,0,,CHEMBL627999,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,BAO_0000218,,12660,,0,,CHEMBL628000,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,,BAO_0000218,,12661,,0,,CHEMBL628001,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,BAO_0000218,,12662,,0,,CHEMBL628002,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,,BAO_0000218,,12663,,0,,CHEMBL625610,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,BAO_0000218,,12664,,0,,CHEMBL625611,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,,BAO_0000218,,12665,,0,,CHEMBL625612,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,,BAO_0000218,,12666,,0,,CHEMBL625613,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,BAO_0000218,,12667,,0,,CHEMBL875479,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,,BAO_0000218,,12668,,0,,CHEMBL625614,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,,BAO_0000218,,12669,,0,,CHEMBL625615,,,Autocuration,A,
,9196,,1,,U,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,,BAO_0000218,,12670,,0,,CHEMBL626302,,,Autocuration,A,
,8374,Rattus norvegicus,1,,N,50597,,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,,12671,Blood,1,10116.0,CHEMBL626303,,178.0,Intermediate,A,
,8374,Rattus norvegicus,1,,N,50597,,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,,12672,Blood,1,10116.0,CHEMBL627420,,178.0,Intermediate,A,
,13477,Rattus norvegicus,1,,N,50597,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,,,BAO_0000218,,12673,,1,10116.0,CHEMBL627421,,,Intermediate,A,
,13477,Rattus norvegicus,1,,N,50597,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,,,BAO_0000218,,12674,,1,10116.0,CHEMBL625695,,,Intermediate,A,
,13477,Rattus norvegicus,1,,N,50597,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,,,BAO_0000218,,12675,,1,10116.0,CHEMBL625696,,,Intermediate,A,
,10009,Mus musculus,1,,N,50594,,Distribution of compound in mice brain was measured after 1 hr,,,BAO_0000218,,12676,Brain,1,10090.0,CHEMBL875606,,955.0,Intermediate,A,
,10009,Mus musculus,1,,N,50594,,Distribution of compound in mice brain was measured after 24 hr r,,,BAO_0000218,,12677,Brain,1,10090.0,CHEMBL625697,,955.0,Intermediate,A,
,10009,Mus musculus,1,,N,50594,,Distribution of compound in mice brain was measured after 2 hr,,,BAO_0000218,,12678,Brain,1,10090.0,CHEMBL625698,,955.0,Intermediate,A,
,10009,Mus musculus,1,,N,50594,,Distribution of compound in mice brain was measured after 3 hr,,,BAO_0000218,,12679,Brain,1,10090.0,CHEMBL625699,,955.0,Intermediate,A,
,10009,Mus musculus,1,,N,50594,,Distribution of compound in mice brain was measured after 6 hr,,,BAO_0000218,,12680,Brain,1,10090.0,CHEMBL625700,,955.0,Intermediate,A,
,10009,Mus musculus,1,,N,50594,,Distribution of compound in mice liver was measured after 1 hr,,,BAO_0000218,,12681,,1,10090.0,CHEMBL625701,,,Intermediate,A,
,10009,Mus musculus,1,,N,50594,,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,,,BAO_0000218,,12682,,1,10090.0,CHEMBL625702,,,Intermediate,A,
,10009,Mus musculus,1,,N,50594,,Distribution of compound in mice liver was measured after 2 hr,,,BAO_0000218,,12683,,1,10090.0,CHEMBL625703,,,Intermediate,A,
,10009,Mus musculus,1,,N,50594,,Distribution of compound in mice liver was measured after 3 hr,,,BAO_0000218,,12684,,1,10090.0,CHEMBL625704,,,Intermediate,A,
,10009,Mus musculus,1,,N,50594,,Distribution of compound in mice liver was measured after 6 hr,,,BAO_0000218,,12685,,1,10090.0,CHEMBL625705,,,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in dog adrenal medulla 30 min after administration.,,,BAO_0000218,,12686,Adrenal medulla,1,9615.0,CHEMBL625706,,1236.0,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in dog adrenal medulla 72 hours after administration.,,,BAO_0000218,,12687,Adrenal medulla,1,9615.0,CHEMBL625707,,1236.0,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog Ovary 24 hours after administration.,,,BAO_0000218,,12688,,1,9615.0,CHEMBL625708,,,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog Ovary 72 hours after administration.,,,BAO_0000218,,12689,,1,9615.0,CHEMBL625709,,,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog adipose 24 hours after administration.,,,BAO_0000218,,12690,,1,9615.0,CHEMBL624180,,,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog adipose 72 hours after administration.,,,BAO_0000218,,12691,,1,9615.0,CHEMBL624181,,,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog adrenal cortex 72 hours after administration.,,,BAO_0000218,,12692,Adrenal cortex,1,9615.0,CHEMBL624182,,1235.0,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog adrenal cortex 72 hours after administration.,,,BAO_0000218,,12693,Adrenal cortex,1,9615.0,CHEMBL624183,,1235.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,BAO_0000218,,12694,Liver,1,10116.0,CHEMBL624184,,2107.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,BAO_0000218,,12695,Liver,1,10116.0,CHEMBL877489,,2107.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,BAO_0000218,,12696,Liver,1,10116.0,CHEMBL624185,,2107.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,BAO_0000218,,12697,Liver,1,10116.0,CHEMBL624186,,2107.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,BAO_0000218,,12698,Liver,1,10116.0,CHEMBL624187,,2107.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,BAO_0000218,,12699,Liver,1,10116.0,CHEMBL624188,,2107.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,BAO_0000218,,12700,Lung,1,10116.0,CHEMBL624189,,2048.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,BAO_0000218,,12701,Lung,1,10116.0,CHEMBL624190,,2048.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,BAO_0000218,,12702,Lung,1,10116.0,CHEMBL624191,,2048.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,BAO_0000218,,12703,Lung,1,10116.0,CHEMBL624192,,2048.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,BAO_0000218,,12704,Lung,1,10116.0,CHEMBL624193,,2048.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,BAO_0000218,,12705,Lung,1,10116.0,CHEMBL624194,,2048.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,BAO_0000218,,12706,Lung,1,10116.0,CHEMBL624891,,2048.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,BAO_0000218,,12707,Lung,1,10116.0,CHEMBL624892,,2048.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,BAO_0000218,,12708,Lung,1,10116.0,CHEMBL624893,,2048.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,BAO_0000218,,12709,Lung,1,10116.0,CHEMBL627632,,2048.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,BAO_0000218,,12710,,1,10116.0,CHEMBL627633,,,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,BAO_0000218,,12711,,1,10116.0,CHEMBL627634,,,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,BAO_0000218,,12712,,1,10116.0,CHEMBL627635,,,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,BAO_0000218,,12713,,1,10116.0,CHEMBL627636,,,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,BAO_0000218,,12714,,1,10116.0,CHEMBL626816,,,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,BAO_0000218,,12715,,1,10116.0,CHEMBL626817,,,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,BAO_0000218,,12716,,1,10116.0,CHEMBL626818,,,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,BAO_0000218,,12717,,1,10116.0,CHEMBL626819,,,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,BAO_0000218,,12718,,1,10116.0,CHEMBL626820,,,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,BAO_0000218,,12719,,1,10116.0,CHEMBL626821,,,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,BAO_0000218,,12720,Thyroid gland,1,10116.0,CHEMBL626822,,2046.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,BAO_0000218,,12721,Thyroid gland,1,10116.0,CHEMBL626823,,2046.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,BAO_0000218,,12722,Thyroid gland,1,10116.0,CHEMBL626824,,2046.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,BAO_0000218,,12723,Thyroid gland,1,10116.0,CHEMBL626825,,2046.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,BAO_0000218,,12724,Thyroid gland,1,10116.0,CHEMBL626826,,2046.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,BAO_0000218,,12725,Thyroid gland,1,10116.0,CHEMBL626827,,2046.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,BAO_0000218,,12726,Thyroid gland,1,10116.0,CHEMBL626828,,2046.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,BAO_0000218,,12727,Thyroid gland,1,10116.0,CHEMBL626829,,2046.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,BAO_0000218,,12728,Thyroid gland,1,10116.0,CHEMBL626830,,2046.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,BAO_0000218,,12729,,1,10116.0,CHEMBL627150,,,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,BAO_0000218,,12730,,1,10116.0,CHEMBL627151,,,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,BAO_0000218,,12731,,1,10116.0,CHEMBL627152,,,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,BAO_0000218,,12732,,1,10116.0,CHEMBL627153,,,Intermediate,A,
,12904,,1,,U,22224,,Rate of acetate production by the compound was determined,,,BAO_0000019,,12733,,0,,CHEMBL627154,,,Autocuration,A,
,12904,,1,,U,22224,,Rate of acetate production by the compound was determined; Not determined,,,BAO_0000019,,12734,,0,,CHEMBL627155,,,Autocuration,A,
,3730,,1,,U,22224,,Rate of hydrolysis of nitrocefin by compound was evaluated in water,,,BAO_0000019,,12735,,0,,CHEMBL627156,,,Autocuration,A,
,3627,,1,,U,22224,,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,,,BAO_0000019,,12736,,0,,CHEMBL627157,,,Autocuration,A,
,13799,Oryctolagus cuniculus,1,,N,50592,,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,,BAO_0000218,,12737,,1,9986.0,CHEMBL627158,,,Intermediate,A,
,13799,Oryctolagus cuniculus,1,,N,50592,,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,,BAO_0000218,,12738,Plasma,1,9986.0,CHEMBL627159,,1969.0,Intermediate,A,
,13799,Mus musculus,1,,N,50594,,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,,BAO_0000218,,12739,,1,10090.0,CHEMBL627160,,,Intermediate,A,
,13799,Rattus norvegicus,1,,N,50597,,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,,BAO_0000218,,12740,,1,10116.0,CHEMBL628540,,,Intermediate,A,
,13799,Rattus norvegicus,1,,N,50597,,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,,BAO_0000218,,12741,Plasma,1,10116.0,CHEMBL628541,,1969.0,Intermediate,A,
,13799,Rattus norvegicus,1,,N,50597,,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,,BAO_0000218,,12742,Plasma,1,10116.0,CHEMBL628542,,1969.0,Intermediate,A,
,6629,,1,,U,22229,,Solubility after at a pH 1.2,,,BAO_0000100,,12743,,0,,CHEMBL628543,,,Autocuration,P,
,6629,,1,,U,22229,,Solubility after at pH 1.2,,,BAO_0000100,,12744,,0,,CHEMBL628544,,,Autocuration,P,
,6629,,1,,U,22229,,Solubility after injection of water,,,BAO_0000100,,12745,,0,,CHEMBL628545,,,Autocuration,P,
,14000,,1,,U,22224,,Statistical significance of IC 50 values; Expressed as R value,,,BAO_0000019,,12746,,0,,CHEMBL628546,,,Autocuration,A,
,8267,,1,,U,22224,,Systemic availability with respect to methyldopa was determined,,,BAO_0000019,,12747,,0,,CHEMBL874455,,,Autocuration,A,
,13799,Rattus norvegicus,1,,N,50597,,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,,,BAO_0000218,,12748,,1,10116.0,CHEMBL628547,,,Intermediate,A,
,13799,Rattus norvegicus,1,,N,50597,,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,,,BAO_0000218,,12749,Plasma,1,10116.0,CHEMBL628548,,1969.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",,,BAO_0000218,,12750,Feces,1,9986.0,CHEMBL628549,,1988.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",,,BAO_0000218,,12751,Feces,1,9986.0,CHEMBL628550,,1988.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",,,BAO_0000218,,12752,Feces,1,9986.0,CHEMBL628551,,1988.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",,,BAO_0000218,,12753,Urine,1,9986.0,CHEMBL628552,,1088.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",,,BAO_0000218,,12754,Urine,1,9986.0,CHEMBL628553,,1088.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",,,BAO_0000218,,12755,Urine,1,9986.0,CHEMBL628554,,1088.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",,,BAO_0000218,,12756,Urine,1,9986.0,CHEMBL628555,,1088.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",,,BAO_0000218,,12757,Urine,1,9986.0,CHEMBL628556,,1088.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",,,BAO_0000218,,12758,Kidney,1,9986.0,CHEMBL628557,,2113.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",,,BAO_0000218,,12759,Feces,1,9986.0,CHEMBL628558,,1988.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",,,BAO_0000218,,12760,Feces,1,9986.0,CHEMBL628559,,1988.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",,,BAO_0000218,,12761,Feces,1,9986.0,CHEMBL628560,,1988.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",,,BAO_0000218,,12762,Urine,1,9986.0,CHEMBL874456,,1088.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",,,BAO_0000218,,12763,Feces,1,9986.0,CHEMBL628561,,1988.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",,,BAO_0000218,,12764,Feces,1,9986.0,CHEMBL628562,,1988.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",,,BAO_0000218,,12765,Urine,1,9986.0,CHEMBL628563,,1088.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",,,BAO_0000218,,12766,Urine,1,9986.0,CHEMBL628564,,1088.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",,,BAO_0000218,,12767,Urine,1,9986.0,CHEMBL628565,,1088.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",,,BAO_0000218,,12768,Urine,1,9986.0,CHEMBL631248,,1088.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",,,BAO_0000218,,12769,Urine,1,9986.0,CHEMBL631249,,1088.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",,,BAO_0000218,,12770,Kidney,1,9986.0,CHEMBL627214,,2113.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",,,BAO_0000218,,12771,Feces,1,9986.0,CHEMBL874591,,1988.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",,,BAO_0000218,,12772,Feces,1,9986.0,CHEMBL627215,,1988.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,,,BAO_0000218,,12773,Feces,1,9986.0,CHEMBL625471,,1988.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,,,BAO_0000218,,12774,,1,9986.0,CHEMBL625472,,,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,,,BAO_0000218,,12775,,1,9986.0,CHEMBL625473,,,Intermediate,A,
,13317,Canis lupus familiaris,1,,N,50588,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,,,BAO_0000218,,12776,,1,9615.0,CHEMBL625474,In vivo,,Intermediate,A,
,15341,Canis lupus familiaris,1,,N,50588,,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,,,BAO_0000218,,12777,,1,9615.0,CHEMBL625475,In vivo,,Intermediate,A,
,15341,Rattus norvegicus,1,,N,50597,,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,,,BAO_0000218,,12778,,1,10116.0,CHEMBL625476,In vivo,,Intermediate,A,
,15341,Rattus norvegicus,1,,N,50597,,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,,,BAO_0000218,,12779,,1,10116.0,CHEMBL625477,In vivo,,Intermediate,A,
,15341,Rattus norvegicus,1,,N,50597,,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,,,BAO_0000218,,12780,,1,10116.0,CHEMBL625478,In vivo,,Intermediate,A,
,12801,Rattus norvegicus,1,,N,50597,,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,,,BAO_0000218,,12781,esophageal tunica muscularis mucosae,1,10116.0,CHEMBL625479,In vitro,,Intermediate,A,
,12801,Rattus norvegicus,1,,N,50597,,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,,,BAO_0000218,,12782,esophageal tunica muscularis mucosae,1,10116.0,CHEMBL625480,In vitro,,Intermediate,A,
,14856,Rattus norvegicus,1,,N,50597,,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,,,BAO_0000218,,12783,Plasma,1,10116.0,CHEMBL625481,In vivo,1969.0,Intermediate,A,
,14062,Rattus norvegicus,1,,N,50597,,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,,,BAO_0000218,,12784,,1,10116.0,CHEMBL625482,In vivo,,Intermediate,A,
,14062,Rattus norvegicus,1,,N,50597,,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,,,BAO_0000218,,12785,,1,10116.0,CHEMBL625483,In vivo,,Intermediate,A,
,14062,Rattus norvegicus,1,,N,50597,,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,,,BAO_0000218,,12786,,1,10116.0,CHEMBL625484,In vivo,,Intermediate,A,
,14062,Rattus norvegicus,1,,N,50597,,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,,,BAO_0000218,,12787,,1,10116.0,CHEMBL625485,In vivo,,Intermediate,A,
,14346,Canis lupus familiaris,1,,N,50588,,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,,,BAO_0000218,,12788,Plasma,1,9615.0,CHEMBL625486,In vivo,1969.0,Intermediate,A,
,14346,Rattus norvegicus,1,,N,50597,,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,,,BAO_0000218,,12789,Plasma,1,10116.0,CHEMBL625487,In vivo,1969.0,Intermediate,A,
,14346,Rattus norvegicus,1,,N,50597,,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,,,BAO_0000218,,12790,Plasma,1,10116.0,CHEMBL625488,In vivo,1969.0,Intermediate,A,
,14346,Rattus norvegicus,1,,N,50597,,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,,,BAO_0000218,,12791,Plasma,1,10116.0,CHEMBL625489,In vivo,1969.0,Intermediate,A,
,14346,Rattus norvegicus,1,,N,50597,,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,,,BAO_0000218,,12792,Plasma,1,10116.0,CHEMBL625490,In vivo,1969.0,Intermediate,A,
,14346,Canis lupus familiaris,1,,N,50588,,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,,,BAO_0000218,,12793,Plasma,1,9615.0,CHEMBL625491,In vivo,1969.0,Intermediate,A,
,14346,Rattus norvegicus,1,,N,50597,,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,,,BAO_0000218,,12794,Plasma,1,10116.0,CHEMBL625492,In vivo,1969.0,Intermediate,A,
,15711,Homo sapiens,1,,N,50587,,plasma clearance in human,,,BAO_0000218,,12795,Plasma,1,9606.0,CHEMBL625493,In vivo,1969.0,Intermediate,A,
,14886,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,,BAO_0000218,,12796,,1,10116.0,CHEMBL625494,In vivo,,Intermediate,A,
,14886,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,,BAO_0000218,,12797,,1,10116.0,CHEMBL625495,In vivo,,Intermediate,A,
,14886,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,,BAO_0000218,,12798,,1,10116.0,CHEMBL625496,In vivo,,Intermediate,A,
,4115,,1,,U,22229,,1-Octanol/water partition coefficient measured at 7.4,,,BAO_0000100,,12799,,0,,CHEMBL625497,,,Autocuration,P,
,13733,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,12800,,0,,CHEMBL625498,,,Autocuration,P,
,12102,,1,,U,22224,,Partition coefficient (logP),,,BAO_0000019,,12801,,0,,CHEMBL625499,,,Autocuration,A,
,12676,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,12802,,0,,CHEMBL625500,,,Autocuration,P,
,13733,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,12803,,0,,CHEMBL625501,,,Autocuration,P,
,13740,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,12804,,0,,CHEMBL625502,,,Autocuration,P,
,12766,,1,,U,22229,,Calculated partition coefficient (clogP) (relative to BAY K 8644),,,BAO_0000100,,12805,,0,,CHEMBL625503,,,Autocuration,P,
,2764,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,12806,,0,,CHEMBL625504,,,Autocuration,P,
,12355,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,12807,,0,,CHEMBL625505,,,Autocuration,P,
,11314,,1,,U,22229,,Calculated partition coefficient of the compound,,,BAO_0000100,,12808,,0,,CHEMBL625506,,,Autocuration,P,
,12706,,1,,U,22224,,Partition coefficient (logP),,,BAO_0000019,,12809,,0,,CHEMBL625507,,,Autocuration,A,
,12645,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,12810,,0,,CHEMBL625508,,,Autocuration,P,
,13668,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,12811,,0,,CHEMBL625509,,,Autocuration,P,
,12819,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,12812,,0,,CHEMBL625510,,,Autocuration,P,
,13668,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,12813,,0,,CHEMBL883125,,,Autocuration,P,
,13017,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,12814,,0,,CHEMBL625511,,,Autocuration,P,
,2448,,1,,U,22224,,Partition coefficient of the compound,,,BAO_0000019,,12815,,0,,CHEMBL874650,,,Autocuration,A,
,11526,,1,,U,22224,,Partition coefficient of the compound,,,BAO_0000019,,12816,,0,,CHEMBL625512,,,Autocuration,A,
,12426,,1,,U,22224,,Partition coefficient of compound was determined,,,BAO_0000019,,12817,,0,,CHEMBL625513,,,Autocuration,A,
,2448,,1,,U,22224,,Partition coefficient was determined,,,BAO_0000019,,12818,,0,,CHEMBL625514,,,Autocuration,A,
,12001,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,12819,,0,,CHEMBL625515,,,Autocuration,P,
,12426,,1,,U,22229,,partition coefficient of compound was determined,,,BAO_0000100,,12820,,0,,CHEMBL625516,,,Autocuration,P,
,13204,Canis lupus familiaris,1,,N,50588,,The total body administered intravenously in dog,,,BAO_0000218,,12821,,1,9615.0,CHEMBL625517,In vivo,,Intermediate,A,
,13204,Rattus norvegicus,1,,N,50597,,The total body administered intravenously in rats,,,BAO_0000218,,12822,,1,10116.0,CHEMBL625518,In vivo,,Intermediate,A,
,13889,Mus musculus,1,,N,50594,,Time taken for the administration to female NIH mice weighing 25-30 g.,,,BAO_0000218,,12823,,1,10090.0,CHEMBL625519,,,Intermediate,A,
,13889,,1,,U,22224,,Time taken for the administration,,,BAO_0000019,,12824,,0,,CHEMBL625520,,,Autocuration,A,
,17025,Canis lupus familiaris,1,,N,50588,,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,,,BAO_0000218,,12825,,1,9615.0,CHEMBL874651,In vivo,,Intermediate,A,
,17025,Simiiformes,1,,U,22224,,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,,,BAO_0000218,,12826,,0,314293.0,CHEMBL625521,In vivo,,Autocuration,A,
,17025,Oryctolagus cuniculus,1,,N,50592,,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,,,BAO_0000218,,12827,,1,9986.0,CHEMBL623171,In vivo,,Intermediate,A,
,17025,Rattus norvegicus,1,,N,50597,,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,,,BAO_0000218,,12828,,1,10116.0,CHEMBL623853,In vivo,,Intermediate,A,
,15067,,1,,U,22224,,Plasma clearance for the compound was determined.,,,BAO_0000019,,12829,,0,,CHEMBL623854,,,Autocuration,A,
,3091,,1,,U,22224,,CLog P value of the compound,,,BAO_0000100,,12830,,0,,CHEMBL874405,,,Autocuration,P,
,15592,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,12831,,0,,CHEMBL623855,,,Autocuration,P,
,14738,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,12832,,0,,CHEMBL623856,,,Autocuration,P,
,14738,,1,,U,22224,,ClogP value of the compound; nd ='no data',,,BAO_0000100,,12833,,0,,CHEMBL623857,,,Autocuration,P,
,14738,,1,,U,22224,,ClogP value of the compound; nd ='not determined',,,BAO_0000100,,12834,,0,,CHEMBL623858,,,Autocuration,P,
,6076,,1,,U,22224,,CLog P was determined,,,BAO_0000100,,12835,,0,,CHEMBL623859,,,Autocuration,P,
,17840,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,12836,,0,,CHEMBL839829,,,Autocuration,P,
,13589,,1,,U,22224,,CLogP was calculated,,,BAO_0000019,,12837,,0,,CHEMBL623860,,,Autocuration,A,
,17655,,1,,U,22224,,CLogP value was determined,,,BAO_0000019,,12838,,0,,CHEMBL623861,,,Autocuration,A,
,5867,,1,,U,22224,,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,,,BAO_0000019,,12839,,0,,CHEMBL623862,,,Autocuration,A,
,5867,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,12840,,0,,CHEMBL874406,,,Autocuration,P,
,10783,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,12841,,0,,CHEMBL623863,,,Autocuration,P,
,14849,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,12842,,0,,CHEMBL624021,,,Autocuration,P,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog adrenal medulla 24 hours after administration.,,,BAO_0000218,,12843,Adrenal medulla,1,9615.0,CHEMBL624022,,1236.0,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog adrenal medulla 72 hours after administration.,,,BAO_0000218,,12844,Adrenal medulla,1,9615.0,CHEMBL624023,,1236.0,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog bile 24 hours after administration.,,,BAO_0000218,,12845,,1,9615.0,CHEMBL624024,,,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog bile 72 hr after administration.,,,BAO_0000218,,12846,,1,9615.0,CHEMBL624025,,,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog blood 24 hours after administration.,,,BAO_0000218,,12847,,1,9615.0,CHEMBL624026,,,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog blood 72 hours after administration.,,,BAO_0000218,,12848,,1,9615.0,CHEMBL624027,,,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog heart 24 hours after administration.,,,BAO_0000218,,12849,,1,9615.0,CHEMBL624028,,,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog heart 72 hours after administration.,,,BAO_0000218,,12850,,1,9615.0,CHEMBL624029,,,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog kidney 24 hours after administration.,,,BAO_0000218,,12851,,1,9615.0,CHEMBL624030,,,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog kidney 72 hours after administration.,,,BAO_0000218,,12852,,1,9615.0,CHEMBL624031,,,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog large intestine 24 hours after administration.,,,BAO_0000218,,12853,Intestine,1,9615.0,CHEMBL624032,,160.0,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog large intestine 72 hours after administration.,,,BAO_0000218,,12854,Intestine,1,9615.0,CHEMBL874407,,160.0,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog liver 24 hours after administration.,,,BAO_0000218,,12855,,1,9615.0,CHEMBL624033,,,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog liver 72 hours after administration.,,,BAO_0000218,,12856,,1,9615.0,CHEMBL624034,,,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog lung 24 hours after administration.,,,BAO_0000218,,12857,,1,9615.0,CHEMBL624035,,,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog lung 72 hours after administration.,,,BAO_0000218,,12858,,1,9615.0,CHEMBL624036,,,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog muscle 24 hours after administration.,,,BAO_0000218,,12859,Muscle tissue,1,9615.0,CHEMBL624037,,2385.0,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog muscle 72 hours after administration.,,,BAO_0000218,,12860,Muscle tissue,1,9615.0,CHEMBL624038,,2385.0,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog pancreas 24 hours after administration.,,,BAO_0000218,,12861,,1,9615.0,CHEMBL624039,,,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog pancreas 72 hours after administration.,,,BAO_0000218,,12862,,1,9615.0,CHEMBL624040,,,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog small intestine 24 hours after administration.,,,BAO_0000218,,12863,Intestine,1,9615.0,CHEMBL624041,,160.0,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog small intestine 72 hours after administration.,,,BAO_0000218,,12864,Intestine,1,9615.0,CHEMBL624042,,160.0,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog spleen 24 hours after administration.,,,BAO_0000218,,12865,Spleen,1,9615.0,CHEMBL624043,,2106.0,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog spleen 72 hours after administration.,,,BAO_0000218,,12866,Spleen,1,9615.0,CHEMBL624044,,2106.0,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog stomach 24 hours after administration.,,,BAO_0000218,,12867,Stomach,1,9615.0,CHEMBL624045,,945.0,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog stomach 72 hours after administration.,,,BAO_0000218,,12868,Stomach,1,9615.0,CHEMBL624046,,945.0,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog thyroid 24 hours after administration.,,,BAO_0000218,,12869,Thyroid gland,1,9615.0,CHEMBL624047,,2046.0,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog thyroid 72 hours after administration.,,,BAO_0000218,,12870,Thyroid gland,1,9615.0,CHEMBL624048,,2046.0,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog urine 24 hours after administration.,,,BAO_0000218,,12871,Urine,1,9615.0,CHEMBL874408,,1088.0,Intermediate,A,
,8170,Canis lupus familiaris,1,,N,50588,,Distribution in female dog urine 72 hr after administration.,,,BAO_0000218,,12872,Urine,1,9615.0,CHEMBL624049,,1088.0,Intermediate,A,
,14283,,1,,U,22224,,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,,,BAO_0000218,,12873,Plasma,0,,CHEMBL624050,,1969.0,Autocuration,A,
,5623,,1,,U,22224,,Plasma concentration at 7 hr after intravenous dosing,,,BAO_0000019,,12874,,0,,CHEMBL624051,,,Autocuration,A,
,13477,Rattus norvegicus,1,,N,50597,,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,,,BAO_0000218,,12875,,1,10116.0,CHEMBL623278,,,Intermediate,A,
,13477,Rattus norvegicus,1,,N,50597,,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,,,BAO_0000218,,12876,,1,10116.0,CHEMBL623279,,,Intermediate,A,
,13477,Rattus norvegicus,1,,N,50597,,Plasma concentration of 3 mg/kg iv after 1 hr in rats,,,BAO_0000218,,12877,,1,10116.0,CHEMBL623280,,,Intermediate,A,
,13477,Rattus norvegicus,1,,N,50597,,Plasma concentration of 3 mg/kg iv after 2 hr in rats,,,BAO_0000218,,12878,,1,10116.0,CHEMBL623963,,,Intermediate,A,
,13477,Rattus norvegicus,1,,N,50597,,Plasma concentration of 3 mg/kg iv after 4 hr in rats,,,BAO_0000218,,12879,,1,10116.0,CHEMBL623964,,,Intermediate,A,
,13477,Rattus norvegicus,1,,N,50597,,Plasma concentration of 3 mg/kg iv after 6 hr in rats,,,BAO_0000218,,12880,,1,10116.0,CHEMBL623965,,,Intermediate,A,
,13477,Rattus norvegicus,1,,N,50597,,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,,,BAO_0000218,,12881,,1,10116.0,CHEMBL623966,,,Intermediate,A,
,13477,Rattus norvegicus,1,,N,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,,,BAO_0000218,,12882,,1,10116.0,CHEMBL874415,,,Intermediate,A,
,13477,Rattus norvegicus,1,,N,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,,,BAO_0000218,,12883,,1,10116.0,CHEMBL623967,,,Intermediate,A,
,13477,Rattus norvegicus,1,,N,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,,,BAO_0000218,,12884,,1,10116.0,CHEMBL623968,,,Intermediate,A,
,13477,Rattus norvegicus,1,,N,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,,,BAO_0000218,,12885,,1,10116.0,CHEMBL623969,,,Intermediate,A,
,13477,Rattus norvegicus,1,,N,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,,,BAO_0000218,,12886,,1,10116.0,CHEMBL628409,,,Intermediate,A,
,13477,Rattus norvegicus,1,,N,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,,,BAO_0000218,,12887,,1,10116.0,CHEMBL628410,,,Intermediate,A,
,13477,Rattus norvegicus,1,,N,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,,,BAO_0000218,,12888,,1,10116.0,CHEMBL628411,,,Intermediate,A,
,13477,Rattus norvegicus,1,,N,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,,,BAO_0000218,,12889,,1,10116.0,CHEMBL628412,,,Intermediate,A,
,12553,,1,,U,22224,,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,,,BAO_0000019,,12890,,0,,CHEMBL628413,,,Autocuration,A,
,14548,,1,,U,22224,,The concentration in plasmat; Not determined,,,BAO_0000019,,12891,Plasma,0,,CHEMBL628414,,1969.0,Autocuration,A,
,14393,Rattus norvegicus,1,,N,50597,,Tissue level at 10 mg/kg/po in wistar rats in blood,,,BAO_0000218,,12892,,1,10116.0,CHEMBL628415,,,Intermediate,A,
,14393,Rattus norvegicus,1,,N,50597,,Tissue level at 10 mg/kg/po in wistar rats in brown fat,,,BAO_0000218,,12893,,1,10116.0,CHEMBL628416,,,Intermediate,A,
,14393,Rattus norvegicus,1,,N,50597,,Tissue level at 10 mg/kg/po in wistar rats in heart,,,BAO_0000218,,12894,,1,10116.0,CHEMBL628417,,,Intermediate,A,
,14393,Rattus norvegicus,1,,N,50597,,Tissue level at 10 mg/kg/po in wistar rats in liver,,,BAO_0000218,,12895,Liver,1,10116.0,CHEMBL874908,,2107.0,Intermediate,A,
,14393,Rattus norvegicus,1,,N,50597,,Tissue level at 10 mg/kg/po in wistar rats in plasma,,,BAO_0000218,,12896,,1,10116.0,CHEMBL628418,,,Intermediate,A,
,14393,Rattus norvegicus,1,,N,50597,,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,,,BAO_0000218,,12897,Muscle tissue,1,10116.0,CHEMBL628419,,2385.0,Intermediate,A,
,14393,Rattus norvegicus,1,,N,50597,,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,,,BAO_0000218,,12898,,1,10116.0,CHEMBL628420,,,Intermediate,A,
,1629,,1,,U,22224,,Water solubility at 37 degree C.,,,BAO_0000019,,12899,,0,,CHEMBL628421,,,Autocuration,A,
,8194,,1,,U,22229,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,,BAO_0000100,,12900,,0,,CHEMBL626726,,,Autocuration,P,
,8194,,1,,U,22229,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,,BAO_0000100,,12901,,0,,CHEMBL626727,,,Autocuration,P,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12902,Blood,1,10116.0,CHEMBL626728,,178.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12903,Blood,1,10116.0,CHEMBL626729,,178.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12904,Blood,1,10116.0,CHEMBL626730,,178.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12905,Blood,1,10116.0,CHEMBL626731,,178.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12906,Blood,1,10116.0,CHEMBL626732,,178.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12907,Heart,1,10116.0,CHEMBL626733,,948.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12908,Heart,1,10116.0,CHEMBL626734,,948.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12909,Heart,1,10116.0,CHEMBL626735,,948.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12910,Heart,1,10116.0,CHEMBL874909,,948.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12911,Heart,1,10116.0,CHEMBL626736,,948.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12912,Kidney,1,10116.0,CHEMBL626737,,2113.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12913,Kidney,1,10116.0,CHEMBL630999,,2113.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12914,Kidney,1,10116.0,CHEMBL631000,,2113.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12915,Kidney,1,10116.0,CHEMBL631001,,2113.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12916,Kidney,1,10116.0,CHEMBL631002,,2113.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12917,Liver,1,10116.0,CHEMBL631003,,2107.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12918,Liver,1,10116.0,CHEMBL631004,,2107.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12919,Liver,1,10116.0,CHEMBL631005,,2107.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12920,Liver,1,10116.0,CHEMBL631006,,2107.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12921,Liver,1,10116.0,CHEMBL631007,,2107.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12922,Lung,1,10116.0,CHEMBL631008,,2048.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12923,Lung,1,10116.0,CHEMBL631009,,2048.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12924,Lung,1,10116.0,CHEMBL631010,,2048.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12925,Lung,1,10116.0,CHEMBL631011,,2048.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12926,Lung,1,10116.0,CHEMBL631012,,2048.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12927,Thyroid gland,1,10116.0,CHEMBL630271,,2046.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12928,Thyroid gland,1,10116.0,CHEMBL630272,,2046.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12929,Thyroid gland,1,10116.0,CHEMBL630273,,2046.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12930,Thyroid gland,1,10116.0,CHEMBL630274,,2046.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12931,Thyroid gland,1,10116.0,CHEMBL630275,,2046.0,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12932,,1,10116.0,CHEMBL875782,,,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12933,,1,10116.0,CHEMBL630276,,,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12934,,1,10116.0,CHEMBL630277,,,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12935,,1,10116.0,CHEMBL630278,,,Intermediate,A,
,8594,Rattus norvegicus,1,,N,50597,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,,,BAO_0000218,,12936,,1,10116.0,CHEMBL630279,,,Intermediate,A,
,8151,,1,,U,22224,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,,,BAO_0000019,,12937,,0,,CHEMBL630280,,,Autocuration,A,
,8151,,1,,U,22224,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,,BAO_0000019,,12938,,0,,CHEMBL630281,,,Autocuration,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,,,BAO_0000218,,12939,,1,9986.0,CHEMBL630282,,,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,,,BAO_0000218,,12940,,1,9986.0,CHEMBL630283,,,Intermediate,A,
,5797,,1,,U,22224,,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),,,BAO_0000019,,12941,,0,,CHEMBL630284,,,Autocuration,A,
,7849,,1,,U,22224,,Alkylating activity was determined,,,BAO_0000019,,12942,,0,,CHEMBL630285,,,Autocuration,A,
,14220,,1,,U,22224,,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),,,BAO_0000251,,12943,,0,,CHEMBL630286,,,Autocuration,A,Microsomes
,8650,Oryctolagus cuniculus,1,,N,50592,,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",,,BAO_0000218,,12944,,1,9986.0,CHEMBL630069,,,Intermediate,A,
,8650,Oryctolagus cuniculus,1,,N,50592,,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",,,BAO_0000218,,12945,,1,9986.0,CHEMBL630070,,,Intermediate,A,
,8650,Oryctolagus cuniculus,1,,N,50592,,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",,,BAO_0000218,,12946,,1,9986.0,CHEMBL630071,,,Intermediate,A,
,8650,Oryctolagus cuniculus,1,,N,50592,,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",,,BAO_0000218,,12947,,1,9986.0,CHEMBL630072,,,Intermediate,A,
,8650,Oryctolagus cuniculus,1,,N,50592,,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",,,BAO_0000218,,12948,,1,9986.0,CHEMBL875110,,,Intermediate,A,
,7116,Rattus norvegicus,1,,N,50597,,Compound was tested for antidiuretic activity in rats,,,BAO_0000218,,12949,,1,10116.0,CHEMBL630073,,,Intermediate,A,
,14131,,1,,U,22224,,Compound was tested for inactivation kinetic values,,,BAO_0000019,,12950,,0,,CHEMBL630074,,,Autocuration,A,
,7415,,1,,U,22224,,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,,,BAO_0000218,,12951,,0,,CHEMBL630075,In vivo,,Autocuration,A,
,13178,,1,,U,22224,,Dissociation rate calculated from the first-order equation using the t1/2 value,,,BAO_0000019,,12952,,0,,CHEMBL630076,,,Autocuration,A,
,8815,,1,,U,22229,,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,,,BAO_0000100,,12953,,0,,CHEMBL630077,,,Autocuration,P,
,1450,,1,,U,22229,,Aqueous solubility was measured,,,BAO_0000100,,12954,,0,,CHEMBL630078,,,Autocuration,P,
,1450,,1,,U,22229,,Aqueous solubility was measured at a pH 4,,,BAO_0000100,,12955,,0,,CHEMBL630079,,,Autocuration,P,
,1450,,1,,U,22229,,Aqueous solubility (pH 7),,,BAO_0000100,,12956,,0,,CHEMBL630080,,,Autocuration,P,
,1450,,1,,U,22229,,Aqueous solubility was measured at a pH 9,,,BAO_0000100,,12957,,0,,CHEMBL630081,,,Autocuration,P,
,12711,,1,,U,22224,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",,,BAO_0000019,,12958,,0,,CHEMBL630082,,,Autocuration,A,
,12711,,1,,U,22224,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,,BAO_0000019,,12959,,0,,CHEMBL630083,,,Autocuration,A,
,12711,,1,,U,22224,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,,BAO_0000019,,12960,,0,,CHEMBL630084,,,Autocuration,A,
,15032,,1,,U,22229,,Aqueous solubility of the compound,,,BAO_0000100,,12961,,0,,CHEMBL629198,,,Autocuration,P,
,9964,,1,,U,22229,,Aqueous solubility at 37 degree Celsius at pH 7.38,,,BAO_0000100,,12962,,0,,CHEMBL629199,,,Autocuration,P,
,14962,,1,,U,22229,,Aqueous solubility in pH 7.4 phosphate buffer,,,BAO_0000100,,12963,,0,,CHEMBL629200,,,Autocuration,P,
,12487,Canis lupus familiaris,1,,N,50588,,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,,,BAO_0000218,,12964,,1,9615.0,CHEMBL629201,,,Intermediate,A,
,12487,Canis lupus familiaris,1,,N,50588,,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,,,BAO_0000218,,12965,,1,9615.0,CHEMBL629202,,,Intermediate,A,
,10026,Homo sapiens,1,,N,50587,,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,,,BAO_0000218,,12966,,1,9606.0,CHEMBL875111,,,Intermediate,A,
,10026,Homo sapiens,1,,N,50587,,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,,,BAO_0000218,,12967,,1,9606.0,CHEMBL629203,,,Intermediate,A,
,10026,Homo sapiens,1,,N,50587,,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,,,BAO_0000218,,12968,,1,9606.0,CHEMBL629204,,,Intermediate,A,
,10026,Homo sapiens,1,,N,50587,,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,,,BAO_0000218,,12969,,1,9606.0,CHEMBL629205,,,Intermediate,A,
,10026,Homo sapiens,1,,N,50587,,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,,,BAO_0000218,,12970,,1,9606.0,CHEMBL629206,,,Intermediate,A,
,10026,,1,,U,22224,,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,,,BAO_0000019,,12971,,0,,CHEMBL631185,,,Autocuration,A,
,7415,Rattus norvegicus,1,,N,50597,,Compound was evaluated for the average bile flow rat in rats,,,BAO_0000218,,12972,,1,10116.0,CHEMBL631186,,,Intermediate,A,
,17025,Oryctolagus cuniculus,1,,N,50592,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,,BAO_0000218,,12973,,1,9986.0,CHEMBL631187,,,Intermediate,A,
,17025,Oryctolagus cuniculus,1,,N,50592,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,,BAO_0000218,,12974,,1,9986.0,CHEMBL631188,,,Intermediate,A,
,10184,,1,,U,22224,,Average half life period was determined,,,BAO_0000019,,12975,,0,,CHEMBL876419,,,Autocuration,A,
,10184,,1,,U,22224,,Average half life period was determined,,,BAO_0000019,,12976,,0,,CHEMBL631189,,,Autocuration,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,,BAO_0000218,,12977,,1,10298.0,CHEMBL631190,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,,BAO_0000218,,12978,,1,10298.0,CHEMBL631191,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,,,BAO_0000218,,12979,,1,10298.0,CHEMBL631192,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,,,BAO_0000218,,12980,,1,10298.0,CHEMBL632400,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,,BAO_0000218,,12981,,1,10298.0,CHEMBL630564,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,,BAO_0000218,,12982,,1,10298.0,CHEMBL630565,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,,,BAO_0000218,,12983,,1,10298.0,CHEMBL630566,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,,,BAO_0000218,,12984,,1,10298.0,CHEMBL631229,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,,,BAO_0000218,,12985,,1,10298.0,CHEMBL631230,,,Intermediate,A,
,6030,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,12986,,0,,CHEMBL876428,,,Autocuration,P,
,6147,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,12987,,0,,CHEMBL631231,,,Autocuration,P,
,14556,,1,,U,22229,,Calculated partition coefficient (clogP) (MacLogP),,,BAO_0000100,,12988,,0,,CHEMBL631232,,,Autocuration,P,
,768,,1,,U,22224,,Hydrophilicity was determined,,,BAO_0000019,,12989,,0,,CHEMBL631233,,,Autocuration,A,
,14452,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,12990,,0,,CHEMBL631234,,,Autocuration,P,
,5237,,1,,U,22224,,Increased absorption was determined,,,BAO_0000019,,12991,,0,,CHEMBL883126,,,Autocuration,A,
,14378,,1,,U,22224,,Lipophilicity value was evaluated,,,BAO_0000100,,12992,,0,,CHEMBL631235,,,Autocuration,P,
,14418,,1,,U,22224,,Log P value of the compound.,,,BAO_0000100,,12993,,0,,CHEMBL631236,,,Autocuration,P,
,5249,,1,,U,22224,,Partition coefficient of compound was determined,,,BAO_0000019,,12994,,0,,CHEMBL631237,,,Autocuration,A,
,14621,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,12995,,0,,CHEMBL631238,,,Autocuration,P,
,12542,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,12996,,0,,CHEMBL876429,,,Autocuration,P,
,12542,,1,,U,22224,,Partition coefficient was measured by medchem software; Not calculated,,,BAO_0000019,,12997,,0,,CHEMBL631414,,,Autocuration,A,
,12542,,1,,U,22224,,Partition coefficient was measured by octanol-water using standard shake-flask method,,,BAO_0000100,,12998,,0,,CHEMBL631415,,,Autocuration,P,
,15462,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,12999,,0,,CHEMBL631416,,,Autocuration,P,
,14884,,1,,U,22224,,Partition coefficient (logP),,,BAO_0000019,,13000,,0,,CHEMBL631417,,,Autocuration,A,
,16526,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13001,,0,,CHEMBL631418,,,Autocuration,P,
,13693,,1,,U,22229,,The Octanol/Water partition coefficient CLogP,,,BAO_0000100,,13002,,0,,CHEMBL631419,,,Autocuration,P,
,13693,,1,,U,22224,,The pharmacokinetic parameter C Log p was reported,,,BAO_0000019,,13003,,0,,CHEMBL631420,,,Autocuration,A,
,13779,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13004,,0,,CHEMBL631421,,,Autocuration,P,
,14772,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13005,,0,,CHEMBL631422,,,Autocuration,P,
,14393,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13006,,0,,CHEMBL631423,,,Autocuration,P,
,14793,Rattus norvegicus,1,,N,50597,,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,,BAO_0000218,,13007,Plasma,1,10116.0,CHEMBL876430,In vivo,1969.0,Intermediate,A,
,14793,Rattus norvegicus,1,,N,50597,,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,,,BAO_0000218,,13008,Plasma,1,10116.0,CHEMBL631424,In vivo,1969.0,Intermediate,A,
,13744,Canis lupus familiaris,1,,N,50588,,Compound was administered intravenously in dog to evaluate plasma clearance values,,,BAO_0000218,,13009,Plasma,1,9615.0,CHEMBL631425,In vivo,1969.0,Intermediate,A,
,13744,Simiiformes,1,,U,22224,,Compound was administered intravenously in monkey to evaluate plasma clearance values,,,BAO_0000218,,13010,Plasma,0,314293.0,CHEMBL631426,In vivo,1969.0,Autocuration,A,
,13744,Mus musculus,1,,N,50594,,Compound was administered intravenously in mouse to evaluate plasma clearance values,,,BAO_0000218,,13011,Plasma,1,10090.0,CHEMBL631427,In vivo,1969.0,Intermediate,A,
,13207,Canis lupus familiaris,1,,N,50588,,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,,,BAO_0000218,,13012,Plasma,1,9615.0,CHEMBL631428,In vivo,1969.0,Intermediate,A,
,5669,Macaca mulatta,1,,N,50797,,Intrinsic clearance in Rhesus liver microsome,,,BAO_0000218,,13013,Liver,1,9544.0,CHEMBL631429,In vitro,2107.0,Intermediate,A,Microsomes
,5669,Canis lupus familiaris,1,,N,50588,,Intrinsic clearance in dog liver microsome,,,BAO_0000218,,13014,Liver,1,9615.0,CHEMBL631430,In vitro,2107.0,Intermediate,A,Microsomes
,5669,Rattus norvegicus,1,,N,50597,,Intrinsic clearance in rat liver microsome,,,BAO_0000218,,13015,Liver,1,10116.0,CHEMBL631431,In vitro,2107.0,Intermediate,A,Microsomes
,4853,Macaca mulatta,1,,N,50797,,Low plasma clearance was calculated in rhesus monkey,,,BAO_0000218,,13016,Plasma,1,9544.0,CHEMBL631432,In vivo,1969.0,Intermediate,A,
,16452,Canis lupus familiaris,1,,N,50588,,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,,,BAO_0000218,,13017,,1,9615.0,CHEMBL631433,In vivo,,Intermediate,A,
,11954,,1,,U,22224,,Plasma clearance after intravenous dose of 0.3 mg/kg,,,BAO_0000218,,13018,,0,,CHEMBL631434,In vivo,,Autocuration,A,
,11954,,1,,U,22224,,Plasma clearance after intravenous dose of 1 mg/kg,,,BAO_0000218,,13019,,0,,CHEMBL631435,In vivo,,Autocuration,A,
,11954,,1,,U,22224,,Plasma clearance after intravenous dose of 3 mg/kg,,,BAO_0000218,,13020,,0,,CHEMBL631436,In vivo,,Autocuration,A,
,11954,,1,,U,22224,,Plasma clearance after intravenous dose of 3.87 mg/kg,,,BAO_0000218,,13021,,0,,CHEMBL631437,In vivo,,Autocuration,A,
,5669,Rattus norvegicus,1,,N,50597,,Plasma clearance after peroral administration at 10 mpk in Rat,,,BAO_0000218,,13022,,1,10116.0,CHEMBL631438,In vivo,,Intermediate,A,
,5669,Macaca mulatta,1,,N,50797,,Plasma clearance after peroral administration at 10 mpk in Rhesus,,,BAO_0000218,,13023,,1,9544.0,CHEMBL876431,In vivo,,Intermediate,A,
,5669,Canis lupus familiaris,1,,N,50588,,Plasma clearance after peroral administration at 10 mpk in dog,,,BAO_0000218,,13024,,1,9615.0,CHEMBL631439,In vivo,,Intermediate,A,
,13662,Rattus norvegicus,1,,N,50597,,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,,,BAO_0000218,,13025,,1,10116.0,CHEMBL631440,In vivo,,Intermediate,A,
,8272,,1,,U,22224,,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),,,BAO_0000019,,13026,,0,,CHEMBL631441,,,Autocuration,A,
,13410,,1,,U,22224,,Critical Micellar concentration was determined,,,BAO_0000019,,13027,,0,,CHEMBL631442,,,Autocuration,A,
,13410,,1,,U,22224,,Critical Micellar concentration of the compound. was determined,,,BAO_0000019,,13028,,0,,CHEMBL626525,,,Autocuration,A,
,12628,,1,,U,22224,,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,,,BAO_0000019,,13029,,0,,CHEMBL627168,,,Autocuration,A,
,9675,,1,,U,22224,,Critical micellar concentration was measured in water by the dye solubilization method,,,BAO_0000019,,13030,,0,,CHEMBL875618,,,Autocuration,A,
,12628,,1,,U,22224,,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,,,BAO_0000019,,13031,,0,,CHEMBL626612,,,Autocuration,B,
,12766,,1,,U,22224,,CMR value (relative to BAY K 8644),,,BAO_0000019,,13032,,0,,CHEMBL626613,,,Autocuration,A,
,7849,,1,,U,22224,,Carbamoylating activity was determined,,,BAO_0000019,,13033,,0,,CHEMBL626614,,,Autocuration,A,
,12187,Simiiformes,1,,U,22224,,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,,,BAO_0000218,,13034,,0,314293.0,CHEMBL626615,,,Autocuration,A,
,2040,,1,,U,22224,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,,,BAO_0000019,,13035,,0,,CHEMBL626616,,,Autocuration,A,
,2040,,1,,U,22224,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,,,BAO_0000019,,13036,,0,,CHEMBL626617,,,Autocuration,A,
,14180,Canis lupus familiaris,1,,N,50588,,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,,,BAO_0000218,,13037,Plasma,1,9615.0,CHEMBL626618,In vivo,1969.0,Intermediate,A,
,14180,Rattus norvegicus,1,,N,50597,,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,,,BAO_0000218,,13038,Plasma,1,10116.0,CHEMBL626619,In vivo,1969.0,Intermediate,A,
,14474,Canis lupus familiaris,1,,N,50588,,"Clearance rate at 0.46 mg/kg, iv, in dogs",,,BAO_0000218,,13039,,1,9615.0,CHEMBL626620,In vivo,,Intermediate,A,
,14474,Rattus norvegicus,1,,N,50597,,"Clearance rate at 5.5 mg/kg, iv, in rat",,,BAO_0000218,,13040,,1,10116.0,CHEMBL626621,In vivo,,Intermediate,A,
,14548,Macaca fascicularis,1,,N,100710,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,,BAO_0000218,,13041,,1,9541.0,CHEMBL626622,In vivo,,Intermediate,A,
,14548,Macaca fascicularis,1,,N,100710,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,,BAO_0000218,,13042,,1,9541.0,CHEMBL626623,In vivo,,Intermediate,A,
,14548,Canis lupus familiaris,1,,N,50588,,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,,BAO_0000218,,13043,,1,9615.0,CHEMBL626624,In vivo,,Intermediate,A,
,14548,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,,BAO_0000218,,13044,,1,10116.0,CHEMBL626625,In vivo,,Intermediate,A,
,6125,Rattus norvegicus,1,,N,50597,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,,BAO_0000218,,13045,Liver,1,10116.0,CHEMBL626626,Ex vivo,2107.0,Intermediate,A,
,6874,,1,,U,22224,,Tested for the total clearance of the compound,,,BAO_0000218,,13046,,0,,CHEMBL626627,In vivo,,Autocuration,A,
,15343,Canis lupus familiaris,1,,N,50588,,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,,,BAO_0000218,,13047,,1,9615.0,CHEMBL626628,In vivo,,Intermediate,A,
,6236,,1,,U,22224,,Total body clearance was determined,,,BAO_0000218,,13048,,0,,CHEMBL626629,In vivo,,Autocuration,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,,BAO_0000218,,13049,,1,10116.0,CHEMBL626630,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,,BAO_0000218,,13050,,1,10116.0,CHEMBL626631,,,Intermediate,A,
,8194,,1,,U,22229,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,,BAO_0000100,,13051,,0,,CHEMBL626632,,,Autocuration,P,
,8194,,1,,U,22229,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,,BAO_0000100,,13052,,0,,CHEMBL626633,,,Autocuration,P,
,8194,,1,,U,22229,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,,,BAO_0000100,,13053,,0,,CHEMBL626634,,,Autocuration,P,
,8194,,1,,U,22229,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,,BAO_0000100,,13054,,0,,CHEMBL626635,,,Autocuration,P,
,8194,,1,,U,22229,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,,BAO_0000100,,13055,,0,,CHEMBL626636,,,Autocuration,P,
,8194,,1,,U,22229,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,,BAO_0000100,,13056,,0,,CHEMBL626637,,,Autocuration,P,
,13273,Pneumocystis carinii,1,,N,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),,,BAO_0000218,,13057,,1,4754.0,CHEMBL626638,,,Intermediate,A,
,13273,Pneumocystis carinii,1,,N,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,,,BAO_0000218,,13058,,1,4754.0,CHEMBL626639,,,Intermediate,A,
,13273,Pneumocystis carinii,1,,N,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,,,BAO_0000218,,13059,,1,4754.0,CHEMBL626640,,,Intermediate,A,
,13273,Pneumocystis carinii,1,,N,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,,,BAO_0000218,,13060,,1,4754.0,CHEMBL626641,,,Intermediate,A,
,13273,Pneumocystis carinii,1,,N,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,,,BAO_0000218,,13061,,1,4754.0,CHEMBL627272,,,Intermediate,A,
,13273,Pneumocystis carinii,1,,N,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,,,BAO_0000218,,13062,,1,4754.0,CHEMBL627273,,,Intermediate,A,
,13273,Pneumocystis carinii,1,,N,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),,,BAO_0000218,,13063,,1,4754.0,CHEMBL627441,,,Intermediate,A,
,13273,Pneumocystis carinii,1,,N,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),,,BAO_0000218,,13064,,1,4754.0,CHEMBL628355,,,Intermediate,A,
,13273,Pneumocystis carinii,1,,N,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),,,BAO_0000218,,13065,,1,4754.0,CHEMBL628356,,,Intermediate,A,
,13273,Pneumocystis carinii,1,,N,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),,,BAO_0000218,,13066,,1,4754.0,CHEMBL628357,,,Intermediate,A,
,13273,Pneumocystis carinii,1,,N,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),,,BAO_0000218,,13067,,1,4754.0,CHEMBL628358,,,Intermediate,A,
,13273,Pneumocystis carinii,1,,N,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),,,BAO_0000218,,13068,,1,4754.0,CHEMBL622307,,,Intermediate,A,
,13118,,1,,U,22224,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,,,BAO_0000019,,13069,,0,,CHEMBL622527,,,Autocuration,A,
,13118,,1,,U,22224,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,,,BAO_0000019,,13070,,0,,CHEMBL622528,,,Autocuration,A,
,13118,,1,,U,22224,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,,,BAO_0000019,,13071,,0,,CHEMBL622529,,,Autocuration,A,
,13118,,1,,U,22224,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,,,BAO_0000019,,13072,,0,,CHEMBL622992,,,Autocuration,A,
,13118,,1,,U,22224,,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,,,BAO_0000019,,13073,,0,,CHEMBL622993,,,Autocuration,A,
,13118,,1,,U,22224,,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,,,BAO_0000019,,13074,,0,,CHEMBL622994,,,Autocuration,A,
,10633,Rattus norvegicus,1,,N,50597,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",,,BAO_0000218,,13075,,1,10116.0,CHEMBL622995,,,Intermediate,A,
,10633,Rattus norvegicus,1,,N,50597,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",,,BAO_0000218,,13076,,1,10116.0,CHEMBL622996,,,Intermediate,A,
,10633,Rattus norvegicus,1,,N,50597,,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",,,BAO_0000218,,13077,,1,10116.0,CHEMBL622997,,,Intermediate,A,
,10633,Rattus norvegicus,1,,N,50597,,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",,,BAO_0000218,,13078,,1,10116.0,CHEMBL622998,,,Intermediate,A,
,5767,,1,,U,22224,,Cp max following ip administration at 1 mg/kg,,,BAO_0000218,,13079,,0,,CHEMBL622999,,,Autocuration,A,
,3302,,1,,U,22224,,Maximum concentration in plasma was reported at 0.5 hour,,,BAO_0000218,,13080,Plasma,0,,CHEMBL623000,In vivo,1969.0,Autocuration,A,
,3302,,1,,U,22224,,Maximum concentration in plasma was reported at 2 hour,,,BAO_0000218,,13081,Plasma,0,,CHEMBL623001,In vivo,1969.0,Autocuration,A,
,12467,Mus musculus,1,,N,50594,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,,,BAO_0000218,,13082,,1,10090.0,CHEMBL623002,,,Intermediate,A,
,11778,,1,,U,22229,,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),,,BAO_0000100,,13083,,0,,CHEMBL623003,,,Autocuration,P,
,4321,,1,,U,22224,,Steady state concentration was evaluated,,,BAO_0000019,,13084,,0,,CHEMBL623004,,,Autocuration,A,
,14884,,1,,U,22224,,Partition coefficient (logP),,,BAO_0000019,,13085,,0,,CHEMBL623005,,,Autocuration,A,
,15234,,1,,U,22224,,Partition coefficient (logD7.4),,,BAO_0000019,,13086,,0,,CHEMBL623006,,,Autocuration,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,,,BAO_0000218,,13087,Liver,1,10116.0,CHEMBL623007,In vivo,2107.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,,,BAO_0000218,,13088,Bone,1,10116.0,CHEMBL623008,In vivo,10000001.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,,,BAO_0000218,,13089,Cerebellum,1,10116.0,CHEMBL876654,In vivo,2037.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,,,BAO_0000218,,13090,,1,10116.0,CHEMBL623009,In vivo,,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,,,BAO_0000218,,13091,,1,10116.0,CHEMBL623010,In vivo,,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,,,BAO_0000218,,13092,Heart,1,10116.0,CHEMBL623011,In vivo,948.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,,,BAO_0000218,,13093,Intestine,1,10116.0,CHEMBL623012,In vivo,160.0,Intermediate,A,
,8151,,1,,U,22224,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,,BAO_0000019,,13094,,0,,CHEMBL623013,,,Autocuration,A,
,8151,,1,,U,22224,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,,BAO_0000019,,13095,,0,,CHEMBL623014,,,Autocuration,A,
,8151,,1,,U,22224,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,,,BAO_0000019,,13096,Urine,0,,CHEMBL623015,,1088.0,Autocuration,A,
,8151,,1,,U,22224,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,,BAO_0000019,,13097,Urine,0,,CHEMBL623016,,1088.0,Autocuration,A,
,8151,,1,,U,22224,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,,,BAO_0000019,,13098,Urine,0,,CHEMBL624858,,1088.0,Autocuration,A,
,8151,Rattus norvegicus,1,,N,50597,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,,,BAO_0000218,,13099,,1,10116.0,CHEMBL624859,,,Intermediate,A,
,8151,Rattus norvegicus,1,,N,50597,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,,BAO_0000218,,13100,,1,10116.0,CHEMBL624860,,,Intermediate,A,
,8151,Rattus norvegicus,1,,N,50597,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,,BAO_0000218,,13101,,1,10116.0,CHEMBL624861,,,Intermediate,A,
,8151,Rattus norvegicus,1,,N,50597,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,,BAO_0000218,,13102,,1,10116.0,CHEMBL624862,,,Intermediate,A,
,8151,Rattus norvegicus,1,,N,50597,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,,,BAO_0000218,,13103,,1,10116.0,CHEMBL624863,,,Intermediate,A,
,8151,Rattus norvegicus,1,,N,50597,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,,BAO_0000218,,13104,,1,10116.0,CHEMBL876655,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,,BAO_0000218,,13105,,1,9615.0,CHEMBL624864,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,,BAO_0000218,,13106,,1,9615.0,CHEMBL624865,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,,BAO_0000218,,13107,,1,9615.0,CHEMBL624866,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,,,BAO_0000218,,13108,,1,9615.0,CHEMBL624867,,,Expert,F,
,6996,Canis lupus familiaris,1,,N,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,,BAO_0000218,,13109,,1,9615.0,CHEMBL624868,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,,,BAO_0000218,,13110,,1,9615.0,CHEMBL628450,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,,BAO_0000218,,13111,,1,9615.0,CHEMBL628451,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,,BAO_0000218,,13112,,1,9615.0,CHEMBL628452,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,,BAO_0000218,,13113,,1,9615.0,CHEMBL628453,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,,,BAO_0000218,,13114,,1,9615.0,CHEMBL628454,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,,BAO_0000218,,13115,,1,9615.0,CHEMBL628455,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,,BAO_0000218,,13116,,1,9615.0,CHEMBL628456,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,,BAO_0000218,,13117,,1,9615.0,CHEMBL628457,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,,,BAO_0000218,,13118,,1,9615.0,CHEMBL877505,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,,,BAO_0000218,,13119,,1,9615.0,CHEMBL628458,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,,BAO_0000218,,13120,,1,9615.0,CHEMBL628459,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,,BAO_0000218,,13121,,1,9615.0,CHEMBL628460,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,,BAO_0000218,,13122,,1,9615.0,CHEMBL628461,,,Intermediate,A,
,6996,,1,,U,22224,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",,,BAO_0000218,,13123,,0,,CHEMBL628462,,,Autocuration,B,
,6996,Canis lupus familiaris,1,,N,50588,,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,,BAO_0000218,,13124,,1,9615.0,CHEMBL628463,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",,,BAO_0000218,,13125,,1,10116.0,CHEMBL625666,,,Expert,F,
,6996,,1,,U,22224,,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,,BAO_0000218,,13126,,0,,CHEMBL625667,,,Autocuration,B,
,6996,Rattus norvegicus,1,,N,50597,,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,,BAO_0000218,,13127,,1,10116.0,CHEMBL625668,,,Expert,A,
,6996,Rattus norvegicus,1,,N,50597,,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,,BAO_0000218,,13128,,1,10116.0,CHEMBL625669,,,Intermediate,A,
,7114,,1,,U,22224,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,,,BAO_0000019,,13129,,0,,CHEMBL625670,,,Autocuration,A,
,7114,Rattus norvegicus,1,,N,50597,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,,,BAO_0000218,,13130,,1,10116.0,CHEMBL625671,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,,,BAO_0000218,,13131,,1,10298.0,CHEMBL625672,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,,,BAO_0000218,,13132,,1,10298.0,CHEMBL625673,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,,,BAO_0000218,,13133,,1,10298.0,CHEMBL625674,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,,,BAO_0000218,,13134,,1,10298.0,CHEMBL625675,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,,BAO_0000218,,13135,,1,10298.0,CHEMBL627637,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,,,BAO_0000218,,13136,,1,10298.0,CHEMBL627638,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,,,BAO_0000218,,13137,,1,10298.0,CHEMBL627639,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,,,BAO_0000218,,13138,,1,10298.0,CHEMBL627640,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,,,BAO_0000218,,13139,,1,10298.0,CHEMBL627641,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,,BAO_0000218,,13140,,1,10298.0,CHEMBL627642,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,,BAO_0000218,,13141,,1,10298.0,CHEMBL877506,,,Intermediate,A,
,8613,Mus musculus,1,,N,50594,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,,BAO_0000218,,13142,,1,10090.0,CHEMBL627275,,,Intermediate,A,
,11219,Mustela putorius furo,1,,N,50506,,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",,,BAO_0000218,,13143,,1,9669.0,CHEMBL627643,,,Intermediate,A,
,11219,Mustela putorius furo,1,,N,50506,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,,BAO_0000218,,13144,,1,9669.0,CHEMBL631246,,,Intermediate,A,
,11219,Mustela putorius furo,1,,N,50506,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,,BAO_0000218,,13145,,1,9669.0,CHEMBL631247,,,Intermediate,A,
,11219,Mustela putorius furo,1,,N,50506,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,,BAO_0000218,,13146,,1,9669.0,CHEMBL629532,,,Intermediate,A,
,11219,Mustela putorius furo,1,,N,50506,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,,,BAO_0000218,,13147,,1,9669.0,CHEMBL629533,,,Intermediate,A,
,11219,Mustela putorius furo,1,,N,50506,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,,BAO_0000218,,13148,,1,9669.0,CHEMBL629534,,,Intermediate,A,
,11219,Mustela putorius furo,1,,N,50506,,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,,,BAO_0000218,,13149,,1,9669.0,CHEMBL629535,,,Intermediate,A,
,14837,,1,,U,22224,,Pharmacokinetic parameter :drug bound to plasma was reported,,,BAO_0000019,,13150,,0,,CHEMBL625932,,,Autocuration,A,
,14837,,1,,U,22224,,compound was evaluated for drug bound in plasma,,,BAO_0000019,,13151,,0,,CHEMBL625933,,,Autocuration,A,
,15343,Rattus norvegicus,1,,N,50597,,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,,,BAO_0000218,,13152,,1,10116.0,CHEMBL625934,,,Intermediate,A,
,13761,Eutheria,1,,U,22224,,Bioavailability,,,BAO_0000218,,13153,,0,9347.0,CHEMBL625935,,,Autocuration,A,
,14810,Rattus norvegicus,1,,N,50597,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,,,BAO_0000218,,13154,,1,10116.0,CHEMBL625936,,,Intermediate,A,
,14810,Rattus norvegicus,1,,N,50597,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,,,BAO_0000218,,13155,,1,10116.0,CHEMBL625937,,,Intermediate,A,
,13249,Canis lupus familiaris,1,,N,50588,,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,,BAO_0000218,,13156,,1,9615.0,CHEMBL625938,,,Intermediate,A,
,9267,Rattus norvegicus,1,,N,50597,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,,,BAO_0000218,,13157,Bile,1,10116.0,CHEMBL625939,,1970.0,Intermediate,A,
,9267,Rattus norvegicus,1,,N,50597,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,,,BAO_0000218,,13158,Bile,1,10116.0,CHEMBL625940,,1970.0,Intermediate,A,
,9267,Rattus norvegicus,1,,N,50597,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,,,BAO_0000218,,13159,Bile,1,10116.0,CHEMBL874464,,1970.0,Intermediate,A,
,9267,Rattus norvegicus,1,,N,50597,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,,,BAO_0000218,,13160,Bile,1,10116.0,CHEMBL625941,,1970.0,Intermediate,A,
,9267,Rattus norvegicus,1,,N,50597,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,,,BAO_0000218,,13161,Bile,1,10116.0,CHEMBL625942,,1970.0,Intermediate,A,
,9267,Rattus norvegicus,1,,N,50597,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,,,BAO_0000218,,13162,Bile,1,10116.0,CHEMBL625943,,1970.0,Intermediate,A,
,15549,Homo sapiens,1,,N,50587,,In vitro protein binding in human serum at 5 ug/ml,,,BAO_0000218,,13163,Serum,1,9606.0,CHEMBL625944,,1977.0,Intermediate,A,
,10929,,1,,U,22224,,Serum protein binding ability was measured,,,BAO_0000019,,13164,,0,,CHEMBL625945,,,Autocuration,A,
,15444,,1,,U,22224,,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),,,BAO_0000019,,13165,,0,,CHEMBL625946,,,Autocuration,A,
,12860,Canis lupus familiaris,1,,U,22224,,Oral bioavailability in dog,,,BAO_0000218,,13166,,0,9615.0,CHEMBL625947,In vivo,,Autocuration,A,
,12170,Rattus norvegicus,1,,N,50597,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,,BAO_0000218,,13167,,1,10116.0,CHEMBL625948,In vivo,,Intermediate,A,
,15173,,1,,U,22224,,Absolute oral bioavailability at an iv dose of 14 mg/kg,,,BAO_0000218,,13168,,0,,CHEMBL625949,In vivo,,Autocuration,A,
,15173,,1,,U,22224,,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,,,BAO_0000218,,13169,,0,,CHEMBL625950,In vivo,,Autocuration,A,
,15173,Eutheria,1,,U,22224,,Oral bioavailability (dose 15 mg/kg i.v.),,,BAO_0000218,,13170,,0,9347.0,CHEMBL625951,In vivo,,Autocuration,A,
,15173,,1,,U,22224,,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,,,BAO_0000218,,13171,,0,,CHEMBL625952,In vivo,,Autocuration,A,
,15173,,1,,U,22224,,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,,,BAO_0000218,,13172,,0,,CHEMBL625953,In vivo,,Autocuration,A,
,15173,,1,,U,22224,,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,,,BAO_0000218,,13173,,0,,CHEMBL625954,In vivo,,Autocuration,A,
,15173,,1,,U,22224,,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,,,BAO_0000218,,13174,,0,,CHEMBL882959,In vivo,,Autocuration,A,
,11767,Canis lupus familiaris,1,,N,50588,,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,,,BAO_0000218,,13175,,1,9615.0,CHEMBL625955,In vivo,,Intermediate,A,
,11219,Mustela putorius furo,1,,U,22224,,Bioavailability in ferret,,,BAO_0000218,,13176,,0,9669.0,CHEMBL625956,In vivo,,Autocuration,A,
,12186,Macaca fascicularis,1,,N,100710,,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,,,BAO_0000218,,13177,,1,9541.0,CHEMBL625957,In vivo,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,,BAO_0000218,,13178,,1,10116.0,CHEMBL625958,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,,BAO_0000218,,13179,,1,10116.0,CHEMBL625959,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,,BAO_0000218,,13180,,1,10116.0,CHEMBL626642,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,,BAO_0000218,,13181,,1,10116.0,CHEMBL631330,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,,BAO_0000218,,13182,,1,10116.0,CHEMBL631331,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,,BAO_0000218,,13183,,1,10116.0,CHEMBL631332,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,,BAO_0000218,,13184,,1,10116.0,CHEMBL631333,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,,BAO_0000218,,13185,,1,10116.0,CHEMBL632018,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,,BAO_0000218,,13186,,1,10116.0,CHEMBL632019,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,,BAO_0000218,,13187,,1,10116.0,CHEMBL632020,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,,BAO_0000218,,13188,,1,10116.0,CHEMBL632021,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,,BAO_0000218,,13189,,1,10116.0,CHEMBL632022,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,,BAO_0000218,,13190,,1,10116.0,CHEMBL632023,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,,BAO_0000218,,13191,,1,10116.0,CHEMBL632024,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,,BAO_0000218,,13192,,1,10116.0,CHEMBL874472,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,,BAO_0000218,,13193,,1,10116.0,CHEMBL632025,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,,BAO_0000218,,13194,,1,10116.0,CHEMBL632026,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,,BAO_0000218,,13195,,1,10116.0,CHEMBL632027,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,,BAO_0000218,,13196,,1,10116.0,CHEMBL632028,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,,BAO_0000218,,13197,,1,10116.0,CHEMBL626430,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,,BAO_0000218,,13198,,1,10116.0,CHEMBL626431,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,,BAO_0000218,,13199,,1,10116.0,CHEMBL626432,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,,BAO_0000218,,13200,,1,10116.0,CHEMBL626433,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,,BAO_0000218,,13201,,1,10116.0,CHEMBL626434,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,,BAO_0000218,,13202,,1,10116.0,CHEMBL627280,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,,BAO_0000218,,13203,,1,10116.0,CHEMBL627281,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,,BAO_0000218,,13204,,1,10116.0,CHEMBL627282,,,Intermediate,A,
,7199,,1,,U,22224,,Total body clearance was measured at given dose,,,BAO_0000019,,13205,,0,,CHEMBL627283,,,Autocuration,A,
,7199,,1,,U,22224,,Total body clearance was measured at given dose.,,,BAO_0000218,,13206,,0,,CHEMBL627284,,,Autocuration,A,
,7095,Rattus norvegicus,1,,N,50597,,Metabolic clearance from the body in rat,,,BAO_0000218,,13207,,1,10116.0,CHEMBL627285,,,Intermediate,A,
,7095,,1,,U,22224,,Renal clearance from the body,,,BAO_0000218,,13208,,0,,CHEMBL627286,In vivo,,Autocuration,A,
,7095,Rattus norvegicus,1,,N,50597,,Renal clearance from the body in rat,,,BAO_0000218,,13209,,1,10116.0,CHEMBL875477,In vivo,,Intermediate,A,
,12528,Rattus norvegicus,1,,N,50597,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,,,BAO_0000218,,13210,,1,10116.0,CHEMBL627287,In vivo,,Intermediate,A,
,12528,Canis lupus familiaris,1,,N,50588,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,,,BAO_0000218,,13211,,1,9615.0,CHEMBL627288,In vivo,,Intermediate,A,
,7095,Rattus norvegicus,1,,N,50597,,Total clearance from the body in rat,,,BAO_0000218,,13212,,1,10116.0,CHEMBL627289,,,Intermediate,A,
,14223,Rattus norvegicus,1,,N,50597,,Clearance into cortex from rat plasma or PBS,,,BAO_0000218,,13213,Plasma,1,10116.0,CHEMBL627290,In vivo,1969.0,Intermediate,A,
,13569,,1,,U,22224,,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,,,BAO_0000218,,13214,,0,,CHEMBL627291,In vivo,,Autocuration,A,
,13569,,1,,U,22224,,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,,,BAO_0000218,,13215,,0,,CHEMBL627292,In vivo,,Autocuration,A,
,13569,,1,,U,22224,,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,,,BAO_0000218,,13216,,0,,CHEMBL627293,In vivo,,Autocuration,A,
,13569,,1,,U,22224,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,,BAO_0000218,,13217,,0,,CHEMBL627294,In vivo,,Autocuration,A,
,13569,,1,,U,22224,,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,,,BAO_0000218,,13218,,0,,CHEMBL875478,In vivo,,Autocuration,A,
,13979,,1,,U,22224,,Clearance was determined,,,BAO_0000218,,13219,,0,,CHEMBL627295,In vivo,,Autocuration,A,
,14315,Mus musculus,1,,N,50594,,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,,,BAO_0000218,,13220,,1,10090.0,CHEMBL627296,In vivo,,Intermediate,A,
,14315,Oryctolagus cuniculus,1,,N,50592,,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,,,BAO_0000218,,13221,,1,9986.0,CHEMBL626119,In vivo,,Intermediate,A,
,14315,Rattus norvegicus,1,,N,50597,,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,,,BAO_0000218,,13222,,1,10116.0,CHEMBL626120,In vivo,,Intermediate,A,
,12174,Rattus norvegicus,1,,N,50597,,Clearance in rat after iv dose (100 ug/kg),,,BAO_0000218,,13223,,1,10116.0,CHEMBL626121,In vivo,,Intermediate,A,
,12797,Cavia porcellus,1,,U,22224,,Clearance in guinea pig,,,BAO_0000218,,13224,,0,10141.0,CHEMBL626122,In vivo,,Autocuration,A,
,12797,Rattus norvegicus,1,,N,50597,,Compound was evaluated for clearance in rat,,,BAO_0000218,,13225,,1,10116.0,CHEMBL626123,In vivo,,Intermediate,A,
,12797,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for the clearance in dog,,,BAO_0000218,,13226,,1,9615.0,CHEMBL623456,In vivo,,Intermediate,A,
,12797,Rattus norvegicus,1,,N,50597,,Compound was evaluated for the clearance in rat,,,BAO_0000218,,13227,,1,10116.0,CHEMBL623457,In vivo,,Intermediate,A,
,11500,Rattus norvegicus,1,,N,50597,,Compound was tested in vivo for clearance after iv administration in the rat,,,BAO_0000218,,13228,,1,10116.0,CHEMBL623458,In vivo,,Intermediate,A,
,15173,,1,,U,22224,,IV clearance determined at an iv dose of 14 mg/kg,,,BAO_0000218,,13229,,0,,CHEMBL623459,In vivo,,Autocuration,A,
,15173,,1,,U,22224,,IV clearance determined at an iv dose of 15.2 mg/kg,,,BAO_0000218,,13230,,0,,CHEMBL875484,In vivo,,Autocuration,A,
,15173,,1,,U,22224,,IV clearance determined at an iv dose of 15 mg/kg,,,BAO_0000218,,13231,,0,,CHEMBL623460,In vivo,,Autocuration,A,
,15173,,1,,U,22224,,IV clearance determined at an peroral dose of 30 mg/kg.,,,BAO_0000218,,13232,,0,,CHEMBL623461,In vivo,,Autocuration,A,
,15173,,1,,U,22224,,IV clearance determined at an peroral dose of 30.2 mg/kg.,,,BAO_0000218,,13233,,0,,CHEMBL623462,In vivo,,Autocuration,A,
,15173,,1,,U,22224,,IV clearance determined at an peroral dose of 30.3 mg/kg.,,,BAO_0000218,,13234,,0,,CHEMBL627386,In vivo,,Autocuration,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,,,BAO_0000218,,13235,Kidney,1,10116.0,CHEMBL627387,In vivo,2113.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,,,BAO_0000218,,13236,Liver,1,10116.0,CHEMBL627388,In vivo,2107.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,,,BAO_0000218,,13237,Lung,1,10116.0,CHEMBL627389,In vivo,2048.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,,,BAO_0000218,,13238,Muscle tissue,1,10116.0,CHEMBL627390,In vivo,2385.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,,,BAO_0000218,,13239,Plasma,1,10116.0,CHEMBL627391,In vivo,1969.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,,,BAO_0000218,,13240,,1,10116.0,CHEMBL627392,In vivo,,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,,,BAO_0000218,,13241,Spleen,1,10116.0,CHEMBL627393,In vivo,2106.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,,,BAO_0000218,,13242,Trachea,1,10116.0,CHEMBL627394,In vivo,3126.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,,,BAO_0000218,,13243,Bone,1,10116.0,CHEMBL627395,In vivo,10000001.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,,,BAO_0000218,,13244,Cerebellum,1,10116.0,CHEMBL875485,In vivo,2037.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,,,BAO_0000218,,13245,,1,10116.0,CHEMBL627396,In vivo,,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,,,BAO_0000218,,13246,,1,10116.0,CHEMBL627397,In vivo,,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,,,BAO_0000218,,13247,Heart,1,10116.0,CHEMBL627398,In vivo,948.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,,,BAO_0000218,,13248,Bone,1,10116.0,CHEMBL627399,In vivo,10000001.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,,,BAO_0000218,,13249,Kidney,1,10116.0,CHEMBL627400,In vivo,2113.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,,,BAO_0000218,,13250,Liver,1,10116.0,CHEMBL627401,In vivo,2107.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,,,BAO_0000218,,13251,Lung,1,10116.0,CHEMBL627402,In vivo,2048.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,,,BAO_0000218,,13252,Muscle tissue,1,10116.0,CHEMBL627403,In vivo,2385.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,,,BAO_0000218,,13253,Plasma,1,10116.0,CHEMBL627404,In vivo,1969.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,,,BAO_0000218,,13254,,1,10116.0,CHEMBL623101,In vivo,,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,,,BAO_0000218,,13255,Spleen,1,10116.0,CHEMBL877480,In vivo,2106.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,,,BAO_0000218,,13256,Trachea,1,10116.0,CHEMBL623102,In vivo,3126.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,,,BAO_0000218,,13257,Bone,1,10116.0,CHEMBL623103,In vivo,10000001.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,,,BAO_0000218,,13258,Cerebellum,1,10116.0,CHEMBL623104,In vivo,2037.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,,,BAO_0000218,,13259,,1,10116.0,CHEMBL623105,In vivo,,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,,,BAO_0000218,,13260,,1,10116.0,CHEMBL623106,In vivo,,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,,,BAO_0000218,,13261,Heart,1,10116.0,CHEMBL623107,In vivo,948.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,,,BAO_0000218,,13262,Intestine,1,10116.0,CHEMBL623108,In vivo,160.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,,,BAO_0000218,,13263,Kidney,1,10116.0,CHEMBL623109,In vivo,2113.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,,,BAO_0000218,,13264,Liver,1,10116.0,CHEMBL623110,In vivo,2107.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,,,BAO_0000218,,13265,Lung,1,10116.0,CHEMBL623111,In vivo,2048.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,,,BAO_0000218,,13266,Muscle tissue,1,10116.0,CHEMBL625060,In vivo,2385.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,,,BAO_0000218,,13267,Plasma,1,10116.0,CHEMBL625061,In vivo,1969.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,,,BAO_0000218,,13268,,1,10116.0,CHEMBL625062,In vivo,,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,,,BAO_0000218,,13269,Spleen,1,10116.0,CHEMBL625063,In vivo,2106.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,,,BAO_0000218,,13270,Trachea,1,10116.0,CHEMBL625064,In vivo,3126.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,,,BAO_0000218,,13271,Bone,1,10116.0,CHEMBL625065,In vivo,10000001.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,,,BAO_0000218,,13272,Cerebellum,1,10116.0,CHEMBL625066,In vivo,2037.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,,,BAO_0000218,,13273,,1,10116.0,CHEMBL625067,In vivo,,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,,,BAO_0000218,,13274,,1,10116.0,CHEMBL625068,In vivo,,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,,,BAO_0000218,,13275,Heart,1,10116.0,CHEMBL622159,In vivo,948.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,,,BAO_0000218,,13276,Intestine,1,10116.0,CHEMBL622160,In vivo,160.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,,,BAO_0000218,,13277,Kidney,1,10116.0,CHEMBL622161,In vivo,2113.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,,,BAO_0000218,,13278,Lung,1,10116.0,CHEMBL622162,In vivo,2048.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,,,BAO_0000218,,13279,Muscle tissue,1,10116.0,CHEMBL622163,In vivo,2385.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,,,BAO_0000218,,13280,Plasma,1,10116.0,CHEMBL622313,In vivo,1969.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,,,BAO_0000218,,13281,,1,10116.0,CHEMBL622314,In vivo,,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,,,BAO_0000218,,13282,Spleen,1,10116.0,CHEMBL622315,In vivo,2106.0,Intermediate,A,
,14198,Rattus norvegicus,1,,N,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,,,BAO_0000218,,13283,Trachea,1,10116.0,CHEMBL622316,In vivo,3126.0,Intermediate,A,
,15599,Escherichia coli,1,,N,50212,,Normal diffusion coefficient in water for Escherichia coli,,,BAO_0000218,,13284,,1,562.0,CHEMBL877486,,,Intermediate,A,
,8204,,1,,U,22224,,Average max percent decrease in RVR (renal vascular resistance) was determined,,,BAO_0000019,,13285,,0,,CHEMBL622317,,,Autocuration,A,
,8204,,1,,U,22224,,Average max percent decrease in RVR (renal vascular resistance) was determined.,,,BAO_0000019,,13286,,0,,CHEMBL622318,,,Autocuration,A,
,6154,,1,,U,22224,,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,,,BAO_0000019,,13287,,0,,CHEMBL622319,,,Autocuration,A,
,6154,,1,,U,22224,,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,,,BAO_0000019,,13288,,0,,CHEMBL622320,,,Autocuration,A,
,6154,,1,,U,22224,,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,,,BAO_0000019,,13289,,0,,CHEMBL622321,,,Autocuration,A,
,6154,,1,,U,22224,,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,,,BAO_0000019,,13290,,0,,CHEMBL622322,,,Autocuration,A,
,7114,,1,,U,22224,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,,,BAO_0000019,,13291,,0,,CHEMBL622323,,,Autocuration,A,
,7114,Rattus norvegicus,1,,N,50597,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,,,BAO_0000218,,13292,,1,10116.0,CHEMBL622324,,,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,,BAO_0000218,,13293,Urine,1,9615.0,CHEMBL622325,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,,BAO_0000218,,13294,Urine,1,9615.0,CHEMBL622326,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",,,BAO_0000218,,13295,Urine,1,9615.0,CHEMBL877487,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,,BAO_0000218,,13296,Urine,1,9615.0,CHEMBL622327,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",,,BAO_0000218,,13297,Urine,1,9615.0,CHEMBL622328,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,,BAO_0000218,,13298,Urine,1,9615.0,CHEMBL622329,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,,BAO_0000218,,13299,Urine,1,9615.0,CHEMBL622330,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,,BAO_0000218,,13300,Urine,1,9615.0,CHEMBL622331,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,,BAO_0000218,,13301,Urine,1,9615.0,CHEMBL622332,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",,,BAO_0000218,,13302,Urine,1,9615.0,CHEMBL622333,,1088.0,Intermediate,A,
,8133,Simiiformes,1,,U,22224,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,,BAO_0000218,,13303,Urine,0,314293.0,CHEMBL627658,,1088.0,Autocuration,A,
,8133,Simiiformes,1,,U,22224,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",,,BAO_0000218,,13304,Urine,0,314293.0,CHEMBL630428,,1088.0,Autocuration,A,
,8133,Simiiformes,1,,U,22224,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,,BAO_0000218,,13305,Urine,0,314293.0,CHEMBL630429,,1088.0,Autocuration,A,
,8133,Simiiformes,1,,U,22224,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",,,BAO_0000218,,13306,Urine,0,314293.0,CHEMBL630430,,1088.0,Autocuration,A,
,8133,Simiiformes,1,,U,22224,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",,,BAO_0000218,,13307,Urine,0,314293.0,CHEMBL630431,,1088.0,Autocuration,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,,BAO_0000218,,13308,Urine,1,10116.0,CHEMBL630432,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,,BAO_0000218,,13309,Urine,1,10116.0,CHEMBL630433,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,,BAO_0000218,,13310,Urine,1,10116.0,CHEMBL630434,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,,BAO_0000218,,13311,Urine,1,10116.0,CHEMBL629372,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",,,BAO_0000218,,13312,Urine,1,10116.0,CHEMBL629553,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,,BAO_0000218,,13313,Urine,1,10116.0,CHEMBL629554,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,,BAO_0000218,,13314,Urine,1,10116.0,CHEMBL874447,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,,BAO_0000218,,13315,Urine,1,10116.0,CHEMBL629555,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,,BAO_0000218,,13316,Urine,1,10116.0,CHEMBL629556,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",,,BAO_0000218,,13317,Urine,1,10116.0,CHEMBL629557,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,,BAO_0000218,,13318,Urine,1,10116.0,CHEMBL629558,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,,BAO_0000218,,13319,Urine,1,10116.0,CHEMBL629559,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,,BAO_0000218,,13320,Urine,1,10116.0,CHEMBL629560,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,,BAO_0000218,,13321,Urine,1,9615.0,CHEMBL629561,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,,BAO_0000218,,13322,Urine,1,9615.0,CHEMBL629562,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,,BAO_0000218,,13323,Urine,1,9615.0,CHEMBL629563,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,,BAO_0000218,,13324,Urine,1,9615.0,CHEMBL629564,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,,BAO_0000218,,13325,Urine,1,9615.0,CHEMBL629565,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,,BAO_0000218,,13326,Urine,1,9615.0,CHEMBL629566,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",,,BAO_0000218,,13327,Urine,1,9615.0,CHEMBL629567,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,,BAO_0000218,,13328,Urine,1,9615.0,CHEMBL629568,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",,,BAO_0000218,,13329,Urine,1,9615.0,CHEMBL629569,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,,BAO_0000218,,13330,Urine,1,9615.0,CHEMBL629570,,1088.0,Intermediate,A,
,8133,Simiiformes,1,,U,22224,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,,BAO_0000218,,13331,Urine,0,314293.0,CHEMBL629571,,1088.0,Autocuration,A,
,12170,Rattus norvegicus,1,,U,22224,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,,BAO_0000218,,13332,,0,10116.0,CHEMBL629572,In vivo,,Autocuration,A,
,12170,Rattus norvegicus,1,,U,22224,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,,BAO_0000218,,13333,,0,10116.0,CHEMBL629573,In vivo,,Autocuration,A,
,4985,Eutheria,1,,U,22224,,Bioavailability (dose 20 mg/kg),,,BAO_0000218,,13334,,0,9347.0,CHEMBL629574,In vivo,,Autocuration,A,
,15145,Canis lupus familiaris,1,,U,22224,,Bioavailability in dog,,,BAO_0000218,,13335,,0,9615.0,CHEMBL629575,In vivo,,Autocuration,A,
,14080,Rattus norvegicus,1,,U,22224,,Bioavailability in rat (Sprague-Dawley) (male),,,BAO_0000218,,13336,,0,10116.0,CHEMBL874448,In vivo,,Autocuration,A,
,11219,Primates,1,,U,22224,,Bioavailability in monkey (dose 10 mg/kg i.d.),,,BAO_0000218,,13337,,0,9443.0,CHEMBL629576,In vivo,,Autocuration,A,
,15145,Rattus norvegicus,1,,U,22224,,Bioavailability in rat,,,BAO_0000218,,13338,,0,10116.0,CHEMBL629577,In vivo,,Autocuration,A,
,15145,Rattus norvegicus,1,,U,22224,,Bioavailability in rat,,,BAO_0000218,,13339,,0,10116.0,CHEMBL629578,In vivo,,Autocuration,A,
,1202,Canis lupus familiaris,1,,U,22224,,Bioavailability in dog (dose 3.0 mg/kg p.o.),,,BAO_0000218,,13340,,0,9615.0,CHEMBL629579,In vivo,,Autocuration,A,
,1202,Canis lupus familiaris,1,,U,22224,,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,,,BAO_0000218,,13341,,0,9615.0,CHEMBL882958,In vivo,,Autocuration,A,
,1202,Pan troglodytes,1,,N,50505,,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,,,BAO_0000218,,13342,,1,9598.0,CHEMBL629580,In vivo,,Intermediate,A,
,4026,Eutheria,1,,U,22224,,Bioavailability,,,BAO_0000218,,13343,,0,9347.0,CHEMBL629581,In vivo,,Autocuration,A,
,1492,Saimiri,1,,U,22224,,Bioavailability in squirrel monkey,,,BAO_0000218,,13344,,0,9520.0,CHEMBL629582,In vivo,,Autocuration,A,
,12793,Canis lupus familiaris,1,,N,50588,,Bioavailability was evaluated in dog,,,BAO_0000218,,13345,,1,9615.0,CHEMBL628522,In vivo,,Intermediate,A,
,12793,Cricetinae,1,,N,100712,,Bioavailability was evaluated in hamster,,,BAO_0000218,,13346,,1,10026.0,CHEMBL625432,In vivo,,Intermediate,A,
,12793,Rattus norvegicus,1,,U,22224,,Bioavailability in rat,,,BAO_0000218,,13347,,0,10116.0,CHEMBL625433,In vivo,,Autocuration,A,
,14793,Rattus norvegicus,1,,N,50597,,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,,BAO_0000218,,13348,Plasma,1,10116.0,CHEMBL625434,In vivo,1969.0,Intermediate,A,
,14793,Rattus norvegicus,1,,N,50597,,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,,,BAO_0000218,,13349,Plasma,1,10116.0,CHEMBL625435,In vivo,1969.0,Intermediate,A,
,14793,Rattus norvegicus,1,,U,22224,,Bioavailability in rat (dose 10 mg/kg p.o.),,,BAO_0000218,,13350,,0,10116.0,CHEMBL625436,In vivo,,Autocuration,A,
,14731,Macaca fascicularis,1,,N,100710,,Bioavailability was measured in cynomolgus monkeys.,,,BAO_0000218,,13351,,1,9541.0,CHEMBL874588,In vivo,,Intermediate,A,
,14731,Mus musculus,1,,N,50594,,Bioavailability was measured in nude mice.,,,BAO_0000218,,13352,,1,10090.0,CHEMBL625437,In vivo,,Intermediate,A,
,12187,Mustela putorius furo,1,,U,22224,,Bioavailability in ferret (dose 10 mg/kg i.d.),,,BAO_0000218,,13353,,0,9669.0,CHEMBL625438,In vivo,,Autocuration,A,
,12187,Simiiformes,1,,U,22224,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),,,BAO_0000218,,13354,,0,314293.0,CHEMBL625439,In vivo,,Autocuration,A,
,12187,Simiiformes,1,,U,22224,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",,,BAO_0000218,,13355,,0,314293.0,CHEMBL625440,In vivo,,Autocuration,A,
,12187,Simiiformes,1,,U,22224,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),,,BAO_0000218,,13356,,0,314293.0,CHEMBL625441,In vivo,,Autocuration,A,
,12187,Rattus norvegicus,1,,U,22224,,Bioavailability in rat (dose 10 mg/kg i.d.),,,BAO_0000218,,13357,,0,10116.0,CHEMBL625442,In vivo,,Autocuration,A,
,12187,Rattus norvegicus,1,,N,50597,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,,BAO_0000218,,13358,,1,10116.0,CHEMBL625443,In vivo,,Intermediate,A,
,17431,,1,,U,22224,,Bioavailability was determined; extremely poor,,,BAO_0000218,,13359,,0,,CHEMBL625444,In vivo,,Autocuration,A,
,13318,Mus musculus,1,,N,50594,,% bioavailability in mice after oral administration of prodrug,,,BAO_0000218,,13360,,1,10090.0,CHEMBL625445,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,,,BAO_0000218,,13361,,1,9615.0,CHEMBL625446,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,,,BAO_0000218,,13362,,1,9615.0,CHEMBL882960,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,,,BAO_0000218,,13363,,1,9615.0,CHEMBL625447,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,,,BAO_0000218,,13364,,1,9615.0,CHEMBL625448,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,,,BAO_0000218,,13365,,1,9615.0,CHEMBL625449,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),,,BAO_0000218,,13366,,1,9615.0,CHEMBL874589,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,,,BAO_0000218,,13367,,1,9615.0,CHEMBL625450,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,,,BAO_0000218,,13368,,1,9615.0,CHEMBL625451,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,,,BAO_0000218,,13369,,1,9615.0,CHEMBL626584,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,,,BAO_0000218,,13370,,1,9615.0,CHEMBL626585,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,,,BAO_0000218,,13371,,1,9615.0,CHEMBL626586,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,,,BAO_0000218,,13372,,1,9615.0,CHEMBL626587,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,,,BAO_0000218,,13373,,1,9615.0,CHEMBL626588,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,,,BAO_0000218,,13374,,1,9615.0,CHEMBL626589,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,,,BAO_0000218,,13375,,1,9615.0,CHEMBL626590,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,,,BAO_0000218,,13376,,1,9615.0,CHEMBL626591,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,,,BAO_0000218,,13377,,1,9615.0,CHEMBL627181,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,,,BAO_0000218,,13378,,1,9615.0,CHEMBL628083,In vivo,,Intermediate,A,
,15173,,1,,U,22224,,IV clearance determined at an peroral dose of 15 mg/kg.,,,BAO_0000218,,13379,,0,,CHEMBL628084,In vivo,,Autocuration,A,
,7732,Hymenolepis nana,1,,N,50064,,Mouse oral clearance was measured against Hymenolepiasis nana.,,,BAO_0000218,,13380,,1,102285.0,CHEMBL628085,In vivo,,Expert,F,
,7732,Heligmosomoides polygyrus,1,,N,50545,,Mouse oral clearance was measured against Nematospiroides dubius,,,BAO_0000218,,13381,,1,6339.0,CHEMBL628086,In vivo,,Expert,F,
,7732,,1,,U,22224,,Mouse oral clearance was measured against N. dubius; NT is Not Tested,,,BAO_0000218,,13382,,0,,CHEMBL628087,In vivo,,Autocuration,F,
,7732,Mus musculus,1,,N,50594,,Mouse oral clearance was measured against N. nana; NT is Not Tested,,,BAO_0000218,,13383,,1,10090.0,CHEMBL628088,In vivo,,Intermediate,A,
,7732,,1,,U,22224,,Mouse oral clearance was measured against N. nana; NT is Not Tested,,,BAO_0000218,,13384,,0,,CHEMBL628089,In vivo,,Autocuration,B,
,8328,,1,,U,22224,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,,,BAO_0000218,,13385,,0,,CHEMBL628090,In vivo,,Autocuration,A,
,8328,,1,,U,22224,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,,,BAO_0000218,,13386,,0,,CHEMBL628091,In vivo,,Autocuration,A,
,8328,,1,,U,22224,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,,,BAO_0000218,,13387,,0,,CHEMBL628092,In vivo,,Autocuration,A,
,8328,,1,,U,22224,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,,,BAO_0000218,,13388,,0,,CHEMBL628093,In vivo,,Autocuration,A,
,8328,,1,,U,22224,,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,,,BAO_0000218,,13389,,0,,CHEMBL875607,In vivo,,Autocuration,A,
,8328,,1,,U,22224,,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,,,BAO_0000218,,13390,,0,,CHEMBL625710,In vivo,,Autocuration,A,
,8328,,1,,U,22224,,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,,,BAO_0000218,,13391,,0,,CHEMBL625711,In vivo,,Autocuration,A,
,8328,,1,,U,22224,,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,,,BAO_0000218,,13392,,0,,CHEMBL625712,In vivo,,Autocuration,A,
,8328,,1,,U,22224,,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,,,BAO_0000218,,13393,,0,,CHEMBL625713,In vivo,,Autocuration,A,
,13376,Canis lupus familiaris,1,,N,50588,,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,,,BAO_0000218,,13394,,1,9615.0,CHEMBL625714,In vivo,,Intermediate,A,
,13477,Macaca mulatta,1,,N,50797,,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,,,BAO_0000218,,13395,,1,9544.0,CHEMBL625715,In vivo,,Intermediate,A,
,13477,Rattus norvegicus,1,,N,50597,,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,,,BAO_0000218,,13396,,1,10116.0,CHEMBL625716,In vivo,,Intermediate,A,
,13477,Rattus norvegicus,1,,N,50597,,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,,,BAO_0000218,,13397,,1,10116.0,CHEMBL625717,In vivo,,Intermediate,A,
,13313,Rattus norvegicus,1,,N,50597,,Plasma clearance was determined for the compound in rats,,,BAO_0000218,,13398,,1,10116.0,CHEMBL625718,In vivo,,Intermediate,A,
,12504,Rattus norvegicus,1,,N,50597,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,,,BAO_0000218,,13399,,1,10116.0,CHEMBL625719,In vivo,,Intermediate,A,
,12504,Rattus norvegicus,1,,N,50597,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,,,BAO_0000218,,13400,,1,10116.0,CHEMBL625720,In vivo,,Intermediate,A,
,12504,Rattus norvegicus,1,,N,50597,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,,,BAO_0000218,,13401,,1,10116.0,CHEMBL625721,In vivo,,Intermediate,A,
,12504,Rattus norvegicus,1,,N,50597,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,,,BAO_0000218,,13402,,1,10116.0,CHEMBL625722,In vivo,,Intermediate,A,
,13129,Rattus norvegicus,1,,N,50597,,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,,,BAO_0000218,,13403,,1,10116.0,CHEMBL625723,In vivo,,Intermediate,A,
,7732,Heligmosomoides polygyrus,1,,N,50545,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,,,BAO_0000218,,13404,,1,6339.0,CHEMBL625724,In vivo,,Intermediate,A,
,7732,Heligmosomoides polygyrus,1,,N,50545,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,,,BAO_0000218,,13405,,1,6339.0,CHEMBL625725,In vivo,,Intermediate,A,
,7732,Heligmosomoides polygyrus,1,,N,50545,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,,,BAO_0000218,,13406,,1,6339.0,CHEMBL625726,In vivo,,Intermediate,A,
,7732,Heligmosomoides polygyrus,1,,N,50545,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,,,BAO_0000218,,13407,,1,6339.0,CHEMBL875608,In vivo,,Intermediate,A,
,7732,Heligmosomoides polygyrus,1,,N,50545,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,,,BAO_0000218,,13408,,1,6339.0,CHEMBL625727,In vivo,,Intermediate,A,
,9278,Rattus norvegicus,1,,U,22224,,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,,,BAO_0000218,,13409,Urine,0,10116.0,CHEMBL625728,In vivo,1088.0,Autocuration,A,
,9278,Rattus norvegicus,1,,U,22224,,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,,BAO_0000218,,13410,,0,10116.0,CHEMBL625729,In vivo,,Autocuration,A,
,9278,Rattus norvegicus,1,,U,22224,,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,,,BAO_0000218,,13411,,0,10116.0,CHEMBL625730,In vivo,,Autocuration,A,
,9278,Rattus norvegicus,1,,U,22224,,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,,BAO_0000218,,13412,Urine,0,10116.0,CHEMBL625731,In vivo,1088.0,Autocuration,A,
,9278,Rattus norvegicus,1,,U,22224,,Urinary clearance was determined in rat at 25 mg/kg os dosage,,,BAO_0000218,,13413,Urine,0,10116.0,CHEMBL626417,In vivo,1088.0,Autocuration,A,
,9278,Homo sapiens,1,,N,50587,,Urinary clearance was determined at 100 mg/kg oral dosage in human,,,BAO_0000218,,13414,Urine,1,9606.0,CHEMBL626418,In vivo,1088.0,Intermediate,A,
,9278,Canis lupus familiaris,1,,N,50588,,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,,,BAO_0000218,,13415,Urine,1,9615.0,CHEMBL626419,In vivo,1088.0,Intermediate,A,
,5932,Canis lupus familiaris,1,,N,50588,,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,,,BAO_0000218,,13416,Plasma,1,9615.0,CHEMBL626592,In vivo,1969.0,Intermediate,A,
,5932,Rattus norvegicus,1,,N,50597,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,,BAO_0000218,,13417,Plasma,1,10116.0,CHEMBL626593,In vivo,1969.0,Intermediate,A,
,5182,Rattus norvegicus,1,,N,50597,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,,BAO_0000218,,13418,,1,10116.0,CHEMBL626594,In vivo,,Intermediate,A,
,10499,Canis lupus familiaris,1,,N,50588,,Clearance rate in dogs,,,BAO_0000218,,13419,,1,9615.0,CHEMBL625035,In vivo,,Intermediate,A,
,6051,,1,,U,22224,,Compound was measured for intrinsic clearance,,,BAO_0000019,,13420,,0,,CHEMBL625036,In vitro,,Autocuration,A,
,17508,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13421,,0,,CHEMBL625037,,,Autocuration,P,
,6228,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13422,,0,,CHEMBL625038,,,Autocuration,P,
,6231,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13423,,0,,CHEMBL625039,,,Autocuration,P,
,17740,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13424,,0,,CHEMBL625040,,,Autocuration,P,
,6495,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13425,,0,,CHEMBL625041,,,Autocuration,P,
,2171,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13426,,0,,CHEMBL625042,,,Autocuration,P,
,3255,,1,,U,22224,,Partition coefficient of the compound,,,BAO_0000019,,13427,,0,,CHEMBL874411,,,Autocuration,A,
,6821,,1,,U,22224,,Permeability,,,BAO_0000019,,13428,,0,,CHEMBL625043,,,Autocuration,A,
,2685,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13429,,0,,CHEMBL625044,,,Autocuration,P,
,17584,,1,,U,22224,,Partition coefficient (logD),,,BAO_0000019,,13430,,0,,CHEMBL625045,,,Autocuration,A,
,13824,,1,,U,22229,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,,BAO_0000100,,13431,,0,,CHEMBL625046,,,Autocuration,P,
,13824,,1,,U,22229,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,,BAO_0000100,,13432,,0,,CHEMBL625047,,,Autocuration,P,
,16479,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13433,,0,,CHEMBL625048,,,Autocuration,P,
,11997,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13434,,0,,CHEMBL625049,,,Autocuration,P,
,2988,,1,,U,22229,,Calculated logarithm of partition coefficient (P) was determined,,,BAO_0000100,,13435,,0,,CHEMBL625050,,,Autocuration,P,
,931,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13436,,0,,CHEMBL625051,,,Autocuration,P,
,4381,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13437,,0,,CHEMBL874412,,,Autocuration,P,
,4397,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13438,,0,,CHEMBL625052,,,Autocuration,P,
,5889,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13439,,0,,CHEMBL625053,,,Autocuration,P,
,6154,,1,,U,22224,,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,,,BAO_0000019,,13440,,0,,CHEMBL623250,,,Autocuration,A,
,6154,,1,,U,22224,,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,,,BAO_0000019,,13441,,0,,CHEMBL623251,,,Autocuration,A,
,6154,,1,,U,22224,,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,,,BAO_0000019,,13442,,0,,CHEMBL623252,,,Autocuration,A,
,6154,,1,,U,22224,,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,,,BAO_0000019,,13443,,0,,CHEMBL623253,,,Autocuration,A,
,6154,,1,,U,22224,,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,,,BAO_0000019,,13444,,0,,CHEMBL623254,,,Autocuration,A,
,6154,,1,,U,22224,,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,,,BAO_0000019,,13445,,0,,CHEMBL623255,,,Autocuration,A,
,6887,,1,,U,22224,,Percent degradation of compound at a pH of 1 over a 18 hr period,,,BAO_0000019,,13446,,0,,CHEMBL626831,,,Autocuration,A,
,6887,,1,,U,22224,,Percent degradation of compound at pH of 1 over an 18 hr period,,,BAO_0000019,,13447,,0,,CHEMBL877494,,,Autocuration,A,
,14116,,1,,U,22224,,Delta Logarithm of Partition Coefficient value was determined.,,,BAO_0000019,,13448,,0,,CHEMBL626832,,,Autocuration,A,
,11137,,1,,U,22224,,Delta logPoct-cyc,,,BAO_0000019,,13449,,0,,CHEMBL626833,,,Autocuration,A,
,7230,,1,,U,22224,,Lipophilicity estimated on reversed phase TLC,,,BAO_0000100,,13450,,0,,CHEMBL626834,,,Autocuration,P,
,15741,,1,,U,22224,,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,,,BAO_0000019,,13451,,0,,CHEMBL626835,,,Autocuration,A,
,9663,,1,,U,22224,,Delta logPoct-cyc,,,BAO_0000019,,13452,,0,,CHEMBL626836,,,Autocuration,A,
,9663,,1,,U,22229,,Change in logarithm of partition coefficient of the compound,,,BAO_0000100,,13453,,0,,CHEMBL626837,,,Autocuration,P,
,13807,,1,,U,22224,,Delta logD (pH 6.5),,,BAO_0000019,,13454,,0,,CHEMBL626838,,,Autocuration,A,
,13807,,1,,U,22224,,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",,,BAO_0000100,,13455,,0,,CHEMBL626839,,,Autocuration,P,
,17425,,1,,U,22224,,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,,,BAO_0000019,,13456,,0,,CHEMBL626840,,,Autocuration,A,
,12143,,1,,U,22224,,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),,,BAO_0000019,,13457,,0,,CHEMBL626841,,,Autocuration,A,
,12608,,1,,U,22224,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,,,BAO_0000219,,13458,,0,,CHEMBL626842,,,Autocuration,A,
,12608,,1,,U,22224,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,,,BAO_0000219,,13459,,0,,CHEMBL626843,,,Autocuration,A,
,8649,Rattus norvegicus,1,,N,50597,,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,,,BAO_0000218,,13460,,1,10116.0,CHEMBL626844,,,Intermediate,A,
,8649,Rattus norvegicus,1,,N,50597,,Amount of deuterium retained was reported after normal workup in rats,,,BAO_0000218,,13461,,1,10116.0,CHEMBL877495,,,Intermediate,A,
,8649,Rattus norvegicus,1,,N,50597,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,,,BAO_0000218,,13462,,1,10116.0,CHEMBL626845,,,Intermediate,A,
,8649,Rattus norvegicus,1,,N,50597,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,,,BAO_0000218,,13463,,1,10116.0,CHEMBL626846,,,Intermediate,A,
,8649,Rattus norvegicus,1,,N,50597,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,,BAO_0000218,,13464,,1,10116.0,CHEMBL626847,,,Intermediate,A,
,8649,Rattus norvegicus,1,,N,50597,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,,BAO_0000218,,13465,,1,10116.0,CHEMBL628677,,,Intermediate,A,
,8649,Rattus norvegicus,1,,N,50597,,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,,,BAO_0000218,,13466,,1,10116.0,CHEMBL628678,,,Intermediate,A,
,9659,,1,,U,22224,,Compound was subjected to electrochemical oxidation,,,BAO_0000019,,13467,,0,,CHEMBL628679,,,Autocuration,A,
,9659,,1,,U,22224,,Compound was subjected to photochemical oxidation,,,BAO_0000019,,13468,,0,,CHEMBL628680,,,Autocuration,A,
,9659,,1,,U,22224,,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,,,BAO_0000019,,13469,,0,,CHEMBL628681,,,Autocuration,A,
,9659,,1,,U,22224,,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,,,BAO_0000019,,13470,,0,,CHEMBL628682,,,Autocuration,A,
,9659,,1,,U,22224,,Oxidation of compound by methemoglobin in presence of hydroperoxide,,,BAO_0000019,,13471,,0,,CHEMBL628683,,,Autocuration,A,
,9607,Rattus norvegicus,1,,N,50597,,Percent diffusion through fuzzy rat skin after 48 h of incubation,,,BAO_0000218,,13472,,1,10116.0,CHEMBL628684,,,Intermediate,A,
,7057,,1,,U,22229,,Dissociation constant (pKa),,,BAO_0000100,,13473,,0,,CHEMBL877501,,,Autocuration,P,
,7057,,1,,U,22224,,Dissociation constant value of the compound; ND means not determined.,,,BAO_0000100,,13474,,0,,CHEMBL628685,,,Autocuration,P,
,7911,Rattus norvegicus,1,,N,50597,,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,,,BAO_0000218,,13475,Blood,1,10116.0,CHEMBL628686,,178.0,Intermediate,A,
,7911,Rattus norvegicus,1,,N,50597,,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,,BAO_0000218,,13476,Blood,1,10116.0,CHEMBL628687,,178.0,Intermediate,A,
,7911,Rattus norvegicus,1,,N,50597,,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,,,BAO_0000218,,13477,,1,10116.0,CHEMBL628688,,,Intermediate,A,
,7911,Rattus norvegicus,1,,N,50597,,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,,BAO_0000218,,13478,,1,10116.0,CHEMBL628689,,,Intermediate,A,
,7911,Rattus norvegicus,1,,N,50597,,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,,,BAO_0000218,,13479,Liver,1,10116.0,CHEMBL628690,,2107.0,Intermediate,A,
,7911,Rattus norvegicus,1,,N,50597,,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,,BAO_0000218,,13480,Liver,1,10116.0,CHEMBL629363,,2107.0,Intermediate,A,
,7911,Rattus norvegicus,1,,N,50597,,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,,,BAO_0000218,,13481,Spleen,1,10116.0,CHEMBL629364,,2106.0,Intermediate,A,
,7911,Rattus norvegicus,1,,N,50597,,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,,BAO_0000218,,13482,Spleen,1,10116.0,CHEMBL629365,,2106.0,Intermediate,A,
,7911,Rattus norvegicus,1,,N,50597,,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,,,BAO_0000218,,13483,,1,10116.0,CHEMBL629366,,,Intermediate,A,
,7911,Rattus norvegicus,1,,N,50597,,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,,,BAO_0000218,,13484,Urine,1,10116.0,CHEMBL629367,,1088.0,Intermediate,A,
,7911,Rattus norvegicus,1,,N,50597,,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,,BAO_0000218,,13485,Feces,1,10116.0,CHEMBL629368,,1988.0,Intermediate,A,
,7911,Rattus norvegicus,1,,N,50597,,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,,BAO_0000218,,13486,Urine,1,10116.0,CHEMBL877502,,1088.0,Intermediate,A,
,13792,Mus musculus,1,,N,50594,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,,,BAO_0000218,,13487,Cerebellum,1,10090.0,CHEMBL629369,,2037.0,Intermediate,A,
,13792,Mus musculus,1,,N,50594,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,,,BAO_0000218,,13488,Brain,1,10090.0,CHEMBL629370,,955.0,Intermediate,A,
,8133,Simiiformes,1,,U,22224,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",,,BAO_0000218,,13489,Urine,0,314293.0,CHEMBL629371,,1088.0,Autocuration,A,
,8133,Simiiformes,1,,U,22224,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,,BAO_0000218,,13490,Urine,0,314293.0,CHEMBL626276,,1088.0,Autocuration,A,
,8133,Simiiformes,1,,U,22224,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,,BAO_0000218,,13491,Urine,0,314293.0,CHEMBL626277,,1088.0,Autocuration,A,
,8133,Simiiformes,1,,U,22224,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,,BAO_0000218,,13492,Urine,0,314293.0,CHEMBL631250,,1088.0,Autocuration,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,,BAO_0000218,,13493,Urine,1,10116.0,CHEMBL631251,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,,BAO_0000218,,13494,Urine,1,10116.0,CHEMBL631252,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",,,BAO_0000218,,13495,Urine,1,10116.0,CHEMBL631253,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,,BAO_0000218,,13496,Urine,1,10116.0,CHEMBL631254,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,,BAO_0000218,,13497,Urine,1,10116.0,CHEMBL631255,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,,BAO_0000218,,13498,Urine,1,10116.0,CHEMBL631256,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,,BAO_0000218,,13499,Urine,1,10116.0,CHEMBL631257,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",,,BAO_0000218,,13500,Urine,1,10116.0,CHEMBL628009,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,,BAO_0000218,,13501,Urine,1,10116.0,CHEMBL628010,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,,BAO_0000218,,13502,Urine,1,10116.0,CHEMBL628011,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",,,BAO_0000218,,13503,Urine,1,10116.0,CHEMBL628012,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,,BAO_0000218,,13504,Urine,1,10116.0,CHEMBL628013,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,,BAO_0000218,,13505,Urine,1,10116.0,CHEMBL628014,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",,,BAO_0000218,,13506,Urine,1,9615.0,CHEMBL628015,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,,BAO_0000218,,13507,Urine,1,9615.0,CHEMBL628016,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",,,BAO_0000218,,13508,Urine,1,9615.0,CHEMBL874461,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,,BAO_0000218,,13509,Urine,1,9615.0,CHEMBL628017,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,,BAO_0000218,,13510,Urine,1,9615.0,CHEMBL628018,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,,BAO_0000218,,13511,Urine,1,9615.0,CHEMBL628019,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,,BAO_0000218,,13512,Urine,1,9615.0,CHEMBL628020,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,,BAO_0000218,,13513,Urine,1,9615.0,CHEMBL628021,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,,BAO_0000218,,13514,Urine,1,9615.0,CHEMBL628022,,1088.0,Intermediate,A,
,8133,Canis lupus familiaris,1,,N,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,,BAO_0000218,,13515,Urine,1,9615.0,CHEMBL628023,,1088.0,Intermediate,A,
,8133,Simiiformes,1,,U,22224,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,,BAO_0000218,,13516,Urine,0,314293.0,CHEMBL628024,,1088.0,Autocuration,A,
,8133,Simiiformes,1,,U,22224,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",,,BAO_0000218,,13517,Urine,0,314293.0,CHEMBL628025,,1088.0,Autocuration,A,
,8133,Simiiformes,1,,U,22224,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,,BAO_0000218,,13518,Urine,0,314293.0,CHEMBL628026,,1088.0,Autocuration,A,
,8133,Simiiformes,1,,U,22224,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,,BAO_0000218,,13519,Urine,0,314293.0,CHEMBL628027,,1088.0,Autocuration,A,
,8133,Simiiformes,1,,U,22224,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,,BAO_0000218,,13520,Urine,0,314293.0,CHEMBL628028,,1088.0,Autocuration,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,,BAO_0000218,,13521,Urine,1,10116.0,CHEMBL628029,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",,,BAO_0000218,,13522,Urine,1,10116.0,CHEMBL628030,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,,BAO_0000218,,13523,Urine,1,10116.0,CHEMBL628031,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",,,BAO_0000218,,13524,Urine,1,10116.0,CHEMBL628032,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,,BAO_0000218,,13525,Urine,1,10116.0,CHEMBL628033,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",,,BAO_0000218,,13526,Urine,1,10116.0,CHEMBL628034,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,,BAO_0000218,,13527,Urine,1,10116.0,CHEMBL628035,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",,,BAO_0000218,,13528,Urine,1,10116.0,CHEMBL628036,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,,BAO_0000218,,13529,Urine,1,10116.0,CHEMBL874462,,1088.0,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,,,BAO_0000218,,13530,,1,9615.0,CHEMBL628037,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,,,BAO_0000218,,13531,,1,9615.0,CHEMBL628123,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,,,BAO_0000218,,13532,,1,9615.0,CHEMBL628124,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,,,BAO_0000218,,13533,,1,9615.0,CHEMBL628125,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,,,BAO_0000218,,13534,,1,9615.0,CHEMBL628126,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),,,BAO_0000218,,13535,,1,9615.0,CHEMBL628127,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,,,BAO_0000218,,13536,,1,9615.0,CHEMBL628128,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,,,BAO_0000218,,13537,,1,9615.0,CHEMBL628129,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,,,BAO_0000218,,13538,,1,9615.0,CHEMBL628130,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,,,BAO_0000218,,13539,,1,9615.0,CHEMBL628131,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,,,BAO_0000218,,13540,,1,9615.0,CHEMBL628132,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,,,BAO_0000218,,13541,,1,9615.0,CHEMBL628133,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,,,BAO_0000218,,13542,,1,9615.0,CHEMBL628134,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,,,BAO_0000218,,13543,,1,9615.0,CHEMBL628135,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,,,BAO_0000218,,13544,,1,9615.0,CHEMBL628136,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,,,BAO_0000218,,13545,,1,9615.0,CHEMBL628137,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,,,BAO_0000218,,13546,,1,9615.0,CHEMBL628138,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,,,BAO_0000218,,13547,,1,9615.0,CHEMBL628139,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,,,BAO_0000218,,13548,,1,9615.0,CHEMBL628140,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,,,BAO_0000218,,13549,,1,9615.0,CHEMBL628141,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,,,BAO_0000218,,13550,,1,9615.0,CHEMBL628142,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,,,BAO_0000218,,13551,,1,9615.0,CHEMBL628143,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,,,BAO_0000218,,13552,,1,9615.0,CHEMBL628144,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,,,BAO_0000218,,13553,,1,9615.0,CHEMBL628145,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,,,BAO_0000218,,13554,,1,9615.0,CHEMBL628146,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,,,BAO_0000218,,13555,,1,9615.0,CHEMBL625355,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,,,BAO_0000218,,13556,,1,9615.0,CHEMBL625356,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,,,BAO_0000218,,13557,,1,9615.0,CHEMBL625357,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,,,BAO_0000218,,13558,,1,9615.0,CHEMBL625527,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),,,BAO_0000218,,13559,,1,9615.0,CHEMBL875473,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,,,BAO_0000218,,13560,,1,9615.0,CHEMBL625528,In vivo,,Intermediate,A,
,9025,Rattus norvegicus,1,,N,50597,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,,,BAO_0000218,,13561,,1,10116.0,CHEMBL626304,In vivo,,Intermediate,A,
,9025,Canis lupus familiaris,1,,N,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,,,BAO_0000218,,13562,Artery,1,9615.0,CHEMBL624138,In vivo,1637.0,Intermediate,A,
,6448,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13563,,0,,CHEMBL624139,,,Autocuration,P,
,17221,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13564,,0,,CHEMBL624140,,,Autocuration,P,
,6545,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13565,,0,,CHEMBL624141,,,Autocuration,P,
,577,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13566,,0,,CHEMBL624142,,,Autocuration,P,
,6285,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13567,,0,,CHEMBL624143,,,Autocuration,P,
,6500,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13568,,0,,CHEMBL624144,,,Autocuration,P,
,6716,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13569,,0,,CHEMBL624145,,,Autocuration,P,
,13658,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13570,,0,,CHEMBL624146,,,Autocuration,P,
,6549,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13571,,0,,CHEMBL624147,,,Autocuration,P,
,14685,,1,,U,22229,,Calculated partition coefficient (clogP) (MacLogP),,,BAO_0000100,,13572,,0,,CHEMBL883123,,,Autocuration,P,
,6893,,1,,U,22224,,Partition coefficient (logP),,,BAO_0000019,,13573,,0,,CHEMBL624148,,,Autocuration,A,
,3687,,1,,U,22224,,Kinetic parameter was determined,,,BAO_0000019,,13574,,0,,CHEMBL874416,,,Autocuration,A,
,4207,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13575,,0,,CHEMBL624149,,,Autocuration,P,
,4626,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13576,,0,,CHEMBL624150,,,Autocuration,P,
,1021,,1,,U,22224,,Lipophilicity was determined,,,BAO_0000100,,13577,,0,,CHEMBL624151,,,Autocuration,P,
,3777,,1,,U,22224,,Lipophilicity was determined,,,BAO_0000100,,13578,,0,,CHEMBL624152,,,Autocuration,P,
,17533,,1,,U,22224,,Lipophilicity was determined,,,BAO_0000100,,13579,,0,,CHEMBL622139,,,Autocuration,P,
,6524,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13580,,0,,CHEMBL622140,,,Autocuration,P,
,17533,,1,,U,22224,,Lipophilicity was determined,,,BAO_0000100,,13581,,0,,CHEMBL622141,,,Autocuration,P,
,6480,,1,,U,22224,,Lipophilicity in octanol-water,,,BAO_0000100,,13582,,0,,CHEMBL622142,,,Autocuration,P,
,17606,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13583,,0,,CHEMBL622143,,,Autocuration,P,
,6863,,1,,U,22229,,Octanol-water partition coefficient was determined,,,BAO_0000100,,13584,,0,,CHEMBL622144,,,Autocuration,P,
,1356,,1,,U,22224,,Partition coefficient (logP),,,BAO_0000019,,13585,,0,,CHEMBL877473,,,Autocuration,A,
,3326,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13586,,0,,CHEMBL622145,,,Autocuration,P,
,1356,,1,,U,22224,,Partition coefficient was determined; ND means not determined,,,BAO_0000019,,13587,,0,,CHEMBL622146,,,Autocuration,A,
,12984,,1,,U,22229,,Calculated partition coefficient (clogP),,,BAO_0000100,,13588,,0,,CHEMBL622147,,,Autocuration,P,
,17363,,1,,U,22224,,Partition coefficient of the compound,,,BAO_0000019,,13589,,0,,CHEMBL622148,,,Autocuration,A,
,6827,,1,,U,22224,,Permeability was determined,,,BAO_0000019,,13590,,0,,CHEMBL883124,,,Autocuration,A,
,261,,1,,U,22229,,The compound was evaluated for the partition coefficient,,,BAO_0000100,,13591,,0,,CHEMBL622149,,,Autocuration,P,
,2685,,1,,U,22224,,Partition coefficient (logP),,,BAO_0000019,,13592,,0,,CHEMBL622150,,,Autocuration,A,
,414,,1,,U,22224,,The lipophilicity was reported,,,BAO_0000100,,13593,,0,,CHEMBL622151,,,Autocuration,P,
,15769,,1,,U,22229,,logarithm of the octanol-water partition coefficient for the compound,,,BAO_0000100,,13594,,0,,CHEMBL622152,,,Autocuration,P,
,17248,,1,,U,22224,,Clogp value was determined,,,BAO_0000019,,13595,,0,,CHEMBL622153,,,Autocuration,A,
,16935,,1,,U,22224,,Clp at a dose of 1.5 mg/kg,,,BAO_0000218,,13596,,0,,CHEMBL877474,In vivo,,Autocuration,A,
,16935,,1,,U,22224,,Clp at a dose of 2.0 mg/kg,,,BAO_0000218,,13597,,0,,CHEMBL622154,In vivo,,Autocuration,A,
,14832,,1,,U,22224,,"Clp, plasma clearance at a dose of 10 mg/kg",,,BAO_0000218,,13598,Plasma,0,,CHEMBL622155,In vivo,1969.0,Autocuration,A,
,14832,,1,,U,22224,,"Clp, plasma clearance at a dose of 50 mg/kg",,,BAO_0000218,,13599,Plasma,0,,CHEMBL622156,In vivo,1969.0,Autocuration,A,
,2399,Rattus norvegicus,1,,N,50597,,Compound was tested for plasma clearance in rat,,,BAO_0000218,,13600,Plasma,1,10116.0,CHEMBL622157,In vivo,1969.0,Intermediate,A,
,2399,Rattus norvegicus,1,,N,50597,,Compound was tested for plasma clearance in rat; Not determined,,,BAO_0000218,,13601,Plasma,1,10116.0,CHEMBL622158,In vivo,1969.0,Intermediate,A,
,6227,Rattus norvegicus,1,,N,50597,,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,,,BAO_0000218,,13602,,1,10116.0,CHEMBL622807,In vivo,,Intermediate,A,
,6227,Macaca mulatta,1,,N,50797,,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,,,BAO_0000218,,13603,,1,9544.0,CHEMBL622808,In vivo,,Intermediate,A,
,5623,,1,,U,22224,,Plasma clearance by iv administration at a dose 0.003 ug/mL,,,BAO_0000218,,13604,,0,,CHEMBL622809,In vivo,,Autocuration,A,
,4854,,1,,U,22224,,Plasma clearance determined,,,BAO_0000218,,13605,,0,,CHEMBL622810,In vivo,,Autocuration,A,
,4493,Cricetinae,1,,N,100712,,Plasma clearance after iv administration at 3 mg/kg in hamster,,,BAO_0000218,,13606,,1,10026.0,CHEMBL876653,In vivo,,Intermediate,A,
,4493,Cricetinae,1,,N,100712,,Plasma clearance after iv administration at 4 mg/kg in hamster,,,BAO_0000218,,13607,,1,10026.0,CHEMBL622811,In vivo,,Intermediate,A,
,14956,Rattus norvegicus,1,,N,50597,,Rate of clearance in rat was determined,,,BAO_0000218,,13608,,1,10116.0,CHEMBL622986,In vivo,,Intermediate,A,
,15372,Rattus norvegicus,1,,N,50597,,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,,,BAO_0000218,,13609,Plasma,1,10116.0,CHEMBL622987,In vivo,1969.0,Intermediate,A,
,15372,Rattus norvegicus,1,,N,50597,,Total plasma clearance after iv dose of 5.10 mg/kg in rats,,,BAO_0000218,,13610,Plasma,1,10116.0,CHEMBL622988,In vivo,1969.0,Intermediate,A,
,15372,Rattus norvegicus,1,,N,50597,,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,,,BAO_0000218,,13611,Plasma,1,10116.0,CHEMBL622989,In vivo,1969.0,Intermediate,A,
,15372,Rattus norvegicus,1,,N,50597,,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,,,BAO_0000218,,13612,Plasma,1,10116.0,CHEMBL622990,In vivo,1969.0,Intermediate,A,
,15604,Simiiformes,1,,U,22224,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,,BAO_0000218,,13613,Plasma,0,314293.0,CHEMBL622991,In vivo,1969.0,Autocuration,A,
,15604,Rattus norvegicus,1,,N,50597,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,,BAO_0000218,,13614,Plasma,1,10116.0,CHEMBL622227,In vivo,1969.0,Intermediate,A,
,15604,Canis lupus familiaris,1,,N,50588,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,,BAO_0000218,,13615,Plasma,1,9615.0,CHEMBL622228,In vivo,1969.0,Intermediate,A,
,14964,Rattus norvegicus,1,,N,50597,,Clpl value in rat,,,BAO_0000218,,13616,,1,10116.0,CHEMBL622229,In vivo,,Intermediate,A,
,15240,Cavia porcellus,1,,N,50512,,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,,,BAO_0000218,,13617,,1,10141.0,CHEMBL622230,In vivo,,Intermediate,A,
,16449,Rattus norvegicus,1,,N,50597,,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,,,BAO_0000218,,13618,,1,10116.0,CHEMBL622231,In vivo,,Intermediate,A,
,16449,Macaca fascicularis,1,,N,100710,,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,,,BAO_0000218,,13619,,1,9541.0,CHEMBL622232,In vivo,,Intermediate,A,
,12902,,1,,U,22224,,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,,,BAO_0000218,,13620,,0,,CHEMBL622233,In vivo,,Autocuration,A,
,12902,,1,,U,22224,,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,,,BAO_0000218,,13621,,0,,CHEMBL622234,In vivo,,Autocuration,A,
,12902,,1,,U,22224,,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,,,BAO_0000218,,13622,,0,,CHEMBL622235,In vivo,,Autocuration,A,
,12902,,1,,U,22224,,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,,,BAO_0000218,,13623,,0,,CHEMBL622236,In vivo,,Autocuration,A,
,12902,,1,,U,22224,,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,,,BAO_0000218,,13624,,0,,CHEMBL622237,In vivo,,Autocuration,A,
,12902,,1,,U,22224,,Cmax in minutes at a po dose of 10.0(pmol/g/h).,,,BAO_0000218,,13625,,0,,CHEMBL877482,In vivo,,Autocuration,A,
,12902,,1,,U,22224,,Cmax in minutes at a po dose of 20.0(pmol/g/h).,,,BAO_0000218,,13626,,0,,CHEMBL622238,In vivo,,Autocuration,A,
,12902,,1,,U,22224,,Cmax in minutes at a po dose of 40.0(pmol/g/h).,,,BAO_0000218,,13627,,0,,CHEMBL622239,In vivo,,Autocuration,A,
,11149,,1,,U,22224,,Cmax was calculated as maximum concentration reached in the blood,,,BAO_0000218,,13628,Blood,0,,CHEMBL622240,In vivo,178.0,Autocuration,A,
,11149,,1,,U,22224,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,,,BAO_0000218,,13629,Blood,0,,CHEMBL622241,In vivo,178.0,Autocuration,A,
,5669,Rattus norvegicus,1,,N,50597,,Cmax was determine after peroral administration at 10 mpk in Rat,,,BAO_0000218,,13630,,1,10116.0,CHEMBL631013,In vivo,,Intermediate,A,
,5669,Macaca mulatta,1,,N,50797,,Cmax was determine after peroral administration at 10 mpk in Rhesus,,,BAO_0000218,,13631,,1,9544.0,CHEMBL631014,In vivo,,Intermediate,A,
,5669,Canis lupus familiaris,1,,N,50588,,Cmax was determine after peroral administration at 10 mpk in dog,,,BAO_0000218,,13632,,1,9615.0,CHEMBL631015,In vivo,,Intermediate,A,
,5669,Rattus norvegicus,1,,N,50597,,Cmax was determine after peroral administration at 160 mpk in Rat,,,BAO_0000218,,13633,,1,10116.0,CHEMBL631016,In vivo,,Intermediate,A,
,5669,Rattus norvegicus,1,,N,50597,,Cmax was determine after peroral administration at 20 mpk in Rat,,,BAO_0000218,,13634,,1,10116.0,CHEMBL631017,In vivo,,Intermediate,A,
,5669,Rattus norvegicus,1,,N,50597,,Cmax was determine after peroral administration at 50 mpk in Rat,,,BAO_0000218,,13635,,1,10116.0,CHEMBL631018,In vivo,,Intermediate,A,
,4236,,1,,U,22224,,Cmax was determined,,,BAO_0000218,,13636,,0,,CHEMBL631019,In vivo,,Autocuration,A,
,13792,Mus musculus,1,,N,50594,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,,,BAO_0000218,,13637,Brain,1,10090.0,CHEMBL875761,,955.0,Intermediate,A,
,13792,Mus musculus,1,,N,50594,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,,,BAO_0000218,,13638,Brain,1,10090.0,CHEMBL631020,,955.0,Intermediate,A,
,13792,Mus musculus,1,,N,50594,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,,,BAO_0000218,,13639,Brain,1,10090.0,CHEMBL631669,,955.0,Intermediate,A,
,13792,Mus musculus,1,,N,50594,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,,,BAO_0000218,,13640,Brain,1,10090.0,CHEMBL631670,,955.0,Intermediate,A,
,13792,Mus musculus,1,,N,50594,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,,,BAO_0000218,,13641,Striatum,1,10090.0,CHEMBL631671,,2435.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,,,BAO_0000218,,13642,Blood,1,10116.0,CHEMBL631672,,178.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,,,BAO_0000218,,13643,Blood,1,10116.0,CHEMBL631673,,178.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,,,BAO_0000218,,13644,Blood,1,10116.0,CHEMBL631856,,178.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,,,BAO_0000218,,13645,Blood,1,10116.0,CHEMBL631857,,178.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,,,BAO_0000218,,13646,Blood,1,10116.0,CHEMBL631858,,178.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,,,BAO_0000218,,13647,Blood,1,10116.0,CHEMBL631859,,178.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,,,BAO_0000218,,13648,Blood,1,10116.0,CHEMBL631860,,178.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,,,BAO_0000218,,13649,Blood,1,10116.0,CHEMBL631861,,178.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,,,BAO_0000218,,13650,Blood,1,10116.0,CHEMBL631862,,178.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,,,BAO_0000218,,13651,Blood,1,10116.0,CHEMBL631863,,178.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,,,BAO_0000218,,13652,Blood,1,10116.0,CHEMBL631864,,178.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,,,BAO_0000218,,13653,Blood,1,10116.0,CHEMBL631865,,178.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,,,BAO_0000218,,13654,Blood,1,10116.0,CHEMBL631866,,178.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,,,BAO_0000218,,13655,Blood,1,10116.0,CHEMBL629360,,178.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,,,BAO_0000218,,13656,Blood,1,10116.0,CHEMBL629361,,178.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,,,BAO_0000218,,13657,Blood,1,10116.0,CHEMBL629362,,178.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,,,BAO_0000218,,13658,Blood,1,10116.0,CHEMBL630740,,178.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,,,BAO_0000218,,13659,Blood,1,10116.0,CHEMBL630741,,178.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,,,BAO_0000218,,13660,Blood,1,10116.0,CHEMBL630742,,178.0,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,,,BAO_0000218,,13661,,1,10116.0,CHEMBL630743,,,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,,,BAO_0000218,,13662,,1,10116.0,CHEMBL630744,,,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,,,BAO_0000218,,13663,,1,10116.0,CHEMBL630745,,,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,,,BAO_0000218,,13664,,1,10116.0,CHEMBL630746,,,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,,,BAO_0000218,,13665,,1,10116.0,CHEMBL630747,,,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,,,BAO_0000218,,13666,,1,10116.0,CHEMBL630748,,,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,,,BAO_0000218,,13667,,1,10116.0,CHEMBL632056,,,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,,,BAO_0000218,,13668,,1,10116.0,CHEMBL632057,,,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,,,BAO_0000218,,13669,,1,10116.0,CHEMBL632058,,,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,,,BAO_0000218,,13670,,1,10116.0,CHEMBL632059,,,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,,,BAO_0000218,,13671,,1,10116.0,CHEMBL632060,,,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,,,BAO_0000218,,13672,,1,10116.0,CHEMBL632061,,,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,,,BAO_0000218,,13673,,1,10116.0,CHEMBL629207,,,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,,,BAO_0000218,,13674,,1,10116.0,CHEMBL629208,,,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,,,BAO_0000218,,13675,,1,10116.0,CHEMBL629209,,,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,,,BAO_0000218,,13676,,1,10116.0,CHEMBL629210,,,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,,,BAO_0000218,,13677,,1,10116.0,CHEMBL629211,,,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,,,BAO_0000218,,13678,,1,10116.0,CHEMBL629212,,,Intermediate,A,
,8418,Rattus norvegicus,1,,N,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,,,BAO_0000218,,13679,,1,10116.0,CHEMBL629213,,,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,,BAO_0000218,,13680,Urine,1,10116.0,CHEMBL629214,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",,,BAO_0000218,,13681,Urine,1,10116.0,CHEMBL629215,,1088.0,Intermediate,A,
,8133,Rattus norvegicus,1,,N,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",,,BAO_0000218,,13682,Urine,1,10116.0,CHEMBL635154,,1088.0,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,,BAO_0000218,,13683,,1,10116.0,CHEMBL629216,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,,,BAO_0000218,,13684,,1,10116.0,CHEMBL629217,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,,13685,,1,10116.0,CHEMBL629218,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,,BAO_0000218,,13686,,1,10116.0,CHEMBL629219,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,,BAO_0000218,,13687,,1,10116.0,CHEMBL629220,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,,BAO_0000218,,13688,,1,10116.0,CHEMBL629221,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,,13689,,1,10116.0,CHEMBL631127,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,,,BAO_0000218,,13690,,1,10116.0,CHEMBL631128,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,,13691,,1,10116.0,CHEMBL631129,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,,BAO_0000218,,13692,,1,10116.0,CHEMBL631130,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,,BAO_0000218,,13693,,1,10116.0,CHEMBL631131,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,,BAO_0000218,,13694,,1,10116.0,CHEMBL631132,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,,13695,,1,10116.0,CHEMBL631133,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,,,BAO_0000218,,13696,,1,10116.0,CHEMBL631134,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,,13697,,1,10116.0,CHEMBL875120,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,,BAO_0000218,,13698,,1,10116.0,CHEMBL631135,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,,BAO_0000218,,13699,,1,10116.0,CHEMBL631136,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,,BAO_0000218,,13700,,1,10116.0,CHEMBL631137,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,,13701,,1,10116.0,CHEMBL631138,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,,,BAO_0000218,,13702,,1,10116.0,CHEMBL631139,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,,13703,,1,10116.0,CHEMBL631140,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,,BAO_0000218,,13704,,1,10116.0,CHEMBL631141,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,,BAO_0000218,,13705,,1,10116.0,CHEMBL631142,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,,BAO_0000218,,13706,,1,10116.0,CHEMBL631143,,,Intermediate,A,
,6996,Rattus norvegicus,1,,N,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,,13707,,1,10116.0,CHEMBL631144,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,,,BAO_0000218,,13708,,1,9615.0,CHEMBL631145,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,,BAO_0000218,,13709,,1,9615.0,CHEMBL631146,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,,,BAO_0000218,,13710,,1,9615.0,CHEMBL631147,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,,13711,,1,9615.0,CHEMBL631148,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,,13712,,1,9615.0,CHEMBL631149,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),,,BAO_0000218,,13713,,1,9615.0,CHEMBL631150,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,,13714,,1,9615.0,CHEMBL631151,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,,13715,,1,9615.0,CHEMBL631152,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,,13716,,1,9615.0,CHEMBL631443,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),,,BAO_0000218,,13717,,1,9615.0,CHEMBL631444,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,,BAO_0000218,,13718,,1,9615.0,CHEMBL631445,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,,BAO_0000218,,13719,,1,9615.0,CHEMBL631446,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),,,BAO_0000218,,13720,,1,9615.0,CHEMBL631447,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,,13721,,1,9615.0,CHEMBL631448,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,,,BAO_0000218,,13722,,1,9615.0,CHEMBL631449,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),,,BAO_0000218,,13723,,1,9615.0,CHEMBL631450,,,Intermediate,A,
,6996,Canis lupus familiaris,1,,N,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,,BAO_0000218,,13724,,1,9615.0,CHEMBL629724,,,Intermediate,A,
,9716,Mus musculus,1,,N,50594,,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,BAO_0000218,,13725,Zone of skin,1,10090.0,CHEMBL629725,In vivo,14.0,Intermediate,A,
,9716,Mus musculus,1,,N,50594,,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,BAO_0000218,,13726,Zone of skin,1,10090.0,CHEMBL629726,In vivo,14.0,Intermediate,A,
,9716,Mus musculus,1,,N,50594,,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,BAO_0000218,,13727,Spleen,1,10090.0,CHEMBL629727,In vivo,2106.0,Intermediate,A,
,9716,Mus musculus,1,,N,50594,,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,BAO_0000218,,13728,Spleen,1,10090.0,CHEMBL630404,In vivo,2106.0,Intermediate,A,
,9716,Mus musculus,1,,N,50594,,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,BAO_0000218,,13729,Spleen,1,10090.0,CHEMBL630405,In vivo,2106.0,Intermediate,A,
,9716,Mus musculus,1,,N,50594,,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,BAO_0000218,,13730,Spleen,1,10090.0,CHEMBL630406,In vivo,2106.0,Intermediate,A,
,9716,Mus musculus,1,,N,50594,,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,BAO_0000218,,13731,Stomach,1,10090.0,CHEMBL630407,In vivo,945.0,Intermediate,A,
,9716,Mus musculus,1,,N,50594,,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,BAO_0000218,,13732,Stomach,1,10090.0,CHEMBL630573,In vivo,945.0,Intermediate,A,
,9716,Mus musculus,1,,N,50594,,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,BAO_0000218,,13733,Stomach,1,10090.0,CHEMBL630574,In vivo,945.0,Intermediate,A,
,9716,Mus musculus,1,,N,50594,,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,BAO_0000218,,13734,Stomach,1,10090.0,CHEMBL630575,In vivo,945.0,Intermediate,A,
,9716,Mus musculus,1,,N,50594,,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,BAO_0000218,,13735,,1,10090.0,CHEMBL630576,In vivo,,Intermediate,A,
,9716,Mus musculus,1,,N,50594,,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,BAO_0000218,,13736,,1,10090.0,CHEMBL630577,In vivo,,Intermediate,A,
,9716,Mus musculus,1,,N,50594,,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,BAO_0000218,,13737,,1,10090.0,CHEMBL630578,In vivo,,Intermediate,A,
,9716,Mus musculus,1,,N,50594,,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,BAO_0000218,,13738,,1,10090.0,CHEMBL630579,In vivo,,Intermediate,A,
,12192,Mus musculus,1,,N,50594,,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),,,BAO_0000218,,13739,Kidney,1,10090.0,CHEMBL630580,,2113.0,Intermediate,A,
,12192,Mus musculus,1,,N,50594,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,,,BAO_0000218,,13740,Kidney,1,10090.0,CHEMBL630581,,2113.0,Intermediate,A,
,12192,Mus musculus,1,,N,50594,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),,,BAO_0000218,,13741,Kidney,1,10090.0,CHEMBL630582,,2113.0,Intermediate,A,
,12192,Mus musculus,1,,N,50594,,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,,,BAO_0000218,,13742,,1,10090.0,CHEMBL630583,,,Intermediate,A,
,12192,Mus musculus,1,,N,50594,,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),,,BAO_0000218,,13743,,1,10090.0,CHEMBL630584,,,Intermediate,A,
,12192,Mus musculus,1,,N,50594,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,,,BAO_0000218,,13744,,1,10090.0,CHEMBL630585,,,Intermediate,A,
,12192,Mus musculus,1,,N,50594,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),,,BAO_0000218,,13745,,1,10090.0,CHEMBL630586,,,Intermediate,A,
,12192,Mus musculus,1,,N,50594,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,,,BAO_0000218,,13746,,1,10090.0,CHEMBL630587,,,Intermediate,A,
,12192,Mus musculus,1,,N,50594,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),,,BAO_0000218,,13747,,1,10090.0,CHEMBL630588,,,Intermediate,A,
,12192,Mus musculus,1,,N,50594,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,,,BAO_0000218,,13748,,1,10090.0,CHEMBL630589,,,Intermediate,A,
,12192,Mus musculus,1,,N,50594,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),,,BAO_0000218,,13749,,1,10090.0,CHEMBL630590,,,Intermediate,A,
,12192,,1,,U,22224,,Removal of 238-Plutonium(IV) in feces at 24 h,,,BAO_0000019,,13750,Feces,0,,CHEMBL630591,,1988.0,Autocuration,A,
,12192,,1,,U,22224,,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),,,BAO_0000019,,13751,Feces,0,,CHEMBL630592,,1988.0,Autocuration,A,
,12192,,1,,U,22224,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,,,BAO_0000019,,13752,,0,,CHEMBL630593,,,Autocuration,A,
,12192,,1,,U,22224,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),,,BAO_0000019,,13753,,0,,CHEMBL630594,,,Autocuration,A,
,12192,,1,,U,22224,,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),,,BAO_0000019,,13754,Urine,0,,CHEMBL630595,,1088.0,Autocuration,A,
,12192,,1,,U,22224,,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),,,BAO_0000019,,13755,Urine,0,,CHEMBL630596,,1088.0,Autocuration,A,
,12192,,1,,U,22224,,Removal of 238-Plutonium(IV) in urine after 0-24 h,,,BAO_0000019,,13756,Urine,0,,CHEMBL630597,,1088.0,Autocuration,A,
,12192,,1,,U,22224,,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),,,BAO_0000019,,13757,Urine,0,,CHEMBL630598,,1088.0,Autocuration,A,
,12192,,1,,U,22224,,Removal of 238-Plutonium(IV) in urine after 0-4 h,,,BAO_0000019,,13758,Urine,0,,CHEMBL630599,,1088.0,Autocuration,A,
,12192,,1,,U,22224,,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),,,BAO_0000019,,13759,Urine,0,,CHEMBL630600,,1088.0,Autocuration,A,
,12192,,1,,U,22224,,Removal of 238-Plutonium(IV) in urine after 4-24 h,,,BAO_0000019,,13760,Urine,0,,CHEMBL630601,,1088.0,Autocuration,A,
,12192,,1,,U,22224,,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),,,BAO_0000019,,13761,Urine,0,,CHEMBL630602,,1088.0,Autocuration,A,
,12192,,1,,U,22224,,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),,,BAO_0000019,,13762,Urine,0,,CHEMBL630603,,1088.0,Autocuration,A,
,12192,,1,,U,22224,,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),,,BAO_0000019,,13763,Urine,0,,CHEMBL630604,,1088.0,Autocuration,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13764,Blood,1,10116.0,CHEMBL624869,In vivo,178.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13765,Blood,1,10116.0,CHEMBL624870,In vivo,178.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,,13766,Blood,1,10116.0,CHEMBL623189,In vivo,178.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13767,Blood,1,10116.0,CHEMBL623190,In vivo,178.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13768,Blood,1,10116.0,CHEMBL623191,In vivo,178.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13769,,1,10116.0,CHEMBL623192,In vivo,,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13770,,1,10116.0,CHEMBL623193,In vivo,,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,,13771,,1,10116.0,CHEMBL623194,In vivo,,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13772,,1,10116.0,CHEMBL623195,In vivo,,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13773,,1,10116.0,CHEMBL623196,In vivo,,Intermediate,A,
,11836,Rattus norvegicus,1,,N,50597,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,,,BAO_0000218,,13774,,1,10116.0,CHEMBL623197,,,Intermediate,A,
,11836,Rattus norvegicus,1,,N,50597,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,,BAO_0000218,,13775,,1,10116.0,CHEMBL623198,,,Intermediate,A,
,11836,Rattus norvegicus,1,,N,50597,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,,BAO_0000218,,13776,,1,10116.0,CHEMBL623199,,,Intermediate,A,
,11836,Rattus norvegicus,1,,N,50597,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,,,BAO_0000218,,13777,Muscle tissue,1,10116.0,CHEMBL623200,,2385.0,Intermediate,A,
,11836,Rattus norvegicus,1,,N,50597,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,,,BAO_0000218,,13778,Muscle tissue,1,10116.0,CHEMBL623201,,2385.0,Intermediate,A,
,11836,Rattus norvegicus,1,,N,50597,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,,,BAO_0000218,,13779,Muscle tissue,1,10116.0,CHEMBL623202,,2385.0,Intermediate,A,
,11836,Rattus norvegicus,1,,N,50597,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,,,BAO_0000218,,13780,Muscle tissue,1,10116.0,CHEMBL623203,,2385.0,Intermediate,A,
,11836,Rattus norvegicus,1,,N,50597,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,,,BAO_0000218,,13781,Muscle tissue,1,10116.0,CHEMBL623204,,2385.0,Intermediate,A,
,11836,Rattus norvegicus,1,,N,50597,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,,,BAO_0000218,,13782,Muscle tissue,1,10116.0,CHEMBL623205,,2385.0,Intermediate,A,
,11836,Rattus norvegicus,1,,N,50597,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,,BAO_0000218,,13783,Muscle tissue,1,10116.0,CHEMBL623206,,2385.0,Intermediate,A,
,11836,Rattus norvegicus,1,,N,50597,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,,,BAO_0000218,,13784,Muscle tissue,1,10116.0,CHEMBL623207,,2385.0,Intermediate,A,
,11836,Rattus norvegicus,1,,N,50597,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,,,BAO_0000218,,13785,Muscle tissue,1,10116.0,CHEMBL623208,,2385.0,Intermediate,A,
,11836,Rattus norvegicus,1,,N,50597,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,,BAO_0000218,,13786,Muscle tissue,1,10116.0,CHEMBL623209,,2385.0,Intermediate,A,
,11836,Rattus norvegicus,1,,N,50597,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,,BAO_0000218,,13787,Muscle tissue,1,10116.0,CHEMBL623210,,2385.0,Intermediate,A,
,11836,Rattus norvegicus,1,,N,50597,,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,,BAO_0000218,,13788,,1,10116.0,CHEMBL623211,,,Intermediate,A,
,11836,Rattus norvegicus,1,,N,50597,,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,,BAO_0000218,,13789,Uterus,1,10116.0,CHEMBL623212,,995.0,Intermediate,A,
,12640,,1,,U,22224,,Tested in vitro for intrinsic activity relative to quinpirole,,,BAO_0000019,,13790,,0,,CHEMBL623213,,,Autocuration,A,
,14218,,1,,U,22224,,"Relative ion enhancement, determined in pulsed ultrafiltration",,,BAO_0000019,,13791,,0,,CHEMBL623214,,,Autocuration,A,
,11296,,1,,U,22224,,% ionization at the pH 7.4 at 37 degree Centigrade,,,BAO_0000019,,13792,,0,,CHEMBL623215,,,Autocuration,A,
,10929,,1,,U,22224,,Percentage ionization was measured,,,BAO_0000019,,13793,,0,,CHEMBL623216,,,Autocuration,A,
,13841,Bos taurus,1,,N,50591,,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,,,BAO_0000218,,13794,,1,9913.0,CHEMBL623217,,,Intermediate,A,
,10431,,1,,U,22224,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,,,BAO_0000019,,13795,,0,,CHEMBL623218,,,Autocuration,A,
,10431,,1,,U,22224,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,,,BAO_0000019,,13796,,0,,CHEMBL623913,,,Autocuration,A,
,10431,,1,,U,22224,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,,,BAO_0000019,,13797,,0,,CHEMBL623914,,,Autocuration,A,
,8826,,1,,U,22229,,Compound was evaluated for the partition coefficient in octanol/water,,,BAO_0000100,,13798,,0,,CHEMBL623915,,,Autocuration,P,
,8826,,1,,U,22229,,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),,,BAO_0000100,,13799,,0,,CHEMBL624080,,,Autocuration,P,
,9884,,1,,U,22224,,Equilibrium constant measured by the pulse radiolysis at pH 7,,,BAO_0000019,,13800,,0,,CHEMBL624081,,,Autocuration,A,
,9827,Homo sapiens,1,,N,50587,,In vitro hydrolytic rate constant determined in human blood,,,BAO_0000218,,13801,,1,9606.0,CHEMBL624082,,,Intermediate,A,
,10009,Homo sapiens,1,,N,50587,,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,,,BAO_0000218,,13802,,1,9606.0,CHEMBL625054,,,Intermediate,A,
,10009,,1,,U,22224,,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,,,BAO_0000019,,13803,,0,,CHEMBL877485,,,Autocuration,A,
,10009,Mus musculus,1,,N,50594,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,,,BAO_0000218,,13804,,1,10090.0,CHEMBL625055,,,Intermediate,A,
,10009,Mus musculus,1,,N,50594,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,,,BAO_0000218,,13805,,1,10090.0,CHEMBL625056,,,Intermediate,A,
,10009,Homo sapiens,1,,N,50587,,In vitro oxidation of compound in presence of human plasma,,,BAO_0000218,,13806,,1,9606.0,CHEMBL625057,,,Intermediate,A,
,10009,,1,,U,22224,,In vitro oxidation of compound in presence of hydrogen peroxide,,,BAO_0000019,,13807,,0,,CHEMBL625058,,,Autocuration,A,
,10009,Mus musculus,1,,N,50594,,In vitro oxidation of compound in presence of mouse brain homogenate,,,BAO_0000218,,13808,,1,10090.0,CHEMBL625059,,,Intermediate,A,
,10009,Mus musculus,1,,N,50594,,In vitro oxidation of compound in presence of mouse liver homogenate,,,BAO_0000218,,13809,,1,10090.0,CHEMBL629536,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,,BAO_0000218,,13810,,1,10116.0,CHEMBL629537,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,,BAO_0000218,,13811,,1,10116.0,CHEMBL629538,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,,BAO_0000218,,13812,,1,10116.0,CHEMBL629539,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,,BAO_0000218,,13813,,1,10116.0,CHEMBL874445,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,,BAO_0000218,,13814,,1,10116.0,CHEMBL629540,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,,BAO_0000218,,13815,,1,10116.0,CHEMBL629541,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,,BAO_0000218,,13816,,1,10116.0,CHEMBL629542,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,,BAO_0000218,,13817,,1,10116.0,CHEMBL630243,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,,BAO_0000218,,13818,,1,10116.0,CHEMBL630244,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,,BAO_0000218,,13819,,1,10116.0,CHEMBL630245,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,,BAO_0000218,,13820,,1,10116.0,CHEMBL630246,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,,BAO_0000218,,13821,,1,10116.0,CHEMBL630247,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,,BAO_0000218,,13822,,1,10116.0,CHEMBL630248,,,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood at 240 minutes after dose administration.,,,BAO_0000218,,13823,Blood,1,10116.0,CHEMBL630249,In vivo,178.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood at 30 minutes after dose administration.,,,BAO_0000218,,13824,Blood,1,10116.0,CHEMBL630250,In vivo,178.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood at 360 minutes after dose administration.,,,BAO_0000218,,13825,Blood,1,10116.0,CHEMBL630251,In vivo,178.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood at 3 hr after dose administration.,,,BAO_0000218,,13826,Blood,1,10116.0,CHEMBL630252,In vivo,178.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood at 60 minutes after dose administration.,,,BAO_0000218,,13827,Blood,1,10116.0,CHEMBL630408,In vivo,178.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat cerebellum at 120 minutes after dose administration.,,,BAO_0000218,,13828,Cerebellum,1,10116.0,CHEMBL630409,In vivo,2037.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,,,BAO_0000218,,13829,Cerebellum,1,10116.0,CHEMBL874446,In vivo,2037.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat cerebellum at 15 minutes after dose administration.,,,BAO_0000218,,13830,Cerebellum,1,10116.0,CHEMBL630410,In vivo,2037.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat cerebellum at 240 minutes after dose administration.,,,BAO_0000218,,13831,Cerebellum,1,10116.0,CHEMBL630411,In vivo,2037.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat cerebellum at 30 minutes after dose administration.,,,BAO_0000218,,13832,Cerebellum,1,10116.0,CHEMBL630412,In vivo,2037.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat cerebellum at 360 minutes after dose administration.,,,BAO_0000218,,13833,Cerebellum,1,10116.0,CHEMBL630413,In vivo,2037.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat cerebellum at 3 hr after dose administration.,,,BAO_0000218,,13834,Cerebellum,1,10116.0,CHEMBL630414,In vivo,2037.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat cerebellum at 60 minutes after dose administration.,,,BAO_0000218,,13835,Cerebellum,1,10116.0,CHEMBL630415,In vivo,2037.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat cortex at 120 minutes after dose administration.,,,BAO_0000218,,13836,,1,10116.0,CHEMBL630416,In vivo,,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat cortex at 1440 minutes after dose administration.,,,BAO_0000218,,13837,,1,10116.0,CHEMBL630417,In vivo,,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat cortex at 15 minutes after dose administration.,,,BAO_0000218,,13838,,1,10116.0,CHEMBL630418,In vivo,,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat cortex at 240 minutes after dose administration.,,,BAO_0000218,,13839,,1,10116.0,CHEMBL630419,In vivo,,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat cortex at 30 minutes after dose administration.,,,BAO_0000218,,13840,,1,10116.0,CHEMBL630420,In vivo,,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat cortex at 360 minutes after dose administration.,,,BAO_0000218,,13841,,1,10116.0,CHEMBL630421,In vivo,,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat cortex at 3 hr after dose administration.,,,BAO_0000218,,13842,,1,10116.0,CHEMBL630422,In vivo,,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat cortex at 60 minutes after dose administration.,,,BAO_0000218,,13843,,1,10116.0,CHEMBL630423,In vivo,,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart at 120 minutes after dose administration.,,,BAO_0000218,,13844,Heart,1,10116.0,CHEMBL630424,In vivo,948.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart at 15 minutes after dose administration.,,,BAO_0000218,,13845,Heart,1,10116.0,CHEMBL630425,In vivo,948.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart at 240 minutes after dose administration.,,,BAO_0000218,,13846,Heart,1,10116.0,CHEMBL629462,In vivo,948.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart at 30 minutes after dose administration.,,,BAO_0000218,,13847,Heart,1,10116.0,CHEMBL630426,In vivo,948.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart at 360 minutes after dose administration.,,,BAO_0000218,,13848,Heart,1,10116.0,CHEMBL630427,In vivo,948.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart at 3 hr after dose administration.,,,BAO_0000218,,13849,Heart,1,10116.0,CHEMBL625877,In vivo,948.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart at 60 minutes after dose administration.,,,BAO_0000218,,13850,Heart,1,10116.0,CHEMBL625878,In vivo,948.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,,,BAO_0000218,,13851,Hippocampus,1,10116.0,CHEMBL625879,In vivo,10000000.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat hippocampus at 240 minutes after dose administration.,,,BAO_0000218,,13852,Hippocampus,1,10116.0,CHEMBL625880,In vivo,10000000.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat hippocampus at 30 minutes after dose administration.,,,BAO_0000218,,13853,Hippocampus,1,10116.0,CHEMBL625881,In vivo,10000000.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat hippocampus at 360 minutes after dose administration.,,,BAO_0000218,,13854,Hippocampus,1,10116.0,CHEMBL625882,In vivo,10000000.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat hippocampus at 15 minutes after dose administration.,,,BAO_0000218,,13855,Hippocampus,1,10116.0,CHEMBL625883,In vivo,10000000.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat kidney at 120 minutes after dose administration.,,,BAO_0000218,,13856,Kidney,1,10116.0,CHEMBL625884,In vivo,2113.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat kidney at 1440 minutes after dose administration.,,,BAO_0000218,,13857,Kidney,1,10116.0,CHEMBL625885,In vivo,2113.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat kidney at 15 minutes after dose administration.,,,BAO_0000218,,13858,Kidney,1,10116.0,CHEMBL628649,In vivo,2113.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat kidney at 240 minutes after dose administration.,,,BAO_0000218,,13859,Kidney,1,10116.0,CHEMBL628650,In vivo,2113.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat kidney at 30 minutes after dose administration.,,,BAO_0000218,,13860,Kidney,1,10116.0,CHEMBL628651,In vivo,2113.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat kidney at 360 minutes after dose administration.,,,BAO_0000218,,13861,Kidney,1,10116.0,CHEMBL628652,In vivo,2113.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat kidney at 60 minutes after dose administration.,,,BAO_0000218,,13862,Kidney,1,10116.0,CHEMBL628653,In vivo,2113.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver at 120 minutes after dose administration.,,,BAO_0000218,,13863,Liver,1,10116.0,CHEMBL628654,In vivo,2107.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver at 1440 minutes after dose administration.,,,BAO_0000218,,13864,Liver,1,10116.0,CHEMBL628655,In vivo,2107.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver at 15 minutes after dose administration.,,,BAO_0000218,,13865,Liver,1,10116.0,CHEMBL625238,In vivo,2107.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver at 240 minutes after dose administration.,,,BAO_0000218,,13866,Liver,1,10116.0,CHEMBL625239,In vivo,2107.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver at 30 minutes after dose administration.,,,BAO_0000218,,13867,Liver,1,10116.0,CHEMBL625240,In vivo,2107.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver at 360 minutes after dose administration.,,,BAO_0000218,,13868,Liver,1,10116.0,CHEMBL625241,In vivo,2107.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver at 60 minutes after dose administration.,,,BAO_0000218,,13869,Liver,1,10116.0,CHEMBL625242,In vivo,2107.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat lung at 120 minutes after dose administration.,,,BAO_0000218,,13870,Lung,1,10116.0,CHEMBL874587,In vivo,2048.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat lung at 1440 minutes after dose administration.,,,BAO_0000218,,13871,Lung,1,10116.0,CHEMBL625405,In vivo,2048.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat lung at 15 minutes after dose administration.,,,BAO_0000218,,13872,Lung,1,10116.0,CHEMBL625406,In vivo,2048.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat lung at 240 minutes after dose administration.,,,BAO_0000218,,13873,Lung,1,10116.0,CHEMBL625407,In vivo,2048.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat lung at 30 minutes after dose administration.,,,BAO_0000218,,13874,Lung,1,10116.0,CHEMBL625408,In vivo,2048.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat lung at 360 minutes after dose administration.,,,BAO_0000218,,13875,Lung,1,10116.0,CHEMBL625409,In vivo,2048.0,Intermediate,A,
,12361,Rattus norvegicus,1,,N,50597,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,,,BAO_0000218,,13876,Thoracic aorta,1,10116.0,CHEMBL625410,,1515.0,Intermediate,A,
,12361,Rattus norvegicus,1,,N,50597,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,,,BAO_0000218,,13877,Thoracic aorta,1,10116.0,CHEMBL625411,,1515.0,Intermediate,A,
,12361,Rattus norvegicus,1,,N,50597,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,,,BAO_0000218,,13878,Thoracic aorta,1,10116.0,CHEMBL625412,,1515.0,Intermediate,A,
,12361,Rattus norvegicus,1,,N,50597,,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,,,BAO_0000218,,13879,Thoracic aorta,1,10116.0,CHEMBL625413,,1515.0,Intermediate,A,
,12361,Rattus norvegicus,1,,N,50597,,Percent of maximal contractile response to compound in rat thoracic aorta strips v,,,BAO_0000218,,13880,Thoracic aorta,1,10116.0,CHEMBL625414,,1515.0,Intermediate,A,
,12361,Rattus norvegicus,1,,N,50597,,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,,,BAO_0000218,,13881,Thoracic aorta,1,10116.0,CHEMBL625415,,1515.0,Intermediate,A,
,12361,Rattus norvegicus,1,,N,50597,,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,,,BAO_0000218,,13882,Thoracic aorta,1,10116.0,CHEMBL625416,,1515.0,Intermediate,A,
,12712,Rattus norvegicus,1,,N,50597,,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,,,BAO_0000218,,13883,Urine,1,10116.0,CHEMBL625417,,1088.0,Intermediate,A,
,7415,Rattus norvegicus,1,,N,50597,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,,,BAO_0000218,,13884,Feces,1,10116.0,CHEMBL625418,,1988.0,Intermediate,A,
,7415,Rattus norvegicus,1,,N,50597,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,,,BAO_0000218,,13885,Urine,1,10116.0,CHEMBL625419,,1088.0,Intermediate,A,
,7415,Rattus norvegicus,1,,N,50597,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,,,BAO_0000218,,13886,,1,10116.0,CHEMBL625420,,,Intermediate,A,
,7415,Rattus norvegicus,1,,N,50597,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,,,BAO_0000218,,13887,,1,10116.0,CHEMBL626996,,,Intermediate,A,
,7415,Rattus norvegicus,1,,N,50597,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",,,BAO_0000218,,13888,Feces,1,10116.0,CHEMBL626997,,1988.0,Intermediate,A,
,7415,Rattus norvegicus,1,,N,50597,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",,,BAO_0000218,,13889,Urine,1,10116.0,CHEMBL626998,,1088.0,Intermediate,A,
,7415,Rattus norvegicus,1,,N,50597,,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",,,BAO_0000218,,13890,,1,10116.0,CHEMBL626999,,,Intermediate,A,
,8050,Mus musculus,1,,N,50594,,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,,,BAO_0000218,,13891,,1,10090.0,CHEMBL627000,,,Intermediate,A,
,8050,Mus musculus,1,,N,50594,,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,,,BAO_0000218,,13892,,1,10090.0,CHEMBL627001,,,Intermediate,A,
,8050,Mus musculus,1,,N,50594,,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,,,BAO_0000218,,13893,,1,10090.0,CHEMBL627002,,,Intermediate,A,
,8050,Mus musculus,1,,N,50594,,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,,,BAO_0000218,,13894,,1,10090.0,CHEMBL627003,,,Intermediate,A,
,8050,Mus musculus,1,,N,50594,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,,,BAO_0000218,,13895,Urine,1,10090.0,CHEMBL627004,,1088.0,Intermediate,A,
,8050,Mus musculus,1,,N,50594,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,,,BAO_0000218,,13896,Urine,1,10090.0,CHEMBL627005,,1088.0,Intermediate,A,
,8050,Mus musculus,1,,N,50594,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,,,BAO_0000218,,13897,Urine,1,10090.0,CHEMBL874594,,1088.0,Intermediate,A,
,8050,Mus musculus,1,,N,50594,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,,,BAO_0000218,,13898,Urine,1,10090.0,CHEMBL627006,,1088.0,Intermediate,A,
,8050,Mus musculus,1,,N,50594,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,,,BAO_0000218,,13899,Urine,1,10090.0,CHEMBL627007,,1088.0,Intermediate,A,
,8050,Mus musculus,1,,N,50594,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,,,BAO_0000218,,13900,Urine,1,10090.0,CHEMBL627884,,1088.0,Intermediate,A,
,8050,Mus musculus,1,,N,50594,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,,,BAO_0000218,,13901,Urine,1,10090.0,CHEMBL627885,,1088.0,Intermediate,A,
,8050,Mus musculus,1,,N,50594,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,,,BAO_0000218,,13902,Urine,1,10090.0,CHEMBL627886,,1088.0,Intermediate,A,
,8050,Mus musculus,1,,N,50594,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,,,BAO_0000218,,13903,Urine,1,10090.0,CHEMBL627887,,1088.0,Intermediate,A,
,8050,Mus musculus,1,,N,50594,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,,,BAO_0000218,,13904,Urine,1,10090.0,CHEMBL627888,,1088.0,Intermediate,A,
,8050,Mus musculus,1,,N,50594,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,,,BAO_0000218,,13905,Urine,1,10090.0,CHEMBL628057,,1088.0,Intermediate,A,
,8050,Mus musculus,1,,N,50594,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,,,BAO_0000218,,13906,Urine,1,10090.0,CHEMBL627405,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,,BAO_0000218,,13907,Urine,1,9615.0,CHEMBL627406,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,,BAO_0000218,,13908,Urine,1,9615.0,CHEMBL627407,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,,BAO_0000218,,13909,Urine,1,9615.0,CHEMBL627408,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,,BAO_0000218,,13910,Urine,1,9615.0,CHEMBL627409,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,,BAO_0000218,,13911,Urine,1,9615.0,CHEMBL875486,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,,BAO_0000218,,13912,Urine,1,9615.0,CHEMBL627410,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,,BAO_0000218,,13913,Urine,1,9615.0,CHEMBL627411,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,,BAO_0000218,,13914,Urine,1,9615.0,CHEMBL627412,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,,BAO_0000218,,13915,Urine,1,9615.0,CHEMBL627413,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,,BAO_0000218,,13916,Urine,1,9615.0,CHEMBL627414,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,,BAO_0000218,,13917,Urine,1,9615.0,CHEMBL627415,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,,,BAO_0000218,,13918,Urine,1,9615.0,CHEMBL627416,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,,BAO_0000218,,13919,Urine,1,9615.0,CHEMBL627417,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,,BAO_0000218,,13920,Urine,1,9615.0,CHEMBL627418,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,,BAO_0000218,,13921,Urine,1,9615.0,CHEMBL627419,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,,BAO_0000218,,13922,Urine,1,9615.0,CHEMBL627320,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,,BAO_0000218,,13923,Urine,1,9615.0,CHEMBL627321,,1088.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13924,Kidney,1,10116.0,CHEMBL627322,In vivo,2113.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13925,Kidney,1,10116.0,CHEMBL627323,In vivo,2113.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,,13926,Kidney,1,10116.0,CHEMBL627491,In vivo,2113.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13927,Kidney,1,10116.0,CHEMBL627492,In vivo,2113.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13928,Kidney,1,10116.0,CHEMBL627493,In vivo,2113.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13929,Liver,1,10116.0,CHEMBL627494,In vivo,2107.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13930,Liver,1,10116.0,CHEMBL627495,In vivo,2107.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,,13931,Liver,1,10116.0,CHEMBL627496,In vivo,2107.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13932,Liver,1,10116.0,CHEMBL627497,In vivo,2107.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13933,Liver,1,10116.0,CHEMBL627498,In vivo,2107.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13934,Lung,1,10116.0,CHEMBL627499,In vivo,2048.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13935,Lung,1,10116.0,CHEMBL627500,In vivo,2048.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,,13936,Lung,1,10116.0,CHEMBL627501,In vivo,2048.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13937,Lung,1,10116.0,CHEMBL625616,In vivo,2048.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13938,Lung,1,10116.0,CHEMBL625617,In vivo,2048.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13939,Muscle tissue,1,10116.0,CHEMBL625618,In vivo,2385.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13940,Muscle tissue,1,10116.0,CHEMBL625619,In vivo,2385.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,,13941,Muscle tissue,1,10116.0,CHEMBL625620,In vivo,2385.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13942,Muscle tissue,1,10116.0,CHEMBL625621,In vivo,2385.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13943,Muscle tissue,1,10116.0,CHEMBL625622,In vivo,2385.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13944,Spleen,1,10116.0,CHEMBL625788,In vivo,2106.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13945,Spleen,1,10116.0,CHEMBL625789,In vivo,2106.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,,13946,Spleen,1,10116.0,CHEMBL625790,In vivo,2106.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13947,Spleen,1,10116.0,CHEMBL625791,In vivo,2106.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13948,Spleen,1,10116.0,CHEMBL622334,In vivo,2106.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13949,Thyroid gland,1,10116.0,CHEMBL622335,In vivo,2046.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13950,Thyroid gland,1,10116.0,CHEMBL622336,In vivo,2046.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,,13951,Thyroid gland,1,10116.0,CHEMBL622337,In vivo,2046.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13952,Thyroid gland,1,10116.0,CHEMBL622338,In vivo,2046.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13953,Thyroid gland,1,10116.0,CHEMBL622339,In vivo,2046.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13954,,1,10116.0,CHEMBL624153,In vivo,,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13955,,1,10116.0,CHEMBL628430,In vivo,,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,,13956,,1,10116.0,CHEMBL628431,In vivo,,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13957,,1,10116.0,CHEMBL628432,In vivo,,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,13958,,1,10116.0,CHEMBL628433,In vivo,,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,,BAO_0000218,,13959,Spleen,1,10116.0,CHEMBL628434,In vivo,2106.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,,BAO_0000218,,13960,Spleen,1,10116.0,CHEMBL626789,In vivo,2106.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",,,BAO_0000218,,13961,Spleen,1,10116.0,CHEMBL626790,In vivo,2106.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,,BAO_0000218,,13962,Spleen,1,10116.0,CHEMBL626791,In vivo,2106.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,,BAO_0000218,,13963,Spleen,1,10116.0,CHEMBL626792,In vivo,2106.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,,BAO_0000218,,13964,Spleen,1,10116.0,CHEMBL626793,In vivo,2106.0,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,,BAO_0000218,,13965,,1,10116.0,CHEMBL627436,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,,BAO_0000218,,13966,,1,10116.0,CHEMBL627437,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,,BAO_0000218,,13967,,1,10116.0,CHEMBL627438,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,,BAO_0000218,,13968,,1,10116.0,CHEMBL627439,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,,BAO_0000218,,13969,,1,10116.0,CHEMBL627440,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,,BAO_0000218,,13970,,1,10116.0,CHEMBL627602,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,,BAO_0000218,,13971,,1,10116.0,CHEMBL627603,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,,BAO_0000218,,13972,,1,10116.0,CHEMBL627604,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,,BAO_0000218,,13973,,1,10116.0,CHEMBL627605,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,,BAO_0000218,,13974,,1,10116.0,CHEMBL627606,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,,BAO_0000218,,13975,,1,10116.0,CHEMBL627607,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,,BAO_0000218,,13976,,1,10116.0,CHEMBL627608,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,,BAO_0000218,,13977,,1,10116.0,CHEMBL627609,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,,BAO_0000218,,13978,,1,10116.0,CHEMBL627610,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,,BAO_0000218,,13979,,1,10116.0,CHEMBL627611,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,,BAO_0000218,,13980,,1,10116.0,CHEMBL627612,,,Intermediate,A,
,8362,,1,,U,22229,,Octanol:water partition coefficient is evaluated,,,BAO_0000100,,13981,,0,,CHEMBL627613,,,Autocuration,P,
,8257,,1,,U,22224,,Partition coefficient in 1-octanol/water system,,,BAO_0000100,,13982,,0,,CHEMBL627614,,,Autocuration,P,
,8257,,1,,U,22224,,Partition coefficient in 1-octanol/water system measured using radio active compounds,,,BAO_0000100,,13983,,0,,CHEMBL627615,,,Autocuration,P,
,9468,,1,,U,22224,,Partition coefficient in octanol/water system was determined,,,BAO_0000100,,13984,,0,,CHEMBL627616,,,Autocuration,P,
,9468,,1,,U,22224,,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,,,BAO_0000100,,13985,,0,,CHEMBL627617,,,Autocuration,P,
,10568,,1,,U,22224,,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,,,BAO_0000019,,13986,,0,,CHEMBL627618,,,Autocuration,A,
,10568,,1,,U,22224,,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",,,BAO_0000019,,13987,,0,,CHEMBL627619,,,Autocuration,A,
,15359,,1,,U,22224,,Pseudo-first-order rate constant of the compound,,,BAO_0000019,,13988,,0,,CHEMBL627620,,,Autocuration,A,
,15359,,1,,U,22224,,Pseudo-first-order rate constant with 1-min time point,,,BAO_0000019,,13989,,0,,CHEMBL627621,,,Autocuration,A,
,15359,,1,,U,22224,,Pseudo-first-order rate constant without 1-min time point,,,BAO_0000019,,13990,,0,,CHEMBL627622,,,Autocuration,A,
,10431,,1,,U,22224,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,,,BAO_0000019,,13991,,0,,CHEMBL627623,,,Autocuration,A,
,10431,,1,,U,22224,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,,,BAO_0000019,,13992,,0,,CHEMBL627624,,,Autocuration,A,
,10431,,1,,U,22224,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,,,BAO_0000019,,13993,,0,,CHEMBL627625,,,Autocuration,A,
,15704,,1,,U,22224,,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,,,BAO_0000019,,13994,,0,,CHEMBL628523,,,Autocuration,A,
,15287,,1,,U,22224,,The alkaline hydrolysis second order rate constant(K OH) of the compound,,,BAO_0000019,,13995,,0,,CHEMBL628524,,,Autocuration,A,
,7516,,1,,U,22224,,The efflux rate constant of the compound,,,BAO_0000019,,13996,,0,,CHEMBL628525,,,Autocuration,A,
,12973,,1,,U,22224,,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,,BAO_0000019,,13997,,0,,CHEMBL625732,,,Autocuration,A,
,12973,,1,,U,22224,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,,BAO_0000019,,13998,,0,,CHEMBL625733,,,Autocuration,A,
,12973,,1,,U,22224,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,,BAO_0000019,,13999,,0,,CHEMBL625734,,,Autocuration,F,
,12973,,1,,U,22224,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,,,BAO_0000019,,14000,,0,,CHEMBL625913,,,Autocuration,A,
,8696,,1,,U,22224,,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,,,BAO_0000019,,14001,,0,,CHEMBL625914,,,Autocuration,A,
,15052,,1,,U,22224,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,,,BAO_0000019,,14002,,0,,CHEMBL625915,,,Autocuration,A,
,15052,,1,,U,22224,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,,,BAO_0000019,,14003,,0,,CHEMBL625916,,,Autocuration,A,
,10503,,1,,U,22224,,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),,,BAO_0000019,,14004,,0,,CHEMBL625917,,,Autocuration,A,
,8354,,1,,U,22224,,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,,14005,,0,,CHEMBL625918,,,Autocuration,A,
,8354,,1,,U,22224,,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,,14006,,0,,CHEMBL625919,,,Autocuration,A,
,8354,,1,,U,22224,,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,,14007,,0,,CHEMBL625920,,,Autocuration,A,
,8354,,1,,U,22224,,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,,14008,,0,,CHEMBL874453,,,Autocuration,A,
,8354,,1,,U,22224,,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,,14009,,0,,CHEMBL625921,,,Autocuration,A,
,10503,,1,,U,22224,,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,,,BAO_0000019,,14010,,0,,CHEMBL625922,,,Autocuration,A,
,8354,,1,,U,22224,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,,14011,,0,,CHEMBL625923,,,Autocuration,A,
,8354,,1,,U,22224,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,,14012,,0,,CHEMBL625924,,,Autocuration,A,
,8354,,1,,U,22224,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,,14013,,0,,CHEMBL625925,,,Autocuration,A,
,8354,,1,,U,22224,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,,14014,,0,,CHEMBL625926,,,Autocuration,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat lung at 60 minutes after dose administration.,,,BAO_0000218,,14015,Lung,1,10116.0,CHEMBL627704,In vivo,2048.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,,,BAO_0000218,,14016,,1,10116.0,CHEMBL627705,In vivo,,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,,,BAO_0000218,,14017,,1,10116.0,CHEMBL627706,In vivo,,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,,,BAO_0000218,,14018,,1,10116.0,CHEMBL627707,In vivo,,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,,,BAO_0000218,,14019,,1,10116.0,CHEMBL627708,In vivo,,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,,,BAO_0000218,,14020,,1,10116.0,CHEMBL628361,In vivo,,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,,,BAO_0000218,,14021,,1,10116.0,CHEMBL628362,In vivo,,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat striatum at 120 minutes after dose administration.,,,BAO_0000218,,14022,Striatum,1,10116.0,CHEMBL628363,In vivo,2435.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat striatum at 1440 minutes after dose administration.,,,BAO_0000218,,14023,Striatum,1,10116.0,CHEMBL628364,In vivo,2435.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat striatum at 15 minutes after dose administration.,,,BAO_0000218,,14024,Striatum,1,10116.0,CHEMBL628365,In vivo,2435.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat striatum at 240 minutes after dose administration.,,,BAO_0000218,,14025,Striatum,1,10116.0,CHEMBL874454,In vivo,2435.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat striatum at 30 minutes after dose administration.,,,BAO_0000218,,14026,Striatum,1,10116.0,CHEMBL628531,In vivo,2435.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat striatum at 360 minutes after dose administration.,,,BAO_0000218,,14027,Striatum,1,10116.0,CHEMBL628532,In vivo,2435.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat striatum at 3 hr after dose administration.,,,BAO_0000218,,14028,Striatum,1,10116.0,CHEMBL628533,In vivo,2435.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat striatum at 60 minutes after dose administration.,,,BAO_0000218,,14029,Striatum,1,10116.0,CHEMBL628534,In vivo,2435.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat thyroid at 120 minutes after dose administration.,,,BAO_0000218,,14030,Thyroid gland,1,10116.0,CHEMBL628535,In vivo,2046.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat thyroid at 1440 minutes after dose administration.,,,BAO_0000218,,14031,Thyroid gland,1,10116.0,CHEMBL628536,In vivo,2046.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat thyroid at 15 minutes after dose administration.,,,BAO_0000218,,14032,Thyroid gland,1,10116.0,CHEMBL628537,In vivo,2046.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat thyroid at 240 minutes after dose administration.,,,BAO_0000218,,14033,Thyroid gland,1,10116.0,CHEMBL628538,In vivo,2046.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat thyroid at 30 minutes after dose administration.,,,BAO_0000218,,14034,Thyroid gland,1,10116.0,CHEMBL628539,In vivo,2046.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat thyroid at 360 minutes after dose administration.,,,BAO_0000218,,14035,Thyroid gland,1,10116.0,CHEMBL630297,In vivo,2046.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rat thyroid at 60 minutes after dose administration.,,,BAO_0000218,,14036,Thyroid gland,1,10116.0,CHEMBL630298,In vivo,2046.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rest of brain of rat 120 minutes after dose administration.,,,BAO_0000218,,14037,Brain,1,10116.0,CHEMBL630299,In vivo,955.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,,,BAO_0000218,,14038,Brain,1,10116.0,CHEMBL628094,In vivo,955.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,,,BAO_0000218,,14039,Brain,1,10116.0,CHEMBL628095,In vivo,955.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,,,BAO_0000218,,14040,Brain,1,10116.0,CHEMBL874648,In vivo,955.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,,,BAO_0000218,,14041,Brain,1,10116.0,CHEMBL628096,In vivo,955.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,,,BAO_0000218,,14042,Brain,1,10116.0,CHEMBL628097,In vivo,955.0,Intermediate,A,
,13100,Rattus norvegicus,1,,N,50597,,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,,,BAO_0000218,,14043,Brain,1,10116.0,CHEMBL628098,In vivo,955.0,Intermediate,A,
,13331,,1,,U,22224,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",,,BAO_0000019,,14044,,0,,CHEMBL628099,,,Autocuration,A,
,13331,,1,,U,22224,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,,BAO_0000019,,14045,,0,,CHEMBL628100,,,Autocuration,A,
,13331,,1,,U,22224,,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),,,BAO_0000019,,14046,,0,,CHEMBL628101,,,Autocuration,A,
,13331,,1,,U,22224,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",,,BAO_0000019,,14047,,0,,CHEMBL628102,,,Autocuration,A,
,13331,,1,,U,22224,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",,,BAO_0000019,,14048,,0,,CHEMBL628103,,,Autocuration,A,
,13331,,1,,U,22224,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,,BAO_0000019,,14049,,0,,CHEMBL628104,,,Autocuration,A,
,13331,,1,,U,22224,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",,,BAO_0000019,,14050,,0,,CHEMBL628105,,,Autocuration,A,
,13331,,1,,U,22224,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",,,BAO_0000019,,14051,,0,,CHEMBL628106,,,Autocuration,A,
,10086,Rattus norvegicus,1,,N,50597,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,,BAO_0000218,,14052,Urine,1,10116.0,CHEMBL628107,,1088.0,Intermediate,A,
,10086,,1,,U,22224,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,,BAO_0000218,,14053,Urine,0,,CHEMBL628108,,1088.0,Autocuration,F,
,10086,Rattus norvegicus,1,,N,50597,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,,BAO_0000218,,14054,Urine,1,10116.0,CHEMBL628109,,1088.0,Intermediate,A,
,10086,,1,,U,22224,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,,BAO_0000218,,14055,Urine,0,,CHEMBL625299,,1088.0,Autocuration,F,
,10086,Rattus norvegicus,1,,N,50597,,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,,,BAO_0000218,,14056,Urine,1,10116.0,CHEMBL625300,,1088.0,Intermediate,A,
,10086,Rattus norvegicus,1,,N,50597,,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,,,BAO_0000218,,14057,Urine,1,10116.0,CHEMBL625301,,1088.0,Intermediate,A,
,10086,Rattus norvegicus,1,,N,50597,,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,,,BAO_0000218,,14058,Urine,1,10116.0,CHEMBL625302,,1088.0,Intermediate,A,
,10086,Rattus norvegicus,1,,N,50597,,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,,,BAO_0000218,,14059,Urine,1,10116.0,CHEMBL874649,,1088.0,Intermediate,A,
,13248,Rattus norvegicus,1,,N,50597,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,,,BAO_0000218,,14060,,1,10116.0,CHEMBL625303,,,Intermediate,A,
,13248,Rattus norvegicus,1,,N,50597,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,,,BAO_0000218,,14061,,1,10116.0,CHEMBL625463,,,Intermediate,A,
,14527,Homo sapiens,1,,N,50587,,In vitro metabolism in human liver microsomes,,,BAO_0000218,,14062,Liver,1,9606.0,CHEMBL625464,,2107.0,Intermediate,A,
,3008,Homo sapiens,1,,N,50587,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,,,BAO_0000218,,14063,,1,9606.0,CHEMBL625465,,,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,,BAO_0000218,,14064,Urine,1,9615.0,CHEMBL625466,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,,BAO_0000218,,14065,Urine,1,9615.0,CHEMBL625467,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,,BAO_0000218,,14066,Urine,1,10116.0,CHEMBL625468,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,,,BAO_0000218,,14067,Urine,1,10116.0,CHEMBL625469,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,,,BAO_0000218,,14068,Urine,1,10116.0,CHEMBL625470,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,,,BAO_0000218,,14069,Urine,1,10116.0,CHEMBL632418,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,,,BAO_0000218,,14070,Urine,1,10116.0,CHEMBL627250,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,,,BAO_0000218,,14071,Urine,1,10116.0,CHEMBL627251,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,,,BAO_0000218,,14072,Urine,1,10116.0,CHEMBL627252,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,,,BAO_0000218,,14073,Urine,1,10116.0,CHEMBL627253,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,,,BAO_0000218,,14074,Urine,1,10116.0,CHEMBL627254,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,,,BAO_0000218,,14075,Urine,1,10116.0,CHEMBL875471,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,,,BAO_0000218,,14076,Urine,1,10116.0,CHEMBL627255,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,,,BAO_0000218,,14077,Urine,1,10116.0,CHEMBL627256,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,,,BAO_0000218,,14078,Urine,1,10116.0,CHEMBL627257,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,,,BAO_0000218,,14079,Urine,1,10116.0,CHEMBL627258,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,,,BAO_0000218,,14080,Urine,1,10116.0,CHEMBL627259,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,,,BAO_0000218,,14081,Urine,1,10116.0,CHEMBL627260,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,,,BAO_0000218,,14082,Urine,1,10116.0,CHEMBL623256,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,,,BAO_0000218,,14083,Urine,1,10116.0,CHEMBL874413,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,,,BAO_0000218,,14084,Urine,1,10116.0,CHEMBL623257,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,,,BAO_0000218,,14085,Urine,1,10116.0,CHEMBL623258,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,,,BAO_0000218,,14086,Urine,1,10116.0,CHEMBL623259,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,,,BAO_0000218,,14087,Urine,1,10116.0,CHEMBL623260,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,,,BAO_0000218,,14088,Urine,1,10116.0,CHEMBL623261,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,,,BAO_0000218,,14089,Urine,1,10116.0,CHEMBL623262,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,,,BAO_0000218,,14090,Urine,1,10116.0,CHEMBL623263,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,,,BAO_0000218,,14091,Urine,1,10116.0,CHEMBL623264,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,,,BAO_0000218,,14092,Urine,1,10116.0,CHEMBL623265,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,,,BAO_0000218,,14093,Urine,1,10116.0,CHEMBL623266,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,,,BAO_0000218,,14094,Urine,1,10116.0,CHEMBL623267,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,,,BAO_0000218,,14095,Urine,1,10116.0,CHEMBL623268,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,,,BAO_0000218,,14096,Urine,1,10116.0,CHEMBL623269,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,,,BAO_0000218,,14097,Urine,1,10116.0,CHEMBL623270,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,,,BAO_0000218,,14098,Urine,1,10116.0,CHEMBL623271,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,,,BAO_0000218,,14099,Urine,1,10116.0,CHEMBL623272,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,,,BAO_0000218,,14100,Urine,1,10116.0,CHEMBL623273,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,,,BAO_0000218,,14101,Urine,1,10116.0,CHEMBL623274,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,,,BAO_0000218,,14102,Urine,1,10116.0,CHEMBL874414,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,,,BAO_0000218,,14103,Urine,1,10116.0,CHEMBL623275,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,,,BAO_0000218,,14104,Urine,1,10116.0,CHEMBL629150,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,,,BAO_0000218,,14105,Urine,1,10116.0,CHEMBL623276,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,,,BAO_0000218,,14106,Urine,1,10116.0,CHEMBL623277,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,,,BAO_0000218,,14107,Urine,1,10116.0,CHEMBL623112,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,,,BAO_0000218,,14108,Urine,1,10116.0,CHEMBL623113,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,,,BAO_0000218,,14109,Urine,1,10116.0,CHEMBL623800,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,,,BAO_0000218,,14110,Urine,1,10116.0,CHEMBL623801,,1088.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,,BAO_0000218,,14111,Spleen,1,10116.0,CHEMBL623802,In vivo,2106.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14112,Uterus,1,10116.0,CHEMBL623803,In vivo,995.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14113,Uterus,1,10116.0,CHEMBL623970,In vivo,995.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14114,Uterus,1,10116.0,CHEMBL623971,In vivo,995.0,Intermediate,A,
,14045,Rattus norvegicus,1,,N,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),,,BAO_0000218,,14115,Blood,1,10116.0,CHEMBL623972,In vivo,178.0,Intermediate,A,
,14045,Rattus norvegicus,1,,N,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),,,BAO_0000218,,14116,Blood,1,10116.0,CHEMBL623973,In vivo,178.0,Intermediate,A,
,14045,Rattus norvegicus,1,,N,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),,,BAO_0000218,,14117,Blood,1,10116.0,CHEMBL623974,In vivo,178.0,Intermediate,A,
,14045,Rattus norvegicus,1,,N,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),,,BAO_0000218,,14118,Blood,1,10116.0,CHEMBL623975,In vivo,178.0,Intermediate,A,
,14045,Rattus norvegicus,1,,N,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),,,BAO_0000218,,14119,Brain,1,10116.0,CHEMBL623976,In vivo,955.0,Intermediate,A,
,14045,Rattus norvegicus,1,,N,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),,,BAO_0000218,,14120,Brain,1,10116.0,CHEMBL623977,In vivo,955.0,Intermediate,A,
,14045,Rattus norvegicus,1,,N,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),,,BAO_0000218,,14121,Brain,1,10116.0,CHEMBL623978,In vivo,955.0,Intermediate,A,
,14045,Rattus norvegicus,1,,N,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),,,BAO_0000218,,14122,Brain,1,10116.0,CHEMBL623979,In vivo,955.0,Intermediate,A,
,14045,Rattus norvegicus,1,,N,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),,,BAO_0000218,,14123,,1,10116.0,CHEMBL623980,In vivo,,Intermediate,A,
,14045,Rattus norvegicus,1,,N,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),,,BAO_0000218,,14124,,1,10116.0,CHEMBL623981,In vivo,,Intermediate,A,
,14045,Rattus norvegicus,1,,N,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),,,BAO_0000218,,14125,,1,10116.0,CHEMBL626278,In vivo,,Intermediate,A,
,14045,Rattus norvegicus,1,,N,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),,,BAO_0000218,,14126,,1,10116.0,CHEMBL626279,In vivo,,Intermediate,A,
,14045,Mus musculus,1,,N,50594,,Biodistribution in mice bladder plus excreted urine was determined,,,BAO_0000218,,14127,,1,10090.0,CHEMBL626280,In vivo,,Intermediate,A,
,14045,Mus musculus,1,,N,50594,,"Percentage biodistribution in mouse blood, 10 minutes post injection",,,BAO_0000218,,14128,,1,10090.0,CHEMBL626281,,,Intermediate,A,
,14045,Mus musculus,1,,N,50594,,"Percentage biodistribution in mouse blood, 30 minutes post injection",,,BAO_0000218,,14129,,1,10090.0,CHEMBL626282,,,Intermediate,A,
,14045,Mus musculus,1,,N,50594,,"Percentage biodistribution in mouse blood, 5 minutes post injection",,,BAO_0000218,,14130,,1,10090.0,CHEMBL626283,,,Intermediate,A,
,14045,Mus musculus,1,,N,50594,,"Percentage biodistribution in mouse blood, 60 minutes post injection",,,BAO_0000218,,14131,,1,10090.0,CHEMBL626284,,,Intermediate,A,
,14045,Mus musculus,1,,N,50594,,"Percentage biodistribution in mouse brain, 10 minutes post injection",,,BAO_0000218,,14132,Brain,1,10090.0,CHEMBL626285,,955.0,Intermediate,A,
,14045,Mus musculus,1,,N,50594,,"Percentage biodistribution in mouse brain, 30 minutes post injection",,,BAO_0000218,,14133,Brain,1,10090.0,CHEMBL626286,,955.0,Intermediate,A,
,14045,Mus musculus,1,,N,50594,,"Percentage biodistribution in mouse brain, 5 minutes post injection",,,BAO_0000218,,14134,Brain,1,10090.0,CHEMBL626287,,955.0,Intermediate,A,
,14045,Mus musculus,1,,N,50594,,"Percentage biodistribution in mouse brain, 60 minutes post injection",,,BAO_0000218,,14135,Brain,1,10090.0,CHEMBL626288,,955.0,Intermediate,A,
,14045,Mus musculus,1,,N,50594,,"Percentage biodistribution in mouse heart, 10 minutes post injection",,,BAO_0000218,,14136,,1,10090.0,CHEMBL626289,,,Intermediate,A,
,14045,Mus musculus,1,,N,50594,,"Percentage biodistribution in mouse heart, 30 minutes post injection",,,BAO_0000218,,14137,,1,10090.0,CHEMBL626290,,,Intermediate,A,
,14045,Mus musculus,1,,N,50594,,"Percentage biodistribution in mouse heart, 5 minutes post injection",,,BAO_0000218,,14138,,1,10090.0,CHEMBL626291,,,Intermediate,A,
,14045,Mus musculus,1,,N,50594,,"Percentage biodistribution in mouse heart, 60 minutes post injection",,,BAO_0000218,,14139,,1,10090.0,CHEMBL839888,,,Intermediate,A,
,14045,Mus musculus,1,,N,50594,,"Percentage biodistribution in mouse intestine, 10 minutes post injection",,,BAO_0000218,,14140,Intestine,1,10090.0,CHEMBL626292,,160.0,Intermediate,A,
,14045,Mus musculus,1,,N,50594,,"Percentage biodistribution in mouse intestine, 30 minutes post injection",,,BAO_0000218,,14141,Intestine,1,10090.0,CHEMBL626293,,160.0,Intermediate,A,
,14045,Mus musculus,1,,N,50594,,"Percentage biodistribution in mouse intestine, 5 minutes post injection",,,BAO_0000218,,14142,Intestine,1,10090.0,CHEMBL626294,,160.0,Intermediate,A,
,14045,Mus musculus,1,,N,50594,,"Percentage biodistribution in mouse intestine, 60 minutes post injection",,,BAO_0000218,,14143,Intestine,1,10090.0,CHEMBL626295,,160.0,Intermediate,A,
,14045,Mus musculus,1,,N,50594,,"Percentage biodistribution in mouse liver, 10 minutes post injection",,,BAO_0000218,,14144,Liver,1,10090.0,CHEMBL627659,,2107.0,Intermediate,A,
,14045,Mus musculus,1,,N,50594,,"Percentage biodistribution in mouse liver, 30 minutes of post injection",,,BAO_0000218,,14145,Liver,1,10090.0,CHEMBL627660,,2107.0,Intermediate,A,
,14045,Mus musculus,1,,N,50594,,"Percentage biodistribution in mouse liver, 5 minutes post injection",,,BAO_0000218,,14146,Liver,1,10090.0,CHEMBL627661,,2107.0,Intermediate,A,
,14045,Mus musculus,1,,N,50594,,Biodistribution in mice liver at 60 minutes of post injection,,,BAO_0000218,,14147,Liver,1,10090.0,CHEMBL627662,In vivo,2107.0,Intermediate,A,
,14045,Mus musculus,1,,N,50594,,Biodistribution in mice lungs at 10 min of post injection,,,BAO_0000218,,14148,Lung,1,10090.0,CHEMBL627663,In vivo,2048.0,Intermediate,A,
,14045,Mus musculus,1,,N,50594,,"Percentage biodistribution in mouse lung, 30 minutes post injection",,,BAO_0000218,,14149,,1,10090.0,CHEMBL627664,,,Intermediate,A,
,14045,Mus musculus,1,,N,50594,,"Percentage biodistribution in mousee lung, 5 minutes post injection",,,BAO_0000218,,14150,,1,10090.0,CHEMBL627665,,,Intermediate,A,
,14045,Mus musculus,1,,N,50594,,Biodistribution in mice lungs at 60 min of post injection,,,BAO_0000218,,14151,Lung,1,10090.0,CHEMBL627666,In vivo,2048.0,Intermediate,A,
,14045,Mus musculus,1,,N,50594,,Percentage biodistribution in mouse spleen,,,BAO_0000218,,14152,Spleen,1,10090.0,CHEMBL627667,,2106.0,Intermediate,A,
,14045,Mus musculus,1,,N,50594,,Percentage biodistribution in mouse stomach,,,BAO_0000218,,14153,Stomach,1,10090.0,CHEMBL627668,,945.0,Intermediate,A,
,11745,Mus musculus,1,,N,50594,,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,,,BAO_0000218,,14154,Urine,1,10090.0,CHEMBL627669,,1088.0,Intermediate,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,,,BAO_0000218,,14155,Urinary bladder,0,,CHEMBL627670,In vivo,1255.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,,,BAO_0000218,,14156,Blood,0,,CHEMBL627671,In vivo,178.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,,,BAO_0000218,,14157,Bone element,0,,CHEMBL627672,In vivo,1474.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,,,BAO_0000218,,14158,,0,,CHEMBL627673,In vivo,,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,,,BAO_0000218,,14159,Kidney,0,,CHEMBL627674,In vivo,2113.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,,,BAO_0000218,,14160,Liver,0,,CHEMBL627675,In vivo,2107.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,,,BAO_0000218,,14161,Lung,0,,CHEMBL627676,In vivo,2048.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,,,BAO_0000218,,14162,Muscle tissue,0,,CHEMBL627677,In vivo,2385.0,Autocuration,A,
,8354,,1,,U,22224,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,,14163,,0,,CHEMBL627678,,,Autocuration,A,
,7095,Rattus norvegicus,1,,N,50597,,Affinity for protein binding expressed as association constant in fresh rat serum,,,BAO_0000218,,14164,Serum,1,10116.0,CHEMBL627679,,1977.0,Intermediate,A,
,12185,,1,,U,22224,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,,BAO_0000019,,14165,,0,,CHEMBL627680,,,Autocuration,A,
,12185,,1,,U,22224,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,,BAO_0000019,,14166,,0,,CHEMBL627681,,,Autocuration,A,
,12185,,1,,U,22224,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,,BAO_0000019,,14167,,0,,CHEMBL627682,,,Autocuration,A,
,12185,,1,,U,22224,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,,BAO_0000019,,14168,,0,,CHEMBL627683,,,Autocuration,A,
,12686,,1,,U,22224,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,,,BAO_0000019,,14169,,0,,CHEMBL627684,,,Autocuration,A,
,12686,,1,,U,22224,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,,BAO_0000019,,14170,,0,,CHEMBL874441,,,Autocuration,A,
,12686,,1,,U,22224,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,,,BAO_0000019,,14171,,0,,CHEMBL627685,,,Autocuration,A,
,12686,,1,,U,22224,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,,BAO_0000019,,14172,,0,,CHEMBL627686,,,Autocuration,A,
,8057,,1,,U,22224,,Apparent rate constant Koff for inactivation of dTMP synthase.,,,BAO_0000019,,14173,,0,,CHEMBL627687,,,Autocuration,A,
,15778,,1,,U,22224,,The irreversible inhibitor activity by second order rate equation.,,,BAO_0000019,,14174,,0,,CHEMBL627688,,,Autocuration,A,
,12375,Rattus norvegicus,1,,N,50597,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,,,BAO_0000218,,14175,,1,10116.0,CHEMBL628038,,,Intermediate,A,
,12375,Rattus norvegicus,1,,N,50597,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,,,BAO_0000218,,14176,,1,10116.0,CHEMBL628039,,,Intermediate,A,
,12375,Rattus norvegicus,1,,N,50597,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,,,BAO_0000218,,14177,,1,10116.0,CHEMBL628040,,,Intermediate,A,
,13588,,1,,U,22224,,Dissociation rate calculated from the first-order equation using t1/2 value,,,BAO_0000019,,14178,,0,,CHEMBL628041,,,Autocuration,A,
,15039,,1,,U,22224,,The compound was tested for Binding constant against DNA,,,BAO_0000019,,14179,,0,,CHEMBL630226,,,Autocuration,A,
,9500,,1,,U,22224,,First order rate constant for cyclization of the compound,,,BAO_0000019,,14180,,0,,CHEMBL628042,,,Autocuration,A,
,10014,,1,,U,22224,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,,BAO_0000019,,14181,,0,,CHEMBL625232,,,Autocuration,A,
,10014,,1,,U,22224,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,,BAO_0000019,,14182,,0,,CHEMBL625233,,,Autocuration,A,
,568,,1,,U,22224,,Hydrolysis rate constant was determined,,,BAO_0000019,,14183,,0,,CHEMBL625979,,,Autocuration,A,
,10026,,1,,U,22224,,Observed first order rate constant,,,BAO_0000019,,14184,,0,,CHEMBL625980,,,Autocuration,A,
,10281,,1,,U,22224,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,,BAO_0000019,,14185,,0,,CHEMBL625981,,,Autocuration,A,
,10281,,1,,U,22224,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,,BAO_0000019,,14186,,0,,CHEMBL625982,,,Autocuration,A,
,9680,,1,,U,22224,,Second-order rate constant for attack on PNPA at 25 degree Centigrade,,,BAO_0000019,,14187,,0,,CHEMBL625983,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14188,,0,,CHEMBL625984,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14189,,0,,CHEMBL625985,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14190,,0,,CHEMBL625986,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14191,,0,,CHEMBL625987,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14192,,0,,CHEMBL625988,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14193,,0,,CHEMBL625989,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14194,,0,,CHEMBL625990,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14195,,0,,CHEMBL625991,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14196,,0,,CHEMBL625992,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14197,,0,,CHEMBL625993,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14198,,0,,CHEMBL631973,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14199,,0,,CHEMBL632143,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14200,,0,,CHEMBL632144,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14201,,0,,CHEMBL632145,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14202,,0,,CHEMBL632146,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14203,,0,,CHEMBL632147,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14204,,0,,CHEMBL632148,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14205,,0,,CHEMBL632149,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14206,,0,,CHEMBL632150,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14207,,0,,CHEMBL632151,,,Autocuration,A,
,3008,Homo sapiens,1,,N,50587,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,,,BAO_0000218,,14208,,1,9606.0,CHEMBL632152,,,Intermediate,A,
,4509,Homo sapiens,1,,N,50587,,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,,BAO_0000218,,14209,,1,9606.0,CHEMBL632153,,,Intermediate,A,
,4509,Homo sapiens,1,,N,50587,,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,,BAO_0000218,,14210,,1,9606.0,CHEMBL632154,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,,,BAO_0000218,,14211,,1,10298.0,CHEMBL632155,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,,,BAO_0000218,,14212,,1,10298.0,CHEMBL632156,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,,,BAO_0000218,,14213,,1,10298.0,CHEMBL632157,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,,,BAO_0000218,,14214,,1,10298.0,CHEMBL632158,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,,,BAO_0000218,,14215,,1,10298.0,CHEMBL632159,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,,,BAO_0000218,,14216,,1,10298.0,CHEMBL626305,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,,,BAO_0000218,,14217,,1,10298.0,CHEMBL626306,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,,,BAO_0000218,,14218,,1,10298.0,CHEMBL626307,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,,,BAO_0000218,,14219,,1,10298.0,CHEMBL626308,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,,,BAO_0000218,,14220,,1,10298.0,CHEMBL626479,,,Intermediate,A,
,8613,Human herpesvirus 1,1,,N,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,,,BAO_0000218,,14221,,1,10298.0,CHEMBL626480,,,Intermediate,A,
,6021,,1,,U,22229,,Calculated partition coefficient (clogP) (MlogP),,,BAO_0000100,,14222,,0,,CHEMBL626481,,,Autocuration,P,
,9348,,1,,U,22224,,Equipotent potent ratio relative to carbachol (nicotinic activity),,,BAO_0000019,,14223,,0,,CHEMBL626482,,,Autocuration,A,
,15592,Canis lupus familiaris,1,,N,50588,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",,,BAO_0000218,,14224,,1,9615.0,CHEMBL626483,,,Intermediate,A,
,15592,Canis lupus familiaris,1,,N,50588,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",,,BAO_0000218,,14225,,1,9615.0,CHEMBL626484,,,Intermediate,A,
,15592,,1,,U,22229,,Solubility at pH 7.4 in micro g/mL;NA denotes available,,,BAO_0000100,,14226,,0,,CHEMBL626485,,,Autocuration,P,
,15592,,1,,U,22229,,Solubility at pH 7.4 in micro g/mL;NA denotes not available,,,BAO_0000100,,14227,,0,,CHEMBL626486,,,Autocuration,P,
,15592,,1,,U,22229,,Solubility at pH 7.4 in ug/mL;NA denotes not available,,,BAO_0000100,,14228,,0,,CHEMBL626487,,,Autocuration,P,
,15592,Canis lupus familiaris,1,,N,50588,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,,BAO_0000218,,14229,Plasma,1,9615.0,CHEMBL626488,In vivo,1969.0,Intermediate,A,
,7095,Rattus norvegicus,1,,N,50597,,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,,,BAO_0000218,,14230,Serum,1,10116.0,CHEMBL626489,,1977.0,Intermediate,A,
,16618,,1,,U,22224,,Area under the MAP curve measured over 5 min; ND means Not determined,,,BAO_0000019,,14231,,0,,CHEMBL626490,,,Autocuration,A,
,16835,,1,,U,22224,,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,,,BAO_0000100,,14232,,0,,CHEMBL626491,,,Autocuration,P,
,15284,,1,,U,22229,,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,,,BAO_0000100,,14233,,0,,CHEMBL626492,,,Autocuration,P,
,15750,,1,,U,22224,,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,,,BAO_0000019,,14234,,0,,CHEMBL626493,,,Autocuration,A,
,16618,Rattus norvegicus,1,,N,50597,,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,,,BAO_0000218,,14235,,1,10116.0,CHEMBL626494,In vivo,,Intermediate,A,
,16618,,1,,U,22224,,Half life after oral tested,,,BAO_0000218,,14236,,0,,CHEMBL626495,In vivo,,Autocuration,A,
,15812,Rattus norvegicus,1,,N,50597,,Half life was determined in plasma of rat; NT indicates not tested,,,BAO_0000218,,14237,Plasma,1,10116.0,CHEMBL626496,,1969.0,Intermediate,A,
,16618,Rattus norvegicus,1,,N,50597,,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,,,BAO_0000218,,14238,,1,10116.0,CHEMBL626497,In vivo,,Intermediate,A,
,16618,,1,,U,22224,,Oral bioavailability after oral tested,,,BAO_0000218,,14239,,0,,CHEMBL626498,In vivo,,Autocuration,A,
,13098,Rattus norvegicus,1,,N,50597,,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),,,BAO_0000218,,14240,,1,10116.0,CHEMBL626499,,,Intermediate,A,
,13098,Rattus norvegicus,1,,N,50597,,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),,,BAO_0000218,,14241,,1,10116.0,CHEMBL626500,,,Intermediate,A,
,15812,Rattus norvegicus,1,,N,50597,,half life was determined in plasma of rat; NT indicates not tested,,,BAO_0000218,,14242,Plasma,1,10116.0,CHEMBL626501,,1969.0,Intermediate,A,
,15812,Rattus norvegicus,1,,N,50597,,half life was determined in plasma of rat; NT means not tested,,,BAO_0000218,,14243,Plasma,1,10116.0,CHEMBL626502,,1969.0,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,,,BAO_0000218,,14244,,1,10116.0,CHEMBL626503,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats (Control/Drug treatment value); inactive,,,BAO_0000218,,14245,,1,10116.0,CHEMBL626504,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,,,BAO_0000218,,14246,,1,10116.0,CHEMBL626505,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,,,BAO_0000218,,14247,,1,10116.0,CHEMBL626506,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,,,BAO_0000218,,14248,,1,10116.0,CHEMBL626507,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,,,BAO_0000218,,14249,,1,10116.0,CHEMBL626508,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,,,BAO_0000218,,14250,,1,10116.0,CHEMBL626509,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,,,BAO_0000218,,14251,,1,10116.0,CHEMBL875480,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,,,BAO_0000218,,14252,,1,10116.0,CHEMBL626510,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,,,BAO_0000218,,14253,,1,10116.0,CHEMBL626511,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,,,BAO_0000218,,14254,,1,10116.0,CHEMBL626512,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,,,BAO_0000218,,14255,,1,10116.0,CHEMBL628208,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,,,BAO_0000218,,14256,,1,10116.0,CHEMBL628209,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,,,BAO_0000218,,14257,,1,10116.0,CHEMBL628210,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,,,BAO_0000218,,14258,,1,10116.0,CHEMBL628211,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,,,BAO_0000218,,14259,,1,10116.0,CHEMBL628212,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,,,BAO_0000218,,14260,,1,10116.0,CHEMBL628213,,,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,,,BAO_0000218,,14261,Urine,1,10116.0,CHEMBL628214,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,,,BAO_0000218,,14262,Urine,1,10116.0,CHEMBL628215,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,,,BAO_0000218,,14263,Urine,1,10116.0,CHEMBL628216,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,,,BAO_0000218,,14264,Urine,1,10116.0,CHEMBL626595,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,,,BAO_0000218,,14265,Urine,1,10116.0,CHEMBL626596,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,,,BAO_0000218,,14266,Urine,1,10116.0,CHEMBL626597,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,,,BAO_0000218,,14267,Urine,1,10116.0,CHEMBL626598,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,,,BAO_0000218,,14268,Urine,1,10116.0,CHEMBL622242,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,,,BAO_0000218,,14269,Urine,1,10116.0,CHEMBL622243,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,,,BAO_0000218,,14270,Urine,1,10116.0,CHEMBL622244,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,,,BAO_0000218,,14271,Urine,1,10116.0,CHEMBL622245,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,,,BAO_0000218,,14272,Urine,1,10116.0,CHEMBL622246,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,,,BAO_0000218,,14273,Urine,1,10116.0,CHEMBL622247,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,,,BAO_0000218,,14274,Urine,1,10116.0,CHEMBL622248,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,,,BAO_0000218,,14275,Urine,1,10116.0,CHEMBL877483,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,,,BAO_0000218,,14276,Urine,1,10116.0,CHEMBL622249,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,,BAO_0000218,,14277,Urine,1,9615.0,CHEMBL622250,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,,BAO_0000218,,14278,Urine,1,9615.0,CHEMBL622251,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,,BAO_0000218,,14279,Urine,1,9615.0,CHEMBL622252,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,,BAO_0000218,,14280,Urine,1,9615.0,CHEMBL622253,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,,BAO_0000218,,14281,Urine,1,9615.0,CHEMBL622254,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,,BAO_0000218,,14282,Urine,1,9615.0,CHEMBL622255,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,,BAO_0000218,,14283,Urine,1,9615.0,CHEMBL622256,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,,BAO_0000218,,14284,Urine,1,9615.0,CHEMBL622257,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,,BAO_0000218,,14285,Urine,1,9615.0,CHEMBL622258,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,,BAO_0000218,,14286,Urine,1,9615.0,CHEMBL622259,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,,BAO_0000218,,14287,Urine,1,9615.0,CHEMBL622927,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,,BAO_0000218,,14288,Urine,1,9615.0,CHEMBL622928,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,,BAO_0000218,,14289,Urine,1,9615.0,CHEMBL622929,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,,BAO_0000218,,14290,Urine,1,9615.0,CHEMBL623182,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,,BAO_0000218,,14291,Urine,1,9615.0,CHEMBL623183,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,,,BAO_0000218,,14292,Urine,1,10116.0,CHEMBL623184,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,,BAO_0000218,,14293,Urine,1,10116.0,CHEMBL623185,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,,BAO_0000218,,14294,Urine,1,10116.0,CHEMBL877484,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,,BAO_0000218,,14295,Urine,1,10116.0,CHEMBL627274,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,,,BAO_0000218,,14296,Urine,1,10116.0,CHEMBL623186,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,,,BAO_0000218,,14297,Urine,1,10116.0,CHEMBL623187,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,,BAO_0000218,,14298,Urine,1,10116.0,CHEMBL623188,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,,,BAO_0000218,,14299,Urine,1,10116.0,CHEMBL628055,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,,BAO_0000218,,14300,Urine,1,10116.0,CHEMBL628056,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,,,BAO_0000218,,14301,Urine,1,10116.0,CHEMBL628200,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,,BAO_0000218,,14302,Urine,1,10116.0,CHEMBL628201,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,,,BAO_0000218,,14303,Urine,1,10116.0,CHEMBL628202,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,,BAO_0000218,,14304,Urine,1,10116.0,CHEMBL628203,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,,,BAO_0000218,,14305,Urine,1,10116.0,CHEMBL628204,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,,BAO_0000218,,14306,Urine,1,10116.0,CHEMBL628205,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,,,BAO_0000218,,14307,Urine,1,10116.0,CHEMBL628206,,1088.0,Intermediate,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),,,BAO_0000218,,14308,Prostate gland,0,,CHEMBL628207,In vivo,2367.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,,,BAO_0000218,,14309,Prostate gland,0,,CHEMBL627220,In vivo,2367.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,,,BAO_0000218,,14310,Muscle tissue,0,,CHEMBL627221,In vivo,2385.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),,,BAO_0000218,,14311,Prostate gland,0,,CHEMBL627222,In vivo,2367.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,,,BAO_0000218,,14312,,0,,CHEMBL627223,In vivo,,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,,,BAO_0000218,,14313,Muscle tissue,0,,CHEMBL632062,In vivo,2385.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,,,BAO_0000218,,14314,Spleen,0,,CHEMBL632063,In vivo,2106.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,,,BAO_0000218,,14315,Urinary bladder,0,,CHEMBL632064,In vivo,1255.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,,,BAO_0000218,,14316,Blood,0,,CHEMBL632065,In vivo,178.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,,,BAO_0000218,,14317,Bone element,0,,CHEMBL632066,In vivo,1474.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,,,BAO_0000218,,14318,,0,,CHEMBL632067,In vivo,,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,,,BAO_0000218,,14319,Kidney,0,,CHEMBL629188,In vivo,2113.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,,,BAO_0000218,,14320,Liver,0,,CHEMBL629189,In vivo,2107.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,,,BAO_0000218,,14321,Lung,0,,CHEMBL629190,In vivo,2048.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,,,BAO_0000218,,14322,Muscle tissue,0,,CHEMBL629191,In vivo,2385.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),,,BAO_0000218,,14323,Prostate gland,0,,CHEMBL629192,In vivo,2367.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,,,BAO_0000218,,14324,Muscle tissue,0,,CHEMBL629193,In vivo,2385.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),,,BAO_0000218,,14325,Prostate gland,0,,CHEMBL629194,In vivo,2367.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,,,BAO_0000218,,14326,,0,,CHEMBL629195,In vivo,,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,,,BAO_0000218,,14327,Muscle tissue,0,,CHEMBL629373,In vivo,2385.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,,,BAO_0000218,,14328,Spleen,0,,CHEMBL629374,In vivo,2106.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,,,BAO_0000218,,14329,Prostate gland,0,,CHEMBL629375,In vivo,2367.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,,,BAO_0000218,,14330,Urinary bladder,0,,CHEMBL629376,In vivo,1255.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,,,BAO_0000218,,14331,Blood,0,,CHEMBL629377,In vivo,178.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,,,BAO_0000218,,14332,Bone element,0,,CHEMBL629378,In vivo,1474.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,,,BAO_0000218,,14333,,0,,CHEMBL629379,In vivo,,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,,,BAO_0000218,,14334,Kidney,0,,CHEMBL629151,In vivo,2113.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,,,BAO_0000218,,14335,Liver,0,,CHEMBL629152,In vivo,2107.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,,,BAO_0000218,,14336,Lung,0,,CHEMBL629153,In vivo,2048.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,,,BAO_0000218,,14337,Muscle tissue,0,,CHEMBL629154,In vivo,2385.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),,,BAO_0000218,,14338,Prostate gland,0,,CHEMBL629155,In vivo,2367.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,,,BAO_0000218,,14339,Prostate gland,0,,CHEMBL629156,In vivo,2367.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,,,BAO_0000218,,14340,Muscle tissue,0,,CHEMBL629157,In vivo,2385.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),,,BAO_0000218,,14341,Prostate gland,0,,CHEMBL629158,In vivo,2367.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,,,BAO_0000218,,14342,,0,,CHEMBL629159,In vivo,,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,,,BAO_0000218,,14343,Muscle tissue,0,,CHEMBL629160,In vivo,2385.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,,,BAO_0000218,,14344,Spleen,0,,CHEMBL629161,In vivo,2106.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,,,BAO_0000218,,14345,Urinary bladder,0,,CHEMBL629162,In vivo,1255.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,,,BAO_0000218,,14346,Blood,0,,CHEMBL629163,In vivo,178.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,,,BAO_0000218,,14347,Bone element,0,,CHEMBL629164,In vivo,1474.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,,,BAO_0000218,,14348,,0,,CHEMBL629165,In vivo,,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,,,BAO_0000218,,14349,Liver,0,,CHEMBL629166,In vivo,2107.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,,,BAO_0000218,,14350,Lung,0,,CHEMBL629167,In vivo,2048.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,,,BAO_0000218,,14351,Muscle tissue,0,,CHEMBL629168,In vivo,2385.0,Autocuration,A,
,2193,,1,,U,22224,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,,,BAO_0000019,,14352,,0,,CHEMBL629169,,,Autocuration,A,
,2193,,1,,U,22224,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,,,BAO_0000019,,14353,,0,,CHEMBL629170,,,Autocuration,A,
,2193,,1,,U,22224,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,,,BAO_0000019,,14354,,0,,CHEMBL631153,,,Autocuration,A,
,2193,,1,,U,22224,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,,,BAO_0000019,,14355,,0,,CHEMBL875121,,,Autocuration,A,
,2193,,1,,U,22224,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,,,BAO_0000019,,14356,,0,,CHEMBL631154,,,Autocuration,A,
,2193,,1,,U,22224,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,,,BAO_0000019,,14357,,0,,CHEMBL631155,,,Autocuration,A,
,568,,1,,U,22224,,Hydrolysis rate constant was determined,,,BAO_0000019,,14358,,0,,CHEMBL631156,,,Autocuration,A,
,9680,,1,,U,22224,,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",,,BAO_0000019,,14359,,0,,CHEMBL631157,,,Autocuration,A,
,9680,,1,,U,22224,,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,,BAO_0000019,,14360,,0,,CHEMBL631158,,,Autocuration,A,
,9680,,1,,U,22224,,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,,BAO_0000019,,14361,,0,,CHEMBL631159,,,Autocuration,A,
,10026,,1,,U,22224,,Observed second order rate constant,,,BAO_0000019,,14362,,0,,CHEMBL631160,,,Autocuration,A,
,10281,,1,,U,22224,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,,BAO_0000019,,14363,,0,,CHEMBL631161,,,Autocuration,A,
,10014,,1,,U,22224,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,,BAO_0000019,,14364,,0,,CHEMBL631162,,,Autocuration,A,
,10014,,1,,U,22224,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,,BAO_0000019,,14365,,0,,CHEMBL630313,,,Autocuration,A,
,9680,,1,,U,22224,,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,,BAO_0000019,,14366,,0,,CHEMBL630314,,,Autocuration,A,
,9680,,1,,U,22224,,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,,BAO_0000019,,14367,,0,,CHEMBL630315,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14368,,0,,CHEMBL630316,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14369,,0,,CHEMBL630986,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14370,,0,,CHEMBL630987,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14371,,0,,CHEMBL630988,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14372,,0,,CHEMBL630989,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14373,,0,,CHEMBL630990,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14374,,0,,CHEMBL630991,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14375,,0,,CHEMBL630992,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14376,,0,,CHEMBL630993,,,Autocuration,A,
,13028,,1,,U,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,,14377,,0,,CHEMBL630994,,,Autocuration,A,
,10014,Rattus norvegicus,1,,N,50597,,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,,,BAO_0000218,,14378,,1,10116.0,CHEMBL630995,,,Intermediate,A,
,9962,,1,,U,22224,,Association constant for compound at 31 degree C was determined,,,BAO_0000019,,14379,,0,,CHEMBL629252,,,Autocuration,A,
,12029,,1,,U,22224,,Calculated antagonist equilibrium dissociation constant of the compound,,,BAO_0000019,,14380,,0,,CHEMBL629253,,,Autocuration,A,
,12029,,1,,U,22224,,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,,,BAO_0000019,,14381,,0,,CHEMBL629944,,,Autocuration,A,
,10583,Cavia porcellus,1,,N,50512,,Dissociation constants vs LTE4 on guinea pig trachea,,,BAO_0000218,,14382,Trachea,1,10141.0,CHEMBL629945,,3126.0,Intermediate,A,
,568,,1,,U,22224,,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",,,BAO_0000019,,14383,,0,,CHEMBL629946,,,Autocuration,A,
,568,,1,,U,22224,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",,,BAO_0000019,,14384,,0,,CHEMBL629947,,,Autocuration,A,
,568,,1,,U,22224,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",,,BAO_0000019,,14385,,0,,CHEMBL629948,,,Autocuration,A,
,568,,1,,U,22224,,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",,,BAO_0000019,,14386,,0,,CHEMBL856024,,,Autocuration,A,
,7493,,1,,U,22224,,Affinity constant KD value was derived from TMP,,,BAO_0000019,,14387,,0,,CHEMBL629949,,,Autocuration,A,
,8371,,1,,U,22224,,Apparent dissociation (binding) rate constant was evaluated,,,BAO_0000019,,14388,,0,,CHEMBL629950,,,Autocuration,A,
,13114,,1,,U,22224,,Dissociation constant (KD) of the compound,,,BAO_0000100,,14389,,0,,CHEMBL630127,,,Autocuration,P,
,15515,,1,,U,22224,,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,,,BAO_0000100,,14390,,0,,CHEMBL630128,,,Autocuration,P,
,522,,1,,U,22224,,Dissociation constant from ESR titration experiments,,,BAO_0000100,,14391,,0,,CHEMBL630129,,,Autocuration,P,
,13888,,1,,U,22224,,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),,,BAO_0000019,,14392,,0,,CHEMBL630130,,,Autocuration,,
,2616,,1,,U,22224,,Dissociation constant was evaluated.,,,BAO_0000100,,14393,,0,,CHEMBL875234,,,Autocuration,P,
,3798,,1,,U,22224,,Dissociation constant was reported,,,BAO_0000100,,14394,,0,,CHEMBL630131,,,Autocuration,P,
,8731,Rattus norvegicus,1,,N,50597,,Dissociation constant was determined in rat pituitary cells.,,,BAO_0000218,,14395,,1,10116.0,CHEMBL630132,,,Intermediate,A,
,11892,,1,,U,22224,,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,,,BAO_0000019,,14396,,0,,CHEMBL630133,,,Autocuration,A,
,11892,,1,,U,22224,,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,,,BAO_0000019,,14397,,0,,CHEMBL630134,,,Autocuration,A,
,2582,,1,,U,22224,,Equilibrium dissociation constant of the compound,,,BAO_0000019,,14398,,0,,CHEMBL630135,,,Autocuration,A,
,11892,,1,,U,22224,,Equilibrium dissociation constant was determined,,,BAO_0000019,,14399,,0,,CHEMBL630136,,,Autocuration,A,
,13396,,1,,U,22224,,Kinetic constant KD was evaluated,,,BAO_0000019,,14400,,0,,CHEMBL630137,,,Autocuration,A,
,603,,1,,U,22224,,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,,,BAO_0000019,,14401,,0,,CHEMBL630138,,,Autocuration,A,
,15673,,1,,U,22224,,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,,,BAO_0000019,,14402,,0,,CHEMBL630139,,,Autocuration,A,
,10368,,1,,U,22224,,Rate constant for hydrolysis in aqueous acetone.,,,BAO_0000019,,14403,,0,,CHEMBL630140,,,Autocuration,A,
,14228,,1,,U,22224,,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,,,BAO_0000019,,14404,,0,,CHEMBL875235,,,Autocuration,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,,,BAO_0000218,,14405,,1,10116.0,CHEMBL876439,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,,,BAO_0000218,,14406,,1,10116.0,CHEMBL630605,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,,,BAO_0000218,,14407,,1,10116.0,CHEMBL630606,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,,,BAO_0000218,,14408,,1,10116.0,CHEMBL630607,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,,,BAO_0000218,,14409,,1,10116.0,CHEMBL630608,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,,,BAO_0000218,,14410,,1,10116.0,CHEMBL630609,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,,,BAO_0000218,,14411,,1,10116.0,CHEMBL630610,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,,,BAO_0000218,,14412,,1,10116.0,CHEMBL630611,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,,,BAO_0000218,,14413,,1,10116.0,CHEMBL629552,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,,BAO_0000218,,14414,,1,10116.0,CHEMBL629733,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,,BAO_0000218,,14415,,1,10116.0,CHEMBL629734,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,,BAO_0000218,,14416,,1,10116.0,CHEMBL629735,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,,BAO_0000218,,14417,,1,10116.0,CHEMBL629736,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,,BAO_0000218,,14418,,1,10116.0,CHEMBL629737,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,,BAO_0000218,,14419,,1,10116.0,CHEMBL629738,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,,BAO_0000218,,14420,,1,10116.0,CHEMBL629739,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,,BAO_0000218,,14421,,1,10116.0,CHEMBL629740,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,,BAO_0000218,,14422,,1,10116.0,CHEMBL629741,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,,BAO_0000218,,14423,,1,10116.0,CHEMBL629742,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,,BAO_0000218,,14424,,1,10116.0,CHEMBL629743,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,,BAO_0000218,,14425,,1,10116.0,CHEMBL629744,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,,BAO_0000218,,14426,,1,10116.0,CHEMBL629745,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,,BAO_0000218,,14427,,1,10116.0,CHEMBL629746,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,,BAO_0000218,,14428,,1,10116.0,CHEMBL629747,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,,BAO_0000218,,14429,,1,10116.0,CHEMBL629748,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,,BAO_0000218,,14430,,1,10116.0,CHEMBL629749,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,,BAO_0000218,,14431,,1,10116.0,CHEMBL629750,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,,BAO_0000218,,14432,,1,10116.0,CHEMBL629751,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,,BAO_0000218,,14433,,1,10116.0,CHEMBL629752,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,,BAO_0000218,,14434,,1,10116.0,CHEMBL629753,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,,BAO_0000218,,14435,,1,10116.0,CHEMBL629754,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,,BAO_0000218,,14436,,1,10116.0,CHEMBL629755,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,,BAO_0000218,,14437,,1,10116.0,CHEMBL629756,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,,BAO_0000218,,14438,,1,10116.0,CHEMBL629757,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,,BAO_0000218,,14439,,1,10116.0,CHEMBL629758,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,,BAO_0000218,,14440,,1,10116.0,CHEMBL629759,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,,BAO_0000218,,14441,,1,10116.0,CHEMBL629760,,,Intermediate,A,
,11510,Rattus norvegicus,1,,N,50597,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,,BAO_0000218,,14442,,1,10116.0,CHEMBL876443,,,Intermediate,A,
,8310,Canis lupus familiaris,1,,N,50588,,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,,,BAO_0000218,,14443,,1,9615.0,CHEMBL629761,,,Intermediate,A,
,8310,Canis lupus familiaris,1,,N,50588,,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,,,BAO_0000218,,14444,,1,9615.0,CHEMBL629762,,,Intermediate,A,
,8310,Mus musculus,1,,N,50594,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,,BAO_0000218,,14445,,1,10090.0,CHEMBL629763,,,Intermediate,A,
,8310,Mus musculus,1,,N,50594,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,,BAO_0000218,,14446,,1,10090.0,CHEMBL629764,,,Intermediate,A,
,8310,Mus musculus,1,,N,50594,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,,BAO_0000218,,14447,,1,10090.0,CHEMBL629765,,,Intermediate,A,
,8310,Mus musculus,1,,N,50594,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,,,BAO_0000218,,14448,,1,10090.0,CHEMBL629766,,,Intermediate,A,
,8310,Mus musculus,1,,N,50594,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,,BAO_0000218,,14449,,1,10090.0,CHEMBL629767,,,Intermediate,A,
,8310,Canis lupus familiaris,1,,N,50588,,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,,,BAO_0000218,,14450,,1,9615.0,CHEMBL629768,,,Intermediate,A,
,8310,Mus musculus,1,,N,50594,,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,,,BAO_0000218,,14451,,1,10090.0,CHEMBL629769,,,Intermediate,A,
,8310,Canis lupus familiaris,1,,N,50588,,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,,,BAO_0000218,,14452,,1,9615.0,CHEMBL629770,,,Intermediate,A,
,8310,Canis lupus familiaris,1,,N,50588,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,,,BAO_0000218,,14453,,1,9615.0,CHEMBL629771,,,Intermediate,A,
,8310,Mus musculus,1,,N,50594,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,,BAO_0000218,,14454,,1,10090.0,CHEMBL629772,,,Intermediate,A,
,8310,Mus musculus,1,,N,50594,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,,BAO_0000218,,14455,,1,10090.0,CHEMBL629773,,,Intermediate,A,
,8310,Mus musculus,1,,N,50594,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,,BAO_0000218,,14456,,1,10090.0,CHEMBL625455,,,Intermediate,A,
,8310,Mus musculus,1,,N,50594,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,,,BAO_0000218,,14457,,1,10090.0,CHEMBL625456,,,Intermediate,A,
,8310,Mus musculus,1,,N,50594,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,,,BAO_0000218,,14458,,1,10090.0,CHEMBL625457,,,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,,BAO_0000218,,14459,Urine,1,10116.0,CHEMBL625458,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,,,BAO_0000218,,14460,Urine,1,10116.0,CHEMBL625459,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,,BAO_0000218,,14461,Urine,1,10116.0,CHEMBL875483,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,,,BAO_0000218,,14462,Urine,1,10116.0,CHEMBL634779,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,,,BAO_0000218,,14463,Urine,1,10116.0,CHEMBL625460,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,,BAO_0000218,,14464,Urine,1,10116.0,CHEMBL626117,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,,,BAO_0000218,,14465,Urine,1,10116.0,CHEMBL626118,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,,,BAO_0000218,,14466,Urine,1,10116.0,CHEMBL628342,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,,BAO_0000218,,14467,Urine,1,10116.0,CHEMBL628343,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,,,BAO_0000218,,14468,Urine,1,10116.0,CHEMBL628344,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,,BAO_0000218,,14469,Urine,1,10116.0,CHEMBL628345,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,,,BAO_0000218,,14470,Urine,1,10116.0,CHEMBL628346,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,,,BAO_0000218,,14471,Urine,1,10116.0,CHEMBL628347,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,,BAO_0000218,,14472,Urine,1,10116.0,CHEMBL628348,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,,BAO_0000218,,14473,Urine,1,10116.0,CHEMBL628349,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,,,BAO_0000218,,14474,Urine,1,10116.0,CHEMBL875611,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,,,BAO_0000218,,14475,Urine,1,10116.0,CHEMBL628350,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,,BAO_0000218,,14476,Urine,1,10116.0,CHEMBL628351,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,,,BAO_0000218,,14477,Urine,1,10116.0,CHEMBL628352,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,,BAO_0000218,,14478,Urine,1,10116.0,CHEMBL628353,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,,,BAO_0000218,,14479,Urine,1,10116.0,CHEMBL628354,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,,BAO_0000218,,14480,Urine,1,10116.0,CHEMBL626667,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,,BAO_0000218,,14481,Urine,1,10116.0,CHEMBL626668,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,,BAO_0000218,,14482,Urine,1,10116.0,CHEMBL626669,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,,,BAO_0000218,,14483,Urine,1,10116.0,CHEMBL626670,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,,,BAO_0000218,,14484,Urine,1,10116.0,CHEMBL626671,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,,BAO_0000218,,14485,Urine,1,10116.0,CHEMBL626672,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,,,BAO_0000218,,14486,Urine,1,10116.0,CHEMBL626673,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,,BAO_0000218,,14487,Urine,1,10116.0,CHEMBL626674,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,,BAO_0000218,,14488,Urine,1,10116.0,CHEMBL626675,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,,,BAO_0000218,,14489,Urine,1,10116.0,CHEMBL626676,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,,,BAO_0000218,,14490,Urine,1,10116.0,CHEMBL626677,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,,BAO_0000218,,14491,Urine,1,10116.0,CHEMBL626678,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,,BAO_0000218,,14492,Urine,1,10116.0,CHEMBL626679,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,,BAO_0000218,,14493,Urine,1,10116.0,CHEMBL875612,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,,BAO_0000218,,14494,Urine,1,10116.0,CHEMBL626680,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,,BAO_0000218,,14495,Urine,1,10116.0,CHEMBL626681,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,,BAO_0000218,,14496,Urine,1,10116.0,CHEMBL626682,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,,BAO_0000218,,14497,Urine,1,10116.0,CHEMBL626683,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,,BAO_0000218,,14498,Urine,1,10116.0,CHEMBL626684,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,,BAO_0000218,,14499,Urine,1,10116.0,CHEMBL626685,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,,BAO_0000218,,14500,Urine,1,10116.0,CHEMBL626686,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,,BAO_0000218,,14501,Urine,1,10116.0,CHEMBL626687,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,,BAO_0000218,,14502,Urine,1,10116.0,CHEMBL624978,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,,BAO_0000218,,14503,Urine,1,10116.0,CHEMBL624979,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,,BAO_0000218,,14504,Urine,1,10116.0,CHEMBL624980,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,,BAO_0000218,,14505,Urine,1,10116.0,CHEMBL624981,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,,BAO_0000218,,14506,Urine,1,9615.0,CHEMBL624982,,1088.0,Intermediate,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),,,BAO_0000218,,14507,Prostate gland,0,,CHEMBL627564,In vivo,2367.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),,,BAO_0000218,,14508,Prostate gland,0,,CHEMBL627565,In vivo,2367.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,,,BAO_0000218,,14509,,0,,CHEMBL627566,In vivo,,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,,,BAO_0000218,,14510,Muscle tissue,0,,CHEMBL627567,In vivo,2385.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,,,BAO_0000218,,14511,Spleen,0,,CHEMBL627568,In vivo,2106.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,,,BAO_0000218,,14512,Kidney,0,,CHEMBL627569,In vivo,2113.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,,,BAO_0000218,,14513,Urinary bladder,0,,CHEMBL627570,In vivo,1255.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,,,BAO_0000218,,14514,Blood,0,,CHEMBL627571,In vivo,178.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,,,BAO_0000218,,14515,Bone element,0,,CHEMBL627572,In vivo,1474.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,,,BAO_0000218,,14516,,0,,CHEMBL627573,In vivo,,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,,,BAO_0000218,,14517,Kidney,0,,CHEMBL627574,In vivo,2113.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,,,BAO_0000218,,14518,Liver,0,,CHEMBL627575,In vivo,2107.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,,,BAO_0000218,,14519,Lung,0,,CHEMBL627576,In vivo,2048.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,,,BAO_0000218,,14520,Muscle tissue,0,,CHEMBL627577,In vivo,2385.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),,,BAO_0000218,,14521,Prostate gland,0,,CHEMBL627578,In vivo,2367.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,,,BAO_0000218,,14522,Prostate gland,0,,CHEMBL627579,In vivo,2367.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,,,BAO_0000218,,14523,Muscle tissue,0,,CHEMBL627580,In vivo,2385.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),,,BAO_0000218,,14524,Prostate gland,0,,CHEMBL627581,In vivo,2367.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,,,BAO_0000218,,14525,,0,,CHEMBL627582,In vivo,,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,,,BAO_0000218,,14526,Muscle tissue,0,,CHEMBL627583,In vivo,2385.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,,,BAO_0000218,,14527,Spleen,0,,CHEMBL627584,In vivo,2106.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,,,BAO_0000218,,14528,Prostate gland,0,,CHEMBL627585,In vivo,2367.0,Autocuration,A,
,13257,,1,,U,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,,,BAO_0000218,,14529,Muscle tissue,0,,CHEMBL627586,In vivo,2385.0,Autocuration,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,,,BAO_0000218,,14530,,1,10116.0,CHEMBL627587,In vivo,,Intermediate,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,,BAO_0000218,,14531,,1,10116.0,CHEMBL627588,In vivo,,Intermediate,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,,,BAO_0000218,,14532,,1,10116.0,CHEMBL628250,In vivo,,Intermediate,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,,BAO_0000218,,14533,,1,10116.0,CHEMBL628251,In vivo,,Intermediate,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,,,BAO_0000218,,14534,Hippocampus,1,10116.0,CHEMBL628252,In vivo,10000000.0,Intermediate,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,,BAO_0000218,,14535,Hippocampus,1,10116.0,CHEMBL628253,In vivo,10000000.0,Intermediate,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,,,BAO_0000218,,14536,Hypothalamus,1,10116.0,CHEMBL628254,In vivo,1898.0,Intermediate,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,,BAO_0000218,,14537,Hypothalamus,1,10116.0,CHEMBL877493,In vivo,1898.0,Intermediate,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,,BAO_0000218,,14538,,1,10116.0,CHEMBL628255,In vivo,,Intermediate,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,,BAO_0000218,,14539,,1,10116.0,CHEMBL628256,In vivo,,Intermediate,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,,BAO_0000218,,14540,Hippocampus,1,10116.0,CHEMBL628257,In vivo,10000000.0,Intermediate,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,,BAO_0000218,,14541,Hypothalamus,1,10116.0,CHEMBL628258,In vivo,1898.0,Intermediate,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,,BAO_0000218,,14542,,1,10116.0,CHEMBL628259,In vivo,,Intermediate,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,,BAO_0000218,,14543,,1,10116.0,CHEMBL628429,In vivo,,Intermediate,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,,BAO_0000218,,14544,Hippocampus,1,10116.0,CHEMBL626862,In vivo,10000000.0,Intermediate,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,,,BAO_0000218,,14545,Hypothalamus,1,10116.0,CHEMBL626863,In vivo,1898.0,Intermediate,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,,,BAO_0000218,,14546,Cerebellum,1,10116.0,CHEMBL625886,In vivo,2037.0,Intermediate,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,,,BAO_0000218,,14547,Cerebellum,1,10116.0,CHEMBL625887,In vivo,2037.0,Intermediate,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the [11C]-radiolabeled compound in rat cortex,,,BAO_0000218,,14548,,1,10116.0,CHEMBL625888,In vivo,,Intermediate,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,,,BAO_0000218,,14549,,1,10116.0,CHEMBL625889,In vivo,,Intermediate,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,,,BAO_0000218,,14550,Hippocampus,1,10116.0,CHEMBL625890,In vivo,10000000.0,Intermediate,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,,,BAO_0000218,,14551,Hippocampus,1,10116.0,CHEMBL625891,In vivo,10000000.0,Intermediate,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,,,BAO_0000218,,14552,Hypothalamus,1,10116.0,CHEMBL625892,In vivo,1898.0,Intermediate,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,,,BAO_0000218,,14553,Hypothalamus,1,10116.0,CHEMBL625893,In vivo,1898.0,Intermediate,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,,,BAO_0000218,,14554,Cerebellum,1,10116.0,CHEMBL625894,In vivo,2037.0,Intermediate,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the [18F]-radiolabeled compound in rat cortex,,,BAO_0000218,,14555,,1,10116.0,CHEMBL625895,In vivo,,Intermediate,A,
,12404,,1,,U,22224,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,,BAO_0000019,,14556,,0,,CHEMBL625896,,,Autocuration,A,
,568,,1,,U,22224,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",,,BAO_0000019,,14557,,0,,CHEMBL625897,,,Autocuration,A,
,568,,1,,U,22224,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,,BAO_0000019,,14558,,0,,CHEMBL625898,,,Autocuration,A,
,568,,1,,U,22224,,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,,BAO_0000019,,14559,,0,,CHEMBL625899,,,Autocuration,A,
,12404,,1,,U,22224,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,,BAO_0000019,,14560,,0,,CHEMBL626124,,,Autocuration,A,
,7624,Escherichia coli,1,,N,50212,,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,,,BAO_0000218,,14561,,1,562.0,CHEMBL628500,,,Intermediate,A,
,7624,Rattus norvegicus,1,,N,50597,,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",,,BAO_0000218,,14562,,1,10116.0,CHEMBL857856,,,Intermediate,A,
,7624,Rattus norvegicus,1,,N,50597,,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",,,BAO_0000218,,14563,,1,10116.0,CHEMBL628501,,,Intermediate,A,
,4643,,1,,U,22224,,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",,,BAO_0000019,,14564,,0,,CHEMBL628502,,,Autocuration,A,
,11532,,1,,U,22224,,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,,,BAO_0000019,,14565,,0,,CHEMBL628503,,,Autocuration,A,
,11018,,1,,U,22224,,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,,,BAO_0000019,,14566,,0,,CHEMBL628504,,,Autocuration,A,
,2276,,1,,U,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,,BAO_0000019,,14567,,0,,CHEMBL628505,,,Autocuration,A,
,2276,,1,,U,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",,,BAO_0000019,,14568,,0,,CHEMBL874452,,,Autocuration,A,
,2276,,1,,U,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",,,BAO_0000019,,14569,,0,,CHEMBL628506,,,Autocuration,A,
,2276,,1,,U,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,,BAO_0000019,,14570,,0,,CHEMBL628507,,,Autocuration,A,
,2276,,1,,U,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",,,BAO_0000019,,14571,,0,,CHEMBL628508,,,Autocuration,A,
,8949,,1,,U,22224,,Michaelis constant (KM) was evaluated,,,BAO_0000019,,14572,,0,,CHEMBL628509,,,Autocuration,A,
,12404,,1,,U,22224,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,,BAO_0000019,,14573,,0,,CHEMBL628510,,,Autocuration,A,
,7625,,1,,U,22224,,Substrate concentration for half maximal velocity was reported for rat hexokinase I,,,BAO_0000019,,14574,,0,,CHEMBL628511,,,Autocuration,B,
,7625,,1,,U,22224,,Substrate concentration for half maximal velocity was reported for rat hexokinase II,,,BAO_0000019,,14575,,0,,CHEMBL628512,,,Autocuration,B,
,7625,,1,,U,22224,,Substrate concentration for half maximal velocity was reported for rat hexokinase III,,,BAO_0000019,,14576,,0,,CHEMBL628513,,,Autocuration,B,
,7625,,1,,U,22224,,Substrate concentration for half maximal velocity was reported for yeast hexokinase,,,BAO_0000019,,14577,,0,,CHEMBL628514,,,Autocuration,B,
,12908,,1,,U,22224,,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,,,BAO_0000019,,14578,,0,,CHEMBL628515,,,Autocuration,A,
,10368,,1,,U,22224,,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,,,BAO_0000019,,14579,,0,,CHEMBL628516,,,Autocuration,A,
,13108,,1,,U,22224,,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,,BAO_0000019,,14580,,0,,CHEMBL628517,,,Autocuration,A,
,13108,,1,,U,22224,,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,,BAO_0000019,,14581,,0,,CHEMBL628518,,,Autocuration,A,
,15217,,1,,U,22224,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,,,BAO_0000019,,14582,,0,,CHEMBL628519,,,Autocuration,A,
,15217,,1,,U,22224,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,,,BAO_0000019,,14583,,0,,CHEMBL628520,,,Autocuration,A,
,10933,,1,,U,22224,,Binding constant was determined,,,BAO_0000019,,14584,,0,,CHEMBL628521,,,Autocuration,A,
,2363,,1,,U,22224,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,,,BAO_0000019,,14585,,0,,CHEMBL630443,,,Autocuration,A,
,2363,,1,,U,22224,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,,,BAO_0000019,,14586,,0,,CHEMBL630444,,,Autocuration,A,
,2276,,1,,U,22224,,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,,,BAO_0000019,,14587,,0,,CHEMBL857732,,,Autocuration,A,
,14915,,1,,U,22224,,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,,,BAO_0000100,,14588,,0,,CHEMBL630445,,,Autocuration,P,
,8847,,1,,U,22224,,Catalytic rate constant of the compound,,,BAO_0000019,,14589,,0,,CHEMBL630446,,,Autocuration,A,
,15357,,1,,U,22224,,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,,,BAO_0000019,,14590,,0,,CHEMBL630447,,,Autocuration,B,
,2869,,1,,U,22224,,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),,,BAO_0000019,,14591,,0,,CHEMBL630448,,,Autocuration,A,
,3484,,1,,U,22224,,Catalytic rate constant against phospholipase A2 was determined,,,BAO_0000019,,14592,,0,,CHEMBL630449,,,Autocuration,A,
,1373,,1,,U,22224,,"Compound was evaluated for catalytic constant, Kcat",,,BAO_0000019,,14593,,0,,CHEMBL630450,,,Autocuration,A,
,8142,,1,,U,22224,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,,,BAO_0000019,,14594,,0,,CHEMBL630451,,,Autocuration,A,
,14131,,1,,U,22224,,Kcat calculated from 0.693/T1/2,,,BAO_0000019,,14595,,0,,CHEMBL630452,,,Autocuration,A,
,17269,,1,,U,22224,,Kcat was determined,,,BAO_0000019,,14596,,0,,CHEMBL630453,,,Autocuration,A,
,3485,,1,,U,22224,,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,,,BAO_0000019,,14597,,0,,CHEMBL630454,,,Autocuration,A,
,3485,,1,,U,22224,,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,,,BAO_0000019,,14598,,0,,CHEMBL630455,,,Autocuration,A,
,3485,,1,,U,22224,,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,,,BAO_0000019,,14599,,0,,CHEMBL631487,,,Autocuration,A,
,5962,,1,,U,22224,,Kcat value was determined,,,BAO_0000019,,14600,,0,,CHEMBL631488,,,Autocuration,A,
,3133,,1,,U,22224,,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,,,BAO_0000019,,14601,,0,,CHEMBL876440,,,Autocuration,A,
,3133,,1,,U,22224,,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,,,BAO_0000019,,14602,,0,,CHEMBL631489,,,Autocuration,A,
,2276,,1,,U,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,,BAO_0000019,,14603,,0,,CHEMBL857742,,,Autocuration,A,
,2276,,1,,U,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",,,BAO_0000019,,14604,,0,,CHEMBL631490,,,Autocuration,A,
,2276,,1,,U,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",,,BAO_0000019,,14605,,0,,CHEMBL631491,,,Autocuration,A,
,2276,,1,,U,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,,BAO_0000019,,14606,,0,,CHEMBL631492,,,Autocuration,A,
,2276,,1,,U,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",,,BAO_0000019,,14607,,0,,CHEMBL631493,,,Autocuration,A,
,4892,,1,,U,22224,,Kinetic parameter for rate of conversion to PABA was determined,,,BAO_0000019,,14608,,0,,CHEMBL631494,,,Autocuration,A,
,3133,,1,,U,22224,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,,BAO_0000019,,14609,,0,,CHEMBL631495,,,Autocuration,A,
,11488,Rattus norvegicus,1,,N,50597,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,,BAO_0000218,,14610,Feces,1,10116.0,CHEMBL631496,,1988.0,Intermediate,A,
,11488,Rattus norvegicus,1,,N,50597,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,,BAO_0000218,,14611,Urine,1,10116.0,CHEMBL631497,,1088.0,Intermediate,A,
,11488,Rattus norvegicus,1,,N,50597,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,,BAO_0000218,,14612,Urine,1,10116.0,CHEMBL631498,,1088.0,Intermediate,A,
,11488,Rattus norvegicus,1,,N,50597,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,,BAO_0000218,,14613,Urine,1,10116.0,CHEMBL629776,,1088.0,Intermediate,A,
,11488,Rattus norvegicus,1,,N,50597,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,,BAO_0000218,,14614,Urine,1,10116.0,CHEMBL629777,,1088.0,Intermediate,A,
,11488,Rattus norvegicus,1,,N,50597,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,,BAO_0000218,,14615,Urine,1,10116.0,CHEMBL629778,,1088.0,Intermediate,A,
,11488,Rattus norvegicus,1,,N,50597,,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,,,BAO_0000218,,14616,,1,10116.0,CHEMBL630456,,,Intermediate,A,
,11488,Rattus norvegicus,1,,N,50597,,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,,,BAO_0000218,,14617,,1,10116.0,CHEMBL630457,,,Intermediate,A,
,11488,Rattus norvegicus,1,,N,50597,,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,,,BAO_0000218,,14618,,1,10116.0,CHEMBL630458,,,Intermediate,A,
,11488,Rattus norvegicus,1,,N,50597,,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,,,BAO_0000218,,14619,,1,10116.0,CHEMBL630459,,,Intermediate,A,
,11488,Rattus norvegicus,1,,N,50597,,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,,,BAO_0000218,,14620,,1,10116.0,CHEMBL630460,,,Intermediate,A,
,11488,Rattus norvegicus,1,,N,50597,,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,,,BAO_0000218,,14621,,1,10116.0,CHEMBL876550,,,Intermediate,A,
,11488,Rattus norvegicus,1,,N,50597,,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,,,BAO_0000218,,14622,,1,10116.0,CHEMBL630461,,,Intermediate,A,
,11488,Rattus norvegicus,1,,N,50597,,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,,,BAO_0000218,,14623,,1,10116.0,CHEMBL630462,,,Intermediate,A,
,11488,Rattus norvegicus,1,,N,50597,,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,,,BAO_0000218,,14624,,1,10116.0,CHEMBL630463,,,Intermediate,A,
,11488,Rattus norvegicus,1,,N,50597,,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,,,BAO_0000218,,14625,,1,10116.0,CHEMBL630464,,,Intermediate,A,
,11488,Rattus norvegicus,1,,N,50597,,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,,,BAO_0000218,,14626,,1,10116.0,CHEMBL630465,,,Intermediate,A,
,11488,Rattus norvegicus,1,,N,50597,,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,,,BAO_0000218,,14627,,1,10116.0,CHEMBL630466,,,Intermediate,A,
,11488,Rattus norvegicus,1,,N,50597,,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,,,BAO_0000218,,14628,,1,10116.0,CHEMBL630467,,,Intermediate,A,
,11488,Rattus norvegicus,1,,N,50597,,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,,,BAO_0000218,,14629,,1,10116.0,CHEMBL630633,,,Intermediate,A,
,11488,Rattus norvegicus,1,,N,50597,,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,,,BAO_0000218,,14630,,1,10116.0,CHEMBL630634,,,Intermediate,A,
,11488,Rattus norvegicus,1,,N,50597,,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,,,BAO_0000218,,14631,,1,10116.0,CHEMBL630635,,,Intermediate,A,
,11488,Rattus norvegicus,1,,N,50597,,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,,,BAO_0000218,,14632,,1,10116.0,CHEMBL630636,,,Intermediate,A,
,11488,Rattus norvegicus,1,,N,50597,,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,,,BAO_0000218,,14633,,1,10116.0,CHEMBL630637,,,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,,BAO_0000218,,14634,Feces,1,9986.0,CHEMBL630638,,1988.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,,BAO_0000218,,14635,Feces,1,9986.0,CHEMBL630639,,1988.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,,BAO_0000218,,14636,Feces,1,9986.0,CHEMBL630640,,1988.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,,BAO_0000218,,14637,Feces,1,9986.0,CHEMBL876551,,1988.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",,,BAO_0000218,,14638,Urine,1,9986.0,CHEMBL630641,,1088.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,,BAO_0000218,,14639,Urine,1,9986.0,CHEMBL630642,,1088.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,,BAO_0000218,,14640,Urine,1,9986.0,CHEMBL630643,,1088.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,,BAO_0000218,,14641,Urine,1,9986.0,CHEMBL630644,,1088.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,,BAO_0000218,,14642,Urine,1,9986.0,CHEMBL630645,,1088.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,,BAO_0000218,,14643,Feces,1,9986.0,CHEMBL625599,,1988.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,,BAO_0000218,,14644,Feces,1,9986.0,CHEMBL625600,,1988.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,,BAO_0000218,,14645,Feces,1,9986.0,CHEMBL625601,,1988.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,,BAO_0000218,,14646,Feces,1,9986.0,CHEMBL625602,,1988.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",,,BAO_0000218,,14647,Urine,1,9986.0,CHEMBL627470,,1088.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,,BAO_0000218,,14648,Urine,1,9986.0,CHEMBL627471,,1088.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,,BAO_0000218,,14649,Urine,1,9986.0,CHEMBL627472,,1088.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,,BAO_0000218,,14650,Urine,1,9986.0,CHEMBL627473,,1088.0,Intermediate,A,
,7132,Oryctolagus cuniculus,1,,N,50592,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,,BAO_0000218,,14651,Urine,1,9986.0,CHEMBL627474,,1088.0,Intermediate,A,
,13925,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,,14652,Blood,1,10116.0,CHEMBL627475,In vivo,178.0,Intermediate,A,
,13925,Rattus norvegicus,1,,N,50597,,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,,14653,Blood,1,10116.0,CHEMBL627476,In vivo,178.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,,BAO_0000218,,14654,Urine,1,9615.0,CHEMBL627477,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,,BAO_0000218,,14655,Urine,1,9615.0,CHEMBL627478,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,,BAO_0000218,,14656,Urine,1,9615.0,CHEMBL627479,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,,BAO_0000218,,14657,Urine,1,9615.0,CHEMBL627480,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,,BAO_0000218,,14658,Urine,1,9615.0,CHEMBL627481,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,,BAO_0000218,,14659,Urine,1,9615.0,CHEMBL627482,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,,BAO_0000218,,14660,Urine,1,9615.0,CHEMBL627483,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,,BAO_0000218,,14661,Urine,1,9615.0,CHEMBL875636,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,,BAO_0000218,,14662,Urine,1,9615.0,CHEMBL625764,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,,BAO_0000218,,14663,Urine,1,9615.0,CHEMBL625765,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,,,BAO_0000218,,14664,Urine,1,9615.0,CHEMBL625766,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,,BAO_0000218,,14665,Urine,1,9615.0,CHEMBL625767,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,,BAO_0000218,,14666,Urine,1,9615.0,CHEMBL625768,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,,BAO_0000218,,14667,Urine,1,9615.0,CHEMBL625769,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,,BAO_0000218,,14668,Urine,1,9615.0,CHEMBL625770,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,,BAO_0000218,,14669,Urine,1,9615.0,CHEMBL625771,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,,,BAO_0000218,,14670,Urine,1,9615.0,CHEMBL625772,,1088.0,Intermediate,A,
,12582,Canis lupus familiaris,1,,N,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,,BAO_0000218,,14671,Urine,1,9615.0,CHEMBL625773,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,,BAO_0000218,,14672,Urine,1,10116.0,CHEMBL625774,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,,,BAO_0000218,,14673,Urine,1,10116.0,CHEMBL625775,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,,BAO_0000218,,14674,Urine,1,10116.0,CHEMBL625776,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,,BAO_0000218,,14675,Urine,1,10116.0,CHEMBL625777,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,,BAO_0000218,,14676,Urine,1,10116.0,CHEMBL625778,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,,,BAO_0000218,,14677,Urine,1,10116.0,CHEMBL625779,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,,,BAO_0000218,,14678,Urine,1,10116.0,CHEMBL625780,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,,BAO_0000218,,14679,Urine,1,10116.0,CHEMBL625781,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,,,BAO_0000218,,14680,Urine,1,10116.0,CHEMBL875637,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,,BAO_0000218,,14681,Urine,1,10116.0,CHEMBL626473,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,,,BAO_0000218,,14682,Urine,1,10116.0,CHEMBL626474,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,,BAO_0000218,,14683,Urine,1,10116.0,CHEMBL626475,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,,,BAO_0000218,,14684,Urine,1,10116.0,CHEMBL626476,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,,BAO_0000218,,14685,Urine,1,10116.0,CHEMBL634397,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,,,BAO_0000218,,14686,Urine,1,10116.0,CHEMBL626477,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,,BAO_0000218,,14687,Urine,1,10116.0,CHEMBL631069,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,,,BAO_0000218,,14688,Urine,1,10116.0,CHEMBL631070,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,,BAO_0000218,,14689,Urine,1,10116.0,CHEMBL631071,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,,,BAO_0000218,,14690,Urine,1,10116.0,CHEMBL631072,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,,BAO_0000218,,14691,Urine,1,10116.0,CHEMBL631073,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,,,BAO_0000218,,14692,Urine,1,10116.0,CHEMBL631074,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,,,BAO_0000218,,14693,Urine,1,10116.0,CHEMBL631075,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,,BAO_0000218,,14694,Urine,1,10116.0,CHEMBL631725,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,,,BAO_0000218,,14695,Urine,1,10116.0,CHEMBL631726,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,,,BAO_0000218,,14696,Urine,1,10116.0,CHEMBL631727,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,,BAO_0000218,,14697,Urine,1,10116.0,CHEMBL631728,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,,BAO_0000218,,14698,Urine,1,10116.0,CHEMBL631729,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,,,BAO_0000218,,14699,Urine,1,10116.0,CHEMBL631730,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,,,BAO_0000218,,14700,Urine,1,10116.0,CHEMBL631731,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,,BAO_0000218,,14701,Urine,1,10116.0,CHEMBL631910,,1088.0,Intermediate,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,,,BAO_0000218,,14702,Hippocampus,1,10116.0,CHEMBL631911,In vivo,10000000.0,Intermediate,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,,,BAO_0000218,,14703,Hypothalamus,1,10116.0,CHEMBL631912,In vivo,1898.0,Intermediate,A,
,15413,Rattus norvegicus,1,,N,50597,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,,,BAO_0000218,,14704,Hypothalamus,1,10116.0,CHEMBL631913,In vivo,1898.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14705,Blood,1,10116.0,CHEMBL631914,In vivo,178.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14706,Blood,1,10116.0,CHEMBL631915,In vivo,178.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,,14707,Blood,1,10116.0,CHEMBL875778,In vivo,178.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14708,Blood,1,10116.0,CHEMBL631916,In vivo,178.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14709,Blood,1,10116.0,CHEMBL631917,In vivo,178.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14710,Blood,1,10116.0,CHEMBL631918,In vivo,178.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14711,Blood,1,10116.0,CHEMBL631919,In vivo,178.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,,14712,Blood,1,10116.0,CHEMBL631920,In vivo,178.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14713,Blood,1,10116.0,CHEMBL631921,In vivo,178.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14714,Blood,1,10116.0,CHEMBL631922,In vivo,178.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,,14715,Blood,1,10116.0,CHEMBL631923,In vivo,178.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14716,,1,10116.0,CHEMBL631924,In vivo,,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14717,,1,10116.0,CHEMBL630234,In vivo,,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,,14718,,1,10116.0,CHEMBL630235,In vivo,,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14719,,1,10116.0,CHEMBL630236,In vivo,,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14720,,1,10116.0,CHEMBL630237,In vivo,,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14721,,1,10116.0,CHEMBL630238,In vivo,,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14722,,1,10116.0,CHEMBL630239,In vivo,,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,,14723,,1,10116.0,CHEMBL630303,In vivo,,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14724,,1,10116.0,CHEMBL630304,In vivo,,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14725,,1,10116.0,CHEMBL630305,In vivo,,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14726,Kidney,1,10116.0,CHEMBL630306,In vivo,2113.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14727,Kidney,1,10116.0,CHEMBL630307,In vivo,2113.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,,14728,Kidney,1,10116.0,CHEMBL630308,In vivo,2113.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14729,Kidney,1,10116.0,CHEMBL630309,In vivo,2113.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14730,Kidney,1,10116.0,CHEMBL629309,In vivo,2113.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14731,Kidney,1,10116.0,CHEMBL629993,In vivo,2113.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14732,Kidney,1,10116.0,CHEMBL629994,In vivo,2113.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,,14733,Kidney,1,10116.0,CHEMBL629995,In vivo,2113.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14734,Kidney,1,10116.0,CHEMBL631993,In vivo,2113.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14735,Kidney,1,10116.0,CHEMBL631994,In vivo,2113.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14736,Kidney,1,10116.0,CHEMBL631995,In vivo,2113.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,,14737,Liver,1,10116.0,CHEMBL631996,In vivo,2107.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14738,Liver,1,10116.0,CHEMBL631997,In vivo,2107.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14739,Liver,1,10116.0,CHEMBL631998,In vivo,2107.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14740,Liver,1,10116.0,CHEMBL631999,In vivo,2107.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,,14741,Liver,1,10116.0,CHEMBL632000,In vivo,2107.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14742,Liver,1,10116.0,CHEMBL632001,In vivo,2107.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14743,Liver,1,10116.0,CHEMBL874424,In vivo,2107.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14744,Liver,1,10116.0,CHEMBL632002,In vivo,2107.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14745,Liver,1,10116.0,CHEMBL632003,In vivo,2107.0,Intermediate,A,
,3133,,1,,U,22224,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,,BAO_0000019,,14746,,0,,CHEMBL632004,,,Autocuration,A,
,2742,,1,,U,22224,,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,,,BAO_0000019,,14747,,0,,CHEMBL632005,,,Autocuration,A,
,2742,,1,,U,22224,,Compound was tested for amidase rate in the presence of N62C screen enzyme,,,BAO_0000019,,14748,,0,,CHEMBL632006,,,Autocuration,A,
,2742,,1,,U,22224,,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,,,BAO_0000019,,14749,,0,,CHEMBL632007,,,Autocuration,A,
,2742,,1,,U,22224,,Compound was tested for amidase rate in the presence of S166C screen enzyme,,,BAO_0000019,,14750,,0,,CHEMBL632008,,,Autocuration,A,
,2742,,1,,U,22224,,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,,,BAO_0000019,,14751,,0,,CHEMBL632009,,,Autocuration,A,
,2742,,1,,U,22224,,Compound was tested for esterase rate in the presence of N62C screen enzyme,,,BAO_0000019,,14752,,0,,CHEMBL632010,,,Autocuration,A,
,2742,,1,,U,22224,,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,,,BAO_0000019,,14753,,0,,CHEMBL857750,,,Autocuration,A,
,2742,,1,,U,22224,,Compound was tested for esterase rate in the presence of S166C screen enzyme,,,BAO_0000019,,14754,,0,,CHEMBL632011,,,Autocuration,A,
,2276,,1,,U,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,BAO_0000019,,14755,,0,,CHEMBL632012,,,Autocuration,A,
,2276,,1,,U,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,BAO_0000019,,14756,,0,,CHEMBL632013,,,Autocuration,A,
,2276,,1,,U,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",,,BAO_0000019,,14757,,0,,CHEMBL632014,,,Autocuration,A,
,2276,,1,,U,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,BAO_0000019,,14758,,0,,CHEMBL629622,,,Autocuration,A,
,2276,,1,,U,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,BAO_0000019,,14759,,0,,CHEMBL629623,,,Autocuration,A,
,2276,,1,,U,22224,,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",,,BAO_0000019,,14760,,0,,CHEMBL629624,,,Autocuration,A,
,17269,,1,,U,22224,,Ratio of Kcat to that of Km was determined,,,BAO_0000019,,14761,,0,,CHEMBL629625,,,Autocuration,A,
,2276,,1,,U,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,,BAO_0000019,,14762,,0,,CHEMBL629626,,,Autocuration,A,
,2276,,1,,U,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,,BAO_0000019,,14763,,0,,CHEMBL629627,,,Autocuration,A,
,15917,,1,,U,22224,,"Compound was evaluated for constant, Kd",,,BAO_0000019,,14764,,0,,CHEMBL629628,,,Autocuration,A,
,10933,,1,,U,22224,,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,,,BAO_0000019,,14765,,0,,CHEMBL629629,,,Autocuration,A,
,10933,,1,,U,22224,,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,,,BAO_0000019,,14766,,0,,CHEMBL629630,,,Autocuration,A,
,14293,,1,,U,22224,,Dissociation Constant of compound determined,,,BAO_0000019,,14767,,0,,CHEMBL856030,,,Autocuration,A,
,6698,,1,,U,22224,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,,,BAO_0000019,,14768,,0,,CHEMBL629631,,,Autocuration,B,
,6698,,1,,U,22224,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,,,BAO_0000019,,14769,,0,,CHEMBL629632,,,Autocuration,B,
,4318,,1,,U,22224,,Dissociation constant of compound with Fructose was determined,,,BAO_0000100,,14770,,0,,CHEMBL629633,,,Autocuration,P,
,4318,,1,,U,22224,,Dissociation constant of compound with Fructose was determined; Not determined,,,BAO_0000100,,14771,,0,,CHEMBL629634,,,Autocuration,P,
,4318,,1,,U,22224,,Dissociation constant of compound with Lactulose was determined,,,BAO_0000100,,14772,,0,,CHEMBL629635,,,Autocuration,P,
,4318,,1,,U,22224,,Dissociation constant of compound with Lactulose was determined; Not determined,,,BAO_0000100,,14773,,0,,CHEMBL629636,,,Autocuration,P,
,14959,,1,,U,22224,,Dissociation constant of the Compound,,,BAO_0000100,,14774,,0,,CHEMBL629637,,,Autocuration,P,
,5913,,1,,U,22224,,Dissociation constant by non-linear regression analysis,,,BAO_0000100,,14775,,0,,CHEMBL629638,,,Autocuration,P,
,14218,,1,,U,22224,,Dissociation constant was determined,,,BAO_0000100,,14776,,0,,CHEMBL629639,,,Autocuration,P,
,10689,,1,,U,22224,,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,,,BAO_0000100,,14777,,0,,CHEMBL629640,,,Autocuration,P,
,13925,,1,,U,22224,,Dissociation constant was determined,,,BAO_0000100,,14778,,0,,CHEMBL629641,,,Autocuration,P,
,16359,,1,,U,22224,,Dissociation constant was determined,,,BAO_0000100,,14779,,0,,CHEMBL631344,,,Autocuration,P,
,10944,Rattus norvegicus,1,,N,50597,,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,,,BAO_0000218,,14780,Muscle tissue,1,10116.0,CHEMBL631345,,2385.0,Intermediate,A,
,11080,,1,,U,22224,,The dissociation constant determined by fluorescence displacement assay,,,BAO_0000019,,14781,,0,,CHEMBL631346,,,Autocuration,A,
,17805,,1,,U,22224,,kd value surface plasmon resonance (SPR) method,,,BAO_0000019,,14782,,0,,CHEMBL631524,,,Autocuration,A,
,10944,Rattus norvegicus,1,,N,50597,,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,,,BAO_0000218,,14783,Muscle tissue,1,10116.0,CHEMBL631525,,2385.0,Intermediate,A,
,16645,,1,,U,22224,,First dissociation constant of the binding of compound to V30M TTR,,,BAO_0000019,,14784,,0,,CHEMBL631526,,,Autocuration,F,
,16645,,1,,U,22224,,Second dissociation constant of the binding of compound to V30M TTR,,,BAO_0000019,,14785,,0,,CHEMBL631527,,,Autocuration,F,
,7793,,1,,U,22224,,"Compound was evaluated for equilibrium constant, Ke",,,BAO_0000019,,14786,,0,,CHEMBL631528,,,Autocuration,A,
,12199,,1,,U,22224,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,,,BAO_0000019,,14787,Hypothalamus,0,,CHEMBL631529,,1898.0,Autocuration,A,
,12199,,1,,U,22224,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,,,BAO_0000019,,14788,Hypothalamus,0,,CHEMBL631530,,1898.0,Autocuration,A,
,9680,,1,,U,22224,,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,,,BAO_0000019,,14789,,0,,CHEMBL631531,,,Autocuration,A,
,9680,,1,,U,22224,,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,,,BAO_0000019,,14790,,0,,CHEMBL631532,,,Autocuration,A,
,9680,,1,,U,22224,,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,,,BAO_0000019,,14791,,0,,CHEMBL631533,,,Autocuration,A,
,13758,Mus musculus,1,,N,50594,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,,BAO_0000218,,14792,,1,10090.0,CHEMBL876552,,,Intermediate,A,
,13758,Mus musculus,1,,N,50594,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,,BAO_0000218,,14793,,1,10090.0,CHEMBL631534,,,Intermediate,A,
,13758,Mus musculus,1,,N,50594,,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,,BAO_0000218,,14794,,1,10090.0,CHEMBL631535,,,Intermediate,A,
,13758,Mus musculus,1,,N,50594,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,,BAO_0000218,,14795,,1,10090.0,CHEMBL631536,,,Intermediate,A,
,13758,Mus musculus,1,,N,50594,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,,,BAO_0000218,,14796,,1,10090.0,CHEMBL631537,,,Intermediate,A,
,13758,Mus musculus,1,,N,50594,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,,BAO_0000218,,14797,,1,10090.0,CHEMBL631538,,,Intermediate,A,
,13758,Mus musculus,1,,N,50594,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,,,BAO_0000218,,14798,,1,10090.0,CHEMBL631539,,,Intermediate,A,
,13758,Mus musculus,1,,N,50594,,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,,BAO_0000218,,14799,,1,10090.0,CHEMBL631540,,,Intermediate,A,
,14393,Rattus norvegicus,1,,N,50597,,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,BAO_0000218,,14800,,1,10116.0,CHEMBL625637,,,Intermediate,A,
,14393,Rattus norvegicus,1,,N,50597,,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,BAO_0000218,,14801,,1,10116.0,CHEMBL625638,,,Intermediate,A,
,15078,Rattus norvegicus,1,,N,50597,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,,14802,,1,10116.0,CHEMBL625639,,,Intermediate,A,
,13925,Rattus norvegicus,1,,N,50597,,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,,14803,Brain,1,10116.0,CHEMBL625640,In vivo,955.0,Intermediate,A,
,13925,Rattus norvegicus,1,,N,50597,,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,,14804,Brain,1,10116.0,CHEMBL625641,In vivo,955.0,Intermediate,A,
,13925,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,,14805,Heart,1,10116.0,CHEMBL625642,In vivo,948.0,Intermediate,A,
,13925,Rattus norvegicus,1,,N,50597,,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,,14806,Heart,1,10116.0,CHEMBL625643,In vivo,948.0,Intermediate,A,
,13925,Rattus norvegicus,1,,N,50597,,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,,14807,Kidney,1,10116.0,CHEMBL625644,In vivo,2113.0,Intermediate,A,
,13925,Rattus norvegicus,1,,N,50597,,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,,14808,Kidney,1,10116.0,CHEMBL625645,In vivo,2113.0,Intermediate,A,
,13925,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,,14809,Liver,1,10116.0,CHEMBL625646,In vivo,2107.0,Intermediate,A,
,13925,Rattus norvegicus,1,,N,50597,,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,,14810,Liver,1,10116.0,CHEMBL625647,In vivo,2107.0,Intermediate,A,
,13925,Rattus norvegicus,1,,N,50597,,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,,14811,Lung,1,10116.0,CHEMBL625648,In vivo,2048.0,Intermediate,A,
,13925,Rattus norvegicus,1,,N,50597,,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,,14812,Lung,1,10116.0,CHEMBL625649,In vivo,2048.0,Intermediate,A,
,13925,Rattus norvegicus,1,,N,50597,,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,,14813,Muscle tissue,1,10116.0,CHEMBL625650,In vivo,2385.0,Intermediate,A,
,13925,Rattus norvegicus,1,,N,50597,,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,,14814,Muscle tissue,1,10116.0,CHEMBL625651,In vivo,2385.0,Intermediate,A,
,13925,Rattus norvegicus,1,,N,50597,,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,,14815,Zone of skin,1,10116.0,CHEMBL625652,In vivo,14.0,Intermediate,A,
,13925,Rattus norvegicus,1,,N,50597,,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,,14816,Zone of skin,1,10116.0,CHEMBL625653,In vivo,14.0,Intermediate,A,
,13925,Rattus norvegicus,1,,N,50597,,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,,14817,Spleen,1,10116.0,CHEMBL625654,In vivo,2106.0,Intermediate,A,
,13925,Rattus norvegicus,1,,N,50597,,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,,14818,Spleen,1,10116.0,CHEMBL625655,In vivo,2106.0,Intermediate,A,
,9712,Rattus norvegicus,1,,N,50597,,Biodistribution of Compound in rat blood after 15 minutes of administration,,,BAO_0000218,,14819,Blood,1,10116.0,CHEMBL625656,In vivo,178.0,Intermediate,A,
,9712,Rattus norvegicus,1,,N,50597,,Biodistribution of Compound in rat blood after 2 minutes of administration,,,BAO_0000218,,14820,Blood,1,10116.0,CHEMBL625657,In vivo,178.0,Intermediate,A,
,9712,Rattus norvegicus,1,,N,50597,,Biodistribution of Compound in rat brain after 15 minutes of administration,,,BAO_0000218,,14821,Brain,1,10116.0,CHEMBL625658,In vivo,955.0,Intermediate,A,
,9712,Rattus norvegicus,1,,N,50597,,Biodistribution of Compound in rat brain after 2 minutes of administration,,,BAO_0000218,,14822,Brain,1,10116.0,CHEMBL625659,In vivo,955.0,Intermediate,A,
,9712,Rattus norvegicus,1,,N,50597,,Biodistribution of Compound in rat heart after 15 minutes of administration,,,BAO_0000218,,14823,Heart,1,10116.0,CHEMBL625660,In vivo,948.0,Intermediate,A,
,9712,Rattus norvegicus,1,,N,50597,,Biodistribution of Compound in rat heart after 2 minutes of administration,,,BAO_0000218,,14824,Heart,1,10116.0,CHEMBL625661,In vivo,948.0,Intermediate,A,
,9712,Rattus norvegicus,1,,N,50597,,Biodistribution of Compound in rat liver after 15 minutes of administration,,,BAO_0000218,,14825,Liver,1,10116.0,CHEMBL625662,In vivo,2107.0,Intermediate,A,
,9712,Rattus norvegicus,1,,N,50597,,Biodistribution of Compound in rat liver after 2 minutes of administration,,,BAO_0000218,,14826,Liver,1,10116.0,CHEMBL625663,In vivo,2107.0,Intermediate,A,
,9712,Rattus norvegicus,1,,N,50597,,Biodistribution of Compound in rat lung after 15 minutes of administration,,,BAO_0000218,,14827,Lung,1,10116.0,CHEMBL875621,In vivo,2048.0,Intermediate,A,
,9712,Rattus norvegicus,1,,N,50597,,Biodistribution of Compound in rat lung after 2 minutes of administration,,,BAO_0000218,,14828,Lung,1,10116.0,CHEMBL628382,In vivo,2048.0,Intermediate,A,
,9712,Rattus norvegicus,1,,N,50597,,Biodistribution of Compound in rat muscle after 15 minutes of administration,,,BAO_0000218,,14829,Muscle tissue,1,10116.0,CHEMBL628383,In vivo,2385.0,Intermediate,A,
,9712,Rattus norvegicus,1,,N,50597,,Biodistribution of Compound in rat muscle after 2 minutes of administration,,,BAO_0000218,,14830,Muscle tissue,1,10116.0,CHEMBL628384,In vivo,2385.0,Intermediate,A,
,13925,Rattus norvegicus,1,,N,50597,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,,,BAO_0000218,,14831,,1,10116.0,CHEMBL628385,,,Intermediate,A,
,13925,Rattus norvegicus,1,,N,50597,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,,,BAO_0000218,,14832,,1,10116.0,CHEMBL875753,,,Intermediate,A,
,13925,Rattus norvegicus,1,,N,50597,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,,,BAO_0000218,,14833,,1,10116.0,CHEMBL628386,,,Intermediate,A,
,6941,Rattus norvegicus,1,,N,50597,,Organ distribution in rat blood 2 minutes after intravenous injection,,,BAO_0000218,,14834,,1,10116.0,CHEMBL628387,,,Intermediate,A,
,6941,Rattus norvegicus,1,,N,50597,,Organ distribution in rat blood 2 hr after intravenous injection,,,BAO_0000218,,14835,,1,10116.0,CHEMBL628388,,,Intermediate,A,
,6941,Rattus norvegicus,1,,N,50597,,Organ distribution in rat blood 30 minutes after intravenous injection,,,BAO_0000218,,14836,,1,10116.0,CHEMBL628389,,,Intermediate,A,
,6941,Rattus norvegicus,1,,N,50597,,Organ distribution in rat blood 30 min after intravenous injection,,,BAO_0000218,,14837,,1,10116.0,CHEMBL632756,,,Intermediate,A,
,6941,Rattus norvegicus,1,,N,50597,,Organ distribution in rat brain 2 minutes after intravenous injection,,,BAO_0000218,,14838,,1,10116.0,CHEMBL628390,,,Intermediate,A,
,6941,Rattus norvegicus,1,,N,50597,,Organ distribution in rat brain 2 hr after intravenous injection,,,BAO_0000218,,14839,,1,10116.0,CHEMBL631811,,,Intermediate,A,
,6941,Rattus norvegicus,1,,N,50597,,Organ distribution in rat brain 30 minutes after intravenous injection,,,BAO_0000218,,14840,,1,10116.0,CHEMBL631812,,,Intermediate,A,
,6941,Rattus norvegicus,1,,N,50597,,Organ distribution in rat heart 2 minutes after intravenous injection,,,BAO_0000218,,14841,,1,10116.0,CHEMBL631813,,,Intermediate,A,
,6941,Rattus norvegicus,1,,N,50597,,Organ distribution in rat heart 2 hr after intravenous injection,,,BAO_0000218,,14842,,1,10116.0,CHEMBL631814,,,Intermediate,A,
,6941,Rattus norvegicus,1,,N,50597,,Organ distribution in rat heart 30 minutes after intravenous injection,,,BAO_0000218,,14843,,1,10116.0,CHEMBL631815,,,Intermediate,A,
,6941,Rattus norvegicus,1,,N,50597,,Organ distribution in rat kidney 2 minutes after intravenous injection,,,BAO_0000218,,14844,,1,10116.0,CHEMBL631816,,,Intermediate,A,
,6941,Rattus norvegicus,1,,N,50597,,Organ distribution in rat kidney 2 hr after intravenous injection,,,BAO_0000218,,14845,,1,10116.0,CHEMBL875758,,,Intermediate,A,
,6941,Rattus norvegicus,1,,N,50597,,Organ distribution in rat kidney 30 minutes after intravenous injection,,,BAO_0000218,,14846,,1,10116.0,CHEMBL631817,,,Intermediate,A,
,6941,Rattus norvegicus,1,,N,50597,,Organ distribution in rat liver 2 minutes after intravenous injection,,,BAO_0000218,,14847,Liver,1,10116.0,CHEMBL631818,,2107.0,Intermediate,A,
,6941,Rattus norvegicus,1,,N,50597,,Organ distribution in rat liver 2 hr after intravenous injection,,,BAO_0000218,,14848,Liver,1,10116.0,CHEMBL631819,,2107.0,Intermediate,A,
,6941,Rattus norvegicus,1,,N,50597,,Organ distribution in rat liver 30 minutes after intravenous injection,,,BAO_0000218,,14849,Liver,1,10116.0,CHEMBL631820,,2107.0,Intermediate,A,
,6941,Rattus norvegicus,1,,N,50597,,Organ distribution in rat lung 2 minutes after intravenous injection,,,BAO_0000218,,14850,,1,10116.0,CHEMBL631821,,,Intermediate,A,
,6941,Rattus norvegicus,1,,N,50597,,Organ distribution in rat lung 2 hr after intravenous injection,,,BAO_0000218,,14851,,1,10116.0,CHEMBL631822,,,Intermediate,A,
,6941,Rattus norvegicus,1,,N,50597,,Organ distribution in rat lung 30 minutes after intravenous injection,,,BAO_0000218,,14852,,1,10116.0,CHEMBL631823,,,Intermediate,A,
,6941,Rattus norvegicus,1,,N,50597,,Organ distribution in rat muscle 2 minutes after intravenous injection,,,BAO_0000218,,14853,Muscle tissue,1,10116.0,CHEMBL631824,,2385.0,Intermediate,A,
,6941,Rattus norvegicus,1,,N,50597,,Organ distribution in rat muscle 2 hr after intravenous injection,,,BAO_0000218,,14854,Muscle tissue,1,10116.0,CHEMBL631825,,2385.0,Intermediate,A,
,6941,Rattus norvegicus,1,,N,50597,,Organ distribution in rat muscle 30 minutes after intravenous injection,,,BAO_0000218,,14855,Muscle tissue,1,10116.0,CHEMBL631826,,2385.0,Intermediate,A,
,14439,Mus musculus,1,,N,50594,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),,,BAO_0000218,,14856,,1,10090.0,CHEMBL631827,In vivo,,Intermediate,A,
,14439,Mus musculus,1,,N,50594,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),,,BAO_0000218,,14857,,1,10090.0,CHEMBL631828,In vivo,,Intermediate,A,
,14439,Mus musculus,1,,N,50594,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),,,BAO_0000218,,14858,,1,10090.0,CHEMBL631829,In vivo,,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,,BAO_0000218,,14859,Urine,1,10116.0,CHEMBL875759,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,,,BAO_0000218,,14860,Urine,1,10116.0,CHEMBL631830,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,,,BAO_0000218,,14861,Urine,1,10116.0,CHEMBL631831,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,,BAO_0000218,,14862,Urine,1,10116.0,CHEMBL631832,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,,,BAO_0000218,,14863,Urine,1,10116.0,CHEMBL631833,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,,BAO_0000218,,14864,Urine,1,10116.0,CHEMBL631834,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,,,BAO_0000218,,14865,Urine,1,10116.0,CHEMBL631835,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,,BAO_0000218,,14866,Urine,1,10116.0,CHEMBL631836,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,,BAO_0000218,,14867,Urine,1,10116.0,CHEMBL631837,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,,BAO_0000218,,14868,Urine,1,10116.0,CHEMBL631838,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,,,BAO_0000218,,14869,Urine,1,10116.0,CHEMBL631839,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,,,BAO_0000218,,14870,Urine,1,10116.0,CHEMBL631840,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,,BAO_0000218,,14871,Urine,1,10116.0,CHEMBL631841,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,,BAO_0000218,,14872,Urine,1,10116.0,CHEMBL631842,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,,BAO_0000218,,14873,Urine,1,10116.0,CHEMBL631843,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,,BAO_0000218,,14874,Urine,1,10116.0,CHEMBL631844,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,,BAO_0000218,,14875,Urine,1,10116.0,CHEMBL631845,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,,BAO_0000218,,14876,Urine,1,10116.0,CHEMBL631846,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,,BAO_0000218,,14877,Urine,1,10116.0,CHEMBL875760,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,,BAO_0000218,,14878,Urine,1,10116.0,CHEMBL632199,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,,BAO_0000218,,14879,Urine,1,10116.0,CHEMBL631847,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,,BAO_0000218,,14880,Urine,1,10116.0,CHEMBL631848,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,,BAO_0000218,,14881,Urine,1,10116.0,CHEMBL628707,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,,BAO_0000218,,14882,Urine,1,10116.0,CHEMBL628708,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,,BAO_0000218,,14883,Urine,1,10116.0,CHEMBL628709,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,,BAO_0000218,,14884,Urine,1,10116.0,CHEMBL628710,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,,BAO_0000218,,14885,Urine,1,10116.0,CHEMBL628711,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,,BAO_0000218,,14886,Urine,1,10116.0,CHEMBL628712,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,,BAO_0000218,,14887,Urine,1,10116.0,CHEMBL628713,,1088.0,Intermediate,A,
,12582,Rattus norvegicus,1,,N,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,,BAO_0000218,,14888,Urine,1,10116.0,CHEMBL628714,,1088.0,Intermediate,A,
,7415,Rattus norvegicus,1,,N,50597,,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",,,BAO_0000218,,14889,,1,10116.0,CHEMBL628715,,,Intermediate,A,
,7313,,1,,U,22224,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,,,BAO_0000019,,14890,,0,,CHEMBL629179,,,Autocuration,A,
,7313,,1,,U,22224,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,,,BAO_0000019,,14891,,0,,CHEMBL629180,,,Autocuration,A,
,7313,,1,,U,22224,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,,,BAO_0000019,,14892,,0,,CHEMBL875108,,,Autocuration,A,
,7570,,1,,U,22224,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,,BAO_0000019,,14893,Adrenal cortex,0,,CHEMBL629181,,1235.0,Autocuration,A,
,7570,,1,,U,22224,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,,BAO_0000019,,14894,Adrenal cortex,0,,CHEMBL629182,,1235.0,Autocuration,A,
,7570,,1,,U,22224,,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,,,BAO_0000019,,14895,,0,,CHEMBL629183,,,Autocuration,A,
,7570,,1,,U,22224,,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,,,BAO_0000019,,14896,,0,,CHEMBL629184,,,Autocuration,A,
,7570,,1,,U,22224,,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,,BAO_0000019,,14897,Adrenal cortex,0,,CHEMBL629185,,1235.0,Autocuration,A,
,7570,,1,,U,22224,,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,,,BAO_0000019,,14898,Adrenal cortex,0,,CHEMBL629186,,1235.0,Autocuration,A,
,7570,,1,,U,22224,,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,,,BAO_0000019,,14899,,0,,CHEMBL629187,,,Autocuration,A,
,7570,,1,,U,22224,,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,,,BAO_0000019,,14900,,0,,CHEMBL629887,,,Autocuration,A,
,7570,,1,,U,22224,,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,,,BAO_0000019,,14901,,0,,CHEMBL629888,,,Autocuration,A,
,7570,,1,,U,22224,,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,,,BAO_0000019,,14902,,0,,CHEMBL629889,,,Autocuration,A,
,7570,,1,,U,22224,,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,,,BAO_0000019,,14903,Adrenal cortex,0,,CHEMBL629890,,1235.0,Autocuration,A,
,7570,,1,,U,22224,,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,,,BAO_0000019,,14904,,0,,CHEMBL629891,,,Autocuration,A,
,7570,,1,,U,22224,,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,,,BAO_0000019,,14905,,0,,CHEMBL629892,,,Autocuration,A,
,7570,,1,,U,22224,,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,,BAO_0000019,,14906,Adrenal cortex,0,,CHEMBL629893,,1235.0,Autocuration,A,
,7570,,1,,U,22224,,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,,,BAO_0000019,,14907,,0,,CHEMBL629894,,,Autocuration,A,
,7570,,1,,U,22224,,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,,,BAO_0000019,,14908,,0,,CHEMBL629895,,,Autocuration,A,
,14122,Canis lupus familiaris,1,,U,22224,,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",,,BAO_0000218,,14909,,0,9615.0,CHEMBL875109,In vivo,,Autocuration,A,
,16449,Macaca fascicularis,1,,U,22224,,Absolute bioavailability in male cynomolgus monkeys,,,BAO_0000218,,14910,,0,9541.0,CHEMBL629896,In vivo,,Autocuration,A,
,16449,Rattus norvegicus,1,,U,22224,,Absolute bioavailability in maleSprague-Dawley rats,,,BAO_0000218,,14911,,0,10116.0,CHEMBL629897,In vivo,,Autocuration,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,,14912,Liver,1,10116.0,CHEMBL629898,In vivo,2107.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14913,Liver,1,10116.0,CHEMBL630057,In vivo,2107.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14914,Liver,1,10116.0,CHEMBL630058,In vivo,2107.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14915,Lung,1,10116.0,CHEMBL630059,In vivo,2048.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14916,Lung,1,10116.0,CHEMBL630060,In vivo,2048.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,,14917,Lung,1,10116.0,CHEMBL630061,In vivo,2048.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14918,Lung,1,10116.0,CHEMBL630062,In vivo,2048.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14919,Lung,1,10116.0,CHEMBL630063,In vivo,2048.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14920,Lung,1,10116.0,CHEMBL630064,In vivo,2048.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14921,Lung,1,10116.0,CHEMBL630065,In vivo,2048.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,,14922,Lung,1,10116.0,CHEMBL630066,In vivo,2048.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14923,Lung,1,10116.0,CHEMBL630067,In vivo,2048.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14924,Lung,1,10116.0,CHEMBL630068,In vivo,2048.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14925,Muscle tissue,1,10116.0,CHEMBL631113,In vivo,2385.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14926,Muscle tissue,1,10116.0,CHEMBL631114,In vivo,2385.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,,14927,Muscle tissue,1,10116.0,CHEMBL631115,In vivo,2385.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14928,Muscle tissue,1,10116.0,CHEMBL631116,In vivo,2385.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14929,Muscle tissue,1,10116.0,CHEMBL630528,In vivo,2385.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14930,Muscle tissue,1,10116.0,CHEMBL630529,In vivo,2385.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14931,Muscle tissue,1,10116.0,CHEMBL630530,In vivo,2385.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,,14932,Muscle tissue,1,10116.0,CHEMBL630531,In vivo,2385.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14933,Muscle tissue,1,10116.0,CHEMBL630532,In vivo,2385.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14934,Muscle tissue,1,10116.0,CHEMBL630533,In vivo,2385.0,Intermediate,A,
,15045,Mus musculus,1,,N,50594,,Biodistribution in normal mice blood after 120 hr,,,BAO_0000218,,14935,Blood,1,10090.0,CHEMBL630534,In vivo,178.0,Intermediate,A,
,15045,Mus musculus,1,,N,50594,,Biodistribution in normal mice blood after 24 hr,,,BAO_0000218,,14936,Blood,1,10090.0,CHEMBL630535,In vivo,178.0,Intermediate,A,
,15045,Mus musculus,1,,N,50594,,Biodistribution in normal mice blood after 4 hr,,,BAO_0000218,,14937,Blood,1,10090.0,CHEMBL630536,In vivo,178.0,Intermediate,A,
,15045,Mus musculus,1,,N,50594,,Biodistribution in normal mice bone after 120 hr,,,BAO_0000218,,14938,Bone,1,10090.0,CHEMBL630537,In vivo,10000001.0,Intermediate,A,
,15045,Mus musculus,1,,N,50594,,Biodistribution in normal mice bone after 24 hr,,,BAO_0000218,,14939,Bone,1,10090.0,CHEMBL630538,In vivo,10000001.0,Intermediate,A,
,15045,Mus musculus,1,,N,50594,,Biodistribution in normal mice bone after 4 hr,,,BAO_0000218,,14940,Bone,1,10090.0,CHEMBL630539,In vivo,10000001.0,Intermediate,A,
,15045,Mus musculus,1,,N,50594,,Biodistribution in normal mice heart after 120 hr,,,BAO_0000218,,14941,Heart,1,10090.0,CHEMBL630540,In vivo,948.0,Intermediate,A,
,15045,Mus musculus,1,,N,50594,,Biodistribution in normal mice heart after 24 hr,,,BAO_0000218,,14942,Heart,1,10090.0,CHEMBL630541,In vivo,948.0,Intermediate,A,
,15045,Mus musculus,1,,N,50594,,Biodistribution in normal mice heart after 4 hr,,,BAO_0000218,,14943,Heart,1,10090.0,CHEMBL630542,In vivo,948.0,Intermediate,A,
,15045,Mus musculus,1,,N,50594,,Biodistribution in normal mice kidney after 120 hr,,,BAO_0000218,,14944,Kidney,1,10090.0,CHEMBL630543,In vivo,2113.0,Intermediate,A,
,15045,Mus musculus,1,,N,50594,,Biodistribution in normal mice kidney after 24 hr,,,BAO_0000218,,14945,Kidney,1,10090.0,CHEMBL630544,In vivo,2113.0,Intermediate,A,
,15045,Mus musculus,1,,N,50594,,Biodistribution in normal mice kidney after 4 hr,,,BAO_0000218,,14946,Kidney,1,10090.0,CHEMBL630545,In vivo,2113.0,Intermediate,A,
,15045,Mus musculus,1,,N,50594,,Biodistribution in normal mice liver after 120 hr,,,BAO_0000218,,14947,Liver,1,10090.0,CHEMBL630546,In vivo,2107.0,Intermediate,A,
,15045,Mus musculus,1,,N,50594,,Biodistribution in normal mice liver after 24 hr,,,BAO_0000218,,14948,Liver,1,10090.0,CHEMBL630547,In vivo,2107.0,Intermediate,A,
,15045,Mus musculus,1,,N,50594,,Biodistribution in normal mice liver after 4 hr,,,BAO_0000218,,14949,Liver,1,10090.0,CHEMBL630548,In vivo,2107.0,Intermediate,A,
,15045,Mus musculus,1,,N,50594,,Biodistribution in normal mice spleen after 120 hr,,,BAO_0000218,,14950,Spleen,1,10090.0,CHEMBL630549,In vivo,2106.0,Intermediate,A,
,15045,Mus musculus,1,,N,50594,,Biodistribution in normal mice spleen after 24 hr,,,BAO_0000218,,14951,Spleen,1,10090.0,CHEMBL630550,In vivo,2106.0,Intermediate,A,
,15045,Mus musculus,1,,N,50594,,Biodistribution in normal mice spleen after 4 hr,,,BAO_0000218,,14952,Spleen,1,10090.0,CHEMBL876426,In vivo,2106.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14953,Spleen,1,10116.0,CHEMBL630551,In vivo,2106.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14954,Spleen,1,10116.0,CHEMBL630552,In vivo,2106.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,,14955,Spleen,1,10116.0,CHEMBL630553,In vivo,2106.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14956,Spleen,1,10116.0,CHEMBL630554,In vivo,2106.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14957,Spleen,1,10116.0,CHEMBL630555,In vivo,2106.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14958,Spleen,1,10116.0,CHEMBL630556,In vivo,2106.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14959,Spleen,1,10116.0,CHEMBL630557,In vivo,2106.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,,14960,Spleen,1,10116.0,CHEMBL630558,In vivo,2106.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14961,Spleen,1,10116.0,CHEMBL630559,In vivo,2106.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14962,Spleen,1,10116.0,CHEMBL630560,In vivo,2106.0,Intermediate,A,
,12017,Rattus norvegicus,1,,N,50597,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,,14963,Thyroid gland,1,10116.0,CHEMBL876427,In vivo,2046.0,Intermediate,A,
,14941,Rattus norvegicus,1,,N,50597,,The Kel values in female wistar rats.,,,BAO_0000218,,14964,,1,10116.0,CHEMBL630561,,,Intermediate,A,
,4646,,1,,U,22224,,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,,,BAO_0000019,,14965,,0,,CHEMBL630562,,,Autocuration,A,
,8847,,1,,U,22224,,Hydrolysis rate constant of the compound,,,BAO_0000019,,14966,,0,,CHEMBL630563,,,Autocuration,A,
,11778,,1,,U,22229,,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,,,BAO_0000100,,14967,,0,,CHEMBL629673,,,Autocuration,P,
,2363,,1,,U,22224,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",,,BAO_0000019,,14968,,0,,CHEMBL629674,,,Autocuration,A,
,2363,,1,,U,22224,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",,,BAO_0000019,,14969,,0,,CHEMBL629675,,,Autocuration,A,
,2363,,1,,U,22224,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",,,BAO_0000019,,14970,,0,,CHEMBL629676,,,Autocuration,A,
,2363,,1,,U,22224,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",,,BAO_0000019,,14971,,0,,CHEMBL629677,,,Autocuration,A,
,8371,,1,,U,22224,,Apparent inactivation rate constant was evaluated,,,BAO_0000019,,14972,,0,,CHEMBL629678,,,Autocuration,A,
,14883,,1,,U,22224,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,,,BAO_0000019,,14973,,0,,CHEMBL629679,,,Autocuration,A,
,14883,,1,,U,22224,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,,,BAO_0000019,,14974,,0,,CHEMBL629680,,,Autocuration,A,
,4643,,1,,U,22224,,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,,,BAO_0000019,,14975,,0,,CHEMBL629681,,,Autocuration,A,
,3519,,1,,U,22224,,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,,,BAO_0000019,,14976,,0,,CHEMBL629682,,,Autocuration,A,
,10600,,1,,U,22224,,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,,,BAO_0000019,,14977,,0,,CHEMBL629683,,,Autocuration,A,
,8501,,1,,U,22224,,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,,,BAO_0000019,,14978,,0,,CHEMBL629684,,,Autocuration,F,
,8505,,1,,U,22224,,Dissociation constant was determined,,,BAO_0000100,,14979,,0,,CHEMBL629685,,,Autocuration,P,
,9778,,1,,U,22224,,Dissociation constant was determined,,,BAO_0000100,,14980,,0,,CHEMBL629686,,,Autocuration,P,
,9778,,1,,U,22224,,Dissociation constant at pH 7.4,,,BAO_0000100,,14981,,0,,CHEMBL872932,,,Autocuration,P,
,9778,,1,,U,22224,,Dissociation constant in presence of 1 mM dithiothreitol,,,BAO_0000100,,14982,,0,,CHEMBL629687,,,Autocuration,P,
,13007,,1,,U,22224,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,,BAO_0000019,,14983,,0,,CHEMBL872931,,,Autocuration,A,
,13007,,1,,U,22224,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,,BAO_0000019,,14984,,0,,CHEMBL628151,,,Autocuration,A,
,13007,,1,,U,22224,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,,BAO_0000019,,14985,,0,,CHEMBL628152,,,Autocuration,A,
,13007,,1,,U,22224,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,,BAO_0000019,,14986,,0,,CHEMBL628153,,,Autocuration,A,
,11482,,1,,U,22224,,Kinetic constant for aromatization of androstenedione,,,BAO_0000019,,14987,,0,,CHEMBL628154,,,Autocuration,A,
,11482,,1,,U,22224,,Kinetic constant for aromatization of testosterone,,,BAO_0000019,,14988,,0,,CHEMBL628155,,,Autocuration,A,
,2303,,1,,U,22224,,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,,,BAO_0000019,,14989,,0,,CHEMBL628156,,,Autocuration,A,
,11964,,1,,U,22224,,Local inhibition constant was determined,,,BAO_0000019,,14990,,0,,CHEMBL628157,,,Autocuration,A,
,3140,Saccharomyces cerevisiae,1,,N,50347,,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,,,BAO_0000218,,14991,,1,4932.0,CHEMBL857533,,,Intermediate,A,
,10650,,1,,U,22224,,Dissociation constant value of the compound,,,BAO_0000100,,14992,,0,,CHEMBL628158,,,Autocuration,P,
,4667,,1,,U,22224,,In vitro permeability through cornea without epithelium,,,BAO_0000019,,14993,Cornea,0,,CHEMBL628159,,964.0,Autocuration,A,
,4667,,1,,U,22224,,In vitro permeability through intact cornea,,,BAO_0000019,,14994,Cornea,0,,CHEMBL875616,,964.0,Autocuration,A,
,9199,Oryctolagus cuniculus,1,,N,50592,,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,,,BAO_0000218,,14995,Cornea,1,9986.0,CHEMBL628160,,964.0,Intermediate,A,
,11966,,1,,U,22224,,Rate of enzyme inactivation for the compound was determined,,,BAO_0000019,,14996,,0,,CHEMBL628161,,,Autocuration,A,
,4667,,1,,U,22224,,In vitro permeability through cornea without epithelium,,,BAO_0000019,,14997,Cornea,0,,CHEMBL628162,,964.0,Autocuration,A,
,4667,,1,,U,22224,,In vitro permeability through intact cornea,,,BAO_0000019,,14998,Cornea,0,,CHEMBL628163,,964.0,Autocuration,A,
,8354,,1,,U,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,,14999,,0,,CHEMBL628164,,,Autocuration,A,
,8354,,1,,U,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,,15000,,0,,CHEMBL628165,,,Autocuration,A,
,8354,,1,,U,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,,15001,,0,,CHEMBL628166,,,Autocuration,A,
,8354,,1,,U,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,,15002,,0,,CHEMBL628167,,,Autocuration,A,
,8354,,1,,U,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,,15003,,0,,CHEMBL628168,,,Autocuration,A,
,8354,,1,,U,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,,15004,,0,,CHEMBL628169,,,Autocuration,A,
,8354,,1,,U,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,,15005,,0,,CHEMBL628170,,,Autocuration,A,
,8354,,1,,U,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,,15006,,0,,CHEMBL628171,,,Autocuration,A,
,8354,,1,,U,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,,15007,,0,,CHEMBL627434,,,Autocuration,A,
,8354,,1,,U,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,,15008,,0,,CHEMBL627435,,,Autocuration,A,
,8354,,1,,U,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,,15009,,0,,CHEMBL628110,,,Autocuration,A,
,8354,,1,,U,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,,15010,,0,,CHEMBL628111,,,Autocuration,A,
,8354,,1,,U,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,,15011,,0,,CHEMBL628112,,,Autocuration,A,
,8354,,1,,U,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,,15012,,0,,CHEMBL628260,,,Autocuration,A,
,8354,,1,,U,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,,15013,,0,,CHEMBL628261,,,Autocuration,A,
,14439,Mus musculus,1,,N,50594,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),,,BAO_0000218,,15014,,1,10090.0,CHEMBL628262,In vivo,,Intermediate,A,
,14439,Homo sapiens,1,,N,50587,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,,,BAO_0000218,,15015,,1,9606.0,CHEMBL628263,In vivo,,Intermediate,A,
,14439,Mus musculus,1,,N,50594,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),,,BAO_0000218,,15016,,1,10090.0,CHEMBL628264,In vivo,,Intermediate,A,
,14439,Mus musculus,1,,N,50594,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),,,BAO_0000218,,15017,,1,10090.0,CHEMBL628265,In vivo,,Intermediate,A,
,14439,Mus musculus,1,,N,50594,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),,,BAO_0000218,,15018,,1,10090.0,CHEMBL628266,In vivo,,Intermediate,A,
,14439,Mus musculus,1,,N,50594,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),,,BAO_0000218,,15019,,1,10090.0,CHEMBL628267,In vivo,,Intermediate,A,
,14439,Mus musculus,1,,N,50594,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,,,BAO_0000218,,15020,,1,10090.0,CHEMBL628268,In vivo,,Intermediate,A,
,14439,Mus musculus,1,,N,50594,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),,,BAO_0000218,,15021,,1,10090.0,CHEMBL628269,In vivo,,Intermediate,A,
,14439,Mus musculus,1,,N,50594,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),,,BAO_0000218,,15022,,1,10090.0,CHEMBL628270,In vivo,,Intermediate,A,
,14439,Mus musculus,1,,N,50594,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),,,BAO_0000218,,15023,,1,10090.0,CHEMBL628271,In vivo,,Intermediate,A,
,14439,Mus musculus,1,,N,50594,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),,,BAO_0000218,,15024,,1,10090.0,CHEMBL628272,In vivo,,Intermediate,A,
